Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),0.7871213569744439,2.592563805469111,0.0,0.0,0.0,61/87,12.18%,RPS29;RPS23;RPL17;RPL23;RPS12;RPS16;RPS3;RPS27A;RPL39;RPS18;RPS21;RPL23A;RPS15;RPL37;RPLP1;RPL26;RPS10;RPS20;RPS13;RPLP2;RPSA;RPL41;RPS28;RPL13;RPS24;RPL24;RPL12;RPL36A;RPS8;RPL18A;RPL37A;RPS11;RPL28;RPL30;RPL8;RPL35A;RPS4X;RPS15A;RPL38;RPS17;RPLP0;RPL5;RPL36;RPL14;RPS14;RPL9;RPS9;RPS5;RPS7;RPL34;RPL27;RPL6;ZFAND2B;SRP68;RPS6;SEC63;RPL4;RPL22;RPL15;RPL10;RPL32
prerank,cotranslational protein targeting to membrane (GO:0006613),0.768490748236303,2.5547549640952956,0.0,0.0,0.0,60/91,12.18%,RPS29;RPS23;RPL17;RPL23;RPS12;RPS16;RPS3;RPS27A;RPL39;RPS18;RPS21;RPL23A;RPS15;RPL37;RPLP1;RPL26;RPS10;RPS20;RPS13;RPLP2;RPSA;RPL41;RPS28;RPL13;RPS24;RPL24;RPL12;RPL36A;RPS8;RPL18A;RPL37A;RPS11;RPL28;RPL30;RPL8;RPL35A;RPS4X;RPS15A;RPL38;RPS17;RPLP0;RPL5;RPL36;RPL14;RPS14;RPL9;RPS9;RPS5;RPS7;RPL34;RPL27;RPL6;SRP68;RPS6;SEC63;RPL4;RPL22;RPL15;RPL10;RPL32
prerank,cytoplasmic translation (GO:0002181),0.7571636090998374,2.5205063920912734,0.0,0.0,0.0,61/91,12.67%,RPS29;RPS23;RPL17;RPL23;RPS12;RPS16;RPS3;RPS27A;RPL39;RPS18;RPS21;RPL23A;RPS15;RPL37;RPLP1;RPL26;RPS10;RPS20;RPS13;RPSA;RPL41;RPS28;RPL13;EIF3M;RPS24;RPL24;RPL12;RPL36A;RPS8;RPL18A;RPL37A;RPS11;RPL28;RPL30;RPL8;RPL35A;RPS4X;RPS15A;RPL38;RPS17;RPLP0;RPL5;RPL36;RPL14;RPS14;RPL9;RPS9;RPS5;RPS7;RPL34;RPL27;RPL6;RPL22L1;RPS6;RPL4;EIF3I;RPL22;RPL15;RPL10;RPL32;ETF1
prerank,protein targeting to ER (GO:0045047),0.7382118837880375,2.486585225326758,0.0,0.0,0.0,62/99,12.18%,RPS29;RPS23;RPL17;RPL23;RPS12;RPS16;RPS3;RPS27A;RPL39;RPS18;RPS21;RPL23A;RPS15;RPL37;RPLP1;RPL26;RPS10;RPS20;RPS13;RPLP2;RPSA;RPL41;RPS28;RPL13;RPS24;RPL24;RPL12;RPL36A;RPS8;RPL18A;RPL37A;RPS11;RPL28;RPL30;RPL8;RPL35A;RPS4X;RPS15A;RPL38;RPS17;RPLP0;RPL5;RPL36;RPL14;RPS14;RPL9;RPS9;RPS5;RPS7;RPL34;RPL27;RPL6;ZFAND2B;SRP68;RPS6;SEC63;SRPRB;RPL4;RPL22;RPL15;RPL10;RPL32
prerank,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",0.7119912382812179,2.4514942412352294,0.0,0.0,0.0,68/110,14.84%,DHX34;RPS29;RPS23;RPL17;RPL23;RPS12;RPS16;RPS3;RPS27A;EIF3E;RPL39;RPS18;RPS21;RPL23A;RPS15;RPL37;RPLP1;RPL26;RPS10;RPS20;RPS13;RPLP2;RPSA;RPL41;RPS28;RPL13;RPS24;RPL24;RPL12;RPL36A;RPS8;RPL18A;SMG6;RPL37A;RPS11;RPL28;RPL30;RPL8;RPL35A;RPS4X;RPS15A;RPL38;RPS17;RPLP0;RPL5;RPL36;RPL14;DCP1A;RPS14;RPL9;RPS9;RPS5;RPS7;RPL34;RPL27;PPP2CA;RPL6;RPS6;RPL4;RPL22;RPL15;RPL10;RPL32;ETF1;MAGOHB;RPL19;RPL31;RPL11
prerank,regulation of humoral immune response (GO:0002920),0.7877443980643839,2.3519072979384053,0.0,0.0,0.0,14/44,6.82%,C4B;FCGR2B;CFH;CFP;C1QC;C1QA;C5AR1;C3AR1;C6;C2;CD46;C1QB;CFHR2;CR2
prerank,regulation of immune effector process (GO:0002697),0.8002659999118621,2.3474841195386165,0.0,0.0,0.0,15/41,6.82%,C4B;FCGR2B;CFH;CFP;C1QC;IRF4;C1QA;C5AR1;C3AR1;C6;C2;CD46;C1QB;CFHR2;CR2
prerank,regulation of complement activation (GO:0030449),0.7723009821684365,2.2221199137557237,0.0,0.00040217528033935097,0.003,13/40,6.82%,C4B;CFH;CFP;C1QC;C1QA;C5AR1;C3AR1;C6;C2;CD46;C1QB;CFHR2;CR2
prerank,receptor-mediated endocytosis (GO:0006898),0.6495914333785465,2.2118472409321446,0.0,0.0003574891380794231,0.003,30/132,6.71%,MRC1;CD163;DAB2;STAB1;MSR1;AP2A2;FCGR2B;LRP6;APOE;COLEC12;SNX9;FCHO2;LDLR;EPS15;RAB31;CLTC;ITGB1;FCHSD2;CALCRL;ADRB2;FCER1G;LILRB1;CD36;SCARF1;ADM;INSR;PIKFYVE;AP2S1;SYK;LMBRD1
prerank,nuclear-transcribed mRNA catabolic process (GO:0000956),0.6108490225818666,2.194191461324584,0.0,0.0007507271899667886,0.007,98/168,19.82%,DHX34;RPS29;RPS23;RPL17;RPL23;RPS12;RPS16;RPS3;RPS27A;EIF3E;RPL39;RPS18;RPS21;RPL23A;RPS15;RPL37;RPLP1;SAMD4A;RPL26;TUT7;ZFP36L1;RPS10;RPS20;RPS13;RPLP2;RPSA;RPL41;RPS28;RPL13;RPS24;RPL24;RPL12;RPL36A;RPS8;RPL18A;SMG6;RC3H1;RPL37A;RPS11;RPL28;TENT2;RPL30;RPL8;RPL35A;RPS4X;RPS15A;RPL38;RPS17;RPLP0;RPL5;RPL36;RPL14;DCP1A;RPS14;RPL9;TUT4;RPS9;RPS5;RPS7;RPL34;RPL27;PPP2CA;RPL6;RPS6;RPL4;DCP2;RPL22;RPL15;RPL10;RPL32;ZC3H12A;EXOSC8;DIS3L2;ETF1;MAGOHB;RPL19;POLR2D;RPL31;CNOT9;RPL11;PPP2R2A;TUT1;CNOT11;RPL35;CSDE1;CNOT6L;PYM1;NBDY;RPL7;CNOT4;NBAS;DXO;THRAP3;GSPT1;RPL21;CNOT1;CNOT8;SMG8
prerank,peptide biosynthetic process (GO:0043043),0.6194761644333079,2.1758311059502065,0.0,0.0015599526025283916,0.015,68/153,12.66%,RPS29;RPS23;MRPL23;RPL17;RPL23;MRPS12;RPS12;RPS16;RPS3;RPS27A;RPL39;RPS18;RPS21;EEF1A1;RPL23A;RPS15;RPL37;RPLP1;RPL26;RPS10;RPS20;RPS13;RPLP2;RPSA;RPL41;RPS28;MRPL13;RPL13;RPS24;RSL24D1;RPL24;RPL12;RPL36A;RPS8;RPL18A;RPL37A;RPS11;RPL28;DARS1;RPL30;RPL8;RPL35A;RPS4X;RPS15A;RPL38;RPS17;RPLP0;MRRF;RPL5;RPL36;RPL14;RPS14;RPL9;RPS9;RPS5;RPS7;RPL34;RPL27;MRPS11;RPL6;RPS6;RPL4;RPL22;EIF4EBP2;RPL15;RPL10;RPL32;MRPS17
prerank,regulation of B cell activation (GO:0050864),0.7920521428331424,2.1003402791935915,0.0,0.008758483882945867,0.072,6/25,5.00%,BANK1;FCGR2B;AHR;ZFP36L2;ZFP36L1;THEMIS2
prerank,acylglycerol catabolic process (GO:0046464),-0.6682771038083973,-2.089657523871205,0.0,0.05039916609274524,0.045,10/30,17.06%,ABHD12;MGLL;FABP5;LYPLA2;LIPH;LPL;DAGLA;ABHD16A;FABP4;FAAH
prerank,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),0.7368230469818764,2.053649862462382,0.0,0.02021188588372123,0.164,9/34,3.94%,NRP1;NEDD9;MYADM;RREB1;CASS4;DOCK1;CDC42;CRK;S100A10
prerank,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),-0.4735041396487526,-2.0380050654385364,0.0,0.054820145574564993,0.102,45/159,13.61%,CADM1;GRID2;PTPRM;CDH23;PTPRS;ADGRL3;CDH10;SDK1;PTPRD;NLGN1;ROBO2;CDH2;CLDN11;LRRC4C;CDH13;TENM3;LRFN5;FAT4;CDH8;CD84;ACVR1;ROBO1;PALLD;CNTN4;BSG;CNTN6;TENM2;TENM4;IGSF11;PTPRT;CNTN2;UNC5D;NTNG1;NECTIN2;MAG;CELSR2;PECAM1;LRRC4;CDH9;CDH22;IL1RAPL1;ATP2C1;TGFBR2;IGSF21;DSCAML1
prerank,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),-0.5523775767299318,-1.9932963488299917,0.0,0.07545138315639055,0.204,21/59,13.61%,CADM1;PTPRM;SDK1;ROBO2;CDH2;CDH13;TENM3;CD84;ROBO1;PALLD;CNTN4;BSG;CNTN6;IGSF11;PTPRT;CNTN2;NECTIN2;CELSR2;PECAM1;IGSF21;DSCAML1
prerank,cellular potassium ion homeostasis (GO:0030007),-0.7850052118021892,-1.9846424078612748,0.0,0.06277790864184056,0.219,5/13,4.06%,KCNMA1;SLC12A2;KCNJ2;ATP1B1;ATP1B2
prerank,translation (GO:0006412),0.5516218098451942,1.9844670451018733,0.0,0.06871451932655197,0.475,85/208,15.05%,RPS29;RPS23;MRPL23;RPL17;RPL23;MRPS12;RPS12;RPS16;RPS3;RPS27A;RPL39;RPS18;RPS21;EEF1A1;RPL23A;RPS15;RPL37;RPLP1;RPL26;EEFSEC;RPS10;RPS20;RPS13;RPLP2;RPSA;RPL41;RPS28;MRPL13;RPL13;RPS24;RSL24D1;RPL24;RPL12;RPL36A;RPS8;RPL18A;RPL37A;RPS11;RPL28;DARS1;FARS2;RPL30;RPL8;RPL35A;RPS4X;RPS15A;RPL38;RPS17;RPLP0;MRRF;RPL5;RPL36;RPL14;RPS14;RPL9;NDUFA7;RPS9;RPS5;RPS7;RPL34;RPL27;MRPS11;EEF1D;RPL6;RPL22L1;RPS6;RARS2;RPL4;RPL22;EIF4EBP2;RPL15;RPL10;MRPL16;RPL32;WARS2;MRPS17;ETF1;GTPBP1;RPL19;MRPS34;MRPS14;RARS1;RPL31;RPL11;SRBD1
prerank,cell surface receptor signaling pathway involved in heart development (GO:0061311),0.7904392126502421,1.969027443083629,0.0,0.08107853651641317,0.558,5/17,4.49%,RBPJ;NOTCH2;JAG1;BMP2;HEY2
prerank,regulation of B cell proliferation (GO:0030888),0.6796846541191434,1.9687848206807785,0.0,0.0763462740510868,0.56,12/44,6.34%,VAV3;CD38;FCGR2B;AHR;LYN;BST1;MEF2C;CD74;IRS2;RC3H1;CD40;BCL2
prerank,Notch signaling involved in heart development (GO:0061314),0.8712939846627056,1.968768431987922,0.0,0.07185531675396405,0.56,4/11,4.49%,RBPJ;NOTCH2;JAG1;HEY2
prerank,positive regulation of ATP metabolic process (GO:1903580),0.7213873568329977,1.9644761370168835,0.0,0.07280862112217583,0.581,11/32,9.90%,PID1;P2RX7;APP;NUPR1;ZBTB20;INSR;PFKFB4;PSEN1;SLC4A4;BEND3;IGF1
prerank,regulation of interleukin-12 production (GO:0032655),0.6700163297817282,1.9640703000330924,0.0015060240963855422,0.06937170800520175,0.583,15/47,10.06%,IL16;LILRA5;FOXP1;TLR8;CMKLR1;IRAK3;LILRB1;TLR4;PIBF1;CCL19;TLR2;CD40;SYK;MAPK14;RIPK2
prerank,negative regulation of interleukin-12 production (GO:0032695),0.8245450914255473,1.9509655028922386,0.0035650623885918,0.08327709471560162,0.66,6/14,3.22%,LILRA5;TLR8;CMKLR1;IRAK3;LILRB1;PIBF1
prerank,purine-containing compound catabolic process (GO:0072523),0.847775249965122,1.9374806004986045,0.0,0.09764560457255099,0.722,4/13,3.66%,GDA;DPYD;XDH;DNPH1
prerank,neuron cell-cell adhesion (GO:0007158),-0.7423066092272558,-1.93302459406567,0.0,0.11052448704549395,0.408,6/14,6.67%,NCAM2;NRXN3;NLGN1;NRXN1;ASTN2;CNTN4
prerank,inflammatory response (GO:0006954),0.5396203456859499,1.9258863913438995,0.0,0.11119537144897693,0.771,35/195,8.22%,HDAC9;FOLR2;PF4;NLRC4;FCGR2B;NRROS;SIGLEC1;ADGRE5;CYBB;HRH1;CCR1;CMKLR1;ALOX15;C5AR1;C3AR1;MFHAS1;CEBPB;CD44;BMP2;CCL8;TLR4;CCL19;ADM;TUSC2;TLR2;IL10RB;MAPKAPK2;CD40;CCRL2;PLA2G2D;TNF;CXCR4;REL;CCR2;CCL24
prerank,response to molecule of bacterial origin (GO:0002237),0.6168805288003352,1.9198334963579178,0.0014104372355430183,0.11647928698987814,0.803,15/69,5.47%,C4B;FCGR2B;FOXP1;FER;IRAK3;PTPN22;IFNAR1;TLR4;PELI1;RPS6KA3;LBP;TNFRSF11A;GCH1;MAPKAPK2;LY96
prerank,icosanoid biosynthetic process (GO:0046456),0.8851438848020067,1.9188547656972514,0.0,0.11283250920631793,0.804,4/10,4.04%,ALOX5;LTC4S;ALOX5AP;MGST3
prerank,purine nucleotide catabolic process (GO:0006195),0.8471842198386769,1.9187232143959292,0.0,0.10857660101748239,0.806,4/13,3.66%,GDA;HINT1;XDH;DNPH1
prerank,cellular monovalent inorganic cation homeostasis (GO:0030004),-0.6859957672190171,-1.9094676710838436,0.0,0.12835577095550033,0.522,6/20,4.06%,KCNMA1;SLC12A2;KCNJ2;ATP1B1;SLC8A1;ATP1B2
prerank,positive regulation of excitatory postsynaptic potential (GO:2000463),-0.6897957939404997,-1.9087595909622632,0.0,0.11153499664133847,0.523,7/18,5.61%,RIMS1;PTK2B;NLGN1;RIMS2;NRXN1;DLG4;SHANK1
prerank,regulation of ERBB signaling pathway (GO:1901184),0.8001354964824658,1.9064318031461323,0.001841620626151013,0.1259324236795937,0.851,5/15,1.93%,RBPJ;EGFR;PTPN18;FER;PTPN12
prerank,regulation of platelet activation (GO:0010543),0.7550122416913868,1.9034657326374134,0.0,0.12627310777272066,0.86,7/21,6.57%,APOE;C1QTNF1;LYN;FCER1G;TLR4;PDGFRA;SYK
prerank,positive regulation of ERBB signaling pathway (GO:1901186),0.7286568004467932,1.8986998520951879,0.0017825311942959,0.13095593176002296,0.875,7/25,10.93%,RBPJ;HIP1;ARAP1;CBL;RTN4;NUP62;PDE6H
prerank,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),-0.6435487660885133,-1.8974327736574887,0.0,0.11682438280708711,0.581,16/25,26.00%,ABI3;ARHGAP24;PRKCD;EVL;CEP97;CCP110;EVI5L;CDK10;LIMK2;TBC1D7;PLXNB3;ARHGAP44;CAPZB;ODF2L;TCHP;KANK1
prerank,negative regulation of ossification (GO:0030279),0.7286821610494124,1.893677084242705,0.0,0.13572260035360167,0.892,5/23,3.76%,RBPJ;CCR1;MEF2C;FGF23;SRGN
prerank,negative regulation of multicellular organismal process (GO:0051241),0.5292031006345778,1.893263186652484,0.0,0.13194924086511506,0.893,45/199,10.98%,RBPJ;HDAC9;PAEP;FCGR2B;EGFR;RAB11FIP5;SPRED1;ATP2B1;IL15;GAS6;MEF2C;NR1H4;BMP2;TNNT1;TLR4;NR1D1;GRN;HMGCR;SRGN;ADM;RGCC;IL17RD;MCC;NPR3;HEY2;GRHL2;SPI1;GSK3B;RB1;LNPEP;ROCK1;PLCL2;TNF;ARRDC3;VASN;TRPV3;FOXC2;RPS6KA6;USF3;CORO1C;PPP2CA;SFRP1;DOCK7;PTGER4;SPRED2
prerank,B cell activation (GO:0042113),0.5899517463313605,1.891624072639973,0.0027662517289073307,0.1308064288140289,0.9,18/68,11.05%,BANK1;HDAC9;ITGA4;PTPRJ;ITGB1;MEF2C;KLF6;CD40;BCL2;CR2;ZAP70;LYL1;CHRNA4;PRKCB;CEBPG;NHEJ1;SLC25A5;CASP8
prerank,lipoxygenase pathway (GO:0019372),0.8246790683428664,1.8880410606716602,0.0017543859649122807,0.13368976610613925,0.912,4/14,3.19%,ALOX5;LTC4S;ALOX15;ALOX5AP
prerank,clathrin-dependent endocytosis (GO:0072583),0.7205459479858769,1.8823895213328417,0.0,0.14068822534052935,0.925,10/26,7.72%,ITSN1;AP2A2;SIGLEC1;FCHO2;CLTC;FCHSD2;AP2S1;LMBRD1;ITSN2;CANX
prerank,cellular macromolecule biosynthetic process (GO:0034645),0.5012670317544284,1.8784240610229592,0.0,0.143805262985655,0.935,104/306,14.46%,EXT1;APOE;RBMS1;RPS29;MEF2A;RPS23;MRPL23;RPL17;RPL23;MRPS12;RPS12;RBBP8;RPS16;RPS3;RPS27A;ORC5;RPL39;RPS18;RPS21;EEF1A1;RPL23A;RPS15;RPL37;RPLP1;RPL26;EEFSEC;RPS10;RPS20;RPS13;RPLP2;RPSA;RPL41;RPS28;MRPL13;RPL13;FAM111A;RPS24;RSL24D1;RPL24;RPL12;RPL36A;RPS8;RPL18A;RPL37A;THRB;RPS11;RPL28;ORC2;MCM9;POLE2;DARS1;EPC1;RPL30;RPL8;RPL35A;RPS4X;CHEK1;RPS15A;RPL38;RPS17;RPLP0;TOPBP1;MRRF;RPL5;RPL36;TIPIN;RPA1;NR4A2;RPL14;RPS14;RPL9;RPS9;BRIP1;RPS5;RPS7;TOP1MT;RPL34;RPL27;MRPS11;MED20;EEF1D;POLR2B;RPL6;RPS6;RHNO1;B4GALT5;RPL4;POLE3;RPL22;EIF4EBP2;RPL15;RPL10;RPL32;RPA3;MRPS17;GTPBP1;NFKBIB;RPL19;KAT7;KIN;MRPS14;MMS19;POLR2D;RPL31
prerank,leukotriene metabolic process (GO:0006691),0.7462885277917873,1.8698465209012312,0.00505902192242833,0.15587547817800218,0.956,8/19,8.38%,ALOX5;LTC4S;ALOX15;ALOX5AP;MGST3;MAPKAPK2;ABCC1;DPEP2
prerank,negative regulation of B cell activation (GO:0050869),0.7339895400382832,1.8691922803402834,0.005235602094240838,0.15264786195991367,0.958,4/21,5.30%,BANK1;FCGR2B;LYN;RC3H1
prerank,negative regulation of lymphocyte activation (GO:0051250),0.7390482485135758,1.8652570452820818,0.008389261744966443,0.15565270309350018,0.962,4/21,3.22%,BANK1;FCGR2B;PTPN22;PIBF1
prerank,peptide cross-linking (GO:0018149),0.7144359064670159,1.8613626328617994,0.007155635062611807,0.15875340013395436,0.966,3/25,4.49%,F13A1;TGM7;KRT10
prerank,cellular modified amino acid catabolic process (GO:0042219),-0.7044503925162012,-1.8602665584760167,0.0023148148148148147,0.17330239568733452,0.758,8/15,23.22%,ABHD12;GGT5;GGT7;ABHD16A;ALDH4A1;SARDH;PRODH;HOGA1
prerank,dendritic cell migration (GO:0036336),0.7675173027202535,1.8584081287852365,0.00929368029739777,0.16095260962914335,0.973,7/16,10.88%,EPS8;ALOX5;CCR1;CCL19;CXCR4;CCR2;TRPM2
prerank,regulation of neutrophil chemotaxis (GO:0090022),0.7257848995931081,1.8542251313883298,0.0069084628670120895,0.16529404021947325,0.974,8/23,4.25%,MPP1;RIPOR2;BST1;CD74;THBS4;CAMK1D;CCL19;MCU
prerank,membrane depolarization during cardiac muscle cell action potential (GO:0086012),-0.6868620184956306,-1.8514810045492278,0.0,0.1751592070696988,0.79,7/17,5.40%,CACNB2;KCNJ2;SCN1B;SLC8A1;ANK2;CACNA2D1;CACNA1D
prerank,lipid oxidation (GO:0034440),0.8217698025230327,1.8485578768250601,0.007339449541284404,0.17188252143804067,0.979,4/12,5.81%,ALOX5;ALOX15;PLA2G7;ADIPOR2
prerank,purinergic nucleotide receptor signaling pathway (GO:0035590),0.7434430757756444,1.8465244733835602,0.001763668430335097,0.17213101998524222,0.981,6/20,1.78%,P2RX7;APP;TXNIP;PSTPIP1;C3AR1;ANO6
prerank,actin nucleation (GO:0045010),0.7184402480771813,1.8465064336296133,0.005235602094240838,0.16817785521415465,0.981,5/21,8.66%,IQGAP2;ACTR3;ARPC2;ARPC5;TRIM27
prerank,Arp2/3 complex-mediated actin nucleation (GO:0034314),0.7650251578994245,1.8414773953983261,0.0056925996204933585,0.17449532314844932,0.986,5/15,8.66%,IQGAP2;ACTR3;ARPC2;ARPC5;TRIM27
prerank,modulation by symbiont of host process (GO:0044003),0.8597495801830093,1.8358297863180162,0.0,0.18322509957030697,0.987,4/10,4.23%,MRC1;RPS27A;B2M;TLR2
prerank,potassium ion homeostasis (GO:0055075),-0.625747151278721,-1.835235230775532,0.0026246719160104987,0.19564843743180527,0.859,6/23,4.45%,KCNMA1;SLC12A2;KCNJ2;ATP1B1;ATP1B2;SLC12A9
prerank,response to muscle stretch (GO:0035994),-0.6986241381712376,-1.8331955790280923,0.004395604395604396,0.1839864294350656,0.863,3/15,2.58%,CTNNB1;SLC8A1;CDH2
prerank,regulation of substrate adhesion-dependent cell spreading (GO:1900024),0.6143202275892524,1.8311697010329724,0.0029411764705882353,0.1889874099959872,0.989,10/47,3.95%,NRP1;NEDD9;MYADM;RREB1;CASS4;DOCK1;CDC42;CRK;S100A10;ITGB1BP1
prerank,nucleotide catabolic process (GO:0009166),0.761904827662546,1.8295287785155967,0.005366726296958855,0.18859453571658077,0.989,3/16,3.66%,GDA;XDH;DNPH1
prerank,linoleic acid metabolic process (GO:0043651),0.7570013494574506,1.8265635306501082,0.0051813471502590676,0.19121200273023145,0.991,4/17,7.30%,ALOX5;ALOX15;PNPLA8;ELOVL5
prerank,positive regulation of endocytosis (GO:0045807),0.6222222610822356,1.82489062441667,0.004594180704441042,0.19057089338311453,0.991,10/45,3.98%,DAB2;HIP1;APOE;RAB31;ANO6;ANKFY1;CDC42;CBL;CCL19;B2M
prerank,positive regulation of interleukin-1 production (GO:0032732),0.6108864343990733,1.820988006498344,0.006060606060606061,0.19491022786366308,0.992,16/51,11.05%,NLRC4;P2RX7;APP;IL16;LILRA5;TLR8;CD36;TLR4;CCL19;TMED10;TMEM106A;HSPB1;TNF;RIPK2;TRIM16;CASP8
prerank,barbed-end actin filament capping (GO:0051016),0.7385437566512492,1.8198785244478772,0.003484320557491289,0.1899092298135766,0.994,3/18,1.03%,EPS8;ADD3;FLII
prerank,actin filament capping (GO:0051693),0.7385437566512492,1.8198785244478772,0.003484320557491289,0.1899092298135766,0.994,3/18,1.03%,EPS8;ADD3;FLII
prerank,negative regulation of androgen receptor signaling pathway (GO:0060766),0.7992956000129222,1.8157542608003692,0.0078125,0.1947641294725159,0.995,5/12,10.04%,DAB2;FOXP1;PIAS2;NCOR1;SFRP1
prerank,chemokine-mediated signaling pathway (GO:0070098),0.6227766767418511,1.80609404747473,0.0015384615384615385,0.21099803349754395,0.995,11/42,10.46%,PF4;CCR1;OXSR1;CCL8;THPO;CCL19;WNK1;CCR2;CCL24;SH2B3;RBM15
prerank,cardiac left ventricle morphogenesis (GO:0003214),0.7960705513359295,1.8049982839301397,0.005376344086021506,0.20975512681747385,0.995,3/13,5.19%,RBPJ;HEY2;SMAD4
prerank,positive regulation of biomineral tissue development (GO:0070169),0.6242536518704553,1.803942703408165,0.0015698587127158557,0.2080012247507472,0.995,11/40,7.63%,NELL1;P2RX7;ALOX5;ATP2B1;ANO6;MEF2C;CEBPB;OSR1;BMP2;ACVR2A;WNT6
prerank,negative regulation of lymphocyte proliferation (GO:0050672),0.6592984562917997,1.802475838564819,0.008130081300813009,0.2078328957487004,0.995,9/31,9.08%,FCGR2B;VSIG4;LYN;CEBPB;LILRB1;RC3H1;PLA2G2D;CD80;SDC4
prerank,positive regulation of glycolytic process (GO:0045821),0.7267545632349671,1.801113286734721,0.0034071550255536627,0.20371427646386925,0.995,8/20,9.90%,P2RX7;APP;ZBTB20;INSR;PFKFB4;PSEN1;SLC4A4;IGF1
prerank,positive regulation of purine nucleotide metabolic process (GO:1900544),0.7267545632349671,1.801113286734721,0.0034071550255536627,0.20371427646386925,0.995,8/20,9.90%,P2RX7;APP;ZBTB20;INSR;PFKFB4;PSEN1;SLC4A4;IGF1
prerank,regulation of ossification (GO:0030278),0.6308426325474755,1.7967103091662082,0.009852216748768473,0.20997124525094915,0.997,9/36,11.26%,RBPJ;LRP6;ZBTB16;MEF2C;BMP2;NOTUM;DDR2;SFRP1;S1PR1
prerank,cyclic-nucleotide-mediated signaling (GO:0019935),0.6493860510440651,1.7954453516657403,0.004629629629629629,0.2092014715085437,0.997,10/35,6.13%,PDE7B;APOE;ADGRG6;AHR;IRAG1;CD36;RAPGEF2;PDE2A;PDE4D;PDE7A
prerank,cellular protein metabolic process (GO:0044267),0.4707994525282691,1.7952155765173847,0.0,0.20644997724086683,0.997,118/396,15.74%,APOE;PADI4;IGFBP4;APP;ST8SIA4;CP;RPS29;RPS23;GAS6;MRPL23;RPL17;RPL23;MRPS12;RPS12;DNAJC3;RPS16;RPS3;RPS27A;SHISA5;RPL39;RPS18;RPS21;EEF1A1;RIPK1;RPL23A;SIAH2;FGF23;RPS15;RPL37;RPLP1;RPL26;ST3GAL1;CLN5;RPS10;RPS20;RPS13;PRKN;RPLP2;RPSA;LOX;DUSP12;RPL41;RPS28;MRPL13;RPL13;SERP1;RPS24;RSL24D1;RPL24;RPL12;MANBA;RPL36A;RPS8;RPL18A;NOTUM;RPL37A;RPS11;RPL28;PARL;DARS1;RPL30;RPL8;RPL35A;RPS4X;MSRA;RPS15A;RPL38;RPS17;RPLP0;MRRF;RPL5;RPL36;PSEN1;RPL14;RPS14;RPL9;RPS9;RPS5;RPS7;UBE2D3;RPL34;RPL27;MRPS11;RPL6;IGF1;FBXO11;RPS6;GNMT;PPP4R2;IGFALS;RPL4;RPL22;EIF4EBP2;WFS1;RPL15;RPL10;DENND3;STK38;RPL32;NUCB1;LOXL2;ERO1A;MRPS17;RPL19;SERPIND1;MRPS14;RPN2;RPL31;RPL11;GPC3;SRBD1;MELTF;FN1;ICMT;USP25;NCSTN;ZDHHC2;FBXW2
prerank,regulation of endocytosis (GO:0030100),0.5812821243129411,1.7947208614074803,0.0014684287812041115,0.20407522796648211,0.997,9/61,6.24%,DAB2;MCTP1;HIP1;APOE;OPHN1;LILRB1;CCL19;ROCK1;AP2S1
prerank,immune response-activating cell surface receptor signaling pathway (GO:0002429),0.7274442659061181,1.793183320478602,0.009771986970684038,0.2043553143224327,0.997,6/18,6.87%,CMKLR1;C5AR1;C3AR1;LYN;FCER1G;SPG21
prerank,retrograde axonal transport (GO:0008090),-0.6804690042679348,-1.7929968613678442,0.004273504273504274,0.27335256211436315,0.972,7/16,11.42%,DST;DLG2;DYNC1H1;KIF1A;KIF5A;TMEM108;KIF1C
prerank,positive regulation of ossification (GO:0045778),0.6197808623068439,1.7928700466076055,0.006339144215530904,0.20190436535436462,0.997,9/39,2.60%,NELL1;P2RX7;ALOX5;ATP2B1;ZBTB16;ANO6;MEF2C;OSR1;BMP2
prerank,regulation of trans-synaptic signaling (GO:0099177),-0.5608227297947745,-1.7928511617071665,0.0,0.2545221044533375,0.972,10/33,11.45%,CX3CR1;GRID2;NRG3;GRIK2;NLGN1;LRRC4C;FABP5;BDNF;ABR;LRRC4
prerank,immunoglobulin mediated immune response (GO:0016064),0.8362475580663684,1.7922586193060965,0.0057361376673040155,0.20006392127426625,0.997,4/10,2.77%,FCGR2B;TLR8;FCER1G;CD74
prerank,positive regulation of immune effector process (GO:0002699),0.6902146742307124,1.7913776477902872,0.0016286644951140066,0.19891869487670108,0.997,7/27,7.58%,PTPRJ;DDX60;LILRB1;ANKRD17;CD46;LBP;CCR2
prerank,aorta morphogenesis (GO:0035909),0.7238623094215949,1.7911485261437803,0.0018083182640144665,0.1964192526018148,0.997,3/17,4.49%,RBPJ;JAG1;HEY2
prerank,regulation of B cell receptor signaling pathway (GO:0050855),0.6836760893783363,1.7897135192658795,0.003590664272890485,0.1964169668656378,0.997,8/21,10.75%,FCGR2B;FOXP1;LYN;PTPN22;ELF2;CBFB;PRKCB;ELF1
prerank,B cell mediated immunity (GO:0019724),0.8318418588884019,1.7888766767412776,0.005484460694698354,0.19503585976075957,0.997,4/10,2.77%,FCGR2B;TLR8;FCER1G;CD74
prerank,negative regulation of cytokine production involved in inflammatory response (GO:1900016),-0.6697308581435305,-1.7879904157359434,0.004434589800443459,0.25211372324990805,0.978,9/16,18.94%,SIRPA;TREM2;CUEDC2;PDCD4;APOD;ADCY7;ABCD2;CHID1;PYCARD
prerank,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),-0.6516805636828862,-1.7865815110897647,0.002288329519450801,0.2400039236192901,0.979,5/17,4.93%,SCN1B;SNTA1;NOS1AP;ANK2;CACNA2D1
prerank,cellular response to zinc ion (GO:0071294),-0.672657067835057,-1.782580783260748,0.009302325581395349,0.23675645413227694,0.983,13/15,25.93%,GLRA1;ATP13A2;HVCN1;MT2A;GLRA2;MT1E;MT1F;MT1M;MT1G;MT1H;MT1A;MT1X;MT1B
prerank,leukotriene biosynthetic process (GO:0019370),0.7525015938054926,1.7817616862399253,0.012612612612612612,0.20580800730980872,0.999,4/14,4.04%,ALOX5;LTC4S;ALOX5AP;MGST3
prerank,positive regulation of bone mineralization (GO:0030501),0.6272745337178885,1.7806978238321247,0.008064516129032258,0.2047519038349896,0.999,8/35,2.60%,NELL1;P2RX7;ALOX5;ATP2B1;ANO6;MEF2C;OSR1;BMP2
prerank,regulation of dendritic cell apoptotic process (GO:2000668),0.8112508781606704,1.7791144659878912,0.003875968992248062,0.2051791768116667,1.0,5/10,3.92%,GAS6;LYN;LILRB1;CCL19;RAPGEF2
prerank,positive regulation of receptor-mediated endocytosis (GO:0048260),0.6113025717141979,1.7761705280329827,0.0015479876160990713,0.2086094048722385,1.0,9/40,7.63%,DAB2;HIP1;TBC1D5;CBL;CCL19;B2M;INSR;ANXA2;HFE
prerank,cellular response to epidermal growth factor stimulus (GO:0071364),0.6810005646439474,1.7749240765381367,0.006802721088435374,0.2084590661968732,1.0,8/26,7.38%,EGFR;IQGAP1;ZFP36L2;PTPN12;EEF1A1;ZFP36L1;PDE8A;DUSP22
prerank,regulation of Rho protein signal transduction (GO:0035023),0.5625587804471724,1.7734398996165281,0.005681818181818182,0.2086654691360696,1.0,8/72,2.55%,ARHGEF3;EPS8;STARD8;NRP1;APOE;RIPOR2;OPHN1;GPR65
prerank,epithelial cell migration (GO:0010631),0.6236823540418852,1.7708513547886187,0.0062402496099844,0.2106214576378066,1.0,12/37,12.75%,ZEB2;PLEKHG5;NRP1;RHOA;PKN2;ROCK1;TNFSF12;STARD13;PXN;KANK2;LOXL2;PLXND1
prerank,cellular response to peptide (GO:1901653),0.588151887855932,1.770146388590158,0.0014705882352941176,0.20947488533230813,1.0,23/56,13.91%,FCGR2B;ITGA4;APP;RPL23;PTPN22;ADRB2;CD36;TLR4;SNX6;ZFP36L1;VIM;GSK3B;ABCC1;DDX11;PSEN1;FYN;MDM2;IGF1;RIPK2;CHMP5;NOD2;GJA1;ATP1A3
prerank,positive regulation of B cell proliferation (GO:0030890),0.6564014126936234,1.7690511162350735,0.007911392405063292,0.20918544792401886,1.0,8/29,6.34%,VAV3;CD38;BST1;MEF2C;CD74;IRS2;CD40;BCL2
prerank,regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),0.731140962300731,1.7663915763472733,0.0055658627087198514,0.2124960122886351,1.0,6/16,11.15%,IGFBP4;BMP2;MYORG;IGF1;ZFAND2B;PHIP
prerank,regulation of cardiac muscle cell membrane repolarization (GO:0099623),-0.6195848317880177,-1.766209037442646,0.0023752969121140144,0.2689429184773686,0.992,6/21,5.40%,SCN1B;SNTA1;NOS1AP;ANK2;CACNA2D1;CACNA1D
prerank,chondroitin sulfate catabolic process (GO:0030207),-0.686706036578322,-1.763034765545534,0.009029345372460496,0.2635834503687064,0.994,10/13,23.03%,HEXB;CSPG5;CSPG4;HYAL1;IDUA;VCAN;BCAN;BGN;NCAN;DCN
prerank,positive regulation of carbohydrate metabolic process (GO:0045913),0.6861804442694407,1.7628395336138034,0.006557377049180328,0.2167046193683673,1.0,8/23,9.90%,P2RX7;APP;ZBTB20;INSR;PFKFB4;PSEN1;SLC4A4;IGF1
prerank,negative regulation of epithelial cell proliferation (GO:0050680),0.5626276019761246,1.7627228478701917,0.0027359781121751026,0.2143888518804111,1.0,18/66,8.11%,MTSS1;APOE;ALOX5;FBXW7;CASK;NUPR1;XDH;CNMD;TNMD;RGCC;B2M;MCC;CDK6;KLF9;GHRL;PTPRK;SYNJ2BP;CDC73
prerank,N-acetylneuraminate metabolic process (GO:0006054),0.80467359209619,1.7618017356600832,0.0055762081784386614,0.21376989037539673,1.0,4/10,3.59%,NPL;ST6GAL1;GNPDA1;ST3GAL1
prerank,cellular response to chemokine (GO:1990869),0.6029375380213071,1.7603012134605005,0.006006006006006006,0.21459562260139084,1.0,12/46,9.36%,PF4;CCR1;RIPOR2;OXSR1;CCL8;CCL19;RHOA;DUSP1;WNK1;CCR2;CCL24;SH2B3
prerank,regulation of interleukin-10 production (GO:0032653),0.5933281065654525,1.7577460526935975,0.006006006006006006,0.2173576017068549,1.0,9/44,6.57%,FCGR2B;LILRA5;IRF4;TSLP;LILRB1;TLR4;PIBF1;CD46;SYK
prerank,synaptic membrane adhesion (GO:0099560),-0.6925522266247639,-1.7575519078919417,0.004576659038901602,0.26530297870400366,0.995,7/14,16.84%,PTPRS;PTPRD;LRRC4C;LRFN5;NTNG1;LRRC4;GPC6
prerank,positive regulation of granulocyte chemotaxis (GO:0071624),0.698131455986669,1.756908409684148,0.007042253521126761,0.21662594712480202,1.0,6/19,4.25%,RIPOR2;CD74;THBS4;CAMK1D;CCL19;MCU
prerank,positive regulation of inflammatory response (GO:0050729),0.5332911045954666,1.7558521265738214,0.002702702702702703,0.21608369315152443,1.0,20/86,8.54%,APP;IL16;LILRA5;IL15;NUPR1;TSLP;PLA2G7;RIPK1;TLR4;GRN;NFKBIZ;LBP;PDE2A;TLR2;IL17RA;GPRC5B;TNF;ABCC1;CCR2;NINJ1
prerank,regulation of inflammatory response (GO:0050727),0.4889291750878055,1.7553616940553831,0.0,0.21457879275560462,1.0,35/190,7.58%,AOAH;APOE;ALOX5;APP;IL16;LILRA5;FOXP1;IL15;ALOX15;BST1;C1QTNF3;MFHAS1;NR1H4;TSLP;METRNL;PLA2G7;TNFRSF1B;RIPK1;TLR4;NR1D1;GRN;SNX6;NFKBIZ;PDE2A;TLR2;IL17RA;BIRC3;RB1;GHRL;CD200R1;GPRC5B;TNF;ABCC1;KLF4;CCR2
prerank,regulation of protein tyrosine kinase activity (GO:0061097),0.6160887420581538,1.7527244517016405,0.004754358161648178,0.21779523646002788,1.0,9/38,5.14%,NEDD9;APP;LILRA5;GAS6;SH3BP5;RAP2B;CASS4;DOK7;GPRC5B
prerank,positive regulation of phospholipase C activity (GO:0010863),0.6006840885645786,1.7516421725126263,0.003076923076923077,0.21759172204434218,1.0,9/40,5.33%,RASGRP4;EGFR;FGFR1;GNAQ;C5AR1;ESR1;ANG;P2RY6;PDGFRA
prerank,regulation of retinoic acid receptor signaling pathway (GO:0048385),0.7668078889752177,1.7516056516918461,0.009208103130755065,0.21529488706928246,1.0,8/12,14.89%,KLF2;DHRS3;CYP26C1;ASXL1;CYP26B1;TRIM16;CTBP2;SNW1
prerank,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),0.6799691250323622,1.750301573590385,0.012152777777777778,0.2154144059533585,1.0,3/20,5.19%,RBPJ;BMP2;SMAD4
prerank,negative regulation of ATP metabolic process (GO:1903579),0.7146728695342135,1.7493474387345267,0.029876977152899824,0.2148970996164532,1.0,3/17,2.06%,PID1;NUPR1;CBFA2T3
prerank,plasma membrane invagination (GO:0099024),0.6542104369241306,1.7492410912792307,0.004754358161648178,0.21278209867599707,1.0,8/29,3.74%,MSR1;FCGR2B;SNX9;DOCK1;CD36;HAVCR1;CDC42;RHOA
prerank,positive regulation of interleukin-1 beta production (GO:0032731),0.5971618819244984,1.7489505815405975,0.007704160246533128,0.21101643059938663,1.0,16/45,13.90%,NLRC4;P2RX7;APP;LILRA5;TLR8;CD36;TLR4;CCL19;TMEM106A;HSPB1;TNF;RIPK2;TRIM16;CASP8;NOD2;STAT3
prerank,platelet-derived growth factor receptor signaling pathway (GO:0048008),0.7344283012197081,1.7460717999729567,0.011884550084889643,0.2147280850945185,1.0,6/16,9.45%,NRP1;PTPRJ;FER;PDGFRA;PIK3C2A;PDGFC
prerank,positive regulation of myeloid leukocyte differentiation (GO:0002763),0.6229716665228684,1.7449427442061802,0.011235955056179775,0.21488045562598723,1.0,7/33,6.94%,PF4;CCR1;RIPK1;CD74;DCSTAMP;ZFP36L1;TNF
prerank,regulation of NIK/NF-kappaB signaling (GO:1901222),0.5421458368635287,1.7449038972728776,0.005398110661268556,0.21277534627586397,1.0,15/76,7.19%,EGFR;APP;SASH1;C1QTNF3;RPS3;PTPN22;RASSF2;TLR4;CCL19;RHOA;TLR2;SPI1;TNF;UACA;PPM1B
prerank,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),-0.5373630963742237,-1.7434919096511043,0.005141388174807198,0.29068992707127245,0.997,11/37,14.58%,CADM1;GRID2;PTPRD;NLGN1;TENM3;FAT4;TENM2;TENM4;IL1RAPL1;IGSF21;CXADR
prerank,sulfur compound catabolic process (GO:0044273),-0.5247815866349594,-1.7427165122728765,0.008670520231213872,0.2798480011991906,0.997,16/38,24.04%,HEXB;GNS;CSPG5;GGT5;CSPG4;HYAL1;GGT7;IDUA;VCAN;BCAN;BGN;TST;NCAN;FMOD;DCN;PRELP
prerank,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),0.6784728292610871,1.7415277382289118,0.00644122383252818,0.21499754253234585,1.0,9/23,16.01%,DAB2;ZEB2;SMAD4;SDCBP;RNF111;CREBBP;EP300;SNW1;HSP90AB1
prerank,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),0.6784728292610871,1.7415277382289118,0.00644122383252818,0.21499754253234585,1.0,9/23,16.01%,DAB2;ZEB2;SMAD4;SDCBP;RNF111;CREBBP;EP300;SNW1;HSP90AB1
prerank,positive regulation of defense response (GO:0031349),0.5298390829353358,1.7404375462033217,0.0027247956403269754,0.21482265601440023,1.0,21/89,8.54%,APP;IL16;LILRA5;TLR8;IL15;MEF2C;TSLP;PLA2G7;RIPK1;TLR4;GRN;NFKBIZ;PDE2A;TLR2;IL17RA;GPRC5B;RIOK3;TNF;ABCC1;CCR2;NINJ1
prerank,synaptic vesicle cycle (GO:0099504),-0.5567097664466837,-1.7365292908822811,0.002680965147453083,0.2852492848269792,0.997,19/30,33.57%,RIMS1;NLGN1;SNAP25;PIP5K1C;PCLO;SYNDIG1;CPLX1;VAMP2;SLC17A6;CPLX2;BRSK1;SYT7;WNT7A;DNAJC5;SLC18A2;RAB3A;SNAPIN;SLC17A8;STX1A
prerank,odontogenesis of dentin-containing tooth (GO:0042475),0.715393409586948,1.7326250543765263,0.014545454545454545,0.2280149837761873,1.0,5/15,7.63%,LRP6;BMP2;ANKRD11;EDA;WNT6
prerank,embryonic appendage morphogenesis (GO:0035113),0.7654502090456321,1.732341476100215,0.017793594306049824,0.22640515975919348,1.0,3/12,9.99%,LRP6;MBNL1;CYP26B1
prerank,monocyte chemotaxis (GO:0002548),0.6227799582176883,1.7294726778448344,0.015527950310559006,0.23007519691413486,1.0,7/32,8.25%,FOLR2;CCL8;MSMP;CCL19;TNFRSF11A;CCL24;IL6R
prerank,cellular response to amyloid-beta (GO:1904646),0.6206828305873712,1.7292453526606528,0.006349206349206349,0.2283538474297618,1.0,12/35,9.90%,FCGR2B;ITGA4;APP;ADRB2;CD36;TLR4;SNX6;GSK3B;ABCC1;PSEN1;FYN;IGF1
prerank,regulation of antigen receptor-mediated signaling pathway (GO:0050854),0.7620518167553147,1.7270823111070008,0.0075046904315197,0.23021625984507152,1.0,6/12,10.75%,LYN;PTPN22;RC3H1;ELF2;CBFB;ELF1
prerank,cellular response to estradiol stimulus (GO:0071392),0.7010400922165153,1.7263316637669197,0.014760147601476014,0.22980871844537423,1.0,6/18,10.04%,EGFR;ESR1;NCOA3;NRIP1;LCOR;SFRP1
prerank,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),0.6451468203386587,1.724817994038301,0.008756567425569177,0.23083868066095192,1.0,11/26,17.18%,DAB2;FOXP1;CLOCK;PIAS2;NCOR1;SFRP1;KANK2;CNOT9;PER1;STRN3;ZBTB7A
prerank,"synaptic transmission, glutamatergic (GO:0035249)",-0.6201574821953485,-1.7247044790390798,0.008791208791208791,0.30851068483965544,1.0,6/18,10.62%,GRID2;UNC13C;GRIA2;GRIK2;CDH8;NAPA
prerank,neurotransmitter secretion (GO:0007269),-0.49492453383438395,-1.7236167837786576,0.003048780487804878,0.2998838802107978,1.0,17/44,22.33%,RIMS1;RIMS2;SNAP25;NRXN1;PIP5K1C;PCLO;DVL1;SYN3;CPLX1;PTPRN2;LIN7A;VAMP2;LIN7C;SYT1;CPLX2;BRSK1;GAD1
prerank,ribosomal small subunit biogenesis (GO:0042274),0.5975576839739593,1.7235800798194927,0.0078125,0.23149553506603673,1.0,15/39,10.33%,RPS16;RPS15;ERAL1;SNU13;RPSA;RPS28;RPS24;RIOK3;LTV1;RPS17;RPS14;RPS5;RPS7;MRPS11;RPS6
prerank,activation of phospholipase C activity (GO:0007202),0.6300746982780419,1.7212737011858403,0.013289036544850499,0.23392464245289812,1.0,6/29,3.28%,RASGRP4;EGFR;GNAQ;C5AR1;ANG;P2RY6
prerank,smooth muscle cell differentiation (GO:0051145),0.7742762455957835,1.721091464329205,0.005607476635514018,0.23202977435073907,1.0,3/12,4.49%,EDNRB;MEF2C;HEY2
prerank,long-chain fatty acid biosynthetic process (GO:0042759),0.6626388202718742,1.7200290237179845,0.011437908496732025,0.2320455611538927,1.0,3/23,1.41%,ALOX5;LTC4S;ALOX15
prerank,substrate-dependent cell migration (GO:0006929),0.738577717237162,1.719589225630178,0.01436265709156194,0.2309126742337796,1.0,5/14,6.90%,NRP1;OPHN1;ANKS1A;ITGB1BP1;SDCBP
prerank,microtubule polymerization or depolymerization (GO:0031109),-0.5782012110809002,-1.7184033831207493,0.009389671361502348,0.3032451849183599,1.0,16/24,29.17%,FGF13;NCKAP5L;MAPT;STMN3;NCKAP5;TPPP;STMN4;CKAP5;KIF2A;KATNB1;PIN1;KIF14;HDGFL3;MAP7D3;TPPP3;KIF2C
prerank,ephrin receptor signaling pathway (GO:0048013),0.5338009453094351,1.7179069386654762,0.001326259946949602,0.2324902386672838,1.0,19/82,8.07%,ITSN1;VAV3;AP2A2;LYN;ACTR3;RASA1;CDC42;ANKS1A;CRK;RHOA;ROCK1;ACTB;AP2S1;NGEF;SDCBP;ARPC2;ARPC5;PSEN1;FYN
prerank,T cell activation involved in immune response (GO:0002286),0.7660698328188777,1.7176632020057678,0.012939001848428836,0.23093487459810663,1.0,4/12,4.01%,FCER1G;LILRB1;CD74;LCP1
prerank,negative regulation of hormone secretion (GO:0046888),0.7928858762345743,1.7173842573402938,0.011560693641618497,0.22950802664698963,1.0,2/10,2.94%,RAB11FIP5;FGF23
prerank,Rho protein signal transduction (GO:0007266),0.5665965644191074,1.716987736756707,0.004457652303120356,0.22832556257488076,1.0,9/53,7.94%,ARHGEF3;EPS8;PLEKHG5;CDC42;RHOA;ROCK1;CELSR1;ARHGAP29;ARHGDIA
prerank,positive regulation of ERK1 and ERK2 cascade (GO:0070374),0.48391234271069744,1.7157513954141554,0.0012515644555694619,0.22879910750876434,1.0,25/151,5.33%,NRP1;EGFR;APOE;APP;NOTCH2;CCR1;FBXW7;GAS6;ALOX15;C5AR1;MFHAS1;PTPN22;CD44;BMP2;CD36;CD74;CCL8;P2RY6;THPO;CCL19;RAPGEF2;TNFRSF11A;PDE8A;RAP1A;PDGFRA
prerank,positive regulation of neutrophil chemotaxis (GO:0090023),0.6981367562193135,1.7135830389043012,0.012237762237762238,0.23105814761546847,1.0,6/17,4.25%,RIPOR2;CD74;THBS4;CAMK1D;CCL19;MCU
prerank,purine ribonucleotide catabolic process (GO:0009154),0.6733604317465139,1.7118836307108127,0.016666666666666666,0.23259137046292463,1.0,8/21,14.82%,HINT1;XDH;PDE2A;PDE4D;AMPD3;NT5C2;ACAT1;NUDT18
prerank,regulation of response to oxidative stress (GO:1902882),0.7819979821844208,1.7104035768872492,0.011406844106463879,0.23387766660748108,1.0,3/11,4.00%,MCTP1;ALOX5;PRKN
prerank,rRNA metabolic process (GO:0016072),0.4858706988507821,1.7098646596339568,0.0,0.23305947611709013,1.0,56/160,14.84%,RPL17;RPL23;RPS16;NOL6;RPL39;RPL23A;RPS15;RPL37;RPLP1;RPL26;RPLP2;SNU13;RPL41;RPS28;RPL13;RPS24;RPL24;RPL12;RPL36A;RPL18A;RPL37A;RPL28;WDR36;NOP53;RPL30;NOL9;RPL8;RPL35A;RPL38;RPS17;RPLP0;RPL5;RPL36;RPL14;RPS14;RPL9;RPS9;RPS7;RPL34;RPL27;MTREX;RPL6;HEATR1;RPS6;RPL4;RPL22;RPL15;RPL10;DDX10;RPL32;EXOSC8;ESF1;RPL19;EXOSC1;RPL31;RPL11
prerank,adenine nucleotide transport (GO:0051503),0.694017874363613,1.7087188210261783,0.02413793103448276,0.2337281423257809,1.0,7/17,18.52%,LRRC8D;SLC25A17;SLC25A24;ABCC4;SLC25A5;LRRC8C;SLC25A4
prerank,myeloid cell development (GO:0061515),0.6954726900228043,1.707846146212261,0.010619469026548672,0.23352113051962317,1.0,7/18,9.36%,NRROS;APP;FOXP1;THPO;TLR2;ANXA2;SH2B3
prerank,positive regulation of phagocytosis (GO:0050766),0.5846422693288967,1.7078388931919595,0.00792393026941363,0.23167012095409398,1.0,11/47,3.48%,C4B;FCGR2B;PTPRJ;IL15;DOCK2;GAS6;RAB31;ANO6;FCER1G;C2;CAMK1D
prerank,negative regulation of ERBB signaling pathway (GO:1901185),0.5967134991129226,1.7073619801790387,0.009615384615384616,0.23080179686099137,1.0,7/39,3.50%,EGFR;PTPRJ;PTPN18;EPS15;PTPN12;CDC42;CBL
prerank,adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),0.704778025024198,1.7041552195791962,0.008665511265164644,0.23497169922188854,1.0,6/17,8.64%,ADRB2;DRD1;RAPGEF2;ADCY9;ADRA1D;ADRA1A
prerank,macrophage activation (GO:0042116),0.6162299337302273,1.7030095785415464,0.009708737864077669,0.23536470416693142,1.0,10/34,6.94%,APP;FOXP1;C1QA;C5AR1;CD93;TLR4;LBP;TMEM106A;SYK;TNF
prerank,cardiac muscle cell development (GO:0055013),0.6698177932392322,1.699837570715827,0.020942408376963352,0.23977544724066607,1.0,5/20,5.33%,PDLIM5;MYH6;ALPK3;HEY2;PDGFRA
prerank,response to interferon-alpha (GO:0035455),0.6927652266327504,1.6996538198357223,0.009124087591240875,0.23831875894242402,1.0,8/16,9.46%,IFITM3;GAS6;IFNAR1;LAMP3;BST2;IFNAR2;RO60;IFITM2
prerank,fructose 6-phosphate metabolic process (GO:0006002),-0.7174131219768387,-1.6985868880250645,0.010183299389002037,0.35384209852638876,1.0,4/10,9.30%,HK2;PFKL;GFPT1;PFKP
prerank,response to amyloid-beta (GO:1904645),0.5900608590161635,1.6969219013330206,0.010752688172043012,0.24195192336181537,1.0,12/44,9.90%,FCGR2B;ITGA4;APP;ADRB2;CD36;TLR4;SNX6;GSK3B;ABCC1;PSEN1;FYN;IGF1
prerank,B cell differentiation (GO:0030183),0.5667478964992483,1.6963047827860458,0.01167883211678832,0.24144328900695947,1.0,12/46,10.32%,HDAC9;ITGA4;PTPRJ;ITGB1;KLF6;IRF2BP2;CR2;LYL1;CEBPG;FNIP1;NHEJ1;SLC25A5
prerank,positive regulation of cell-substrate adhesion (GO:0010811),0.542441309725928,1.6955797830747248,0.0042796005706134095,0.24104713093101193,1.0,14/67,4.76%,NRP1;NEDD9;MYADM;RREB1;ALOX15;CASS4;DOCK1;CD36;CDC42;CRK;UTRN;S100A10;CDK6;GSK3B
prerank,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),0.6363469630813404,1.6947122424110619,0.011647254575707155,0.2410650635586319,1.0,3/24,2.18%,RBPJ;KLF2;CEBPB
prerank,adrenergic receptor signaling pathway (GO:0071875),0.6791931596903751,1.6920685411110234,0.008488964346349746,0.24487211538133638,1.0,8/20,12.97%,ADRB2;DRD1;RAPGEF2;ADCY9;PDE4D;ADRA1D;ADRA1A;LMBRD2
prerank,positive regulation of lymphocyte proliferation (GO:0050671),0.5526293163831177,1.691625908980544,0.004273504273504274,0.24393113621053225,1.0,12/63,6.96%,VAV3;CD38;IL15;BST1;MEF2C;CD74;CD46;CCL19;IRS2;CD40;BCL2;CD80
prerank,positive regulation of interleukin-10 production (GO:0032733),0.619620231113488,1.6882822883933428,0.01644736842105263,0.24901597406510473,1.0,7/30,6.57%,LILRA5;IRF4;TSLP;TLR4;PIBF1;CD46;SYK
prerank,membrane organization (GO:0061024),0.46275477396193,1.6882147118098023,0.0,0.24728145401193835,1.0,42/227,10.87%,DAB2;ITSN1;TMCC1;AP2A2;HIP1;EGFR;SNX9;FCHO2;MYADM;LDLR;REEP3;EPS15;REPS2;CLTC;ACTR3;RPS27A;ADRB2;SPTBN1;SYNJ1;DCSTAMP;CBL;AGFG1;MYOF;SERP1;SNX3;OCRL;ACTB;GAPVD1;AP2S1;EPN2;ARPC2;ARPC5;VPS4B;FNBP1;PIK3C2A;RABEP1;GLTP;CORO1C;ARRB1;PACSIN2;ATP10B;CHMP5
prerank,regulation of tumor necrosis factor production (GO:0032680),0.4993681309295079,1.683583742250391,0.003911342894393742,0.2550157768014624,1.0,27/112,8.69%,PF4;APP;LILRA5;PTPRJ;FOXP1;OAS2;GAS6;IRAK3;NR1H4;PTPN22;RIPK1;LILRB1;TLR4;CCL19;LBP;TLR2;NFKBIL1;GHRL;MAPKAPK2;LY96;TMEM106A;SYK;HSPB1;CCR2;PSEN1;TRIM27;CD33
prerank,regulation of interleukin-13 production (GO:0032656),0.7201244035099417,1.681586998110595,0.020257826887661142,0.2576756172338047,1.0,3/13,2.14%,LILRA5;IRF4;TSLP
prerank,triglyceride catabolic process (GO:0019433),-0.6048471642815891,-1.6812081574257147,0.014018691588785047,0.4061301222548851,1.0,4/19,15.18%,FABP5;LIPH;LPL;FABP4
prerank,positive regulation of B cell activation (GO:0050871),0.5679827456604131,1.6805940081368318,0.014641288433382138,0.25779530546650825,1.0,19/50,17.66%,VAV3;CD38;BST1;MEF2C;CD74;IRS2;PPP2R3C;CD40;BCL2;SYK;NFATC2;KMT5B;NOD2;GPR183;TIRAP;SHLD3;CHRNB2;XBP1;IL6
prerank,negative regulation of cell activation (GO:0050866),0.7194697566124478,1.6790775344830016,0.02640845070422535,0.25930298403551055,1.0,5/14,5.33%,APOE;LDLR;C1QTNF1;NR1D1;PDGFRA
prerank,positive regulation of cardiac muscle cell proliferation (GO:0060045),0.7186947219359037,1.678635374783357,0.011976047904191617,0.2583296509331272,1.0,2/13,2.01%,RBPJ;MEF2C
prerank,regulation of mitochondrial fusion (GO:0010635),0.7650262399914547,1.6774288298898745,0.025,0.25900088053854203,1.0,2/11,4.00%,PID1;PRKN
prerank,regulation of interleukin-1 beta production (GO:0032651),0.532614365485921,1.675948344517525,0.00583941605839416,0.2602989359261201,1.0,23/66,13.90%,NLRC4;P2RX7;APP;LILRA5;FOXP1;TLR8;CD36;TLR4;CCL19;GHRL;TMEM106A;HSPB1;TNF;CD33;CARD16;IGF1;RIPK2;TRIM16;CASP8;ZC3H12A;NOD2;FFAR1;STAT3
prerank,endothelial cell development (GO:0001885),0.6377274919411251,1.674716708015323,0.025817555938037865,0.261050321693148,1.0,10/25,8.63%,RAP1B;MYADM;CNMD;TNMD;RAPGEF2;PDE2A;RAP1A;PDE4D;COL22A1;MSN
prerank,positive regulation of BMP signaling pathway (GO:0030513),0.620761817373068,1.6743304392967406,0.025167785234899327,0.2600405173176506,1.0,3/25,6.32%,RBPJ;SMAD4;ACVR2A
prerank,sterol transport (GO:0015918),0.689229236625926,1.6734997779094627,0.022452504317789293,0.25984870950790606,1.0,3/19,2.76%,MSR1;LDLR;CD36
prerank,regulation of membrane protein ectodomain proteolysis (GO:0051043),0.6553924839239924,1.6729642819256179,0.021487603305785124,0.25917722585162145,1.0,6/22,6.94%,APOE;SNX9;TNFRSF1B;ADAM9;ROCK1;TNF
prerank,positive regulation of macrophage derived foam cell differentiation (GO:0010744),0.7014158362670345,1.6719375893135284,0.012455516014234875,0.25945846663528366,1.0,3/15,2.76%,MSR1;PF4;CD36
prerank,positive regulation of response to external stimulus (GO:0032103),0.4850140180371248,1.6717931189115225,0.0,0.25801009110618284,1.0,28/128,8.54%,APP;IL16;LILRA5;TLR8;SASH1;IL15;TSLP;PLA2G7;DDX60;RIPK1;TLR4;GRN;ANKRD17;CCL19;SCARF1;NFKBIZ;PDE2A;TLR2;IL17RA;GPRC5B;PUM2;LY96;RIOK3;TNF;ABCC1;USP15;CCR2;NINJ1
prerank,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),0.5571637289407504,1.671454753763903,0.016566265060240965,0.2571240625636251,1.0,9/48,3.94%,NRP1;NEDD9;MYADM;RREB1;CASS4;DOCK1;CDC42;CRK;S100A10
prerank,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),0.4950761414759612,1.670763993666529,0.006535947712418301,0.2568103833689377,1.0,22/121,6.96%,BANK1;NRP1;NEDD9;LILRA5;PTPRJ;CLEC6A;IL15;GAS6;LYN;TSLP;CD44;CASS4;PARP14;CD74;THBS4;PIBF1;DOK7;GPRC5B;PAK2;CD40;TNF;CD80
prerank,response to tumor necrosis factor (GO:0034612),0.5024019505468805,1.6702427647282099,0.006915629322268326,0.2562361431135252,1.0,21/91,11.05%,PID1;GBP3;ZFP36L2;RPS3;RIPK1;CCL8;NR1D1;DCSTAMP;ADAM9;CCL19;ZFP36L1;TNFRSF11A;GSDME;GCH1;TRIM32;CD40;CXCL16;CCL24;IGBP1;SFRP1;CASP8
prerank,cellular response to fluid shear stress (GO:0071498),0.7493195189526464,1.6701334774773775,0.02707581227436823,0.25488744906909266,1.0,8/12,16.14%,MTSS1;KLF2;MEF2C;KLF4;ASS1;SREBF2;PKD2;MAPK7
prerank,high-density lipoprotein particle remodeling (GO:0034375),0.6991185848790614,1.6691710386801306,0.023593466424682397,0.2552334950064743,1.0,2/15,0.49%,PLTP;APOE
prerank,heterocycle biosynthetic process (GO:0018130),0.7323761219309082,1.6675004656570738,0.022944550669216062,0.25721457334858466,1.0,4/14,4.55%,ALOX5;MOCS1;HDC;GCH1
prerank,B cell receptor signaling pathway (GO:0050853),0.5880181744525633,1.6672551103546966,0.004901960784313725,0.25602783795983086,1.0,8/32,9.25%,VAV3;CD38;MEF2C;RFTN1;BCL2;SYK;PRKCB;NFATC2
prerank,negative regulation of protein transport (GO:0051224),0.6352280639438904,1.6658739231045083,0.023423423423423424,0.25730449340218403,1.0,6/25,6.40%,APOE;HMGCR;NDFIP1;SNX3;RHBDF1;DPH3
prerank,regulation of protein kinase activity (GO:0045859),0.5024699557975315,1.6642994362232124,0.004005340453938585,0.2591416418866608,1.0,27/106,9.65%,LRP6;GNAQ;SPRED1;DEPTOR;IQGAP1;SNX9;PRKAG2;GAS6;C5AR1;RAP2B;RASSF2;UVRAG;CCL19;RAPGEF2;ITGB1BP1;RAP1A;RB1;CAMKK2;PAK2;SFN;CEP85;HSPB1;TNF;DDR2;TRIM27;SMCR8;CACUL1
prerank,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),0.6097813053881316,1.663948042505729,0.014084507042253521,0.25829811462424307,1.0,7/32,12.01%,PF4;ANG;RPL39;RPL30;RNASE6;ROMO1;FAM3A
prerank,regulation of bone mineralization (GO:0030500),0.5490090865921139,1.6633924547360706,0.009036144578313253,0.2577165677091456,1.0,13/55,6.32%,NELL1;P2RX7;ALOX5;ATP2B1;CCR1;ANO6;MEF2C;OSR1;BMP2;FGF23;SRGN;NOTUM;ACVR2A
prerank,purine ribonucleotide transport (GO:0015868),0.6875591031479236,1.6621021765744597,0.031141868512110725,0.2587344085736546,1.0,4/16,6.85%,LRRC8D;SLC25A17;SLC25A24;ABCC4
prerank,synaptic vesicle exocytosis (GO:0016079),-0.49520411739810927,-1.6617375168905655,0.0,0.47261795136336604,1.0,15/40,19.42%,RIMS1;UNC13C;RIMS2;SNAP25;PIP5K1C;PCLO;SNAP47;STX3;CPLX1;VAMP2;SYT8;STX2;RIMS3;SYT1;CPLX2
prerank,regulation of transcription by RNA polymerase III (GO:0006359),-0.6072297004018664,-1.6605605569143127,0.012106537530266344,0.46155025790198273,1.0,11/19,21.95%,RPTOR;POLR3C;AR;ICE2;ZNF76;MAF1;BRF2;MTOR;PRDX5;POLR3G;ELL
prerank,negative regulation of cellular carbohydrate metabolic process (GO:0010677),0.6388697969722237,1.660065627808977,0.024734982332155476,0.26128968294697735,1.0,7/23,15.43%,NUPR1;C1QTNF3;CBFA2T3;C1QTNF12;NCOR1;EP300;HDAC4
prerank,cardiac ventricle morphogenesis (GO:0003208),0.5752745666424453,1.6600104851012087,0.01228878648233487,0.25981010595110365,1.0,5/41,4.49%,RBPJ;JAG1;MEF2C;MYH6;HEY2
prerank,rRNA processing (GO:0006364),0.4675601701382031,1.6599530497617587,0.0,0.25834189453702217,1.0,58/172,14.84%,RPL17;RPL23;RPS16;NOL6;RPL39;RPL23A;RPS15;RPL37;RPLP1;RPL26;RPLP2;SNU13;RPL41;RPS28;RPL13;RPS24;RPL24;RPL12;RPL36A;RPL18A;RPL37A;RIOK3;RPL28;WDR36;NOP53;RPL30;NOL9;RPL8;RPL35A;RPL38;RPS17;RPLP0;RPL5;RPL36;RPL14;RPS14;RPL9;RPS9;RPS7;RPL34;RPL27;MTREX;RPL6;HEATR1;RPS6;MRPL1;RPL4;RPL22;RPL15;RPL10;DDX10;RPL32;EXOSC8;ESF1;RPL19;EXOSC1;RPL31;RPL11
prerank,regulation of dendrite morphogenesis (GO:0048814),-0.5256573137257677,-1.6572857198477127,0.007853403141361256,0.45992447835060385,1.0,14/32,12.45%,ADGRB3;CUX1;SEMA4D;PTPRD;YWHAH;HECW2;SS18L1;NSMF;SDC2;KNDC1;HECW1;CAPRIN1;SS18L2;IL1RAPL1
prerank,innate immune response (GO:0045087),0.459052184180732,1.657273907665598,0.001148105625717566,0.26230497924887486,1.0,46/217,11.03%,NRROS;APP;CFP;CYBB;COLEC12;TLR8;CLEC6A;IFITM3;LYN;ANG;MFHAS1;FER;ALPK1;RPL39;FCER1G;CD74;TLR4;ANKRD17;SERINC3;B2M;LBP;BCL10;TLR2;FRK;TRIM56;GCH1;TRIM32;CD40;SYK;CR2;ZAP70;BST2;REL;RNASE6;CXCL16;FYN;TRIM68;MFAP4;CLEC4D;TRIM27;IFITM2;RIPK2;STYK1;SP100;NCF2;SLA
prerank,positive regulation of neutrophil migration (GO:1902624),0.6662458809581145,1.657116645181842,0.022298456260720412,0.2610436756132816,1.0,6/18,4.25%,RIPOR2;CD74;THBS4;CAMK1D;CCL19;MCU
prerank,positive regulation of MAPK cascade (GO:0043410),0.45165889313924584,1.6567121037329915,0.0011560693641618498,0.2602161320759777,1.0,43/245,10.21%,NRP1;EGFR;APOE;FGFR1;APP;LILRA5;PTPRJ;NOTCH2;CCR1;IQGAP1;FBXW7;GAS6;ALOX15;C5AR1;MFHAS1;PTPN22;CD44;ADRB2;BMP2;CD36;CD74;CCL8;P2RY6;THPO;CCL19;RAPGEF2;PDE8A;GSDME;RAP1A;INSR;PDGFRA;ROCK1;TMEM106A;CD40;PIK3R6;TNF;CCL24;ADRA1D;ADRA1A;PDGFC;MYDGF;IGF1;ARRB1
prerank,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),0.5078240144957339,1.6566320537893535,0.00823045267489712,0.2588053129512398,1.0,10/86,7.63%,RBPJ;DAB2;ZEB2;BMP2;GDF3;SMAD4;GDF10;ACVR2A;SDCBP;HFE
prerank,positive regulation of protein binding (GO:0032092),0.5422892399027639,1.6559805316780114,0.011594202898550725,0.2585210924848038,1.0,19/56,14.84%,APOE;APP;TCF7L2;BMP2;RAPGEF2;B2M;PRKN;GSK3B;STK3;NMD3;HFE;PSEN1;PPP2CA;PPP2CB;RIPK2;AMFR;RALB;ADD1;RPL11
prerank,regulation of lymphocyte proliferation (GO:0050670),0.6779171070733248,1.6538246580643097,0.022530329289428077,0.26119569757233196,1.0,3/16,2.42%,AHR;PTPN22;TNFRSF1B
prerank,negative regulation of B cell proliferation (GO:0030889),0.7477598021176749,1.6526181299861444,0.027726432532347505,0.2620973977258947,1.0,3/11,5.30%,FCGR2B;LYN;RC3H1
prerank,endothelial tube morphogenesis (GO:0061154),0.7695996450451115,1.6501055712769754,0.015748031496062992,0.2655959387755245,1.0,3/10,4.43%,RBPJ;RHOA;CCM2
prerank,regulation of epithelial cell proliferation (GO:0050678),0.49940321356389805,1.6476925002296672,0.006501950585175552,0.26884613140124936,1.0,16/85,10.04%,MTSS1;EGFR;TCF7L2;C5AR1;NUPR1;OSR1;NR1D1;GRN;ZFP36L1;B2M;MCC;CDK6;NR4A1;CDC73;IGF1;SFRP1
prerank,Golgi localization (GO:0051645),0.7338514707342287,1.6471303040365706,0.03435114503816794,0.2685555902290284,1.0,3/11,3.32%,ARHGAP21;UVRAG;CDC42
prerank,spliceosomal complex assembly (GO:0000245),-0.4768189076439628,-1.6462529444675955,0.0056657223796034,0.4949562841114833,1.0,18/46,18.00%,LUC7L3;SETX;SRSF5;DDX39B;SRPK1;PUF60;SRSF10;CELF4;SNRNP200;SRPK2;PRPF19;SF3B1;DDX1;NCBP1;PRPF6;DDX23;RBM5;SRSF9
prerank,embryonic eye morphogenesis (GO:0048048),0.741601240094906,1.6406543203174837,0.040152963671128104,0.28095010770282525,1.0,2/11,1.94%,LRP6;RARG
prerank,signal release from synapse (GO:0099643),-0.4758401675997327,-1.6405756438784391,0.006134969325153374,0.505974403240511,1.0,16/43,22.33%,RIMS1;SNAP25;NRXN1;PIP5K1C;PCLO;DVL1;SYN3;CPLX1;PTPRN2;LIN7A;VAMP2;LIN7C;SYT1;CPLX2;BRSK1;GAD1
prerank,negative regulation of inflammatory response (GO:0050728),0.4592049996434045,1.6372965318741075,0.0024509803921568627,0.2866560795910907,1.0,39/182,13.33%,CD163;AOAH;APOE;ALOX5;LYN;C1QTNF3;MFHAS1;CYSLTR1;NR1H4;GNG2;METRNL;TNFRSF1B;CALCRL;ADRB2;DRD1;NR1D1;GRN;ADM;RB1;GHRL;CD200R1;ADCY9;ADCYAP1R1;SYK;KLF4;GNB1;FYN;FCGR3A;MAPK14;IGF1;TSHR;PTGER4;PRKACB;HTR6;RAMP2;TNFRSF1A;GLP2R;CREB1;GPR27
prerank,negative regulation of protein localization to plasma membrane (GO:1903077),0.651307321625709,1.63666067282862,0.039723661485319514,0.28658246568628437,1.0,3/20,1.61%,DAB2;PID1;CLTC
prerank,toll-like receptor signaling pathway (GO:0002224),0.5079317021706449,1.6365944405062816,0.006887052341597796,0.28517504359825707,1.0,23/84,11.05%,COLEC12;TLR8;IRAK3;NR1H4;RPS27A;S100A1;RIPK1;CD36;TLR4;MAP3K1;RPS6KA3;RFTN1;LBP;BCL10;TLR2;BIRC3;MAPKAPK2;CTSB;LY96;EPG5;UBE2D3;RIPK2;CASP8
prerank,regulation of Notch signaling pathway (GO:0008593),0.50975972513518,1.6343403260797662,0.014164305949008499,0.2885174353674257,1.0,22/76,15.56%,RBPJ;EGFR;FBXW7;JAG1;CD46;ITGB1BP1;NRARP;EPN2;SYNJ2BP;POGLUT1;ARRB1;MAML1;EGFL7;SREBF2;CREBBP;NIBAN2;NOD2;STAT3;EP300;LFNG;SNW1;TSPAN14
prerank,regulation of small GTPase mediated signal transduction (GO:0051056),0.46728802823216514,1.6340091729910542,0.0024937655860349127,0.2875980473588625,1.0,26/140,7.94%,ARHGEF3;ITSN1;ARHGAP15;STARD8;VAV3;PLEKHG5;FGD4;ARHGAP9;OPHN1;ARAP1;ARHGAP21;ARHGAP10;ARHGAP18;CDC42;ARHGAP31;RHOA;TRIO;OCRL;ARHGAP29;NGEF;FOXM1;DEPDC1B;ARHGAP12;ARHGAP23;ARHGEF12;ARHGDIA
prerank,negative regulation of gene expression (GO:0010629),0.43595005208078036,1.6338869562250675,0.0011261261261261261,0.28633121816859763,1.0,70/302,13.83%,HDAC9;MSR1;FCGR2B;APOE;APP;ATP2B1;NOTCH2;CCR1;FOXP1;FBXW7;MYADM;ESR1;ZFP36L2;RPS3;DAPK1;MEF2C;PTPN22;BMP2;XDH;PARP14;ERN1;PPHLN1;CD46;SAMD4A;SRGN;RGCC;RPS13;PRKN;JARID2;MRPL13;HEY2;PTBP3;SPI1;RB1;NDFIP1;RACK1;EPC1;SETDB2;TNF;ZNF148;KLF4;YY1;REL;MALSU1;PSEN1;PTBP2;RBM4;NCOR1;TRIM27;SMCR8;H3-3A;ILF3;IGF1;SFRP1;DDX6;PTGER4;EMILIN1;DCP2;HINFP;NANOS3;ROCK2;TRIM71;ZC3H12A;ATP2B4;DIS3L2;ZC3H12D;LSM2;SHMT1;TNRC6C;NDFIP2
prerank,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),0.5214650824263056,1.6317780777895903,0.012084592145015106,0.28949042969006594,1.0,10/65,5.99%,HIP1;EGFR;PTPRJ;EPS15;ARAP1;FER;PTPN12;CDC42;CBL;RHBDF1
prerank,negative regulation of protein localization to cell periphery (GO:1904376),0.6531403739942643,1.630704265669766,0.04521739130434783,0.29027345062561416,1.0,3/20,1.61%,DAB2;PID1;CLTC
prerank,second-messenger-mediated signaling (GO:0019932),0.5051773855773458,1.6306168950377722,0.006858710562414266,0.2888858192912138,1.0,13/82,7.81%,MCTP1;EDNRB;APOE;HRH1;CCR1;RCAN3;CD36;MCU;CAMKK2;CCRL2;CXCR4;CCR2;MCTP2
prerank,placenta development (GO:0001890),0.7210132373924201,1.6304988639293043,0.024778761061946902,0.28762199621103446,1.0,5/12,16.88%,ADAM19;ANG;PLAC1;E2F8;CUL7
prerank,energy reserve metabolic process (GO:0006112),0.6569812694932861,1.6289796459788535,0.023214285714285715,0.28925815269343447,1.0,6/19,9.41%,PID1;PRKAG2;GBE1;GSK3B;GFPT2;PPP1R3C
prerank,positive regulation of nitric oxide metabolic process (GO:1904407),0.6305704592109149,1.6286624330228217,0.011494252873563218,0.2884313156916996,1.0,10/26,16.01%,KLF2;CD36;TLR4;INSR;TMEM106A;TNF;KLF4;ASS1;PKD2;HSP90AB1
prerank,clathrin coat assembly (GO:0048268),0.6833561195224093,1.627889810424026,0.037300177619893425,0.28848244529941824,1.0,6/15,8.29%,HIP1;FCHO2;EPS15;CLTC;AP2S1;PIK3C2A
prerank,positive regulation of NIK/NF-kappaB signaling (GO:1901224),0.5520877111160764,1.6265620162570673,0.014903129657228018,0.2897009621476925,1.0,9/50,6.94%,EGFR;APP;SASH1;RPS3;TLR4;CCL19;RHOA;TLR2;TNF
prerank,regulation of interleukin-6 production (GO:0032675),0.49162693019728065,1.625678256120092,0.004037685060565276,0.28999630596358456,1.0,23/96,8.25%,APP;IL16;LILRA5;TLR8;GAS6;C1QTNF3;IRAK3;PTPN22;TSLP;CD74;TLR4;LBP;BCL10;TLR2;IL17RA;GHRL;CD200R1;MAPKAPK2;TMEM106A;SYK;TNF;RAB7B;IL6R
prerank,mitochondrion morphogenesis (GO:0070584),0.7332733078133034,1.6256442950307997,0.034026465028355386,0.28854374586391907,1.0,2/11,2.48%,PID1;MTM1
prerank,defense response to bacterium (GO:0042742),0.4844655622745914,1.6250589198190397,0.010230179028132993,0.2882947198583801,1.0,23/105,11.65%,STAB1;NLRC4;CFP;COLEC12;OAS2;ANG;CEBPB;RPL39;FCER1G;TLR4;ANKRD17;LBP;TLR2;GBP7;DROSHA;RPL30;SYK;RNASE6;IL6R;RAB1A;SHC1;ROMO1;CHGA
prerank,dopaminergic neuron differentiation (GO:0071542),0.6567821152500334,1.6240099190196406,0.03418803418803419,0.2891152155470633,1.0,5/19,7.86%,LRP6;PHOX2A;WNT2;MANF;NR4A2
prerank,negative regulation of cysteine-type endopeptidase activity (GO:2000117),0.5517928553275226,1.6237679576179946,0.017133956386292833,0.2880833514909727,1.0,22/44,20.34%,GAS6;CD44;SH3RF1;SIAH2;LAMP3;RPS6KA3;SFN;TNF;KLF4;FNIP1;CARD16;IGBP1;PCID2;YWHAE;LAMTOR5;CAST;USP47;BEX3;HGF;RAF1;CSNK2A1;SNCA
prerank,regulation of immune response (GO:0050776),0.46461181929964984,1.6236615369372882,0.001272264631043257,0.28687142331617055,1.0,26/135,9.29%,FCGR2B;ITGA4;COLEC12;IRF4;FOXP1;IL15;AHR;LYN;ITGB1;PTPN22;CD300LG;CLEC2D;LILRB1;DENND1B;CD300LD;B2M;KIR3DL2;BIRC3;CD200R1;CD40;SYK;ZMPSTE24;FCGR3B;FCGR3A;CD33;RAET1E
prerank,heart trabecula morphogenesis (GO:0061384),0.6567268988811764,1.6235740915665,0.03590664272890485,0.2855688233003537,1.0,2/18,0.88%,RBPJ;ADGRG6
prerank,actin cytoskeleton reorganization (GO:0031532),0.5319457081323902,1.6228146390858906,0.014265335235378032,0.28563741418111815,1.0,15/63,11.26%,NRP1;NEDD9;CDC42BPG;FER;CASS4;GPR65;RHOA;MCU;S1PR2;EFS;NRK;GAB1;ANTXR1;PIP5K1A;S1PR1
prerank,positive regulation of protein metabolic process (GO:0051247),0.4844745888529292,1.622304009836474,0.00261437908496732,0.2852709698503085,1.0,32/110,15.31%,WWP1;PAEP;APOE;APP;KLF2;SMURF2;RILP;AXIN1;PRKN;BCL10;GSK3B;TRIM32;TNF;CD80;KLF4;MTPN;PSEN1;RAB7A;TNFSF12;RANBP9;RAB1A;NKD1;ATG7;WFS1;ROCK2;FOXO1;TFR2;NR1H2;NEDD4L;GPC3;PRMT1;RNF41
prerank,positive regulation of transport (GO:0051050),0.4996200295999772,1.6214036175290485,0.009859154929577466,0.28563382132545906,1.0,14/85,6.94%,DAB2;FCGR2B;APOE;IL15;DOCK2;GAS6;KMT2A;FCER1G;CAMK1D;CCL19;GSK3B;ACTB;ANXA2;TNF
prerank,positive regulation of fibroblast proliferation (GO:0048146),0.6070807926614252,1.620962219140992,0.028892455858747994,0.2852338582303801,1.0,11/27,15.37%,GAS6;LIG4;CD74;WNT2;CDK6;PDGFRA;DDR2;PDGFC;IGF1;MYC;FN1
prerank,"phototransduction, visible light (GO:0007603)",0.6858795768798879,1.6204779045565803,0.04007285974499089,0.28472160766277366,1.0,4/14,8.00%,GNAQ;RP1;PDE6A;GNB1
prerank,amide transport (GO:0042886),0.6242523571278649,1.619972226704193,0.022187004754358162,0.28466124058215475,1.0,3/26,4.17%,PLTP;FOLR2;SLC14A1
prerank,regulation of interleukin-8 production (GO:0032677),0.5159408985868683,1.619544475338557,0.013043478260869565,0.28412539154770927,1.0,26/69,19.40%,TLR8;PTPN22;RIPK1;CD74;TLR4;LBP;BCL10;TLR2;SYK;TNF;KLF4;CD33;RAB1A;SSC5D;ARRB1;LAMTOR5;NOD2;STAT3;PRKD2;TIRAP;RELA;TLR7;IL6;F2R;MAPKBP1;BCL3
prerank,regulation of axon guidance (GO:1902667),0.741541529974304,1.6182934495865537,0.041121495327102804,0.28507849839252014,1.0,3/10,6.20%,NRP1;ZSWIM6;MYCBP2
prerank,negative regulation of viral life cycle (GO:1903901),0.6827069663303971,1.6173370533896874,0.03169014084507042,0.28598094845953614,1.0,7/15,14.92%,IFITM3;SNX3;BST2;IFITM2;LY6E;MID2;PPIA
prerank,cholesterol transport (GO:0030301),0.5494175486531488,1.6172125845442993,0.021505376344086023,0.2848690008137026,1.0,4/45,2.76%,MSR1;APOE;LDLR;CD36
prerank,regulation of reactive oxygen species metabolic process (GO:2000377),0.5395390583309982,1.6160727129868726,0.01859799713876967,0.2858818401054663,1.0,12/55,12.28%,PID1;ALOX5;BST1;XDH;RIPK1;PRKN;PARL;PIKFYVE;FOXM1;MAPK14;ROMO1;ZC3H12A
prerank,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),0.5853160022182728,1.6146456162338374,0.03912363067292645,0.28747233689272467,1.0,10/32,11.96%,HDAC9;RHOA;HMOX1;ITGB1BP1;KLF4;PIK3C2A;FOXC2;STARD13;MMRN2;MAP3K3
prerank,mesenchymal cell differentiation (GO:0048762),0.5353498670236871,1.6144113185255708,0.02147239263803681,0.28655211095976735,1.0,10/51,5.43%,RBPJ;LRP6;FGFR1;S100A4;MEF2C;FBXL17;BMP2;HEY2;GSK3B;ROCK1
prerank,positive regulation of lipid storage (GO:0010884),0.6318288331410415,1.613938448833432,0.034722222222222224,0.28611103559940465,1.0,6/21,12.28%,MSR1;EHD1;OSBPL11;VSTM2A;SREBF2;ZC3H12A
prerank,negative regulation of cold-induced thermogenesis (GO:0120163),0.5481500305959554,1.6136731132577926,0.021052631578947368,0.2854273839358639,1.0,11/46,10.08%,RBPJ;IL15;TLR4;NR1D1;NPR3;RB1;LNPEP;PLCL2;ARRDC3;FOXC2;DOCK7
prerank,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),0.5109598539209876,1.6131480294969314,0.008253094910591471,0.28492552508926433,1.0,17/73,7.76%,PF4;APP;LILRA5;PTPRJ;OAS2;RIPK1;TLR4;CCL19;LBP;BCL10;TLR2;LY96;TMEM106A;SYK;HSPB1;CCR2;PSEN1
prerank,negative regulation of protein metabolic process (GO:0051248),0.5320690164978822,1.6127157216158448,0.022590361445783132,0.28451812266661586,1.0,10/48,5.43%,EDNRB;EGFR;APOE;LDLR;IRAK3;RILP;HMGCR;SF3B3;SNX3;ROCK1
prerank,cellular response to cytokine stimulus (GO:0071345),0.42402896771362186,1.6126731188766554,0.0,0.28330021167410724,1.0,70/416,9.60%,F13A1;PID1;PF4;LIFR;ALOX5;IL16;PTPRJ;IRF4;CCR1;PTPN18;GAS6;RIPOR2;ALOX15;PTPN20;GBP3;ZFP36L2;ITGB1;FER;PTPN12;RPS3;DAPK1;IRAK3;IFNAR1;RPS27A;OXSR1;TNFRSF1B;RIPK1;CD36;CCL8;TLR4;NR1D1;DCSTAMP;CBL;CCL19;CRK;ZFP36L1;RHOA;HMOX1;LBP;VIM;PDE2A;TLR2;DUSP1;GSDME;MCL1;GSK3B;IL10RB;GBP7;RC3H1;WNK1;TCF7;CD40;BCL2;SYK;TNF;CD80;CXCR4;CCR2;IL20RB;STAT4;IFNAR2;FYN;CCL24;IL6R;RO60;UBE2K;SH2B3;NDN;IFITM2;STAT6
prerank,glycolipid metabolic process (GO:0006664),-0.4597281854057713,-1.6125019387226434,0.014792899408284023,0.6261407234339667,1.0,12/47,9.70%,HEXB;CERK;ST3GAL6;ST6GALNAC3;SMPD4;ESYT1;NEU1;ASAH1;ST6GALNAC4;ESYT2;SCCPDH;GBA2
prerank,positive regulation of proteolysis (GO:0045862),0.5284885946913839,1.6117587764208148,0.013254786450662739,0.2839913481887531,1.0,11/55,6.94%,NLRC4;APOE;CTSC;SNX9;TNFRSF1B;RCN3;ADAM9;CLN6;RHBDD1;TRIM32;TNF
prerank,cAMP-mediated signaling (GO:0019933),0.6281293007595378,1.611751775039027,0.027868852459016394,0.28270339430826674,1.0,7/24,6.13%,PDE7B;ADGRG6;AHR;RAPGEF2;PDE2A;PDE4D;PDE7A
prerank,positive regulation of membrane protein ectodomain proteolysis (GO:0051044),0.680160897011863,1.6108476901602151,0.035211267605633804,0.2833272818181247,1.0,5/15,6.94%,APOE;SNX9;TNFRSF1B;ADAM9;TNF
prerank,gene expression (GO:0010467),0.423741676791306,1.6101884230043513,0.0011025358324145535,0.2832727680635072,1.0,104/348,15.09%,DHX8;RBMS1;RPS29;MEF2A;RPS23;MRPL23;RPL17;RPL23;MRPS12;RPS12;RPS16;RPS3;RPS27A;RPL39;RPS18;RPS21;EEF1A1;RPL23A;RPS15;RPL37;RPLP1;AGFG1;RPL26;RPS10;RPS20;RPS13;RPLP2;RPSA;RPL41;RPS28;MRPL13;RPL13;RPS24;RSL24D1;RPL24;RPL12;RPL36A;RPS8;RPL18A;SMG6;DROSHA;RPL37A;THRB;RPS11;RPL28;RNASEL;ATXN1;DARS1;EPC1;RPL30;NOL9;HNRNPF;RPL8;RPL35A;RPS4X;RPS15A;RPL38;RPS17;RPLP0;CPSF3;MRRF;SRSF4;RPL5;RPL36;NR4A2;RNGTT;RPL14;NUP133;RBM4;RPS14;RPL9;RPS9;RPS5;RPS7;RPL34;RPL27;MRPS11;MED20;APOBEC1;POLR2B;RPL6;RPS6;NUP62;THOC6;RPL4;RPL22;EIF4EBP2;RPL15;RPL10;RPL32;NUP98;MRPS17;MRPL44;MAGOHB;NFKBIB;RPL19;MRPS14;MMS19;POLR2D;RPL31;RPL11;NOVA1;SRBD1;NOX4
prerank,cellular response to organic cyclic compound (GO:0071407),0.4608092754908395,1.6097115914123574,0.0025188916876574307,0.28294699119717887,1.0,36/141,12.28%,EGFR;P2RX7;RAP1B;HRH1;CTNNA1;AHR;DIAPH1;ESR1;NCOA3;MEF2C;NR1H4;GNG2;DRD1;P2RY6;ZFP36L1;RAPGEF2;PDE2A;AOC1;NR3C1;RAP1A;ACTB;RIOK3;TNF;EPG5;NRIP1;GNB1;MSN;HCN3;LCOR;SFRP1;SPIDR;TRPM2;JUP;KCNQ1;ROCK2;ZC3H12A
prerank,positive regulation of purine nucleotide biosynthetic process (GO:1900373),0.7313832564665248,1.6093105010329518,0.03642987249544627,0.28248405216292144,1.0,1/13,0.05%,PID1
prerank,keratan sulfate catabolic process (GO:0042340),-0.6775684462211539,-1.6088225313736204,0.018480492813141684,0.6279306628577823,1.0,2/11,2.47%,HEXB;GNS
prerank,positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),0.6721632901997115,1.6086958058570415,0.043782837127845885,0.28239076963785964,1.0,10/16,18.57%,ALOX5;FUT4;RHOA;TNF;ITGB2;MDK;ST3GAL4;RELA;IL6;TRAF6
prerank,regulation of protein binding (GO:0043393),0.4774449949381851,1.6072040751797172,0.006402048655569782,0.28421344037505425,1.0,28/114,11.25%,DAB2;APP;TCF7L2;BMP2;NES;CRK;RAPGEF2;ITGB1BP1;B2M;PRKN;BTBD1;GSK3B;RACK1;CFHR2;ROCK1;DISC1;ACTB;STK3;NMD3;DDX11;HFE;PSEN1;CARD16;PPP2CA;RIPK2;MARK2;PPP1CA;AMFR
prerank,negative regulation of macrophage activation (GO:0043031),0.6715165005729737,1.6071768876612933,0.03436426116838488,0.2830313004002408,1.0,4/16,3.26%,FCGR2B;LDLR;NR1D1;GRN
prerank,ribosome biogenesis (GO:0042254),0.4451528068170899,1.6064754795184033,0.0024067388688327317,0.28335917804865285,1.0,62/187,16.16%,RPL17;RPL23;RPS16;NOL6;RPL39;RPL23A;RPS15;RPL37;RPLP1;RPL26;RPLP2;SNU13;RPL41;RPS28;RPL13;RPS24;RPL24;RPL12;RPL36A;RPL18A;RPL37A;RPL28;WDR36;LTV1;NOP53;RPL30;NOL9;RPL8;RPL35A;RPL38;RPS17;RPLP0;RPL5;MALSU1;RPL36;RPL14;RPS14;RPL9;RPS9;RPS7;RPL34;RPL27;MTREX;RPL6;HEATR1;RPS6;RPL4;RPL22;RPL15;RPL10;DDX10;RPL32;EXOSC8;ESF1;RPL19;EXOSC1;RPL31;RPL11;XPO1;NOP58;MPHOSPH6;LSG1
prerank,detection of visible light (GO:0009584),0.6586198106943452,1.606237082723666,0.040955631399317405,0.2826636692795657,1.0,5/16,18.29%,GNAQ;RP1;GNA11;REEP6;ABCA4
prerank,"synaptic transmission, cholinergic (GO:0007271)",0.6510308951915238,1.6055659102118967,0.04054054054054054,0.2826704245229586,1.0,5/19,11.75%,APOE;RAPSN;CHRNA4;ACHE;COLQ
prerank,glycosphingolipid metabolic process (GO:0006687),-0.4741541123511549,-1.6032294431024927,0.028328611898016998,0.6400104629847736,1.0,11/42,9.70%,HEXB;LARGE1;CERK;ST3GAL5;ST6GALNAC3;SMPD4;ESYT1;NEU1;ASAH1;ESYT2;GBA2
prerank,positive regulation of cholesterol efflux (GO:0010875),0.6370259060289364,1.6031911919214792,0.03745928338762215,0.28621298495090647,1.0,2/21,0.49%,PLTP;APOE
prerank,negative regulation of protein secretion (GO:0050709),0.5579537839980129,1.6029996355825522,0.032,0.2852856579909817,1.0,9/38,11.90%,APOE;RAB11FIP5;HMGCR;PRKN;RHBDF1;DPH3;SFRP1;CHGA;KCNB1
prerank,negative regulation of T cell activation (GO:0050868),0.5723911933737658,1.6024258835241032,0.0390015600624025,0.2851695497175637,1.0,9/35,9.08%,FCGR2B;VSIG4;RIPOR2;PTPN22;CEBPB;LILRB1;PLA2G2D;CD80;SDC4
prerank,regulation of cellular respiration (GO:0043457),0.6553198938967535,1.6011169042217999,0.04436229205175601,0.2862794590360422,1.0,4/17,6.27%,CBFA2T3;IFNAR1;IL10RB;NOP53
prerank,autonomic nervous system development (GO:0048483),0.6466763003322689,1.600168848378196,0.046762589928057555,0.2871082722340184,1.0,3/17,2.92%,NRP1;EDNRB;PHOX2A
prerank,negative regulation of protein catabolic process (GO:0042177),0.5564115254533348,1.6001309861452793,0.024691358024691357,0.2859958936576164,1.0,9/40,5.43%,NELL1;EGFR;IRAK3;RILP;HMGCR;RIC1;SF3B3;SNX3;ROCK1
prerank,regulation of histone modification (GO:0031056),-0.6516169828188669,-1.6000662269846357,0.019067796610169493,0.6391063527664195,1.0,7/13,20.20%,CDK9;AKAP8L;FLCN;HPF1;AKAP8;PARK7;PARG
prerank,hemidesmosome assembly (GO:0031581),-0.665543773263506,-1.5994911271407437,0.01348314606741573,0.6251032304162516,1.0,4/11,17.75%,DST;ITGA6;LAMA3;ITGB4
prerank,positive regulation of cardiac muscle tissue growth (GO:0055023),0.661808529955253,1.5971989821952548,0.03614457831325301,0.2905291406715849,1.0,2/16,2.01%,RBPJ;MEF2C
prerank,negative regulation of defense response (GO:0031348),0.49809181158483085,1.5963268524712222,0.016666666666666666,0.2910931046035872,1.0,13/77,7.22%,AOAH;APOE;ALOX5;C1QTNF3;MFHAS1;IRAK3;NR1H4;METRNL;NR1D1;RB1;GHRL;PPM1B;KLF4
prerank,protein localization to synapse (GO:0035418),-0.6485208382848054,-1.594683355331907,0.02386117136659436,0.6336510540378483,1.0,5/12,5.61%,NLGN1;NRXN1;DLG4;PCLO;SHANK1
prerank,positive regulation of cell cycle (GO:0045787),0.521488903276051,1.5933215178775575,0.017518248175182483,0.29613223651969023,1.0,21/62,16.20%,EGFR;LRP6;APP;NUPR1;ANKRD17;RGCC;PKN2;TRIM32;CHEK1;RPS15A;CCND3;CCNYL1;MDM2;CCND2;TTL;EIF4EBP1;CCNY;RARA;PKD2;USP22;HCFC1
prerank,alcohol catabolic process (GO:0046164),0.7251920657879734,1.5933105530920864,0.03875968992248062,0.29490600808749384,1.0,3/10,6.24%,APOE;SCARF1;CYP27A1
prerank,regulation of keratinocyte proliferation (GO:0010837),0.6218025228481195,1.5918955124922802,0.043859649122807015,0.29663371723104937,1.0,5/22,5.25%,NOTCH2;CASK;ZFP36L1;KLF9;PTPRK
prerank,positive regulation of tumor necrosis factor production (GO:0032760),0.5096450149191548,1.5915471192642285,0.011188811188811189,0.29612612752809014,1.0,16/69,7.76%,PF4;APP;LILRA5;PTPRJ;OAS2;RIPK1;TLR4;CCL19;LBP;TLR2;LY96;TMEM106A;SYK;HSPB1;CCR2;PSEN1
prerank,superoxide anion generation (GO:0042554),0.7081396550733283,1.5898549575708822,0.0364963503649635,0.2983061437595359,1.0,4/13,15.09%,CYBB;NCF2;CYBA;NOX4
prerank,cGMP-mediated signaling (GO:0019934),0.6834055703261736,1.5890001104894544,0.03512014787430684,0.2986555847641785,1.0,4/13,4.20%,APOE;IRAG1;CD36;PDE2A
prerank,ribosomal small subunit assembly (GO:0000028),0.6536352693747763,1.5873662028008593,0.042328042328042326,0.300860210539953,1.0,7/16,9.26%,RPS15;ERAL1;RPSA;RPS28;RPS14;RPS5;MRPS11
prerank,cardiac atrium morphogenesis (GO:0003209),0.6325816950838603,1.5868325203711768,0.03717472118959108,0.300677667513162,1.0,4/16,4.49%,NOTCH2;BMP2;MYH6;HEY2
prerank,regulation of glycolytic process (GO:0006110),0.4999607833988461,1.5834906978199235,0.01694915254237288,0.30666439661990286,1.0,21/68,17.18%,P2RX7;APP;PRKAG2;NUPR1;ZBTB20;CBFA2T3;PGAM1;INSR;PFKFB4;PSEN1;SLC4A4;NUP133;NCOR1;IGF1;NUP62;NUP98;EP300;HDAC4;ARNT;NUP153;ZBTB7A
prerank,response to fatty acid (GO:0070542),0.6651373141083161,1.583250391267446,0.03904923599320883,0.3060063425723511,1.0,7/17,13.56%,PID1;NR1H4;CD36;KCNK4;FOXO3;FOXO1;FFAR1
prerank,negative regulation of protein localization to membrane (GO:1905476),0.6203735805618728,1.583141734940393,0.04827586206896552,0.3049932331106832,1.0,4/24,3.95%,DAB2;PID1;CLTC;ITGB1BP1
prerank,endocrine system development (GO:0035270),-0.5507416846250276,-1.5829550388394575,0.012106537530266344,0.6771614272303323,1.0,6/21,19.28%,TGFBR1;SALL1;NF1;PAX8;WNT4;DKK3
prerank,defense response to protozoan (GO:0042832),0.7121463141238,1.582620174558841,0.022222222222222223,0.30496562306248787,1.0,5/12,6.13%,PF4;IRF4;GBP7;BATF2;CD40
prerank,regulation of ERK1 and ERK2 cascade (GO:0070372),0.4334148621626502,1.5822974398247691,0.0011976047904191617,0.3044601468982923,1.0,42/214,11.24%,NRP1;EGFR;APOE;APP;SPRED1;NOTCH2;CCR1;FBXW7;GAS6;ALOX15;C5AR1;LYN;MFHAS1;PTPN22;CD44;BMP2;CD36;CD74;CCL8;TLR4;P2RY6;THPO;CCL19;RAPGEF2;ITGB1BP1;PDE8A;RAP1A;SMAD4;PDGFRA;SYK;TNF;SYNJ2BP;CCL24;ADRA1A;RANBP9;CNKSR3;RPS6KA6;PDGFC;ARRB1;SPRED2;EMILIN1;SHC1
prerank,regulation of macrophage differentiation (GO:0045649),0.6651163085430184,1.5816840390654525,0.05026929982046679,0.3045635861650407,1.0,3/15,2.67%,PF4;C1QC;RIPK1
prerank,positive regulation of interleukin-12 production (GO:0032735),0.5783694502106107,1.5805167306674806,0.033950617283950615,0.3057728508571046,1.0,11/31,16.73%,IL16;TLR4;CCL19;TLR2;CD40;SYK;MAPK14;RIPK2;MDK;SCIMP;TIRAP
prerank,positive regulation of nitric oxide biosynthetic process (GO:0045429),0.6147897003825001,1.5797754277542346,0.026272577996715927,0.30611284194972316,1.0,9/25,16.01%,KLF2;CD36;TLR4;INSR;TNF;KLF4;ASS1;PKD2;HSP90AB1
prerank,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),0.5247396743819196,1.5780306133135338,0.02457757296466974,0.3086671432220309,1.0,22/50,20.34%,GAS6;CD44;SH3RF1;SIAH2;LAMP3;RPS6KA3;PAK2;SFN;TNF;KLF4;FNIP1;CARD16;IGBP1;YWHAE;LAMTOR5;USP47;BEX3;HGF;RAF1;PLAUR;CSNK2A1;SNCA
prerank,regulation of clathrin-dependent endocytosis (GO:2000369),0.6773472330944598,1.5777311438352806,0.038869257950530034,0.308102154397506,1.0,1/15,0.03%,DAB2
prerank,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),0.4885036514320358,1.5775301094129999,0.015235457063711912,0.30731448611133466,1.0,19/86,10.06%,BANK1;NRP1;EGFR;APP;PTPRJ;CLEC6A;IL15;RAP2B;BST1;CD44;CD74;THBS4;PAK2;CD80;FYN;IL6R;IGF1;SFRP1;RIPK2
prerank,positive regulation of interleukin-6 production (GO:0032755),0.5003413670235145,1.5772410098862406,0.018439716312056736,0.30667540856210257,1.0,16/68,8.25%,APP;IL16;LILRA5;TLR8;TSLP;CD74;TLR4;LBP;BCL10;TLR2;IL17RA;TMEM106A;SYK;TNF;RAB7B;IL6R
prerank,intraciliary retrograde transport (GO:0035721),-0.6428956845419079,-1.5768246111925552,0.03177966101694915,0.6929076621993603,1.0,6/12,18.45%,IFT140;DYNLT2B;WDR19;DYNC2H1;IFT43;DYNC2I1
prerank,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),0.48612730167344703,1.5765640785081956,0.013908205841446454,0.3070803875935857,1.0,10/80,5.36%,EPS8;NRP1;P2RX7;RIPOR2;ARAP1;ACTR3;WASF2;CDC42;CCL19;DOCK11
prerank,cardiac muscle cell contraction (GO:0086003),-0.5717111623659038,-1.5756014034751888,0.027777777777777776,0.6833360619066072,1.0,9/19,22.63%,FGF12;KCNJ2;SCN1B;CACNA2D1;CACNA1D;CACNA1C;SCN1A;CAMK2D;SCN2B
prerank,regulation of glucose import (GO:0046324),0.5693915953008529,1.575486390373494,0.04173354735152488,0.3081390096226916,1.0,5/30,4.97%,PID1;PRKAG2;C1QTNF12;IRS2;INSR
prerank,neuron fate commitment (GO:0048663),-0.6063627651228074,-1.5753637931104543,0.032188841201716736,0.6688016634706402,1.0,2/14,2.63%,TGFBR1;MYT1L
prerank,negative regulation of purine nucleotide metabolic process (GO:1900543),0.7324024374015949,1.5734741846733153,0.058935361216730035,0.3099100837174987,1.0,4/10,15.43%,NUPR1;CBFA2T3;NCOR1;HDAC4
prerank,negative regulation of glycolytic process (GO:0045820),0.7324024374015949,1.5734741846733153,0.058935361216730035,0.3099100837174987,1.0,4/10,15.43%,NUPR1;CBFA2T3;NCOR1;HDAC4
prerank,cardiac muscle cell action potential (GO:0086001),-0.502892952167604,-1.5732816874210636,0.017994858611825194,0.6639708320854846,1.0,8/30,5.40%,FGF12;KCNJ2;ATP1B1;SCN1B;SLC8A1;ANK2;CACNA2D1;CACNA1D
prerank,positive regulation of pattern recognition receptor signaling pathway (GO:0062208),0.6814761872418007,1.5726996160363704,0.04283054003724395,0.3103293353468077,1.0,5/14,7.06%,DDX60;ANKRD17;TLR2;PUM2;USP15
prerank,positive regulation of cell differentiation (GO:0045597),0.429737652618701,1.5722782281475098,0.0023094688221709007,0.31008225787548616,1.0,34/237,6.90%,DAB2;MSR1;PF4;NELL1;FGFR1;TCF4;CTNNA1;CMKLR1;MEF2A;ZBTB16;RIPOR2;WDFY2;MEF2C;RIN2;CEBPB;KITLG;BMP2;CD36;ALX1;CDC42;GDF3;ZFP36L1;RHOA;RPS6KA3;RGCC;RAPGEF2;RAP1A;GPRC5B;SMAD4;MEDAG;TRIM32;BLOC1S5;ACVR2A;SDCBP
prerank,regulation of response to endoplasmic reticulum stress (GO:1905897),0.7040834082229975,1.5719851327353578,0.052158273381294966,0.30941704356491023,1.0,6/13,13.67%,FCGR2B;ALOX5;NUPR1;MANF;WFS1;NR1H2
prerank,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),0.6188286174662325,1.5702313705947832,0.035,0.3119539591165566,1.0,3/22,2.10%,FCGR2B;PTPRJ;PTPN22
prerank,ncRNA processing (GO:0034470),0.43011903772163257,1.5686595604692808,0.0,0.31411558801327366,1.0,63/200,14.84%,RPL17;RPL23;RPS16;NOL6;RPL39;RPL23A;PRKRA;RPS15;RPL37;RPLP1;RPL26;TUT7;RPLP2;SNU13;RPL41;RPS28;RPL13;RPS24;RPL24;RPL12;RPL36A;RPL18A;DROSHA;RPL37A;RPL28;WDR36;FARS2;NOP53;RPL30;NOL9;RPL8;RPL35A;RPL38;RPS17;RPLP0;RPL5;RPL36;RPL14;RPS14;RPL9;TUT4;RPS9;RPS7;RPL34;RPL27;MTREX;RPL6;HEATR1;RPS6;RPL4;RPL22;RPL15;RPL10;DDX10;RPL32;EXOSC8;ESF1;MRPL44;RPP30;RPL19;EXOSC1;RPL31;RPL11
prerank,negative regulation of small molecule metabolic process (GO:0062014),0.6079312661219385,1.5679095688813898,0.028268551236749116,0.3145272761358708,1.0,5/20,13.99%,C1QTNF3;C1QTNF12;UGT1A8;NCOR1;EP300
prerank,negative regulation of myotube differentiation (GO:0010832),-0.6393435506421168,-1.5666829792057526,0.03640256959314775,0.6842497309995167,1.0,7/12,19.51%,TMEM119;BHLHE41;BDNF;HDAC5;NOTCH1;HDAC3;HDAC1
prerank,response to cytokine (GO:0034097),0.448131516405736,1.5665751545092286,0.0075282308657465494,0.3163337031495156,1.0,29/141,9.46%,PID1;LIFR;APP;IFITM3;PTPN18;PTPN20;PTPN12;IRAK3;RIPK1;CD74;LAMP3;ADAM9;RHOA;TNFRSF11A;TRIM56;GCH1;MCL1;MAPKAPK2;TRIM32;CD40;BCL2;BST2;CXCR4;REL;IFNAR2;CXCL16;IL6R;IGBP1;IFITM2
prerank,protein localization to mitochondrion (GO:0070585),-0.6578105313441396,-1.56532604632904,0.023206751054852322,0.6770057318659727,1.0,2/11,8.84%,HK2;MTCH2
prerank,regulation of monocyte chemotaxis (GO:0090025),0.596958794135189,1.565307516795917,0.03664921465968586,0.3178065098379128,1.0,6/24,7.58%,CCR1;LYN;ANO6;PLA2G7;DUSP1;CCR2
prerank,positive regulation of p38MAPK cascade (GO:1900745),0.6090884555044218,1.5650626197639979,0.044407894736842105,0.3172071556841614,1.0,6/22,4.74%,SASH1;RELL1;MFHAS1;BMP2;XDH;SPI1
prerank,calcium-mediated signaling (GO:0019722),0.48036049718938567,1.5640468240001824,0.011235955056179775,0.31806603035233116,1.0,14/93,7.81%,MCTP1;EDNRB;EGFR;P2RX7;PTPRJ;CCR1;PPP3CA;RCAN3;MCU;CAMKK2;CCRL2;CXCR4;CCR2;MCTP2
prerank,triglyceride homeostasis (GO:0070328),0.5731584234010411,1.56367422893113,0.043478260869565216,0.3177748650498323,1.0,4/26,4.93%,APOE;C1QTNF3;NR1H4;PNPLA8
prerank,positive regulation of T cell migration (GO:2000406),0.6193237879138712,1.5635918633470034,0.03697183098591549,0.31678400537553414,1.0,5/20,7.58%,APP;OXSR1;RHOA;WNK1;CCR2
prerank,positive regulation of nervous system process (GO:0031646),-0.5676808617439119,-1.5626315324750597,0.028037383177570093,0.6768989903632201,1.0,8/18,12.21%,RIMS1;RIMS2;PARD3;ITGAX;CST7;TENM4;TPPP;RNF10
prerank,myoblast fusion (GO:0007520),-0.6408309744107004,-1.5624263035564292,0.027837259100642397,0.6637179654560321,1.0,3/12,1.66%,CD9;ADGRB3;JAM2
prerank,neuron migration (GO:0001764),0.5247475957935273,1.56103186744487,0.02848575712143928,0.32093096314571856,1.0,14/48,10.58%,NRP1;FGFR1;NAV1;MEF2C;SH3RF1;RAPGEF2;LRP12;USP9X;DISC1;CELSR1;NR4A2;TUBGCP2;CCK;MARK2
prerank,membrane depolarization during action potential (GO:0086010),-0.5219422184905097,-1.5606811052654934,0.027093596059113302,0.6587981220479899,1.0,8/26,14.31%,KCNJ2;YWHAH;SCN1B;SLC8A1;CACNA1D;SCN8A;CACNA1C;SCN1A
prerank,cellular response to oxygen-containing compound (GO:1901701),0.4147679861590251,1.5606451809759274,0.0,0.3206442721693395,1.0,67/291,13.56%,PID1;PF4;EGFR;P2RX7;RAP1B;AHR;ESR1;LYN;NCOA3;FER;RPS3;DAPK1;MEF2C;NR1H4;GNG2;TNFRSF1B;LILRB1;DRD1;WNT2;TLR4;NR1D1;P2RY6;ADAM9;ZFP36L1;RHOA;RAPGEF2;LBP;BCL10;VIM;PDE2A;TLR2;NFKBIL1;AOC1;RAP1A;CAMKK2;PTPRK;PDGFRA;MTR;LY96;ACTB;CD80;WNT6;NRIP1;GNB1;CDC73;MAPK14;HCN3;CARD16;LCOR;SFRP1;TSHR;CD68;PXN;CHMP5;KCNK4;ROMO1;KCNQ1;ROCK2;LAMTOR5;ZC3H12A;ATP2B4;NOD2;AGAP3;FOXO1;CREB1;NFKBIB;SHMT1
prerank,mRNA splice site selection (GO:0006376),-0.5046468691292482,-1.5604349290119415,0.017543859649122806,0.6467185625185214,1.0,15/30,30.06%,LUC7L3;SETX;SRSF5;PUF60;SRSF10;CELF4;SRSF12;SFSWAP;SRSF9;CELF6;CELF5;SRSF6;ISY1;PSIP1;SNRPC
prerank,regulation of epidermal cell differentiation (GO:0045604),0.6204879564199065,1.5595255492484241,0.033391915641476276,0.3220015163324043,1.0,6/21,6.03%,SGPP1;GDF3;ZFP36L1;ROCK1;CBFB;SFN
prerank,positive regulation of binding (GO:0051099),0.4841098838001042,1.5594635126770282,0.016597510373443983,0.32095141671680555,1.0,26/84,15.27%,APOE;APP;TCF7L2;BMP2;CLN5;RAPGEF2;B2M;PRKN;GSK3B;STK3;NMD3;DPH3;DDX11;HFE;CEBPG;PSEN1;GMNN;KDM4D;IGF1;RIPK2;AMFR;RARA;RALB;ADD1;RPL11;STMN1
prerank,Notch signaling pathway (GO:0007219),0.5008188026632922,1.5590194205099188,0.03129657228017884,0.32071421753944784,1.0,19/59,15.71%,RBPJ;NOTCH2;JAG1;BMP2;NRARP;HEY2;GMDS;DTX2;PSEN1;MAML1;CREBBP;MIB1;PLXND1;EP300;MDK;WWC1;SNW1;MYC;NCSTN
prerank,polarized epithelial cell differentiation (GO:0030859),0.6867598282826016,1.5588351361603079,0.04251386321626617,0.31998878468132186,1.0,6/13,11.55%,OPHN1;CDC42;RAB10;RHOA;MSN;MYO9A
prerank,regulation of Rac protein signal transduction (GO:0035020),-0.584776407347311,-1.5582086287468493,0.03953488372093023,0.6451856095546685,1.0,9/16,21.20%,ARHGAP24;PIK3CB;RASGRF1;CADM4;STMN3;AUTS2;ARF6;SH3BP1;ARHGAP44
prerank,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),0.5341838922547211,1.5545411413131607,0.03194888178913738,0.328032801895524,1.0,8/45,7.63%,DAB2;BMP2;GDF3;SMAD4;GDF10;ACVR2A;SDCBP;HFE
prerank,cellular response to fatty acid (GO:0071398),0.703503182837214,1.5539754062870292,0.05935251798561151,0.3281290658677287,1.0,2/12,2.03%,PID1;NR1H4
prerank,"mRNA cis splicing, via spliceosome (GO:0045292)",-0.5919682899287616,-1.553027496442637,0.03935185185185185,0.6587089390239061,1.0,12/16,37.18%,DCPS;WBP4;SNRNP200;SRSF12;SFSWAP;DDX23;SART1;PSIP1;SNRPC;RBM22;SRSF1;NCBP2
prerank,establishment of apical/basal cell polarity (GO:0035089),0.6627558191537027,1.5523456480524236,0.04905660377358491,0.3303275968054171,1.0,5/14,11.55%,OPHN1;CDC42;RHOA;MSN;MYO9A
prerank,regulation of protein kinase B signaling (GO:0051896),0.42780618302100293,1.55223177792017,0.0047562425683709865,0.3293844069048812,1.0,34/193,9.90%,BANK1;HIP1;EGFR;FGFR1;PTPRJ;TCF7L2;GAS6;ESR1;ITGB1;MFHAS1;CASS4;RCN3;KITLG;XDH;FGF23;MYORG;THPO;CCL19;ITGB1BP1;FRS2;ICOS;IRS2;INSR;RACK1;PDGFRA;NOP53;TNF;CD80;GAB1;FYN;TSPYL5;SH2B3;MYDGF;RTN4
prerank,negative regulation of metabolic process (GO:0009892),0.5163918619344335,1.551291163231889,0.02564102564102564,0.3301191127975614,1.0,11/54,10.08%,RBPJ;IL15;TLR4;NR1D1;NPR3;RB1;LNPEP;PLCL2;ARRDC3;FOXC2;DOCK7
prerank,actin filament polymerization (GO:0030041),0.577640833342441,1.5511689062443073,0.038461538461538464,0.32925504875857287,1.0,5/29,1.76%,PSTPIP2;DIAPH1;GAS7;PSTPIP1;ANG
prerank,myofibril assembly (GO:0030239),0.5304375225965843,1.5509428172838615,0.030864197530864196,0.3286303570275168,1.0,7/42,5.33%,FLII;TMOD1;MYH6;MYOM2;TNNT1;TMOD3;PDGFRA
prerank,regulation of biosynthetic process (GO:0009889),0.7142093490573561,1.550259406015021,0.038112522686025406,0.3288987567672181,1.0,2/11,6.05%,ALOX5;PIKFYVE
prerank,lipid catabolic process (GO:0016042),-0.5662008620322821,-1.549886504726318,0.018779342723004695,0.6616454575432891,1.0,5/18,9.77%,LIPH;LPL;PPT1;ACADL;SIRT2
prerank,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),0.6250365725262933,1.5497710871430441,0.04903677758318739,0.32876544635778027,1.0,5/18,11.96%,HDAC9;HMOX1;PIK3C2A;FOXC2;MAP3K3
prerank,response to reactive oxygen species (GO:0000302),0.5142131125411494,1.548565050342859,0.026627218934911243,0.3303013443594453,1.0,15/54,12.85%,EGFR;APOE;FER;RPS3;ADAM9;HMOX1;CAMKK2;PTPRK;PDGFRA;STK24;FYN;TXNRD2;PXN;ROMO1;AGAP3
prerank,positive regulation of dendrite morphogenesis (GO:0050775),-0.5577834885943282,-1.5483789463250979,0.03286384976525822,0.6562534690809411,1.0,12/19,28.75%,CUX1;PTPRD;SS18L1;CAPRIN1;SS18L2;IL1RAPL1;CDKL5;DBN1;FBXW8;CDKL3;CUX2;CAMK2B
prerank,positive regulation of nitrogen compound metabolic process (GO:0051173),0.6311781116115454,1.5478359363043404,0.04607508532423208,0.3307801226143335,1.0,6/19,7.31%,APP;KLF2;TMEM106A;TNF;KLF4;MTPN
prerank,regulation of myeloid cell differentiation (GO:0045637),0.4958820846562048,1.5477547419054656,0.02604920405209841,0.3298244096767389,1.0,23/62,18.45%,PF4;ZBTB16;KMT2A;LYN;MEF2C;CDK6;SPI1;CBFB;PRKCB;CDC73;ASH2L;KMT2C;H3-3A;RBM15;CREBBP;KMT2E;TNRC6C;EP300;PRMT1;PRKCQ;FES;MAFB;CNOT4
prerank,regulation of vasculogenesis (GO:2001212),0.6683647693200889,1.54751206033175,0.05679862306368331,0.32927697981140264,1.0,5/14,4.84%,RIN2;XDH;RAPGEF2;HEY2;RAP1A
prerank,positive regulation of interleukin-8 production (GO:0032757),0.5202254761178206,1.5470458279165655,0.0350076103500761,0.3290822186586805,1.0,19/49,18.04%,TLR8;RIPK1;CD74;TLR4;LBP;BCL10;TLR2;SYK;TNF;RAB1A;LAMTOR5;NOD2;STAT3;PRKD2;TIRAP;RELA;TLR7;IL6;F2R
prerank,positive chemotaxis (GO:0050918),0.6423866629707013,1.546318289712513,0.044905008635578586,0.3295622818285701,1.0,2/17,0.78%,NRP1;PTPRJ
prerank,intestinal lipid absorption (GO:0098856),0.6925680307375748,1.5457925026685098,0.06486486486486487,0.3296122810059236,1.0,2/11,2.76%,LDLR;CD36
prerank,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.43951607035862145,1.5453954741698894,0.008706467661691543,0.32934928968843236,1.0,57/158,18.91%,PLEKHG5;CLEC6A;S100A4;SHISA5;ALPK1;RIPK1;CD74;ANKRD17;CCL19;PELI1;RHOA;HMOX1;PRKN;BCL10;BIRC3;NDFIP1;GPRC5B;TRIM32;TMEM106A;CD40;TNF;BST2;MIER1;REL;PRKCB;TRIM68;TRIM27;TFG;CARD16;EEF1D;RIPK2;NUP62;WLS;CASP8;MAP3K3;LAMTOR5;VAPA;TERF2IP;NOD2;TNFRSF1A;UBE2N;GJA1;NDFIP2;MID2;RHOC;TRIM25;PPM1A;BRD4;TIRAP;TAB3;RELA;F2R;ECM1;TRAF6;IRAK4;PLK2;DDX21
prerank,cardiac epithelial to mesenchymal transition (GO:0060317),0.6079443354526002,1.5448979228070565,0.04788213627992634,0.32916778575522554,1.0,3/20,4.49%,RBPJ;BMP2;HEY2
prerank,negative regulation of transport (GO:0051051),0.5104139551619625,1.5446441649175027,0.024539877300613498,0.3286047379228847,1.0,16/51,13.83%,MCTP1;FCGR2B;LILRB1;PRKN;TLR2;NDFIP1;RACK1;SNX3;BST2;RAB7A;CRYAB;PIP4P2;SNX33;RUBCN;NR1H2;NDFIP2
prerank,"retrograde transport, endosome to Golgi (GO:0042147)",0.4789789884861186,1.5427002238764749,0.01662049861495845,0.33160116626816827,1.0,17/80,9.18%,SNX2;TBC1D5;SNX8;CLTC;ANKFY1;EVI5;SNX6;CLN5;RIC1;SNX3;TBC1D14;PIKFYVE;RAB7A;RAB7B;TRIM27;DENND5A;TRAPPC10
prerank,keratinocyte differentiation (GO:0030216),0.5694770834210222,1.5424976964491786,0.04201680672268908,0.33099429092276755,1.0,6/29,5.23%,TXNIP;JAG1;EXPH5;ADAM9;KRT10;CLIC4
prerank,response to prostaglandin E (GO:0034695),0.7026846856228474,1.5421162968805566,0.0550098231827112,0.3307382258769399,1.0,5/10,10.80%,GNG2;CCL19;GNB1;SFRP1;PTGER4
prerank,regulation of cartilage development (GO:0061035),0.6273366835619981,1.5420636011649227,0.044036697247706424,0.32981045248825713,1.0,3/18,2.60%,TRPS1;ZBTB16;BMP2
prerank,actin crosslink formation (GO:0051764),0.6842635938449577,1.5418740236211508,0.0603290676416819,0.32918357427228684,1.0,2/12,4.01%,EPS8;LCP1
prerank,regulation of fatty acid metabolic process (GO:0019217),0.6414935067590531,1.541692480387441,0.03541315345699832,0.32845818847024066,1.0,4/17,8.14%,PRKAG2;UGT1A8;ADIPOR2;NCOR1
prerank,regulation of microtubule polymerization (GO:0031113),-0.4629879450819038,-1.5416099544209048,0.01092896174863388,0.6784515494245725,1.0,12/40,13.14%,NAV3;MAP2;PAK1;TBCD;CAMSAP1;MAPT;MAPRE3;GBA2;TOGARAM1;NUMA1;MAPRE1;EML2
prerank,negative regulation of immune response (GO:0050777),0.4399481988778551,1.541041842744363,0.01020408163265306,0.3287677081174105,1.0,33/154,13.33%,CD163;FCGR2B;ALOX15;LYN;CYSLTR1;FER;IRAK3;GNG2;CALCRL;ADRB2;LILRB1;DRD1;ADM;SPI1;RC3H1;ADCY9;ADCYAP1R1;SYK;PPM1B;CCR2;GNB1;FYN;FCGR3A;TRIM27;MAPK14;TSHR;PTGER4;PRKACB;HTR6;RAMP2;GLP2R;CREB1;GPR27
prerank,cellular response to nitrogen compound (GO:1901699),0.61263313029945,1.540438274384852,0.047285464098073555,0.3290611329811335,1.0,9/20,12.32%,NR1H4;AOC1;RIOK3;EPG5;DDX11;ATRX;SPIDR;ROCK2;ATP2B4
prerank,platelet degranulation (GO:0002576),0.45429258263208333,1.5391253533592597,0.013003901170351105,0.33091928361099066,1.0,18/118,10.64%,F13A1;PF4;APP;PHACTR2;GAS6;SELENOP;LYN;CD36;SRGN;MANF;APOOL;FAM3C;ABCC4;VCL;PROS1;IGF1;LAMP2;CALM1
prerank,negative regulation of RNA metabolic process (GO:0051253),0.6234277830844515,1.5388826445253254,0.056363636363636366,0.3302920165517912,1.0,7/18,12.28%,ESR1;RPS13;PTBP3;TNF;PTBP2;NCOR1;ZC3H12A
prerank,negative regulation of tumor necrosis factor production (GO:0032720),0.531457884614032,1.5386095427969404,0.040061633281972264,0.32981158617474154,1.0,15/41,14.55%,GAS6;IRAK3;NR1H4;PTPN22;LILRB1;TLR4;LBP;NFKBIL1;GHRL;TRIM27;CD33;IGF1;ZC3H12A;RARA;ARG2
prerank,sensory perception of smell (GO:0007608),-0.6370296960323953,-1.5371241536798843,0.03131991051454139,0.6899254265628435,1.0,4/11,21.47%,ADCY3;SLC24A4;BBS4;MKKS
prerank,positive regulation of heart rate (GO:0010460),0.6489049597410091,1.5342441388032035,0.06642728904847396,0.33795218314496606,1.0,7/17,14.25%,ADM;PDE4D;ADRA1D;ADRA1A;KCNQ1;SCN3B;ATP2A2
prerank,acute inflammatory response (GO:0002526),0.5902712258745784,1.5341779645868387,0.05442176870748299,0.3369796402705762,1.0,4/23,8.25%,ANO6;CEBPB;LBP;IL6R
prerank,pattern recognition receptor signaling pathway (GO:0002221),0.5087721626476378,1.5334810377191916,0.033873343151693665,0.33732721048484726,1.0,13/56,5.47%,TLR8;RPS27A;ALPK1;S100A1;CD36;TLR4;RPS6KA3;LBP;BCL10;TLR2;MAPKAPK2;CTSB;LY96
prerank,neutrophil activation involved in immune response (GO:0002283),0.4017314450492444,1.5327843040397056,0.0010672358591248667,0.337889108605107,1.0,90/428,11.67%,IQGAP2;HGSNAT;AP2A2;ALOX5;ADGRE5;CFP;CYBB;STOM;RAP1B;PTPRJ;IQGAP1;CTSC;ARHGAP9;CLEC12A;DIAPH1;DOCK2;RAB31;C5AR1;RAP2B;CD93;GMFG;C3AR1;DNAJC3;ANO6;BST1;NRAS;CD44;TNFRSF1B;GYG1;EEF1A1;KCNAB2;FCER1G;LILRB3;CD36;GRN;ATP8B4;RAB10;ARL8A;RHOA;S100A11;B2M;TLR2;AOC1;FRK;LAMP1;FTL;PGAM1;RAP1A;MANBA;TXNDC5;CTSB;ROCK1;PRCP;ATP6V0A1;DNASE1L1;ANXA2;CNN2;SYK;SDCBP;YPEL5;BST2;ARPC5;PSEN1;HMOX2;CD53;RAB7A;OSTF1;FCGR3B;CLEC4D;CD33;VCL;RAB14;MGST1;MAPK14;IMPDH2;CMTM6;LRG1;ARMC8;LAMP2;AMPD3;ENPP4;CD68;ATG7;TRPM2;FTH1;JUP;STK10;SNAP23;CDK13;NPC2
prerank,negative regulation of protein processing (GO:0010955),-0.6393816725487476,-1.532607305442449,0.03587443946188341,0.7004537842160392,1.0,5/12,18.67%,SERPINE2;TMEM59;PRNP;GAS1;SERPINE1
prerank,negative regulation of cilium assembly (GO:1902018),-0.6219774010971488,-1.5324142947202313,0.05168986083499006,0.6892307012157003,1.0,9/12,25.97%,CEP97;CCP110;EVI5L;MAP4;CDK10;LIMK2;TBC1D7;ODF2L;TCHP
prerank,regulation of protein transport (GO:0051223),0.571292403892356,1.5307816685899318,0.04297520661157025,0.3412673546029309,1.0,10/27,13.83%,LCP1;NDFIP1;SNX3;RHBDF1;GAPVD1;STXBP5;TNF;DNAJC1;DISP1;NDFIP2
prerank,positive regulation of stress-activated MAPK cascade (GO:0032874),0.4631852556026737,1.529889300123729,0.023192360163710776,0.3421341826486041,1.0,16/93,7.38%,FCGR2B;APP;MAP3K5;SASH1;RELL1;MFHAS1;RASSF2;SH3RF1;BMP2;XDH;RIPK1;AXIN1;CCL19;SPI1;SDCBP;DUSP22
prerank,negative regulation of reproductive process (GO:2000242),0.6270786738282432,1.5293231933011624,0.05405405405405406,0.3423418126002292,1.0,6/17,14.86%,PAEP;DUSP1;IGF1;GJA1;NPPC;ARHGDIB
prerank,actin filament organization (GO:0007015),0.4383957162548639,1.5291831991617997,0.0062266500622665,0.341584265319111,1.0,35/151,14.38%,EPS8;HIP1;NEDD9;MYO5A;FLII;ABI1;TMOD1;NRAP;CASS4;CDC42;RHOA;LCP1;MCU;TMOD3;GHRL;EFS;MYO7A;ARHGAP12;DSTN;RHOBTB1;PLS1;CORO1C;RFLNB;MYO1E;MYO1C;GAS2L1;ARHGAP17;SVIL;NEB;CORO7;RND3;TPM3;WASL;RHOC;CGNL1
prerank,organic cyclic compound biosynthetic process (GO:1901362),0.5606276403972477,1.5287571979724983,0.061855670103092786,0.34143032001553986,1.0,4/31,4.55%,ALOX5;MOCS1;HDC;GCH1
prerank,sequestering of extracellular ligand from receptor (GO:0035581),0.6713785565237849,1.5287260349414875,0.07392996108949416,0.3404038553104574,1.0,3/13,3.41%,NRROS;BMP2;CD46
prerank,positive regulation of endothelial cell apoptotic process (GO:2000353),0.6580189396320919,1.5277351763861124,0.0625,0.3413707485089017,1.0,4/14,6.13%,ITGA4;ANO6;RGCC;CD40
prerank,negative regulation of immune system process (GO:0002683),0.6522368038890323,1.527090272644918,0.07326007326007326,0.34189926019849076,1.0,3/16,3.80%,FCGR2B;LYN;HMOX1
prerank,regulation of developmental growth (GO:0048638),0.565129961595051,1.5270448573287414,0.04173354735152488,0.3409243610084158,1.0,7/29,13.88%,APOE;APP;GSK3B;INSR;IGF1;LATS2;MFSD2A
prerank,neutrophil degranulation (GO:0043312),0.400181174559155,1.5269098146425129,0.0010649627263045794,0.34016201702971643,1.0,89/425,11.67%,IQGAP2;HGSNAT;AP2A2;ALOX5;ADGRE5;CFP;CYBB;STOM;RAP1B;PTPRJ;IQGAP1;CTSC;ARHGAP9;CLEC12A;DIAPH1;DOCK2;RAB31;C5AR1;RAP2B;CD93;GMFG;C3AR1;DNAJC3;ANO6;BST1;NRAS;CD44;TNFRSF1B;GYG1;EEF1A1;KCNAB2;FCER1G;LILRB3;CD36;GRN;ATP8B4;RAB10;ARL8A;RHOA;S100A11;B2M;TLR2;AOC1;FRK;LAMP1;FTL;PGAM1;RAP1A;MANBA;TXNDC5;CTSB;ROCK1;PRCP;ATP6V0A1;DNASE1L1;ANXA2;CNN2;SDCBP;YPEL5;BST2;ARPC5;PSEN1;HMOX2;CD53;RAB7A;OSTF1;FCGR3B;CLEC4D;CD33;VCL;RAB14;MGST1;MAPK14;IMPDH2;CMTM6;LRG1;ARMC8;LAMP2;AMPD3;ENPP4;CD68;ATG7;TRPM2;FTH1;JUP;STK10;SNAP23;CDK13;NPC2
prerank,odontogenesis (GO:0042476),0.5378793020621429,1.5268924340622427,0.0463258785942492,0.3391520481732315,1.0,7/35,7.63%,LRP6;OSR1;BMP2;ANKRD11;EDA;TUFT1;WNT6
prerank,negative regulation of protein binding (GO:0032091),0.48249577223498097,1.5266710653074542,0.023545706371191136,0.3385322835073781,1.0,14/71,7.63%,DAB2;ITGA4;ADRB2;NES;ITGB1BP1;B2M;GSK3B;RACK1;CFHR2;ROCK1;DISC1;ACTB;DDX11;HFE
prerank,transition metal ion homeostasis (GO:0055076),0.5721615903509393,1.526512713929987,0.03709949409780776,0.3378107359863743,1.0,12/28,17.84%,CP;HMOX1;B2M;PRKN;FTL;FBXL5;HFE;HMOX2;TFR2;ABCB7;NEO1;PICALM
prerank,amyloid fibril formation (GO:1990000),0.5121025372438556,1.5258690026613302,0.04078549848942598,0.33818253143823807,1.0,10/51,5.03%,TGFBI;APP;ITM2B;RPS27A;RIPK1;SIAH2;CD36;B2M;PRKN;USP9X
prerank,negative regulation of canonical Wnt signaling pathway (GO:0090090),0.429803854122391,1.5254326291179467,0.0112079701120797,0.3380436967980204,1.0,20/161,5.73%,DAB2;LRP6;APOE;IGFBP4;TCF7L2;TLE4;PSMA7;TNN;BMP2;PRICKLE1;SIAH2;AXIN1;PRKN;MCC;UBAC2;ZNRF3;GSK3B;NOTUM;CTNND1;STK3
prerank,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),0.5811221543900875,1.524394391856281,0.04582651391162029,0.33899452471335684,1.0,12/25,19.39%,OPHN1;RPL23;LAMP3;RPL5;HFE;RPS7;RPL11;PRKCG;HSP90AB1;EFNA1;CSNK2A2;CSNK2A1
prerank,negative regulation of transcription by RNA polymerase II (GO:0000122),0.39126252142598467,1.5241298517557178,0.0,0.33851178915371755,1.0,136/572,16.62%,RBPJ;DAB2;HDAC9;ZEB2;TRPS1;EDNRB;KLF2;TCF7L2;FOXP1;MEF2A;ZBTB16;RREB1;TFEC;ESR1;RPL23;SMURF2;RARG;MEF2C;NR1H4;RPS27A;CEBPB;MITF;OSR1;NCOA5;BMP2;NR2C1;ALX1;NR1D1;PRKN;LARP7;PDE2A;FRK;NR3C1;NKAP;IRF2BP2;HEY2;SPI1;SAP130;RB1;NFIC;USP9X;ARID5A;SMAD4;TRIM33;THRB;IRX2;CBFB;PHF21A;ORC2;ATXN1;NOP53;EPC1;DMAP1;FOXM1;BAG3;SDCBP;ZNF568;TNF;ZNF148;KLF4;YY1;BRMS1L;DUSP22;MIER1;THAP11;GATAD2A;TBL1XR1;PSEN1;NR4A2;NRIP1;IRF2;KLF10;CDC73;RPS14;NCOR1;ZBTB5;FNIP1;ATRX;FOXC2;BACH1;TRIM27;MDM2;HIVEP1;TBL1X;ESR2;LRRFIP1;UBE2D3;BEND3;IGBP1;LCOR;NR2F1;PURA;ZNF205;SPEN;SP100;MIER3;HSBP1;ETS2;SREBF2;CREBBP;KANK2;WFS1;FOXO3;RPL10;LOXL2;NFIX;PEG3;CTBP2;WWOX;NR1H2;RARA;STAT3;EP300;BCOR;NEDD4L;WWC1;SNW1;GATAD2B;MYC;HDAC4;NR2C2;ZHX1;SFPQ;RUNX3;HEXIM2;E2F8;KDM1A;HCFC1;ZGPAT;PPM1A;LIN37;PER1;ZNF177;TBX2;NFATC3;GLIS2
prerank,vascular endothelial growth factor receptor signaling pathway (GO:0048010),0.492940610220859,1.5233269429232228,0.029957203994293864,0.3392311928273304,1.0,18/67,11.99%,VAV3;NRP1;CYBB;ABI1;WASF2;DOCK1;CDC42;CRK;RHOA;PAK2;MAPKAPK2;ROCK1;HSPB1;FYN;MAPK14;PXN;NCF2;ROCK2
prerank,RNA transport (GO:0050658),-0.4062035002954196,-1.5228749575675373,0.012738853503184714,0.7282027593257757,1.0,30/71,21.56%,THOC1;RBFOX1;SRRM1;SRSF5;HNRNPA2B1;NXF1;DDX39B;SRSF3;FLOT1;KIF5C;SRSF2;FMR1;RNPS1;U2AF1;CKAP5;UPF3B;CASC3;TGFBR2;SIDT2;NCBP1;HNRNPA1;ATXN2;SRSF11;THOC3;SIDT1;SRSF9;TST;POLDIP3;ALYREF;U2AF2
prerank,regulation of heart rate by cardiac conduction (GO:0086091),-0.4571616823294793,-1.522778389594014,0.013812154696132596,0.7165965642081646,1.0,8/38,8.24%,CACNB2;BIN1;KCNJ2;SCN1B;ANK2;CACNA2D1;CACNA1D;CTNNA3
prerank,histone deubiquitination (GO:0016578),0.6148881892279454,1.522181743044296,0.054249547920433995,0.34060074638109095,1.0,11/18,21.80%,USP3;ATXN7;BRCC3;USP15;USP21;USP16;ENY2;USP22;USP7;UIMC1;ATXN7L3
prerank,epithelial cell differentiation (GO:0030855),0.4640341425999585,1.521158788497378,0.02309782608695652,0.3417230056705108,1.0,7/88,5.37%,DAB2;MAF;JAG1;RAB10;DNPH1;GRHL2;CTSB
prerank,establishment of epithelial cell apical/basal polarity (GO:0045198),0.7008833912596044,1.520665553321816,0.05927342256214149,0.3417080860380792,1.0,5/10,11.55%,OPHN1;CDC42;RHOA;MSN;MYO9A
prerank,regulation of cellular component size (GO:0032535),0.5584337950142239,1.517735209246003,0.055105348460291734,0.3469753183089016,1.0,13/30,17.91%,EPS8;VAV3;RARG;MTPN;MSN;PPP1CA;LAMTOR5;NEB;RAB3B;PTEN;LARS1;PICALM;RAB22A
prerank,negative regulation of biomineral tissue development (GO:0070168),0.5913917367497494,1.5177017418318064,0.06960950764006792,0.3460132031811959,1.0,6/21,5.43%,CCR1;GAS6;FGF23;SRGN;HEY2;ROCK1
prerank,glycolytic process (GO:0006096),-0.49327551090956334,-1.5172569019852953,0.03571428571428571,0.7337231488204405,1.0,13/28,21.84%,HK2;PFKL;PGM1;ALDOA;PKM;PGK1;ENO1;ENO3;TPI1;GAPDHS;GAPDH;PFKFB2;LDHA
prerank,negative regulation of glucose transmembrane transport (GO:0010829),0.6896757475524006,1.517053832895536,0.06776556776556776,0.3463750561259182,1.0,1/10,0.05%,PID1
prerank,regulation of establishment of cell polarity (GO:2000114),0.631059907416285,1.5170255154910206,0.06181818181818182,0.3454140672819214,1.0,7/16,12.68%,RAP1B;KIF20B;RIPOR2;RACK1;ROCK1;ROCK2;BCAS3
prerank,granulocyte differentiation (GO:0030851),0.6117776908418024,1.5169556928858292,0.05518394648829431,0.3445698190804877,1.0,6/18,13.99%,CBFA2T3;SPI1;LBR;DEK;RARA;EP300
prerank,regulation of nitric-oxide synthase activity (GO:0050999),0.5289626289875466,1.516393876785267,0.05061349693251534,0.3447112741086019,1.0,12/36,14.11%,EGFR;APOE;S100A1;CYGB;NPR3;GCH1;NOSTRIN;TNF;NUS1;CALM1;ATP2B4;WASL
prerank,protein hydroxylation (GO:0018126),-0.5813970948763613,-1.5159825913397003,0.05434782608695652,0.7282208880005235,1.0,7/15,19.16%,ASPH;P3H2;OGFOD1;PLOD3;P3H3;VIPAS39;P3H4
prerank,regulation of mRNA processing (GO:0050684),-0.47133478822545133,-1.515805859062508,0.03931203931203931,0.7174337433386108,1.0,16/32,19.82%,SON;PABPN1;SAFB;SRSF3;SAFB2;TIA1;SRPK1;SRSF10;KHDRBS3;SRPK2;QKI;NCBP1;CDK11B;RBM39;DHX9;AHCYL1
prerank,regulation of cardiac muscle cell proliferation (GO:0060043),0.5999198335953484,1.5148078575623278,0.06972477064220184,0.34718924514817007,1.0,2/19,2.01%,RBPJ;MEF2C
prerank,positive regulation of phosphate metabolic process (GO:0045937),0.5864137139986297,1.5138258468961059,0.03767123287671233,0.3483443352891979,1.0,8/25,9.20%,NRP1;EGFR;APP;ANG;BCL10;SDCBP;PSEN1;KCTD20
prerank,regulation of Ras protein signal transduction (GO:0046578),0.4671672480659472,1.5138243801507982,0.019204389574759947,0.34732892047084996,1.0,19/85,12.12%,EPS8;STARD8;DENND1A;RASGRP4;NOTCH2;OPHN1;LYN;SYNGAP1;IRS2;FOXM1;ARHGDIA;DENND4C;IGF1;STARD13;NUP62;SHC1;KANK2;DENND3;ARHGAP17
prerank,acute-phase response (GO:0006953),0.671287205768413,1.511628684327735,0.0761904761904762,0.3511846138921274,1.0,6/12,23.64%,CEBPB;LBP;IL6R;IL6;IL22;PLSCR1
prerank,blood vessel morphogenesis (GO:0048514),0.5049587654535536,1.511592121601234,0.034074074074074076,0.3502416693324292,1.0,8/54,6.57%,RBPJ;NRP1;RASA1;ADM;LOX;CCM2;HEY2;SYK
prerank,negative regulation of alcohol biosynthetic process (GO:1902931),0.6504030258492838,1.511036670580762,0.06923076923076923,0.350376658532243,1.0,3/13,6.29%,APOE;BMP2;ERLIN1
prerank,negative regulation of viral entry into host cell (GO:0046597),0.6594635060210403,1.5100004089272978,0.08247422680412371,0.35170112030046086,1.0,5/12,13.84%,IFITM3;SNX3;IFITM2;LY6E;MID2
prerank,neutrophil mediated immunity (GO:0002446),0.39620316051831667,1.5099211205713994,0.0010649627263045794,0.3508390159286949,1.0,89/432,11.67%,IQGAP2;HGSNAT;AP2A2;ALOX5;ADGRE5;CFP;CYBB;STOM;RAP1B;PTPRJ;IQGAP1;CTSC;ARHGAP9;CLEC12A;DIAPH1;DOCK2;RAB31;C5AR1;RAP2B;CD93;GMFG;C3AR1;DNAJC3;ANO6;BST1;NRAS;CD44;TNFRSF1B;GYG1;EEF1A1;KCNAB2;FCER1G;LILRB3;CD36;GRN;ATP8B4;RAB10;ARL8A;RHOA;S100A11;B2M;TLR2;AOC1;FRK;LAMP1;FTL;PGAM1;RAP1A;MANBA;TXNDC5;CTSB;ROCK1;PRCP;ATP6V0A1;DNASE1L1;ANXA2;CNN2;SDCBP;YPEL5;BST2;ARPC5;PSEN1;HMOX2;CD53;RAB7A;OSTF1;FCGR3B;CLEC4D;CD33;VCL;RAB14;MGST1;MAPK14;IMPDH2;CMTM6;LRG1;ARMC8;LAMP2;AMPD3;ENPP4;CD68;ATG7;TRPM2;FTH1;JUP;STK10;SNAP23;CDK13;NPC2
prerank,synaptic vesicle endocytosis (GO:0048488),0.537755462033757,1.509783897666202,0.05891472868217054,0.35010822009924886,1.0,6/33,7.72%,ITSN1;FCHO2;OPHN1;SYNJ1;ITSN2;CANX
prerank,dendritic cell chemotaxis (GO:0002407),0.6485402422170821,1.509365922078972,0.059961315280464215,0.3499962067182455,1.0,7/14,16.81%,CCR1;CCL19;CXCR4;CCR2;TRPM2;GPR183;CCL5
prerank,transcription initiation from RNA polymerase II promoter (GO:0006367),0.4337502851601954,1.508770905954967,0.007802340702210663,0.3503413981129094,1.0,38/138,17.68%,RBPJ;HDAC9;NOTCH2;ESR1;RARG;NR1H4;NR2C1;NR1D1;NR3C1;THRB;NR4A1;TBL1XR1;NR4A2;NCOR1;GTF2A2;ESRRB;TBL1X;ESR2;NR2F1;POLR2B;MED26;MAML1;CREBBP;GTF2E2;GTF2A1;NR1H2;RARA;POLR2D;MED27;SNW1;NR2C2;GTF2H3;GTF2B;MED17;NR5A2;TAF12;GTF2H1;NR6A1
prerank,regulation of canonical Wnt signaling pathway (GO:0060828),0.40832395576260383,1.5086102547545979,0.006896551724137931,0.3497710392521699,1.0,52/248,14.85%,DAB2;ZEB2;EGFR;LRP6;APOE;IGFBP4;GNAQ;TCF7L2;TLE4;SMURF2;PSMA7;BMP2;PRICKLE1;SIAH2;AXIN1;PRKN;NRARP;MCC;UBAC2;ZNRF3;GSK3B;GPRC5B;NOTUM;CTNND1;FRAT1;STK3;WNK1;PPM1B;PSMB2;TBL1XR1;PSEN1;CDK14;LIMD1;TBL1X;CUL3;NKD1;SFRP1;WLS;PPP1CA;JUP;AMFR;PSMA6;LRRK1;PLEKHA4;LATS2;CCNY;MDK;PSMA3;PSMD1;PSMD5;NPHP3;GPC3
prerank,cardiac conduction system development (GO:0003161),0.5844645823820357,1.5082058519796493,0.045454545454545456,0.3497096869496265,1.0,8/24,20.10%,NOTCH2;HEY2;SMAD4;MAML1;GJA1;BMPR1A;SMAD1;SMAD5
prerank,synapse assembly (GO:0007416),-0.3963513884249552,-1.5079803479814997,0.016025641025641024,0.7461369964832489,1.0,17/67,13.86%,GRID2;DNM3;ADGRL3;SDK1;GABRB3;NLGN1;CDH2;NRXN1;FARP1;FGF13;DVL1;BDNF;SHANK2;GABRA2;LRRC4;SPOCK2;GABRG2
prerank,thyroid hormone generation (GO:0006590),0.6944652985134542,1.5076162729684746,0.07421875,0.35001629856132666,1.0,2/10,3.44%,CPQ;TPO
prerank,mesenchymal to epithelial transition (GO:0060231),-0.6352072610272324,-1.507316744264546,0.04700854700854701,0.7381947493535779,1.0,3/10,11.81%,SALL1;BASP1;PAX8
prerank,cellular response to cAMP (GO:0071320),0.5514028035570794,1.5070717102441302,0.04654895666131621,0.3502727048005656,1.0,8/30,11.86%,RAP1B;AHR;ZFP36L1;RAPGEF2;PDE2A;RAP1A;HCN3;KCNQ1
prerank,positive regulation of immune response (GO:0050778),0.4846087188692866,1.5070673926448224,0.037037037037037035,0.3492950842299801,1.0,8/64,5.78%,FCGR2B;TLR8;IL15;LILRB1;CD74;GRN;CD46;RIOK3
prerank,cell morphogenesis involved in differentiation (GO:0000904),0.47734502899060416,1.5066044668994352,0.03125,0.349347222541367,1.0,11/70,4.87%,NRP1;ITGA4;ATRNL1;PEAK1;OPHN1;FER;MEF2C;RHOA;GRHL2;SPI1;RB1
prerank,positive regulation of protein dephosphorylation (GO:0035307),-0.4838171522849748,-1.5063305363387463,0.03875968992248062,0.7316051197035667,1.0,22/32,32.44%,PRKCD;CALM2;MAGI2;PPP1R16B;NSMF;CAMTA1;PPP1R7;ANKLE2;PPP2R5A;CDCA2;MTOR;PTPA;SPPL3;CALM3;TGFB1;PIN1;PDGFRB;SMPD1;PTBP1;CDH5;SYMPK;PPP1R15A
prerank,regulation of protein metabolic process (GO:0051246),0.5194843973953155,1.506227385643467,0.046476761619190406,0.3490806330585466,1.0,16/44,16.14%,APOE;APP;KLF2;LDLR;SPOP;PARL;KLF4;MTPN;SPOPL;MDM2;WFS1;ROCK2;NEDD4L;ZDHHC2;HSP90AB1;MAPK7
prerank,positive regulation of calcium ion transmembrane transport (GO:1904427),-0.502182397831325,-1.506203381199349,0.028205128205128206,0.7213454879888596,1.0,6/25,5.92%,CACNB2;CAPN3;PLCG1;ANK2;TRPC1;AKAP6
prerank,regulation of hydrolase activity (GO:0051336),0.48162561008029403,1.5054412170804732,0.03872752420470263,0.3498161030598637,1.0,13/71,7.32%,ARHGAP15;VAV3;FGD4;FGD6;ARHGAP9;CRK;PLXNC1;ITGB1BP1;OCRL;PLXNA4;NGEF;PPP1R17;ARHGAP12
prerank,negative regulation of type I interferon production (GO:0032480),-0.44964452130462584,-1.5051578018836256,0.031496062992125984,0.7158085896299343,1.0,15/40,15.35%,SIRPA;PTPRS;HAVCR2;CYLD;OTUD5;IRF3;MAVS;UBA7;RNF216;NLRC5;IKBKE;UFD1;NPLOC4;ITCH;PCBP2
prerank,negative regulation of macromolecule metabolic process (GO:0010605),0.4201935548018689,1.5050005156543689,0.013597033374536464,0.34979465738321225,1.0,39/182,12.32%,MSR1;APOE;APP;NOTCH2;CCR1;FOXP1;FBXW7;MYADM;LDLR;ESR1;MEF2C;PTPN22;BMP2;XDH;PARP14;CD46;PRKN;HEY2;SPI1;RB1;NDFIP1;RACK1;SETDB2;SDCBP;TNF;ZNF148;KLF4;YY1;REL;PSEN1;SMCR8;APOBEC1;IGF1;SFRP1;EMILIN1;HINFP;ROCK2;ZC3H12A;ATP2B4
prerank,negative regulation of intracellular signal transduction (GO:1902532),0.41674275198362903,1.5049464697727195,0.008433734939759036,0.34895408490777685,1.0,32/190,9.36%,BANK1;P2RX7;SPRED1;DEPTOR;PTPRJ;MYADM;ESR1;LYN;C1QTNF3;NR1H4;XDH;RIPK1;NR1D1;PDE2A;DUSP1;NPRL3;MCL1;SPI1;RACK1;BCL2L2;PDE4D;RIOK3;NOP53;BCL2;UACA;PPM1B;ARHGAP12;FNIP1;LIMD1;MDM2;MAPK14;SH2B3
prerank,negative regulation of gene silencing by miRNA (GO:0060965),0.661192449513228,1.5040516087094666,0.07809523809523809,0.349838276359751,1.0,4/12,12.28%,ESR1;TNF;NCOR1;ZC3H12A
prerank,negative regulation of blood vessel morphogenesis (GO:2000181),0.4696258642420068,1.504043586670561,0.036414565826330535,0.3488955732187404,1.0,18/75,12.32%,STAB1;PF4;ALOX5;SPRED1;THBS4;CNMD;TNMD;RGCC;GHRL;ROCK1;KLF4;CCR2;SYNJ2BP;AMOT;EMILIN1;ROCK2;NIBAN2;ATP2B4
prerank,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),0.5628084207953286,1.5038528576434012,0.05519480519480519,0.3483628244634947,1.0,7/27,5.47%,IRAK3;RPS27A;CD36;TLR4;MAP3K1;TLR2;LY96
prerank,regulation of keratinocyte differentiation (GO:0045616),0.569542709765228,1.501845140304296,0.04631217838765009,0.35170449241105,1.0,8/24,11.99%,SGPP1;NCOA3;ZFP36L1;GRHL2;ROCK1;CBFB;TRIM16;ROCK2
prerank,actin filament bundle assembly (GO:0051017),0.5414174981020076,1.5014821444800732,0.04567699836867863,0.35153718878597473,1.0,3/33,4.01%,EPS8;NEDD9;LCP1
prerank,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),0.44063634889741593,1.5010503986077068,0.01837270341207349,0.35154075324088846,1.0,24/116,13.33%,CD163;FCGR2B;LYN;CYSLTR1;GNG2;CALCRL;ADRB2;DRD1;ADM;ADCY9;ADCYAP1R1;SYK;GNB1;FYN;FCGR3A;MAPK14;TSHR;PTGER4;PRKACB;HTR6;RAMP2;GLP2R;CREB1;GPR27
prerank,cytokine-mediated signaling pathway (GO:0019221),0.3905817363556445,1.4999296445721846,0.0020768431983385254,0.3530054255383343,1.0,95/532,11.96%,F13A1;PF4;TNFRSF25;LIFR;ALOX5;IL16;RAP1B;PTPRJ;IRF4;CCR1;IFITM3;IL15;OAS2;ALOX15;SERPINB2;PSMA7;ITGB1;FER;IRAK3;IFNAR1;RPS27A;TSLP;CD44;TNFRSF1B;RIPK1;FCER1G;CD36;CCL8;PLVAP;CDC42;CBL;CCL19;CRK;PITPNA;PELI1;HMOX1;IL17RB;IL17RC;B2M;LCP1;LBP;VIM;TNFRSF11A;MCL1;IL17RA;SPI1;BIRC3;IRS2;IL10RB;SMAD4;PAK2;ADIPOR2;RNASEL;ANXA2;CD40;EDARADD;BCL2;HNRNPF;CNN2;SYK;MAP3K8;TNF;CD80;RPLP0;BST2;EDA;PSMB2;CCR2;IL20RB;STAT4;CANX;IFNAR2;IRF2;FYN;CCL24;IL6R;TRIM68;TNFSF12;MSN;SH2B3;NDN;IFITM2;STAT6;IL1RL1;RIPK2;SP100;PLP2;SLA;SHC1;S1PR1;IL15RA;PSMA6;FOXO3;JAK1;MAP3K3
prerank,early endosome to Golgi transport (GO:0034498),0.6962043654532117,1.4999062948323223,0.0812274368231047,0.3520840577417223,1.0,2/11,1.46%,SNX2;SNX8
prerank,regulation of monocyte differentiation (GO:0045655),0.643228387530882,1.4996707482332823,0.06712564543889846,0.3516007397562612,1.0,5/14,4.56%,FOXP1;CD74;DCSTAMP;ZFP36L1;CDK6
prerank,positive regulation of fat cell differentiation (GO:0045600),0.5058488423404154,1.4991766517073613,0.04504504504504504,0.35161568815946415,1.0,14/47,13.07%,CMKLR1;ZBTB16;RREB1;WDFY2;METRNL;CEBPB;BMP2;GDF3;ZFP36L1;MEDAG;VSTM2A;SFRP1;ZC3H12A;CREB1
prerank,gluconeogenesis (GO:0006094),-0.44993967035259524,-1.4990801175705426,0.01871657754010695,0.7362660785722782,1.0,16/39,21.17%,PGM1;ALDOA;MDH1;CRTC2;PGK1;ENO1;PCK2;ENO3;SLC37A4;TPI1;SLC39A14;SLC25A10;GAPDHS;ATF4;GAPDH;SLC25A1
prerank,positive regulation of non-canonical Wnt signaling pathway (GO:2000052),0.6906964508361637,1.4988075085838424,0.0777988614800759,0.35143687587921596,1.0,1/11,0.03%,DAB2
prerank,regulation of cell size (GO:0008361),0.5816595566340682,1.4984417449347591,0.07060755336617405,0.35119559946307327,1.0,6/23,8.63%,VAV3;DEPTOR;RARG;RHOA;MTPN;MSN
prerank,regulation of macrophage derived foam cell differentiation (GO:0010743),0.5564091723510894,1.4983203300941648,0.05970149253731343,0.35051857909483425,1.0,3/27,2.76%,MSR1;PF4;CD36
prerank,negative regulation of angiogenesis (GO:0016525),0.46248235931727166,1.497922188347235,0.03581267217630854,0.3504444991819757,1.0,22/84,12.32%,STAB1;PF4;ALOX5;KLF2;SPRED1;THBS4;CNMD;TNMD;RGCC;GHRL;ROCK1;TNF;EPN2;KLF4;CCR2;SYNJ2BP;AMOT;ADAMTS9;EMILIN1;ROCK2;NIBAN2;ATP2B4
prerank,cellular sodium ion homeostasis (GO:0006883),-0.57737131340768,-1.4971865634077743,0.03953488372093023,0.7349941545375087,1.0,4/15,4.06%,SLC12A2;ATP1B1;SLC8A1;ATP1B2
prerank,regulation of high voltage-gated calcium channel activity (GO:1901841),-0.6491492410751502,-1.4970890625290754,0.051224944320712694,0.7251402627250729,1.0,4/10,4.93%,CACNB2;PDE4B;NOS1AP;CACNA2D1
prerank,regulation of T cell proliferation (GO:0042129),0.486446426623109,1.4967269372460927,0.04341534008683068,0.35197236570058144,1.0,10/61,9.08%,VSIG4;IL15;CEBPB;TNFRSF1B;LILRB1;CD46;CCL19;PLA2G2D;CD80;SDC4
prerank,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),-0.6173995899155346,-1.495482959469083,0.05496828752642706,0.7234687312026822,1.0,4/11,4.93%,CACNB2;BIN1;NOS1AP;CACNA2D1
prerank,calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),-0.6009240540327676,-1.4951775156120215,0.05104408352668213,0.7151933574329076,1.0,8/12,26.37%,RIMS1;UNC13C;RIMS2;SYT8;RIMS3;SYT1;SYT7;SYT5
prerank,carbohydrate derivative catabolic process (GO:1901136),0.6065797930734054,1.4947502033307096,0.061946902654867256,0.3552206032829936,1.0,8/18,21.18%,AOAH;MANBA;ADAMTS9;NGLY1;SAMHD1;NEU4;DERA;FBXO6
prerank,negative regulation of secretion by cell (GO:1903531),0.5247953936200945,1.494720935241499,0.047058823529411764,0.3543210446833399,1.0,8/38,6.40%,APOE;TNFRSF1B;LILRB1;FGF23;HMGCR;STXBP6;RHBDF1;DPH3
prerank,mitochondrial calcium ion transmembrane transport (GO:0006851),0.5780411262085328,1.4928291350959224,0.0905982905982906,0.3573387656641992,1.0,5/20,12.17%,MCUB;MCU;PARL;SLC8B1;MICU3
prerank,negative regulation of T cell proliferation (GO:0042130),0.5537031570746356,1.4921844925059686,0.0667779632721202,0.3577824866861321,1.0,7/28,9.08%,VSIG4;CEBPB;LILRB1;RC3H1;PLA2G2D;CD80;SDC4
prerank,positive regulation of phosphorylation (GO:0042327),0.40808419287464154,1.4918380368674966,0.0011534025374855825,0.3575691027550461,1.0,42/240,10.21%,DAB2;NRP1;EGFR;P2RX7;FGFR1;APP;GAS6;WDFY2;ZBTB20;LYN;ANG;KRAS;BMP2;RIPK1;CD74;FGF23;AXIN1;THPO;NIBAN1;BCL10;PDE8A;INSR;CAMKK2;RACK1;PFKFB4;PDGFRA;CD40;ACVR2A;SDCBP;TNF;FAM20A;CCND3;PSEN1;SLC4A4;FNIP1;DDR2;KCTD20;CCND2;MYDGF;EPHB4;IGF1;ARRB1
prerank,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),0.5173246296267456,1.491676541320112,0.038397328881469114,0.35696557131026746,1.0,6/43,3.50%,EGFR;PTPRJ;EPS15;SNX6;CDC42;CBL
prerank,positive regulation of cell population proliferation (GO:0008284),0.3870615498973025,1.4915963328916513,0.0010834236186348862,0.3561799042988652,1.0,99/423,17.35%,RBPJ;PID1;FOLR2;EGFR;LIFR;FGFR1;CHP2;TCF7L2;FOXP1;IL15;KIF20B;GAS6;C5AR1;RPL23;LYN;GRK5;BST1;FER;LIG4;MEF2C;TSLP;KRAS;OSR1;KITLG;BMP2;CD74;FGF23;WNT2;GRN;NES;THPO;HMOX1;ITGB1BP1;TNFRSF11A;CDK6;IRS2;INSR;S1PR2;PDGFRA;ACER3;BCL2;RPS4X;FOXM1;RPS15A;SDCBP;TNF;BST2;TIPIN;IL6R;RPS9;DDR2;ADRA1D;ASH2L;TSPYL5;MDM2;PDGFC;CCND2;CACUL1;CUL3;IGF1;SFRP1;TSHR;SLC25A5;RPS6;PHIP;SHC1;ROMO1;CDK13;MAP3K3;NAMPT;NOD2;GLP2R;RBPMS2;GJA1;CRLF2;RNF187;RARA;DERL2;MDK;HMGN5;PRMT1;IL13RA1;BMPR1A;MYC;FN1;HDAC4;KDM1A;PTEN;TBX2;PRDX3;CCL5;IGF1R;EAPP;RELA;CNOT6L;GDF9;NACC1;XBP1;GAREM1
prerank,Fc-gamma receptor signaling pathway (GO:0038094),0.47807132788230194,1.4914718268247218,0.035161744022503515,0.35551034702791295,1.0,17/71,8.23%,VAV3;FCGR2B;LYN;ACTR3;ABI1;WASF2;DOCK1;FCER1G;CDC42;CRK;WIPF1;ACTB;SYK;ARPC2;ARPC5;FYN;FCGR3A
prerank,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),-0.4825710285020697,-1.490751357205867,0.0425,0.7268687697771388,1.0,13/27,23.03%,CHST11;XYLT1;CSPG5;CHPF2;CSPG4;VCAN;PXYLP1;BCAN;BGN;NCAN;UGDH;B3GAT1;DCN
prerank,regulation of muscle cell differentiation (GO:0051147),0.5380615022478791,1.490639112718044,0.06467661691542288,0.3564222564329673,1.0,7/31,9.18%,HDAC9;CTNNA1;MEF2A;MEF2C;CDC42;RBM4;MAPK14
prerank,cell part morphogenesis (GO:0032990),0.6531789970410948,1.4901095192543732,0.07076350093109869,0.35651323915962707,1.0,2/13,2.48%,PID1;MTM1
prerank,actin filament bundle organization (GO:0061572),0.537396651080909,1.4900435366516132,0.05654281098546042,0.3557257719682749,1.0,5/33,9.63%,EPS8;NEDD9;LCP1;PLS1;RFLNB
prerank,positive regulation of filopodium assembly (GO:0051491),0.5644439955083979,1.4885981713420555,0.06491228070175438,0.3578244573484744,1.0,5/24,5.36%,NRP1;RIPOR2;ARAP1;CDC42;DOCK11
prerank,regulation of chromatin organization (GO:1902275),-0.5971808571237641,-1.4882951403300975,0.04157043879907621,0.7298624499732784,1.0,7/14,24.64%,CDK9;HNRNPU;SSRP1;HPF1;TLK2;PARG;MKI67
prerank,regulation of melanin biosynthetic process (GO:0048021),0.6892563237947285,1.4882888779571208,0.06629834254143646,0.35753797035859375,1.0,3/10,5.58%,ZEB2;RAPGEF2;ATP7A
prerank,Fc receptor mediated stimulatory signaling pathway (GO:0002431),0.4744042294749153,1.48798120389662,0.0335195530726257,0.3572336574100502,1.0,17/73,8.23%,VAV3;FCGR2B;LYN;ACTR3;ABI1;WASF2;DOCK1;FCER1G;CDC42;CRK;WIPF1;ACTB;SYK;ARPC2;ARPC5;FYN;FCGR3A
prerank,regulation of dendrite development (GO:0050773),-0.4598968116269422,-1.4874039906280505,0.03485254691689008,0.7248777568270048,1.0,10/37,8.98%,CSMD3;ADGRB3;SEMA4D;HECW2;NSMF;SDC2;KNDC1;BCL11A;HECW1;ALK
prerank,purine nucleotide metabolic process (GO:0006163),0.580914405747473,1.4872858353512401,0.04957264957264957,0.3578081283872478,1.0,3/24,3.66%,GDA;XDH;DNPH1
prerank,negative regulation of catabolic process (GO:0009895),0.5075429231999609,1.4872127136632651,0.0529595015576324,0.3570191907214363,1.0,10/47,8.14%,EGFR;NUPR1;IRAK3;CBFA2T3;RILP;HMGCR;SF3B3;SNX3;TNF;NCOR1
prerank,regulation of cell junction assembly (GO:1901888),0.5453255433429587,1.4866941655142312,0.05672609400324149,0.3572383485055154,1.0,7/27,5.69%,PDLIM5;RAP1B;MEF2C;RAPGEF2;RAP1A;ROCK1;CBFB
prerank,protein localization to cell junction (GO:1902414),-0.510901737620169,-1.4859249030985802,0.05868544600938967,0.7226177086011313,1.0,7/22,5.61%,TJP1;NLGN1;DLG4;PCLO;FERMT2;TJP2;SHANK1
prerank,positive regulation of cell death (GO:0010942),0.4853155658347958,1.4854540792038597,0.046579330422125184,0.35887816076096835,1.0,11/59,10.06%,FCGR2B;MAP3K5;C1QA;RARG;RIPK1;CD36;GSK3B;TNF;HTATIP2;FYN;RIPK2
prerank,female gamete generation (GO:0007292),0.5481577976219402,1.485408523654508,0.05853658536585366,0.3580707384284305,1.0,10/29,17.61%,DIAPH2;USP9X;MCM9;NANOS3;HORMAD1;PIWIL2;MDK;MCM8;GDF9;DMC1
prerank,phasic smooth muscle contraction (GO:0014821),0.6800295218165434,1.4849067613333942,0.07751937984496124,0.3582122616777154,1.0,4/10,19.58%,EDNRB;HTR1D;GDNF;TIFAB
prerank,inorganic anion transmembrane transport (GO:0098661),-0.4005569909186904,-1.4847709080430602,0.023178807947019868,0.7186925619163401,1.0,30/63,25.15%,SLC1A3;SLC12A2;GABRB3;ANO4;SLC25A3;SLC37A2;SLC12A9;GABRB1;ANO3;GLRB;SLC1A1;SLC25A14;GABRA2;SLC12A6;GLRA1;SLC37A4;GABRG2;SLC6A1;GLRA3;CFTR;SLC25A10;SLC20A2;SLC37A3;SLC12A4;GLRA2;ANO5;SLC12A5;GABRA4;GABRR2;SLC12A1
prerank,cell-matrix adhesion (GO:0007160),0.4444399428823746,1.4843622065235782,0.03116531165311653,0.3584695249580954,1.0,18/95,11.35%,LYVE1;ITGA4;SIGLEC1;PEAK1;ITGB1;TNN;CD44;ADAM9;ITGB1BP1;ITGBL1;PTPRK;VCL;RCC2;ADAMTS9;PIP5K1A;THSD1;EMILIN1;PPFIA1
prerank,negative regulation of protein localization to nucleus (GO:1900181),0.6040178422092262,1.4840477591973003,0.0711864406779661,0.3581635949167568,1.0,8/18,13.27%,CTNNA1;MDFIC;MFHAS1;GSK3B;POLR1A;RAB23;UFM1;LATS2
prerank,regulation of cell development (GO:0060284),0.528664855939565,1.4835727021130585,0.05642633228840126,0.35832806987582055,1.0,5/36,4.61%,HDAC9;NOTCH2;GRN;HEY2;CLOCK
prerank,response to chemokine (GO:1990868),0.6551015771542051,1.4832679801883397,0.08214285714285714,0.3580589703897452,1.0,7/13,12.28%,RIPOR2;OXSR1;RHOA;DUSP1;WNK1;SH2B3;ZC3H12A
prerank,regulation of MAPK cascade (GO:0043408),0.4269530521484174,1.4831533332936822,0.01507537688442211,0.35742657748025924,1.0,27/157,9.90%,EGFR;P2RX7;FGFR1;LILRA5;SPRED1;PTPRJ;IQGAP1;LYN;ADRB2;BMP2;CD74;THPO;DUSP1;GSDME;INSR;PAK2;ROCK1;STK3;TMEM106A;VRK2;SYK;NRK;ADRA1D;ADRA1A;LBH;MYDGF;IGF1
prerank,ceramide transport (GO:0035627),0.6725015460054413,1.4827619024134469,0.06866197183098592,0.35732688615141694,1.0,2/12,1.59%,PLTP;SGPP1
prerank,glycerolipid catabolic process (GO:0046503),-0.5370081905527353,-1.4826562570307442,0.06074766355140187,0.7204517702398425,1.0,4/19,5.00%,ABHD12;MGLL;SMPD4;LYPLA2
prerank,regulation of mesenchymal cell proliferation (GO:0010464),-0.6188848153140013,-1.4810556441366534,0.06437768240343347,0.7192270469998473,1.0,6/11,20.22%,LRP5;STAT1;FGFR2;TGFBR2;PDGFA;WNT5A
prerank,regulation of megakaryocyte differentiation (GO:0045652),0.5021093462294721,1.4807923901280535,0.049924357034795766,0.3607572290805223,1.0,17/49,18.92%,PF4;KMT2A;MEF2C;THPO;CBFB;RAB7B;ASH2L;KMT2C;H3-3A;RBM15;KMT2E;TNRC6C;EP300;PRMT1;PRKCQ;CNOT4;PITHD1
prerank,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.4413244554603313,1.4805016020270088,0.02257636122177955,0.3604900952856829,1.0,20/110,11.26%,PF4;ADGRE5;GNAQ;ADGRG6;ADGRE1;GNG2;CALCRL;ADRB2;GPR65;DRD1;ADM;RAPGEF2;S1PR2;ADCY9;GNB1;ADRA1D;ADRA1A;TSHR;PTGER4;S1PR1
prerank,cyclooxygenase pathway (GO:0019371),-0.639803788412552,-1.480489457889466,0.05077262693156733,0.7129675404335203,1.0,5/10,24.98%,HPGDS;PTGS1;PTGES3;PTGIS;PTGDS
prerank,positive regulation of cilium assembly (GO:0045724),-0.5428212156005535,-1.480012227980354,0.034722222222222224,0.7064509554412275,1.0,9/18,23.42%,CEP135;CROCC;CCP110;WRAP73;ENTR1;KCTD17;BBS4;HAP1;TAPT1
prerank,chloride transmembrane transport (GO:1902476),-0.42099013982469535,-1.479652733982584,0.03076923076923077,0.6996226662386283,1.0,23/48,25.15%,SLC1A3;SLC12A2;GABRB3;ANO4;SLC12A9;GABRB1;ANO3;GLRB;SLC1A1;GABRA2;SLC12A6;GLRA1;GABRG2;SLC6A1;GLRA3;CFTR;SLC12A4;GLRA2;ANO5;SLC12A5;GABRA4;GABRR2;SLC12A1
prerank,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),0.4584687580674085,1.4792124299387157,0.036671368124118475,0.36225772462672506,1.0,16/76,10.12%,DAB2;FBXW7;CBFA2T3;ARIH1;PIAS1;PRICKLE1;AXIN1;PRKN;GSK3B;RACK1;ANKIB1;NOP53;MDM2;RNF19B;COP1;RNF14
prerank,positive regulation of Notch signaling pathway (GO:0045747),0.508622356991739,1.4791505460389613,0.0499219968798752,0.36149566449360215,1.0,12/39,15.56%,RBPJ;JAG1;ITGB1BP1;EPN2;POGLUT1;MAML1;CREBBP;NOD2;STAT3;EP300;SNW1;TSPAN14
prerank,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),0.45960287818608353,1.4784660111319592,0.03576341127922971,0.36201322475787645,1.0,13/76,8.64%,HRH1;CMKLR1;C5AR1;ESR1;C3AR1;GPR65;DRD1;P2RY6;ANO1;P2RY10;HOMER1;ADRA1D;ADRA1A
prerank,regulation of myelination (GO:0031641),-0.48015463633865885,-1.4778244238831615,0.05687203791469194,0.700041048662912,1.0,9/25,12.21%,JAM2;PARD3;ITGAX;CST7;TENM4;NSUN5;SIRT2;TPPP;RNF10
prerank,positive regulation of macromolecule metabolic process (GO:0010604),0.3949289491398381,1.4777405371659311,0.004362050163576881,0.3626547243719172,1.0,59/348,12.33%,RBPJ;PID1;PF4;P2RX7;APP;KLF2;TBC1D5;GAS6;ADAM19;RPL23;C1QTNF1;RPS3;MEF2C;PTPN22;KRAS;MITF;OSR1;BMP2;LILRB1;CD36;CD74;FGF23;DRD1;LAMP3;TLR4;PPHLN1;CD46;RGCC;PRKN;PDE2A;TLR2;HEY2;GSK3B;INSR;ROCK1;ANXA2;SETDB2;TNF;KLF4;MTPN;RPL5;HFE;WNT6;PSEN1;VSTM2A;MSN;RPS7;MAPK14;IGF1;ARRB1;MED26;SP1;EMILIN1;HINFP;WFS1;ROCK2;LAMTOR5;ZC3H12A;SLC38A2
prerank,cellular response to vascular endothelial growth factor stimulus (GO:0035924),0.525730600053424,1.4776541571023778,0.05591054313099041,0.36193409493598416,1.0,13/34,17.43%,NRP1;ERN1;ITGB1BP1;MAPKAPK2;NR4A1;HSPB1;GAB1;MAPK14;NUS1;RAMP2;PRKD2;RELA;SPRY2
prerank,negative regulation of response to stimulus (GO:0048585),0.47563849286512416,1.4774055246832067,0.044642857142857144,0.3615840931207485,1.0,11/60,11.96%,MCTP1;FCGR2B;ALOX5;CASK;LYN;CDK6;KLF4;SH2B3;VPS13C;WFS1;MAP3K3
prerank,negative regulation of interleukin-6 production (GO:0032715),0.5522501970034625,1.4773191266678998,0.07321131447587355,0.3608669744719102,1.0,10/27,12.28%,GAS6;C1QTNF3;IRAK3;PTPN22;TLR4;GHRL;CD200R1;TNF;ARRB1;ZC3H12A
prerank,negative regulation of blood vessel endothelial cell migration (GO:0043537),0.5382652622525289,1.4770495349983495,0.06677265500794913,0.3605473663263507,1.0,11/33,12.32%,APOE;MEF2C;RHOA;RGCC;ITGB1BP1;TNF;KLF4;STARD13;JUP;MMRN2;ATP2B4
prerank,positive regulation of cellular respiration (GO:1901857),0.678005355291119,1.4763266951602434,0.09288537549407115,0.36115079866848904,1.0,3/11,5.07%,NUPR1;IFNAR1;IL10RB
prerank,maintenance of blood-brain barrier (GO:0035633),-0.4704780475221453,-1.4760639171321865,0.0335195530726257,0.7002415407015973,1.0,10/30,11.08%,F11R;TJP1;MBP;SLC12A2;JAM2;TJP2;LAMA2;WNK3;PECAM1;SLC1A1
prerank,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),0.5067146607396003,1.4754727729247783,0.06346749226006192,0.3621148570961215,1.0,15/43,14.55%,GAS6;IRAK3;NR1H4;PTPN22;LILRB1;TLR4;LBP;NFKBIL1;GHRL;TRIM27;CD33;IGF1;ZC3H12A;RARA;ARG2
prerank,positive regulation of T-helper 17 type immune response (GO:2000318),0.6749255072051081,1.475209934744167,0.08185053380782918,0.36189558028140206,1.0,2/11,4.08%,CLEC6A;NFKBIZ
prerank,establishment of epithelial cell polarity (GO:0090162),0.5945522073324272,1.4749678289444157,0.07853403141361257,0.36153264172796484,1.0,11/19,20.49%,OPHN1;CDC42;RHOA;MSN;CLASP1;CYTH1;MYO9A;SIPA1L3;GOLPH3;EZR;CYTH3
prerank,"regulation of mRNA splicing, via spliceosome (GO:0048024)",-0.38396566835515367,-1.4747854416507258,0.013422818791946308,0.6981446296127648,1.0,34/84,20.25%,DDX5;SON;DDX17;RBM25;NCL;RBFOX1;SRRM4;FXR2;SRSF3;TIA1;HNRNPU;SRPK1;PUF60;SRSF10;FMR1;CELF4;KHDRBS3;RNPS1;SRPK2;CIRBP;NOVA2;C1QBP;QKI;SRSF12;NCBP1;RBMXL1;SFSWAP;HNRNPA1;RBM5;RBM39;SRSF9;MBNL3;FXR1;CELF6
prerank,regulation of T cell migration (GO:2000404),0.5995482437655144,1.4739660848129446,0.058823529411764705,0.36276210286609456,1.0,4/18,5.09%,APP;RIPOR2;RHOA;CD200R1
prerank,negative regulation of receptor binding (GO:1900121),0.6755524210474368,1.4734668669741138,0.10126582278481013,0.36295434972272367,1.0,3/10,14.25%,B2M;HFE;ATP2A2
prerank,modulation of chemical synaptic transmission (GO:0050804),-0.359272558456349,-1.473195489478391,0.00390625,0.697315503923258,1.0,30/107,12.48%,CX3CR1;GRID2;NRG3;SLC12A2;DGKI;RIMS1;SNCAIP;DLGAP2;GRM7;GRIK2;NLGN1;RIMS2;CDH2;LRRC4C;DLG4;DLGAP1;GRM3;CLN3;USP46;BDNF;KCTD13;FMR1;DGKZ;SYN3;CPLX1;ABR;TMEM108;LRRC4;NPTX1;LGI1
prerank,ciliary basal body-plasma membrane docking (GO:0097711),-0.37504663152479595,-1.4729170218893295,0.011194029850746268,0.6906976625892132,1.0,38/94,28.95%,CSNK1E;SDCCAG8;CEP135;TMEM67;SCLT1;ODF2;DYNC1H1;CEP97;RAB3IP;CEP162;CEP192;AHI1;CEP250;HAUS8;MKS1;CEP63;CCP110;HAUS7;CKAP5;MAPRE1;HAUS3;TCTN1;B9D2;DCTN2;CEP89;IQCB1;CNTRL;HAUS2;DCTN1;PLK4;CDK1;HAUS6;YWHAG;TTBK2;TUBA4A;CEP152;TCTN2;B9D1
prerank,positive regulation of protein catabolic process (GO:0045732),0.4560017796298876,1.4722391091634055,0.036284470246734396,0.3647415493017042,1.0,23/84,15.60%,WWP1;APOE;SNX9;SMURF2;TNFRSF1B;RILP;ADAM9;AXIN1;PRKN;GSK3B;TRIM32;TNF;RAB7A;TNFSF12;MSN;NKD1;ATG7;SNX33;FOXO1;NEDD4L;GPC3;RNF41;VGLL4
prerank,positive regulation of intracellular signal transduction (GO:1902533),0.38323932293862994,1.4717896078686397,0.0010504201680672268,0.3647873769508584,1.0,105/509,13.10%,PLEKHG5;HIP1;EGFR;FGFR1;APP;LILRA5;PTPRJ;TCF7L2;IQGAP1;SASH1;CLEC6A;GAS6;ESR1;NUPR1;RPL23;S100A4;LYN;ITGB1;MFHAS1;RPS3;SHISA5;DDX60;ALPK1;CASS4;KITLG;ADRB2;BMP2;RIPK1;CD74;FGF23;MYORG;TLR4;RPS15;RPL37;ANKRD17;THPO;CBL;CCL19;PELI1;RHOA;HMOX1;RAPGEF2;RPS20;ITGB1BP1;PRKN;FRS2;BCL10;TLR2;ICOS;GSDME;BIRC3;IRS2;NDFIP1;INSR;RACK1;GPRC5B;PDGFRA;PUM2;ROCK1;TRIM32;TMEM106A;CD40;BCL2;MIOS;TNF;CD80;USP15;BST2;MIER1;REL;GAB1;PRKCB;FYN;TRIM68;FNIP1;ADRA1D;ADRA1A;TSPYL5;TRIM27;SMCR8;TFG;CARD16;PDGFC;MYDGF;EEF1D;IGF1;RTN4;RIPK2;NUP62;WLS;F10;CASP8;SHC1;MAP3K3;ROCK2;STRN;DHX33;LAMTOR5;VAPA;TERF2IP;HTR6;NOD2;TNFRSF1A;UBE2N;GJA1
prerank,ceramide catabolic process (GO:0046514),-0.5836040012669367,-1.4708341838427523,0.058577405857740586,0.6926830391256605,1.0,5/14,13.09%,HEXB;NEU1;ASAH1;ASAH2;ACER2
prerank,regulation of peptidyl-lysine acetylation (GO:2000756),-0.6332716480321863,-1.4705680406055963,0.059447983014861996,0.6863128547576992,1.0,4/10,16.22%,DIP2B;DIP2A;FLCN;PARK7
prerank,blood vessel diameter maintenance (GO:0097746),0.5370107471042253,1.4702662496119157,0.07596899224806201,0.36721284263518345,1.0,6/34,11.99%,EDNRB;KLF2;ITGB1BP1;ROCK1;GCLM;ROCK2
prerank,regulation of short-term neuronal synaptic plasticity (GO:0048172),-0.5741211918004159,-1.4700858084807271,0.061269146608315096,0.681034885407096,1.0,10/13,35.55%,GRIK2;SYNGR1;SLC4A10;CLN3;SHISA7;SHISA9;SHISA8;SYP;RAB3A;SHISA6
prerank,regulation of protein phosphorylation (GO:0001932),0.39714681112625283,1.4696289240833356,0.00684931506849315,0.36766781337196003,1.0,41/256,9.58%,DAB2;PID1;EGFR;LRP6;APP;MYADM;GAS6;WDFY2;LYN;BST1;FER;CEBPB;KRAS;BMP2;XDH;RIPK1;CD74;FGF23;AXIN1;THPO;NIBAN1;PRKN;PDE8A;INSR;CAMKK2;RACK1;CD40;NOP53;ACVR2A;HSPB1;TNF;FAM20A;CCND3;MOB1B;FYN;FNIP1;KDM4D;CORO1C;CCND2;MYDGF;PPP2CA
prerank,regulation of adaptive immune response (GO:0002819),0.6042169743787943,1.4696185220868134,0.09821428571428571,0.3668118109812336,1.0,3/18,1.41%,FCGR2B;AHR;ALOX15
prerank,regulation of BMP signaling pathway (GO:0030510),0.45785097495169974,1.4691011511736565,0.04317548746518106,0.3670424648332052,1.0,9/73,6.39%,RBPJ;SMURF2;CRIM1;BMP2;GDF3;SMAD4;TRIM33;ACVR2A;HTRA3
prerank,positive regulation of actin filament depolymerization (GO:0030836),-0.6396025689777995,-1.468777197290327,0.06823027718550106,0.6792738865566454,1.0,4/10,32.09%,ACTN2;PLEK;WDR1;CARMIL2
prerank,negative regulation of endothelial cell proliferation (GO:0001937),0.5347728048277057,1.4680459013602036,0.061788617886178863,0.3683166746624796,1.0,9/35,7.79%,APOE;ALOX5;MEF2C;XDH;CNMD;TNMD;RGCC;GHRL;SYNJ2BP
prerank,amino acid import (GO:0043090),-0.5176672290771335,-1.4677435442277882,0.05895691609977324,0.6764288756839362,1.0,6/21,21.95%,SLC1A3;SLC36A1;SLC1A1;SLC7A8;SLC6A1;SLC22A4
prerank,regulation of androgen receptor signaling pathway (GO:0060765),0.5365047379316012,1.46752337286638,0.06324786324786325,0.3685376553233601,1.0,9/30,10.12%,DAB2;FOXP1;NCOA2;PIAS2;NCOR1;TRIM68;H3-3A;SFRP1;RNF14
prerank,positive regulation of protein kinase B signaling (GO:0051897),0.42002566633720945,1.467099993541508,0.009950248756218905,0.36860151170958205,1.0,28/150,9.90%,HIP1;EGFR;FGFR1;PTPRJ;TCF7L2;GAS6;ESR1;ITGB1;MFHAS1;CASS4;KITLG;FGF23;MYORG;THPO;CCL19;ITGB1BP1;FRS2;ICOS;IRS2;INSR;PDGFRA;TNF;CD80;GAB1;FYN;TSPYL5;MYDGF;RTN4
prerank,regulation of B cell apoptotic process (GO:0002902),0.6553604461021456,1.4668418951659394,0.08858267716535433,0.3682506495100388,1.0,4/12,8.33%,FOXP1;LYN;IRS2;FNIP1
prerank,positive regulation of blood vessel endothelial cell migration (GO:0043536),0.4993721174134851,1.4665479720976586,0.04585798816568047,0.36801168051289174,1.0,11/48,11.96%,HDAC9;FGFR1;HMOX1;CD40;HSPB1;PIK3C2A;FOXC2;MAPK14;NUS1;SP1;MAP3K3
prerank,negative regulation of cyclase activity (GO:0031280),0.6175588374923348,1.4661113112721287,0.07526881720430108,0.36796631974159694,1.0,3/14,7.58%,EDNRB;GNAI3;CCR2
prerank,regulation of multicellular organism growth (GO:0040014),0.6282808593550384,1.4654446643486911,0.081374321880651,0.36845989776801863,1.0,4/15,13.88%,APP;GHRL;IGF1;MFSD2A
prerank,positive regulation of epithelial cell proliferation (GO:0050679),0.42630173891110057,1.4653606148245775,0.02349869451697128,0.36777420840931835,1.0,21/113,10.83%,NRP1;EGFR;TCF7L2;NOTCH2;RREB1;C5AR1;ANG;NRAS;OSR1;BMP2;THBS4;GRN;NRARP;NR4A1;CCL24;TNFSF12;MYDGF;IGF1;RTN4;SFRP1;EGFL7
prerank,regulation of cholesterol efflux (GO:0010874),0.5439018552111489,1.46512299754645,0.06103286384976526,0.36744918267646925,1.0,2/30,0.49%,PLTP;APOE
prerank,negative regulation of gluconeogenesis (GO:0045721),0.647081315865606,1.4650079713537159,0.07722007722007722,0.36685320691105544,1.0,2/11,3.09%,C1QTNF3;C1QTNF12
prerank,negative regulation of kinase activity (GO:0033673),0.4817030014525704,1.464881740688497,0.05873925501432665,0.36627974656233464,1.0,14/62,8.89%,LRP6;GNAQ;SPRED1;DEPTOR;PRKAG2;ITGB1BP1;IRS2;RB1;PAK2;SFN;CEP85;HSPB1;TRIM27;SMCR8
prerank,positive regulation of nervous system development (GO:0051962),-0.42961181929776326,-1.4647836300731907,0.045454545454545456,0.6822229784200499,1.0,11/42,9.33%,CX3CR1;NUMB;GRID2;PTPRD;NLGN1;NRXN1;TGM2;EPHB1;BDNF;NUMBL;SYNDIG1
prerank,mitochondrial protein processing (GO:0034982),0.6535203076225725,1.464710370324167,0.08092485549132948,0.3658667111221395,1.0,1/11,0.60%,IMMP2L
prerank,negative regulation of response to external stimulus (GO:0032102),0.43702898467908385,1.464557805939497,0.03153745072273324,0.36531044286873415,1.0,17/105,7.22%,AOAH;APOE;ALOX5;CASK;C1QTNF3;MFHAS1;IRAK3;NR1H4;METRNL;DRD1;NR1D1;CRK;NFKBIL1;RB1;GHRL;PPM1B;KLF4
prerank,positive regulation of monooxygenase activity (GO:0032770),0.5505462011734165,1.4642634607775096,0.05872756933115824,0.3651027568622725,1.0,8/26,10.36%,APOE;S100A1;FGF23;NPR3;GCH1;ATP7A;TNF;NUS1
prerank,neuron maturation (GO:0042551),0.6004213630654116,1.4630935388787367,0.08290155440414508,0.3667691643350465,1.0,6/18,4.20%,APP;C1QA;ANKS1A;SCARF1;CLN5;B4GALT6
prerank,response to axon injury (GO:0048678),-0.535896638177672,-1.4628226134188855,0.04918032786885246,0.684088404028952,1.0,4/18,6.60%,RTN4RL1;TREM2;APOD;P2RY12
prerank,protein deneddylation (GO:0000338),-0.6222825591377669,-1.4628005849195242,0.0784313725490196,0.6771006387624573,1.0,6/10,21.40%,COPS7A;COPS8;COPS4;COPS6;GPS1;TOR1A
prerank,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),0.44402437678468853,1.4627712759837455,0.041666666666666664,0.3665322289185393,1.0,19/95,11.64%,DAB2;ZEB2;SPRED1;SMURF2;RPS27A;SNX6;IL17RD;SMAD4;TRIM33;SNX25;HTRA3;SDCBP;VASN;RNF111;DAND5;SPRED2;EMILIN1;CREBBP;PMEPA1
prerank,respiratory system development (GO:0060541),-0.46107727973201595,-1.4625798154032177,0.0345679012345679,0.6710317619673433,1.0,16/32,29.16%,CHD7;BASP1;FGF2;FGFR2;LOXL3;BAG6;CCDC39;SPEF2;PROX1;PDPN;CCDC40;FGF1;WNT7B;FGF7;SMCHD1;BMP4
prerank,regulation of fat cell differentiation (GO:0045598),0.45587167189825056,1.4623491887804971,0.039603960396039604,0.3665839867422891,1.0,19/74,13.07%,ALOX5;CMKLR1;ZBTB16;ZFP36L2;WDFY2;CEBPB;BMP2;NR1D1;GDF3;ZFP36L1;TRIO;MEDAG;TNF;ASXL1;SFRP1;TRIB2;ZC3H12A;FOXO1;CREB1
prerank,lymphocyte proliferation (GO:0046651),0.5643829637688573,1.462227229368091,0.08090614886731391,0.36603726270764875,1.0,5/22,8.63%,MEF2C;CD40;BCL2;CR2;MSN
prerank,endocytic recycling (GO:0032456),0.4826414000798216,1.4622137193926257,0.06481481481481481,0.3652333880728857,1.0,11/50,9.73%,DENND1A;EHD4;EPS15;DENND1B;SNX27;EHD1;SNX3;EIPR1;RAB7A;RAB14;CMTM6
prerank,positive regulation of signaling receptor activity (GO:2000273),0.515805563827912,1.4620379498773433,0.06050955414012739,0.3647914387802825,1.0,7/36,7.63%,NRP1;FBXW7;NCOA3;ITGB1;ADRB2;CCR2;HFE
prerank,dendrite morphogenesis (GO:0048813),-0.43579407628487227,-1.4619847834393385,0.047493403693931395,0.6667288178939482,1.0,13/35,10.64%,MAP2;CTNNA2;DOCK10;DLG4;FARP1;DIP2A;SHANK1;DVL1;EPHB1;SDC2;MAP6;CELSR2;MINK1
prerank,negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),0.6409325797212136,1.461968565826902,0.0847145488029466,0.3641292572725335,1.0,6/13,12.09%,CNMD;TNMD;EPN2;EMILIN1;MMRN2;NIBAN2
prerank,regulation of inclusion body assembly (GO:0090083),-0.6250149594590279,-1.4618944266610634,0.07142857142857142,0.6604139531387478,1.0,6/11,20.52%,SNCAIP;SACS;DNAJB2;DNAJB1;BAG5;DNAJA4
prerank,canonical glycolysis (GO:0061621),-0.49918481312490387,-1.461849598875814,0.0630841121495327,0.6474415020939842,1.0,9/24,13.08%,HK2;PFKL;ALDOA;PKM;PGK1;ENO1;PFKP;ENO3;TPI1
prerank,glucose catabolic process to pyruvate (GO:0061718),-0.49918481312490387,-1.461849598875814,0.0630841121495327,0.6474415020939842,1.0,9/24,13.08%,HK2;PFKL;ALDOA;PKM;PGK1;ENO1;PFKP;ENO3;TPI1
prerank,heme catabolic process (GO:0042167),0.6249716562731652,1.4605744855945406,0.07468123861566485,0.3654372598130455,1.0,6/14,7.95%,BLVRB;UGT1A4;UGT1A1;HMOX1;ABCC1;HMOX2
prerank,porphyrin-containing compound catabolic process (GO:0006787),0.6249716562731652,1.4605744855945406,0.07468123861566485,0.3654372598130455,1.0,6/14,7.95%,BLVRB;UGT1A4;UGT1A1;HMOX1;ABCC1;HMOX2
prerank,negative regulation of neuroinflammatory response (GO:0150079),0.631952211522679,1.4604119610362722,0.07747747747747748,0.3649484248598857,1.0,6/14,9.90%,LDLR;TNFRSF1B;NR1D1;GRN;CD200R1;IGF1
prerank,regulation of chemokine production (GO:0032642),0.5152580765937498,1.459865592059794,0.052969502407704656,0.365325970278258,1.0,9/36,8.25%,APP;FOXP1;TSLP;CD74;TLR4;HMOX1;TLR2;TNF;IL6R
prerank,regulation of cardiac muscle cell differentiation (GO:2000725),0.6634418100048208,1.4596193406199414,0.072265625,0.36500914901296466,1.0,3/11,4.00%,MEF2C;BMP2;FRS2
prerank,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.3899479195078356,1.4590250047429703,0.0010857763300760044,0.3654158639011042,1.0,74/390,11.24%,ITSN1;VAV3;MTSS1;AP2A2;NRP1;NEDD9;RASGRP4;EGFR;FGFR1;CYBB;SPRED1;PTPRJ;LYN;FER;ACTR3;ABI1;WASF2;RASA1;CASS4;DOCK1;ADRB2;ATP6V1B1;FGF23;CDC42;ANKS1A;CBL;CRK;RHOA;RAPGEF2;FRS2;FRK;GSK3B;IRS2;INSR;PAK2;MAPKAPK2;PDGFRA;ROCK1;EFS;ATP6V0A1;ACTB;KIF16B;AP2S1;HNRNPF;SYK;NGEF;SDCBP;ZAP70;ARPC2;ARPC5;GAB1;PSEN1;FYN;AP3S1;PIK3C2A;ATP6V1A;FOXC2;DDR2;SULF2;RAB14;MAPK14;PDGFC;ZNF106;POLR2B;EPHB4;IGF1;NUS1;STYK1;PXN;NCF2;SPRED2;SLA;PHIP;SHC1
prerank,negative regulation of osteoclast differentiation (GO:0045671),0.6014432099895441,1.4587918988363298,0.08333333333333333,0.3650717125691521,1.0,4/18,3.18%,FBXW7;LILRB3;LILRB1;TLR4
prerank,response to glucocorticoid (GO:0051384),0.54800089825014,1.4572718614781925,0.06473594548551959,0.3674861794628831,1.0,7/26,11.10%,ZFP36L2;ADAM9;ZFP36L1;NR3C1;TNF;PDCD7;SLIT3
prerank,neuron remodeling (GO:0016322),0.6852593655746343,1.4570755508063549,0.08969465648854962,0.36708215786417686,1.0,4/10,3.55%,APP;C1QA;ANKS1A;SCARF1
prerank,dopamine metabolic process (GO:0042417),0.5797607935373843,1.4568611159184703,0.08258527827648116,0.3666964519374907,1.0,6/18,5.58%,DRD1;PRKN;DAO;GCH1;MOXD1;ATP7A
prerank,brain development (GO:0007420),-0.34312496716907115,-1.4558596253012623,0.004484304932735426,0.6687468296166021,1.0,57/136,21.55%,CX3CR1;ADGRL3;CTNNA2;ROBO2;EPHA7;ZFHX3;CNTNAP2;CDH2;PBX2;BPTF;PITPNM1;AFF2;AATK;NDRG4;APOD;NF1;CIC;CNTN4;SYNJ2;BAG6;PPT1;RAB18;UTP3;ZFHX2;SPEF2;MEIS3;SHROOM2;GRIN2A;NKX2-2;SMARCA1;PROX1;EML1;CTNS;MEIS1;TGFBR2;DSCAML1;EEF1AKMT4-ECE2;ZIC1;POU6F1;SHROOM4;CDK5RAP3;SMG9;TBC1D23;DNAJC30;ADGRL2;EGR2;PBX1;PTPN11;PLXNB2;BBS4;PAFAH1B3;ROGDI;HAP1;NNAT;CDK5RAP1;MKKS;PBX4
prerank,regulation of lipid biosynthetic process (GO:0046890),0.5352599004413527,1.455612956290854,0.081377151799687,0.36841966311010643,1.0,4/32,5.81%,APOE;PRKAG2;ZBTB20;ADIPOR2
prerank,actin polymerization or depolymerization (GO:0008154),0.4888336469186949,1.4553053682926946,0.04661654135338346,0.368192645101788,1.0,8/50,4.90%,PSTPIP2;FLII;DIAPH1;GAS7;PSTPIP1;ANG;ABI1;GHRL
prerank,glutamate receptor signaling pathway (GO:0007215),-0.4374159833524322,-1.4550150476925139,0.036458333333333336,0.665696496847916,1.0,14/37,10.88%,GRID2;PTK2B;GRM7;GRIA2;GRIK2;DAGLB;GRM3;GRIA4;CLN3;GRIN3A;FMR1;DAGLA;PLCB1;GRIN2A
prerank,positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),0.6442331363297731,1.4549718923977366,0.10363636363636364,0.3680698778642421,1.0,2/12,6.96%,PAEP;CD80
prerank,negative regulation of adenylate cyclase activity (GO:0007194),0.6280170834604527,1.4546563576453493,0.08992805755395683,0.36791954714526437,1.0,3/13,7.58%,EDNRB;GNAI3;CCR2
prerank,positive regulation of protein phosphorylation (GO:0001934),0.3834661573229597,1.4545290818049716,0.004434589800443459,0.36735864212679226,1.0,57/348,10.21%,DAB2;BANK1;NRP1;EGFR;APP;PTPRJ;IQGAP1;SNX9;CLEC6A;IL15;PRKAG2;GAS6;WDFY2;LYN;RASSF2;KRAS;CD44;BMP2;RIPK1;CD74;FGF23;THBS4;GDF3;AXIN1;THPO;CCL19;NIBAN1;RAPGEF2;PDE8A;RAP1A;INSR;CAMKK2;RACK1;SMAD4;PAK2;S1PR2;GDF10;CD40;ACVR2A;SDCBP;TNF;FAM20A;CD80;CCND3;HFE;IL6R;FNIP1;DDR2;UBE2K;PDGFC;CCND2;MYDGF;CACUL1;IGF1;RIPK2;DOCK7;ARRB1
prerank,vascular endothelial growth factor signaling pathway (GO:0038084),0.6291565530079681,1.4544055521951276,0.08458646616541353,0.3668421419420011,1.0,4/14,10.51%,NRP1;GAB1;NUS1;MYO1C
prerank,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.3754527636997733,1.4538470941696964,0.0010626992561105207,0.36724680798062354,1.0,142/497,19.76%,RBPJ;HDAC9;WWP1;CD38;TCF7L2;MDFIC;FOXP1;AHR;ZBTB16;GAS6;SMURF2;RPS3;DAPK1;CBFA2T3;TSHZ3;BMP2;PRICKLE1;ALX1;NR1D1;SNX6;SAMD4A;S100A11;YWHAQ;JARID2;NR3C1;NKAP;MRPL13;HEY2;CLOCK;SPI1;GSK3B;RB1;RACK1;ARID5A;SMAD4;PTPRK;TRIM33;ATXN1;EPC1;SETDB2;DMAP1;FOXM1;ZNF568;TNF;ZNF148;KLF4;MALSU1;GATAD2A;GMNN;KLF10;RBM4;BTAF1;NCOR1;MIDEAS;LIMD1;MDM2;LBH;ILF3;GCFC2;SFRP1;SPEN;RBM15;RCOR2;DDX6;ZMYND15;PHC3;SHC1;CRYAB;FOXK2;HINFP;NANOS3;NIBAN2;TRIM71;KDM5C;FOXK1;LOXL2;SP3;FOXO1;CTBP2;PSPC1;SHMT1;NR1H2;RARA;KAT7;MBD1;BCOR;TERF1;KAT6A;CNOT9;EHMT1;NAB1;SNW1;HDAC4;PEX14;ZHX1;VGLL4;SFPQ;HEXIM2;USP47;KDM1A;CREB3L1;ATR;ZGPAT;PER1;TBX2;RCOR1;GLIS2;FOXP2;RELA;LHX1;NACC1;ZBTB7A;NR2F2;SYNCRIP;PA2G4;MECOM;ARID4A;GZF1;RFX3;ZBTB14;TRAF6;SUMO1;ID3;THRA;RNF139;BRMS1;EIF2AK2;EIF2AK1;INPP5K;ENPP1;SFMBT1;CIART;BCL3;TLE1;CTCF;SET;EIF2AK3;MECP2;CREBZF;CNOT1;CNOT8;ERN2
prerank,Rap protein signal transduction (GO:0032486),0.6856869116561596,1.4535158640031216,0.10612244897959183,0.36710884579501485,1.0,4/10,4.84%,RAP1B;RAP2B;RAPGEF2;RAP1A
prerank,positive regulation of neuron death (GO:1901216),0.49064155601956033,1.4529570622607566,0.06356589147286822,0.3674254830425853,1.0,9/46,8.07%,FCGR2B;MAP3K5;C1QA;NUPR1;TLR4;GRN;GSK3B;TNF;FYN
prerank,myeloid cell activation involved in immune response (GO:0002275),0.6037358409512067,1.4529421043773278,0.0677361853832442,0.36665904265145177,1.0,4/18,6.57%,DOCK2;FCER1G;LBP;SYK
prerank,positive regulation of transcription of Notch receptor target (GO:0007221),0.5911450959943993,1.452789575215999,0.08224299065420561,0.3661634390363051,1.0,7/17,14.89%,RBPJ;MAML1;CREBBP;PLXND1;EP300;WWC1;SNW1
prerank,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),0.4650095642743238,1.452408804674806,0.04073033707865169,0.3661900861568841,1.0,16/70,8.23%,VAV3;FCGR2B;LYN;ACTR3;ABI1;WASF2;DOCK1;CDC42;CRK;WIPF1;ACTB;SYK;ARPC2;ARPC5;FYN;FCGR3A
prerank,response to insulin (GO:0032868),0.4479034715763786,1.4514426222138332,0.053824362606232294,0.36749347543608263,1.0,11/80,4.97%,HDAC9;MYO5A;TBC1D4;RAB31;FER;RAB8B;RAB10;ZFP36L1;SLC2A4;IRS2;INSR
prerank,positive regulation of interleukin-4 production (GO:0032753),0.5958675096699103,1.4508946596824521,0.099644128113879,0.36777611718736236,1.0,4/17,6.57%,IRF4;CEBPB;FCER1G;SYK
prerank,"regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",0.6710138612128642,1.450404161599001,0.09386973180076628,0.367915777567245,1.0,3/10,5.69%,IRF4;SH3RF1;CBFB
prerank,positive regulation of epithelial cell apoptotic process (GO:1904037),0.5820952535032897,1.450332869956232,0.09655172413793103,0.3672607613919898,1.0,4/20,6.13%,ITGA4;ANO6;RGCC;CD40
prerank,positive regulation of voltage-gated potassium channel activity (GO:1903818),-0.6050771790898042,-1.44972651226054,0.06666666666666667,0.6821656359284075,1.0,3/11,5.92%,TREM2;NOS1AP;AKAP6
prerank,negative regulation of apoptotic process (GO:0043066),0.3788439157471813,1.449387770457143,0.003205128205128205,0.36847566732294673,1.0,78/444,12.28%,DAB2;CD38;EGFR;APOE;TNFAIP8;NOTCH2;TPT1;GAS6;NUPR1;GRK5;DNAJC3;ITGB1;LIG4;MEF2C;NR1H4;RPS27A;TSLP;BABAM2;RASA1;CD44;OSR1;SH3RF1;RIPK1;ARHGAP10;SIAH2;CD74;LAMP3;GRN;SNX6;CBL;RPS6KA3;PRKN;MCL1;GSK3B;BIRC3;RB1;GHRL;RHBDD1;GLO1;PAK2;BCL2L2;TXNDC5;SFN;BCL2;HIGD1A;BAG3;HSPB1;TNF;KLF4;HTATIP2;PSEN1;NR4A2;BIRC6;ARHGDIA;FNIP1;MAPK8IP2;TRIM27;CARD16;IGBP1;CCND2;MYDGF;IGF1;SFRP1;RIPK2;NUP62;THOC6;PCID2;PHIP;DFFA;SHC1;CRYAB;WFS1;YWHAE;RPL10;NIBAN2;LAMTOR5;UFM1;ZC3H12A
prerank,regulation of cilium assembly (GO:1902017),-0.39519346792406357,-1.4490489450850335,0.027950310559006212,0.6785403517829952,1.0,32/62,23.52%,TBC1D16;TBC1D8;SDCCAG8;CYLD;SGSM3;CEP97;IFT140;TBC1D10A;IFT88;CROCC;TBC1D22A;IFT20;DYNLT2B;TBC1D22B;TBC1D9B;CCP110;EVI5L;TBC1D24;ENTR1;TBC1D20;CDK10;CDKL5;LIMK2;TBC1D7;TBC1D1;KCTD17;BBS4;TBC1D2;TBC1D10B;ODF2L;TAPT1;TBC1D15
prerank,positive regulation of JUN kinase activity (GO:0043507),0.5583299378004399,1.4485064896847153,0.10154905335628227,0.3695899939249633,1.0,5/23,6.94%,MAP3K5;SASH1;RPS3;TNFRSF11A;TNF
prerank,regulation of aerobic respiration (GO:1903715),0.6039436619416473,1.4480992877785863,0.09074410163339383,0.3696611519668842,1.0,4/15,9.82%,CBFA2T3;ATP7A;NOP53;COX7A2L
prerank,response to lipopolysaccharide (GO:0032496),0.41769517541118506,1.447929547921651,0.028930817610062894,0.36921161418315407,1.0,29/138,10.87%,PF4;FOXP1;FER;IRAK3;MEF2C;PTPN22;IFNAR1;TNFRSF1B;LILRB1;TLR4;NR1D1;ADAM9;PELI1;RHOA;RPS6KA3;LBP;BCL10;VIM;TNFRSF11A;NFKBIL1;GCH1;MAPKAPK2;LY96;CD80;CDC73;MAPK14;CARD16;CD68;CHMP5
prerank,striated muscle cell development (GO:0055002),0.6174123316366567,1.446128153972413,0.1044776119402985,0.3719610509975899,1.0,4/14,4.86%,FLII;TMOD1;MYH6;TMOD3
prerank,positive regulation of protein maturation (GO:1903319),0.666743376158268,1.4445852843553122,0.07722772277227723,0.3743925162952919,1.0,2/11,4.92%,NLRC4;RHBDD1
prerank,negative regulation of nucleic acid-templated transcription (GO:1903507),0.37590108711333653,1.444395692346485,0.004333694474539545,0.3739875990556924,1.0,118/417,19.76%,RBPJ;HDAC9;WWP1;CD38;TCF7L2;MDFIC;FOXP1;AHR;ZBTB16;GAS6;SMURF2;CBFA2T3;TSHZ3;BMP2;PRICKLE1;ALX1;NR1D1;SNX6;YWHAQ;JARID2;NR3C1;NKAP;HEY2;CLOCK;SPI1;RB1;ARID5A;SMAD4;PTPRK;TRIM33;ATXN1;EPC1;SETDB2;DMAP1;FOXM1;ZNF568;TNF;ZNF148;KLF4;GATAD2A;GMNN;KLF10;BTAF1;NCOR1;MIDEAS;LIMD1;MDM2;LBH;ILF3;GCFC2;SFRP1;SPEN;RBM15;RCOR2;ZMYND15;PHC3;SHC1;CRYAB;FOXK2;HINFP;NIBAN2;KDM5C;FOXK1;LOXL2;SP3;FOXO1;CTBP2;PSPC1;NR1H2;RARA;KAT7;MBD1;BCOR;KAT6A;EHMT1;NAB1;SNW1;HDAC4;PEX14;ZHX1;VGLL4;SFPQ;HEXIM2;USP47;KDM1A;CREB3L1;ZGPAT;PER1;TBX2;RCOR1;GLIS2;FOXP2;RELA;LHX1;NACC1;ZBTB7A;NR2F2;PA2G4;MECOM;ARID4A;GZF1;RFX3;ZBTB14;TRAF6;SUMO1;ID3;THRA;BRMS1;INPP5K;SFMBT1;CIART;BCL3;TLE1;CTCF;SET;MECP2;CREBZF;ERN2
prerank,regulation of biomineral tissue development (GO:0070167),0.5386458455769312,1.443570283026288,0.09375,0.37487447804551993,1.0,8/26,11.99%,GAS6;CEBPB;HEY2;NOTUM;ROCK1;DDR2;S1PR1;ROCK2
prerank,positive regulation of cholesterol transport (GO:0032376),0.5549399393535555,1.4435335044899311,0.07540983606557378,0.37418813487384295,1.0,2/27,0.49%,PLTP;APOE
prerank,toxin transport (GO:1901998),0.662974001990642,1.4434842387880347,0.10485436893203884,0.37350912007960724,1.0,3/10,9.31%,ANTXR2;ANTXRL;ANTXR1
prerank,lipopolysaccharide-mediated signaling pathway (GO:0031663),0.5698613185718795,1.4428957124254218,0.0920138888888889,0.3738942477360283,1.0,6/20,6.94%,LYN;PTPN22;TLR4;LBP;BCL10;TNF
prerank,organophosphate catabolic process (GO:0046434),-0.5959483017851838,-1.4425034965337722,0.08403361344537816,0.7011256384630116,1.0,2/11,2.40%,ABHD12;ENPP2
prerank,cardiac muscle cell action potential involved in contraction (GO:0086002),-0.46154212061045574,-1.44240856670872,0.0521978021978022,0.6951184542639183,1.0,7/30,5.40%,FGF12;KCNJ2;SCN1B;SNTA1;ANK2;CACNA2D1;CACNA1D
prerank,response to histamine (GO:0034776),0.6517927198971122,1.4413182200649606,0.07468123861566485,0.3762847599408521,1.0,3/10,4.28%,HRH1;DIAPH1;AOC1
prerank,regulation of establishment of protein localization (GO:0070201),-0.5643777478877152,-1.4407458503619535,0.06334841628959276,0.6958048614451471,1.0,3/13,2.04%,CTSD;CEP135;TREM2
prerank,myeloid leukocyte differentiation (GO:0002573),0.4579562924515566,1.4406541151698742,0.053824362606232294,0.37689569128944894,1.0,16/65,13.99%,FOXP1;IL15;CBFA2T3;CDC42;DCSTAMP;CCL19;TNFRSF11A;SPI1;GLO1;BATF2;MAPK14;CASP8;SNX10;DEK;RARA;EP300
prerank,regulation of osteoblast proliferation (GO:0033688),0.5925512180861034,1.439941549961817,0.09012131715771231,0.3775794367483494,1.0,5/17,4.47%,NELL1;TNN;BMP2;RHOA;NPR3
prerank,negative regulation of interleukin-8 production (GO:0032717),0.5869369873820749,1.4397046726847098,0.09605488850771869,0.377287402509966,1.0,5/17,10.21%,PTPN22;KLF4;CD33;SSC5D;ARRB1
prerank,regulation of cytoplasmic translation (GO:2000765),-0.5635265562826808,-1.4391083203423662,0.07982261640798226,0.6966409117783467,1.0,7/14,29.41%,PKM;CPEB2;FMR1;UNK;DHX9;CPEB1;CNBP
prerank,phospholipid metabolic process (GO:0006644),-0.37650975824618593,-1.4386014024540328,0.019672131147540985,0.6925504548993213,1.0,21/71,22.16%,ABHD12;LPCAT1;PLCB2;ENPP2;PCYT2;PLPP3;LPL;GNPAT;PLPPR1;GPX4;PIP4K2B;ANGPTL3;SMPD2;LGALS13;PLA2G3;ABCA2;ACP6;PLPP2;AGPAT3;GDE1;TNFAIP8L3
prerank,regulation of ATP biosynthetic process (GO:2001169),0.6125706540248864,1.4384803681870162,0.10086956521739131,0.37903558217946937,1.0,1/16,0.05%,PID1
prerank,integrin-mediated signaling pathway (GO:0007229),0.45169468357325593,1.437467057006769,0.04335260115606936,0.3802788871160017,1.0,12/73,6.57%,DAB2;NRP1;NEDD9;ITGB1;DOCK1;CDC42;ADAM9;ITGB1BP1;ITGBL1;CCM2;PTPRA;SYK
prerank,regulation of apoptotic process (GO:0042981),0.36931744014196416,1.4368736723369322,0.0010224948875255625,0.3807588972414987,1.0,115/676,13.49%,DAB2;ARHGEF3;ITSN1;VAV3;CD38;TNFRSF25;PLEKHG5;HIP1;NLRC4;FGD4;EGFR;TNFAIP8;MAP3K5;STK17B;NOTCH2;IFT57;TPT1;GAS6;NUPR1;GRK5;DNAJC3;ANO6;ITGB1;RARG;RPS3;DAPK1;MEF2C;NR1H4;RPS27A;TSLP;BABAM2;RASA1;RASSF2;STEAP3;CD44;OSR1;SH3RF1;RYBP;BMP2;RIPK1;ARHGAP10;LILRB1;SIAH2;CD74;CBL;RPS6KA3;PRKN;BCL10;MCL1;TRIO;GSK3B;BIRC3;GHRL;RHBDD1;GLO1;RACK1;PAK2;BCL2L2;TXNDC5;CTSB;STK3;NOP53;BCL2;HIGD1A;NGEF;TRIM24;BAG3;HSPB1;TNF;HTATIP2;PSEN1;ARHGEF12;BIRC6;ARHGDIA;ATF6;MAP3K20;CCND2;MYDGF;IGF1;RTN4;SFRP1;RIPK2;FBXO11;RPS6;NUP62;ATG7;THOC6;PCID2;CASP8;CTNNBL1;PHIP;CHM;DFFA;SHC1;CREBBP;CRYAB;WFS1;FOXO3;RPL10;NIBAN2;UFM1;DIABLO;MAP3K11;ITGB3BP;FBXO10;PPP1R13B;ARHGEF9;FAM162A;GLS2;FOXO1;NET1;SOS2;LATS2;TMBIM4;DDX42
prerank,regulation of microtubule depolymerization (GO:0031114),-0.485693925915432,-1.4359510172993202,0.052256532066508314,0.698196128975679,1.0,5/25,4.15%,NAV3;CLASP2;CAMSAP1;MAP1B;FGF13
prerank,"phagocytosis, engulfment (GO:0006911)",0.5097161642948208,1.4359163596520224,0.054773082942097026,0.3820791271355365,1.0,8/36,7.97%,MSR1;FCGR2B;DOCK1;CD36;HAVCR1;CDC42;ARHGAP12;RHOBTB1
prerank,chaperone-mediated protein complex assembly (GO:0051131),-0.5141187709525284,-1.4356256563849366,0.053738317757009345,0.6932332665679908,1.0,12/20,31.97%,HSPA4;BBS12;PTGES3;PSMG2;NDUFAF1;HOPX;TMEM35A;CCT2;MKKS;PSMG1;BBS10;HSPA1A
prerank,cholesterol homeostasis (GO:0042632),0.45886920000088094,1.4354271518758022,0.0611353711790393,0.3823039912498219,1.0,5/64,4.03%,HDAC9;APOE;LDLR;NR1D1;EHD1
prerank,positive regulation of epithelial to mesenchymal transition (GO:0010718),0.496298163286103,1.4348953531167412,0.08242612752721618,0.3826677315072492,1.0,8/40,6.90%,DAB2;TCF7L2;JAG1;BMP2;ALX1;RGCC;SMAD4;SDCBP
prerank,embryonic organ development (GO:0048568),0.46808793701019513,1.4348323964521938,0.061946902654867256,0.3820229200860323,1.0,7/61,4.68%,RBPJ;KMT2A;KITLG;NES;TPO;HEY2;PBX3
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),0.4473881908275792,1.434273968803937,0.03566333808844508,0.382403157970159,1.0,20/80,12.10%,MAP3K5;GAS6;DAPK1;CD44;SH3RF1;SIAH2;LAMP3;RPS6KA3;BCL10;SFN;SYK;TNF;UACA;KLF4;FNIP1;CARD16;CYCS;IGBP1;YWHAE;LAMTOR5
prerank,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),0.5504134852153333,1.433630601599602,0.08223684210526316,0.3829772452298185,1.0,5/26,6.94%,PF4;FGFR1;MCL1;BCL2;TNF
prerank,neuromuscular junction development (GO:0007528),-0.48837348388667645,-1.4334417802459545,0.06435643564356436,0.6967072426225653,1.0,5/24,6.34%,CACNB2;CACNB4;UNC13C;DVL1;DNAJA3
prerank,positive regulation of cellular biosynthetic process (GO:0031328),0.4086327469597271,1.4332923314635715,0.02669902912621359,0.3829163655006359,1.0,45/166,17.73%,ZEB2;EGFR;KLF2;LDLR;EIF3E;CD36;TLR4;NR1D1;CCL19;SAMD4A;NIBAN1;RPL26;RGCC;VIM;IRS2;INSR;ATP7A;NMD3;RPS4X;TNF;KLF4;ELOVL5;RPL5;LARP4B;ZNF205;IGF1;SP1;ASS1;ARPP19;LARP4;PIWIL2;NR1H2;KAT7;MFSD2A;PRKD2;PKD2;PRMT1;MYC;HSP90AB1;ARNT;CCL5;ABCB10;IL6;HGF;PYM1
prerank,homeostasis of number of cells (GO:0048872),-0.5773477416676098,-1.432844136589599,0.08008213552361396,0.6932173388536921,1.0,5/12,23.87%,CX3CR1;OCIAD1;LPCAT3;NOTCH1;NAPEPLD
prerank,superoxide metabolic process (GO:0006801),0.5342067720519955,1.4328303588299234,0.08653846153846154,0.38316493052890166,1.0,7/29,17.04%,NRROS;CYBB;ATP7A;NCF2;CYBA;NOX4;PRDX2
prerank,inositol phosphate-mediated signaling (GO:0048016),0.5841313649135846,1.4320904356006958,0.09481216457960644,0.38394980794366407,1.0,2/19,1.02%,HRH1;PPP3CA
prerank,sterol homeostasis (GO:0055092),0.45843365706094885,1.432074121586903,0.060382916053019146,0.38320251343284667,1.0,5/65,4.03%,HDAC9;APOE;LDLR;NR1D1;EHD1
prerank,lipid droplet formation (GO:0140042),-0.61756217563811,-1.432006951046045,0.0651685393258427,0.6906646362998036,1.0,6/10,29.30%,AUP1;CDS1;SQLE;CDS2;BSCL2;ZFYVE1
prerank,positive regulation of interleukin-13 production (GO:0032736),0.6537236652061726,1.4316262824875778,0.09487666034155598,0.3833909813404683,1.0,2/10,2.14%,IRF4;TSLP
prerank,cytoskeleton-dependent intracellular transport (GO:0030705),-0.48172001920283747,-1.431095041665631,0.08060453400503778,0.6884151067250888,1.0,7/23,11.42%,CCDC88B;KIF1A;KIF5A;MYO10;KIF5C;MAP6;KIF1C
prerank,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),0.5338169738636639,1.4309553286888304,0.09106529209621993,0.3840634506476951,1.0,5/28,4.00%,CTSC;FBXW7;NUPR1;AXIN1;PRKN
prerank,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.39426348438276637,1.4304189243463092,0.016412661195779603,0.38440143415088723,1.0,68/208,19.45%,PLEKHG5;CLEC6A;ESR1;S100A4;NR1H4;SHISA5;ALPK1;RIPK1;CD74;NR1D1;ANKRD17;CCL19;PELI1;RHOA;HMOX1;PRKN;BCL10;BIRC3;NDFIP1;GPRC5B;RIOK3;TRIM32;TMEM106A;CD40;HSPB1;TNF;BST2;PPM1B;MIER1;REL;PRKCB;TRIM68;TRIM27;TFG;CARD16;EEF1D;RIPK2;NUP62;WLS;CASP8;MAP3K3;LAMTOR5;ZC3H12A;VAPA;TERF2IP;NOD2;TNFRSF1A;UBE2N;GJA1;NDFIP2;MID2;RHOC;TRIM25;PPM1A;PER1;BRD4;TIRAP;TAB3;RELA;F2R;ECM1;TRAF6;NLRX1;IRAK4;PLK2;DDX21;MAPKBP1;TLE1
prerank,"negative regulation of transcription, DNA-templated (GO:0045892)",0.36360731733309554,1.4302548167909588,0.001017293997965412,0.38400528958617075,1.0,181/807,16.62%,RBPJ;DAB2;HDAC9;WWP1;CD38;ZEB2;TRPS1;EDNRB;KLF2;TCF7L2;MDFIC;FOXP1;MEF2A;AHR;ZBTB16;RREB1;GAS6;TFEC;ESR1;RPL23;SMURF2;RARG;MEF2C;NR1H4;CBFA2T3;RPS27A;CEBPB;MITF;OSR1;NCOA5;TSHZ3;BMP2;PRICKLE1;NR2C1;ALX1;NR1D1;SNX6;YWHAQ;PRKN;JARID2;LARP7;PDE2A;FRK;NR3C1;NKAP;IRF2BP2;HEY2;CLOCK;SPI1;SAP130;RB1;NFIC;USP9X;ARID5A;SMAD4;PTPRK;TRIM33;THRB;IRX2;CBFB;PHF21A;ORC2;ATXN1;NOP53;EPC1;SETDB2;DMAP1;FOXM1;SDCBP;ZNF568;TNF;ZNF148;KLF4;YY1;BRMS1L;DUSP22;MIER1;THAP11;GATAD2A;TBL1XR1;PSEN1;NR4A2;GMNN;NRIP1;IRF2;KLF10;BTAF1;CDC73;RPS14;NCOR1;ZBTB5;FNIP1;FOXC2;MIDEAS;LIMD1;BACH1;TRIM27;MDM2;HIVEP1;TBL1X;LBH;ESR2;LRRFIP1;UBE2D3;BEND3;IGBP1;LCOR;NR2F1;PURA;ILF3;ZNF205;GCFC2;SFRP1;SPEN;RBM15;RCOR2;SP100;MIER3;HSBP1;ZMYND15;ETS2;PHC3;SHC1;SREBF2;CREBBP;KANK2;CRYAB;FOXK2;HINFP;WFS1;FOXO3;RPL10;NIBAN2;KDM5C;FOXK1;LOXL2;SP3;NFIX;FOXO1;CREB1;PEG3;CTBP2;PSPC1;WWOX;NR1H2;RARA;KAT7;STAT3;MBD1;EP300;BCOR;NEDD4L;KAT6A;EHMT1;WWC1;NAB1;SNW1;GATAD2B;MYC;HDAC4;KDM2A;PEX14;NR2C2;ZHX1;VGLL4;SFPQ;RUNX3;HEXIM2;USP47;E2F8;KDM1A;CREB3L1;HCFC1;ZGPAT;PPM1A;LIN37;PER1;ZNF177;TBX2;RCOR1;GLIS2
prerank,adherens junction organization (GO:0034332),-0.4097017040843427,-1.430198842306657,0.04899135446685879,0.686377846934697,1.0,16/48,12.08%,CADM1;TJP1;CTNNB1;CDH10;SMAD7;TBCD;CDH2;CDH13;PIP5K1C;FERMT2;CDH8;CADM2;NECTIN2;AFDN;CDH9;CDH22
prerank,protein deacylation (GO:0035601),-0.47871062241940654,-1.429823156261466,0.05398457583547558,0.6821721204159134,1.0,13/23,21.31%,ABHD17C;LYPLA2;SIRT7;PPT1;HDAC7;SIRT2;ABHD17A;HDAC5;ABHD10;SIRT5;HDAC3;HDAC1;HDAC6
prerank,aortic valve development (GO:0003176),0.500818487848447,1.429008429936566,0.08507223113964688,0.38586865850218544,1.0,10/34,12.88%,JAG1;TNFRSF1B;BMP2;HEY2;RB1;ROCK1;SLIT3;EMILIN1;ROCK2;TNFRSF1A
prerank,negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),-0.5048851495832266,-1.4279847242783885,0.06813186813186813,0.684389914438548,1.0,8/20,16.91%,GRK2;GRK3;YWHAB;APLP1;RGS2;MRAP2;GPRASP1;PLEK
prerank,myeloid cell differentiation (GO:0030099),0.473746536171934,1.4275135289215548,0.06855439642324888,0.3882970413003391,1.0,13/47,16.74%,RASGRP4;ZBTB16;LYN;MFHAS1;SPI1;RPS14;NCOA6;SLC25A5;KMT2E;TET2;KAT6A;TIRAP;PRDX3
prerank,negative regulation of complement activation (GO:0045916),0.6552794608100795,1.4270638808732756,0.09671532846715329,0.3885899851930496,1.0,3/10,6.82%,VSIG4;CD46;CR2
prerank,regulation of amyloid-beta clearance (GO:1900221),0.5914535072287019,1.4259257191406212,0.1045045045045045,0.3902149372196938,1.0,4/16,6.94%,APOE;HMGCR;ROCK1;TNF
prerank,icosanoid metabolic process (GO:0006690),0.4987599081176076,1.4253925111019925,0.07598784194528875,0.39059390145778383,1.0,8/40,8.38%,ALOX5;LTC4S;ALOX15;ALOX5AP;PNPLA8;MAPKAPK2;ABCC1;DPEP2
prerank,negative regulation of cell development (GO:0010721),0.5345161831839477,1.4250070068478382,0.0823327615780446,0.39062725522934444,1.0,7/25,9.90%,FBXW7;LILRB1;B2M;GSK3B;TNF;RFLNB;IGF1
prerank,regulation of protein export from nucleus (GO:0046825),0.5405580922113148,1.4248277989098797,0.0912280701754386,0.39020747108026776,1.0,9/23,16.28%,TCF7L2;GAS6;GSK3B;BAG3;SP100;YWHAE;UHMK1;PTPN14;ANP32B
prerank,negative regulation of Wnt signaling pathway (GO:0030178),0.3949458181176153,1.4241547834987272,0.022085889570552148,0.39087021206690997,1.0,37/186,15.72%,DAB2;LRP6;APOE;IGFBP4;TCF7L2;TLE4;PSMA7;BMP2;PRICKLE1;SIAH2;AXIN1;PRKN;MCC;UBAC2;ZNRF3;GSK3B;RACK1;NOTUM;CTNND1;STK3;PSMB2;LIMD1;CUL3;NKD1;SFRP1;AMFR;PSMA6;LATS2;WWOX;MDK;PSMA3;PSMD1;PSMD5;NPHP3;NLK;VGLL4;TMEM131L
prerank,negative regulation of programmed cell death (GO:0043069),0.37933519274048566,1.4238857112025927,0.006607929515418502,0.39067406423362555,1.0,58/355,12.13%,DAB2;CD38;EGFR;TNFAIP8;NOTCH2;TPT1;GAS6;NUPR1;GRK5;DNAJC3;NR1H4;RPS27A;TSLP;BABAM2;RASA1;CD44;OSR1;SH3RF1;RIPK1;ARHGAP10;SIAH2;CD74;CBL;RPS6KA3;MCL1;GSK3B;BIRC3;GHRL;RHBDD1;GLO1;PAK2;BCL2L2;TXNDC5;BCL2;HIGD1A;BAG3;HSPB1;HTATIP2;PSEN1;BIRC6;ARHGDIA;RAB7A;CCND2;MYDGF;IGF1;SFRP1;RIPK2;NUP62;THOC6;PCID2;PHIP;SHC1;KANK2;CRYAB;WFS1;RPL10;NIBAN2;UFM1
prerank,epithelial to mesenchymal transition (GO:0001837),0.48114064254492256,1.423816187890913,0.07465007776049767,0.39006184468204647,1.0,7/47,5.43%,RBPJ;FGFR1;S100A4;BMP2;HEY2;GSK3B;ROCK1
prerank,regulation of neuron projection development (GO:0010975),-0.3320373104607652,-1.423779185151857,0.005050505050505051,0.6963484781814301,1.0,55/163,21.20%,CSMD3;ABI3;RTN4RL1;MYLIP;TANC2;PTPRS;PTK2B;CTNNA2;SETX;ITGA6;SCN1B;MAGI2;PAK1;ULK4;CDH2;LRRC4C;TENM3;PRAG1;PPFIA2;FBXO7;ATP1B2;KIF1A;NDRG4;SCARB2;NTRK3;TWF2;BDNF;KNDC1;SERPINI1;NTNG1;MAG;EFNB2;SPOCK1;IL1RAPL1;RAPGEF1;NDNF;EPHA3;MINAR1;CDKL5;BRSK2;GPC2;SRCIN1;FUT9;NCS1;ZDHHC15;PAK3;DBN1;FKBP4;PLXNB2;PLA2G3;PLXNB3;WNT5A;BAG5;TWF1;ARHGAP44
prerank,positive regulation of programmed cell death (GO:0043068),0.38497620154603474,1.4233474331513887,0.008036739380022962,0.3903551424054267,1.0,46/272,13.27%,ARHGEF3;ITSN1;VAV3;PLEKHG5;NLRC4;FGD4;TNFAIP8;MAP3K5;STK17B;ANO6;ITGB1;RARG;DAPK1;RPS27A;RASSF2;RYBP;BMP2;RIPK1;LILRB1;BCL10;TRIO;RACK1;STK3;SYK;NGEF;TNF;HTATIP2;PSEN1;ARHGEF12;ATF6;MAP3K20;SFRP1;RPS6;ATG7;CASP8;CTNNBL1;FOXO3;DIABLO;MAP3K11;ITGB3BP;ARHGEF9;FAM162A;FOXO1;NET1;SOS2;LATS2
prerank,regulation of macrophage migration (GO:1905521),-0.6223183847473592,-1.4233124491579592,0.08350730688935282,0.6924130757022002,1.0,6/10,13.12%,CX3CR1;PTK2B;CSF1;P2RY12;MTUS1;CD200
prerank,lymphocyte differentiation (GO:0030098),0.4484234809373228,1.4232776022045912,0.05507246376811594,0.3897334064266997,1.0,17/68,15.43%,HDAC9;ITGA4;PTPRJ;ITGB1;PTPN22;KLF6;CR2;ZAP70;LYL1;CEBPG;NHEJ1;SLC25A5;LY6D;KAT7;LFNG;NFAM1;HDAC4
prerank,receptor catabolic process (GO:0032801),0.5372902721775467,1.4231557734580447,0.07082630691399663,0.38923070277254496,1.0,10/24,13.96%,AP2A2;CLTC;UVRAG;ZNRF3;KIF16B;SNX25;AP2S1;VLDLR;AP2B1;CLTA
prerank,sodium ion homeostasis (GO:0055078),-0.5011496710539306,-1.4231062625846616,0.07881773399014778,0.6874550619156251,1.0,4/21,4.06%,SLC12A2;ATP1B1;SLC8A1;ATP1B2
prerank,positive regulation of transmembrane transport (GO:0034764),0.6306753624973352,1.4229195832030614,0.10093457943925234,0.38896065278174075,1.0,2/13,1.78%,P2RX7;ANO6
prerank,negative regulation of response to cytokine stimulus (GO:0060761),0.6501852522494972,1.4218030542665083,0.11302681992337164,0.39063329060468616,1.0,6/10,23.64%,IRAK3;KLF4;SH2B3;MAPK7;PTPRC;TLE5
prerank,neuromuscular process controlling balance (GO:0050885),-0.5916235005970009,-1.4214621846740654,0.08316008316008316,0.6888820548663209,1.0,5/12,6.62%,CDH23;NRXN1;CLN3;SHANK1;PCDH15
prerank,protein exit from endoplasmic reticulum (GO:0032527),-0.4726146168778984,-1.4213669664615256,0.07192575406032482,0.6837757829841001,1.0,11/23,24.75%,PREB;AUP1;SURF4;UFD1;NPLOC4;SYVN1;SEC13;SELENOS;TMEM129;FAF2;SEC61B
prerank,regulation of amyloid fibril formation (GO:1905906),0.6014548718001708,1.421068194497804,0.10942760942760943,0.3914982254064809,1.0,3/15,1.24%,APOE;APP;LDLR
prerank,cellular response to organonitrogen compound (GO:0071417),0.4245137054030007,1.4210468046224358,0.04217687074829932,0.390785221789676,1.0,22/99,12.10%,P2RX7;RAP1B;HRH1;CTNNA1;AHR;DIAPH1;MEF2C;NR1H4;P2RY6;ZFP36L1;RAPGEF2;PDE2A;AOC1;RAP1A;ACTB;HCN3;SFRP1;TSHR;TRPM2;JUP;KCNQ1;LAMTOR5
prerank,negative regulation of inclusion body assembly (GO:0090084),-0.6241397810910179,-1.4210201610798758,0.09090909090909091,0.6799466443038789,1.0,5/10,20.52%,SORL1;SACS;DNAJB2;DNAJB1;DNAJA4
prerank,substrate adhesion-dependent cell spreading (GO:0034446),0.4831783376566916,1.4208733028049636,0.07931570762052877,0.39037813878273,1.0,6/46,3.74%,NRP1;ITGA4;ATRNL1;PEAK1;FER;RHOA
prerank,regulation of inflammatory response to antigenic stimulus (GO:0002861),0.41741085566728325,1.4203139997869314,0.03306878306878307,0.3908310041016022,1.0,24/117,13.33%,CD163;LYN;CYSLTR1;GNG2;CALCRL;ADRB2;DRD1;ADM;ADCY9;ADCYAP1R1;SYK;PLA2G2D;GNB1;FYN;FCGR3A;MAPK14;TSHR;PTGER4;PRKACB;HTR6;RAMP2;GLP2R;CREB1;GPR27
prerank,endoplasmic reticulum organization (GO:0007029),0.4510017429807258,1.419532332935038,0.06723891273247497,0.39174440474148187,1.0,8/72,4.62%,TMCC1;APP;REEP3;ATL1;VCPIP1;RAB10;HMOX1;SERP1
prerank,"alternative mRNA splicing, via spliceosome (GO:0000380)",-0.5301468203081066,-1.4194214810917685,0.07809110629067245,0.6811185547379485,1.0,8/16,19.31%,DDX5;DDX17;PUF60;CELF4;PQBP1;SRSF9;DHX9;RBM17
prerank,midbrain dopaminergic neuron differentiation (GO:1904948),0.643671651693262,1.4191845571021782,0.11627906976744186,0.3917294887368085,1.0,3/11,7.86%,LRP6;WNT2;NR4A2
prerank,pyruvate metabolic process (GO:0006090),-0.40461515696353983,-1.4189809049817501,0.047337278106508875,0.6776630517526396,1.0,15/52,13.08%,HK2;PFKL;PGM1;SLC16A3;ALDOA;PKM;BSG;PGK1;ENO1;SLC16A1;VDAC1;PCK2;ENO3;PDHX;TPI1
prerank,maintenance of protein localization in organelle (GO:0072595),-0.5090774710236442,-1.418674739160394,0.08088235294117647,0.6737158263466889,1.0,8/19,23.42%,HK2;SKP1;HNRNPU;SUPT7L;ARL2BP;BBS4;TAF8;TAPT1
prerank,"regulation of phagocytosis, engulfment (GO:0060099)",0.6735168894559175,1.4186601623464927,0.09387755102040816,0.3921423886130228,1.0,3/10,1.78%,RAB31;ALOX15;ANO6
prerank,positive regulation of cytoplasmic transport (GO:1903651),0.6568406397653465,1.4186514103534529,0.09906542056074766,0.3914179214757725,1.0,4/11,8.63%,DAB2;PRKN;EIPR1;MSN
prerank,cellular response to growth factor stimulus (GO:0071363),0.40158135459048894,1.4183789999546412,0.023543990086741014,0.39119778117916304,1.0,28/151,8.05%,NRP1;EGFR;IQGAP1;ZFP36L2;PTPN12;MEF2C;CD44;EEF1A1;BMP2;WNT2;ERN1;ZFP36L1;RAPGEF2;ITGB1BP1;EHD1;PDE2A;PDE8A;NR3C1;RAP1A;RACK1;SMAD4;MAPKAPK2;NR4A1;ACVR2A;HSPB1;KLF4;DUSP22;VSTM2A
prerank,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),0.6344583713228127,1.4172565752097777,0.1082024432809773,0.3926858770137475,1.0,4/12,18.20%,CLEC6A;CCR2;PRKCQ;ZBTB1
prerank,positive regulation of JNK cascade (GO:0046330),0.45005624268819017,1.4166037637915698,0.06303724928366762,0.3933132058538935,1.0,11/70,7.38%,FCGR2B;APP;MAP3K5;MFHAS1;RASSF2;SH3RF1;RIPK1;AXIN1;CCL19;SDCBP;DUSP22
prerank,positive regulation of ion transport (GO:0043270),0.4713050714057254,1.416427126275131,0.08841463414634146,0.39294476212190893,1.0,20/48,18.96%,P2RX7;LILRA5;ATP2B1;CCR1;ANO6;STIM2;DRD1;CNKSR3;WFS1;SCN3B;FFAR1;SNX4;RAB3B;CCL5;CHRNB2;F2R;GDNF;CAMK2A;VAMP8;P2RX4
prerank,RNA polyadenylation (GO:0043631),0.5368030951734248,1.4163293824129664,0.0958904109589041,0.39167277458786515,1.0,10/26,16.42%,APP;TENT2;CPSF3;CDC73;GRSF1;SCAF8;PAPOLA;WDR33;TUT1;CPSF2
prerank,mRNA polyadenylation (GO:0006378),0.5368030951734248,1.4163293824129664,0.0958904109589041,0.39167277458786515,1.0,10/26,16.42%,APP;TENT2;CPSF3;CDC73;GRSF1;SCAF8;PAPOLA;WDR33;TUT1;CPSF2
prerank,positive regulation of NF-kappaB transcription factor activity (GO:0051092),0.4030263965002618,1.4162813011024247,0.03645200486026731,0.39103129562899547,1.0,45/149,17.66%,NLRC4;APP;FER;RPS3;IRAK3;RPS27A;RIPK1;CD36;TLR4;BCL10;TNFRSF11A;TLR2;CLOCK;TRIM32;CD40;TNF;MTPN;EDA;PRKCB;RAB7B;TRIM68;TRIM27;CARD16;RIPK2;PSMA6;DHX33;LAMTOR5;TERF2IP;NOD2;UBE2N;NFKBIB;MID2;STAT3;EP300;PRKD2;PPIA;TRIM25;TIRAP;PRDX3;TAB3;PRKCQ;RELA;ZBTB7A;FLOT2;IL6
prerank,positive regulation of neuron differentiation (GO:0045666),0.4949156182379396,1.4158945689401365,0.0907715582450832,0.3911467739651672,1.0,7/40,5.88%,FGFR1;TCF4;MEF2C;BMP2;RHOA;GPRC5B;TRIM32
prerank,ovarian follicle development (GO:0001541),0.6203962857446353,1.4157376401290687,0.1088929219600726,0.3907778036056391,1.0,2/13,2.18%,ANG;CEBPB
prerank,lymphocyte migration (GO:0072676),0.5077665761910302,1.4155737972778584,0.09018987341772151,0.3904442909783746,1.0,10/32,17.31%,CCL8;MSMP;CCL19;ZAP70;CCL24;MSN;S1PR1;CKLF;CCL5;CCL25
prerank,regulation of granulocyte chemotaxis (GO:0071622),0.5676690110842728,1.4155427695500669,0.10756302521008404,0.3897718745541588,1.0,4/19,3.48%,CMKLR1;MPP1;BST1;CAMK1D
prerank,negative regulation of cellular protein catabolic process (GO:1903363),0.6745109932898573,1.41446366548923,0.13419117647058823,0.39133477172764647,1.0,3/10,5.98%,NELL1;RIC1;ANXA2
prerank,glucan biosynthetic process (GO:0009250),0.6220288245299678,1.4134059253460536,0.1265597147950089,0.3919380913852584,1.0,5/12,9.41%,GBE1;GYG1;NR1D1;PGM2L1;PPP1R3C
prerank,glycogen biosynthetic process (GO:0005978),0.6220288245299678,1.4134059253460536,0.1265597147950089,0.3919380913852584,1.0,5/12,9.41%,GBE1;GYG1;NR1D1;PGM2L1;PPP1R3C
prerank,regulation of potassium ion transmembrane transport (GO:1901379),-0.3938742209979482,-1.41334782132726,0.04040404040404041,0.6896659449321274,1.0,9/54,5.92%,KCNMA1;BIN1;DPP10;KCNJ2;DPP6;KCNIP4;NOS1AP;CACNA1D;AKAP6
prerank,positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),0.5968090263663876,1.4127240779593218,0.11524163568773234,0.39269784607871205,1.0,6/15,9.18%,RIPOR2;DCSTAMP;ADAM9;EHD1;CD53;MAPK14
prerank,negative regulation of phosphorylation (GO:0042326),0.43179139829102575,1.4125859074643037,0.06048387096774194,0.3922653642510384,1.0,24/85,16.74%,PID1;LRP6;MYADM;NUPR1;LYN;CBFA2T3;XDH;NIBAN1;PRKN;IRS2;ROCK1;NCOR1;CORO1C;ZC3H12A;CDKN2C;TERF2IP;IBTK;PPIA;HDAC4;NPRL2;PTPN13;PPP1R15B;PTEN;PRDX3
prerank,glycolytic process through glucose-6-phosphate (GO:0061620),-0.47568519486056093,-1.4124988055002896,0.06823529411764706,0.687945216412525,1.0,9/25,13.08%,HK2;PFKL;ALDOA;PKM;PGK1;ENO1;PFKP;ENO3;TPI1
prerank,glycoprotein biosynthetic process (GO:0009101),-0.3622757652562774,-1.4124114297243153,0.033444816053511704,0.6830717030826309,1.0,27/79,18.40%,LARGE1;CHST11;ST3GAL5;XYLT1;GCNT2;ST3GAL6;BMPR1B;COG3;B3GALNT2;B3GALT1;CANT1;B3GALT5;ALG1;GAL3ST4;B3GALT2;ST8SIA1;SERP2;ST3GAL3;B3GNT2;ST8SIA3;B4GALT7;ALG3;MGAT1;FUT9;CHST10;GOLGA2;ST3GAL2
prerank,androgen receptor signaling pathway (GO:0030521),-0.5939974414722133,-1.4122804040306194,0.07725321888412018,0.6785935566442916,1.0,4/11,9.28%,DDX5;DDX17;KDM3A;AR
prerank,regulation of sensory perception of pain (GO:0051930),-0.6054077942977953,-1.412183484752481,0.08714596949891068,0.6739168271760434,1.0,4/11,10.64%,MGLL;CCL3;ZFHX2;TMEM100
prerank,regulation of type I interferon production (GO:0032479),-0.36483898193249215,-1.4115933016092377,0.038461538461538464,0.6712102609696557,1.0,34/84,23.07%,IRF8;CTNNB1;XRCC5;CYLD;DTX4;OTUD5;IRF3;MAVS;UBA7;POLR3E;POLR3C;DDX41;RNF216;NLRC5;CGAS;IRF7;NLRP4;IKBKE;UFD1;PQBP1;XRCC6;NPLOC4;ITCH;PCBP2;DHX9;POLR3G;TRIM21;GAPDH;POLR1C;G3BP1;POLR2L;PIN1;POLR3A;ILRUN
prerank,positive regulation of calcium ion transport (GO:0051928),0.5082143587681085,1.4111882786852565,0.0890625,0.3944345192240371,1.0,5/36,2.75%,P2RX7;LILRA5;ATP2B1;CCR1;STIM2
prerank,positive regulation of phospholipid transport (GO:2001140),0.66990599607937,1.4108868534138015,0.1065891472868217,0.3943184196140474,1.0,1/10,0.49%,APOE
prerank,positive regulation of cytokine production (GO:0001819),0.3757763408867301,1.410632148463541,0.006779661016949152,0.39415740354944834,1.0,64/292,14.81%,PAEP;APP;IL16;LILRA5;IRF4;FOXP1;TLR8;CLEC6A;IL15;C1QTNF3;RPS3;NR1H4;PTPN22;TSLP;CEBPB;SPTBN1;RIPK1;FCER1G;LILRB1;CD74;TLR4;PIBF1;CD46;CCL19;HMOX1;RGCC;RFTN1;LBP;BCL10;TLR2;IL17RA;PDE4D;TMED10;TMEM106A;CD40;SYK;TNF;CD80;CCR2;CEBPG;RAB7B;IL6R;TRIM27;SULF2;LRRFIP1;MAPK14;RAB1A;STAT6;RIPK2;PTGER4;CREBBP;ROCK2;DHX33;LAMTOR5;POLR3D;NOD2;CRLF2;RARA;STAT3;EP300;MDK;CYBA;PRKD2;NFAM1
prerank,retinoic acid metabolic process (GO:0042573),0.606255408639604,1.4105834453212058,0.10380622837370242,0.3935306026315552,1.0,5/14,9.99%,UGT1A7;UGT1A8;UGT1A1;CYP26C1;CYP26B1
prerank,negative regulation of Notch signaling pathway (GO:0045746),0.5284480128032815,1.4105811856954893,0.08275862068965517,0.39281770751621703,1.0,7/28,14.35%,EGFR;FBXW7;NRARP;ARRB1;EGFL7;NIBAN2;LFNG
prerank,cellular response to lipid (GO:0071396),0.39248154507157096,1.410389470914586,0.020581113801452784,0.3925132704355737,1.0,42/191,13.92%,PID1;PF4;EGFR;AHR;ESR1;LYN;NCOA3;MEF2C;NR1H4;TNFRSF1B;LILRB1;WNT2;TLR4;NR1D1;ADAM9;RHOA;LBP;BCL10;VIM;NFKBIL1;NR3C1;LY96;CD80;WNT6;NRIP1;CDC73;MSN;MGST1;MAPK14;CARD16;LCOR;SFRP1;CD68;CHMP5;KCNK4;ROCK2;ZC3H12A;NOD2;CREB1;NFKBIB;ATP1A3;ATP1A1
prerank,"DNA-templated transcription, initiation (GO:0006352)",0.39529806323822225,1.4098850226092186,0.030978934324659233,0.392891000388354,1.0,43/166,17.68%,RBPJ;HDAC9;NOTCH2;ESR1;RARG;NR1H4;NR2C1;NR1D1;NR3C1;THRB;NR4A1;TBL1XR1;POLR1A;NR4A2;NCOR1;GTF2A2;NCOA6;ESRRB;TBL1X;ESR2;POLR1B;NR2F1;POLR2B;MED26;MAML1;CREBBP;GTF2E2;POLR1G;GTF2A1;NR1H2;RARA;POLR2D;MED27;SNW1;NR2C2;GTF2H3;GTF2B;MED17;NR5A2;CRCP;TAF12;GTF2H1;NR6A1
prerank,cranial nerve development (GO:0021545),-0.589445607635112,-1.4098447860288783,0.09032258064516129,0.6735411362546644,1.0,3/11,10.80%,SALL1;CHD7;TMEM126A
prerank,negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),0.6516233945328489,1.4095231035505906,0.11619047619047619,0.3930212142134484,1.0,4/10,9.58%,PARP14;PIBF1;SH2B3;PPP2CA
prerank,positive regulation of protein tyrosine kinase activity (GO:0061098),0.48724160505105496,1.4093976924886007,0.0784313725490196,0.39254842284099767,1.0,7/41,5.14%,NEDD9;LILRA5;FBXW7;GAS6;CASS4;DOK7;GPRC5B
prerank,production of siRNA involved in RNA interference (GO:0030422),0.6359954433028506,1.4093688075032997,0.10297029702970296,0.3919099570313788,1.0,3/10,13.29%,PRKRA;DROSHA;MRPL44
prerank,T cell differentiation in thymus (GO:0033077),0.595796222860326,1.4093116522457134,0.10227272727272728,0.3913029476399355,1.0,3/14,3.70%,ZFP36L2;LIG4;ZFP36L1
prerank,response to lipid (GO:0033993),0.4213490888907738,1.4090387040653307,0.052562417871222074,0.39115388374782095,1.0,26/105,14.36%,FOXP1;ESR1;FER;RARG;IRAK3;PTPN22;IFNAR1;CD36;TLR4;PELI1;RPS6KA3;LBP;TNFRSF11A;GCH1;MAPKAPK2;LY96;OVCA2;VPS4B;ASXL1;TRIM16;FOXO3;FOXO1;FFAR1;RARA;STAT3;RBP4
prerank,positive regulation of protein export from nucleus (GO:0046827),0.5851427960505113,1.4086269684600514,0.10555555555555556,0.3913905944824532,1.0,5/15,11.84%,TCF7L2;GAS6;GSK3B;BAG3;YWHAE
prerank,prostanoid metabolic process (GO:0006692),-0.5588153900542239,-1.4083821720117167,0.11643835616438356,0.674316396904973,1.0,3/13,7.82%,HPGDS;PTGS1;PTGR2
prerank,mesonephros development (GO:0001823),0.6359990012461529,1.4082971763741332,0.08818011257035648,0.3913134076628946,1.0,2/11,2.38%,ZBTB16;OSR1
prerank,cellular zinc ion homeostasis (GO:0006882),-0.4654225625562289,-1.40806945941742,0.08629441624365482,0.6707174462615397,1.0,14/26,25.96%,SLC30A9;ATP13A2;SLC39A13;SLC39A14;MT2A;MT1E;MT1F;MT1M;MT1G;MT1H;MT1A;MT1X;MT1B;SLC39A6
prerank,positive regulation of mononuclear cell migration (GO:0071677),0.5167858843133413,1.4080657188415246,0.09682804674457429,0.39110340451609976,1.0,6/29,7.58%,CCR1;GAS6;ANO6;PLA2G7;TNF;CCR2
prerank,"mRNA splicing, via spliceosome (GO:0000398)",-0.30534188178270344,-1.4069395280856993,0.0,0.6702525255270769,1.0,74/264,18.00%,DDX5;SNRNP70;SRRM2;FUS;DDX17;ZCCHC8;HNRNPA3;ELAVL2;HNRNPUL1;SRRM1;SRSF5;PABPN1;HNRNPA2B1;DDX39B;SRSF3;HNRNPU;DHX35;SNRNP48;SRPK1;PUF60;GEMIN2;PPIL3;SRSF2;PNN;DCPS;SNRPA1;SRSF10;CCAR1;PPIE;PRPF4;CELF4;WBP4;SNRNP200;SYF2;DNAJC8;CSTF2;DDX41;RNPS1;CWC25;DDX20;XAB2;USP49;SRPK2;SNRPN;RAVER2;CD2BP2;PRPF19;SRRT;U2AF1;PQBP1;UPF3B;CASC3;NOVA2;SF3B1;DDX1;SRSF12;POLR2C;NCBP1;TGS1;STRAP;PRPF6;PCBP1;DDX23;PCBP2;HNRNPA1;RBM5;HNRNPH1;SNIP1;ZMAT5;CLP1;SNRPB2;SART1;SRSF11;SRSF9
prerank,L-amino acid transport (GO:0015807),-0.45460523331218167,-1.4058264802076617,0.07960199004975124,0.6699596834600557,1.0,7/28,12.85%,SLC1A3;SLC36A1;SLC36A4;SLC1A1;SLC25A22;SLC7A8;CTNS
prerank,activin receptor signaling pathway (GO:0032924),-0.5378749429301206,-1.4046548977178734,0.10337078651685393,0.6697026032760051,1.0,4/15,15.95%,TGFBR1;ACVR1;ACVR1C;ACVR1B
prerank,relaxation of muscle (GO:0090075),-0.5506277124195766,-1.4042965702856454,0.10822510822510822,0.6663325358570268,1.0,4/13,8.44%,KCNJ2;ATP1B1;SLC8A1;RGS2
prerank,cellular response to tumor necrosis factor (GO:0071356),0.39248290936060276,1.40323316944276,0.028151774785801713,0.4005598401947444,1.0,24/175,8.46%,PID1;TNFRSF25;GBP3;ZFP36L2;PSMA7;RPS3;TNFRSF1B;RIPK1;CCL8;NR1D1;PLVAP;DCSTAMP;CCL19;ZFP36L1;TNFRSF11A;GSDME;BIRC3;CD40;EDARADD;TNF;EDA;PSMB2;CCL24;TNFSF12
prerank,carbohydrate derivative transport (GO:1901264),0.5775800270819405,1.4030208911778916,0.1168141592920354,0.4003570828951406,1.0,7/18,13.88%,PLTP;LBP;SLC29A1;VLDLR;SLC10A7;NPC2;MFSD2A
prerank,response to interferon-gamma (GO:0034341),0.4460910296917753,1.4029231211614481,0.07554945054945054,0.3998480836068447,1.0,16/67,10.54%,IFITM3;GBP3;DAPK1;CD74;CCL8;TLR4;CCL19;TLR2;GCH1;GBP7;CD40;BST2;CXCL16;CCL24;IFITM2;SP100
prerank,regulation of amyloid precursor protein catabolic process (GO:1902991),0.6133139256436675,1.4027326181011917,0.13059033989266547,0.3995381595725544,1.0,8/12,20.32%,APOE;ROCK1;TMED10;RANBP9;ROCK2;FLOT2;PICALM;FKBP1A
prerank,regulated exocytosis (GO:0045055),0.3966826196279307,1.4025504579691823,0.026829268292682926,0.3991796360646427,1.0,17/173,6.85%,F13A1;PF4;RAB11FIP5;APP;PHACTR2;GAS6;RAB31;SELENOP;LYN;CD36;RAB10;SRGN;MANF;TMED10;APOOL;FAM3C;ABCC4
prerank,AMP metabolic process (GO:0046033),0.6169847469422047,1.4022956212677153,0.10873440285204991,0.3989769611467116,1.0,6/13,19.35%,XDH;ADSS2;AMPD3;ADSS1;AK3;AK4
prerank,regulation of gene expression by genetic imprinting (GO:0006349),-0.6058154708182709,-1.402258368781383,0.08731808731808732,0.6695230954974474,1.0,2/10,8.39%,DNMT3A;PCGF5
prerank,regulation of cellular component movement (GO:0051270),0.4661727064875634,1.4019918978566146,0.08270676691729323,0.39888168147750735,1.0,11/49,6.20%,EGFR;ZSWIM6;DIAPH1;LYN;ARAP1;ARHGAP18;RHOA;CDK6;PKN2;ROCK1;MYCBP2
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),0.6153599046118282,1.4015020144113022,0.12248628884826325,0.39922599495019573,1.0,4/12,6.34%,CD44;CD74;RPL26;BCL2
prerank,lipid transport (GO:0006869),0.4246945001437419,1.4010067691909875,0.06141522029372497,0.3995368206830834,1.0,15/97,9.15%,PLTP;APOE;SLC10A6;LDLR;NR1H4;NCOA2;CD36;ABCA9;PITPNA;SLC25A17;LBP;ABCC4;ABCA6;SLC10A3;GLTP
prerank,negative regulation of signaling receptor activity (GO:2000272),0.53848934763779,1.4008872929037677,0.11558669001751314,0.3990753568593266,1.0,6/25,12.21%,CNRIP1;SNX6;CBL;TNF;HFE;CBLB
prerank,positive regulation of cellular catabolic process (GO:0031331),0.4061043698147576,1.4005448953713917,0.02967741935483871,0.3990808240965048,1.0,32/132,12.87%,APOE;P2RX7;APP;SNX9;ZBTB20;DAPK1;TNFRSF1B;ADAM9;TRIM65;GSK3B;IRS2;INSR;PFKFB4;RC3H1;ROCK1;TNF;PSEN1;SLC4A4;ATF6;TRIM68;PIK3C2A;MSN;TRIM27;GRSF1;TPCN1;IGF1;ZC3H18;SNX33;FOXO3;ZC3H12A;GTPBP1;FOXO1
prerank,negative regulation of potassium ion transport (GO:0043267),-0.5696675718192605,-1.3997349576983447,0.08470588235294117,0.6751794062892171,1.0,3/13,8.73%,BIN1;PTK2B;ACTN2
prerank,limb morphogenesis (GO:0035108),0.5621021771600263,1.399596466521175,0.12289562289562289,0.40024937054617665,1.0,2/20,1.18%,LRP6;MBNL1
prerank,Ras protein signal transduction (GO:0007265),0.40432686266552936,1.3995690034307318,0.03201024327784891,0.3996024894422767,1.0,16/137,5.94%,ARHGEF3;EPS8;PLEKHG5;RAP1B;RREB1;RAP2B;NRAS;KRAS;RHOA;RAPGEF2;GRAP;RAP1A;RB1;ROCK1;CELSR1;ARHGAP29
prerank,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),0.6544888068876809,1.399232847686951,0.1322314049586777,0.3995562020224744,1.0,2/10,3.03%,LRP6;WNT2
prerank,catecholamine biosynthetic process (GO:0042423),0.634725589275646,1.3992038661224673,0.13157894736842105,0.3989109224305136,1.0,3/11,4.60%,DAO;GCH1;MOXD1
prerank,negative regulation of macromolecule biosynthetic process (GO:0010558),0.6165687586618901,1.3989982565009802,0.13786764705882354,0.3985960140914824,1.0,2/12,1.61%,PF4;CLTC
prerank,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),0.5897104512232522,1.3982733520174335,0.09671848013816926,0.3993677740193555,1.0,7/17,14.70%,EGFR;RGCC;CCND3;CCNYL1;CCND2;CCNY;PKD2
prerank,regulation of neuroblast proliferation (GO:1902692),-0.536332021259816,-1.3977192214684802,0.0880952380952381,0.6783133379953176,1.0,3/15,5.52%,CX3CR1;CTNNB1;NF1
prerank,ventricular cardiac muscle tissue morphogenesis (GO:0055010),0.5065115357547572,1.397419609791205,0.08828250401284109,0.40047315871152683,1.0,3/31,5.19%,RBPJ;MYH6;SMAD4
prerank,thymus development (GO:0048538),-0.5596479627456337,-1.3968193041519994,0.09955752212389381,0.6775440706268622,1.0,1/13,0.14%,TGFBR1
prerank,negative regulation of protein depolymerization (GO:1901880),-0.4783681559591261,-1.3960035509432471,0.07692307692307693,0.6759011452711999,1.0,6/24,8.78%,NAV3;CLASP2;CAMSAP1;FGF13;PLEKHH2;ARHGEF2
prerank,regulation of RIG-I signaling pathway (GO:0039535),0.5615244982714434,1.3957796329474639,0.11948529411764706,0.4031899277712564,1.0,6/18,7.06%,DDX60;ANKRD17;BIRC3;PUM2;NOP53;USP15
prerank,T-helper cell differentiation (GO:0042093),0.6016257265740748,1.3956215700598273,0.12477064220183487,0.40281205786655494,1.0,6/14,17.97%,FOXP1;ATP7A;PTGER4;GPR183;IL6;BATF
prerank,negative regulation of protein kinase B signaling (GO:0051898),0.4842162055017772,1.3945284284997173,0.10299003322259136,0.4043908456041205,1.0,5/38,6.27%,BANK1;PTPRJ;XDH;RACK1;NOP53
prerank,regulation of mitochondrial membrane potential (GO:0051881),0.485856461784115,1.3944674770845733,0.09062980030721966,0.403808102700129,1.0,4/40,6.34%,PID1;RTL10;TUSC2;BCL2
prerank,regulation of establishment or maintenance of cell polarity (GO:0032878),0.5602966851147684,1.394326531196292,0.10600706713780919,0.4034144525330045,1.0,7/18,12.68%,RAP1B;KIF20B;RIPOR2;RACK1;ROCK1;ROCK2;BCAS3
prerank,cellular response to molecule of bacterial origin (GO:0071219),0.4164545548030222,1.3937395045400303,0.047493403693931395,0.40388198279338877,1.0,24/95,13.39%,PF4;FCGR2B;MEF2C;TNFRSF1B;LILRB1;TLR4;NR1D1;ADAM9;RHOA;LBP;BCL10;VIM;TLR2;NFKBIL1;LY96;CD80;CDC73;MAPK14;CARD16;CD68;CHMP5;ZC3H12A;NOD2;NFKBIB
prerank,regulation of protein catabolic process (GO:0042176),0.4160449269627376,1.3937336201085802,0.06043956043956044,0.4031997543753273,1.0,26/99,15.73%,WWP1;EGFR;SMURF2;IRAK3;EEF1A1;RILP;AXIN1;HMGCR;PRKN;GSK3B;SF3B3;SNX3;TRIM32;TNF;RAB7A;TNFSF12;MDM2;NKD1;ATG7;FOXO1;NEDD4L;GPC3;WDR91;RNF41;PRKCG;ZDHHC2
prerank,neural crest cell differentiation (GO:0014033),0.5678705432576794,1.3935951438918788,0.11320754716981132,0.4027483685967876,1.0,4/18,6.88%,LRP6;MEF2C;FBXL17;CYP26C1
prerank,pulmonary valve development (GO:0003177),0.5533460843196835,1.3923599822756174,0.11461794019933555,0.40471020331845964,1.0,4/18,4.49%,NOTCH2;JAG1;TNFRSF1B;HEY2
prerank,regulation of endothelial cell proliferation (GO:0001936),0.42706874090438707,1.3923577003804677,0.06102635228848821,0.4040227156453847,1.0,18/88,9.58%,NRP1;APOE;ALOX5;ANG;NRAS;BMP2;XDH;THBS4;CNMD;TNMD;RGCC;NRARP;GHRL;NR4A1;SYNJ2BP;CCL24;TNFSF12;MYDGF
prerank,negative regulation of microtubule polymerization or depolymerization (GO:0031111),-0.44420903624293295,-1.3916557635684328,0.0731070496083551,0.6883314679741601,1.0,11/32,16.45%,NAV3;MAP2;CLASP2;TBCD;CAMSAP1;FGF13;ARHGEF2;MAPRE1;EML2;CLIP3;APC2
prerank,negative regulation of programmed necrotic cell death (GO:0062099),0.6398885245853756,1.3913482073900922,0.13218390804597702,0.40546784696494403,1.0,5/11,11.05%,NUPR1;RIPK1;PELI1;BIRC3;CASP8
prerank,positive regulation of transcription by RNA polymerase II (GO:0045944),0.3527112816608631,1.3894619963637782,0.00202020202020202,0.40867963049328065,1.0,183/834,16.92%,RBPJ;DAB2;PID1;ZEB2;PF4;ETV1;EGFR;LRP6;APP;KLF2;CHP2;TCF7L2;TCF4;IRF4;PPP3CA;MEF2A;AHR;RREB1;TFEC;KMT2A;ESR1;NCOA3;JAG1;RARG;TCF12;MEF2C;NR1H4;ACTR3;RPS27A;NCOA2;CEBPB;MITF;OSR1;BMP2;RIPK1;KLF6;LILRB1;HOXD8;PHOX2A;FOXA3;RAX;WNT2;ALX1;HOXA10;TLR4;NR1D1;CDK12;RPS6KA3;RGCC;ITGB1BP1;PRKN;LARP7;TLR2;NR3C1;HEY2;CLOCK;GRHL2;SPI1;NCOA7;NFIC;SMAD4;THRB;NR4A1;RNASEL;FOSL2;CD40;EPC1;ACVR2A;FOXM1;TNF;KLF4;YY1;REL;HTATIP2;MED16;SATB2;TBL1XR1;CEBPG;E2F5;FIZ1;NR4A2;NRIP1;IRF2;KLF10;CDC73;ATF6;ATRX;TET3;NCOA6;FOXC2;ESRRB;KMT2C;HIVEP1;TBL1X;FOXJ3;MED6;ASXL1;MLXIP;MYDGF;STAT6;NR2F1;USP16;IGF1;RIPK2;ARRB1;RNF111;ZNF296;CREBRF;MAML1;SP1;TFDP1;ELF1;JUP;PHIP;MLLT10;SREBF2;CREBBP;EAF2;BCL11B;MYBL2;FOXK2;CDK13;HINFP;NFIA;CRTC3;FOXO3;DCAF6;ZC3H12A;NAMPT;BCAS3;NOD2;PLXND1;SP3;NFIX;FOXO1;TNFRSF1A;CREB1;PEG3;CTBP2;WWOX;TFR2;NR1H2;RARA;KAT7;TET2;STAT3;EP300;KLF5;WASL;JUND;CRLF3;KAT6A;USF1;PRKD2;PKD2;WWC1;RTRAF;SNW1;BMPR1A;MYC;MTF1;SMARCD1;HDAC4;NR2C2;SFPQ;SENP1;ELK1;E2F8;KDM1A;HOXB3;MAPK7;HCFC1;PPARGC1B;ACTR2;PER1;NFATC3;ARNT;BRD4;GLIS2;MED17;NR5A2;EAPP;RELA
prerank,ATP transport (GO:0015867),0.6373319293599569,1.389235946396477,0.12476722532588454,0.40844930606421337,1.0,5/10,22.81%,SLC25A17;SLC25A24;SLC25A5;SLC25A4;CD47
prerank,positive regulation of reactive oxygen species metabolic process (GO:2000379),0.473731643325065,1.388811528117004,0.1037593984962406,0.40859914127973734,1.0,12/47,15.31%,PID1;XDH;RIPK1;CD36;TLR4;SYK;MAPK14;ROMO1;ZC3H12A;ITGB2;CYBA;RNF41
prerank,carboxylic acid catabolic process (GO:0046395),0.6046478803133988,1.3883573817956105,0.10956521739130434,0.4088832089540433,1.0,2/12,2.52%,NPL;GNPDA1
prerank,regulation of mRNA metabolic process (GO:1903311),-0.5915361907156903,-1.3881826330716802,0.06832298136645963,0.6981264288487132,1.0,7/11,18.92%,SAFB;SAFB2;SRPK1;SRPK2;NCBP1;CDK11B;DHX9
prerank,regulation of signal transduction (GO:0009966),0.38529347860894636,1.3877796484838298,0.023980815347721823,0.4094589700492709,1.0,37/190,11.28%,RASGRP4;LIFR;IGFBP4;APP;MDFIC;ALOX15;CDC42SE2;ESR1;GRK5;BST1;FBXL17;CD36;DHRS3;AXIN1;CD46;CRK;ITGB1BP1;INTU;SNX3;CBFB;RGS8;CD80;SYNJ2BP;FYN;HOMER1;MAPK8IP2;ZDHHC3;PPP2CA;ZFAND2B;NUP62;SP100;PXN;ELF1;WDR11;AMFR;SREBF2;CREBBP
prerank,positive regulation of biosynthetic process (GO:0009891),0.47880391857199467,1.387762967212406,0.09782608695652174,0.40880062472071127,1.0,13/40,18.04%,APOE;ZBTB20;CD36;TLR4;RGCC;VIM;MTPN;CREB1;CYBA;CREB3L1;CCL5;SLC5A3;F2R
prerank,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),0.5006498691628847,1.3875396956552575,0.1013745704467354,0.40855030201283826,1.0,4/33,3.50%,HIP1;FBXW7;ARAP1;CBL
prerank,modification-dependent macromolecule catabolic process (GO:0043632),0.6535499847626136,1.387026264187647,0.1320754716981132,0.40898083662902823,1.0,4/10,12.66%,RPS27A;TUT7;TUT4;DIS3L2
prerank,lymphocyte chemotaxis (GO:0048247),0.4940874742800787,1.3865750357138469,0.10108864696734059,0.40936297861558424,1.0,12/34,17.31%,GAS6;CCL8;MSMP;CCL19;HSD3B7;CXCL16;CCL24;CKLF;CYP7B1;GPR183;CCL5;CCL25
prerank,regulation of cAMP-mediated signaling (GO:0043949),-0.4666921325270752,-1.385763427065604,0.07160493827160494,0.7035884996804826,1.0,8/24,11.23%,PEX5L;PDE3B;PRKAR1A;UBE2B;GNAI1;PRKAR1B;CGAS;PDE3A
prerank,fat cell differentiation (GO:0045444),0.45843885223470016,1.3855948114134276,0.08047690014903129,0.41068111853731804,1.0,9/57,7.86%,PID1;TCF7L2;C1QTNF3;METRNL;NR4A1;TRIM32;OSBPL11;KLF4;NR4A2
prerank,negative regulation of lyase activity (GO:0051350),0.5659316348871942,1.3851825260449324,0.10918544194107452,0.4108593872875287,1.0,3/16,7.58%,EDNRB;GNAI3;CCR2
prerank,response to UV-A (GO:0070141),0.6085371688293014,1.3848578513448886,0.12015503875968993,0.4108376553334162,1.0,1/14,0.45%,EGFR
prerank,positive regulation of cell-matrix adhesion (GO:0001954),0.48790452136194085,1.3848073290038636,0.0943683409436834,0.4102492741502217,1.0,9/42,5.43%,NRP1;PTPRJ;RIN2;CD36;UTRN;S100A10;CDK6;GSK3B;ROCK1
prerank,regulation of early endosome to late endosome transport (GO:2000641),0.5629107985223237,1.3845971033401496,0.10434782608695652,0.4100066200219523,1.0,3/18,8.63%,DAB2;SNX3;MSN
prerank,T cell differentiation (GO:0030217),0.47406792803513914,1.3845131913458777,0.0864,0.40948593321307514,1.0,9/40,9.39%,ZFP36L2;LIG4;PTPN22;FCER1G;ZFP36L1;SPI1;TCF7;ZAP70;NHEJ1
prerank,negative regulation of sprouting angiogenesis (GO:1903671),0.6327218975193162,1.3843261883159905,0.14587332053742802,0.40920609832953203,1.0,5/11,9.09%,ALOX5;KLF2;EPN2;SYNJ2BP;ADAMTS9
prerank,L-glutamate transmembrane transport (GO:0015813),-0.6032606034967265,-1.3842963995097928,0.10309278350515463,0.7048986524992694,1.0,5/10,24.81%,SLC1A3;SLC1A1;SLC25A22;SLC1A2;SLC25A13
prerank,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.3930779414188121,1.3837092470760375,0.041820418204182044,0.4098339803622917,1.0,17/152,5.83%,PF4;ADGRE5;GNAQ;ADGRG6;ADGRE1;GRK5;WASF2;GNAI3;CALCRL;ADRB2;GPR65;DRD1;ADM;PDE2A;S1PR2;ADCY9;ADCYAP1R1
prerank,regulation of JUN kinase activity (GO:0043506),0.4962402368671737,1.3832933559335712,0.08881578947368421,0.41005071269465293,1.0,6/33,6.94%,MAP3K5;SASH1;RPS3;PTPN22;TNFRSF11A;TNF
prerank,phagosome acidification (GO:0090383),-0.44372772348099565,-1.3832066778252756,0.06683168316831684,0.7048856530629124,1.0,10/26,12.34%,TCIRG1;ATP6V1C1;ATP6V0A2;ATP6V1D;ATP6V1H;ATP6V1G1;ATP6V0B;RAB38;ATP6V0D2;ATP6V0C
prerank,positive regulation of organelle organization (GO:0010638),0.5041690769127384,1.3829522631870061,0.10210696920583469,0.41014953722237096,1.0,8/32,8.89%,P2RX7;LIG4;ADRB2;UVRAG;SYNJ1;GSK3B;ANXA2;SMCR8
prerank,endothelial cell migration (GO:0043542),0.48731208206144544,1.382892504166592,0.07890499194847021,0.4096080999557164,1.0,9/37,12.75%,PLEKHG5;NRP1;RHOA;NR4A1;TNFSF12;STARD13;PXN;LOXL2;PLXND1
prerank,positive regulation of mesenchymal cell proliferation (GO:0002053),-0.5912280237237026,-1.3827951442016024,0.10176991150442478,0.7018595781302144,1.0,5/10,18.81%,LRP5;STAT1;FGFR2;TGFBR2;PDGFA
prerank,transport along microtubule (GO:0010970),0.6136184769781265,1.3824997121940759,0.11132075471698114,0.40974095392989324,1.0,6/13,13.19%,APP;ARHGAP21;CDC42;BAG3;DYNC1I2;BORCS5
prerank,microvillus organization (GO:0032528),0.6161431503562952,1.3805574146281165,0.12737642585551331,0.41320561652895477,1.0,4/13,4.84%,RAP1B;RAP2B;RAPGEF2;RAP1A
prerank,positive regulation of endothelial cell proliferation (GO:0001938),0.4352534545648623,1.380037209617575,0.06142857142857143,0.41361081692900015,1.0,15/75,10.83%,NRP1;ITGA4;FGFR1;ANG;NRAS;BMP2;THBS4;HMOX1;NRARP;NR4A1;CCL24;TNFSF12;MYDGF;SP1;EGFL7
prerank,regulation of metal ion transport (GO:0010959),0.5832013007500264,1.3799595732231884,0.1289198606271777,0.413111278110155,1.0,4/16,8.81%,IL16;BCL2;STIM1;PLN
prerank,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),-0.4252465175157418,-1.3799378914664149,0.05649717514124294,0.7089055046743348,1.0,14/35,27.93%,CTNNB1;XRCC5;HNRNPA2B1;ATM;MAPK3;MAP2K7;MAP3K4;CCT7;HNRNPA1;CCT2;ACD;CCT8;FBXO4;AURKB
prerank,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),0.556062524945035,1.3795887641819364,0.10902896081771721,0.41327268086176405,1.0,8/20,16.01%,EGFR;RGCC;CCND3;CCNYL1;CCND2;CCNY;PKD2;HSP90AB1
prerank,regulation of lamellipodium organization (GO:1902743),0.5912413577904282,1.378541035690697,0.1431159420289855,0.41477106784274514,1.0,3/14,3.32%,FER;CD44;CDC42
prerank,cardiac myofibril assembly (GO:0055003),0.5814468158847371,1.3777764996472541,0.1263537906137184,0.4158089347229682,1.0,3/15,5.33%,MEF2A;NRAP;PDGFRA
prerank,embryonic hemopoiesis (GO:0035162),0.6119106614959189,1.3775683152657443,0.12915129151291513,0.4155697510137526,1.0,4/12,9.36%,KMT2A;KITLG;TPO;SH2B3
prerank,collagen fibril organization (GO:0030199),-0.35877300776189497,-1.377403749782146,0.04669260700389105,0.7150790773548594,1.0,39/88,25.79%,DST;TGFBR1;COL27A1;COL11A1;ITGA6;TLL1;NF1;P3H2;ADAMTS3;LOXL3;PLOD3;COL23A1;LAMA3;COL25A1;COL1A2;COL19A1;COL11A2;COL8A1;COL26A1;ITGB4;COL6A2;COL16A1;COLGALT2;COL6A3;COL4A2;P3H4;COL4A6;TGFB2;ADAMTS2;COL9A3;COL9A1;COL3A1;COL6A1;COL20A1;COL13A1;COL5A3;P4HA1;P4HA3;COL4A4
prerank,chromatin organization involved in regulation of transcription (GO:0034401),0.5832383989754275,1.3772494935006092,0.12453531598513011,0.4155758829485302,1.0,7/13,15.73%,ARID1B;SPI1;CHEK1;ELOF1;SERTAD2;SMARCD1;ARID1A
prerank,interleukin-12-mediated signaling pathway (GO:0035722),0.46554657866985977,1.376991001307193,0.09312977099236641,0.41544074313627866,1.0,12/46,8.63%,RAP1B;SERPINB2;CDC42;PITPNA;LCP1;PAK2;ANXA2;HNRNPF;CNN2;RPLP0;STAT4;MSN
prerank,embryonic limb morphogenesis (GO:0030326),0.4883250845052442,1.376562118281634,0.11710323574730354,0.4157012532958723,1.0,8/34,11.28%,LRP6;MBNL1;RARG;OSR1;INTU;MAP3K20;CYP26B1;CREBBP
prerank,positive regulation of gene expression (GO:0010628),0.3608211076990429,1.3763877765816497,0.006322444678609062,0.41536124112445877,1.0,79/442,13.99%,RBPJ;PID1;PF4;EGFR;P2RX7;APP;CLEC6A;IL15;GAS6;ADAM19;RPL23;C1QTNF1;C1QTNF3;RPS3;MEF2C;PTPN22;KRAS;EIF3E;MITF;OSR1;BMP2;RIPK1;LILRB1;CD36;CD74;FGF23;DRD1;LAMP3;ERN1;TLR4;CD46;SAMD4A;NIBAN1;RPL26;RGCC;PRKN;VIM;PDE2A;TLR2;HEY2;GSK3B;ROCK1;ACTB;RPS4X;TNF;KLF4;RPL5;HFE;WNT6;PSEN1;POLR1A;LARP4B;VSTM2A;MSN;RPS7;MAPK14;POLR1B;DYRK1A;IGF1;MYO1C;MED26;SP1;PTGER4;EMILIN1;HINFP;ROCK2;LAMTOR5;DEK;ZC3H12A;SLC38A2;POLR1G;RAMP2;GJA1;LARP4;TFR2;PIWIL2;TNRC6C;STAT3;EP300
prerank,negative regulation of protein phosphorylation (GO:0001933),0.3966208023969654,1.376134073974517,0.04826732673267327,0.4151993385009338,1.0,34/150,12.59%,PID1;LRP6;GNAQ;SPRED1;DEPTOR;MYADM;PRKAG2;LYN;DNAJC3;RASSF2;XDH;NIBAN1;ITGB1BP1;PRKN;RB1;RACK1;PAK2;PDE4D;SFN;CEP85;SNX25;HSPB1;TRIM27;SMCR8;CNKSR3;CORO1C;SFRP1;CALM1;SPRED2;EMILIN1;PMEPA1;TRIB2;ZC3H12A;TERF2IP
prerank,establishment of spindle localization (GO:0051293),-0.5467854879288676,-1.3756005147113755,0.08685446009389672,0.7176704343855227,1.0,7/14,22.45%,CLASP2;DYNC1H1;LLGL1;MAP4;LLGL2;NUSAP1;ESPL1
prerank,toll-like receptor 4 signaling pathway (GO:0034142),0.5547726543427778,1.3755372945028208,0.1258741258741259,0.41580375962917043,1.0,7/19,16.73%,NR1H4;TLR4;LBP;LY96;ITGB2;SCIMP;TIRAP
prerank,regulation of vascular endothelial cell proliferation (GO:1905562),0.5609125774630378,1.3750451015442764,0.1234991423670669,0.4161017886490805,1.0,3/18,2.01%,ITGA4;FGFR1;MEF2C
prerank,spliceosomal tri-snRNP complex assembly (GO:0000244),-0.5586258577817728,-1.3747964602369205,0.12895927601809956,0.716363045804766,1.0,9/13,27.52%,SRSF10;DDX20;CD2BP2;PRPF19;SRSF12;PRPF6;SART3;PRPF31;AAR2
prerank,positive regulation of ruffle assembly (GO:1900029),0.5907383636346505,1.3745482929635697,0.13818181818181818,0.41644030584918695,1.0,1/13,0.09%,EPS8
prerank,lipoprotein biosynthetic process (GO:0042158),0.62249533326169,1.3738748328325288,0.14233576642335766,0.4171880999145481,1.0,7/11,20.04%,APOE;WIPI1;ATG7;ATG10;WIPI2;UGCG;PIK3C3
prerank,regulation of interleukin-1 production (GO:0032652),0.5721491825124554,1.3738476280795355,0.12777777777777777,0.4165752641597412,1.0,4/15,5.79%,FOXP1;GAS6;TLR4;TMED10
prerank,pinocytosis (GO:0006907),0.6278678006204325,1.3732851308067544,0.1520912547528517,0.4170368600363355,1.0,4/10,12.26%,DOCK2;MAPKAPK2;SNX33;SNX5
prerank,keratan sulfate metabolic process (GO:0042339),-0.4404304302025729,-1.3725013869668083,0.07179487179487179,0.7213968468340615,1.0,5/31,2.99%,HEXB;ST3GAL6;GNS;CHST1;B4GALT4
prerank,protein insertion into membrane (GO:0051205),0.50553502456297,1.3724479847514663,0.10929853181076672,0.4180683894444308,1.0,5/32,8.14%,EGFR;APP;HMOX1;SERP1;TRAM2
prerank,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),-0.49779262509880273,-1.371862285713595,0.09156626506024096,0.7193549196342266,1.0,8/20,21.06%,CALM2;ATP1B1;SLC8A1;ANK2;CACNA1C;SLC9A1;CAMK2D;CALM3
prerank,regulation of p38MAPK cascade (GO:1900744),0.4928099517327225,1.3716388624165696,0.1171875,0.41917371753435434,1.0,8/35,4.74%,SASH1;RELL1;MFHAS1;PTPN22;BMP2;XDH;DUSP1;SPI1
prerank,regulation of phagocytosis (GO:0050764),0.44918640361371787,1.370950148305319,0.07456140350877193,0.4199796077951822,1.0,11/53,6.94%,FCGR2B;IL15;DOCK2;GAS6;FCER1G;CAMK1D;TLR2;RACK1;SNX3;SYK;TNF
prerank,positive regulation of response to biotic stimulus (GO:0002833),0.4841814830687095,1.3704233694715118,0.11145510835913312,0.4203969798774439,1.0,9/38,7.06%,TLR8;SASH1;DDX60;GRN;ANKRD17;PUM2;LY96;RIOK3;USP15
prerank,ribonucleoside monophosphate biosynthetic process (GO:0009156),0.5946425713223342,1.3700195551709338,0.14840989399293286,0.4204975932700416,1.0,6/14,16.33%,ADK;ADSS2;LHPP;IMPDH2;ADSS1;GMPS
prerank,regulation of protein kinase A signaling (GO:0010738),-0.4896028941441613,-1.3696486798739582,0.1079136690647482,0.7239729267662273,1.0,8/20,18.08%,PRKAR1A;PRKAR1B;AKAP6;AKAP7;IAPP;MIF;ADGRV1;PJA2
prerank,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),0.45200739298700116,1.3690671114470878,0.09603658536585366,0.42181164799528503,1.0,9/56,7.63%,DAB2;BMP2;GDF3;SMAD4;GDF10;SNX25;ACVR2A;SDCBP;HFE
prerank,mRNA processing (GO:0006397),-0.29846909824831713,-1.3690475955434163,0.0,0.7217912150993028,1.0,92/287,22.46%,DDX5;GTF2H2;SNRNP70;SON;SRRM2;FUS;CPSF6;ZCCHC8;HNRNPA3;ELAVL2;HNRNPUL1;THOC1;AKAP8L;SRRM4;SRRM1;SRSF5;PABPN1;HNRNPA2B1;DDX39B;SRSF3;RPRD1A;HNRNPU;DHX35;SNRNP48;CCNH;PUF60;GEMIN2;PPIL3;SRSF2;PNN;SNRPA1;SRSF10;CCAR1;PPIE;PRPF4;WBP4;SNRNP200;SYF2;DNAJC8;ERCC2;TCERG1;CSTF2;DDX41;RNPS1;CWC25;XAB2;USP49;SNRPN;RAVER2;CD2BP2;PRPF19;SRRT;U2AF1;PQBP1;UPF3B;CASC3;NOVA2;SF3B1;SRSF12;POLR2C;NCBP1;PRPF6;PCBP1;DDX23;PCBP2;HNRNPA1;RBM5;HNRNPH1;SNIP1;ZMAT5;CLP1;SNRPB2;SART1;SRSF11;THOC3;SRSF9;DHX9;RBM17;POLDIP3;PRMT9;RBM14;GTF2H4;ALYREF;U2AF2;ESS2;METTL3;TFIP11;SART3;ALKBH5;POLR2L;IK;UBL5
prerank,positive regulation of telomere maintenance via telomerase (GO:0032212),-0.43073025568362644,-1.3689850765549239,0.07161803713527852,0.7176046024490192,1.0,13/32,27.93%,CTNNB1;XRCC5;ATM;MAPK3;MAP2K7;MAP3K4;CCT7;HNRNPA1;CCT2;ACD;CCT8;FBXO4;AURKB
prerank,microvillus assembly (GO:0030033),0.5952178322421,1.368468151732169,0.1303538175046555,0.42243148738038383,1.0,4/14,4.84%,RAP1B;RAP2B;RAPGEF2;RAP1A
prerank,nitric oxide mediated signal transduction (GO:0007263),0.5784109853819465,1.3679611528117421,0.14385964912280702,0.42277955145277035,1.0,2/16,2.76%,APOE;CD36
prerank,negative regulation of establishment of protein localization (GO:1904950),0.6318691966916714,1.3677039093558025,0.14814814814814814,0.4226419570597274,1.0,4/10,14.26%,NDFIP1;SNX3;NDFIP2;TERF1
prerank,regulation of Wnt signaling pathway (GO:0030111),0.40589458453090477,1.367702768798026,0.05622489959839357,0.4219753293672042,1.0,23/108,11.02%,APP;GNAQ;MDFIC;ESR1;BMP2;AXIN1;PRKN;TLR2;RACK1;SNX3;NOTUM;DISC1;CBFB;DEPDC1B;PSEN1;CDC73;CDK14;SULF2;PPP2CA;NKD1;SFRP1;WLS;PPP1CA
prerank,regulation of oxidative phosphorylation (GO:0002082),0.5612721906614823,1.367349257921096,0.13237924865831843,0.42204717261640207,1.0,3/16,9.82%,NUPR1;ATP7A;COX7A2L
prerank,positive regulation of proteasomal protein catabolic process (GO:1901800),0.4191962431563905,1.3667378479566208,0.06970128022759602,0.422579141522186,1.0,16/85,10.12%,DAB2;FBXW7;NUPR1;CBFA2T3;ARIH1;PIAS1;PRICKLE1;PRKN;GSK3B;RACK1;ANKIB1;NOP53;MDM2;RNF19B;COP1;RNF14
prerank,regulation of epidermal growth factor-activated receptor activity (GO:0007176),0.5210809033337207,1.3666181570254008,0.12387791741472172,0.42217166256683597,1.0,4/26,3.50%,APP;FBXW7;SNX6;CBL
prerank,cellular response to calcium ion (GO:0071277),0.4356852253661788,1.3659820155668205,0.09090909090909091,0.4228614621569312,1.0,11/67,6.45%,CHP2;IQGAP1;MEF2A;ALOX15;MEF2C;ALOX5AP;CPNE2;CLIC4;CPNE7;SLC25A24;CPNE8
prerank,negative regulation of epithelial cell differentiation (GO:0030857),0.5962737264023074,1.3657153116694267,0.1132404181184669,0.42278209553812635,1.0,4/14,3.37%,SPRED1;OSR1;XDH;GDF3
prerank,folic acid-containing compound metabolic process (GO:0006760),0.5446701071674093,1.3656272082915824,0.12521739130434784,0.42229242300799225,1.0,2/19,6.61%,FOLR2;MTHFD2L
prerank,stem cell differentiation (GO:0048863),0.4755700185569894,1.3652529793282508,0.09146341463414634,0.4224099463421554,1.0,5/39,4.03%,LRP6;MEF2C;OSR1;FBXL17;JARID2
prerank,cardiac cell development (GO:0055006),0.6108783002885354,1.364839818238136,0.13307984790874525,0.42267076741924087,1.0,3/11,2.92%,JAG1;MYH6;ALPK3
prerank,regulation of protein localization to plasma membrane (GO:1903076),0.42271646476491803,1.3647159937782105,0.07223796033994334,0.42225694078636306,1.0,6/78,2.56%,DAB2;PID1;EGFR;CLTC;ITGB1;SPTBN1
prerank,telomere organization (GO:0032200),-0.39882034731389354,-1.3645514619987584,0.072,0.7314264942699578,1.0,14/43,13.42%,DNA2;XRCC5;CTC1;ATM;PARP1;STN1;PTGES3;DOT1L;BLM;LTO1;HUS1;TERF2;PARP3;XRCC6
prerank,glucose homeostasis (GO:0042593),0.4183654316519969,1.3645250383486458,0.07523939808481532,0.4220142621806872,1.0,19/83,14.48%,ALOX5;TCF7L2;FOXA3;NR1D1;LRRC8D;SLC2A4;MCU;INSR;ADIPOR2;RPS6;FOXK2;WFS1;SLC8B1;KCNB1;FOXK1;FOXO1;STAT3;RBP4;USF1
prerank,regulation of SMAD protein signal transduction (GO:0060390),0.5316894157844336,1.3643903099105494,0.11725293132328309,0.4216426423329969,1.0,2/21,5.19%,DAB2;SMAD4
prerank,anterograde trans-synaptic signaling (GO:0098916),-0.30282630395799864,-1.3637421412941013,0.0,0.7303675084554304,1.0,47/224,12.64%,CACNB2;PLP1;SLC1A3;KCND2;MBP;DLG2;GRM7;CACNB4;UNC13C;GRIA2;GRIK2;GABRB3;NLGN1;SNAP25;NRXN1;DLG4;DLGAP1;GRM3;HTR2C;PRKAR1A;PTCHD1;GRIA4;KCNQ3;PRKAR1B;KIF5A;HCRTR2;GABRB1;SPG11;RPS6KA1;APBA1;DTNA;GLRB;HRH2;CACNA1E;CHRM3;CAMK4;KCNA1;HTR7;CPLX1;MINK1;GRIN2A;SLC1A1;GABRA2;RPS6KA2;SLC12A6;NPTX1;GLRA1
prerank,vitamin transport (GO:0051180),0.5135314573197983,1.3632350608945856,0.11514195583596215,0.4233805841815575,1.0,7/29,17.24%,FOLR2;TCN2;AFM;SLC2A2;SLC23A1;SLC5A6;SLC35F3
prerank,cellular response to glucocorticoid stimulus (GO:0071385),0.5459303708141066,1.363177323577605,0.12982456140350876,0.42284887166914964,1.0,4/18,4.89%,ZFP36L2;ZFP36L1;NR3C1;KLF9
prerank,regulation of plasminogen activation (GO:0010755),-0.5594843162150066,-1.3630329022251764,0.10585585585585586,0.7288955134690515,1.0,3/12,7.72%,PLGRKT;SERPINE2;ENO1
prerank,regulation of intracellular signal transduction (GO:1902531),0.35593899657345107,1.3625221849020481,0.009635974304068522,0.4235832525664682,1.0,54/420,7.94%,ARHGEF3;ITSN1;ARHGAP15;STARD8;VAV3;PLEKHG5;FGD4;EGFR;MOB3B;SPRED1;CLEC6A;CMKLR1;SGMS1;ARHGAP9;PRKAG2;OPHN1;RBBP8;LYN;BST1;ARAP1;PTPN22;RASSF2;RCN3;ARHGAP21;ARHGAP10;PRKAG3;ARHGAP18;CDC42;CRK;ARHGAP31;RHOA;PDE2A;PHF20;TRIO;BIRC3;PAK2;OCRL;STK3;ARHGAP29;VRK2;NOP53;CHEK1;NGEF;DEPDC1B;HSPB1;TNF;NRK;TOPBP1;ARHGAP12;ARHGAP23;RPL5;ARHGEF12;RPA1;ARHGDIA
prerank,macrophage chemotaxis (GO:0048246),0.6396998035876168,1.3623584969696714,0.15444015444015444,0.4232214205361747,1.0,1/10,0.44%,EDNRB
prerank,chondroitin sulfate biosynthetic process (GO:0030206),-0.47903711642450797,-1.3613049032726519,0.09876543209876543,0.7316747836226741,1.0,10/21,23.03%,CHST11;CSPG5;CHPF2;CSPG4;VCAN;BCAN;BGN;NCAN;UGDH;DCN
prerank,positive regulation of monocyte chemotaxis (GO:0090026),0.5590296732569306,1.361179905984826,0.12545454545454546,0.4249808874156608,1.0,4/17,7.58%,CCR1;ANO6;PLA2G7;CCR2
prerank,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),0.4058738045461314,1.360551374375404,0.06371191135734072,0.4257530892987644,1.0,19/100,10.12%,DAB2;CBFA2T3;ARIH1;PIAS1;RYBP;PRICKLE1;WAC;PRKN;GSK3B;RACK1;ANKIB1;NOP53;SDCBP;HFE;MDM2;RNF19B;COP1;UBQLN4;RNF14
prerank,regulation of cytokine production involved in immune response (GO:0002718),0.5334941318230672,1.360436015069359,0.11733800350262696,0.425315574179081,1.0,6/22,16.68%,TNFRSF1B;LILRB1;TNF;CCR2;NOD2;SCIMP
prerank,calcium import into the mitochondrion (GO:0036444),0.6323566931262422,1.3596338750115529,0.15019011406844107,0.42637395550227086,1.0,3/10,12.17%,MCUB;MCU;MICU3
prerank,positive regulation of nitric-oxide synthase activity (GO:0051000),0.5577796979256667,1.3590879900507042,0.15658362989323843,0.426894506336641,1.0,6/16,10.36%,APOE;S100A1;NPR3;GCH1;TNF;NUS1
prerank,regulation of toll-like receptor 4 signaling pathway (GO:0034143),0.5365248237424519,1.3587442691818101,0.11367380560131796,0.4269992169305974,1.0,7/22,8.54%,LYN;MFHAS1;PTPN22;NR1D1;LBP;RAB7B;NINJ1
prerank,organophosphate ester transport (GO:0015748),0.5237844923384289,1.3579505516648671,0.1447587354409318,0.42806327043761777,1.0,7/24,15.58%,PLTP;LDLR;PITPNA;EPG5;NPC2;OSBPL8;OSBPL5
prerank,regulation of endothelial cell apoptotic process (GO:2000351),0.48075152022477785,1.3579144842950175,0.11006289308176101,0.42747865535930146,1.0,6/39,6.94%,ITGA4;GAS6;ANO6;RGCC;CD40;TNF
prerank,presynapse assembly (GO:0099054),-0.5125168763597829,-1.3575420089881425,0.10666666666666667,0.7430441418239232,1.0,5/16,12.45%,PTPRD;NLGN1;PCLO;DVL1;IL1RAPL1
prerank,regulation of macrophage activation (GO:0043030),0.5048023998150674,1.357151316684148,0.10483870967741936,0.428364347834762,1.0,5/30,4.14%,FCGR2B;MFHAS1;CD74;TLR4;LBP
prerank,extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),0.5506178039349399,1.3570246699046715,0.13628318584070798,0.42793728211081045,1.0,4/20,6.34%,MCL1;GSK3B;BCL2L2;BCL2
prerank,bile acid and bile salt transport (GO:0015721),0.5292944101011713,1.356967739993285,0.13321799307958476,0.4273912641789714,1.0,5/24,8.56%,SLC10A6;NR1H4;NCOA2;ABCC4;SLC10A3
prerank,lipid droplet organization (GO:0034389),-0.46331075671196886,-1.3565233080251669,0.10317460317460317,0.7427510258767482,1.0,7/22,23.35%,AUP1;RAB18;CDS1;SQLE;CDS2;BSCL2;FAF2
prerank,negative regulation of protein tyrosine kinase activity (GO:0061099),0.5214425417457431,1.3563087854078812,0.13941480206540446,0.42815624963465726,1.0,7/23,16.20%,SH3BP5;SNX6;CBL;DUSP22;CBLB;SH3BP5L;ZGPAT
prerank,positive regulation of Ras protein signal transduction (GO:0046579),0.4423016873324486,1.356286626727547,0.09467455621301775,0.4275499889635413,1.0,8/61,5.60%,ARHGEF3;RASGRP4;NOTCH2;LYN;MAPRE2;GPR65;IRS2;P2RY10
prerank,folic acid metabolic process (GO:0046655),0.5435496710294254,1.356027356036935,0.13356164383561644,0.42746480606212794,1.0,2/18,6.61%,FOLR2;MTHFD2L
prerank,synaptic vesicle localization (GO:0097479),-0.558950120936306,-1.3559236116134374,0.11160714285714286,0.7406719553291601,1.0,6/13,9.33%,NLGN1;RAB27A;KIF5A;SPG11;KIF5C;SYNDIG1
prerank,ribosome assembly (GO:0042255),0.4556119712211783,1.3558007744972398,0.1080669710806697,0.4272829700296129,1.0,15/47,11.89%,RPL23A;RPS15;ERAL1;RPSA;RPS28;RSL24D1;RPL24;NOP53;RPLP0;RPL5;RPS14;RPS5;MRPS11;RPL6;RPL10
prerank,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),-0.3817369825262875,-1.3557536453015788,0.06666666666666667,0.7369118805145931,1.0,20/54,21.69%,IVNS1ABP;SENP2;CTNNB1;CAPN3;SMAD7;HDAC8;SIRT7;ARRB2;UBXN1;ADGRB1;N4BP1;MINAR1;PARK7;SQSTM1;GNL3L;TRIM21;PRR7;BAG5;U2AF2;COPS9
prerank,positive regulation of MAP kinase activity (GO:0043406),0.4326927367186379,1.3556931588238743,0.08550724637681159,0.42687589825885974,1.0,9/66,6.94%,EGFR;FGFR1;MAP3K5;SASH1;RPS3;TNFRSF11A;CD40;PIK3R6;TNF
prerank,negative regulation of MAPK cascade (GO:0043409),0.41798255860559413,1.3546306097906742,0.05810810810810811,0.42840081233377214,1.0,26/87,16.22%,APOE;P2RX7;SPRED1;PTPRJ;LYN;IRAK3;TLR4;ITGB1BP1;DUSP1;SMAD4;FOXM1;SYNJ2BP;RANBP9;CNKSR3;SH2B3;RPS6KA6;IGBP1;SPRED2;EMILIN1;STK38;FOXO1;PPIA;MYC;RGS14;DUSP7;PTEN
prerank,regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),0.5972865929110551,1.3542029817059,0.15296367112810708,0.42871683897028223,1.0,5/12,7.22%,FOXP1;CD74;TLR4;TNF;KLF4
prerank,positive regulation of neuroblast proliferation (GO:0002052),-0.5886863614077316,-1.3540944182670953,0.13901345291479822,0.7393282004732155,1.0,2/10,0.88%,CX3CR1;CTNNB1
prerank,cellular response to alkaloid (GO:0071312),-0.5030904118704376,-1.352637452660216,0.10232558139534884,0.7409768440979355,1.0,5/17,10.59%,SLC8A1;TGM2;CASP7;BLM;CASP6
prerank,regulation of defense response (GO:0031347),0.42035163530029324,1.3515204875947733,0.08333333333333333,0.43372316161147967,1.0,11/76,7.58%,FCGR2B;APOE;ALOX5;FOXP1;ALOX15;BST1;PTPN22;GRN;BIRC3;ZMPSTE24;CCR2
prerank,response to cAMP (GO:0051591),0.4839021810973881,1.3507813082591995,0.11811023622047244,0.4346298435699246,1.0,6/37,4.84%,RAP1B;AHR;ZFP36L1;RAPGEF2;PDE2A;RAP1A
prerank,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),0.417960414803355,1.350745656139869,0.08217270194986072,0.43406277789015785,1.0,14/78,10.12%,DAB2;CBFA2T3;ARIH1;PIAS1;PRICKLE1;PRKN;GSK3B;RACK1;ANKIB1;NOP53;MDM2;RNF19B;COP1;RNF14
prerank,zymogen activation (GO:0031638),-0.40351426772969196,-1.3500076344989358,0.09302325581395349,0.747505379594664,1.0,8/39,7.38%,ASPH;KLK2;LGMN;VSIR;TBC1D10A;PLAU;CYFIP2;PGK1
prerank,glucosamine-containing compound metabolic process (GO:1901071),-0.5300012581165712,-1.3499504365520159,0.13882863340563992,0.7433889776077269,1.0,3/13,9.37%,LARGE1;CHST1;CHST2
prerank,cytoplasmic sequestering of protein (GO:0051220),-0.5398373664671771,-1.3496630252911095,0.12337662337662338,0.7402599839242452,1.0,10/13,32.50%,YWHAB;MDFI;GET4;DBN1;GOPC;FLNA;SUFU;LATS1;PKD1;NFKBIE
prerank,RNA phosphodiester bond hydrolysis (GO:0090501),0.5100229738643167,1.3495933610735489,0.12786885245901639,0.4358149549555549,1.0,9/27,13.46%,RNASE4;ERN1;NYNRIN;CPSF3;RNASE6;LACTB2;ZC3H12A;ZC3H12D;RPP30
prerank,axon extension (GO:0048675),0.5253723242290563,1.34945927953656,0.1423670668953688,0.43547603192491013,1.0,8/23,16.01%,NRP1;USP9X;ALCAM;ULK2;SLIT3;SLIT1;SLC9A6;HSP90AB1
prerank,low-density lipoprotein receptor particle metabolic process (GO:0032799),0.6225631400843237,1.3492206517568746,0.15073529411764705,0.4346532215737981,1.0,6/10,13.96%,AP2A2;CLTC;AP2S1;VLDLR;AP2B1;CLTA
prerank,low-density lipoprotein particle receptor catabolic process (GO:0032802),0.6225631400843237,1.3492206517568746,0.15073529411764705,0.4346532215737981,1.0,6/10,13.96%,AP2A2;CLTC;AP2S1;VLDLR;AP2B1;CLTA
prerank,receptor metabolic process (GO:0043112),0.4521205426666412,1.3492168073377926,0.09228441754916793,0.4340124685563975,1.0,12/53,6.57%,RAB31;CLTC;ITGB1;CALCRL;FCER1G;LILRB1;CD36;UVRAG;ADM;KIF16B;SNX25;SYK
prerank,endoderm development (GO:0007492),0.5951093710128307,1.3489058071508566,0.14095238095238094,0.4340494561077845,1.0,3/13,7.52%,DUSP1;KIF16B;DUSP2
prerank,positive regulation of ion transmembrane transporter activity (GO:0032414),-0.4534390144216407,-1.3486237666273861,0.0979381443298969,0.7405873251505082,1.0,9/25,17.16%,ATP1B1;ATP1B2;ANK2;CTSS;ACTN2;WNK3;GLRX;STAC;CFTR
prerank,regulation of viral entry into host cell (GO:0046596),0.49158021900598425,1.3486075364950845,0.14262295081967213,0.4340530673064363,1.0,9/30,15.82%,IFITM3;CD74;SNX3;TRIM68;TRIM27;IFITM2;LY6E;MID2;TRIM25
prerank,response to amino acid (GO:0043200),-0.4334814131348814,-1.3477363895765821,0.08115183246073299,0.7400367983743857,1.0,14/31,27.37%,RPTOR;IPO5;NSMF;RRAGD;GLRB;GLRA1;GLRA3;RRAGB;MTOR;SESN2;GLRA2;CPEB1;RRAGA;SH3BP4
prerank,hexose biosynthetic process (GO:0019319),-0.39830467501859407,-1.3474928728544078,0.051075268817204304,0.7367599772380439,1.0,17/42,21.17%,PGM1;ALDOA;MDH1;CRTC2;PGK1;ENO1;AKR1B1;PCK2;ENO3;SLC37A4;TPI1;SLC39A14;SLC25A10;GAPDHS;ATF4;GAPDH;SLC25A1
prerank,central nervous system neuron axonogenesis (GO:0021955),0.5962502605277342,1.3467498970680871,0.16393442622950818,0.4373310152677367,1.0,9/12,19.49%,B4GALT6;MYCBP2;B4GALT5;HSP90AB1;EPHB6;PTEN;CHRNB2;ARHGAP35;SPTBN4
prerank,histone H4 deacetylation (GO:0070933),0.6129211041456091,1.3461159459574101,0.15819209039548024,0.4380531850734044,1.0,1/10,0.10%,HDAC9
prerank,regulation of extrinsic apoptotic signaling pathway (GO:2001236),0.43161360151751715,1.3456275410292111,0.10271041369472182,0.438512999786483,1.0,15/63,11.15%,FGFR1;DEPTOR;TCF7L2;SH3RF1;RIPK1;SIAH2;BCL10;PAK2;TNF;BIRC6;TNFSF12;IGF1;SP100;CASP8;PHIP
prerank,regulation of cell morphogenesis (GO:0022604),-0.4288268974097818,-1.3451925465008112,0.09973753280839895,0.7418651940127363,1.0,13/30,18.77%,EFNA5;FMNL2;SPARC;CAMSAP1;FERMT2;MACF1;ZMYM6;NTNG1;BCL9L;ZMYM3;STRIP1;PDPN;MOV10
prerank,enzyme linked receptor protein signaling pathway (GO:0007167),0.3882019496658174,1.3450423514002159,0.049689440993788817,0.4391100501868255,1.0,26/138,11.24%,MTSS1;NEDD9;RASGRP4;EGFR;LIFR;FGFR1;LYN;FER;ABI1;CASS4;FRS2;FRK;TRIO;INSR;PDGFRA;GUCY2D;EFS;ACVR2A;SYK;ZAP70;FYN;DDR2;EPHB4;STYK1;SLA;SHC1
prerank,vasculogenesis (GO:0001570),0.4872724496400521,1.3449206696776788,0.1216,0.4387020737380702,1.0,5/32,4.49%,SPRED1;RASA1;ADM;CCM2;HEY2
prerank,regulation of angiogenesis (GO:0045765),0.3712216439702484,1.3445120427008626,0.04052443384982122,0.438921813908903,1.0,41/192,12.83%,STAB1;PF4;ALOX5;SPRED1;SASH1;ITGB1;THBS4;GRN;CNMD;TNMD;HMOX1;RGCC;GHRL;ROCK1;CD40;PIK3R6;HSPB1;STIM1;KLF4;HTATIP2;GAB1;CCR2;PRKCB;SYNJ2BP;ADAM12;AMOT;TNFSF12;NINJ1;MYDGF;SFRP1;SP100;SP1;JUP;EMILIN1;CEMIP2;ROCK2;NIBAN2;ZC3H12A;ATP2B4;PLXND1;RAMP2
prerank,negative regulation of cytokine production (GO:0001818),0.3787654621972472,1.3443256948838136,0.05867665418227216,0.43865014796716506,1.0,19/163,5.09%,HDAC9;FCGR2B;VSIG4;LILRA5;ATP2B1;TLR8;CMKLR1;GAS6;C1QTNF3;IRAK3;NR1H4;PTPN22;LILRB1;TLR4;PIBF1;SRGN;RGCC;GHRL;CD200R1
prerank,positive regulation of lyase activity (GO:0051349),-0.5190464839244473,-1.344242645235821,0.12723214285714285,0.7414797631921791,1.0,6/14,16.22%,CACNA1D;NF1;ISCU;FXN;CACNA1C;PARK7
prerank,cellular response to fibroblast growth factor stimulus (GO:0044344),0.40272496197700797,1.343896093059597,0.08344923504867872,0.4388771505942028,1.0,17/87,12.18%,FGFR1;SPRED1;ZFP36L2;CD44;FGF23;CBL;ZFP36L1;ITGB1BP1;FRS2;NR4A1;KIF16B;HNRNPF;RAB14;POLR2B;SFRP1;SPRED2;TRIM71
prerank,positive regulation of apoptotic process (GO:0043065),0.36063410237399035,1.343888741466094,0.02491506228765572,0.4382624018012489,1.0,48/293,13.27%,ARHGEF3;ITSN1;VAV3;PLEKHG5;NLRC4;FGD4;TNFAIP8;MAP3K5;STK17B;NUPR1;ANO6;ITGB1;RARG;RPS3;DAPK1;RPS27A;RASSF2;RYBP;BMP2;RIPK1;LILRB1;GRN;BCL10;TRIO;RACK1;STK3;NGEF;TNF;PSEN1;ARHGEF12;ATF6;MAP3K20;SFRP1;RPS6;ATG7;CASP8;CTNNBL1;FOXO3;DIABLO;ZC3H12A;MAP3K11;ITGB3BP;ARHGEF9;FAM162A;FOXO1;NET1;SOS2;LATS2
prerank,manganese ion transport (GO:0006828),-0.540990414165869,-1.3435452688912906,0.135632183908046,0.7403175752278397,1.0,7/14,15.86%,TRPC4;TRPC1;TRPC3;SLC11A2;TRPC5;ATP2C1;SLC39A14
prerank,myoblast differentiation (GO:0045445),0.5700939193924834,1.3433039616309985,0.14513274336283186,0.43884991929524575,1.0,7/14,11.67%,TCF7L2;MBNL1;JAG1;PLEKHM3;RB1;IGF1;HINFP
prerank,regulation of mitochondrion organization (GO:0010821),0.45419239441426074,1.3432234631283395,0.12441679626749612,0.4384147024995418,1.0,6/47,5.82%,PID1;FBXW7;PRKN;PDE2A;GSK3B;PARL
prerank,exit from mitosis (GO:0010458),0.5973390621867076,1.343135194978019,0.15875912408759124,0.43795740068551836,1.0,1/12,0.09%,EPS8
prerank,positive regulation of cytosolic calcium ion concentration (GO:0007204),0.39043171261787324,1.3424391506363647,0.058823529411764705,0.43876507077208016,1.0,19/140,8.64%,P2RX7;CCR1;CMKLR1;C5AR1;ESR1;C3AR1;C1QTNF1;CYSLTR1;GPR65;CD36;DRD1;GHRL;PDGFRA;P2RY10;CCRL2;CXCR4;CCR2;ADRA1D;ADRA1A
prerank,negative regulation of wound healing (GO:0061045),0.4991495683406253,1.3424282042643205,0.1212624584717608,0.43815648448448236,1.0,6/28,9.33%,APOE;ALOX5;CASK;CRK;TNF;CLASP1
prerank,neuron apoptotic process (GO:0051402),0.5395955907788311,1.3419702732264802,0.1456140350877193,0.4384268486723674,1.0,5/19,12.69%,APP;LIG4;BCL2;DIABLO;FAM162A
prerank,regulation of insulin secretion (GO:0050796),0.4013159036388124,1.3415467311424265,0.07313829787234043,0.4386438151395311,1.0,25/101,14.90%,ALOX5;TCF7L2;NR1H4;NR1D1;PRKN;MCU;CLOCK;IRS2;RAP1A;GHRL;TNF;EIPR1;KCNG2;SFRP1;HADH;CHGA;DOC2B;SLC8B1;SLC2A2;KCNB1;GLUD1;FFAR1;TRH;RBP4;ITPR3
prerank,positive regulation of focal adhesion assembly (GO:0051894),0.5506657694188211,1.341236463516361,0.14285714285714285,0.4387009861072699,1.0,4/19,5.43%,NRP1;PTPRJ;S100A10;ROCK1
prerank,regulation of fibroblast proliferation (GO:0048145),0.4601259399693625,1.3411315703643292,0.12518853695324283,0.4382950569797469,1.0,13/45,10.93%,GAS6;LIG4;CD74;WNT2;CDK6;PDGFRA;TRIM32;CDC73;DDR2;PDGFC;IGF1;SFRP1;FTH1
prerank,positive regulation of cell-substrate junction organization (GO:0150117),0.5229524033261275,1.3410934220909576,0.1371610845295056,0.43777164490302667,1.0,5/24,5.43%,NRP1;PTPRJ;MAPRE2;S100A10;ROCK1
prerank,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.39956090861948945,1.3395809812748858,0.07133592736705577,0.4403686607643471,1.0,13/108,7.05%,HIP1;NLRC4;MAP3K5;IFT57;RPS3;DAPK1;XDH;RIPK1;BCL10;RACK1;SYK;TNF;UACA
prerank,regulation of GTPase activity (GO:0043087),0.3772072417499009,1.3391579079722862,0.049939098660170524,0.44060280187244427,1.0,30/177,7.32%,ARHGAP15;VAV3;FGD4;FGD6;SNX9;ARHGAP9;ARAP1;ITGB1;MAPRE2;EVI5;USP6NL;CCL8;CCL19;CRK;PLXNC1;RAPGEF2;S100A10;ITGB1BP1;RIC1;GSK3B;RAP1A;RACK1;DOCK11;OCRL;RGS8;WNK1;CD40;PLXNA4;NGEF;ARHGAP12
prerank,B cell proliferation (GO:0042100),0.5386324265127482,1.3387236191108418,0.14096185737976782,0.44085928737109564,1.0,4/17,6.82%,MEF2C;CD40;BCL2;CR2
prerank,endothelial cell proliferation (GO:0001935),0.563591175068802,1.3380274955677927,0.15063520871143377,0.4417661809841098,1.0,4/17,4.22%,ERN1;HMOX1;ITGB1BP1;NRARP
prerank,regulation of response to biotic stimulus (GO:0002831),0.49933029651757727,1.3378409540304492,0.12121212121212122,0.441504695200725,1.0,6/28,6.67%,FCGR2B;FOXP1;PTPN22;CD36;BIRC3;ZMPSTE24
prerank,peptidyl-serine dephosphorylation (GO:0070262),0.5800528127973368,1.3370586312996497,0.15101289134438306,0.44257155294232575,1.0,7/14,15.67%,PPP3CA;DUSP1;PPP2CA;PPP2CB;PPP1CA;PPP2R2A;PPP1R15B
prerank,negative regulation of cellular protein metabolic process (GO:0032269),0.40899336502674877,1.337012612104257,0.07300275482093664,0.44204421832470364,1.0,31/88,21.16%,NELL1;EDNRB;APOE;RPS3;DAPK1;SAMD4A;RIC1;MRPL13;RACK1;MALSU1;RBM4;DNAJC1;ILF3;DDX6;NANOS3;TRIM71;SHMT1;CNOT9;CLN8;SYNCRIP;TM4SF20;RNF139;EIF2AK2;EIF2AK3;CNOT1;CNOT8;GIGYF2;ENC1;DAPK3;IGF2BP3;PUS7
prerank,acyl-CoA metabolic process (GO:0006637),-0.41214671520181295,-1.3369393651199297,0.10455764075067024,0.7635544496423816,1.0,12/35,26.23%,ACOT9;ACACA;ACSF2;OXSM;ACSL6;ACOT7;ACBD6;THEM4;ACOT11;ACOT8;ACOT1;SUCLG2
prerank,positive regulation of lipid metabolic process (GO:0045834),0.5194052589022954,1.3369090182278671,0.1433389544688027,0.4416646273732777,1.0,2/22,1.70%,APOE;ZBTB20
prerank,regulation of cytokine production (GO:0001817),0.39235122632678665,1.3367996022353656,0.0764163372859025,0.44129676188823835,1.0,17/126,7.58%,HDAC9;FCGR2B;ALOX5;ATP2B1;FOXP1;CLEC6A;IL15;LYN;C1QTNF3;TNFRSF1B;SRGN;RGCC;TRIM56;MAPKAPK2;TRIM32;TNF;CCR2
prerank,I-kappaB kinase/NF-kappaB signaling (GO:0007249),0.43425503403433746,1.3367624646369274,0.10494752623688156,0.44075220666311987,1.0,15/59,12.88%,TLR8;RPS27A;RIPK1;TLR4;BCL10;TLR2;NFKBIL1;BIRC3;ROCK1;LY96;TNF;REL;RIPK2;ROCK2;TNFRSF1A
prerank,regulation of steroid metabolic process (GO:0019218),0.5187268162281611,1.3364932548990336,0.13412563667232597,0.44070371011903664,1.0,4/23,3.64%,APOE;NR1H4;UGT1A8;UGT1A1
prerank,chloride transport (GO:0006821),-0.34876914047572666,-1.3358463327198544,0.04745762711864407,0.7635808880176449,1.0,30/74,25.15%,SLC1A3;SLC12A2;GABRB3;ANO4;SLC4A10;SLC12A9;TTYH1;PACC1;GABRB1;ANO3;GLRB;SLC1A1;GABRA2;CLCN2;SLC12A6;GLRA1;GABRG2;CLCN4;SLC6A1;GLRA3;CFTR;FXYD1;ANO8;SLC12A4;GLRA2;ANO5;SLC12A5;GABRA4;GABRR2;SLC12A1
prerank,negative regulation of immune effector process (GO:0002698),0.5737576682040905,1.3357110749503904,0.16007194244604317,0.4416535935453931,1.0,4/13,5.30%,FER;LILRB1;GRN;RC3H1
prerank,negative regulation of myeloid cell differentiation (GO:0045638),0.527294878353473,1.335496005456251,0.15397631133671744,0.4415011023920542,1.0,5/20,8.11%,PF4;ZBTB16;ZFP36L1;CDK6;CDC73
prerank,mRNA destabilization (GO:0061157),0.4674843791904827,1.33522388202698,0.11867088607594936,0.44143362977041106,1.0,12/38,14.37%,ZFP36L2;TUT7;ZFP36L1;RC3H1;ROCK1;TUT4;ROCK2;TRIM71;ZC3H12A;DIS3L2;ZC3H12D;POLR2D
prerank,positive regulation of microtubule polymerization (GO:0031116),-0.4357733243894235,-1.3343763336178454,0.09647058823529411,0.7654140826141625,1.0,7/28,13.12%,NAV3;PAK1;MAPT;TOGARAM1;NUMA1;CKAP5;MAPRE1
prerank,cellular response to glucose stimulus (GO:0071333),0.4829518688486678,1.3339100019682182,0.1419457735247209,0.4435806678510816,1.0,5/30,5.11%,RAB11FIP5;GAS6;ZBTB20;ERN1;RACK1
prerank,regulation of anatomical structure morphogenesis (GO:0022603),-0.3176192528158014,-1.3338317406678806,0.019801980198019802,0.7634118536731477,1.0,26/118,7.43%,ABI3;TANC2;ADGRB3;SEMA4D;CTNNB1;EFNA5;FMNL2;CLASP2;PAK1;CDH2;HECW2;LRRC4C;SPARC;CAMSAP1;PPFIA2;ETS1;FERMT2;FGF2;KIF1A;NSMF;FGFR2;NF1;MAPT;SDC2;KNDC1;ZMYM6
prerank,regulation of protein dephosphorylation (GO:0035304),-0.4139952284860351,-1.3336182266485495,0.09473684210526316,0.7601599401345609,1.0,18/37,22.47%,PRKCD;CALM2;PPP1R16B;NSMF;YWHAB;CAMTA1;PPP1R7;TSC1;ANKLE2;PPP6R1;PPP1R16A;PPP2R5A;CDCA2;PTPA;SPPL3;CALM3;TGFB1;PIN1
prerank,ventricular septum development (GO:0003281),-0.40306347588731534,-1.3329972963256318,0.10540540540540541,0.7583168246665459,1.0,10/37,13.47%,TGFBR1;SALL1;SMAD7;ROBO2;ACVR1;ROBO1;TGFBR3;MDM4;PROX1;TGFBR2
prerank,positive regulation of SMAD protein signal transduction (GO:0060391),0.5837276439440204,1.332595506363677,0.15,0.4457969886488177,1.0,2/13,5.19%,DAB2;SMAD4
prerank,retina homeostasis (GO:0001895),0.516598215131161,1.3320882315539098,0.1457286432160804,0.4462622647872103,1.0,5/23,6.92%,SLC28A2;B2M;POTEF;ACTB;HSPB1
prerank,regulation of DNA damage checkpoint (GO:2000001),-0.5789482744950895,-1.33200106150858,0.1390728476821192,0.7581436054486222,1.0,4/10,9.17%,THOC1;DDX39B;ETAA1;CCAR2
prerank,"positive regulation of transcription, DNA-templated (GO:0045893)",0.3375011333770708,1.3317885622304304,0.002008032128514056,0.4462831313465033,1.0,229/1082,16.62%,RBPJ;DAB2;PID1;CD38;ZEB2;PF4;ETV1;EGFR;LRP6;APOE;APP;MAP3K5;KLF2;CHP2;TCF7L2;TCF4;IRF4;MDFIC;PPP3CA;FLI1;MEF2A;AHR;ZBTB16;RREB1;TFEC;KMT2A;ESR1;NCOA3;JAG1;RARG;TCF12;MEF2C;NR1H4;ACTR3;RPS27A;NCOA2;CEBPB;MITF;OSR1;RYBP;BMP2;RIPK1;KLF6;LILRB1;CD74;PHF8;HOXD8;PHOX2A;FOXA3;RAX;WNT2;ALX1;HOXA10;TLR4;NR1D1;AXIN1;WAC;RPS6KA3;RGCC;ITGB1BP1;PRKN;BCL10;TLR2;NR3C1;TRIM56;HEY2;RASL11A;CLOCK;GRHL2;ARID1B;SPI1;NCOA7;NFIC;CAMKK2;SMAD4;ELF2;THRB;NR4A1;RNASEL;FOSL2;CD40;EPC1;ACVR2A;CHEK1;FOXM1;TNF;CD80;LYL1;KLF4;YY1;REL;HTATIP2;MED16;SATB2;TBL1XR1;CEBPG;E2F5;PSEN1;FIZ1;NR4A2;NRIP1;IRF2;KLF10;ATF6;ATRX;TET3;NCOA6;FOXC2;ESRRB;KMT2C;SCAF8;HIVEP1;TBL1X;LBH;ESR2;FOXJ3;NFATC2;DYRK1A;MED6;ASXL1;MLXIP;MYDGF;STAT6;NR2F1;USP21;USP16;ILF3;IGF1;HEATR1;SFRP1;RIPK2;RNF14;ARRB1;RNF111;NUP62;ZNF296;CREBRF;SP100;TRIM16;MAML1;SP1;TFDP1;PCID2;ELF1;ELOF1;SERTAD2;JUP;PHIP;ETS2;MLLT10;SHC1;SREBF2;CREBBP;EAF2;ANKRD49;BCL11B;MYBL2;FOXK2;HINFP;NFIA;CRTC3;FOXO3;DCAF6;DHX33;NIBAN2;SNX5;ZC3H12A;FOXK1;NAMPT;BCAS3;NOD2;SP3;NFIX;FOXO1;TNFRSF1A;KMT2E;CREB1;SFR1;PEG3;CTBP2;WWOX;TFR2;XPC;RNF187;NR1H2;RARA;KAT7;TET2;STAT3;EP300;KLF5;WASL;JUND;MMS19;CRLF3;KAT6A;USF1;HMGN5;PRKD2;PKD2;RTRAF;SNW1;ENY2;BMPR1A;MYC;MTF1;NSD3;USP22;SMARCD1;HDAC4;NR2C2;SFPQ;SENP1;ARID1A;RUNX3;ELK1;E2F8;KDM1A;HOXB3;MAPK7;HCFC1;PPARGC1B;ACTR2;PPM1A;PER1;NFATC3;ARNT;BRD4;GLIS2
prerank,organic acid transport (GO:0015849),0.4082619245433483,1.331658483467014,0.10962566844919786,0.4459574500655061,1.0,21/94,17.60%,FOLR2;SLC10A6;NR1H4;SLC16A10;NCOA2;LRRC8D;SLC43A2;SLC25A17;ABCC4;SLC10A3;SLC38A1;SLC38A2;MFSD2A;SLC23A1;SLC23A2;SLC26A7;SLC25A30;SLC7A7;SLC6A6;SLC5A6;SLC36A2
prerank,regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),0.5761473170650265,1.3303666157723901,0.1618705035971223,0.4479992965457636,1.0,2/14,6.96%,PAEP;CD80
prerank,heme biosynthetic process (GO:0006783),-0.46374994019981924,-1.3300009529396095,0.141439205955335,0.7624919750330476,1.0,12/22,25.61%,FECH;CPOX;FXN;ABCG2;COX15;FLVCR1;HMBS;ALAS2;UROD;PGRMC1;PPOX;ALAS1
prerank,T cell activation (GO:0042110),0.4171106538146374,1.329578368038627,0.09193776520509193,0.4491050782776016,1.0,11/69,11.05%,IRF4;PPP3CA;PTPN22;CD44;CD74;CCL19;LCP1;ZAP70;MSN;NHEJ1;CASP8
prerank,peptidyl-tyrosine phosphorylation (GO:0018108),0.4226197210202586,1.3295386412267571,0.10970464135021098,0.4485781670952369,1.0,14/67,9.25%,EGFR;FGFR1;IL15;LYN;FER;ABI1;PIBF1;INSR;PDGFRA;SYK;ZAP70;FYN;DDR2;DYRK1A
prerank,chemical synaptic transmission (GO:0007268),-0.28563967946653335,-1.3294950082616759,0.0,0.7605441411428109,1.0,58/284,13.19%,CACNB2;PLP1;GRID2;SLC1A3;KCND2;MBP;DLG2;RIMS1;DLGAP2;GRM7;CACNB4;UNC13C;GRIA2;GRIK2;GABRB3;NLGN1;SNAP25;NRXN1;DLG4;DLGAP1;GRM3;HTR2C;PRKAR1A;PTCHD1;GRIA4;CDH8;KCNQ3;PRKAR1B;KIF5A;HCRTR2;GABRB1;DVL1;SPG11;RPS6KA1;APBA1;DTNA;GLRB;HRH2;CACNA1E;CHRM3;CAMK4;SYN3;KCNA1;HTR7;CPLX1;NAPA;MINK1;GRIN2A;SLC1A1;GABRA2;RPS6KA2;SLC12A6;TBC1D24;PTPRN2;NPTX1;GLRA1;LIN7A;VAMP2
prerank,positive regulation of nucleic acid-templated transcription (GO:1903508),0.3465490799100659,1.3294076382293107,0.012644889357218124,0.44824663085893024,1.0,125/476,19.45%,CD38;EGFR;LRP6;APOE;MAP3K5;KLF2;TCF4;IRF4;MDFIC;FLI1;AHR;ZBTB16;RREB1;KMT2A;ESR1;MEF2C;NR1H4;CEBPB;MITF;RYBP;BMP2;KLF6;CD74;PHF8;ALX1;NR1D1;AXIN1;WAC;BCL10;TRIM56;HEY2;CLOCK;ARID1B;CAMKK2;SMAD4;ELF2;EPC1;FOXM1;TNF;CD80;LYL1;KLF4;MED16;TBL1XR1;PSEN1;NCOA6;FOXC2;ESRRB;TBL1X;LBH;ESR2;NFATC2;DYRK1A;USP21;USP16;ILF3;IGF1;SFRP1;RNF14;RNF111;NUP62;SP100;TRIM16;SP1;PCID2;ELF1;PHIP;ETS2;SHC1;CREBBP;ANKRD49;FOXK2;HINFP;FOXO3;NIBAN2;SNX5;FOXK1;SP3;FOXO1;KMT2E;CREB1;SFR1;XPC;RNF187;NR1H2;RARA;STAT3;EP300;MMS19;CRLF3;KAT6A;HMGN5;ENY2;MYC;NSD3;USP22;HDAC4;ARID1A;RUNX3;ELK1;HCFC1;PPM1A;BRD4;GLIS2;MED17;NR5A2;RELA;LHX1;NR2F2;GTF2H1;MECOM;IL6;PICALM;F2R;MAFB;RFX3;PHF5A;RAI1;DVL3;PITHD1;THRAP3;INPP5K;RNF6;BCL3;CTCF
prerank,negative regulation of microtubule depolymerization (GO:0007026),-0.4734288901665257,-1.3293043258540693,0.11981566820276497,0.7572625949469877,1.0,5/21,8.78%,NAV3;CLASP2;CAMSAP1;FGF13;ARHGEF2
prerank,positive regulation of vascular endothelial cell proliferation (GO:1905564),0.5763864106965304,1.329163797515938,0.16903914590747332,0.44819753825285075,1.0,2/13,0.59%,ITGA4;FGFR1
prerank,carbohydrate catabolic process (GO:0016052),-0.40497259767224925,-1.3290609704493832,0.09226932668329177,0.7543070562582984,1.0,14/38,21.84%,HK2;PFKL;PGM1;ALDOA;PKM;NEU1;PGK1;ENO1;ENO3;TPI1;GAPDHS;GAPDH;PFKFB2;LDHA
prerank,regulation of neuronal synaptic plasticity (GO:0048168),0.4933479501311858,1.3280259337862268,0.12,0.4500778331938991,1.0,3/29,0.63%,MCTP1;APOE;APP
prerank,cellular glucan metabolic process (GO:0006073),0.6014143020484971,1.3277107225842122,0.18199233716475097,0.45013180453420215,1.0,4/11,9.41%,PRKAG2;GBE1;GSK3B;PPP1R3C
prerank,phospholipid translocation (GO:0045332),0.4932305313420146,1.3274783856117114,0.13793103448275862,0.4500224572600559,1.0,9/28,13.88%,P2RX7;ATP11C;ANO6;PLSCR5;ATP8B4;ABCC1;ATP10B;PLSCR4;MFSD2A
prerank,protein autophosphorylation (GO:0046777),0.3751395936351388,1.3274399177365,0.05818181818181818,0.4494719820924085,1.0,32/157,12.36%,EGFR;FGFR1;STK17B;PEAK1;LYN;GRK5;FER;DAPK1;OXSR1;RIPK1;ERN1;CDK12;GSK3B;INSR;CAMKK2;PAK2;MAPKAPK2;PDGFRA;STK24;PIKFYVE;VRK2;HTATIP2;ULK2;VRK1;DDR2;DYRK1A;EPHB4;MARK2;STK10;MAP3K3;MKNK1;MAP3K11
prerank,regulation of MHC class II biosynthetic process (GO:0045346),0.601541216927014,1.3271354610701063,0.16729323308270677,0.44947775000155393,1.0,2/11,6.06%,PF4;TMEM106A
prerank,regulation of plasma membrane bounded cell projection assembly (GO:0120032),-0.35974232247444426,-1.3261315228583013,0.04966887417218543,0.7620064707481978,1.0,20/67,9.52%,TBC1D16;TBC1D8;SDCCAG8;CYLD;SGSM3;FXR2;PPP1R16B;IFT140;MYO10;ATP8B1;TBC1D10A;IFT88;TWF2;RDX;TBC1D22A;IFT20;FMR1;DYNLT2B;TBC1D22B;TBC1D9B
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),0.5032058705490549,1.3256907267249387,0.1423785594639866,0.45195638143083233,1.0,5/24,6.34%,TPT1;CD44;CD74;TRIM32;BCL2
prerank,mesonephric tubule development (GO:0072164),-0.5097853925771811,-1.3255246384481203,0.1172069825436409,0.7605046787166442,1.0,4/15,4.91%,SALL1;NPNT;ROBO2;FGFR2
prerank,regulation of myoblast fusion (GO:1901739),0.6035773202664206,1.3253411740355343,0.16666666666666666,0.4521018101433124,1.0,4/11,9.18%,RIPOR2;EHD1;CD53;MAPK14
prerank,histone H3-K4 trimethylation (GO:0080182),0.5905647821058232,1.3251233252201082,0.17045454545454544,0.4519035908270255,1.0,5/11,13.84%,KMT2A;TET3;WDR82;BEND3;TET2
prerank,positive regulation of T cell chemotaxis (GO:0010820),0.6015972764962101,1.3246662130762388,0.1660377358490566,0.4521810963576954,1.0,3/10,7.58%,OXSR1;WNK1;CCR2
prerank,regulation of lipoprotein lipase activity (GO:0051004),0.5440683351391506,1.3246500954683198,0.15602836879432624,0.4515998676678494,1.0,1/17,0.10%,HDAC9
prerank,positive regulation of protein-containing complex disassembly (GO:0043243),0.5817462005512489,1.3244600059207827,0.1651031894934334,0.45137380601522803,1.0,7/12,16.89%,ADRB2;UVRAG;INSR;TNF;SMCR8;BNIP3;IGF1R
prerank,regulation of proteasomal protein catabolic process (GO:0061136),0.4312426091303988,1.3243269224910736,0.12098009188361408,0.4510135710309063,1.0,7/53,5.99%,APOE;FBXW7;OPHN1;NUPR1;LAMP3;PRKN;RHBDF1
prerank,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),0.41428626962811876,1.3239941442561607,0.10339943342776203,0.4511722636517809,1.0,15/74,14.95%,RBPJ;PSMA7;RPS27A;HIGD1A;PSMB2;LIMD1;BACH1;CREBBP;PSMA6;HIF3A;EP300;PSMA3;PSMD1;PSMD5;ELOC
prerank,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),0.5441658456814629,1.3232677887172921,0.16981132075471697,0.45205378186503464,1.0,5/15,8.74%,CD44;CD74;PRKN;BCL2;MDM2
prerank,negative regulation of lipid catabolic process (GO:0050995),-0.49014573470182055,-1.3224063425858326,0.13926940639269406,0.7688220050208739,1.0,4/17,8.98%,SORL1;PDE3B;APOC1;ALK
prerank,regulation of blood vessel endothelial cell migration (GO:0043535),0.4443995301974753,1.3221876073710026,0.12388059701492538,0.4536668484768398,1.0,13/54,12.32%,APOE;FGFR1;MEF2C;RGCC;PRCP;CD40;HSPB1;TNF;MAPK14;NUS1;SP1;JUP;ATP2B4
prerank,cobalamin metabolic process (GO:0009235),0.5410084924483405,1.3221409075258703,0.15263157894736842,0.4531699401609305,1.0,5/17,12.22%,TCN2;MTR;LMBRD1;ABCC1;MMAB
prerank,negative regulation of autophagosome assembly (GO:1902902),0.5811587584958278,1.3218877019934956,0.15412186379928317,0.45303235450517637,1.0,4/13,8.89%,NUPR1;MTM1;FEZ2;SMCR8
prerank,negative regulation of cellular response to growth factor stimulus (GO:0090288),0.4109802764232256,1.3213988084919759,0.09436619718309859,0.45346334599072124,1.0,20/79,13.05%,CASK;SMURF2;CRIM1;BMP2;GDF3;CNMD;TNMD;SMAD4;TRIM33;ACVR2A;HTRA3;EPN2;SULF2;UBE2D3;DAND5;EMILIN1;MMRN2;NIBAN2;ATP2B4;RBPMS2
prerank,acylglycerol metabolic process (GO:0006639),-0.40091153356032216,-1.3213790106518435,0.10746268656716418,0.7690871936711553,1.0,10/37,9.25%,ABHD12;DGKI;MGLL;DGKB;LYPLA2;LPL;GK;APOC1;DGKZ;LMF1
prerank,positive regulation of chemokine production (GO:0032722),0.4496747221414989,1.3212219352786583,0.13871951219512196,0.45322269751909544,1.0,10/44,8.25%,APP;TSLP;CD74;TLR4;HMOX1;TLR2;IL17RA;SYK;TNF;IL6R
prerank,morphogenesis of an epithelial sheet (GO:0002011),0.6062103634131899,1.3208537017056023,0.16765285996055226,0.4533798022480703,1.0,2/10,7.32%,LRP6;ARHGAP12
prerank,negative regulation by host of viral process (GO:0044793),0.6090752453439883,1.3207063912989634,0.1657142857142857,0.45309360166231527,1.0,4/10,12.58%,CCL8;PRKN;ZC3H12A;VAPA
prerank,vascular process in circulatory system (GO:0003018),0.5799262295927652,1.3205969982611896,0.1687170474516696,0.4520991436721356,1.0,5/13,15.66%,ITGB1BP1;ROCK1;GCLM;ROCK2;SCPEP1
prerank,regulation of tube diameter (GO:0035296),0.5799262295927652,1.3205969982611896,0.1687170474516696,0.4520991436721356,1.0,5/13,15.66%,ITGB1BP1;ROCK1;GCLM;ROCK2;SCPEP1
prerank,ERBB2 signaling pathway (GO:0038128),0.4733143266788731,1.3205204526389291,0.14772727272727273,0.45164572279801113,1.0,8/31,17.65%,EGFR;PTPN18;PTPN12;GAB1;SHC1;NRG2;CUL5;SOS1
prerank,skeletal system development (GO:0001501),0.37624850940079246,1.3204659293529994,0.05919395465994962,0.4511776840717949,1.0,26/148,11.16%,TRPS1;EXT1;FGFR1;CMKLR1;ZBTB16;CD44;BMP2;GDF3;CNMD;RPS6KA3;NPR3;RPL13;ANKRD11;GHRL;NOTUM;ATP7A;GDF10;VKORC1;COL9A2;PAPSS2;SULF2;RFLNB;IGF1;PTGER4;SLC10A7;ETS2
prerank,negative regulation of T cell receptor signaling pathway (GO:0050860),0.5519572856735727,1.3204562618021083,0.1564625850340136,0.45060595359787486,1.0,2/17,2.10%,PTPRJ;PTPN22
prerank,regulation of cellular protein metabolic process (GO:0032268),0.445071888900896,1.3204423389403488,0.1240768094534712,0.450031446763453,1.0,10/47,15.04%,EDNRB;APOE;APP;KLF4;MTPN;NANOS3;FOXO3;RPL10;NR1H2;WDR91
prerank,pyroptosis (GO:0070269),0.552035228679612,1.3204000841655685,0.14915254237288136,0.44951009212232185,1.0,3/15,11.05%,NLRC4;GSDME;CASP8
prerank,regulation of macrophage cytokine production (GO:0010935),0.5676419811501098,1.3199985304817605,0.16049382716049382,0.4497490184409084,1.0,4/13,5.14%,IRAK3;LILRB1;CD74;GPRC5B
prerank,membrane lipid metabolic process (GO:0006643),-0.4619375860780466,-1.3195336504265311,0.11463414634146342,0.7728187918469638,1.0,10/22,22.64%,CERK;ST3GAL6;B4GALT4;ST6GALNAC4;TECR;CERKL;SERINC1;SPTLC1;ARV1;AGK
prerank,regulation of phosphatase activity (GO:0010921),0.5053507238749687,1.3193342500534222,0.13793103448275862,0.4505521404608109,1.0,4/24,7.06%,CHP2;BMP2;PPP1R26;PPP1R17
prerank,positive regulation of macrophage differentiation (GO:0045651),0.5945083031301794,1.319196521260947,0.17690875232774675,0.4502335305275807,1.0,2/11,2.67%,PF4;RIPK1
prerank,regulation of cytokine-mediated signaling pathway (GO:0001959),0.4173335400519869,1.319056879941302,0.10070921985815603,0.4499499956446273,1.0,26/72,18.84%,LIFR;GAS6;IRAK3;TSLP;PIAS1;RIPK1;CD74;BIRC3;RACK1;CBFB;RNASEL;VRK2;SYK;TNF;IFNAR2;ELF1;CASP8;JAK1;TNFRSF1A;SPPL2B;HSP90AB1;SPPL2A;MADD;IFNGR1;PTPN6;SUMO1
prerank,Golgi to endosome transport (GO:0006895),0.5431703835464575,1.3189508408948365,0.1736111111111111,0.4495988493856878,1.0,8/16,15.02%,EPS15;KIF16B;WIPI1;RAB14;VPS13C;VPS13A;CORO7;MON2
prerank,regulation of actin cytoskeleton organization (GO:0032956),0.4050908221583251,1.3185840663358719,0.10124826629680998,0.44973650765672407,1.0,22/87,14.86%,EPS8;IQGAP2;NOTCH2;IQGAP1;BST1;ARHGAP18;CRK;RHOA;PDGFRA;ROCK1;CELSR1;BST2;ARHGDIA;RHOBTB1;TRPM2;ROCK2;ARHGAP17;NEB;RND3;RHOC;MDK;ARHGDIB
prerank,positive regulation of muscle cell differentiation (GO:0051149),0.5033063843987226,1.3182117013252126,0.1388888888888889,0.44999170166132274,1.0,6/24,9.18%,CTNNA1;MEF2A;MEF2C;CDC42;RBM4;MAPK14
prerank,regulation of neuron projection arborization (GO:0150011),-0.5056777092441391,-1.3180882094390078,0.10599078341013825,0.7746812777280104,1.0,9/15,23.84%,DLG4;DVL1;MACF1;NTNG1;DVL2;GRIP1;MOV10;WNT5A;FZD4
prerank,B cell homeostasis (GO:0001782),0.6080735486674644,1.3175812196435757,0.17836812144212524,0.45070017501056026,1.0,4/10,6.03%,LYN;MEF2C;DOCK11;PPP2R3C
prerank,plasma membrane bounded cell projection assembly (GO:0120031),0.35710824652768064,1.3172264875818525,0.036281179138321996,0.4508287492161946,1.0,58/259,16.41%,MTSS1;NRP1;FGD4;EMP1;P2RX7;RAP1B;EHD4;FGD6;EMP3;RAP2B;OPHN1;ANO6;ITGB1;ACTR3;RILP;PIBF1;RAB8B;RAPGEF2;EHD1;INTU;RAP1A;PMP22;S1PR2;OCRL;DISC1;ABCC4;SDCBP;EXOC4;TEKT5;VCL;FHDC1;RAB1A;RAB23;PIP5K1A;RFX2;PCNT;PDE6D;WDR11;S1PR1;SNX10;CEP19;STK36;PARVB;EXOC2;NTN1;SPEF1;RAB11A;PCM1;IFT80;PARVA;NPHP3;TXNDC15;FXYD5;FGD3;EXOC8;ATP6V0D1;FAM161A;ACTR2
prerank,response to sterol (GO:0036314),-0.5421180756221651,-1.3163712113712553,0.13507625272331156,0.7777753286556216,1.0,5/11,21.94%,TGFBR1;CCL3;TGFBR2;ABCA2;TGFB1
prerank,modified amino acid transport (GO:0072337),0.562782070086995,1.3163024842610815,0.18425760286225404,0.45210019482327124,1.0,1/15,0.22%,FOLR2
prerank,membrane repolarization (GO:0086009),-0.4979650430196261,-1.3160880244767934,0.1391304347826087,0.7749865951743559,1.0,3/15,4.06%,KCNJ2;ATP1B1;ATP1B2
prerank,regulation of cellular amide metabolic process (GO:0034248),0.48753887198210266,1.31577542845727,0.12052117263843648,0.4525685318036377,1.0,9/32,11.89%,APP;NR1H4;PGAM1;ROCK1;TMED10;MTPN;NANOS3;FOXO3;RPL10
prerank,miRNA metabolic process (GO:0010586),0.5199089222013576,1.3157327079837013,0.15045871559633028,0.45206053765611026,1.0,7/20,12.66%,PRKRA;TUT7;SND1;DROSHA;TUT4;TRIM71;DIS3L2
prerank,negative regulation of protein ubiquitination (GO:0031397),-0.3726320729220985,-1.3150609836418414,0.07951070336391437,0.7751347535269401,1.0,18/50,21.56%,IVNS1ABP;SENP2;SMAD7;HDAC8;SIRT7;ARRB2;UBXN1;ADGRB1;LIMK1;N4BP1;MINAR1;PARK7;SQSTM1;GNL3L;PRR7;BAG5;TAF1;U2AF2
prerank,fatty acid transport (GO:0015908),0.5405027265603102,1.3142987662289025,0.15018315018315018,0.4544372798000763,1.0,3/17,3.98%,APOE;CD36;SLC25A17
prerank,intracellular steroid hormone receptor signaling pathway (GO:0030518),-0.41089515504067037,-1.3141336720609833,0.13202247191011235,0.7749119229641026,1.0,13/35,15.10%,DDX5;DDX17;SRC;SAFB;KDM3A;TRIP4;PGR;WBP2;AR;EGLN2;CALCOCO1;PADI2;NCOA4
prerank,peptidyl-tyrosine dephosphorylation (GO:0035335),0.4781377743003521,1.313909273777398,0.1542056074766355,0.4547078869488568,1.0,7/34,7.52%,PTPRJ;PTPN18;PTPN12;PTPN22;DUSP1;DUSP22;DUSP2
prerank,neuron projection organization (GO:0106027),0.5531967345884055,1.3138508446192199,0.16760828625235405,0.45425671559462044,1.0,5/15,9.06%,APP;GSK3B;INSR;PSEN1;PLS1
prerank,negative regulation of signal transduction (GO:0009968),0.3529444587339997,1.312650027749503,0.040236686390532544,0.45631523221414366,1.0,68/249,20.73%,PID1;EGFR;PTPRJ;FBXW7;PTPN18;LYN;HERC4;PTPN12;IRAK3;BMP2;TMEM25;XDH;SIAH2;CNMD;TNMD;NRARP;NFKBIL1;RB1;RACK1;NOTUM;BCL2;CYP26C1;TNF;EPN2;PRKCB;NR4A2;MAPK8IP2;SULF2;CARD16;ASXL1;NKD1;CYP26B1;SFRP1;ARRB1;EGFL7;EMILIN1;KANK2;MMRN2;NIBAN2;NTN1;WWOX;GPC3;NLK;RGS14;VGLL4;PALM;CREB3L1;PTEN;GLIS2;CCL5;PRKCQ;LGR4;ZBTB7A;SPRY2;PIP4K2A;INPP5K;TRIB1;ENPP1;CSNK2A2;CSNK2A1;TLE1;CNOT1;TMBIM6;GRB14;SNCA;NFATC1;SIAH1;PHACTR4
prerank,cytosolic transport (GO:0016482),0.3883625249264342,1.3120290587571535,0.07702349869451697,0.45698046808420945,1.0,25/108,15.04%,SNX2;TBC1D5;EPS15;CLTC;ANKFY1;EVI5;RILP;SNX6;CLN5;RIC1;LAMP1;KIF16B;PIKFYVE;RAB7A;TRIM27;DENND5A;RAB14;SNX16;VPS13C;VPS13A;SNX5;CORO7;VPS26A;MON2;WDR91
prerank,regulation of microtubule polymerization or depolymerization (GO:0031110),-0.4283453000313123,-1.311621793784718,0.14430379746835442,0.7813577855264533,1.0,13/28,20.20%,MAP2;CLASP2;CAMSAP1;MAP1B;MAPT;MAPRE3;GBA2;STMN3;STMN4;MAPRE1;SKA2;FKBP4;PRUNE1
prerank,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),0.5172050115347571,1.3115610208248472,0.1477832512315271,0.4567256991550976,1.0,4/21,6.94%,PF4;MCL1;BCL2;TNF
prerank,negative regulation of signal transduction in absence of ligand (GO:1901099),0.5172050115347571,1.3115610208248472,0.1477832512315271,0.4567256991550976,1.0,4/21,6.94%,PF4;MCL1;BCL2;TNF
prerank,regulation of phosphorylation (GO:0042325),0.3862211898317301,1.3110627100819665,0.08874172185430464,0.4571448210868448,1.0,25/120,12.78%,NRP1;EGFR;APP;PRKAG2;LYN;ANG;FER;BCL10;PGAM1;ROCK1;NOP53;SDCBP;HSPB1;PSEN1;NUP133;FNIP1;KCTD20;KDM4D;CORO1C;PPP2CA;NUP62;PHIP;CDKN2C;NUP98;DSCAM
prerank,pulmonary valve morphogenesis (GO:0003184),0.5263992536372801,1.310877897748435,0.15306122448979592,0.4569352712627133,1.0,3/17,4.49%,NOTCH2;JAG1;HEY2
prerank,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),0.4386137851927084,1.3097588638015842,0.12404287901990811,0.4586288507729946,1.0,11/49,13.90%,IL15;LYN;TSLP;PARP14;PIBF1;CD40;TNF;IL6R;IGF1;TNFRSF1A;STAT3
prerank,regulation of neurotransmitter receptor activity (GO:0099601),-0.3627290542697792,-1.309003400686911,0.0728476821192053,0.7879579242941904,1.0,18/57,13.30%,DLG2;DLGAP2;PTK2B;GRIA2;NLGN1;DLG4;DLGAP1;DLG3;GRIA4;SHANK1;GSG1L;ACTN2;CACNG7;MINK1;GRIN2A;NPTX1;CACNG8;SHISA7
prerank,positive regulation of catabolic process (GO:0009896),0.41713281269078056,1.3085159769197978,0.10549777117384844,0.4606810902522714,1.0,16/65,15.31%,WWP1;SMURF2;RILP;AXIN1;PRKN;GSK3B;TRIM32;TNF;RAB7A;TNFSF12;NKD1;ATG7;FOXO1;NEDD4L;GPC3;RNF41
prerank,microtubule polymerization (GO:0046785),-0.4207293617009495,-1.308371958699795,0.12376237623762376,0.7866179443304141,1.0,14/28,26.85%,CLASP2;FGF13;MAPT;CCDC57;TUBGCP5;TPPP;CKAP5;TUBGCP3;GOLGA2;TUBGCP6;PIN1;HDGFL3;MAP7D3;TPPP3
prerank,positive regulation of leukocyte apoptotic process (GO:2000108),0.5936512330585528,1.3081323388502417,0.17790262172284643,0.4608484166610522,1.0,3/11,3.92%,LYN;MEF2C;RAPGEF2
prerank,lipoprotein localization (GO:0044872),0.5879564931017932,1.307531861551962,0.1687170474516696,0.46148980413432444,1.0,8/11,27.87%,CD36;PRKCB;ZDHHC3;MIA3;UNC119;VMP1;PPARG;ZDHHC17
prerank,high-density lipoprotein particle assembly (GO:0034380),0.6167434186320068,1.306943027503168,0.18326693227091634,0.46222098498536573,1.0,1/10,0.49%,APOE
prerank,relaxation of cardiac muscle (GO:0055119),-0.5119983883111358,-1.3068476412044296,0.14655172413793102,0.7888709524344898,1.0,4/13,8.44%,KCNJ2;ATP1B1;SLC8A1;RGS2
prerank,negative regulation of cartilage development (GO:0061037),-0.5155681340232418,-1.3055713724872768,0.148068669527897,0.7900204489750124,1.0,7/13,35.99%,TGFBR1;PTPN11;GREM1;EFEMP1;PTHLH;WNT9A;SNAI2
prerank,regulation of homotypic cell-cell adhesion (GO:0034110),0.5906146270347001,1.3052612371918892,0.18878504672897195,0.4652211421784237,1.0,6/11,18.32%,LYN;SYK;JAK1;CCL5;PRKCQ;PLAUR
prerank,electron transport chain (GO:0022900),0.5514249746408064,1.3050086968377343,0.14680483592400692,0.4651772127433017,1.0,6/15,17.74%,ENOX2;ETFDH;ETFA;SDHA;UQCRFS1;ETFB
prerank,positive regulation of microtubule polymerization or depolymerization (GO:0031112),-0.4347543975319058,-1.3046260808227474,0.09443099273607748,0.7900439835733515,1.0,6/26,13.12%,NAV3;PAK1;MAPT;TOGARAM1;NUMA1;MAPRE1
prerank,intracellular pH reduction (GO:0051452),-0.40082840644882334,-1.3040764279287747,0.11202185792349727,0.7884774396407443,1.0,13/33,17.26%,TCIRG1;ATP6V1C1;DMXL2;ATP6V0A2;ATP6V1D;ATP6V1H;ATP6V1G1;ATP6V0B;RAB38;ATP6V0D2;ATP6V0C;RAB20;TMEM9
prerank,intracellular cholesterol transport (GO:0032367),0.5458610662702593,1.3033568813925498,0.16453382084095064,0.46818240605840183,1.0,2/15,1.24%,LRP6;LDLR
prerank,regulation of T cell receptor signaling pathway (GO:0050856),0.47504212484250163,1.3027114650278337,0.15789473684210525,0.46895636502157845,1.0,5/33,5.30%,PTPRJ;RPS3;PTPN22;BCL10;RC3H1
prerank,mesoderm development (GO:0007498),-0.46748418348127696,-1.302652144374888,0.12903225806451613,0.7903145990614998,1.0,6/18,19.31%,JAK2;IKZF1;BTK;TBX6;IKZF3;GDF11
prerank,regulation of axon extension involved in axon guidance (GO:0048841),0.4927135062307486,1.30193768321188,0.1344,0.47001469536374757,1.0,2/24,0.82%,NRP1;SEMA4A
prerank,regulation of response to external stimulus (GO:0032101),0.3780698275305944,1.3019251669101897,0.08903225806451613,0.4694327367943243,1.0,29/121,16.92%,FCGR2B;ALOX5;FOXP1;ALOX15;BST1;PTPN22;CD36;GRN;BIRC3;PDE6A;PDGFRA;GUCY2D;STK24;ZMPSTE24;CXCR4;CCR2;PPEF1;CALM1;CASP8;PSMA6;USP14;NOD2;SAMHD1;SEMA7A;GRK4;ERAP1;BRD4;TIRAP;RELA
prerank,purine ribonucleoside monophosphate metabolic process (GO:0009167),0.5278488927679262,1.3016850352198772,0.1793570219966159,0.46931228974975203,1.0,11/20,21.17%,ADSS2;LHPP;IMPDH2;AMPD3;NT5C2;ADSS1;GMPS;AK3;AK4;HPRT1;PAICS
prerank,negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),0.625686094469079,1.3015993046071892,0.17439703153988867,0.4688808334865826,1.0,2/10,1.93%,PTPRJ;PTPN12
prerank,cellular response to lipopolysaccharide (GO:0071222),0.38645920329087424,1.30139516382951,0.09801324503311258,0.46868058723378153,1.0,25/101,13.39%,PF4;LYN;MEF2C;PTPN22;TNFRSF1B;LILRB1;TLR4;NR1D1;ADAM9;RHOA;LBP;BCL10;VIM;NFKBIL1;LY96;TNF;CD80;CDC73;MAPK14;CARD16;CD68;CHMP5;ZC3H12A;NOD2;NFKBIB
prerank,regulation of protein exit from endoplasmic reticulum (GO:0070861),-0.5204783167431674,-1.3013951046851981,0.1655011655011655,0.7917595310840744,1.0,5/13,24.66%,SORL1;GCC2;BRSK2;CD81;TM9SF4
prerank,cellular glucose homeostasis (GO:0001678),0.44891667509422495,1.301103663405113,0.141287284144427,0.46868330739655817,1.0,11/41,12.87%,GAS6;ZBTB20;FOXA3;ERN1;NR1D1;LRRC8D;RACK1;FOXK2;KCNB1;FOXK1;FOXO1
prerank,positive regulation of lipid kinase activity (GO:0090218),-0.4175174230597982,-1.3007093553036426,0.12661498708010335,0.7906764659414193,1.0,17/29,28.56%,FGR;PTK2B;FGF2;FLT1;PIK3R4;P2RY12;DGKZ;FLT3;ATG14;EEF1A2;TGFB1;TNFAIP8L3;TEK;CD81;PDGFRB;IRS1;PRKD1
prerank,cell-cell junction assembly (GO:0007043),-0.3534579878701584,-1.2999970876550748,0.08766233766233766,0.7897287404552559,1.0,13/63,5.53%,CD9;TJP1;CTNNB1;EPB41L3;CDH10;SMAD7;TBCD;CDH2;CLDN11;PIP5K1C;TLN2;CDH8;FLCN
prerank,ribosomal subunit export from nucleus (GO:0000054),0.577776551103439,1.2996314619852605,0.19172932330827067,0.47120256200099253,1.0,6/13,17.54%,RPS15;LTV1;NMD3;XPO1;LSG1;RRS1
prerank,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),0.5613501726226536,1.2990316580862378,0.17537313432835822,0.4719088581249429,1.0,4/14,5.14%,LILRB1;CD74;BCL10;GPRC5B
prerank,regulation of interleukin-4 production (GO:0032673),0.5097403492028072,1.298836317879933,0.18070175438596492,0.4717234975605255,1.0,4/21,6.57%,IRF4;CEBPB;FCER1G;SYK
prerank,proteasome assembly (GO:0043248),-0.5417257830111364,-1.2987936204155146,0.1694915254237288,0.7906745379170808,1.0,5/11,15.01%,PSMD13;POMP;PSMD9;PSMG2;PSMD4
prerank,post-Golgi vesicle-mediated transport (GO:0006892),0.39707173402270357,1.2986894946025895,0.10294117647058823,0.47144878150345465,1.0,26/88,16.25%,APP;MYO5A;EPS15;CLTC;EXOC6B;RAB10;FTL;TXNDC5;STXBP6;KIF16B;AP4S1;EXOC4;RABEP1;RAB14;ARRB1;FTH1;SNAP23;VPS13C;VPS13A;EXOC2;CORO7;CLTA;MON2;OSBPL5;RABIF;EXOC8
prerank,neuron projection morphogenesis (GO:0048812),-0.3151200918114975,-1.29809948839849,0.03414634146341464,0.7897356786879112,1.0,41/137,14.28%,MAP4K4;MAP2;CTNNB1;EPB41L3;NCKAP1;CTNNA2;NLGN1;DOCK10;IMPACT;PAK1;CNTNAP2;PARD3;DLG4;SGK1;MAP1B;NYAP2;FARP1;NEFH;DIP2A;FGFR2;NCKAP1L;ANKRD27;SHANK1;DVL1;MYO16;CNTN4;EPHB1;BDNF;SDC2;NTNG1;MAP6;LLGL1;S100B;CELSR2;MINK1;AFG3L2;CTNND2;DSCAML1;APBB1;SLITRK5;ADGRB1
prerank,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",-0.28747716115097804,-1.2978400614605548,0.007246376811594203,0.7870947367869784,1.0,80/241,23.79%,DDX5;SNRNP70;SRRM2;FUS;ZCCHC8;HNRNPA3;ELAVL2;HNRNPUL1;SRRM1;SRSF5;PABPN1;HNRNPA2B1;DDX39B;SRSF3;HNRNPU;DHX35;SNRNP48;PUF60;PPIL3;SRSF2;PNN;SNRPA1;SRSF10;CCAR1;PPIE;PRPF4;WBP4;SNRNP200;SYF2;DNAJC8;CSTF2;DDX41;RNPS1;CWC25;XAB2;USP49;SNRPN;RAVER2;CD2BP2;PRPF19;SRRT;U2AF1;PQBP1;UPF3B;CASC3;NOVA2;SF3B1;SRSF12;POLR2C;NCBP1;PRPF6;PCBP1;DDX23;PCBP2;HNRNPA1;RBM5;HNRNPH1;SNIP1;ZMAT5;CLP1;SNRPB2;SART1;SRSF11;SRSF9;DHX9;RBM17;RBM14;ALYREF;U2AF2;ESS2;METTL3;TFIP11;SART3;POLR2L;IK;UBL5;PRPF31;TRA2A;ZCRB1;HNRNPA0
prerank,cartilage development (GO:0051216),0.4332965684527769,1.2974502200186404,0.11942675159235669,0.47343523495461237,1.0,8/49,8.81%,ZBTB16;MEF2C;CD44;OSR1;BMP2;GHRL;ATP7A;SULF2
prerank,regulation of transport (GO:0051049),0.456845740094065,1.297442177212311,0.14488188976377953,0.47284681027658626,1.0,8/36,17.26%,NRP1;PRKN;ACTB;GAPVD1;RAB11A;WWC1;REEP6;FES
prerank,regulation of cation transmembrane transport (GO:1904062),-0.4045228265491338,-1.2974275177502859,0.12303664921465969,0.7851823299692697,1.0,7/29,9.41%,DPP10;FGF12;DPP6;SNTA1;KCNIP4;CACNA1D;WNK3
prerank,ventricular septum morphogenesis (GO:0060412),-0.42024934709489464,-1.2967061975820913,0.11386138613861387,0.7844691933063124,1.0,11/27,20.57%,TGFBR1;SMAD7;ROBO2;ACVR1;ROBO1;TGFBR3;PROX1;TGFBR2;NOTCH1;TGFB2;SOX11
prerank,regulation of response to stress (GO:0080134),-0.553425373527175,-1.2966841956601516,0.16432865731462926,0.7809923891025721,1.0,2/10,1.42%,EIF4G1;ADCY8
prerank,organic hydroxy compound biosynthetic process (GO:1901617),0.44232967526703776,1.2964315406662867,0.13841368584758942,0.4744726000984247,1.0,9/44,11.94%,PRKAG2;OSBPL9;ALOX15;HMGCR;HSD3B7;CYP27A1;PMVK;OSBPL1A;LBR
prerank,RNA processing (GO:0006396),-0.2991896108862901,-1.2958509721187006,0.01485148514851485,0.7806117414912871,1.0,50/176,16.95%,IVNS1ABP;SON;LUC7L3;FUS;CPSF6;DDX17;ZCCHC8;HNRNPUL1;THOC1;SETX;ADAR;AKAP8L;SRRM4;SRRM1;ADARB2;SRSF5;PABPN1;HNRNPA2B1;DDX39B;RP9;TARDBP;DDX47;HNRNPU;ELAVL4;SNRNP48;SRPK1;GEMIN2;SRSF2;SNRPA1;PRPF4;WBP4;CCAR2;TCERG1;RNPS1;DDX20;SRPK2;SNRPN;U2AF1;ADARB1;LIN28B;SF3B1;NCBP1;PRPF6;DDX23;RBM5;HNRNPH1;ZMAT5;RBM39;CLP1;PABPC4
prerank,tetrapyrrole metabolic process (GO:0033013),0.5275006886450472,1.2956564234767391,0.17543859649122806,0.4756108615786888,1.0,5/18,12.22%,TCN2;MTR;LMBRD1;ABCC1;MMAB
prerank,regulation of cardiac muscle hypertrophy (GO:0010611),0.4942859692631635,1.2955456769906057,0.16498316498316498,0.47524642080756496,1.0,7/22,11.99%,MEF2A;SMAD4;ROCK1;GLRX3;MTPN;IGF1;ROCK2
prerank,glycogen metabolic process (GO:0005977),0.4858457523526104,1.2954182583993845,0.16440677966101694,0.4749261208913503,1.0,8/27,10.64%,PRKAG2;GBE1;GYG1;NR1D1;PGM2L1;GSK3B;PPP1R3C;CALM1
prerank,mature B cell differentiation involved in immune response (GO:0002313),0.5833321925558281,1.2952000017780592,0.1956124314442413,0.4748022340253204,1.0,3/12,5.36%,FCGR2B;NOTCH2;DOCK11
prerank,positive regulation of cell migration (GO:0030335),0.35288492726022574,1.2949783504499315,0.05710955710955711,0.4746867423580563,1.0,38/253,10.73%,DAB2;NRP1;NEDD9;EGFR;SEMA4A;CCR1;PPP3CA;MYADM;RREB1;KIF20B;SMURF2;ITGB1;FER;CASS4;DOCK1;BMP2;SYNE2;DRD1;GRN;ADAM9;S100A11;RAPGEF2;INSR;RACK1;PDGFRA;TRIM32;SDCBP;GAB1;CCR2;CXCL16;CCL24;DDR2;CLASP1;PDGFC;IGF1;RTN4;MYO1C;F10
prerank,atrial septum morphogenesis (GO:0060413),0.5891667346152869,1.2949279214570852,0.1830708661417323,0.47419207273912256,1.0,2/10,4.49%,NOTCH2;HEY2
prerank,positive regulation of muscle hypertrophy (GO:0014742),0.5378782773898378,1.294634216526646,0.16936936936936936,0.47428594647765754,1.0,5/15,11.99%,MEF2A;ROCK1;MTPN;IGF1;ROCK2
prerank,cellular protein catabolic process (GO:0044257),0.4205192830569067,1.2941429946823146,0.1263001485884101,0.47473125790712273,1.0,17/59,13.96%,AP2A2;CTSC;CLTC;RIPK1;SIAH2;PRKN;CTSB;AP2S1;RAB7A;MDM2;CLPX;VLDLR;CASP8;PSMA6;DENND3;AP2B1;CLTA
prerank,synapse organization (GO:0050808),-0.3146248691048306,-1.2939237541119692,0.06363636363636363,0.7845791714217839,1.0,23/125,8.31%,APBB2;CX3CR1;CACNB2;PTPRS;DNM3;ADGRL3;CACNB4;SDK1;PTPRD;UNC13C;NLGN1;CDH2;NRXN1;LRRC4C;PPFIA2;LRFN5;FARP1;PPFIA4;DVL1;BDNF;MAPT;CNTN2;NTNG1
prerank,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),-0.49544066056734526,-1.2937645817558932,0.1391509433962264,0.7816491768177777,1.0,6/16,21.06%,CALM2;SLC8A1;ANK2;CACNA1C;CAMK2D;CALM3
prerank,positive regulation of lipid transport (GO:0032370),0.573538709856635,1.293746623696355,0.1824561403508772,0.4750172671144143,1.0,1/12,0.49%,APOE
prerank,positive regulation of lipid biosynthetic process (GO:0046889),0.4766591040830275,1.2931006334595199,0.15530903328050713,0.4757470805203481,1.0,7/29,13.88%,APOE;LDLR;ZBTB20;ELOVL5;CREB1;NR1H2;MFSD2A
prerank,neuron projection development (GO:0031175),-0.298435275375488,-1.2930004901614895,0.03184713375796178,0.7811114000139885,1.0,52/168,16.16%,PLP1;MAP4K4;PTPRM;MAP2;EPB41L3;NCKAP1;GRM7;GPM6B;NLGN1;ATXN10;WHRN;DOCK10;PAK1;CNTNAP2;DLG4;SGK1;CAMSAP1;NYAP2;NEFH;DIP2A;MICALL1;NCKAP1L;ZFYVE27;ANKRD27;SHANK1;IFT88;MYO16;CNTN4;EPHB1;BDNF;RASGRF1;MAPT;ERCC6;STX3;STMN3;ADCYAP1;MINK1;TMEM108;STMN4;TBC1D24;LGI1;PPP1R9A;PQBP1;CTNND2;OMG;RAB35;MAP4;EPHB2;ADGRV1;TBC1D23;DCLK1;ULK1
prerank,inner ear morphogenesis (GO:0042472),-0.4341690352351906,-1.2921317456039898,0.13917525773195877,0.7809115066581912,1.0,7/22,16.11%,CHD7;FGFR2;MYO6;PAX8;ZIC1;EPHB2;MYO3B
prerank,negative regulation of response to endoplasmic reticulum stress (GO:1903573),0.49036652315770307,1.2919930082962585,0.1737704918032787,0.4774659696459062,1.0,10/24,19.75%,ALOX5;PRKN;RACK1;WFS1;NR1H2;USP25;CREB3L1;XBP1;TXNDC12;TMBIM6
prerank,positive regulation of actin cytoskeleton reorganization (GO:2000251),0.5279918693029216,1.2918485381695566,0.17328519855595667,0.47717988496725505,1.0,2/17,3.32%,NRP1;CDC42
prerank,sodium-independent organic anion transport (GO:0043252),-0.5504206086507111,-1.29181908428866,0.16233766233766234,0.7785976435981998,1.0,3/10,15.27%,SLCO2B1;SLCO4C1;SLCO4A1
prerank,endosome organization (GO:0007032),0.45111186313435814,1.291525145932772,0.14660493827160495,0.477289350691554,1.0,8/41,11.69%,TMCC1;RILP;SNX3;PI4K2B;WASHC4;CORO1C;SNX10;SNX33
prerank,cardiac muscle cell differentiation (GO:0055007),0.49286946876769555,1.291421213947688,0.17307692307692307,0.47688162848023413,1.0,4/21,2.92%,MEF2C;BMP2;MYH6;ALPK3
prerank,positive regulation of alpha-beta T cell activation (GO:0046635),0.5412175834518245,1.2907543963545431,0.18568994889267462,0.4778161675567243,1.0,3/15,7.58%,NKAP;SYK;CCR2
prerank,endoplasmic reticulum to cytosol transport (GO:1903513),-0.4986295700713559,-1.2907144597176583,0.16964285714285715,0.7795542593489325,1.0,8/15,24.75%,AUP1;UFD1;NPLOC4;SYVN1;SELENOS;TMEM129;FAF2;SEC61B
prerank,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),0.4492656407026481,1.2899468351147207,0.16850393700787403,0.47894507602497943,1.0,14/40,19.39%,FBXW7;RPL23;AXIN1;RPL5;HFE;RPS7;UBQLN4;RPL11;XPO1;PTEN;GLMN;RNF139;CSNK2A2;CSNK2A1
prerank,cellular response to glucagon stimulus (GO:0071377),-0.48393598803129523,-1.2889940930915402,0.18899521531100477,0.7829554662302791,1.0,5/17,10.16%,ADCY3;ADCY8;PRKAR1A;PRKAR1B;ADCY7
prerank,positive regulation of cytoskeleton organization (GO:0051495),0.39766820314773776,1.2879017903497514,0.12412831241283125,0.4825413162270969,1.0,8/76,3.43%,NRP1;P2RX7;SNX9;ALOX15;FER;FCHSD2;CDC42;NES
prerank,positive regulation of calcium-mediated signaling (GO:0050850),-0.5331387988641914,-1.2878402779741038,0.16851441241685144,0.7842934454831472,1.0,3/11,8.70%,TREM2;CDH13;CCL3
prerank,positive regulation of interleukin-17 production (GO:0032740),0.5173047839685839,1.2878271631398968,0.15228426395939088,0.4821383977181373,1.0,3/22,4.11%,IL15;NR1H4;RFTN1
prerank,regulation of calcium ion transport (GO:0051924),0.43233056987702745,1.2874267377092714,0.14473684210526316,0.482393194856684,1.0,20/54,19.24%,IL16;LILRA5;ATP2B1;CCR1;LILRB1;STIM2;BCL2;STIM1;HOMER1;CD33;PLN;WFS1;SLC8B1;FFAR1;PKD2;CCL5;F2R;CAMK2A;P2RX4;INPP5K
prerank,negative regulation of interleukin-10 production (GO:0032693),0.5256397014947873,1.287416276776647,0.17616580310880828,0.48182218526186243,1.0,2/16,2.74%,FCGR2B;LILRB1
prerank,regulation of epithelial cell differentiation (GO:0030856),0.5282996223143124,1.2872831791709745,0.1955403087478559,0.48150352890336445,1.0,2/17,2.38%,CEBPB;OSR1
prerank,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",0.4177087281703359,1.2872115837400626,0.1301169590643275,0.48107748630224595,1.0,7/53,12.60%,HRH1;CCR1;CALCRL;DRD1;TSHR;HTR1D;HTR6
prerank,intracellular estrogen receptor signaling pathway (GO:0030520),-0.4874746106043301,-1.2871810938874773,0.1412037037037037,0.783288978717504,1.0,8/16,15.10%,DDX5;DDX17;SAFB;TRIP4;AR;EGLN2;PADI2;NCOA4
prerank,organic hydroxy compound transport (GO:0015850),0.4582751318891499,1.2871640821400427,0.15483870967741936,0.4805866141120493,1.0,8/36,14.36%,SLC10A6;NR1H4;NCOA2;GHRL;ABCC4;SLC10A3;NPC2;RBP4
prerank,regulation of cholesterol storage (GO:0010885),0.5375765054679466,1.2868252687105035,0.19642857142857142,0.4807259519444123,1.0,2/15,4.03%,MSR1;EHD1
prerank,regulation of mitotic sister chromatid separation (GO:0010965),-0.48644699861522983,-1.2867423331449364,0.17620137299771166,0.7815789778588654,1.0,5/15,15.66%,HECW2;CENPE;NEK6;TACC3;RIOK2
prerank,response to estrogen (GO:0043627),0.47204574599322957,1.2863238600201503,0.16220472440944883,0.4811816941532053,1.0,11/31,15.82%,ESR1;GHRL;ARID5A;TRIM24;ASH2L;SFRP1;BCAS3;SFR1;RARA;EP300;TRIM25
prerank,positive regulation of signal transduction by p53 class mediator (GO:1901798),0.5118564252179442,1.2861695965566147,0.18356643356643357,0.48093140639154097,1.0,7/22,10.98%,SPRED1;RPL23;RPS15;RPL37;RPS20;RPS7;SPRED2
prerank,smooth muscle tissue development (GO:0048745),-0.5524909711869329,-1.2858611789698169,0.19096509240246407,0.7817291249653222,1.0,8/10,36.70%,NF1;PROX1;SMO;ENG;BMP4;MYLK;SHH;EFEMP2
prerank,protein catabolic process (GO:0030163),0.4108247852566046,1.2854521889586952,0.13146233382570163,0.4818407295952923,1.0,14/59,11.97%,APOE;RIPK1;SIAH2;NR1D1;CLN5;CLN6;PRKN;MANBA;TRIM24;ADAMTS9;LAMP2;CLPX;NGLY1;DENND3
prerank,primary neural tube formation (GO:0014020),0.4744380897433668,1.2852401633826238,0.17491749174917492,0.48172250624012286,1.0,5/30,5.59%,LRP6;PRICKLE1;BCL10;GRHL2;CELSR1
prerank,regulation of cation channel activity (GO:2001257),-0.31904128354170996,-1.2845677080317184,0.0622568093385214,0.783309527357611,1.0,25/89,13.30%,CACNB2;FGF14;FGF12;DLG2;PTK2B;CACNB4;CALM2;GRIA2;NLGN1;DLG4;DLG3;GRIA4;FGF13;ANK2;CTSS;SHANK1;JPH1;GSG1L;ACTN2;CACNG7;MINK1;GRIN2A;CACNG8;VAMP2;SHISA7
prerank,positive regulation of cellular metabolic process (GO:0031325),0.38992146305896697,1.2844333769085003,0.11318242343541944,0.48293338451858325,1.0,15/98,12.28%,PID1;APOE;TBC1D5;IFNAR1;XDH;RIPK1;INSR;IL10RB;ANXA2;KLF4;MAPK14;RAB1A;ARRB1;ROMO1;ZC3H12A
prerank,epithelial cell-cell adhesion (GO:0090136),0.5734208246674541,1.2843129622802134,0.19460500963391136,0.4825737601738489,1.0,4/11,11.09%,SERPINB8;THBS4;VCL;JUP
prerank,negative regulation of signal transduction by p53 class mediator (GO:1901797),0.5155650643633114,1.2841673898736017,0.17900172117039587,0.4822867695961128,1.0,5/17,9.25%,CD44;CD74;PRKN;MDM2;DYRK1A
prerank,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),0.4170264575065364,1.2841097122163811,0.13313161875945537,0.48183628337677464,1.0,11/57,9.90%,IL15;LYN;TSLP;PARP14;PIBF1;CD40;TNF;IL6R;SH2B3;PPP2CA;IGF1
prerank,regulation of chromatin binding (GO:0035561),0.5961734365320108,1.2829445251754286,0.21042830540037244,0.4838155607101152,1.0,4/10,9.43%,DDX11;GMNN;BTAF1;KDM4D
prerank,3'-UTR-mediated mRNA destabilization (GO:0061158),0.5384334278351085,1.2826337893229294,0.18214936247723132,0.48387129809426493,1.0,6/16,12.86%,ZFP36L2;ZFP36L1;RC3H1;TRIM71;ZC3H12A;ZC3H12D
prerank,regulation of leukocyte activation (GO:0002694),0.5451423243033233,1.2821765661595994,0.196113074204947,0.4842333197822791,1.0,4/14,8.69%,LYN;MFHAS1;CD74;CD33
prerank,detection of mechanical stimulus involved in sensory perception (GO:0050974),-0.48908143373501467,-1.2820610700068735,0.15513126491646778,0.7897393830213474,1.0,9/15,29.08%,COL11A1;WHRN;KCNA1;PIEZO2;SCN1A;ADGRV1;MKKS;HPN;TMC1
prerank,positive regulation of DNA-binding transcription factor activity (GO:0051091),0.3526074086654881,1.2813241585213484,0.08027522935779817,0.48555670395879236,1.0,64/234,17.33%,NLRC4;LRP6;APP;ESR1;FER;RPS3;IRAK3;RPS27A;RIPK1;CD36;WNT2;TLR4;CAMK1D;RGCC;BCL10;TNFRSF11A;TLR2;CLOCK;STK3;TRIM32;CD40;TNF;MTPN;EDA;PRKCB;CEBPG;RAB7B;TRIM68;DDR2;TRIM27;ESR2;CARD16;RIPK2;TFDP1;JUP;PSMA6;CRTC3;BUD31;STK36;DHX33;LAMTOR5;TERF2IP;NOD2;UBE2N;NFKBIB;MID2;STAT3;EP300;PRKD2;NFAM1;PPIA;HDAC4;TRIM25;KDM1A;PTEN;PPARGC1B;TIRAP;PRDX3;TAB3;PRKCQ;RELA;ZBTB7A;TAF12;FLOT2
prerank,"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",0.5525277350462269,1.2808609319074837,0.18996415770609318,0.48602461672597974,1.0,4/13,9.25%,CD44;CD74;MDM2;DYRK1A
prerank,antibacterial humoral response (GO:0019731),0.5280826397312555,1.2808234826332812,0.19661016949152543,0.48552242826421793,1.0,3/16,7.85%,ANG;RPL39;RNASE6
prerank,toll-like receptor 3 signaling pathway (GO:0034138),0.5820411955935929,1.2803020658448183,0.2058252427184466,0.4860977936976177,1.0,4/11,11.05%,COLEC12;RIPK1;RFTN1;CASP8
prerank,regulation of RNA metabolic process (GO:0051252),0.41956982014378646,1.2796741274090564,0.13501483679525222,0.48686148882900315,1.0,12/59,8.72%,AHNAK;OAS2;MBNL1;RASA1;MITF;TNFRSF1B;PTBP3;RC3H1;MBNL2;HNRNPF;PTBP2;GRSF1
prerank,protein depolymerization (GO:0051261),-0.42108488224050533,-1.2796560070319383,0.1288782816229117,0.7956017444475876,1.0,13/27,24.01%,NCKAP5L;TWF2;MICAL3;STMN3;NCKAP5;STMN4;CKAP5;KIF2A;MICAL2;TWF1;KATNB1;WDR1;KIF14
prerank,response to interleukin-6 (GO:0070741),0.5832639773142889,1.279520441688622,0.18106995884773663,0.48658826241724434,1.0,1/10,0.05%,PID1
prerank,regulation of gene expression (GO:0010468),0.3258844096446448,1.2794798570227601,0.010141987829614604,0.48607364654443724,1.0,165/903,15.75%,RBPJ;PID1;MSR1;AHNAK;PF4;NELL1;APOE;P2RX7;APP;NOTCH2;CCR1;FOXP1;FBXW7;AHR;MBNL1;MYADM;RREB1;CRIP1;GAS6;FOXN2;ADAM19;NFXL1;ESR1;RPL23;C1QTNF1;LYN;HINT1;RPS3;MEF2C;PTPN22;NCOA2;CEBPB;KRAS;MITF;OSR1;RYBP;BMP2;XDH;PARP14;LILRB1;CD36;CD74;FGF23;DRD1;LAMP3;TLR4;CD46;ZFP36L1;RGCC;PRKN;NFKBIZ;PDE2A;TLR2;NR3C1;NKAP;HEY2;PTBP3;CDK6;CLOCK;SPI1;GSK3B;RB1;NDFIP1;INSR;RACK1;RC3H1;PUM2;ROCK1;TGFBRAP1;MBNL2;TCF7;ATXN1;SETDB2;HNRNPF;KDM6A;TNF;ZNF148;LYL1;KLF4;YY1;REL;RPL5;HFE;WNT6;PSEN1;PTBP2;IRF2;VSTM2A;TRIM68;RO60;TDRD7;ATRX;ZNF628;LIMD1;ESRRB;BACH1;MSN;TRIM27;GRSF1;LIN54;SMCR8;RPS7;HMG20A;ESR2;MAPK14;ATF7;NFATC2;PPP2CA;ZNF205;RPL6;GCFC2;IGF1;TESMIN;SFRP1;RNF14;JMJD1C;MED26;SP1;ATXN1L;CASP8;EMILIN1;CREBBP;MYBL2;FOXK2;HINFP;NFIA;ROCK2;AFF1;LAMTOR5;TRIM71;ZC3H12A;ATP2B4;SLC38A2;TERF2IP;SP3;RAMP2;GJA1;LARP4;PEG3;PSPC1;ZNF326;RNF187;TNRC6C;KAT7;NDFIP2;STAT3;EP300;MLF2;HMGN5;ATXN7L3B;WWC1;NAB1;RPL11;NOVA1;BMPR1A;MYC;MYT1;NSD3;FN1;NLK;HDAC4;NR2C2;SFPQ;UBAP2;RUNX3
prerank,regulation of T cell chemotaxis (GO:0010819),0.5742199718653076,1.279386731986626,0.19666048237476808,0.4857030032312536,1.0,3/11,7.58%,OXSR1;WNK1;CCR2
prerank,negative regulation of mRNA processing (GO:0050686),-0.4982167690979782,-1.2789011582616177,0.15592515592515593,0.7949601259001436,1.0,8/15,24.71%,SRSF10;RNPS1;C1QBP;SRSF12;SFSWAP;SRSF9;U2AF2;SRSF6
prerank,tube closure (GO:0060606),0.46865378627682985,1.277886788247476,0.1775244299674267,0.4884145043652364,1.0,5/31,5.59%,LRP6;PRICKLE1;BCL10;GRHL2;CELSR1
prerank,semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),0.5563747294795719,1.2775472261985872,0.181651376146789,0.48852943287767026,1.0,3/13,6.52%,NRP1;PLXNC1;PLXNA4
prerank,positive regulation of synaptic transmission (GO:0050806),-0.341154861072003,-1.277536367144929,0.09540636042402827,0.7966755527668372,1.0,26/72,17.63%,RIMS1;PTK2B;ADCY8;SLC24A2;GRIK2;NLGN1;RIMS2;NRXN1;DLG4;LGMN;FLOT1;KCTD13;FMR1;SHANK2;CACNG7;GRIN2A;LGI1;CACNG8;VAMP2;SHISA7;EPHB2;ADCY1;RIMS3;SQSTM1;CACNG4;SYT1
prerank,transcription by RNA polymerase II (GO:0006366),0.3373322769698083,1.2775041428620046,0.06696428571428571,0.4880393022783414,1.0,74/305,17.68%,RBPJ;HDAC9;MAF;NOTCH2;RREB1;C5AR1;ESR1;RARG;NR1H4;NR2C1;NR1D1;CDK12;NR3C1;NFIC;THRB;CBFB;NR4A1;TRIM24;NELFA;CPSF3;MED16;TBL1XR1;NR4A2;RNGTT;IWS1;CDC73;NCOR1;GTF2A2;SNRPG;ESRRB;SCAF8;MED18;TBL1X;ESR2;MED20;RPRD2;NR2F1;POLR2B;MED26;MAML1;SP1;TFDP1;PCID2;ELOF1;CREBBP;GTF2E2;EAF2;CDK13;DEK;ELP4;NFIX;GTF2A1;KLF13;NR1H2;RARA;MBD1;POLR2D;MED27;SNW1;PAPOLA;ELOC;WDR33;NR2C2;GTF2H3;CPSF2;GTF2B;MED17;NR5A2;LHX1;TAF12;XBP1;GTF2H1;INTS1;NR6A1
prerank,lung epithelium development (GO:0060428),0.5787901575806133,1.2773951478882593,0.20610687022900764,0.4876847198170717,1.0,2/10,4.62%,RCN3;GRHL2
prerank,negative regulation of toll-like receptor signaling pathway (GO:0034122),0.4631840070291631,1.2773819734718501,0.16377952755905512,0.48712901615612736,1.0,8/34,8.16%,LYN;MFHAS1;IRAK3;TLR4;NR1D1;NFKBIL1;LY96;RAB7B
prerank,macrophage migration (GO:1905517),0.5601427332146427,1.2754599576945762,0.2018181818181818,0.49074832128621493,1.0,5/13,18.96%,EDNRB;CCR2;CKLF;CCL5;P2RX4
prerank,synaptic vesicle membrane organization (GO:0048499),-0.4822624281651252,-1.2754395772128109,0.16037735849056603,0.801650964208483,1.0,6/17,15.04%,SYNGR1;SNAP25;SNAP47;AP3D1;STX3;STX2
prerank,positive regulation of stress fiber assembly (GO:0051496),0.4400677515482985,1.2748471357937892,0.17933130699088146,0.4914361948780215,1.0,8/44,3.95%,NRP1;GPR65;CDC42;ARHGEF10L;RHOA;RGCC;S100A10;ITGB1BP1
prerank,positive regulation of synapse assembly (GO:0051965),-0.42040305524655575,-1.2743613064113097,0.15789473684210525,0.8026148344829789,1.0,12/27,19.03%,GRID2;SEMA4D;PTPRD;NLGN1;NRXN1;EPHB1;BDNF;SYNDIG1;IL1RAPL1;EPHB2;IL1RAP;VSTM5
prerank,negative regulation of protein modification process (GO:0031400),0.3892783966047221,1.2740624870247845,0.14145658263305322,0.49261154084498715,1.0,9/79,4.76%,PID1;LRP6;MYADM;LYN;MFHAS1;XDH;NIBAN1;PRKN;GSK3B
prerank,cellular response to type I interferon (GO:0071357),0.4377052271346724,1.273612265918034,0.16767371601208458,0.4924290043098504,1.0,11/41,11.81%,IRF4;IFITM3;OAS2;IFNAR1;RNASEL;BST2;IFNAR2;IRF2;IFITM2;SP100;JAK1
prerank,type I interferon signaling pathway (GO:0060337),0.4377052271346724,1.273612265918034,0.16767371601208458,0.4924290043098504,1.0,11/41,11.81%,IRF4;IFITM3;OAS2;IFNAR1;RNASEL;BST2;IFNAR2;IRF2;IFITM2;SP100;JAK1
prerank,myelin assembly (GO:0032288),-0.551406104971156,-1.273486429551526,0.20041753653444677,0.8025563803026161,1.0,6/10,22.69%,CD9;EPB41L3;TENM4;TPPP;ABCA2;GPC1
prerank,dendritic cell differentiation (GO:0097028),0.4930360282208421,1.272870450637127,0.17881944444444445,0.4934479686559556,1.0,6/22,5.19%,GAS6;LYN;LILRB1;DCSTAMP;CCL19;BATF2
prerank,cytosolic calcium ion transport (GO:0060401),0.46775651542395785,1.2725029682048092,0.18282988871224165,0.4936481304684181,1.0,8/28,14.90%,MCUB;ATP2B1;MCU;ADRA1A;MICU3;SLC35G1;ATP2A2;ITPR3
prerank,cellular polysaccharide catabolic process (GO:0044247),0.5326754573758633,1.272482633860641,0.19776119402985073,0.4931083615919314,1.0,2/16,4.09%,AOAH;PGM2L1
prerank,positive regulation of TORC1 signaling (GO:1904263),-0.47643343209266575,-1.272367724583511,0.1937046004842615,0.8035083963652162,1.0,6/16,17.73%,GPR137B;GPR137C;RRAGD;FLCN;SEH1L;RRAGB
prerank,phospholipid transport (GO:0015914),0.42203645371660686,1.2717917688469662,0.14992721979621543,0.4940027732792239,1.0,6/52,3.71%,PLTP;APOE;LDLR;ATP11C;ATP8B4;PITPNA
prerank,organonitrogen compound catabolic process (GO:1901565),0.41842053591582173,1.271696832690176,0.13943028485757122,0.49363186548758503,1.0,12/57,10.29%,NPL;CPQ;PLA2G7;GNPDA1;CLN5;CLN6;PNPLA8;LNPEP;SGPL1;TRIM24;ENPEP;CLPX
prerank,negative regulation of epithelial cell apoptotic process (GO:1904036),0.463313721833848,1.2715753487612103,0.18167202572347266,0.4932984204848828,1.0,8/33,16.14%,TCF7L2;GAS6;NUPR1;WFS1;CAST;RAMP2;MDK;MAPK7
prerank,activation of GTPase activity (GO:0090630),-0.32026305756083834,-1.271562892656789,0.050724637681159424,0.8031924998083091,1.0,22/89,11.26%,ARHGAP45;SIPA1L2;ARHGAP24;TBC1D16;TBC1D8;ARHGAP25;GARNL3;SGSM3;GMIP;SGSM2;TBC1D10A;NTRK3;ARHGAP22;RASGRF1;TBC1D22A;TBC1D22B;TIAM1;TBC1D9B;TIAM2;ABR;EVI5L;TSC1
prerank,regulation of cell killing (GO:0031341),0.5215126925126692,1.2709594456562014,0.203125,0.4940697326441995,1.0,1/16,0.45%,CFH
prerank,endoplasmic reticulum tubular network organization (GO:0071786),0.5449227637293785,1.270898574457353,0.17482517482517482,0.49361949134258254,1.0,4/15,9.90%,REEP3;ATL1;RAB10;RTN4
prerank,mitotic DNA replication (GO:1902969),-0.562280675860805,-1.2707155066978781,0.15756302521008403,0.8031470517723496,1.0,6/10,26.88%,LIG1;MCM3;GINS3;MCM6;MCM2;MCMDC2
prerank,covalent chromatin modification (GO:0016569),-0.49628849140634684,-1.270327009797682,0.1655328798185941,0.8014468523108492,1.0,8/14,33.91%,SIRT7;PARK7;HDAC1;AURKB;MBD2;HLCS;HELLS;SIRT1
prerank,cellular response to corticosteroid stimulus (GO:0071384),0.5413759297566144,1.270226437929135,0.17805755395683454,0.49449297360765015,1.0,3/15,4.37%,ZFP36L2;ZFP36L1;NR3C1
prerank,embryonic heart tube morphogenesis (GO:0003143),-0.3680868588392311,-1.2701127003343198,0.11716621253405994,0.799029274346278,1.0,17/43,23.61%,NDRG4;ACVR1;AHI1;BBS7;CCDC39;TBX6;VANGL2;TGFBR2;SMO;MICAL2;NOTCH1;SRF;ENG;BBS4;MKKS;CCDC40;STIL
prerank,positive regulation of vasculogenesis (GO:2001214),0.5889631890355513,1.2700928975663994,0.21455223880597016,0.4942329194502834,1.0,3/10,4.84%,RIN2;RAPGEF2;RAP1A
prerank,negative regulation of T cell mediated immunity (GO:0002710),0.563463343787986,1.2696953803675677,0.1900369003690037,0.4945818323153967,1.0,3/11,7.63%,AHR;LILRB1;HFE
prerank,regulation of calcium ion transmembrane transport (GO:1903169),-0.4331589601106748,-1.2691673438876543,0.1318407960199005,0.7992406152395398,1.0,6/23,7.77%,PTK2B;NOS1AP;ANK2;UBASH3B;CACNA2D1;PRNP
prerank,protein localization to condensed chromosome (GO:1903083),-0.5128488509632257,-1.2688050174644512,0.18843683083511778,0.7975302626689151,1.0,7/12,29.81%,KNL1;SPDL1;ZW10;IK;CDK1;AURKB;TTK
prerank,calcineurin-NFAT signaling cascade (GO:0033173),0.5837163518713604,1.2687705819355386,0.22586872586872586,0.49529974081839506,1.0,4/10,20.43%,PPP3CA;NFATC2;NFATC3;NFATC1
prerank,calcineurin-mediated signaling (GO:0097720),0.5837163518713604,1.2687705819355386,0.22586872586872586,0.49529974081839506,1.0,4/10,20.43%,PPP3CA;NFATC2;NFATC3;NFATC1
prerank,positive regulation of myelination (GO:0031643),-0.5352878907047527,-1.2686794255324032,0.1790744466800805,0.7947950649401282,1.0,7/11,17.73%,PARD3;ITGAX;CST7;TENM4;TPPP;RNF10;EGR2
prerank,cellular response to insulin stimulus (GO:0032869),0.3735374057411502,1.268631332437935,0.11081794195250659,0.49501620946819413,1.0,23/124,11.24%,HDAC9;MYO5A;TBC1D4;RAB31;FER;ATP6V1B1;RAB8B;RAB10;ZFP36L1;SLC2A4;GSK3B;IRS2;INSR;ATP6V0A1;GAB1;AP3S1;PIK3C2A;ATP6V1A;FOXC2;DENND4C;ZNF106;PHIP;SHC1
prerank,positive regulation of extracellular matrix organization (GO:1903055),0.5263191274186487,1.26861921640325,0.20422535211267606,0.49447739434940374,1.0,8/18,17.66%,BMP2;RGCC;RB1;DDR2;CLASP1;EMILIN1;MELTF;IL6
prerank,regulation of platelet aggregation (GO:0090330),-0.4689511829749241,-1.2685020577399562,0.18161925601750548,0.7921786675540917,1.0,4/17,0.79%,F11R;CD9;PRKCD;SERPINE2
prerank,positive regulation of protein secretion (GO:0050714),0.39355163383617014,1.268273688815415,0.13194444444444445,0.4947017829751913,1.0,21/69,14.92%,TCF7L2;ANG;C1QTNF3;EXPH5;TLR4;ADAM9;TLR2;MCU;IRS2;GHRL;TMED10;GOLPH3L;CD33;IGF1;WLS;ACHE;DOC2B;GLUD1;TRH;RBP4;PPIA
prerank,negative regulation of calcium ion transport (GO:0051926),0.5379638037856592,1.2677169103915578,0.2073170731707317,0.49531054285968734,1.0,8/15,23.06%,LILRB1;TRIM27;CD33;PLN;SLC30A1;INPP5K;TMBIM6;PACSIN3
prerank,regulation of small molecule metabolic process (GO:0062012),0.4717655083968414,1.2676941795614722,0.18316831683168316,0.4947657965430772,1.0,6/28,12.35%,APOE;NR1H4;PRKN;FMO5;FOXK2;FOXK1
prerank,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),-0.480438098437116,-1.2673301300318267,0.1839080459770115,0.7935658169866465,1.0,6/16,36.06%,CLDN11;CLDN12;CLDN18;CLDN1;CLDN5;CLDN14
prerank,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",-0.44236429775843816,-1.2669959623335278,0.17579908675799086,0.7885930992654957,1.0,6/21,9.14%,GTF2H2;CUL4A;PARP1;DDB2;RBX1;ERCC2
prerank,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",-0.44236429775843816,-1.2669959623335278,0.17579908675799086,0.7885930992654957,1.0,6/21,9.14%,GTF2H2;CUL4A;PARP1;DDB2;RBX1;ERCC2
prerank,energy derivation by oxidation of organic compounds (GO:0015980),0.4965143507882123,1.2665218693661469,0.19407894736842105,0.4967127236804262,1.0,5/24,15.18%,PID1;GFPT2;CYCS;COX10;MYC
prerank,carbohydrate homeostasis (GO:0033500),0.39923508196757784,1.2665151222304165,0.14064697609001406,0.49615023751197934,1.0,13/67,14.48%,ALOX5;TCF7L2;SLC2A4;MCU;INSR;ADIPOR2;RPS6;WFS1;SLC8B1;KCNB1;STAT3;RBP4;USF1
prerank,negative regulation of cell-cell adhesion (GO:0022408),0.44894101550214816,1.265938001507305,0.18989280245022971,0.49679666259648625,1.0,11/39,17.02%,MYADM;JAG1;BMP2;RGCC;WNK1;KLF4;ASS1;FXYD5;MAPK7;MIA3;PODXL
prerank,negative regulation of cellular protein localization (GO:1903828),0.4563338206933386,1.2653888175617254,0.1809672386895476,0.49740444233157505,1.0,10/34,14.32%,CTNNA1;RIPOR2;MFHAS1;SPI1;GSK3B;LEPROTL1;SNX33;ROCK2;LATS2;NEDD4L
prerank,eye photoreceptor cell differentiation (GO:0001754),0.5667232166526497,1.2653446922117875,0.19507908611599298,0.49694453755623275,1.0,6/12,22.93%,MYO7A;NKD1;DSCAM;STAT3;SDK2;PROM1
prerank,regulation of focal adhesion assembly (GO:0051893),0.4237228430931047,1.2644895600508057,0.15948275862068967,0.49815864279060185,1.0,16/54,12.68%,NRP1;PTPRJ;PEAK1;RHOA;S100A10;ITGB1BP1;ROCK1;PTPRA;DUSP22;VCL;RCC2;CLASP1;CORO1C;SFRP1;ROCK2;BCAS3
prerank,positive regulation of tissue remodeling (GO:0034105),0.6007898272603873,1.2638861820217715,0.22117202268431002,0.4988466785265752,1.0,3/10,11.99%,IL15;ROCK1;ROCK2
prerank,positive regulation of protein kinase activity (GO:0045860),0.3627518723616446,1.2635472456201,0.11955168119551682,0.4989919679794193,1.0,29/148,10.64%,NEDD9;LILRA5;IQGAP1;SNX9;PRKAG2;GAS6;RASSF2;CASS4;ADRB2;AXIN1;CCL19;RHOA;RAPGEF2;DOK7;RAP1A;INSR;GPRC5B;INCENP;PAK2;STK3;TNF;NRK;IL6R;DDR2;PPP2CA;CACUL1;PARP16;MARK2;CALM1
prerank,glial cell development (GO:0021782),0.47413790821973817,1.263491596486704,0.178752107925801,0.4985249647987592,1.0,4/25,4.56%,NRROS;APP;TLR2;CDK6
prerank,positive regulation of axonogenesis (GO:0050772),-0.36861770122186266,-1.2633147429167995,0.13134328358208955,0.7993518399339684,1.0,19/43,22.66%,SEMA4D;ROBO2;PLXNA2;ROBO1;ZFYVE27;MACF1;TWF2;BDNF;MAPT;MAP6;TIAM1;TIAM2;LIMK1;CDKL5;DBN1;PLXNB2;PLXNB3;PLXNB1;CHODL
prerank,ubiquitin-dependent ERAD pathway (GO:0030433),-0.3410818763131866,-1.2620087755059408,0.11643835616438356,0.8011902522358484,1.0,35/69,28.82%,TMEM67;MAN1B1;UBE4A;AUP1;USP19;RNF103;BAG6;DNAJB2;EDEM1;UFD1;FBXO44;UBXN4;UBE2J1;NPLOC4;ECPAS;TRIM13;DNAJB14;RNF5;STUB1;SYVN1;FAM8A1;SELENOS;RNF103-CHMP3;TMEM129;FOXRED2;FAF2;UBQLN1;YOD1;SEC61B;SGTA;DNAJC18;UBQLN2;UBE2G2;FBXO2;STT3B
prerank,negative regulation of myeloid leukocyte differentiation (GO:0002762),0.4829604982839876,1.261483925500389,0.19376026272577998,0.502218533637956,1.0,4/26,4.56%,C1QC;LILRB3;TLR4;CDK6
prerank,positive regulation of interleukin-2 production (GO:0032743),0.48186327356972625,1.2614163866298977,0.18257956448911222,0.5017845304523884,1.0,6/25,7.58%,IRF4;RPS3;SPTBN1;PDE4D;CD80;CCR2
prerank,female gonad development (GO:0008585),0.5006522938059655,1.2613097452394473,0.19415807560137457,0.5014410972068785,1.0,2/19,2.18%,ANG;CEBPB
prerank,calcium-ion regulated exocytosis (GO:0017156),-0.4194598047747739,-1.2612642819016573,0.16981132075471697,0.800938193442693,1.0,12/27,27.26%,RIMS1;RIMS2;SYT6;VAMP2;SYT8;RIMS3;SYT1;VAMP7;SYT13;SYT7;SYT5;SYT17
prerank,embryonic heart tube development (GO:0035050),-0.4968793164187748,-1.2611945112199672,0.17943107221006566,0.7980633803650018,1.0,2/14,4.58%,NDRG4;ACVR1
prerank,activation of protein kinase A activity (GO:0034199),-0.48890161122209386,-1.2610993458224695,0.1864406779661017,0.7952423217548503,1.0,5/16,10.16%,ADCY3;ADCY8;PRKAR1A;PRKAR1B;ADCY7
prerank,cellular response to peptide hormone stimulus (GO:0071375),0.3781294009589364,1.2610934942210368,0.13114754098360656,0.5013202964967609,1.0,13/102,5.86%,HDAC9;MYO5A;TBC1D4;RAB31;FER;RAB8B;RAB10;ZFP36L1;SLC2A4;IRS2;INSR;ADCY9;NR4A1
prerank,cellular response to hormone stimulus (GO:0032870),0.4068550288731755,1.260957317220812,0.1470160116448326,0.501052858242935,1.0,20/69,13.92%,NCOA3;MEF2C;NCOA2;ZFP36L1;NR3C1;KLF9;ARID5A;CTSB;THRB;TRIM24;SFRP1;SLIT3;GAS2L1;BCAS3;RAMP2;SFR1;RARA;STAT3;ATP1A3;ATP1A1
prerank,regulation of smooth muscle contraction (GO:0006940),0.5041394758362615,1.2609327748433379,0.18838028169014084,0.5005377848595963,1.0,2/20,2.53%,ATP2B1;ADRB2
prerank,protein complex oligomerization (GO:0051259),0.3830411838686806,1.2607854347994234,0.15405046480743692,0.5003072702312349,1.0,12/85,9.43%,HGSNAT;NLRC4;EHD4;ATL1;LRRC8D;EHD1;BCL10;MCU;MPP2;HOMER1;NINJ1;BEND3
prerank,"regulation of DNA-templated transcription, elongation (GO:0032784)",-0.41978056054694346,-1.2602938755085094,0.15025906735751296,0.795185691499907,1.0,13/25,25.03%,LDB1;THOC1;DDX39B;CCNT2;ERCC6;HTATSF1;CCAR2;HMGN1;EAF1;ALYREF;ELL;CCNK;CCNT1
prerank,proteoglycan metabolic process (GO:0006029),-0.41440490212659487,-1.2601161244517685,0.1783132530120482,0.7927487098839756,1.0,10/26,17.95%,CHST11;XYLT1;BMPR1B;HS3ST4;SULF1;CANT1;GAL3ST4;HPSE;B4GALT7;CHST10
prerank,lamellipodium organization (GO:0097581),0.4626588652395525,1.260086042567214,0.17845117845117844,0.5012949393442461,1.0,13/29,24.55%,SNX2;ITGB1;VCL;S1PR1;PARVB;SPEF1;GOLPH3;ARFIP2;ARHGEF6;KIT;PTPRO;CCDC88A;SNX1
prerank,regulation of programmed cell death (GO:0043067),0.35818026640651596,1.2600587613541674,0.13432835820895522,0.5008032836342086,1.0,29/161,12.84%,TNFRSF25;HIP1;NLRC4;IFT57;TPT1;RARG;RPS3;DAPK1;STEAP3;RIPK1;PRKN;BIRC3;CTSB;ACER3;NOP53;TRIM24;TNF;HTATIP2;RTN4;FBXO11;NUP62;CHM;DFFA;CREBBP;KANK2;WFS1;FBXO10;PPP1R13B;GLS2
prerank,pyrimidine nucleobase metabolic process (GO:0006206),0.5530309945182778,1.2594904609227795,0.20733944954128442,0.5014485126107822,1.0,4/12,15.70%,DPYD;DPYSL2;CRMP1;DPYSL5
prerank,histone H3 deacetylation (GO:0070932),0.5311220176548721,1.259146460341342,0.21052631578947367,0.5016496728835735,1.0,1/15,0.10%,HDAC9
prerank,negative regulation of DNA replication (GO:0008156),0.548257647323416,1.2591402648391656,0.20917431192660552,0.5010973426497135,1.0,4/13,16.18%,S100A11;GMNN;TERF1;ATR
prerank,"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",-0.49848879802981905,-1.2589895265949786,0.19175257731958764,0.7936583491153357,1.0,8/14,24.71%,SRSF10;RNPS1;C1QBP;SRSF12;SFSWAP;SRSF9;U2AF2;SRSF6
prerank,positive regulation of neurogenesis (GO:0050769),-0.33468050341378314,-1.2586402901606197,0.08070175438596491,0.7919664124405211,1.0,17/68,12.45%,CX3CR1;NUMB;CUX1;CTNNB1;PTPRD;ROBO2;PLXNA2;TGM2;SS18L1;ROBO1;NUMBL;MAP6;TIAM1;CAPRIN1;TIAM2;SS18L2;IL1RAPL1
prerank,myeloid dendritic cell activation (GO:0001773),0.5590486864475968,1.258491530522236,0.2048417132216015,0.5019220290541044,1.0,3/12,5.19%,DOCK2;DCSTAMP;BATF2
prerank,ribonucleoside bisphosphate metabolic process (GO:0033875),-0.40193504183348266,-1.2583315293974866,0.1561712846347607,0.7872121411106673,1.0,10/29,25.43%,ACOT9;ACSF2;OXSM;ACSL6;ACOT7;ACBD6;THEM4;ACOT11;ACOT8;ACOT1
prerank,purine nucleoside bisphosphate metabolic process (GO:0034032),-0.40193504183348266,-1.2583315293974866,0.1561712846347607,0.7872121411106673,1.0,10/29,25.43%,ACOT9;ACSF2;OXSM;ACSL6;ACOT7;ACBD6;THEM4;ACOT11;ACOT8;ACOT1
prerank,G protein-coupled glutamate receptor signaling pathway (GO:0007216),-0.4871267125758081,-1.2580094322984465,0.18681318681318682,0.7853616939940482,1.0,5/15,14.64%,GRM7;DAGLB;GRM3;DAGLA;GRM5
prerank,microtubule depolymerization (GO:0007019),-0.46891168223392676,-1.2568947935908115,0.17090069284064666,0.7864972927581096,1.0,12/17,34.75%,NCKAP5L;STMN3;NCKAP5;STMN4;CKAP5;KIF2A;KATNB1;KIF14;KIF2C;KIF18B;KIF19;KIF24
prerank,establishment of endothelial barrier (GO:0061028),0.4696164573613517,1.2567256596725025,0.1975736568457539,0.5051757778993464,1.0,9/29,9.53%,RAP1B;MYADM;RAP2B;RAPGEF2;PDE2A;RAP1A;PDE4D;MSN;RAB1A
prerank,DNA replication initiation (GO:0006270),0.4434398595621534,1.2564453853416533,0.17262830482115085,0.5052084110758603,1.0,13/37,16.82%,ORC5;ORC2;POLE2;PRIM2;TOPBP1;RPA1;GMNN;PURA;POLE3;RPA3;POLE4;MCM8;PRIM1
prerank,positive regulation of lymphocyte activation (GO:0051251),-0.41160814517168565,-1.2563885757642332,0.1443850267379679,0.7855444186086479,1.0,6/28,18.94%,SIRPA;CCDC88B;NCKAP1L;XRCC6;THY1;PYCARD
prerank,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),0.46167502346642636,1.2562035354411643,0.1836734693877551,0.5051853522936279,1.0,4/28,6.34%,MAP3K5;CEBPB;ERN1;BCL2
prerank,dermatan sulfate proteoglycan biosynthetic process (GO:0050651),0.5293711177853052,1.2561379990178678,0.22580645161290322,0.5047311845594601,1.0,3/15,6.70%,DSE;UST;CHST12
prerank,positive regulation of macrophage migration (GO:1905523),-0.4471949549949157,-1.256087233676494,0.17530864197530865,0.7837612523018712,1.0,7/19,10.35%,CSF1;TREM2;MAPK3;P2RY12;AKIRIN1;CCL3;CSF1R
prerank,regulation of wound healing (GO:0061041),0.4327832257060772,1.2550742606544982,0.16770186335403728,0.5064676092800852,1.0,4/42,3.52%,ALOX5;CASK;ITGB1;CRK
prerank,positive regulation of cellular protein catabolic process (GO:1903364),0.5089214700721351,1.2541254495181435,0.1972318339100346,0.5079904585181048,1.0,2/18,1.00%,APOE;CTSC
prerank,positive regulation of Rho protein signal transduction (GO:0035025),0.4611533078902347,1.254110751814031,0.1973018549747049,0.5074540260030438,1.0,6/30,13.18%,ARHGEF3;GPR65;P2RY10;ARRB1;GPR17;NET1
prerank,hepatocyte growth factor receptor signaling pathway (GO:0048012),0.5684902278365624,1.2539484394853324,0.20226843100189035,0.5072145664127952,1.0,1/11,0.34%,NRP1
prerank,establishment of protein localization to mitochondrion (GO:0072655),-0.35840236347436133,-1.2536954393998567,0.1524390243902439,0.7899492563278346,1.0,20/46,32.19%,HK2;FBXO7;TIMM44;GDAP1;TOMM40;TIMM8B;GRPEL1;AIP;TOMM20;TOMM40L;TIMM21;BCAP31;TOMM34;FIS1;TOMM5;AKT1;TIMM17B;TIMM13;DNLZ;CHCHD4
prerank,regulation of potassium ion transport (GO:0043266),-0.3927844629837127,-1.2532217788901978,0.15492957746478872,0.7888616961222833,1.0,7/31,8.73%,DPP10;PTK2B;DPP6;KCNIP4;ANK2;CACNA1D;ACTN2
prerank,negative regulation of response to DNA damage stimulus (GO:2001021),0.4571696536462924,1.2523294298521426,0.18790849673202614,0.5101942463402834,1.0,7/30,9.25%,TPT1;RPS3;CD44;CD74;TRIM32;MDM2;DYRK1A
prerank,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),0.512203400532284,1.252328137126845,0.20802919708029197,0.5096235592638402,1.0,5/18,8.14%,EGFR;ESR1;RIPK1;TNF;NCOR1
prerank,negative regulation of binding (GO:0051100),0.38471262042191373,1.2520338492170615,0.1587516960651289,0.5097179988037555,1.0,15/81,11.02%,DAB2;NES;ITGB1BP1;GSK3B;RACK1;CFHR2;ROCK1;DISC1;ACTB;DDX11;BTAF1;PLN;CARD16;SP100;PPP1CA
prerank,acylglycerol homeostasis (GO:0055090),0.4906593094800752,1.251522085803033,0.20292504570383912,0.5102670686319862,1.0,2/20,4.93%,APOE;PNPLA8
prerank,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),-0.4605400518394781,-1.251256349010401,0.1958997722095672,0.7933909573504253,1.0,6/17,19.60%,ATP1B1;SLC8A1;ATP1B2;CACNA1C;GJC1;GJD3
prerank,chondroitin sulfate metabolic process (GO:0030204),-0.3993385840658279,-1.2507475219444177,0.17708333333333334,0.7924235936632769,1.0,14/30,20.13%,HEXB;CHST11;CSPG5;CHPF2;CSPG4;HYAL1;DSEL;NDNF;IDUA;VCAN;BCAN;BGN;NCAN;UGDH
prerank,positive regulation of leukocyte activation (GO:0002696),0.5080975471596479,1.2502907017727327,0.22597864768683273,0.5123656279770626,1.0,5/18,8.45%,TSLP;HAVCR1;TLR4;LBP;CLEC4D
prerank,positive regulation of response to cytokine stimulus (GO:0060760),0.554206723568131,1.2502045852823185,0.2411214953271028,0.5119586818832693,1.0,3/13,2.77%,GAS6;TSLP;CD74
prerank,negative regulation of heterotypic cell-cell adhesion (GO:0034115),0.5786358709307811,1.249599403088858,0.23992673992673993,0.5121246396470583,1.0,3/10,7.22%,MYADM;WNK1;KLF4
prerank,regulation of cell-cell adhesion involved in gastrulation (GO:0070587),0.5786358709307811,1.249599403088858,0.23992673992673993,0.5121246396470583,1.0,3/10,7.22%,MYADM;WNK1;KLF4
prerank,regulation of adenylate cyclase activity (GO:0045761),0.4916009270051839,1.2493199489205482,0.1896551724137931,0.5121633008475184,1.0,4/22,7.58%,EDNRB;GNAI3;STIM1;CCR2
prerank,negative regulation of JNK cascade (GO:0046329),-0.3951391688104477,-1.249134934123854,0.15776081424936386,0.7954946739605665,1.0,5/31,3.66%,SIRPA;CYLD;DUSP10;PDCD4;GPS2
prerank,positive regulation of histone modification (GO:0031058),-0.3881461196627304,-1.2490133138394528,0.15051020408163265,0.7929964731345598,1.0,8/33,11.96%,CDK9;AKAP8L;MAPK3;FMR1;SAP30BP;BRCA1;PAF1;AKAP8
prerank,ERBB signaling pathway (GO:0038127),0.39824608591700167,1.2489053941929646,0.15429403202328967,0.5124777216019721,1.0,9/64,8.29%,EGFR;IQGAP1;PTPN18;REPS2;PTPN12;CBL;KIF16B;GAB1;PIK3C2A
prerank,positive regulation of osteoclast differentiation (GO:0045672),0.5434795898174437,1.2489009788377585,0.21335807050092764,0.5119220703866236,1.0,2/14,6.94%,CCR1;TNF
prerank,receptor internalization (GO:0031623),0.43211973617451915,1.2487670464031544,0.18799368088467613,0.5116381380572013,1.0,10/44,6.71%,RAB31;CLTC;ITGB1;CALCRL;FCER1G;LILRB1;CD36;ADM;SYK;LMBRD1
prerank,regulation of phosphate metabolic process (GO:0019220),0.5179437970423367,1.248418769251727,0.21153846153846154,0.511808706152433,1.0,4/16,9.45%,PGAM1;SMG6;PSEN1;IGBP1
prerank,positive regulation of lipid catabolic process (GO:0050996),-0.4460465304403759,-1.2482885754982176,0.19138755980861244,0.7928571599814725,1.0,5/19,18.04%,PRKCD;DAGLB;ABCD2;MTLN;ANGPTL3
prerank,chromatin-mediated maintenance of transcription (GO:0048096),0.5557065902975019,1.248265869673508,0.22823984526112184,0.5115681403305222,1.0,6/11,15.73%,ARID1B;CHEK1;ELOF1;SERTAD2;SMARCD1;ARID1A
prerank,regulation of triglyceride biosynthetic process (GO:0010866),0.5216560171149154,1.2470905079735226,0.2118491921005386,0.5135735466709955,1.0,2/15,1.24%,FBXW7;LDLR
prerank,regulation of transcription by RNA polymerase II (GO:0006357),0.31380880442290815,1.246557047596056,0.002,0.5141264685813619,1.0,361/1668,18.02%,RBPJ;DAB2;PID1;HDAC9;ZEB2;MAF;TRPS1;PF4;ETV1;EDNRB;EGFR;LRP6;APOE;APP;KLF2;CHP2;TCF7L2;TCF4;IRF4;FOXP1;PPP3CA;FLI1;MEF2A;AHR;ZBTB16;RREB1;TFEC;KMT2A;HIVEP2;ESR1;RPL23;SMURF2;ZBTB20;RBBP8;NCOA3;JAG1;RARG;TCF12;MEF2C;NR1H4;ACTR3;RPS27A;NCOA2;CEBPB;MITF;PIAS1;OSR1;NCOA5;TSHZ3;BMP2;RIPK1;KLF6;ARID4B;LILRB1;TBX15;PHF8;HOXD8;NR2C1;PHOX2A;FOXA3;RAX;WNT2;ALX1;HOXA10;TLR4;NR1D1;CRK;CDK12;RPS6KA3;RGCC;BAZ2B;ITGB1BP1;PRKN;TOX4;LARP7;PDE2A;PHF20;TLR2;FRK;NR3C1;NKAP;IRF2BP2;HEY2;CTDSP1;CLOCK;GRHL2;PBX3;DMRTA2;ARID1B;SPI1;SAP130;NCOA7;RB1;KLF9;KDM7A;NFIC;USP9X;ARID5A;BATF2;SMAD4;ZFP2;ELF2;TRIM33;THRB;IRX2;CBFB;PHF21A;NR4A1;RNASEL;FOSL2;ORC2;TCF7;ZBTB25;CD40;ATXN1;PIAS2;NOP53;EPC1;ACVR2A;MED13L;DMAP1;FOXM1;ZNF235;SDCBP;ZNF568;TNF;KLF3;ZNF148;TSHZ1;LYL1;KLF4;EPC2;ZSCAN25;YY1;BRMS1L;DUSP22;MIER1;REL;HTATIP2;THAP11;GATAD2A;MED16;SATB2;TBL1XR1;STAT4;PRKCB;CEBPG;E2F5;PSEN1;FIZ1;NR4A2;LHX5;NRIP1;IRF2;KLF10;IRX5;CDC73;RPS14;NCOR1;ZBTB5;ATF6;FNIP1;ATRX;TET3;NCOA6;FOXC2;MIDEAS;ARID3A;ESRRB;BRIP1;BACH1;TRIM27;MDM2;KMT2C;LCORL;OLIG2;HIVEP1;MED18;TBL1X;ESR2;LRRFIP1;UBE2D3;MAPK14;FOXJ3;ATF7;NFATC2;MED20;MAMLD1;MED6;BEND3;IGBP1;ASXL1;MLXIP;MYDGF;LCOR;STAT6;NR2F1;USP16;PURA;ZNF205;IGF1;RIPK2;RFX2;RNF14;JMJD1C;ARRB1;RNF111;ZNF296;SPEN;CREBRF;RCOR2;SP100;MED26;MIER3;MAML1;SP1;TFDP1;ELF1;HSBP1;JUP;PHIP;ETS2;MLLT10;SREBF2;CREBBP;EAF2;KANK2;BCL11B;MYBL2;FOXK2;MED15;CDK13;HINFP;WFS1;NFIA;CRTC3;FOXO3;BUD31;RPL10;DCAF6;DEK;ZC3H12A;ATP2B4;FOXK1;LOXL2;TADA2B;NAMPT;BCAS3;ZBTB8B;NOD2;ELP4;ZFP3;CHD2;SP3;NFIX;FOXO1;TNFRSF1A;CREB1;CCNQ;PEG3;KLF13;CTBP2;ZBTB7C;WWOX;TFR2;NR1H2;ZBTB10;RARA;TNRC6C;KAT7;HIF3A;TET2;STAT3;EP300;KLF5;PROX2;BCOR;WASL;JUND;NEDD4L;CRLF3;KAT6A;MED27;USF1;PRKD2;PKD2;WWC1;RTRAF;SNW1;ELOC;GATAD2B;ENY2;BMPR1A;MYC;MTF1;MYT1;SMARCD1;HDAC4;KDM2A;NR2C2;ZHX1;SFPQ;SENP1;ARID1A;RUNX3;ELK1;HEXIM2;GTF2H3;E2F8;KDM1A;ZFP62;HOXB3;POU5F2;CREB3L1;MAPK7;HCFC1;ZGPAT;PTEN;ZNF569;PPARGC1B;ACTR2;PPM1A;LIN37;PER1;ZNF177;TBX2;NFATC3;ARNT;RCOR1;BRD4;GLIS2;MED17;FOXP2;NR5A2;RELA;LHX1;NACC1;CARF;ZBTB7A;NR2F2;ZNF22;XBP1;MEF2B;GTF2H1;MECOM;ARID4A;ZFP28;IL6;HGF;NR6A1;SP8;GMEB1;ZNF32;ZBTB41;EFNA1;GZF1;SS18;BATF;HSF5;ZBTB12;ZBTB40
prerank,negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),0.5530695858219984,1.246314798265067,0.21739130434782608,0.5141047755223768,1.0,4/13,16.20%,SNX6;CBL;CBLB;ZGPAT
prerank,histone H3-K4 methylation (GO:0051568),0.4664821445862688,1.2453257966587288,0.19931271477663232,0.5156859385837014,1.0,7/26,9.43%,KMT2A;KDM6A;TET3;ASH2L;KMT2C;WDR82;BEND3
prerank,membrane raft organization (GO:0031579),0.527778734342956,1.2452208115261914,0.2146690518783542,0.5153529666950466,1.0,4/15,5.98%,MYADM;S100A10;RFTN1;ANXA2
prerank,cellular response to amino acid stimulus (GO:0071230),-0.3867150789337519,-1.2444102521838307,0.15926892950391644,0.8043397277897772,1.0,16/33,27.37%,RPTOR;IPO5;UBR1;NSMF;RRAGD;SESN3;CASTOR2;GLRA1;RRAGB;MTOR;SESN2;GLRA2;CASTOR1;CPEB1;RRAGA;SH3BP4
prerank,peptidyl-proline hydroxylation (GO:0019511),-0.5236185293324017,-1.244155079446016,0.18681318681318682,0.8023303281345463,1.0,6/11,25.55%,P3H2;OGFOD1;EGLN2;P4HTM;P4HA1;P4HA3
prerank,regulation of toll-like receptor 2 signaling pathway (GO:0034135),0.5608129528612363,1.243896635720587,0.22117202268431002,0.5176854302279283,1.0,5/11,16.96%,LYN;MFHAS1;CYBA;TIRAP;ACOD1
prerank,cell chemotaxis (GO:0060326),0.4007510404899387,1.2437229264383403,0.1627565982404692,0.5174884333004991,1.0,9/60,7.58%,PLEKHG5;NRP1;CCR1;PDGFRA;NR4A1;CCRL2;ABCC1;CXCR4;CCR2
prerank,regulation of histone deacetylation (GO:0031063),-0.5041259972887274,-1.2435725499884274,0.1864754098360656,0.8014801740735552,1.0,5/13,23.54%,AKAP8L;SAP30BP;AKAP8;CAMK2D;CTBP1
prerank,positive regulation of smooth muscle cell migration (GO:0014911),0.5078107224326047,1.242979878552053,0.22591943957968477,0.5185286077608838,1.0,6/17,16.81%,NRP1;S100A11;IGF1;DOCK7;MDK;CCL5
prerank,atrial cardiac muscle cell action potential (GO:0086014),-0.49833406323224594,-1.2419981123440105,0.2088167053364269,0.804560600741433,1.0,6/13,20.73%,CACNB2;ANK2;CACNA1C;KCNN2;GJC1;KCNJ3
prerank,positive regulation of actin filament bundle assembly (GO:0032233),0.41640059421234876,1.2419462872420746,0.191044776119403,0.5201560726698381,1.0,12/51,11.99%,NRP1;GPR65;CDC42;ARHGEF10L;RHOA;RGCC;S100A10;ITGB1BP1;SFRP1;SYNPO;PXN;ROCK2
prerank,chromatin assembly or disassembly (GO:0006333),-0.5306186243822494,-1.2419251933013997,0.1934782608695652,0.8019305655296853,1.0,8/11,38.24%,HDAC8;TP53;HIRIP3;CHAF1A;MTA2;NOC2L;SUV39H2;M1AP
prerank,negative regulation of ERK1 and ERK2 cascade (GO:0070373),0.41825361808211636,1.241923461172043,0.17261904761904762,0.5196455866770737,1.0,11/46,11.22%,SPRED1;LYN;TLR4;ITGB1BP1;SMAD4;SYNJ2BP;RANBP9;CNKSR3;RPS6KA6;SPRED2;EMILIN1
prerank,positive regulation of protein modification process (GO:0031401),0.343113194245405,1.2418791344776532,0.10265700483091787,0.5191748088595061,1.0,35/203,13.06%,DAB2;EGFR;APP;GAS6;WDFY2;LYN;KRAS;BMP2;RIPK1;CD74;FGF23;AXIN1;THPO;NIBAN1;PDE8A;INSR;CAMKK2;RACK1;CD40;ACVR2A;TNF;FAM20A;CCND3;FNIP1;DYRK1A;CCND2;MYDGF;ARRB1;CALM1;ATG7;ROCK2;TERF2IP;BRAT1;UBE2N;ATG10
prerank,dermatan sulfate biosynthetic process (GO:0030208),0.5583421827185254,1.2417853670924501,0.22988505747126436,0.518823051482541,1.0,3/12,6.70%,DSE;UST;CHST12
prerank,modulation of excitatory postsynaptic potential (GO:0098815),-0.41607555619728137,-1.2417207186319972,0.17980295566502463,0.7997583688219725,1.0,7/26,5.61%,RIMS1;PTK2B;NLGN1;RIMS2;NRXN1;DLG4;SHANK1
prerank,water-soluble vitamin metabolic process (GO:0006767),0.3991274960012396,1.2413806623612476,0.16182572614107885,0.5191780909503726,1.0,17/68,20.22%,FOLR2;TPK1;TCN2;MTR;MTHFD2L;LMBRD1;ABCC1;AOX1;MMAB;SHMT1;SLC23A1;SLC23A2;SLC5A6;BTD;ENPP1;CYB5A;MTHFD1L
prerank,negative regulation of viral transcription (GO:0032897),0.5438022353943657,1.2411267660429102,0.2320754716981132,0.5191989611145,1.0,5/13,13.84%,IFITM3;LARP7;TRIM32;TRIM27;MID2
prerank,peptidyl-arginine modification (GO:0018195),0.5261731279624938,1.2405575823133237,0.22361359570661896,0.5198509231333386,1.0,1/15,0.54%,PADI4
prerank,ncRNA 3'-end processing (GO:0043628),-0.4806479671320431,-1.240038116437482,0.1879049676025918,0.8031034067719774,1.0,5/14,25.27%,INTS6L;PTCD1;TRNT1;TOE1;INTS7
prerank,epithelial cell morphogenesis (GO:0003382),0.506315542558919,1.2400255684190027,0.21837088388214904,0.5205049605081479,1.0,4/17,7.67%,CNMD;TNMD;GRHL2;COL22A1
prerank,positive regulation of interferon-beta production (GO:0032728),0.44530574982997606,1.239800362310632,0.18138801261829654,0.5204220748624127,1.0,6/33,5.78%,TLR8;OAS2;TLR4;TLR2;TRIM56;RIOK3
prerank,negative regulation of centrosome duplication (GO:0010826),-0.5110782776698194,-1.2393401793268615,0.20210526315789473,0.8028625052684161,1.0,3/11,8.88%,TMEM67;CENATAC;BRCA1
prerank,cellular response to interleukin-12 (GO:0071349),0.4158194009284736,1.2390899905209802,0.17835365853658536,0.5213990685678583,1.0,12/48,8.63%,RAP1B;SERPINB2;CDC42;PITPNA;LCP1;PAK2;ANXA2;HNRNPF;CNN2;RPLP0;STAT4;MSN
prerank,positive regulation of peptide hormone secretion (GO:0090277),0.43102558687931253,1.2390588098777882,0.19745222929936307,0.5208922056864852,1.0,10/39,14.36%,TCF7L2;MCU;IRS2;GHRL;HFE;DOC2B;GLUD1;TFR2;TRH;RBP4
prerank,estrogen metabolic process (GO:0008210),0.5257372673247975,1.2388896331945736,0.2224334600760456,0.5206898786456013,1.0,4/15,9.82%,UGT1A7;UGT1A1;SULT1A1;HSD17B7
prerank,myotube differentiation (GO:0014902),-0.45727688717546094,-1.2385984992711334,0.20316027088036118,0.8027743553877466,1.0,3/17,1.66%,ADGRB3;SORT1;JAM2
prerank,engulfment of apoptotic cell (GO:0043652),-0.48259315183434737,-1.237733132645095,0.19369369369369369,0.8032198565785069,1.0,8/15,27.76%,XKR6;RHOBTB2;XKR4;RHOH;ADGRB1;RHOG;XKR8;MEGF10
prerank,regulation of JNK cascade (GO:0046328),0.37009689240759636,1.2376972261974204,0.13733333333333334,0.5227104367792953,1.0,15/101,8.50%,FCGR2B;EGFR;APP;MAP3K5;MFHAS1;RASSF2;SH3RF1;RIPK1;AXIN1;CCL19;PRKN;SDCBP;DUSP22;NCOR1;MAPK8IP2
prerank,B cell activation involved in immune response (GO:0002312),0.5523683594618706,1.2374162799307356,0.23238095238095238,0.5227735476647887,1.0,2/13,2.01%,FCGR2B;LIG4
prerank,microglial cell activation (GO:0001774),0.4841318510279349,1.2373326201793833,0.2108843537414966,0.5223839853014635,1.0,5/21,6.94%,APP;C1QA;C5AR1;GRN;TNF
prerank,histone H3 acetylation (GO:0043966),-0.36939690377850715,-1.2373150594237146,0.13101604278074866,0.8020000460404786,1.0,9/40,11.07%,PHF14;LDB1;ING4;TADA1;WDR5;NAA60;SUPT7L;MBIP;BRCA2
prerank,regulation of ventricular cardiac muscle cell action potential (GO:0098911),-0.49345346788910327,-1.2372554584356383,0.22246696035242292,0.7994002645563159,1.0,3/12,11.72%,BIN1;CTNNA3;CACNA1C
prerank,response to copper ion (GO:0046688),-0.43317974790778874,-1.237199887948359,0.21052631578947367,0.7968497515701598,1.0,13/20,25.93%,IL1A;PRNP;HSF1;MT2A;ATP7B;MT1E;MT1F;MT1M;MT1G;MT1H;MT1A;MT1X;MT1B
prerank,sterol metabolic process (GO:0016125),0.3990796247910623,1.237144878859383,0.17404580152671756,0.5222478094848533,1.0,13/60,16.03%,APOE;PRKAG2;HMGCR;CLN6;CYP27A1;CYP26C1;PMVK;OSBPL1A;CYP26B1;LBR;CLN8;OSBPL5;CYP7B1
prerank,negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),0.5447066561328674,1.2371395176061797,0.21023765996343693,0.5216926156369331,1.0,6/14,14.80%,RHOA;ITGB1BP1;KLF4;STARD13;MMRN2;TBXA2R
prerank,intra-Golgi vesicle-mediated transport (GO:0006891),-0.3930080470993118,-1.236596352585983,0.1783783783783784,0.796428633070678,1.0,8/29,19.95%,RAB6B;TRAPPC3;COG3;VTI1B;NAPA;COG2;COPA;GOSR2
prerank,regulation of cytosolic calcium ion concentration (GO:0051480),0.35634892824338815,1.2365403506159658,0.13875,0.5224400731121882,1.0,27/142,14.90%,ATP2B1;CCR1;CMKLR1;C5AR1;ESR1;C3AR1;C1QTNF1;CYSLTR1;CD36;GHRL;PDGFRA;CCRL2;CXCR4;CCR2;ADRA1D;ADRA1A;PLN;PTGER4;TRPC7;YWHAE;SLC8B1;ATP2B4;FFAR1;SLC35G1;CD52;TBXA2R;ITPR3
prerank,protein insertion into mitochondrial membrane (GO:0051204),-0.4255584362718947,-1.2364016189928526,0.203125,0.7943622094577618,1.0,9/23,29.86%,HSPA4;BCL2L11;SAMM50;BMF;TIMM8B;TIMM29;AGK;PMAIP1;TIMM13
prerank,regulation of cell-cell adhesion (GO:0022407),-0.3697099159633537,-1.2362424006639017,0.14285714285714285,0.7921627700260968,1.0,11/39,12.61%,EFNA5;SMAD7;EPHA7;SRC;TENM3;FERMT3;CELSR2;AFDN;MINK1;PTPRG;ADAM8
prerank,body fluid secretion (GO:0007589),-0.4733823705445621,-1.2359723528810782,0.21040723981900453,0.7904772503521157,1.0,11/15,49.39%,ERBB4;SLC22A4;GUCA1B;NPR1;APLN;VEGFA;VIP;PRLR;OXTR;CSN3;SLC22A2
prerank,positive regulation of signal transduction (GO:0009967),0.3351287094377637,1.2355676269724178,0.1,0.5240227517692384,1.0,54/238,15.19%,RBPJ;NRP1;KLF2;SASH1;CLEC6A;GAS6;JAG1;RPS3;TSLP;BMP2;CD74;MYORG;C1QTNF12;ERN1;P2RY6;SLC2A4;ITGB1BP1;TLR2;GHRL;LY96;DISC1;TTC23;DEPDC1B;CD80;EPN2;PRKCB;CDC73;HOMER1;SULF2;GKAP1;ASXL1;POGLUT1;IGF1;SFRP1;MYO1C;WLS;TRIM16;MAML1;PDE6H;PHIP;CREBBP;STK36;SNX5;NOD2;CTBP2;CRLF2;STAT3;EP300;PRKD2;PKD2;SNW1;NECAB2;DSTYK;TXNDC15
prerank,regulation of reactive oxygen species biosynthetic process (GO:1903426),0.46617128501455485,1.23537064484933,0.1901639344262295,0.5239060731156421,1.0,8/26,17.95%,ALOX5;CD36;TLR4;PIKFYVE;CYBA;ABCB7;TRAP1;SLC5A3
prerank,positive regulation of developmental growth (GO:0048639),-0.35922028802442896,-1.2352038076420326,0.125,0.7905504040849088,1.0,15/49,21.82%,SEMA4D;RIMS1;RIMS2;ZFYVE27;MACF1;TWF2;BDNF;MAPT;PLCB1;LIMK1;CDKL5;SYT1;DBN1;CPNE5;SMURF1
prerank,osteoclast differentiation (GO:0030316),0.478188450474596,1.235153150662443,0.21035058430717862,0.5238596125043727,1.0,7/22,11.55%,FOXP1;DCSTAMP;TNFRSF11A;GLO1;ANXA2;MAPK14;SNX10
prerank,positive regulation of interferon-gamma production (GO:0032729),0.41228741702178057,1.2351323639732559,0.19306184012066366,0.5233388905808467,1.0,8/48,8.66%,TLR8;PTPN22;LILRB1;TLR4;PDE4D;CCR2;CEBPG;TRIM27
prerank,nuclear export (GO:0051168),-0.3217565870783672,-1.2350910403036863,0.1040268456375839,0.7882226606850794,1.0,37/80,32.48%,THOC1;SRRM1;SRSF5;NXF1;DDX39B;SRSF3;SRSF2;RANBP17;RANBP3L;RNPS1;U2AF1;UPF3B;CASC3;NCBP1;HNRNPA1;SRSF11;EGR2;THOC3;SRSF9;POLDIP3;ALYREF;U2AF2;SMURF1;TGFB1;RITA1;CSE1L;SRSF6;EIF4E;RANBP3;NUP214;CHP1;MALT1;NEMF;THOC7;U2AF1L4;STRADB;PKD1
prerank,positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),0.47522847376827304,1.234666163045195,0.2110912343470483,0.5237864465750138,1.0,7/21,16.92%,FOXP1;RPS3;BCL10;PRKCB;PRKD2;NFAM1;RELA
prerank,regulation of actin filament depolymerization (GO:0030834),-0.5038400613854911,-1.2339268764497648,0.19376391982182628,0.7896686932927411,1.0,5/12,21.99%,PLEKHH2;PLEK;LIMA1;SH3BP1;WDR1
prerank,sarcomere organization (GO:0045214),0.45710461845535866,1.2337298641573606,0.1983739837398374,0.5252574947772505,1.0,3/27,3.13%,MYH6;MYOM2;TNNT1
prerank,cellular response to low-density lipoprotein particle stimulus (GO:0071404),0.526221438222029,1.2334372403018115,0.22181146025878004,0.525337712303551,1.0,7/13,14.16%,LDLR;ITGB1;FCER1G;CD36;SYK;SREBF2;ITGB2
prerank,cell-cell junction organization (GO:0045216),-0.324312594822959,-1.2329509621324077,0.12237762237762238,0.7905224328177625,1.0,25/79,19.59%,CADM1;TJP1;CDH10;SDK1;CDH2;CDH13;TLN2;CDH8;TJP2;FLCN;CADM2;NECTIN2;CSF1R;AFDN;PKP4;TLN1;CDH9;CDH22;CTNND2;CXADR;MARVELD2;CDH4;ARVCF;TGFB2;GJC1
prerank,pyrimidine-containing compound catabolic process (GO:0072529),0.5128642088561944,1.2328640996729174,0.2198952879581152,0.5260578168344633,1.0,5/16,15.70%,DPYD;DPYSL2;CRMP1;TET2;DPYSL5
prerank,positive regulation of cell communication (GO:0010647),-0.3924447314326012,-1.2324644983032544,0.1618798955613577,0.7896771595240664,1.0,10/28,20.57%,RIMS1;GRIK2;PTPN23;RIMS2;DLG4;KCTD13;LGI1;RIMS3;SYT1;SOX11
prerank,neutrophil chemotaxis (GO:0030593),0.4128571403454243,1.2323359569353884,0.17682926829268292,0.5265803606806669,1.0,12/53,17.31%,PF4;FCER1G;CCL8;CCL19;PIKFYVE;SYK;CCL24;CKLF;ITGB2;PPIA;CCL5;CCL25
prerank,skeletal muscle organ development (GO:0060538),-0.4053402999007916,-1.2320394909908958,0.17518248175182483,0.7885738567649714,1.0,5/26,12.36%,LARGE1;BASP1;IGSF8;CFLAR;ZBTB18
prerank,positive regulation of lymphocyte migration (GO:2000403),0.5309757827248522,1.2317630136177538,0.2356115107913669,0.527310140672426,1.0,2/12,3.74%,APP;RHOA
prerank,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),-0.384021824395282,-1.2315435020936951,0.17079889807162535,0.7876632119487575,1.0,8/35,12.46%,CDH23;CDH10;NLGN1;CDH13;CDH8;CDH9;CDH22;ATP2C1
prerank,regulation of cellular component biogenesis (GO:0044087),0.425162150529074,1.231411015574816,0.19349845201238391,0.527500433233731,1.0,7/39,5.43%,APOE;RAP1B;CD36;CCL19;RAPGEF2;RAP1A;ROCK1
prerank,regulation of lysosomal lumen pH (GO:0035751),0.5272610999753543,1.2312975267756905,0.23551401869158878,0.5271802189580491,1.0,4/12,8.44%,GRN;CLN5;CLN6;TMEM165
prerank,cellular response to osmotic stress (GO:0071470),0.49016917099608404,1.2302945968198153,0.2231833910034602,0.5288297098593564,1.0,4/21,3.70%,OXSR1;RCSD1;LRRC8D;ZFP36L1
prerank,protein neddylation (GO:0045116),-0.5009519438628824,-1.230075117837196,0.22494432071269488,0.7902121244706398,1.0,7/13,33.61%,UBA3;RBX1;RNF7;DCUN1D2;DCUN1D5;DCUN1D3;DCUN1D4
prerank,defense response to Gram-positive bacterium (GO:0050830),0.4229090958815247,1.2297795153148383,0.19452449567723343,0.5294043797371354,1.0,9/40,11.65%,ANG;RPL39;LBP;TLR2;GBP7;DROSHA;RNASE6;ROMO1;CHGA
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),0.5495121552734537,1.2294336150174532,0.24,0.5295939220613956,1.0,3/11,6.34%,CD44;CD74;BCL2
prerank,negative regulation of amyloid fibril formation (GO:1905907),0.547732359854921,1.229240949218803,0.2239858906525573,0.5294402822008849,1.0,2/12,1.24%,APOE;LDLR
prerank,beta-catenin-TCF complex assembly (GO:1904837),0.44828242319276934,1.2289944058266749,0.21794871794871795,0.5294316192726646,1.0,14/29,23.65%,TCF7L2;TLE4;TCF7;CDC73;ASH2L;CREBBP;EP300;MYC;BCL9;TLE1;AXIN2;KAT5;TCF7L1;RBBP5
prerank,circulatory system development (GO:0072359),0.3637290860645227,1.228109952238552,0.15194805194805194,0.5307957328724128,1.0,23/118,14.70%,HDAC9;PDLIM5;FBXW7;MEF2A;CRIP1;MEF2C;OSR1;BMP2;ALPK3;HEY2;PDLIM1;KDM6A;CACYBP;NCOA6;FOXC2;CASP8;WDR11;RAMP2;POPDC3;BCOR;RBP4;SMYD4;PKD2
prerank,protein autoubiquitination (GO:0051865),0.3974372750633245,1.2280144743628496,0.17062314540059348,0.5304507282545565,1.0,23/61,18.57%,SH3RF1;PRKN;RNF141;TRIM68;MDM2;RNF19B;UBE2D3;UHRF2;CUL3;AMFR;RNF185;TRIM71;RNF115;RNF187;BFAR;KLHL24;RNF122;ASB4;RNF41;RNF146;UBE2A;CNOT4;TRAF6
prerank,negative regulation of cellular metabolic process (GO:0031324),0.42466641062158283,1.2276066118946276,0.18298555377207062,0.5307801201944209,1.0,6/37,8.14%,EDNRB;APOE;UGT1A8;PRKN;SDCBP;NCOR1
prerank,lipoprotein transport (GO:0042953),0.5613327108369411,1.22759222090447,0.2345679012345679,0.5302580492286779,1.0,7/10,27.87%,CD36;PRKCB;MIA3;UNC119;VMP1;PPARG;ZDHHC17
prerank,ruffle organization (GO:0031529),-0.4544005772772729,-1.2272671721653163,0.1943231441048035,0.7977939349474473,1.0,8/16,24.46%,PLEKHA1;CSF1R;AIF1;ARF6;PLEK;LIMA1;CORO1B;TPM1
prerank,regulation of urine volume (GO:0035809),0.553311874398134,1.2270045280496304,0.23529411764705882,0.5310456178982651,1.0,2/10,4.47%,ADM;NPR3
prerank,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),-0.4249015866955779,-1.2267977500593192,0.18493150684931506,0.7969384772535465,1.0,5/22,9.42%,MVB12B;PTPN23;SNF8;TOM1L1;VPS37A
prerank,cellular response to oxidative stress (GO:0034599),0.3617278911669369,1.225879090642214,0.1588310038119441,0.5329725077778279,1.0,31/118,17.04%,EGFR;CYBB;FER;RPS3;DAPK1;HMOX1;CAMKK2;PTPRK;PDGFRA;SLC25A24;VRK2;MSRA;RAD52;CYCS;TXNRD2;PXN;NCF2;ROMO1;FOXO3;RBM11;ZC3H12A;ERO1A;AGAP3;FOXO1;CYBA;PKD2;PPIA;NOX4;ARNT;PRDX3;PRDX2
prerank,water transport (GO:0006833),-0.48837604008740754,-1.2255945047600554,0.22294372294372294,0.7987029951445211,1.0,5/12,47.18%,PDPN;CFTR;AQP4;AQP1;SLC5A1
prerank,peptidyl-tyrosine modification (GO:0018212),0.40377721101079106,1.2247896163091598,0.1880466472303207,0.5348359096315396,1.0,12/56,9.25%,EGFR;FGFR1;LYN;FER;ABI1;INSR;PDGFRA;SYK;ZAP70;FYN;DDR2;DYRK1A
prerank,negative regulation of axon extension (GO:0030517),-0.40503588683204383,-1.2247005326414033,0.17962466487935658,0.799289590089853,1.0,7/30,9.72%,MAP2;SEMA4D;PTPRS;SEMA4C;DIP2B;SEMA4G;MAG
prerank,secretion (GO:0046903),-0.4772328422401012,-1.2241063270875736,0.21443298969072164,0.798850497757961,1.0,7/14,33.65%,RIMS1;TPD52;SLC22A4;PRKCI;GUCA1B;NPR1;FBLN5
prerank,ribonucleoprotein complex biogenesis (GO:0022613),0.3984845919482177,1.2239485763404752,0.18468468468468469,0.5361518992599503,1.0,14/57,10.33%,RPS16;RPS15;RPL26;RPS28;RPS24;LTV1;RPL35A;RPL38;RPS17;RPL5;MALSU1;RPL14;RPS7;RPS6
prerank,negative regulation of leukocyte mediated cytotoxicity (GO:0001911),0.5695698426698939,1.223650374053643,0.23333333333333334,0.5362236317467671,1.0,2/10,2.74%,FCGR2B;LILRB1
prerank,positive regulation of leukocyte chemotaxis (GO:0002690),0.4071219655339087,1.2232019050115628,0.1787878787878788,0.5366363017689009,1.0,7/51,8.25%,CCR1;CMKLR1;GAS6;ANO6;PLA2G7;CCR2;IL6R
prerank,import into cell (GO:0098657),-0.36948981394656677,-1.2224883377018683,0.16758241758241757,0.8022750006589179,1.0,13/41,23.77%,SLC1A3;TREM2;IL10RA;SLC36A1;SNAP25;SLC11A2;SLC7A8;SLC12A6;SLC39A14;LRSAM1;SLC12A4;SLC22A4;SLC27A1
prerank,organelle fission (GO:0048285),0.47521075805601687,1.2224775716043048,0.22145328719723184,0.5376614293643394,1.0,2/24,4.00%,TMCC1;PRKN
prerank,antigen receptor-mediated signaling pathway (GO:0050851),0.34454742167149843,1.2223358433092342,0.13607990012484394,0.5374188896310192,1.0,34/163,14.81%,VAV3;CD38;PTPRJ;PSMA7;MEF2C;PTPN22;DENND1B;NFKBIZ;RFTN1;BCL10;THEMIS2;PAK2;RC3H1;PDE4D;WNK1;BCL2;SYK;SPG21;ZAP70;PSMB2;PRKCB;FYN;NFATC2;RIPK2;EIF2B1;PSMA6;ZC3H12A;UBE2N;FYB1;PSMA3;PSMD1;PSMD5;PRKD2;NFAM1
prerank,response to alcohol (GO:0097305),-0.39435308448590134,-1.2220996413027014,0.17480719794344474,0.8010960248014041,1.0,7/27,13.47%,TGFBR1;GRIN3A;TGFBR3;CCL3;GRIN2A;GLRA1;TGFBR2
prerank,regulation of vacuole organization (GO:0044088),0.49185906061223417,1.2220973927276324,0.23539518900343642,0.5373875571957839,1.0,6/20,6.05%,MTM1;MTMR3;NPRL3;TBC1D14;ANXA2;PIKFYVE
prerank,response to laminar fluid shear stress (GO:0034616),0.5631596650146506,1.221950482720004,0.24493554327808473,0.5371435782275797,1.0,5/10,16.14%,KLF2;KLF4;ASS1;SREBF2;MAPK7
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),0.506814245188542,1.221450146448491,0.21908127208480566,0.5377189187353257,1.0,3/16,5.88%,TPT1;RPS3;TRIM32
prerank,regulation of neuroinflammatory response (GO:0150077),0.5000396484961112,1.2210453323498391,0.24168126094570927,0.5380174482588781,1.0,6/19,9.90%,NUPR1;TNFRSF1B;NR1D1;CD200R1;TNF;IGF1
prerank,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),0.3835242154056151,1.2209489762268844,0.1793478260869565,0.5376636636714524,1.0,11/73,12.69%,HIP1;NLRC4;IFT57;XDH;RIPK1;RACK1;TNF;CYCS;CASP8;DIABLO;FAM162A
prerank,granulocyte chemotaxis (GO:0071621),0.4039379479826014,1.2205932086502131,0.19126506024096385,0.5378906526381336,1.0,7/55,8.22%,PF4;FCER1G;CCL8;CCL19;PIKFYVE;SYK;CCL24
prerank,negative regulation of homotypic cell-cell adhesion (GO:0034111),-0.5319152278771105,-1.22054739236086,0.22633744855967078,0.8039862830505161,1.0,4/10,6.57%,CD9;PRKCD;SERPINE2;RDX
prerank,inhibitory synapse assembly (GO:1904862),-0.5128940058496584,-1.2203792898224635,0.2311111111111111,0.8019685675311771,1.0,7/11,28.04%,GABRB3;FGF13;GABRA2;GABRG2;WNT5A;PLXNB1;CBLN4
prerank,regulation of macrophage chemotaxis (GO:0010758),-0.42598820553240224,-1.2199676304829996,0.20941176470588235,0.8009115552070905,1.0,7/21,11.84%,PTK2B;CSF1;MAPK3;AKIRIN1;CSF1R;MTUS1;MIF
prerank,response to estradiol (GO:0032355),0.4394155506840097,1.2192128793747907,0.2079207920792079,0.5403629282481285,1.0,6/31,10.04%,EGFR;ESR1;NCOA3;NRIP1;LCOR;SFRP1
prerank,positive regulation of reproductive process (GO:2000243),-0.3861386384285695,-1.219152406866487,0.16923076923076924,0.8014202324816199,1.0,8/31,15.95%,LHFPL2;SIRT2;TACR3;PLCB1;PDE3A;GLRA1;C1QBP;ACVR1B
prerank,heart looping (GO:0001947),-0.3610407720730416,-1.2190101477455686,0.18157894736842106,0.7994075190009735,1.0,16/39,23.61%,NDRG4;AHI1;BBS7;CCDC39;TBX6;VANGL2;TGFBR2;SMO;MICAL2;NOTCH1;SRF;ENG;BBS4;MKKS;CCDC40;STIL
prerank,response to organonitrogen compound (GO:0010243),0.42256087402270964,1.2189039869737046,0.21428571428571427,0.5405446055489159,1.0,12/38,19.01%,IRAK3;NR1H4;RCN3;PRKN;RHBDD1;TRPM2;RNF185;MEAK7;KAT7;IL6;RRAGC;RNF139
prerank,dermatan sulfate metabolic process (GO:0030205),0.5348936522496408,1.2187339331883058,0.24293785310734464,0.5403544143901305,1.0,3/13,6.70%,DSE;UST;CHST12
prerank,regulation of chondrocyte differentiation (GO:0032330),0.455026056791961,1.2186685608300654,0.21621621621621623,0.5399525513866323,1.0,2/24,1.22%,TRPS1;ZBTB16
prerank,RNA export from nucleus (GO:0006405),-0.3019699875155299,-1.218648939745708,0.10069444444444445,0.7981921580960089,1.0,37/100,26.63%,THOC1;SRRM1;SRSF5;HNRNPA2B1;NXF1;DDX39B;SRSF3;NUP210;RANBP2;SRSF2;UPF1;RNPS1;NUP85;U2AF1;MCM3AP;UPF3B;CASC3;NCBP1;SEH1L;HNRNPA1;NXT1;SRSF11;THOC3;SRSF9;AAAS;SEC13;POLDIP3;GLE1;ALYREF;U2AF2;ALKBH5;SLBP;SRSF6;NDC1;EIF4E;NUP93;NUP50
prerank,production of small RNA involved in gene silencing by RNA (GO:0070918),0.48036149407028617,1.2185117495043063,0.23861566484517305,0.5397490169769157,1.0,5/20,13.29%,PRKRA;PUM2;DROSHA;TRIM71;MRPL44
prerank,nucleoside phosphate biosynthetic process (GO:1901293),0.5367049184524134,1.217842942515364,0.25585585585585585,0.5406911153649513,1.0,7/14,20.58%,CMPK1;NMNAT3;NMNAT2;AK8;AK3;AK4;ME1
prerank,negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),0.5498743896871165,1.2173963989240504,0.24105461393596986,0.541073023634101,1.0,6/12,17.66%,ESR1;TNF;NCOR1;ZC3H12A;STAT3;IL6
prerank,regulation of autophagosome assembly (GO:2000785),0.4370537423773849,1.2173340542095687,0.21958925750394945,0.5406599726318473,1.0,8/33,8.89%,NUPR1;MTM1;MTMR3;NPRL3;FEZ2;TBC1D14;PIKFYVE;SMCR8
prerank,cortical actin cytoskeleton organization (GO:0030866),-0.4360945343666778,-1.2170538632965564,0.1778846153846154,0.8014368663084588,1.0,10/20,16.91%,NCKAP1;FMNL2;RHOQ;NCKAP1L;FHOD1;LLGL1;STRIP1;LLGL2;ARF6;PLEK
prerank,cellular response to copper ion (GO:0071280),-0.45912780394077113,-1.2169800371294108,0.2182254196642686,0.7990977092613338,1.0,11/16,25.93%,PRNP;HSF1;MT2A;MT1E;MT1F;MT1M;MT1G;MT1H;MT1A;MT1X;MT1B
prerank,negative regulation of stem cell differentiation (GO:2000737),0.532487056622975,1.2165025467792123,0.24314442413162707,0.5419916264332827,1.0,3/12,8.59%,ZFP36L2;JAG1;ESRRB
prerank,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),-0.3970756813252723,-1.2161761305049623,0.17010309278350516,0.7995051839901776,1.0,8/27,9.75%,FGR;PTK2B;FGF2;FLT1;PIK3R4;P2RY12;AGAP2;FLT3
prerank,positive regulation of heart contraction (GO:0045823),0.49254658219094627,1.2157325372136127,0.22807017543859648,0.5431262586994848,1.0,6/19,14.25%,ADM;ADRA1A;CHGA;KCNQ1;SCN3B;ATP2A2
prerank,response to calcium ion (GO:0051592),0.3691840433320509,1.2156950195646916,0.18791064388961892,0.5426619320498757,1.0,16/102,8.32%,CHP2;IQGAP1;PPP3CA;MEF2A;ALOX15;MEF2C;ALOX5AP;ADAM9;KCNMB1;CPNE2;CLIC4;CPNE7;SLC25A24;CPNE8;STIM1;HOMER1
prerank,cell junction assembly (GO:0034329),-0.30059247723663746,-1.2152382916843842,0.11923076923076924,0.8003211862712871,1.0,23/100,13.83%,TJP1;FBLIM1;DNM3;ADGRL3;CDH10;SDK1;NLGN1;ITGA6;CDH2;NRXN1;TLN2;FARP1;FERMT2;CDH8;FLCN;BDNF;SHANK2;PKP4;TLN1;CDH9;CDH22;CTNND2;SPOCK2
prerank,regulation of leukocyte cell-cell adhesion (GO:1903037),0.5323995354867113,1.2149035537583175,0.24035087719298245,0.543863671920125,1.0,5/12,16.59%,FUT4;WNK1;ASS1;MDK;MIA3
prerank,central nervous system development (GO:0007417),-0.2691350703354974,-1.2147292168912167,0.04285714285714286,0.799613436220666,1.0,86/250,20.71%,CX3CR1;MBP;CHD7;NCKAP1;ADGRL3;MOG;ROBO2;EPHA7;ZFHX3;CNTNAP2;CDH2;PBX2;ELP3;BPTF;PITPNM1;AFF2;AATK;NDRG4;APOD;NF1;CIC;JRKL;CNTN4;SYNJ2;CNTN6;LOXL3;AHI1;RNF103;SERPINI1;BAG6;PPT1;MAL;RAB18;S100B;UTP3;GBA2;ZFHX2;ADAM22;MEIS3;SHROOM2;TBX6;GRIN2A;SPOCK1;TPPP;NKX2-2;SOX10;SMARCA1;PAX8;ALDH5A1;NPTX1;PROX1;EML1;CTNS;MEIS1;ANKLE2;TGFBR2;DSCAML1;EEF1AKMT4-ECE2;ZIC1;POU6F1;SHROOM4;MARCKS;CDK5RAP3;SMG9;TBC1D23;DCLK1;DNAJC30;ADGRL2;VCAN;SMO;VIT;BCAN;SH3GL2;EGR2;TPP1;PBX1;ZIC4;PTPN11;NCAN;PLXNB2;PAFAH1B3;ROGDI;HAP1;NNAT;SOX11;CDK5RAP1
prerank,regulation of T cell cytokine production (GO:0002724),0.5123620276369603,1.2147178115996837,0.2462962962962963,0.5437147145106987,1.0,4/15,7.63%,TNFRSF1B;B2M;CCR2;HFE
prerank,cellular response to interleukin-4 (GO:0071353),0.5428869445423952,1.2146613642793738,0.2514395393474088,0.5432840051358754,1.0,4/10,17.28%,DCSTAMP;TCF7;STAT6;XBP1
prerank,neurotransmitter uptake (GO:0001504),-0.49991615034656656,-1.214553774422139,0.23673469387755103,0.7977041895522234,1.0,2/12,2.74%,SLC1A3;SNAP25
prerank,negative regulation of bone mineralization (GO:0030502),0.5356510740874908,1.2144304078260044,0.24299065420560748,0.5432790098576795,1.0,7/13,19.31%,CCR1;FGF23;SRGN;RFLNB;BCOR;ECM1;ENPP1
prerank,positive regulation of cellular process (GO:0048522),0.31299740707826706,1.2140226300693528,0.07635983263598327,0.5436755181389915,1.0,76/565,10.33%,FOLR2;FCGR2B;EGFR;LRP6;P2RX7;LIFR;FGFR1;LILRA5;PTPRJ;COLEC12;CHP2;PPP3CA;IL15;KIF20B;DOCK2;GAS6;NUPR1;RPL23;LYN;GRK5;BST1;FER;TSLP;KRAS;TNFRSF1B;KITLG;FCER1G;CD36;FGF23;WNT2;TLR4;GRN;ANKRD17;CDC42;THPO;CAMK1D;DNPH1;ZFP36L1;RPS6KA3;ITGB1BP1;LBP;TNFRSF11A;TLR2;IRS2;INSR;S1PR2;PDGFRA;ACER3;TRIM32;BCL2;RPS4X;CHEK1;FOXM1;RPS15A;SDCBP;TNF;MTPN;TIPIN;CXCL16;IL6R;RPS9;ADRA1D;ASH2L;TSPYL5;MDM2;PDGFC;CCND2;CACUL1;CUL3;H3-3A;IGF1;SFRP1;RIPK2;TSHR;SLC25A5;RPS6
prerank,response to glucagon (GO:0033762),-0.4439809229324499,-1.2135566642513067,0.22794117647058823,0.7989644326251716,1.0,5/19,10.16%,ADCY3;ADCY8;PRKAR1A;PRKAR1B;ADCY7
prerank,response to ethanol (GO:0045471),-0.47548330366271085,-1.213281072072409,0.2264957264957265,0.7974612838130801,1.0,4/14,12.64%,GRIN3A;ADCY7;GRIN2A;GLRA1
prerank,regulation of microtubule cytoskeleton organization (GO:0070507),-0.36970067496686976,-1.2129337952479056,0.17759562841530055,0.7962613671722703,1.0,13/37,13.34%,EFNA5;CYLD;CLASP2;MAPT;BICD2;MAP6;MAPRE3;STMN3;PHLDB1;TPPP;STMN4;MAPRE1;EPHA3
prerank,fatty acid metabolic process (GO:0006631),0.36092791801359086,1.2126575403888205,0.16601307189542483,0.5461137041822139,1.0,10/115,5.81%,AOAH;ALOX5;LTC4S;ALOX15;CD36;ALOX5AP;UGT1A8;PNPLA8;SGPL1;ADIPOR2
prerank,branching involved in blood vessel morphogenesis (GO:0001569),0.52232227522869,1.2124292793682052,0.25688073394495414,0.5460525001562927,1.0,2/13,4.22%,NRP1;NRARP
prerank,acyl-CoA biosynthetic process (GO:0071616),-0.45118709435685733,-1.212364094203215,0.20134228187919462,0.7957984116249656,1.0,9/16,33.44%,ACACA;DIP2A;ACSS1;PPT1;SCD;SLC25A1;GCDH;CBR4;PPCS
prerank,regulation of hormone secretion (GO:0046883),0.4912279776955957,1.2122271884063003,0.2351851851851852,0.5459239831773991,1.0,2/15,3.30%,FGF23;SNX6
prerank,ganglioside metabolic process (GO:0001573),-0.43534288249005504,-1.2120706474107747,0.1990632318501171,0.7943715095090342,1.0,5/20,7.53%,HEXB;ST3GAL5;ST6GALNAC3;NEU1;ST6GALNAC4
prerank,cardiac right ventricle morphogenesis (GO:0003215),0.5429255753397867,1.2120195020486657,0.2514177693761815,0.5458239780391619,1.0,2/11,4.49%,JAG1;HEY2
prerank,cellular response to mechanical stimulus (GO:0071260),0.40906497436129413,1.2118593121011094,0.19969512195121952,0.5456058565670427,1.0,12/46,12.88%,TLR8;TLR4;MAP3K1;BCL10;PDE2A;CD40;CNN2;CHEK1;PTGER4;CASP8;KCNK4;TNFRSF1A
prerank,muscle cell migration (GO:0014812),0.5666179693470289,1.2116381990722098,0.24904214559386972,0.5455410759931559,1.0,3/10,5.43%,THBS4;ITGB1BP1;ROCK1
prerank,positive regulation of mitotic sister chromatid separation (GO:1901970),0.5403674011237181,1.2113665429242928,0.24682395644283123,0.5445183016708562,1.0,4/12,9.68%,RB1;CDC27;NSMCE2;CUL3
prerank,positive regulation of mitotic metaphase/anaphase transition (GO:0045842),0.5403674011237181,1.2113665429242928,0.24682395644283123,0.5445183016708562,1.0,4/12,9.68%,RB1;CDC27;NSMCE2;CUL3
prerank,positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),0.5403674011237181,1.2113665429242928,0.24682395644283123,0.5445183016708562,1.0,4/12,9.68%,RB1;CDC27;NSMCE2;CUL3
prerank,positive regulation of cytokine-mediated signaling pathway (GO:0001961),0.4247207801517694,1.2110641676396419,0.2082018927444795,0.5446255216293374,1.0,8/36,9.00%,GAS6;TSLP;RIPK1;PARP14;CD74;PRKN;CXCR4;UBE2K
prerank,purine nucleoside monophosphate biosynthetic process (GO:0009127),0.5438038318016245,1.2102605230322456,0.26126126126126126,0.5459225978433396,1.0,6/12,21.17%,ADSS2;LHPP;IMPDH2;ADSS1;GMPS;PAICS
prerank,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),-0.4285803973214818,-1.2102525660392136,0.22037914691943128,0.7983547537669531,1.0,7/21,21.06%,CALM2;SLC8A1;ANK2;AKAP6;CACNA1C;CAMK2D;CALM3
prerank,positive regulation of chromatin organization (GO:1905269),0.5377175374138085,1.2101892216700967,0.2390057361376673,0.545522676140145,1.0,6/12,14.26%,MIER1;ATRX;H3-3A;TERF2IP;UBE2N;TERF1
prerank,neuron projection extension (GO:1990138),0.4463739713405702,1.2097959355503602,0.23278688524590163,0.5458008486608084,1.0,6/32,8.15%,NRP1;IQGAP1;TNN;USP9X;ALCAM;ULK2
prerank,negative regulation of protein kinase activity (GO:0006469),0.3785553041748721,1.2092464491379478,0.19701086956521738,0.5465194979064429,1.0,15/88,9.55%,LRP6;GNAQ;SPRED1;DEPTOR;PRKAG2;SH3BP5;ITGB1BP1;RB1;PAK2;SFN;CEP85;HSPB1;TRIM27;SMCR8;CORO1C
prerank,reverse cholesterol transport (GO:0043691),0.5238976458587341,1.2086175464545523,0.2514395393474088,0.5474064964035388,1.0,1/13,0.49%,APOE
prerank,positive regulation of brown fat cell differentiation (GO:0090336),0.5377643650772788,1.2086037865939991,0.24319419237749546,0.5468853804765642,1.0,3/13,8.05%,RREB1;METRNL;VSTM2A
prerank,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),0.3800363939586228,1.2081961903799117,0.18655692729766804,0.5471696573421223,1.0,14/74,11.15%,PF4;TCF7L2;SH3RF1;RIPK1;SIAH2;HMOX1;MCL1;GSK3B;BCL2;TNF;BIRC6;IGF1;CASP8;PHIP
prerank,neuropeptide signaling pathway (GO:0007218),-0.32721328225608776,-1.2081192144917055,0.140625,0.8033836763746012,1.0,13/58,18.46%,SORL1;SORT1;SORCS1;HCRTR2;GLRB;ADCYAP1;SORCS3;GPR84;GLRA1;PENK;GLRA3;CPE;GPR149
prerank,positive regulation of cell projection organization (GO:0031346),-0.29562773427791833,-1.2081040929094078,0.0975609756097561,0.8009450321217334,1.0,31/115,13.34%,CUX1;PTK2B;PTPRD;SETX;ITGA6;ROBO2;SCN1B;MAGI2;DLG4;TENM3;PLXNA2;ATP1B2;SS18L1;NDRG4;SCARB2;ROBO1;DVL1;NTRK3;TWF2;BDNF;SERPINI1;MAP6;TIAM1;CAPRIN1;TIAM2;SS18L2;DVL2;IL1RAPL1;RAPGEF1;NDNF;EPHA3
prerank,sphingolipid metabolic process (GO:0006665),-0.30059699338562473,-1.2077362572025816,0.12396694214876033,0.7997919163984278,1.0,35/108,21.21%,HEXB;CERK;ENPP2;ST6GALNAC3;SPNS2;SMPD4;PPM1L;PLPP3;ESYT1;NSMAF;NEU1;ASAH1;PPT1;ASAH2;CERS4;SAMD8;ESYT2;GBA2;DEGS1;TECR;CERS5;ACER2;CERS1;CERKL;PSAP;SERINC1;SGMS2;SPTLC1;SMPD2;CERS2;ABCA2;ARV1;PLPP2;KDSR;ARSA
prerank,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),-0.3020245305240097,-1.206697173678861,0.10652920962199312,0.8009160344073407,1.0,36/96,26.63%,THOC1;SRRM1;SRSF5;HNRNPA2B1;NXF1;DDX39B;SRSF3;NUP210;RANBP2;SRSF2;UPF1;RNPS1;NUP85;U2AF1;MCM3AP;UPF3B;CASC3;NCBP1;SEH1L;NXT1;SRSF11;THOC3;SRSF9;AAAS;SEC13;POLDIP3;GLE1;ALYREF;U2AF2;ALKBH5;SLBP;SRSF6;NDC1;EIF4E;NUP93;NUP50
prerank,protein localization to Golgi apparatus (GO:0034067),-0.39380646578782597,-1.2061685845922163,0.20533333333333334,0.8003054447288089,1.0,6/27,8.04%,SORL1;ARL5C;OPTN;GCC2;BICD2;IFT20
prerank,iron ion homeostasis (GO:0055072),0.39359707849815184,1.2053813606198085,0.20321637426900585,0.5526646364545573,1.0,21/58,18.51%,CP;HMOX1;B2M;FTL;NDFIP1;SMAD4;FBXL5;GLRX3;HFE;HMOX2;ATP6V1A;ACO1;NUBP1;FTH1;TFR2;ABCB7;MYC;ATP6V0D1;NEO1;PICALM;SCARA5
prerank,muscle filament sliding (GO:0030049),0.431669109110075,1.2053316455383534,0.21528861154446177,0.55166526217625,1.0,7/38,15.26%,TMOD1;MYH6;TNNT1;VIM;NEB;TPM3;MYBPC3
prerank,actin-myosin filament sliding (GO:0033275),0.431669109110075,1.2053316455383534,0.21528861154446177,0.55166526217625,1.0,7/38,15.26%,TMOD1;MYH6;TNNT1;VIM;NEB;TPM3;MYBPC3
prerank,negative regulation of nucleocytoplasmic transport (GO:0046823),0.5156638429061849,1.2048741013951934,0.2395644283121597,0.5521327160768262,1.0,5/13,16.84%,MDFIC;RAB23;SP100;UFM1;NUP153
prerank,negative regulation of macrophage derived foam cell differentiation (GO:0010745),-0.4900434862155783,-1.2046845180670773,0.23851203501094093,0.8031544901676423,1.0,5/12,24.35%,ABCG1;ITGB3;ITGAV;ABCA1;ABCA5
prerank,lymphocyte mediated immunity (GO:0002449),0.5465289492102963,1.2046556307211238,0.26968503937007876,0.5520955535323064,1.0,2/12,3.41%,JAG1;CD46
prerank,negative regulation of endocytosis (GO:0045806),0.4614836396950711,1.2045035796145143,0.23051409618573798,0.5518814970855256,1.0,5/24,13.67%,MCTP1;LILRB1;SNX33;RUBCN;NR1H2
prerank,establishment of protein localization to membrane (GO:0090150),0.3851850453849359,1.2042701101575155,0.1941340782122905,0.5518318776741831,1.0,18/66,15.73%,EGFR;RAB10;RFTN1;PIKFYVE;ZDHHC14;SDCBP;ZDHHC3;VPS37C;SEC63;MYO1C;CHM;RAB11A;ZDHHC24;RABGEF1;SYNE3;ZDHHC20;ICMT;ZDHHC2
prerank,cell projection assembly (GO:0030031),-0.40951274280784417,-1.203343991956749,0.19154228855721392,0.805483648908914,1.0,8/22,19.29%,NCKAP1;NEFH;RHOQ;NCKAP1L;RHOH;PARVG;PDGFA;RHOG
prerank,positive regulation of cation transmembrane transport (GO:1904064),-0.35142868752506856,-1.2032393503476835,0.17080745341614906,0.8033750326732783,1.0,7/41,8.73%,KCNMA1;KCNJ2;NOS1AP;ANK2;CTSS;AKAP6;ACTN2
prerank,positive regulation of protein exit from endoplasmic reticulum (GO:0070863),-0.47657388116832805,-1.2031079816347392,0.24770642201834864,0.8014608048165669,1.0,5/13,24.66%,SORL1;EDEM1;BCAP31;CD81;TM9SF4
prerank,positive regulation of hydrolase activity (GO:0051345),0.3469454309966671,1.2027799781912205,0.17639593908629442,0.5545624731360818,1.0,22/137,6.13%,CHP2;SNX9;ARAP1;ITGB1;MAPRE2;EVI5;RPS3;RCN3;USP6NL;BMP2;CCL8;CCL19;RHOA;RAPGEF2;S100A10;RIC1;GSK3B;RAP1A;RACK1;DOCK11;RGS8;CD40
prerank,negative regulation of interleukin-17 production (GO:0032700),-0.5150015816686078,-1.2026020203003704,0.2402464065708419,0.8008897287788178,1.0,4/10,9.18%,VSIR;NCKAP1L;PRNP;DDIT3
prerank,regulation of activin receptor signaling pathway (GO:0032925),-0.4620709660970809,-1.2025166430722953,0.22929936305732485,0.7988006284271317,1.0,3/15,4.58%,SMAD7;MAGI2;ACVR1
prerank,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",-0.3104006240725705,-1.202495280557066,0.14930555555555555,0.7964884285722329,1.0,24/80,20.46%,RAB6B;PLPP3;ARF5;STX18;COG3;KIF5A;BICD2;ATP9A;CENPE;COG4;SURF4;NAPA;ERGIC3;KIF1C;KIF3A;KIF11;KIF15;KIF3B;USE1;KIF2A;TMED7;COPA;DNAJC28;ZW10
prerank,calcium ion homeostasis (GO:0055074),0.3649043955136037,1.2024121514402537,0.18543046357615894,0.5548015299727802,1.0,16/95,12.32%,ATP2B1;CCR1;TPT1;STIM2;CCL8;ATP6V1B1;CCL19;CD40;FAM20A;STIM1;CCR2;TMEM165;SLC10A7;WFS1;SLC8B1;ATP2B4
prerank,positive regulation of calcium ion transmembrane transporter activity (GO:1901021),-0.41941728587776844,-1.2022629918194263,0.20665083135391923,0.7949132259570758,1.0,10/22,23.17%,CALM2;ATP1B1;ANK2;AKAP6;STAC2;SLC9A1;STAC;HAP1;CALM3;STAC3
prerank,regulation of cytoplasmic transport (GO:1903649),-0.5173818957879257,-1.201990219727763,0.24324324324324326,0.7934421348225718,1.0,5/11,20.73%,SRC;MAPK3;ATP9A;MAP2K2;CHMP3
prerank,negative regulation of receptor internalization (GO:0002091),-0.496941553162623,-1.2018507069991764,0.2330508474576271,0.7916176999152809,1.0,6/12,19.61%,RIN3;DLG4;ANKRD13B;ANKRD13D;ATXN2;ANKRD13A
prerank,natural killer cell mediated immunity (GO:0002228),-0.45696471891617574,-1.2017102701138482,0.24660633484162897,0.7898197562659568,1.0,2/15,0.68%,LYST;PLEKHM2
prerank,endoplasmic reticulum membrane organization (GO:0090158),0.5588455119960908,1.20165595961081,0.26779026217228463,0.5559055203034695,1.0,3/11,9.90%,ATL1;VCPIP1;RTN4
prerank,cytoplasmic microtubule organization (GO:0031122),-0.3457975111721834,-1.2013658588207476,0.18484848484848485,0.7887966364659933,1.0,20/54,20.58%,DST;CCDC88B;DYNC1H1;CAMSAP1;FIGN;CLIP2;CRIPT;MAPT;TUBGCP5;PLK3;STMN3;TPPP;NUMA1;TUBGCP3;CLIP3;LIMK2;WDR73;FSD1;TUBGCP6;CLIP4
prerank,negative regulation of proteasomal protein catabolic process (GO:1901799),0.4244853339728612,1.2008323895291422,0.22532894736842105,0.5572608575494323,1.0,12/36,16.01%,OPHN1;RYBP;LAMP3;WAC;NOP53;SDCBP;HFE;EIF3H;RPL11;PRKCG;USP25;HSP90AB1
prerank,nuclear body organization (GO:0030575),-0.4913901222459256,-1.2007351823132477,0.2555066079295154,0.7886559291856609,1.0,5/12,11.35%,AFF2;ETS1;USP50;HABP4;SRPK2
prerank,regulation of MAP kinase activity (GO:0043405),0.3658472734027797,1.2005811613599322,0.1865771812080537,0.5572421992336203,1.0,13/92,9.45%,EGFR;APOE;FGFR1;PTPRJ;LYN;IRAK3;CDK12;DUSP1;CD40;PIK3R6;TNF;SH2B3;PDGFC
prerank,positive regulation of potassium ion transmembrane transport (GO:1901381),-0.34716840662888626,-1.1989419622665591,0.16224188790560473,0.7926155008692934,1.0,9/44,9.41%,KCNMA1;KCNJ2;ATP1B1;NOS1AP;ATP1B2;ANK2;AKAP6;ACTN2;WNK3
prerank,regulation of cell-matrix adhesion (GO:0001952),0.3928207297017557,1.1980987646357388,0.2076271186440678,0.5620819715995171,1.0,18/64,11.99%,PEAK1;CASK;BST1;JAG1;RASA1;CD36;RHOA;UTRN;CDK6;GSK3B;ROCK1;PTPRA;VCL;CLASP1;CORO1C;SFRP1;JUP;ROCK2
prerank,protein polymerization (GO:0051258),0.4018716544291846,1.196615416717391,0.19626168224299065,0.5648709139316744,1.0,6/55,4.00%,PSTPIP2;DIAPH1;GAS7;PSTPIP1;ANG;PRKN
prerank,Rac protein signal transduction (GO:0016601),0.4888791194671437,1.196206957767658,0.2581227436823105,0.5652273089385417,1.0,1/18,0.09%,EPS8
prerank,regulation of neutrophil migration (GO:1902622),0.5562727502078564,1.1960243893555453,0.27599243856332706,0.565084769487206,1.0,2/10,1.79%,MPP1;BST1
prerank,mitotic cell cycle checkpoint signaling (GO:0007093),-0.4134556911444868,-1.1955094224594855,0.22327790973871733,0.8021647513471918,1.0,12/23,28.33%,INTS3;WEE1;PLK3;BUB1B;BUB1;PABIR1;CDK5RAP3;ZFYVE19;ZW10;ZWINT;AURKB;CHMP4C
prerank,cellular response to interleukin-6 (GO:0071354),0.44126447711960043,1.1950487094115174,0.22508591065292097,0.5667120288559236,1.0,5/26,5.19%,PID1;FER;CBL;SPI1;SMAD4
prerank,regulation of interferon-beta production (GO:0032648),0.3998330756249181,1.1948717477408222,0.22767857142857142,0.5665609364449471,1.0,10/46,7.46%,TLR8;OAS2;LILRB1;TLR4;TLR2;TRIM56;RIOK3;PPM1B;YY1;REL
prerank,response to leucine (GO:0043201),-0.5110461965370837,-1.1945820621379553,0.23505154639175257,0.8006368138206502,1.0,4/10,5.88%,RPTOR;UBR1;RRAGD;SESN3
prerank,cellular response to leucine (GO:0071233),-0.5110461965370837,-1.1945820621379553,0.23505154639175257,0.8006368138206502,1.0,4/10,5.88%,RPTOR;UBR1;RRAGD;SESN3
prerank,regulation of autophagosome maturation (GO:1901096),0.5375352335044645,1.1943653989058907,0.28703703703703703,0.5671489748579325,1.0,5/13,13.46%,ADRB2;UVRAG;SMCR8;UBQLN4;RUBCN
prerank,glucose metabolic process (GO:0006006),-0.32756049364206974,-1.1942008994521265,0.16612377850162866,0.7996385769183404,1.0,20/58,21.17%,LRP5;PGM1;ALDOA;MDH1;APOD;CRTC2;GAA;PGK1;ENO1;PCK2;ENO3;SLC37A4;TPI1;HECTD4;SLC39A14;SLC25A10;GAPDHS;ATF4;GAPDH;SLC25A1
prerank,cellular response to reactive oxygen species (GO:0034614),0.3875597934028365,1.1938643357687924,0.22074074074074074,0.5677011627792552,1.0,19/59,17.66%,EGFR;MAP3K5;FER;RPS3;OSER1;RIPK1;CAMKK2;PTPRK;PDGFRA;PXN;TRPM2;ROMO1;AGAP3;NET1;PKD2;MAPK7;PRDX3;RELA;IL6
prerank,negative regulation of intracellular protein transport (GO:0090317),0.46542809966460363,1.1936357494888277,0.24067796610169492,0.5676881994985322,1.0,5/22,12.13%,MDFIC;ITGB1BP1;RAB23;SP100;UFM1
prerank,extrinsic apoptotic signaling pathway (GO:0097191),0.37748542250566514,1.1935811957503417,0.21574344023323616,0.5672712498891203,1.0,14/70,12.88%,P2RX7;TNFRSF1B;RIPK1;MCL1;GSK3B;BCL2L2;BCL2;BAG3;TNF;IL6R;TNFSF12;CASP8;DIABLO;TNFRSF1A
prerank,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),0.4471001110224314,1.1933856701262329,0.2372322899505766,0.5671612351616012,1.0,8/29,11.05%,RPS27A;RIPK1;TLR4;BIRC3;LY96;CD40;UBE2D3;CASP8
prerank,regulation of release of sequestered calcium ion into cytosol (GO:0051279),-0.3357849633532876,-1.1931693338306346,0.17771084337349397,0.8009281533375845,1.0,9/48,8.56%,CAPN3;PTK2B;CALM2;PLCG1;ANK2;UBASH3B;TRPC1;AKAP6;JPH1
prerank,MAPK cascade (GO:0000165),0.3196662859459533,1.192010486174666,0.14238042269187987,0.5696938525782013,1.0,49/295,11.96%,RASGRP4;EGFR;FGFR1;MAP3K5;SPRED1;MEF2A;RGL1;ZFP36L2;PSMA7;MEF2C;RASAL2;RPS27A;RASA1;SYNGAP1;NRAS;KRAS;KITLG;SPTBN1;FGF23;PLVAP;ZFP36L1;RAPGEF2;IL17RD;FRS2;CCM2;IRS2;CAMKK2;MAPKAPK2;PDGFRA;GFRA3;PTPRA;MAP3K8;TNF;NRK;PSMB2;FYN;RANBP9;RASA2;MAP3K20;CUL3;IGF1;CALM1;PTGER4;PDE6D;SHC1;PSMA6;JAK1;YWHAE;MAP3K3
prerank,toll-like receptor 9 signaling pathway (GO:0034162),-0.466356723292774,-1.1918978028804352,0.24175824175824176,0.8029390579225969,1.0,3/13,5.66%,IRAK2;UNC93B1;PIK3R4
prerank,regulation of macromolecule metabolic process (GO:0060255),0.33429922428487413,1.19170795992303,0.1784841075794621,0.5698380348684912,1.0,35/170,17.03%,NELL1;APOE;APP;FOXP1;AHR;LDLR;CRIP1;RASA1;ZFP36L1;MTMR3;NFKBIZ;NKAP;CDK6;KIF16B;KDM6A;PSEN1;TRIM68;RO60;TRIM27;HMG20A;IGF1;HINFP;ROCK2;AFF1;ZC3H12A;PEG3;RNF187;ATXN7L3B;NOVA1;MYC;UBAP2;MKLN1;MTMR1;CAVIN4;LHX1
prerank,telomere maintenance (GO:0000723),-0.33961179189261115,-1.1913990782441126,0.1807909604519774,0.8022858178956153,1.0,13/50,13.42%,DNA2;XRCC5;CTC1;ATM;PARP1;STN1;PTGES3;BLM;LTO1;HUS1;TERF2;PARP3;XRCC6
prerank,cell projection organization (GO:0030030),-0.37418816106702835,-1.1913107686480024,0.18911917098445596,0.8003214283266308,1.0,8/30,7.39%,NCKAP1;ATP1B2;CSPG5;NEFH;RHOQ;NCKAP1L;P2RY12;RHOH
prerank,negative regulation of developmental growth (GO:0048640),-0.38867367004486786,-1.1912992533876174,0.19638242894056848,0.7980575321401755,1.0,5/30,4.15%,MAP2;PTPRS;DUSP10;DIP2B;FGF13
prerank,negative regulation of blood coagulation (GO:0030195),0.4166206354270925,1.1905430580420349,0.24299065420560748,0.5717913328795082,1.0,4/38,5.33%,APOE;SERPINB2;C1QTNF1;PDGFRA
prerank,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",-0.3402032041582642,-1.1904623743297726,0.1686746987951807,0.7987614125315202,1.0,19/52,20.25%,DDX5;DDX17;RBM25;RBFOX1;SRRM4;FXR2;HNRNPU;PUF60;FMR1;CELF4;KHDRBS3;RNPS1;NOVA2;SRSF12;HNRNPA1;RBM5;MBNL3;FXR1;CELF6
prerank,filopodium assembly (GO:0046847),0.49680111785546843,1.190459599351219,0.2704626334519573,0.5714392513608239,1.0,3/16,5.22%,FGD4;FGD6;S1PR2
prerank,negative regulation of cell junction assembly (GO:1901889),0.4594062306612497,1.1899470105444392,0.2360655737704918,0.5720153096225823,1.0,10/25,12.68%,ITGB1BP1;TLR2;ROCK1;TNF;DUSP22;RCC2;CORO1C;SLIT1;ROCK2;BCAS3
prerank,regulation of cholesterol metabolic process (GO:0090181),0.47349440484066535,1.189934999961818,0.24957264957264957,0.5714781756127025,1.0,4/20,11.44%,APOE;NR1H4;SREBF2;FMO5
prerank,regulation of regulated secretory pathway (GO:1903305),-0.3726905008039395,-1.189930979988616,0.2074468085106383,0.7983309295304034,1.0,14/34,27.26%,RIMS1;RIMS2;RAB27A;VPS18;SYT6;SYT8;RIMS3;SYT1;RAB15;SYT13;RIMS4;SYT7;SYT5;SYT17
prerank,phosphatidylinositol 3-kinase signaling (GO:0014065),-0.3741653527823302,-1.1897533105270608,0.2032967032967033,0.7967331419468512,1.0,10/33,14.02%,PIK3CB;NYAP2;PLEKHA1;NF1;MYO16;PIK3C2B;SIRT2;PIK3R5;C1QBP;TYRO3
prerank,negative regulation of translation (GO:0017148),0.35998292215421374,1.1896251923747545,0.19489247311827956,0.5715824413385279,1.0,34/87,23.11%,RPS3;DAPK1;EIF3E;SAMD4A;MRPL13;RACK1;ROCK1;MALSU1;RBM4;ILF3;DDX6;EIF4EBP2;NANOS3;ROCK2;EIF4EBP1;TRIM71;SHMT1;CNOT9;SYNCRIP;EIF2AK4;RNF139;EIF2AK2;EIF2AK3;CNOT1;CNOT8;GIGYF2;ENC1;DAPK3;IGF2BP3;PUS7;METTL16;EPRS1;CPEB3;PCIF1
prerank,vasoconstriction (GO:0042310),0.548842923232789,1.1895985681664643,0.28185328185328185,0.5710810964275556,1.0,2/11,8.29%,EDNRB;PIK3C2A
prerank,negative regulation of proteolysis (GO:0045861),-0.3716048359456101,-1.1894928556049633,0.20977011494252873,0.7954091406349986,1.0,8/34,13.48%,SERPINE2;TMEM59;CLN3;CST7;BAG6;PRNP;GAS1;CST3
prerank,dendritic spine morphogenesis (GO:0060997),-0.4562670824690202,-1.188862666390746,0.23908045977011494,0.7953802865936921,1.0,8/15,18.31%,DOCK10;DLG4;DIP2A;SHANK1;EPHB1;CTNND2;EPHB2;PAK3
prerank,"regulation of transcription, DNA-templated (GO:0006355)",0.2997344901848638,1.1887659320732784,0.014042126379137413,0.5723910314830805,1.0,383/1646,19.47%,RBPJ;HDAC9;WWP1;CD38;ZEB2;MAF;TRPS1;ETV1;EGFR;LRP6;APOE;MAP3K5;KLF2;TCF7L2;TCF4;IRF4;MDFIC;FOXP1;FLI1;MEF2A;AHR;ZBTB16;RREB1;GAS6;FOXN2;TFEC;KMT2A;HIVEP2;NFXL1;ESR1;SMURF2;ZBTB20;RBBP8;HINT1;TCF12;MEF2C;NR1H4;CBFA2T3;NCOA2;CEBPB;MITF;PIAS1;OSR1;RYBP;TSHZ3;BMP2;PRICKLE1;KLF6;ARID4B;TBX15;CD74;PHF8;HOXD8;NR2C1;PHOX2A;FOXA3;RAX;ALX1;HOXA10;NR1D1;SNX6;AXIN1;WAC;CRK;RPS6KA3;YWHAQ;BAZ2B;TOX4;JARID2;BCL10;PHF20;NR3C1;NKAP;TRIM56;IRF2BP2;HEY2;CTDSP1;CLOCK;GRHL2;PBX3;DMRTA2;ARID1B;SPI1;NCOA7;RB1;KLF9;KDM7A;TCEA2;NFIC;INSR;CAMKK2;ARID5A;BATF2;SMAD4;PTPRK;ZFP2;ELF2;TRIM33;TGFBRAP1;IRX2;CBFB;NR4A1;FOSL2;TCF7;ZBTB25;ATXN1;PIAS2;EPC1;SETDB2;MED13L;DMAP1;FOXM1;ZNF235;ZNF568;TNF;CD80;KLF3;ZNF148;TSHZ1;LYL1;KLF4;EPC2;ZSCAN25;YY1;REL;HTATIP2;THAP11;GATAD2A;MED16;SATB2;TBL1XR1;STAT4;PRKCB;CEBPG;E2F5;PSEN1;NR4A2;LHX5;GMNN;IRF2;KLF10;IRX5;BTAF1;NCOR1;ZBTB5;ATF6;CDK14;ATRX;ZNF628;NCOA6;FOXC2;MIDEAS;LIMD1;ARID3A;ESRRB;BRIP1;BACH1;MDM2;LCORL;OLIG2;HIVEP1;LIN54;MED18;TBL1X;HMG20A;LBH;ESR2;LRRFIP1;MAPK14;FOXJ3;ATF7;NFATC2;DYRK1A;MED20;MAMLD1;MED6;MLXIP;PPP2CA;LCOR;STAT6;NR2F1;USP21;USP16;PURA;ILF3;ZNF205;RPL6;GCFC2;IGF1;TESMIN;SFRP1;RFX2;RNF14;JMJD1C;ARRB1;RNF111;NUP62;ZNF296;SPEN;RBM15;CREBRF;RCOR2;SP100;MED26;TRIM16;SP1;TFDP1;PCID2;ELF1;ATXN1L;ZMYND15;PHIP;ETS2;PHC3;SHC1;SREBF2;CREBBP;ANKRD49;CRYAB;BCL11B;MYBL2;FOXK2;HINFP;NFIA;FOXO3;CDK17;NIBAN2;DEK;SNX5;KDM5C;ATP2B4;FOXK1;LOXL2;TADA2B;TERF2IP;ZBTB8B;ELP4;ZFP3;CHD2;SP3;NFIX;FOXO1;KMT2E;CREB1;SFR1;CCNQ;PEG3;KLF13;CTBP2;ZBTB7C;PSPC1;ZNF326;XPC;RNF187;NR1H2;ZBTB10;RARA;KAT7;HIF3A;STAT3;MBD1;EP300;KLF5;MLF2;PROX2;BCOR;JUND;MMS19;CRLF3;KAT6A;MED27;USF1;HMGN5;EHMT1;WWC1;NAB1;SNW1;ELOC;ENY2;MYC;MTF1;MYT1;NSD3;USP22;NLK;RGS14;SMARCD1;HDAC4;KDM2A;PEX14;NR2C2;ZHX1;VGLL4;SFPQ;ARID1A;RUNX3;ELK1;HEXIM2;USP47;E2F8;KDM1A;ZFP62;HOXB3;POU5F2;CREB3L1;HCFC1;ZGPAT;ZNF569;PPARGC1B;PPM1A;PER1;ZNF177;TBX2;NFATC3;ARNT;RCOR1;BRD4;GLIS2;MED17;FOXP2;GPBP1;NR5A2;PRKCQ;RELA;LHX1;NACC1;CARF;ZBTB7A;NR2F2;ZNF22;MEF2B;GTF2H1;PA2G4;MECOM;ARID4A;ZFP28;IL6;NR6A1;SP8;GMEB1;ZNF32;PICALM;ZBTB41;GZF1;BATF;HSF5;ZBTB12;ZBTB40;F2R;ZBTB1;MAFB;ZBTB8A;ATF2;RFX3;SRCAP;PERM1;PHF5A;ZBTB14;TRAF6;PLAG1;PHF20L1;RAI1;DVL3;SUMO1;ID3;THRA;KDM4C;PITHD1;TOX2;BRMS1;WDR77;THRAP3;SMAD1;UXT;INPP5K;ZNF3;RNF6;SFMBT1;CIART;BCL3;TLE1;CTCF;SET
prerank,response to interleukin-1 (GO:0070555),0.37076154485305535,1.188630837843566,0.2023121387283237,0.5721234709553426,1.0,28/73,23.64%,APP;GBP3;IRAK3;CCL8;NR1D1;CCL19;TNFRSF11A;RC3H1;CD40;CCL24;IGBP1;SFRP1;ZC3H12A;HDAC4;CCL5;RELA;ACOD1;CCL25;TRAF6;HAS2;SNCA;CCL14;NFKB1;CD47;IL1R1;TANK;MAPK11;TLE5
prerank,receptor signaling pathway via JAK-STAT (GO:0007259),0.4521359305255393,1.1884523165735266,0.23785594639865998,0.5719591110031027,1.0,8/29,9.60%,IL15;FER;IFNAR1;PIAS1;CCR2;STAT4;IFNAR2;STAT6
prerank,regulation of actin cytoskeleton reorganization (GO:2000249),0.42298309603078177,1.1882315342281657,0.23742138364779874,0.5718903990914564,1.0,5/35,5.33%,IQGAP2;NRP1;NOTCH2;CDC42;PDGFRA
prerank,response to iron ion (GO:0010039),0.5264188489230143,1.1881841871053072,0.26972477064220185,0.5714460421532223,1.0,5/12,13.49%,B2M;BCL2;HFE;ACO1;TFR2
prerank,icosanoid secretion (GO:0032309),0.5202031177204534,1.1880693712826453,0.24729241877256317,0.5711721513382393,1.0,2/12,6.85%,PNPLA8;ABCC4
prerank,cellular response to hexose stimulus (GO:0071331),0.4578813430540636,1.1880627340766976,0.24958123953098826,0.5706311880004645,1.0,4/23,5.11%,GAS6;ZBTB20;ERN1;RACK1
prerank,"tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",-0.47440685251924136,-1.1878068479703892,0.248868778280543,0.7967151439433586,1.0,7/14,23.30%,CSTF2;DDX1;FAM98B;CLP1;RTCB;TSEN54;TSEN15
prerank,purine ribonucleoside monophosphate biosynthetic process (GO:0009168),0.5068193645088598,1.1877262426823818,0.25880281690140844,0.5708540700388186,1.0,6/16,16.33%,ADSS2;LHPP;IMPDH2;AMPD3;ADSS1;GMPS
prerank,positive regulation of cell motility (GO:2000147),0.3296614098917918,1.1869323060552883,0.14512195121951219,0.5721252728427529,1.0,20/205,5.88%,DAB2;NEDD9;EGFR;SEMA4A;CCR1;PPP3CA;MYADM;ITGB1;FER;CASS4;BMP2;SYNE2;DRD1;GRN;ADAM9;CCL19;INSR;RACK1;PDGFRA;TRIM32
prerank,regulation of telomere maintenance via telomerase (GO:0032210),-0.3364979791209036,-1.186742477231617,0.1949685534591195,0.7981044415807276,1.0,17/51,23.12%,CTNNB1;XRCC5;CTC1;SRC;HNRNPU;ATM;MAPK3;MAP2K7;STN1;TERF2;MAP3K4;CCT7;HNRNPA1;GNL3L;CCT2;ACD;CCT8
prerank,positive regulation of toll-like receptor signaling pathway (GO:0034123),0.4419668455790885,1.1867156734967608,0.22919937205651492,0.5720959460140762,1.0,6/26,9.90%,MFHAS1;PTPN22;LBP;TLR2;NINJ1;RTN4
prerank,cellular response to transforming growth factor beta stimulus (GO:0071560),0.34838206946177736,1.1852917115709936,0.20316622691292877,0.5748137153296023,1.0,19/112,7.38%,NRROS;ZFP36L2;ITGB1;MEF2C;RPS27A;WNT2;ADAM9;CBL;ZFP36L1;RHOA;PDE2A;NR3C1;USP9X;SMAD4;PTPRK;TGFBRAP1;GDF10;USP15;DUSP22
prerank,regulation of steroid biosynthetic process (GO:0050810),0.526990958792395,1.1851281649599243,0.2800751879699248,0.5746091207018638,1.0,2/11,2.60%,NR1H4;BMP2
prerank,mRNA transport (GO:0051028),-0.2944929754883681,-1.1845656272307812,0.1166077738515901,0.8033142002351062,1.0,38/101,26.63%,THOC1;SRRM1;SRSF5;HNRNPA2B1;NXF1;DDX39B;SRSF3;NUP210;RANBP2;KIF5C;SRSF2;FMR1;UPF1;RNPS1;NUP85;U2AF1;MCM3AP;UPF3B;CASC3;NCBP1;SEH1L;NXT1;SRSF11;THOC3;SRSF9;AAAS;SEC13;POLDIP3;GLE1;ALYREF;U2AF2;ALKBH5;SLBP;SRSF6;NDC1;EIF4E;NUP93;NUP50
prerank,innate immune response activating cell surface receptor signaling pathway (GO:0002220),0.35055843405636555,1.184526595016602,0.19786096256684493,0.5753613041889828,1.0,20/105,14.43%,CLEC10A;CLEC6A;PSMA7;LYN;NRAS;KRAS;FCER1G;BCL10;PAK2;SYK;PSMB2;FYN;CLEC4D;CREBBP;PSMA6;PRKACB;EP300;PSMA3;PSMD1;PSMD5
prerank,positive regulation of small GTPase mediated signal transduction (GO:0051057),0.43556391330192357,1.183923517616277,0.24378109452736318,0.5761623360362199,1.0,6/29,11.24%,RASGRP4;NOTCH2;LYN;IRS2;IGF1;SHC1
prerank,regulation of cellular protein catabolic process (GO:1903362),0.481203779391957,1.1837108222049384,0.27586206896551724,0.5760811006057084,1.0,6/18,16.72%,NELL1;RIC1;MSN;WDR91;VGLL4;AMER1
prerank,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),0.425069930823584,1.1836157191419743,0.24878048780487805,0.5757244771488653,1.0,9/31,12.56%,YWHAQ;GSK3B;SFN;BCL2;ZNF205;TFDP1;CASP8;YWHAE;PPP1R13B
prerank,lipid homeostasis (GO:0055088),0.3833080672216272,1.1827508877836577,0.2321167883211679,0.5771900915205125,1.0,6/57,4.93%,APOE;FBXW7;ZBTB20;RCN3;IRS2;PNPLA8
prerank,G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),0.4843768326966506,1.1826287872844254,0.2678260869565217,0.5768913659651094,1.0,3/18,8.00%,GNAQ;RGS8;GNB1
prerank,negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),0.49482606264939843,1.1823152674125388,0.26881720430107525,0.5770416029296694,1.0,4/16,9.58%,PARP14;PIBF1;SH2B3;PPP2CA
prerank,dendritic spine organization (GO:0097061),-0.3991754899768296,-1.182041155131474,0.23136246786632392,0.8100219587179996,1.0,8/26,7.77%,TREM2;DOCK10;DLG4;LGMN;DIP2A;SHANK1;EPHB1;PRNP
prerank,regulation of tissue remodeling (GO:0034103),0.47863733735389663,1.1820151828907823,0.24914675767918087,0.5772007378321925,1.0,4/18,14.31%,IL15;THBS4;DDR2;MDK
prerank,regulation of phospholipase C activity (GO:1900274),0.49162889623276274,1.181403985438342,0.2714285714285714,0.5780487222615407,1.0,3/15,5.33%,FGFR1;ESR1;PDGFRA
prerank,phosphatidylinositol dephosphorylation (GO:0046856),0.45565648874705666,1.1812686387430908,0.26837606837606837,0.5778124437942184,1.0,11/23,21.95%,MTM1;SYNJ1;MTMR3;OCRL;PIP4P2;PTEN;MTMR1;PIP4P1;INPP5K;MTMR6;MTMR12
prerank,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.41449192278736047,1.1809347152396181,0.24537037037037038,0.5779897273070813,1.0,13/38,19.45%,ESR1;NR1H4;RIPK1;NR1D1;RIOK3;PPM1B;CASP8;ZC3H12A;PPM1A;PER1;NLRX1;MAPKBP1;TLE1
prerank,regulation of proteolysis (GO:0030162),-0.3355806291343471,-1.180700630934232,0.20215633423180593,0.8124090139780473,1.0,8/48,7.60%,ASPH;SERPINE2;CAPN3;GSAP;CLN3;TBC1D10A;CYFIP2;BAG6
prerank,regulation of microglial cell activation (GO:1903978),0.5084367330064957,1.1804166272885,0.2694300518134715,0.5786668206785033,1.0,3/15,3.26%,LDLR;NR1D1;GRN
prerank,calcium ion transmembrane transport (GO:0070588),0.3615147889905996,1.1803816213087928,0.20334261838440112,0.5782102442074833,1.0,19/86,14.70%,P2RX7;MCUB;ATP2B1;GAS6;ANO6;MCU;PARL;TRPV3;TMEM165;GRIN2D;TRPM2;TRPC7;SLC8B1;MICU3;ATP2B4;MCOLN2;SLC35G1;ATP2A2;PKD2
prerank,positive regulation of embryonic development (GO:0040019),0.46844947506448287,1.1802040496586417,0.2631578947368421,0.5780700826075799,1.0,6/19,17.03%,OSR1;RACK1;B4GALT5;NIBAN2;NR2C2;LHX1
prerank,regulation of protein secretion (GO:0050708),0.34153146497702996,1.1801517253126992,0.19215686274509805,0.5776564939012071,1.0,25/119,12.44%,APOE;ALOX5;ANG;EXPH5;ADAM9;HMGCR;CLOCK;RAP1A;TMED10;RHBDF1;DPH3;STXBP5;TNF;EIPR1;KCNG2;GOLPH3L;CD33;DNAJC1;IGF1;HADH;ACHE;SLC8B1;SLC2A2;KCNB1;DISP1
prerank,pre-miRNA processing (GO:0031054),0.5050923954908295,1.1800507207832263,0.25443786982248523,0.5773429325640582,1.0,5/14,13.29%,PRKRA;TUT7;DROSHA;TUT4;MRPL44
prerank,double-strand break repair via break-induced replication (GO:0000727),-0.4880357607989233,-1.1800397655685853,0.2867132867132867,0.8124756076178872,1.0,9/12,38.25%,CDC7;MCM3;MCM6;MCM2;MCM7;MCMDC2;GINS4;CDC45;MCM5
prerank,positive regulation of actin nucleation (GO:0051127),0.527936856584373,1.1800131051959912,0.27606177606177607,0.5768893279741689,1.0,2/11,2.42%,WASF2;FCHSD2
prerank,cellular response to lectin (GO:1990858),0.3505675279952231,1.1797219458396064,0.21236559139784947,0.5765037476818272,1.0,20/104,14.43%,CLEC10A;CLEC6A;PSMA7;LYN;NRAS;KRAS;FCER1G;BCL10;PAK2;SYK;PSMB2;FYN;CLEC4D;CREBBP;PSMA6;PRKACB;EP300;PSMA3;PSMD1;PSMD5
prerank,stimulatory C-type lectin receptor signaling pathway (GO:0002223),0.3505675279952231,1.1797219458396064,0.21236559139784947,0.5765037476818272,1.0,20/104,14.43%,CLEC10A;CLEC6A;PSMA7;LYN;NRAS;KRAS;FCER1G;BCL10;PAK2;SYK;PSMB2;FYN;CLEC4D;CREBBP;PSMA6;PRKACB;EP300;PSMA3;PSMD1;PSMD5
prerank,centromere complex assembly (GO:0034508),-0.35254939280300485,-1.1795045288484287,0.20512820512820512,0.8121363733403899,1.0,15/36,30.17%,CENPC;CENPE;NASP;KNL1;MIS18BP1;RUVBL1;DLGAP5;CENPX;CENPV;CENPP;CENPN;CENPH;CENPI;MIS18A;CENPF
prerank,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",-0.3983375958059032,-1.1791010480471262,0.2390745501285347,0.8113581280747746,1.0,10/23,18.77%,CUL4A;COPS7A;PARP1;COPS8;DDB2;RBX1;COPS4;COPS6;GPS1;UBB
prerank,neural tube closure (GO:0001843),0.4262261313317727,1.1790418945083714,0.24960254372019078,0.5775353049899455,1.0,5/34,5.59%,LRP6;PRICKLE1;BCL10;GRHL2;CELSR1
prerank,positive regulation of GTPase activity (GO:0043547),-0.267031266342436,-1.1789360278437977,0.09375,0.8096829592184456,1.0,41/188,11.61%,ARHGAP45;SIPA1L2;F11R;ARHGAP24;TBC1D16;MAP4K4;SEMA4D;TBC1D8;ASAP3;ARHGAP25;GARNL3;DOCK9;ITGA6;DOCK10;ARHGAP27;SGSM3;GMIP;TGM2;SGSM2;FERMT2;NF1;FLCN;TBC1D10A;NTRK3;RGS6;ARHGAP22;RASGRF1;TBC1D22A;CCL3;TBC1D22B;TIAM1;TBC1D9B;ADCYAP1;MMUT;TIAM2;AFDN;ABR;PKP4;EVI5L;TSC1;RAPGEF3
prerank,membrane protein proteolysis (GO:0033619),0.4175571258446803,1.1786887771402046,0.2413793103448276,0.5777918194208675,1.0,15/37,22.04%,ADAM19;ADAM9;RHBDD1;PARL;PSEN1;SPPL2B;NCSTN;ERAP1;SPPL2A;PRKCQ;RELA;TRAF6;MBTPS2;ADAM17;NFKB1
prerank,MyD88-independent toll-like receptor signaling pathway (GO:0002756),0.43609168843768764,1.1786341406072078,0.25163398692810457,0.5773741613363086,1.0,8/30,11.05%,RPS27A;RIPK1;TLR4;BIRC3;LY96;CD40;UBE2D3;CASP8
prerank,positive regulation of calcium ion import (GO:0090280),-0.4812396557144366,-1.178553341471484,0.2623318385650224,0.808680721905449,1.0,9/12,49.33%,CCL3;PDGFRB;CXCL12;STC1;RAMP3;ATP2A1;CCL2;PDGFB;CALCR
prerank,negative regulation of hydrolase activity (GO:0051346),-0.34043092838474,-1.1785071017807518,0.18373493975903615,0.8066089143759061,1.0,12/49,15.86%,F11R;MAP2;GMIP;RASA4;CPEB2;RDX;CST7;ARFGEF1;TERF2;CST3;HRAS;SLC39A14
prerank,regulation of hydrogen peroxide-induced cell death (GO:1903205),0.5428638434512509,1.1773220523292376,0.28793774319066145,0.5797159225444424,1.0,2/10,4.33%,RIPK1;PDE8A
prerank,neutrophil migration (GO:1990266),0.3860849604558693,1.1772878059389134,0.22700296735905046,0.5792399519673191,1.0,7/58,8.22%,PF4;FCER1G;CCL8;CCL19;PIKFYVE;SYK;CCL24
prerank,regulation of leukocyte chemotaxis (GO:0002688),0.45677927584534106,1.1771073032552621,0.27181208053691275,0.579113324212195,1.0,6/18,17.66%,LYN;CAMK1D;IL6R;SLC8B1;MDK;IL6
prerank,protein modification process (GO:0036211),0.3689696065035193,1.1765615742696514,0.2323943661971831,0.5798035736607192,1.0,19/76,15.74%,PADI4;ST8SIA4;ST3GAL1;LOX;DUSP12;SERP1;MANBA;MSRA;UBE2D3;FBXO11;GNMT;PPP4R2;STK38;LOXL2;ERO1A;RPN2;ICMT;USP25;FBXW2
prerank,regulation of transferase activity (GO:0051338),-0.43678810101928395,-1.17655348122813,0.2545454545454545,0.8113111708685775,1.0,9/17,27.89%,LDB1;ATM;NLRC5;LDB2;PARP4;BAG5;SLAMF8;EMP2;JMJD8
prerank,regulation of long-term synaptic potentiation (GO:1900271),0.43634598818071996,1.1762753098823082,0.2434640522875817,0.5798931539385784,1.0,3/28,4.76%,APOE;APP;GSK3B
prerank,beta-catenin destruction complex disassembly (GO:1904886),0.46554054133296646,1.1757932645081866,0.2555366269165247,0.5804281766429366,1.0,4/21,5.66%,LRP6;AXIN1;GSK3B;FRAT1
prerank,cellular response to arsenic-containing substance (GO:0071243),-0.4520672419063405,-1.1757738786627692,0.2545454545454545,0.8117903438179525,1.0,6/15,20.02%,CPEB2;ZFAND1;ATF3;HSF1;HNRNPA1;GSTO2
prerank,lipid modification (GO:0030258),0.4176148437378404,1.1746594209750263,0.2562111801242236,0.5824598538936622,1.0,4/37,2.21%,ALOX5;ALOX15;SGPP1;PLA2G7
prerank,regulation of cardiac muscle contraction (GO:0055117),-0.3698832337155943,-1.1744803276043447,0.21899736147757257,0.8141503287690708,1.0,7/34,8.44%,PDE4B;CALM2;SMAD7;ATP1B1;SLC8A1;ANK2;RGS2
prerank,positive regulation of macromolecule biosynthetic process (GO:0010557),0.34026786998463954,1.1743424674501115,0.201765447667087,0.5826176729090278,1.0,33/122,17.73%,EGFR;EIF3E;TLR4;CCL19;SAMD4A;NIBAN1;RPL26;RGCC;VIM;TLR2;IRS2;INSR;TMEM106A;NMD3;RPS4X;KLF4;MTPN;RPL5;LARP4B;IGF1;NAMPT;NOD2;LARP4;PIWIL2;KAT7;PRKD2;PRMT1;MYC;ABCB10;XBP1;IL6;HGF;PYM1
prerank,poly-N-acetyllactosamine metabolic process (GO:0030309),-0.47451827784776035,-1.1737932925924848,0.26666666666666666,0.814471075639057,1.0,4/13,14.99%,B3GALT1;B3GALT5;B3GALT2;B3GNT2
prerank,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),0.45789023732451695,1.1736527847452827,0.25844594594594594,0.5835680650052821,1.0,3/24,5.99%,APOE;CTSC;RHBDF1
prerank,pyrimidine deoxyribonucleotide catabolic process (GO:0009223),-0.4658556386917668,-1.1735906131639184,0.257201646090535,0.8129954855718409,1.0,8/13,41.98%,UPP2;DUT;NT5M;UNG;NEIL2;NEIL1;DCTPP1;MBD4
prerank,regulation of epithelial to mesenchymal transition (GO:0010717),0.3731614993827455,1.1735413316942425,0.2310866574965612,0.5832686361532532,1.0,14/74,10.98%,DAB2;SPRED1;BMP2;ALX1;RGCC;IL17RD;SMAD4;SDCBP;VASN;CLASP1;USF3;PPP2CA;SFRP1;SPRED2
prerank,carbohydrate derivative biosynthetic process (GO:1901137),-0.38806815954711515,-1.1735242742400789,0.22518159806295399,0.8110120478450105,1.0,7/26,18.40%,LARGE1;GK;SCCPDH;GAL3ST4;TPI1;ALG8;ST3GAL2
prerank,oligodendrocyte differentiation (GO:0048709),-0.42354776853524445,-1.1732160973396253,0.24107142857142858,0.8098807720985096,1.0,15/19,45.64%,EIF2B3;NSUN5;TPPP;SOX10;SOX13;SOX8;EIF2B5;SLC8A3;EIF2B2;SHH;PRDM8;SOX6;HES5;MYRF;PTPRZ1
prerank,cellular macromolecule catabolic process (GO:0044265),0.39272956543286935,1.173077107724999,0.2383107088989442,0.5837810914396016,1.0,11/49,11.97%,RIPK1;SIAH2;PRKN;SND1;MANBA;DNASE1L1;RNASE6;ADAMTS9;MTREX;NGLY1;DENND3
prerank,negative regulation of MAP kinase activity (GO:0043407),0.39700495638348704,1.172867096785883,0.21385542168674698,0.5836712212133618,1.0,6/44,4.27%,APOE;PTPRJ;LYN;IRAK3;PTPN22;DUSP1
prerank,positive regulation of protein polymerization (GO:0032273),-0.31677041000677564,-1.1728544994365813,0.1870748299319728,0.8089635920481932,1.0,13/65,13.12%,NAV3;BIN1;NCKAP1;EVL;PTK2B;PRKCE;PAK1;NCKAP1L;MAPT;TPPP;TOGARAM1;NUMA1;MAPRE1
prerank,regulation of actin filament-based process (GO:0032970),0.3691415649293257,1.1726153317582457,0.23470839260312945,0.5837087952522053,1.0,11/70,7.97%,IQGAP2;IQGAP1;BST1;ARHGAP18;CRK;RHOA;ROCK1;CELSR1;CNN2;BST2;RHOBTB1
prerank,cellular response to metal ion (GO:0071248),0.3435855546974002,1.1725844287351936,0.21373056994818654,0.5832264660419995,1.0,16/123,7.63%,EGFR;CHP2;IQGAP1;MEF2A;ALOX15;MEF2C;ALOX5AP;B2M;PRKN;AOC1;CPNE2;CLIC4;CPNE7;SLC25A24;CPNE8;HFE
prerank,amino sugar metabolic process (GO:0006040),0.5319044431742723,1.1721076471484442,0.2839506172839506,0.583752950798342,1.0,4/10,14.21%,ST6GAL1;ST3GAL1;GFPT2;EXTL2
prerank,positive regulation of cell-cell adhesion (GO:0022409),-0.34506469082697555,-1.1720177608693558,0.2238372093023256,0.8097348126114887,1.0,7/41,5.04%,TJP1;GCNT2;PTPN23;SMAD7;PLPP3;FLOT1;PIEZO1
prerank,"chemical synaptic transmission, postsynaptic (GO:0099565)",0.4430257227170735,1.171442160869042,0.26588628762541805,0.5847010989672218,1.0,7/25,10.24%,MEF2C;GSK3B;MPP2;CHRNA4;MAPK8IP2;INSYN2A;GRIN2D
prerank,non-canonical Wnt signaling pathway (GO:0035567),0.33949283227229776,1.1713041419736039,0.20282413350449294,0.584464013874606,1.0,24/124,14.43%,AP2A2;TCF7L2;PPP3CA;CLTC;SMURF2;PSMA7;GNG2;PRICKLE1;CDC42;RHOA;PDE6A;CELSR1;AP2S1;PSMB2;GNB1;SFRP1;CALM1;PLCB3;PSMA6;TNRC6C;AP2B1;PSMA3;PSMD1;PSMD5
prerank,regulation of cell cycle G2/M phase transition (GO:1902749),-0.3068038143804356,-1.1712930374021668,0.18055555555555555,0.8100786456682094,1.0,33/82,31.87%,CSNK1E;SDCCAG8;CEP135;ODF2;DYNC1H1;TP53;CEP192;CEP250;HAUS8;CEP63;CCP110;HAUS7;CKAP5;MAPRE1;HAUS3;DCTN2;HMMR;CNTRL;HAUS2;DCTN1;KIF14;PLK4;CDK1;HAUS6;YWHAG;TUBA4A;CEP152;DYRK3;NEK10;TUBA1A;CENPF;TUBG1;AURKA
prerank,glycolipid biosynthetic process (GO:0009247),-0.3589498636900918,-1.1707032686262286,0.20903954802259886,0.8099562759302525,1.0,12/38,24.12%,LARGE1;ST3GAL5;PGAP2;SCCPDH;ST8SIA1;ST8SIA3;PIGL;ST3GAL2;PIGH;PGAP3;PIGB;DPM2
prerank,zinc ion homeostasis (GO:0055069),-0.38137410836357466,-1.1706716915347326,0.25396825396825395,0.8079117784480226,1.0,15/28,25.96%,SLC30A9;ATP13A2;SLC39A13;SLC39A14;MT2A;TMC8;MT1E;MT1F;MT1M;MT1G;MT1H;MT1A;MT1X;MT1B;SLC39A6
prerank,aortic valve morphogenesis (GO:0003180),0.4181774524310834,1.170512052212986,0.2727272727272727,0.5857315937611344,1.0,7/30,11.99%,JAG1;HEY2;RB1;ROCK1;SLIT3;EMILIN1;ROCK2
prerank,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),0.40608703254526607,1.1700754553919155,0.2353896103896104,0.5861598354629591,1.0,14/37,20.07%,RPL23;RYBP;WAC;NOP53;SDCBP;RPL5;HFE;RPS7;EIF3H;RPL11;HSP90AB1;CSNK2A2;CSNK2A1;USP7
prerank,regulation of dendritic spine development (GO:0060998),-0.41645866255944425,-1.1698135156723501,0.25943396226415094,0.8085703180617515,1.0,8/19,8.11%,TANC2;PTPRS;NLGN1;PPFIA2;KIF1A;GRIN3A;SHANK1;FMR1
prerank,regulation of transforming growth factor beta production (GO:0071634),0.47336723450324525,1.1697335830967932,0.29307282415630553,0.5864054131208914,1.0,3/18,5.19%,LILRB1;CD46;SMAD4
prerank,positive regulation of cytokine production involved in inflammatory response (GO:1900017),0.5031961734951025,1.169204270657225,0.29120879120879123,0.5870376538276869,1.0,6/15,17.66%,TLR4;IL17RA;TNF;NOD2;STAT3;IL6
prerank,regulation of lipid catabolic process (GO:0050994),-0.4271334948776646,-1.1689897853164197,0.2540415704387991,0.8092602941471067,1.0,6/19,22.63%,PDE3B;APOC1;ALK;TYSND1;ANGPTL3;BSCL2
prerank,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),0.44123190042440813,1.1688429772646662,0.25463743676222594,0.5873007180607709,1.0,4/27,5.60%,C3AR1;GPR65;DRD1;P2RY10
prerank,monoacylglycerol metabolic process (GO:0046462),-0.4642600631232406,-1.1687647328258772,0.2471395881006865,0.8078579965870597,1.0,5/13,17.06%,ABHD12;MGLL;ABHD16A;AWAT2;FAAH
prerank,negative chemotaxis (GO:0050919),-0.36613088339187844,-1.168553802687706,0.2206703910614525,0.8064375797606778,1.0,7/33,5.59%,SEMA4D;UNC5C;EPHA7;SEMA4C;ITGB3;ROBO1;SEMA4G
prerank,negative regulation of cardiac muscle hypertrophy (GO:0010614),0.5402934331584163,1.1685155609824311,0.28793774319066145,0.5874509262150963,1.0,7/11,22.41%,SMAD4;GLRX3;ATP2B4;FOXO1;LMNA;P2RX4;MLIP
prerank,chondroitin sulfate proteoglycan metabolic process (GO:0050654),0.5309726527958314,1.1684232328610062,0.29740518962075846,0.5871567053334895,1.0,1/10,0.26%,DSE
prerank,small nucleolar ribonucleoprotein complex assembly (GO:0000491),-0.5141213187586922,-1.1683011112416448,0.2768595041322314,0.8052323547471564,1.0,8/10,44.50%,RUVBL1;ZNHIT6;TAF9;ZNHIT3;PIH1D2;SHQ1;RUVBL2;PIH1D1
prerank,aggrephagy (GO:0035973),0.4304913957062535,1.1681646498980736,0.25120772946859904,0.5872014910869847,1.0,7/27,13.05%,WDFY3;RPS27A;PRKN;VIM;PCNT;DYNC1I2;UBE2N
prerank,protein mono-ADP-ribosylation (GO:0140289),0.5312110637983043,1.168101166245344,0.29739776951672864,0.5867890935965497,1.0,4/11,10.31%,PARP14;PARP8;PARP11;PARP16
prerank,regulation of microtubule nucleation (GO:0010968),-0.5051983158901201,-1.1668632798541574,0.27167630057803466,0.8079846573591233,1.0,9/10,41.79%,PAK1;CKAP5;EML2;DCTN1;HSPA1A;HSPA1B;RANGRF;ARHGEF7;GIT1
prerank,ganglion development (GO:0061548),0.5230261693361502,1.1666499150998024,0.26277372262773724,0.5894062879563821,1.0,1/11,0.34%,NRP1
prerank,pathway-restricted SMAD protein phosphorylation (GO:0060389),-0.49831707589629876,-1.1666196782850804,0.279826464208243,0.8066783272990882,1.0,7/11,21.94%,TGFBR1;SMAD7;ACVR1;TGFBR3;TGFBR2;TGFB2;TGFB1
prerank,long-term memory (GO:0007616),0.46831310168978024,1.16655082448532,0.282312925170068,0.5890976178323103,1.0,3/19,3.91%,APOE;LDLR;SLC2A4
prerank,positive regulation of kinase activity (GO:0033674),0.3498815446143028,1.1665072694070442,0.2125984251968504,0.5886738345321582,1.0,17/107,9.85%,EGFR;FGFR1;IQGAP1;SNX9;PRKAG2;GAS6;RASSF2;CD74;CCL19;RAPGEF2;RAP1A;INSR;PDGFRA;TNF;DDR2;CACUL1;EPHB4
prerank,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),0.3751158421323984,1.1664549744582782,0.24225352112676057,0.5882518046877272,1.0,13/65,11.64%,NRROS;SPRED1;SMURF2;RPS27A;SNX6;IL17RD;SNX25;HTRA3;VASN;DAND5;SPRED2;EMILIN1;PMEPA1
prerank,response to glucose (GO:0009749),0.3941027683268585,1.1662130091428793,0.25,0.5882522908243413,1.0,6/46,5.11%,TCF7L2;GAS6;ZBTB20;ERN1;IRS2;RACK1
prerank,regulation of telomerase activity (GO:0051972),-0.33570888921409653,-1.1659481765268653,0.19287833827893175,0.8068379180838816,1.0,11/45,14.57%,CTNNB1;XRCC5;SRC;TP53;ATM;MAPK3;MAP2K7;PTGES3;MAP3K4;CERS1;PARP4
prerank,regulation of interleukin-17 production (GO:0032660),0.43262135704093313,1.1656764028206736,0.2644230769230769,0.5888921504492312,1.0,4/31,4.11%,IL15;NR1H4;TLR4;RFTN1
prerank,regulation of astrocyte differentiation (GO:0048710),-0.4738992229153634,-1.1655389396432243,0.2605932203389831,0.806181030531281,1.0,2/12,0.79%,BIN1;SERPINE2
prerank,positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),0.5437294534481588,1.1655068998162443,0.3088512241054614,0.5887367498491435,1.0,3/10,8.54%,PTPN22;LBP;NINJ1
prerank,transcription by RNA polymerase I (GO:0006360),-0.36137092704571455,-1.1653401567198556,0.2345360824742268,0.804807410689645,1.0,13/34,23.27%,GTF2H2;CCNH;MAPK3;UBTF;ERCC2;TAF1C;TAF1D;RRN3;GTF2H4;TAF1;POLR1C;POLR2L;TBP
prerank,synaptic vesicle transport along microtubule (GO:0099517),0.488048556574721,1.1648549097581131,0.2908777969018933,0.5890507773296162,1.0,4/15,8.27%,AP3B1;AP3M1;BLOC1S5;AP3S1
prerank,anterograde synaptic vesicle transport (GO:0048490),0.488048556574721,1.1648549097581131,0.2908777969018933,0.5890507773296162,1.0,4/15,8.27%,AP3B1;AP3M1;BLOC1S5;AP3S1
prerank,negative regulation of interleukin-1 production (GO:0032692),0.44930501461190653,1.1647141103942837,0.26804123711340205,0.5888342887439,1.0,7/23,13.56%,GAS6;GHRL;CD33;CARD16;IGF1;ZC3H12A;FFAR1
prerank,negative regulation of platelet activation (GO:0010544),0.47797770557219915,1.164430172819561,0.2931937172774869,0.5889636793861563,1.0,5/16,9.36%,APOE;C1QTNF1;PDGFRA;ADAMTS18;SH2B3
prerank,regulation of glucose transmembrane transport (GO:0010827),0.47990474649339687,1.164230896171158,0.29927007299270075,0.5888526727187107,1.0,3/18,7.67%,PRKAG2;C1QTNF12;PRKCB
prerank,coenzyme A metabolic process (GO:0015936),0.4951375424746407,1.163463978741812,0.30474452554744524,0.5900222222698348,1.0,1/14,0.18%,SLC25A16
prerank,myotube cell development (GO:0014904),0.5438669057220102,1.1628675257211243,0.2965779467680608,0.5908635472505641,1.0,2/10,9.90%,MYORG;IGF1
prerank,positive regulation of natural killer cell activation (GO:0032816),0.5103453987409121,1.162388952387156,0.294010889292196,0.5913979012679601,1.0,2/13,4.55%,GAS6;LAMP1
prerank,regulation of embryonic development (GO:0045995),0.42122115325874304,1.1622584379901477,0.247557003257329,0.5911533392585556,1.0,16/34,22.46%,INSR;RAB14;CLASP1;RPS6KA6;POGLUT1;B4GALT5;CCSAP;NIBAN2;EHMT1;NPHP3;NR2C2;LHX1;TRIP12;RACGAP1;NIPBL;WDPCP
prerank,phosphate ion homeostasis (GO:0055062),0.5441575823444851,1.1622209262921672,0.32038834951456313,0.5907069211430528,1.0,3/10,19.31%,FGF23;XPR1;ENPP1
prerank,regulation of cellular metabolic process (GO:0031323),0.3907255453137471,1.1619845538992821,0.2626728110599078,0.5906964842472419,1.0,5/45,6.63%,PID1;PRKN;PARL;KIF16B;FOXM1
prerank,negative regulation of microtubule polymerization (GO:0031115),-0.48025659434488316,-1.1616715890979175,0.2794759825327511,0.8151399695582107,1.0,5/12,16.02%,MAP2;TBCD;MAPRE1;EML2;CLIP3
prerank,negative regulation of interleukin-2 production (GO:0032703),-0.41985980967941816,-1.161584267188193,0.2621145374449339,0.8133287288548634,1.0,5/18,10.69%,NAV3;HAVCR2;PRNP;HDAC7;CD34
prerank,hyaluronan catabolic process (GO:0030214),0.47250881426931196,1.1613795203187929,0.28865979381443296,0.5915566005172148,1.0,2/18,2.35%,LYVE1;CD44
prerank,transcription-coupled nucleotide-excision repair (GO:0006283),-0.30992302888882295,-1.161324134720355,0.19333333333333333,0.8121870730188945,1.0,22/72,19.24%,GTF2H2;CUL4A;CCNH;COPS7A;COPS8;RBX1;ERCC6;COPS4;PPIE;ERCC2;LIG1;XAB2;XRCC1;HMGN1;UVSSA;PRPF19;RFC2;POLR2C;COPS6;GPS1;UBB;RFC1
prerank,maintenance of gastrointestinal epithelium (GO:0030277),0.50727388823488,1.1612036552173242,0.2826086956521739,0.591416065116372,1.0,3/12,14.36%,TLR4;NOD2;RBP4
prerank,stress-activated protein kinase signaling cascade (GO:0031098),0.43673544030886924,1.1611531855397863,0.2756849315068493,0.5910105589708223,1.0,5/27,9.28%,MAP3K5;RPS27A;CCM2;MAP3K8;MAP3K20
prerank,hyaluronan metabolic process (GO:0030212),0.44925728739329424,1.1607464375205137,0.28378378378378377,0.5914026642932567,1.0,2/23,2.35%,LYVE1;CD44
prerank,protein localization to cilium (GO:0061512),-0.36459218122609977,-1.1603488866335252,0.23056300268096513,0.8133519557695664,1.0,10/32,20.65%,BBS9;ATP6V1D;IFT140;IFT20;WDR19;INVS;TCTN1;TULP3;BBS4;ARL3
prerank,membrane protein ectodomain proteolysis (GO:0006509),0.46271097209695056,1.1603476629812146,0.2885572139303483,0.5917526687993023,1.0,8/21,16.89%,ADAM19;ADAM9;PSEN1;SPPL2B;NCSTN;ERAP1;SPPL2A;PRKCQ
prerank,synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),-0.4749170347657776,-1.1601917665020534,0.279826464208243,0.8118605725369863,1.0,4/12,15.04%,SNAP25;SNAP47;STX3;STX2
prerank,transcription initiation from RNA polymerase I promoter (GO:0006361),-0.36670280733044314,-1.159989571159953,0.272264631043257,0.8104889673787293,1.0,13/32,23.27%,GTF2H2;CCNH;MAPK3;UBTF;ERCC2;TAF1C;TAF1D;RRN3;GTF2H4;TAF1;POLR1C;POLR2L;TBP
prerank,mitochondrial calcium ion homeostasis (GO:0051560),0.45465269850321743,1.1598490225844653,0.28665568369028005,0.5923328904985362,1.0,5/21,14.40%,MCUB;MCU;SLC8B1;MICU3;PDZD8
prerank,canonical Wnt signaling pathway (GO:0060070),0.3678492031192074,1.1598022088120614,0.2542134831460674,0.5919039914442449,1.0,12/68,11.02%,LRP6;TCF7L2;RARG;WNT2;AXIN1;GSK3B;FRAT1;TCF7;WNT6;NR4A2;SFRP1;PPP1CA
prerank,cellular response to ATP (GO:0071318),0.4921019951602329,1.1597093179592026,0.29423076923076924,0.5915881957790085,1.0,1/14,0.51%,P2RX7
prerank,gland development (GO:0048732),-0.3171167579369609,-1.1594276521115132,0.20454545454545456,0.8103151734285283,1.0,13/59,21.11%,TGFBR1;SALL1;FGFR2;NF1;TGFBR3;PAX8;PROX1;CDK5RAP3;WNT4;PHF2;NOTCH4;DKK3;ARID5B
prerank,regulation of osteoclast differentiation (GO:0045670),0.41303346524697293,1.1592216793753105,0.27217125382262997,0.5921084919824053,1.0,5/33,6.94%,CCR1;CEBPB;LILRB3;TLR4;TNF
prerank,regulation of receptor signaling pathway via STAT (GO:1904892),-0.46066580683665836,-1.159064510671315,0.28199566160520606,0.8095148353899994,1.0,6/13,10.70%,JAK2;MGAT5;IL7R;PTPRT;DOT1L;JAK3
prerank,sulfation (GO:0051923),0.5343245201549074,1.1590236570249968,0.27977315689981097,0.5920345988007973,1.0,3/11,13.72%,UST;SULT1A1;SULT6B1
prerank,regulation of heterotypic cell-cell adhesion (GO:0034114),0.44709813396781173,1.1587356537341096,0.2905844155844156,0.592171500813382,1.0,5/22,7.22%,MYADM;CD44;WNK1;TNF;KLF4
prerank,ribosomal large subunit assembly (GO:0000027),0.4433187449715673,1.1583304408275437,0.2741652021089631,0.59251672048188,1.0,11/24,17.69%,RPL23A;RSL24D1;RPL24;NOP53;RPLP0;RPL5;RPL6;RPL10;RPL11;RRS1;DDX28
prerank,hemopoiesis (GO:0030097),0.3522276002245862,1.1578608276067668,0.25068870523415976,0.5930324225281065,1.0,23/87,17.64%,RASGRP4;NOTCH2;ZBTB16;KMT2A;ZFP36L2;JAG1;KITLG;TPO;LYL1;NCOA6;ASH2L;SH2B3;SFRP1;CDK13;TET2;KAT6A;RUNX3;MKNK2;CD164;TIRAP;PRDX3;MECOM;ARMC6
prerank,dephosphorylation (GO:0016311),0.3346956400243044,1.1572876904179072,0.2189873417721519,0.5938222467570653,1.0,26/147,11.02%,PTPRJ;PPP3CA;PTPN18;SGPP1;PTPN12;PTPN22;MTM1;DUSP28;MTMR3;DUSP12;DUSP1;CTDSP1;SSH2;PTPRK;PTPRA;PPM1B;HDHD2;DUSP2;PPP4R1;CTDSP2;LHPP;PPP2CA;PPP2CB;PPEF1;PPP4R2;PPP1CA
prerank,epidermal growth factor receptor signaling pathway (GO:0007173),0.3960381400878201,1.1569898863011585,0.2766295707472178,0.5939627960547735,1.0,7/45,8.29%,EGFR;IQGAP1;REPS2;CBL;KIF16B;GAB1;PIK3C2A
prerank,nuclear membrane organization (GO:0071763),-0.4100608328608777,-1.1568640190279957,0.27058823529411763,0.8148900830061344,1.0,7/19,23.96%,AKAP8L;TARDBP;CHMP4B;NSFL1C;EMD;TOR1A;DCTN1
prerank,fatty acid derivative biosynthetic process (GO:1901570),0.41851508391808634,1.1567527513496874,0.26465927099841524,0.5939238742658396,1.0,4/35,6.21%,ALOX5;LTC4S;ALOX5AP;PAM
prerank,"negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",-0.47224480715822936,-1.1566162399232565,0.27439024390243905,0.8137223731869233,1.0,3/11,5.06%,CD274;TWSG1;VSIR
prerank,regulation of stress fiber assembly (GO:0051492),0.36155074543463367,1.1562953101832723,0.24297752808988765,0.5944012537043437,1.0,22/74,15.27%,NRP1;ARAP1;WASF2;GPR65;CDC42;ARHGEF10L;RHOA;RGCC;S100A10;ITGB1BP1;PAK2;ROCK1;CLASP1;SFRP1;PXN;PTGER4;PPFIA1;ROCK2;ARHGAP28;RHOC;CGNL1;STMN1
prerank,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",0.488256818233686,1.1562641629533783,0.2961608775137112,0.5934158061391099,1.0,10/15,27.00%,ZFP36L2;ZFP36L1;NANOS3;TNRC6C;CNOT1;CPEB3;TOB1;NANOS1;AGO2;ZFP36
prerank,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",0.488256818233686,1.1562641629533783,0.2961608775137112,0.5934158061391099,1.0,10/15,27.00%,ZFP36L2;ZFP36L1;NANOS3;TNRC6C;CNOT1;CPEB3;TOB1;NANOS1;AGO2;ZFP36
prerank,transepithelial transport (GO:0070633),-0.449925424469684,-1.156194907205549,0.2727272727272727,0.8132075972558744,1.0,6/15,18.89%,SLC1A3;SLC12A2;SLC1A1;ABCG2;CXADR;SLC1A2
prerank,membrane protein intracellular domain proteolysis (GO:0031293),0.45605362426820517,1.1561296973918216,0.28836424957841483,0.5932245685161452,1.0,11/20,22.04%,ADAM9;RHBDD1;PSEN1;SPPL2B;NCSTN;SPPL2A;RELA;TRAF6;MBTPS2;ADAM17;NFKB1
prerank,generation of neurons (GO:0048699),0.320355500414281,1.1560919928549067,0.21708185053380782,0.5927869069529539,1.0,26/190,10.58%,NRP1;FGFR1;NAV1;OPHN1;MEF2C;SH3RF1;WNT2;RAPGEF2;LRP12;HEY2;CDK6;USP9X;DISC1;CELSR1;IRX2;MTPN;WNT6;NR4A2;LHX5;IRX5;TUBGCP2;OLIG2;ACSL3;CCK;DOCK7;MARK2
prerank,RNA splicing (GO:0008380),-0.29257490102190187,-1.1555499607719977,0.14772727272727273,0.8134049624113127,1.0,27/95,16.22%,IVNS1ABP;LUC7L3;FUS;SRRM1;DDX39B;RP9;TARDBP;DDX47;SNRNP48;SRPK1;GEMIN2;SRSF2;SNRPA1;SRSF10;PRPF4;WBP4;CCAR2;TCERG1;RNPS1;SRPK2;SNRPN;U2AF1;SF3B1;NCBP1;PRPF6;DDX23;ZMAT5
prerank,peptidyl-lysine monomethylation (GO:0018026),-0.49730073607948433,-1.1553465348326157,0.294478527607362,0.812130623344343,1.0,8/10,36.47%,SETD4;SETD3;SETD2;SETD6;SMYD2;METTL18;EEF1AKMT2;SETD7
prerank,N-glycan processing (GO:0006491),0.48130630816464065,1.1551402383034848,0.2924187725631769,0.5943764232742484,1.0,2/18,0.67%,MAN2A1;ST8SIA4
prerank,oligosaccharide metabolic process (GO:0009311),-0.3364901694861243,-1.1550640315422076,0.2215909090909091,0.8111045684234777,1.0,16/46,18.40%,ST3GAL6;ST6GALNAC3;MAN1B1;B3GALT1;NEU1;ST6GALNAC4;B3GALT5;GAL3ST4;B3GALT2;ST8SIA1;ST6GAL2;ST3GAL3;ST8SIA3;IDUA;FUT9;ST3GAL2
prerank,regulation of glycogen biosynthetic process (GO:0005979),0.44215004687505893,1.1549319786429455,0.2781456953642384,0.5943080070820121,1.0,9/24,19.31%,GSK3B;IRS2;INSR;PPP1R3C;IGF1;PPP1R3D;PPP1R3B;INPP5K;ENPP1
prerank,protein targeting to lysosome (GO:0006622),-0.40638689826922963,-1.1546852421114875,0.24121779859484777,0.8103337255175684,1.0,4/20,5.15%,SORL1;GNPTAB;SCARB2;GCC2
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),-0.48518479120829405,-1.1545540642639187,0.310546875,0.8087875557470705,1.0,4/11,20.29%,HTRA2;ST18;PARK7;PRR7
prerank,ureteric bud development (GO:0001657),-0.42108726971551924,-1.1545341606205202,0.2743142144638404,0.8068582286286512,1.0,4/17,4.91%,SALL1;NPNT;ROBO2;FGFR2
prerank,cellular response to leucine starvation (GO:1990253),-0.4935375582585101,-1.1543074980684185,0.2742616033755274,0.8055917523061583,1.0,7/10,19.45%,GCN1;IMPACT;RRAGD;SESN3;RRAGB;MTOR;SESN2
prerank,regulation of receptor-mediated endocytosis (GO:0048259),0.4095082710495741,1.1534898889017995,0.2663622526636225,0.5970254765318659,1.0,5/35,7.63%,HIP1;CBL;CCL19;B2M;HFE
prerank,negative regulation of chemotaxis (GO:0050922),-0.366359715736745,-1.1531422369344164,0.22070844686648503,0.8073838218977593,1.0,13/31,27.83%,SEMA4D;ROBO2;SEMA4C;ROBO1;SEMA4G;AIF1;NOTCH1;CORO1B;SEMA4F;SEMA3B;SEMA3F;SEMA3A;SEMA3D
prerank,extracellular matrix assembly (GO:0085029),0.4386286942523469,1.1525212033645968,0.28646748681898065,0.5986420423908887,1.0,8/23,14.14%,GAS6;ATP7A;MFAP4;PXDN;EMILIN1;RAMP2;NTN4;TNXB
prerank,phosphate ion transport (GO:0006817),-0.4382197925608629,-1.152404382534065,0.27713625866050806,0.8079101616877079,1.0,7/16,20.92%,SLC25A3;SLC37A2;SLC25A14;SLC37A4;SLC25A10;SLC20A2;SLC37A3
prerank,poly-N-acetyllactosamine biosynthetic process (GO:0030311),-0.4745276729597879,-1.1523621097465564,0.2799097065462754,0.8060602184121611,1.0,4/12,14.99%,B3GALT1;B3GALT5;B3GALT2;B3GNT2
prerank,positive regulation of bone resorption (GO:0045780),0.5154490216374482,1.152356878532469,0.3212996389891697,0.5984850073107041,1.0,3/11,6.57%,DCSTAMP;TNFRSF11A;SYK
prerank,posttranscriptional regulation of gene expression (GO:0010608),0.3924566424234463,1.1514155770172603,0.2526002971768202,0.5999879297872021,1.0,10/45,13.22%,APP;RC3H1;PUM2;MTPN;TDRD7;NANOS3;FOXO3;RPL10;TRIM71;LARP4
prerank,regulation of vasoconstriction (GO:0019229),0.43594535895704156,1.1513190066514434,0.28640776699029125,0.5996677494014019,1.0,4/27,8.64%,ATP2B1;ADM;ADRA1D;ADRA1A
prerank,cardiac muscle tissue development (GO:0048738),0.3805750056677608,1.1511603531010481,0.26148969889064977,0.5995309600868968,1.0,10/50,16.56%,NOTCH2;BMP2;HEY2;SMAD4;ADAMTS9;MAML1;GJA1;RBP4;BMPR1A;TBX2
prerank,nucleoside triphosphate metabolic process (GO:0009141),0.5009921642577913,1.150808883931151,0.3094812164579606,0.5998228329779295,1.0,6/14,19.35%,SMPDL3A;CMPK1;AK8;ENPP1;AK3;AK4
prerank,cell cycle G2/M phase transition (GO:0044839),-0.279172846475129,-1.1503266258701785,0.15668202764976957,0.8111505324475042,1.0,41/129,25.33%,CSNK1E;SDCCAG8;CEP135;AKAP8L;ODF2;OPTN;DYNC1H1;SKP1;CEP192;CCNH;CEP250;FBXL7;CCDC57;HAUS8;WEE1;CEP63;PLK3;CCP110;PLCB1;AKAP8;HAUS7;CKAP5;MAPRE1;HAUS3;CHEK2;BRSK2;FBXL6;FBXL3;TAF2;DCTN2;LCMT1;BRSK1;CNTRL;MASTL;HAUS2;DCTN1;PLK4;CDK1;HAUS6;CCNA2;YWHAG
prerank,negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),-0.4591913053113036,-1.149920020023174,0.28274428274428276,0.8105903528160289,1.0,6/12,11.50%,HNRNPU;NELFB;RNF168;RECQL5;TCERG1;NELFCD
prerank,natural killer cell mediated cytotoxicity (GO:0042267),-0.42954654446978396,-1.149804571350233,0.25882352941176473,0.8090328068533819,1.0,6/16,20.82%,LYST;PLEKHM2;VAMP2;CORO1A;VAMP7;ULBP1
prerank,myelination (GO:0042552),-0.3280571744621169,-1.1493218835444294,0.2,0.8085703858478251,1.0,16/46,13.03%,PLP1;MBP;EPB41L3;PARD3;CMTM8;NF1;MAL;SIRT2;DEGS1;ABCD2;NFASC;TPPP;SOX10;SCN8A;BCAS1;PLLP
prerank,aromatic amino acid family metabolic process (GO:0009072),0.5259704707264856,1.1487524283131116,0.3056092843326886,0.603937446066929,1.0,3/10,10.61%,ATP7A;THAP4;KYAT1
prerank,positive regulation of metabolic process (GO:0009893),0.34659015313285824,1.1481909345250292,0.23237597911227154,0.6047231116816988,1.0,19/103,10.91%,IRF4;CMKLR1;CEBPB;ADRB2;CD36;CAMK1D;GHRL;INSR;ADIPOR2;SYK;TNF;CXCR4;CCR2;BEND3;PDGFC;STAT6;TSHR;HADH;ACHE
prerank,"DNA catabolic process, endonucleolytic (GO:0000737)",0.44094850605282454,1.148085111381525,0.289198606271777,0.6044386903887343,1.0,5/23,19.23%,ENDOG;DNASE1L1;DFFA;FBH1;KPNB1
prerank,protein mannosylation (GO:0035268),-0.4040168648480121,-1.1478603163415524,0.2966507177033493,0.8114099153299336,1.0,9/22,24.12%,LARGE1;DPY19L4;TMTC4;DPY19L1;TMTC2;DPY19L3;TMTC1;FKTN;DPM2
prerank,negative regulation of anoikis (GO:2000811),0.4955483454427968,1.1476590083586165,0.324468085106383,0.604852855796364,1.0,3/14,6.34%,ITGB1;MCL1;BCL2
prerank,positive regulation of lamellipodium organization (GO:1902745),0.41498798072238163,1.1472624906680182,0.2588996763754045,0.605229735749474,1.0,6/32,9.55%,RREB1;ACTR3;WASF2;CDC42;ARPC2;CORO1C
prerank,regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),0.5002480990166916,1.1471713605089515,0.30782918149466193,0.6049062777826344,1.0,7/13,18.57%,RHOA;TNF;ITGB2;MDK;RELA;IL6;TRAF6
prerank,regulation of mononuclear cell migration (GO:0071675),0.44190360342115237,1.1470818607857183,0.304857621440536,0.6045702826187044,1.0,7/23,16.81%,CMKLR1;LYN;TNF;MSN;STK10;MDK;CCL5
prerank,amino acid import across plasma membrane (GO:0089718),-0.38852549397707387,-1.146484943644972,0.2780373831775701,0.8141462754467131,1.0,4/24,11.34%,SLC1A3;SLC36A1;SLC1A1;SLC7A8
prerank,response to muramyl dipeptide (GO:0032495),0.5062850740788295,1.1463261941778944,0.30656934306569344,0.6057907458397965,1.0,5/12,12.73%,PTPN22;VIM;RIPK2;CHMP5;NOD2
prerank,rRNA methylation (GO:0031167),-0.39661779975248246,-1.1461679944983976,0.27790973871733965,0.813264681331601,1.0,12/22,35.25%,NSUN5;TFB2M;FTSJ3;MRM3;MRM2;FDXACB1;MTERF4;EMG1;TFB1M;NOP2;FBL;METTL15
prerank,regulation of cytoskeleton organization (GO:0051493),0.33930115080020273,1.1459341515725943,0.2503293807641634,0.6061393379031377,1.0,23/108,14.35%,IQGAP2;P2RX7;IQGAP1;DIAPH1;BST1;ARHGAP18;CRK;RHOA;GSK3B;PAK2;CLIC4;ROCK1;CELSR1;BST2;RHOBTB1;CLASP1;MARK2;ROCK2;ARHGAP17;RND3;SPEF1;RHOC;KATNBL1
prerank,long-chain fatty acid transport (GO:0015909),0.4186945248244957,1.1459267420250312,0.2662337662337662,0.6056370030748359,1.0,3/30,2.76%,APOE;PRKAG2;CD36
prerank,negative regulation of viral genome replication (GO:0045071),0.4003471618298757,1.1455712043104096,0.2797427652733119,0.6059021229284128,1.0,8/40,9.78%,IFITM3;OAS2;FAM111A;RNASEL;TNF;BST2;IFITM2;ILF3
prerank,neuron development (GO:0048666),0.329228022295428,1.1455151542749764,0.22358722358722358,0.6055080206259744,1.0,21/141,6.22%,ETV1;APOE;APP;OPHN1;LYN;RP1;MEF2C;CLN5;RAPGEF2;EHD1;LRP12;B4GALT6;PBX3;GSK3B;RB1;ROCK1;FRY;ATP7A;MANF;WNK1;BLOC1S5
prerank,determination of heart left/right asymmetry (GO:0061371),-0.33009777850305877,-1.145374078738767,0.25065963060686014,0.8139055031637957,1.0,16/42,23.61%,NDRG4;AHI1;BBS7;CCDC39;TBX6;VANGL2;TGFBR2;SMO;MICAL2;NOTCH1;SRF;ENG;BBS4;MKKS;CCDC40;STIL
prerank,positive regulation of vasoconstriction (GO:0045907),0.4977523400636638,1.145358825307318,0.29432624113475175,0.6053222068981715,1.0,5/13,23.68%,ADRA1D;ADRA1A;TBXA2R;F2R;CAV1
prerank,regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),0.467719313086868,1.145191364169664,0.2830508474576271,0.6051692708693746,1.0,5/17,9.32%,SASH1;CD36;NFKBIL1;LY96;CARD16
prerank,regulation of intrinsic apoptotic signaling pathway (GO:2001242),0.3893270941136576,1.1449251343455489,0.2659732540861813,0.6052405727252301,1.0,7/49,6.34%,SGMS1;NUPR1;GSDME;MCL1;RACK1;BCL2L2;BCL2
prerank,ion transport (GO:0006811),-0.27658513364493936,-1.144843555552836,0.1782608695652174,0.8137204067008947,1.0,31/111,18.89%,SLC1A3;SLC12A2;SLC24A3;SLC24A2;SLC8A1;SLC36A1;SLC9A8;TRPM3;PIEZO1;GABRB1;GLRB;LASP1;SLC24A4;SLC25A26;VDAC1;SLC4A2;SLC1A1;SLC25A22;SLC12A6;PIEZO2;SLC17A5;GLRA1;CTNS;TMEM63C;SLC9A1;KCNN2;SLC25A10;SLC24A5;SLC20A2;SLC17A6;SLC1A2
prerank,cellular response to alcohol (GO:0097306),0.39156245326181566,1.14474459762899,0.2845528455284553,0.6051093286936263,1.0,11/42,11.87%,LRP6;CTNNA1;AHR;GNG2;KLF9;GNB1;SFRP1;SPIDR;PTGER4;JUP;GRAMD1B
prerank,epidermal cell differentiation (GO:0009913),0.39314353065382446,1.1441492279883323,0.25471698113207547,0.6058930633458479,1.0,5/41,5.23%,TXNIP;JAG1;ADAM9;KRT10;CLIC4
prerank,negative regulation of GTPase activity (GO:0034260),-0.4013729879015934,-1.1440596766731603,0.24597701149425288,0.8144035076278061,1.0,9/22,20.54%,F11R;GMIP;RASA4;CPEB2;RDX;ARFGEF1;HRAS;PLXNB3;GPSM1
prerank,negative regulation of apoptotic signaling pathway (GO:2001234),0.3535973701011064,1.1436923320516907,0.2618384401114206,0.6063371108109463,1.0,16/77,11.15%,TCF7L2;SH3RF1;RIPK1;SIAH2;PRKN;MCL1;RB1;BCL2L2;BCL2;TNF;NR4A2;BIRC6;MAPK8IP2;IGF1;SLC25A5;PHIP
prerank,ameboidal-type cell migration (GO:0001667),0.382554477914508,1.1436901897515714,0.27421758569299554,0.6058162820470704,1.0,7/51,9.55%,ITGA4;SEMA4A;PKN2;PDLIM1;SGPL1;AMOT;CORO1C
prerank,aerobic respiration (GO:0009060),-0.40695262573418434,-1.1436688947076394,0.2725060827250608,0.8137423252503421,1.0,12/20,40.23%,SDHB;NDUFS7;SLC25A14;UQCRC1;UQCRB;UQCR10;MTFR1;MTFR2;ATP5F1D;OXA1L;SURF1;SDHC
prerank,regulation of sodium ion transmembrane transporter activity (GO:2000649),-0.3419040099452603,-1.1431510452862412,0.2314540059347181,0.8134035185047124,1.0,9/39,9.41%,FGF14;FGF12;PRKCE;YWHAH;SCN1B;HECW2;FGF13;HECW1;WNK3
prerank,receptor clustering (GO:0043113),-0.3678403861539789,-1.1430017424612913,0.2273838630806846,0.8119788822407848,1.0,8/27,6.34%,DLG2;NLGN1;MAGI2;NRXN1;DLG4;DLG3;DVL1;DNAJA3
prerank,ribonucleoside bisphosphate biosynthetic process (GO:0034030),0.5186117542057187,1.1430016117135973,0.31669865642994244,0.6057842812387108,1.0,1/11,0.18%,SLC25A16
prerank,coenzyme A biosynthetic process (GO:0015937),0.5186117542057187,1.1430016117135973,0.31669865642994244,0.6057842812387108,1.0,1/11,0.18%,SLC25A16
prerank,purine nucleoside bisphosphate biosynthetic process (GO:0034033),0.5186117542057187,1.1430016117135973,0.31669865642994244,0.6057842812387108,1.0,1/11,0.18%,SLC25A16
prerank,COPII-coated vesicle cargo loading (GO:0090110),-0.4564213485806572,-1.1427842248908455,0.29321663019693656,0.8107323862511595,1.0,8/14,19.35%,SEC31A;SEC24A;TBC1D20;SCAP;SEC23B;SEC31B;SEC24B;SEC13
prerank,pharyngeal system development (GO:0060037),-0.4391641750489164,-1.1425878496635886,0.29195402298850576,0.8094396357675956,1.0,1/15,0.14%,TGFBR1
prerank,negative regulation of phagocytosis (GO:0050765),0.4676933254544982,1.1409453274579235,0.3154121863799283,0.6098555493729714,1.0,4/17,5.18%,FCGR2B;TLR2;RACK1;SNX3
prerank,sodium ion transport (GO:0006814),-0.29489703284073226,-1.140431436958001,0.21033210332103322,0.8144983746602134,1.0,11/85,7.43%,SLC12A2;SLC24A3;SLC24A2;ATP1B1;SCN1B;SLC8A1;SGK1;FGF13;SLC38A7;NALCN;SLC24A4
prerank,regulation of innate immune response (GO:0045088),0.38199393036639384,1.1403061064210909,0.277037037037037,0.6107780307345938,1.0,16/57,16.96%,FCGR2B;TLR8;IRAK3;PTPN22;BIRC3;RIOK3;RNASEL;IFNAR2;CASP8;POLR3D;SAMHD1;ERAP1;HSP90AB1;TIRAP;CCL5;ACOD1
prerank,proteolysis involved in cellular protein catabolic process (GO:0051603),0.35954319523046263,1.1402232117717714,0.2579250720461095,0.6104366587283213,1.0,14/71,11.51%,CTSC;RPS27A;FBXL17;NR1D1;PRKN;RHBDD1;USP9X;CTSB;VPS4B;MDM2;CLPX;CASP8;NGLY1;PSMA6
prerank,histone lysine demethylation (GO:0070076),0.4365749726838546,1.140155978498827,0.2879045996592845,0.6100728584462175,1.0,9/25,18.87%,PHF8;KDM7A;KDM6A;KDM4D;JMJD1C;KDM5C;KDM2A;KDM1A;KDM4C
prerank,synaptic vesicle transport (GO:0048489),-0.48474333696888183,-1.1399506611323584,0.3232758620689655,0.8140351595451942,1.0,4/11,6.42%,RAB27A;KIF5A;SPG11;KIF5C
prerank,positive regulation of T-helper cell differentiation (GO:0045624),0.4872305156089632,1.1394739901310529,0.31053604436229204,0.6110212932698325,1.0,4/14,13.72%,CCL19;NFKBIZ;CD80;RARA
prerank,negative regulation of axonogenesis (GO:0050771),-0.384937228346387,-1.139383623504325,0.24128686327077747,0.8141207831816272,1.0,10/27,16.42%,MAP2;PTPRS;DIP2B;FGF13;GDI1;LINGO1;MAG;OMG;ULK1;THY1
prerank,positive regulation of endothelial cell migration (GO:0010595),0.35044218986877623,1.1393308808312828,0.2585499316005472,0.6108000597531356,1.0,16/84,12.68%,NRP1;FGFR1;FOXP1;SASH1;RIN2;GRN;ITGB1BP1;CD40;HSPB1;FOXC2;MAPK14;NUS1;SP1;ROCK2;ZC3H12A;BCAS3
prerank,regulation of response to DNA damage stimulus (GO:2001020),-0.3409245058317875,-1.1388462688475849,0.2521246458923513,0.8139209155073802,1.0,7/40,8.11%,PRKCD;CDK9;FXR2;ETAA1;MAPT;SIRT7;FMR1
prerank,rhodopsin mediated signaling pathway (GO:0016056),0.5202447143201434,1.1387628068230236,0.3293172690763052,0.6115460785088924,1.0,2/10,8.00%,PDE6A;GNB1
prerank,monocarboxylic acid transport (GO:0015718),0.3874678446179025,1.1387055248436542,0.28955223880597014,0.6111339506035152,1.0,7/51,8.56%,SLC10A6;SLC16A7;NR1H4;NCOA2;CD36;ABCC4;SLC10A3
prerank,axon guidance (GO:0007411),-0.25742559034572643,-1.1383004402097903,0.152317880794702,0.8138209106265457,1.0,35/201,7.97%,PTPRM;NCAM1;NRXN3;SEMA4D;UNC5C;PIK3CB;EVL;EFNA5;ROBO2;EPHA7;SCN1B;SRC;NRXN1;SEMA4C;GRB10;PLXNA2;PLCG1;ROBO1;LYPLA2;KIF5A;SEMA4G;PALLD;MAPK3;KIF5C;CNTN4;EPHB1;BDNF;BSG;EPHA10;CNTN6;RHOH;CNTN2;SHC3;UNC5D;LAMA2
prerank,intraciliary transport involved in cilium assembly (GO:0035735),-0.3493138890715581,-1.137934399384773,0.23876404494382023,0.8131949658859263,1.0,13/37,18.45%,IFT81;IFT140;DYNLRB1;IFT88;IFT20;WDR19;DYNC2H1;KIF3A;SSX2IP;IFT52;KIF3B;IFT43;DYNC2I1
prerank,histone deacetylation (GO:0016575),0.3884452382917018,1.1377297177438925,0.275,0.6127583819997053,1.0,13/43,16.60%,HDAC9;BRMS1L;MIER1;TBL1XR1;MIDEAS;TBL1X;RCOR2;MIER3;SMARCAD1;HDAC4;SFPQ;PER1;RCOR1
prerank,response to exogenous dsRNA (GO:0043330),0.46562199947339966,1.13771711735276,0.3048128342245989,0.6122552529656434,1.0,3/18,4.11%,COLEC12;IRAK3;RFTN1
prerank,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),0.4453823646952505,1.1374995562529502,0.32698961937716264,0.6122288212980252,1.0,7/23,10.64%,APP;PRKAG2;AXIN1;S1PR2;UBE2K;RIPK2;CALM1
prerank,negative regulation of viral process (GO:0048525),0.3717784807543539,1.1365736986501853,0.27245508982035926,0.613793307076366,1.0,14/57,14.92%,IFITM3;OAS2;LARP7;FAM111A;RNASEL;TRIM32;TNF;BST2;TRIM27;IFITM2;ILF3;BANF1;MID2;PPIA
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),0.36175020487592024,1.1365436934209727,0.2688953488372093,0.6133536147659906,1.0,15/70,14.48%,CYBB;PSMA7;FCER1G;CD36;B2M;LNPEP;MFSD6;PSMB2;NCF2;SNAP23;PSMA6;PSMA3;PSMD1;PSMD5;CYBA
prerank,protein maturation by iron-sulfur cluster transfer (GO:0097428),-0.453270539699011,-1.1364469324901776,0.2956521739130435,0.8161210183383252,1.0,9/13,27.22%,NFU1;LTO1;YAE1;ISCA1;CIAO1;BOLA2;GLRX5;CIAO2B;CISD3
prerank,regulation of exocytosis (GO:0017157),-0.3294488212768131,-1.136421781034653,0.23054755043227665,0.8143239530535983,1.0,20/46,21.01%,CADPS;CLASP2;RIMS2;RAB27A;RAB3C;LGI3;CPLX1;IL1RAPL1;VAMP2;RAB12;CFTR;SYT1;RAB15;CPLANE2;RAB8A;CPLX2;HAP1;CHMP6;CHMP3;RAB9A
prerank,cellular calcium ion homeostasis (GO:0006874),0.33075002241094587,1.1363308872048603,0.24778761061946902,0.6133171884252322,1.0,25/133,14.40%,MCUB;ATP2B1;CCR1;TPT1;STIM2;CCL8;CCL19;MCU;CD40;BCL2;STIM1;CCR2;PSEN1;TMEM165;PLN;TRPC7;SLC10A7;WFS1;YWHAE;SLC8B1;MICU3;ATP2B4;SLC35G1;ATP2A2;PDZD8
prerank,cellular response to interleukin-15 (GO:0071350),0.498705533071999,1.135584100680332,0.3175182481751825,0.6139315566344374,1.0,5/13,13.90%,IL15;SHC1;IL15RA;JAK1;STAT3
prerank,interleukin-15-mediated signaling pathway (GO:0035723),0.498705533071999,1.135584100680332,0.3175182481751825,0.6139315566344374,1.0,5/13,13.90%,IL15;SHC1;IL15RA;JAK1;STAT3
prerank,negative regulation of insulin receptor signaling pathway (GO:0046627),0.42160557917289426,1.135141414374933,0.3099510603588907,0.6144072953967095,1.0,1/27,0.05%,PID1
prerank,protein localization to chromatin (GO:0071168),0.4599306074885918,1.1350330056117572,0.30594405594405594,0.6141363210485491,1.0,3/18,6.07%,ESR1;PPHLN1;MCM9
prerank,sodium ion export across plasma membrane (GO:0036376),0.4967067384178694,1.134677129007089,0.33025830258302585,0.6143920421084736,1.0,5/13,13.92%,FXYD2;SLC4A4;ATP1A4;ATP1A3;ATP1A1
prerank,regulation of cholesterol esterification (GO:0010872),0.5235527915394301,1.1346252501103615,0.32452830188679244,0.6139844162975142,1.0,1/10,0.49%,APOE
prerank,sensory perception of pain (GO:0019233),0.45341144923110094,1.1340496847309267,0.3010033444816054,0.6147116462559457,1.0,4/21,11.13%,P2RX7;CHRNA4;CCR2;KCNK4
prerank,regulation of organelle organization (GO:0033043),0.3514699006134096,1.1339203970845437,0.2506811989100817,0.6144821263288961,1.0,10/80,5.82%,ZEB2;MYO5A;DIAPH1;USP6NL;MTM1;PRKN;PDE2A;PAK2;CLIC4;PARL
prerank,positive regulation of type 2 immune response (GO:0002830),0.4946474862338103,1.1338181908942886,0.33204633204633205,0.6141932112924836,1.0,5/14,17.66%,CD74;DENND1B;NOD2;RARA;IL6
prerank,vitamin D metabolic process (GO:0042359),0.49890105516427996,1.1336735320803488,0.30490018148820325,0.6139699464534534,1.0,2/13,3.63%,FGF23;UGT1A4
prerank,regulation of cell population proliferation (GO:0042127),0.28942149061575567,1.1327676571022578,0.150460593654043,0.6155329966842366,1.0,120/691,15.44%,FOLR2;PF4;EGFR;LIFR;FGFR1;APP;PTPRJ;CHP2;TCF7L2;SGK3;IL15;KIF20B;NUPR1;RPL23;LYN;GRK5;BST1;FER;JAG1;RARG;BNIPL;CBFA2T3;ABI1;TSLP;KRAS;PIAS1;KITLG;BMP2;FGF23;PRKRA;WNT2;THPO;ZFP36L1;RHOA;S100A11;RGCC;RAPGEF2;ITGB1BP1;TNFRSF11A;FRK;NPR3;GSDME;CDK6;IRS2;GHRL;INSR;S1PR2;PTPRK;PDGFRA;ACER3;BCL2;RPS4X;FOXM1;RPS15A;SDCBP;KLF4;DUSP22;PDS5B;STAT4;TIPIN;BIRC6;KLF10;CDC73;IL6R;RPS9;CGREF1;ADRA1D;ADRA1A;ASH2L;TSPYL5;CD33;MDM2;THAP12;SH2B3;PDGFC;CCND2;STAT6;CACUL1;CUL3;IGF1;SFRP1;TSHR;SLC25A5;RPS6;NUP62;FTH1;JUP;PHIP;SHC1;KANK2;ROMO1;CDK13;STRN;NIBAN2;TRIM71;CDKN2C;NAMPT;DIS3L2;GLP2R;CTBP2;MEAK7;CRLF2;ZBTB7C;RNF187;RARA;STAT3;DERL2;JUND;HMGN5;PKD2;PRMT1;IL13RA1;NOX4;BMPR1A;MYC;MELTF;RNF41;FN1;HDAC4;PINX1
prerank,epithelial tube morphogenesis (GO:0060562),0.403245469851169,1.132392385114953,0.2975609756097561,0.6158474717973312,1.0,3/32,4.43%,MTSS1;MEF2C;CCM2
prerank,regulation of striated muscle contraction (GO:0006942),-0.3812450980001557,-1.1323416897020049,0.29842931937172773,0.8259614885752514,1.0,13/27,34.47%,CALM2;SMAD7;ANK2;GRK2;TNNI1;CALM3;SLC8A3;HCN4;RNF207;DMD;ASB3;MYL2;TNNT3
prerank,metal ion export (GO:0070839),0.4130454750305519,1.1322499534227042,0.28780487804878047,0.6156621965482206,1.0,10/31,17.48%,FXYD2;ATP7A;SLC4A4;KCNQ1;ATP2B4;ATP1A4;ATP1A3;ATP1A1;KCNK5;KCNE3
prerank,microtubule cytoskeleton organization involved in mitosis (GO:1902850),-0.2738843883897201,-1.1322369639324255,0.1759656652360515,0.8243822850244372,1.0,60/125,31.87%,CLASP2;DYNC1H1;CENPC;RANBP2;CENPE;WDR62;KNL1;NEK6;NUP85;TACC3;KIF11;CKAP5;EML1;MAPRE1;BUB1B;KIF3B;BUB1;SEH1L;DLGAP5;MAP4;SPDL1;NDC80;NUSAP1;KIF2A;INTS13;SKA2;BCCIP;NSL1;PTPA;CDCA8;B9D2;RCC1;SEC13;SETD2;DCTN2;ZW10;CENPP;CENPN;CENPH;ESPL1;ZWINT;STIL;BIRC5;MAD2L1;CEP126;CENPI;SPC25;AURKB;PMF1;DYNLL2;KIF2C;TTK;CENPF;SGO1;NUDC;PPP1CC;CLIP1;NUF2;TUBG1;AURKA
prerank,negative regulation of cellular response to insulin stimulus (GO:1900077),0.41548086694311864,1.1319518911171433,0.313915857605178,0.6158100676627367,1.0,1/28,0.05%,PID1
prerank,axonal transport (GO:0098930),-0.3497691283263767,-1.1318599115597272,0.25895316804407714,0.8237250275896354,1.0,9/36,14.09%,DST;DYNC1H1;KIF1A;AP3B2;MAPT;AP3D1;TMEM108;KIF3A;KIF3B
prerank,vesicle transport along microtubule (GO:0047496),-0.39354788067563196,-1.1318114191202784,0.2761904761904762,0.822004071699288,1.0,11/23,26.78%,DYNC1H1;KIF1A;CLN3;KIF5A;KIF1C;KIF3A;KIF3B;BICDL1;HAP1;KIFAP3;KIF5B
prerank,anterior/posterior pattern specification (GO:0009952),-0.3207596800084705,-1.131444013586944,0.24307692307692308,0.8212520745333196,1.0,10/53,17.48%,TGFBR1;BASP1;LRP5;HOXC4;BHLHE41;DDIT3;CELSR2;HOXA3;HOXC5;HOXB9
prerank,protein stabilization (GO:0050821),0.3217995451198895,1.130961144462834,0.22826086956521738,0.617433910106911,1.0,40/168,17.33%,HIP1;GNAQ;FBXW7;RPL23;RASSF2;PRKRA;GRN;PRKN;AFM;LAMP1;USP9X;CTNND1;STK3;NOP53;BAG3;SUGT1;RPL5;CCT6A;RPS7;TBL1X;IGF1;RTN4;LAMP2;CRYAB;WFS1;CREB1;TSPAN1;EP300;PARVA;RPL11;NLK;MCM8;HSP90AB1;HCFC1;PTEN;COG7;SEC16A;CCT3;MFSD1;FLOT2
prerank,innate immune response in mucosa (GO:0002227),0.5374287202846105,1.1305969945387506,0.3258845437616387,0.6176899034453979,1.0,1/10,2.50%,RPL39
prerank,phosphorylation (GO:0016310),0.29498725678894516,1.1303131360312941,0.19135135135135134,0.6178168071639916,1.0,71/384,12.36%,POMK;FGFR1;APP;MAP3K5;STK17B;SGK3;PEAK1;CDC42BPG;PRKAG2;GAS6;GMFG;LYN;GRK5;FER;DAPK1;IRAK3;OXSR1;BMP2;PRKAG3;ERN1;MAP3K1;CDK12;IP6K3;FRK;CDK6;GSK3B;INSR;CAMKK2;GNPTG;PKN2;PAK2;MAPKAPK2;ROCK1;STK24;STK3;RNASEL;WNK1;VRK2;ACVR2A;SYK;CHEK1;FAM20A;ZAP70;NRK;PPP4R1;PRKCB;BIRC6;FYN;CDK14;CDK20;VRK1;LIMD1;DYRK1A;FGGY;MAP3K20;MAST1;ILF3;DGKH;MARK2;MAML1;STK10;CDK13;JAK1;STK36;CDK17;ROCK2;STK38;PRKACB;MKNK1;TRIB2;MAP3K11
prerank,positive regulation of DNA repair (GO:0045739),0.38058815577658345,1.1299134266836397,0.2783661119515885,0.618205996446307,1.0,8/46,7.70%,EGFR;RPS3;BABAM2;FAM168A;FOXM1;BRCC3;DDX11;CEBPG
prerank,axonemal dynein complex assembly (GO:0070286),-0.3668298203382047,-1.1289420296933288,0.291358024691358,0.8276719577836077,1.0,10/27,24.85%,TTC12;CCDC39;DNAI4;DNAH8;DNAH5;ODAD1;ODAD2;CCDC40;DNAI3;SPAG1
prerank,sympathetic nervous system development (GO:0048485),0.4741285297018587,1.1280908083897019,0.3197879858657244,0.6217778039342303,1.0,1/15,0.34%,NRP1
prerank,positive regulation of Wnt signaling pathway (GO:0030177),0.319901810139226,1.1279571421926378,0.2595419847328244,0.6215644198771051,1.0,34/152,17.21%,ZEB2;EGFR;SMURF2;PSMA7;BMP2;AXIN1;NRARP;TLR2;GPRC5B;DISC1;FRAT1;WNK1;DEPDC1B;PPM1B;PSMB2;TBL1XR1;CDC73;SULF2;TBL1X;SFRP1;WLS;JUP;PSMA6;LRRK1;PLEKHA4;PSMA3;PSMD1;PSMD5;GPC3;USP47;PPM1A;AMER1;LGR4;RNF146
prerank,negative regulation of cytokine production involved in immune response (GO:0002719),0.4679158917487348,1.12777648271673,0.3037974683544304,0.6214814158728048,1.0,4/15,7.63%,IRAK3;LILRB1;TNF;HFE
prerank,histone modification (GO:0016570),0.33330552450865686,1.1277246073663767,0.2677595628415301,0.6210786918527365,1.0,27/109,16.64%,HDAC9;PADI4;USP3;ATXN7;PHF20;INCENP;BRMS1L;MIER1;TBL1XR1;MIDEAS;TBL1X;USP21;USP16;RCOR2;MIER3;CREBBP;UBE2N;EP300;KAT6A;EHMT1;PRMT1;ENY2;NSD3;USP22;HDAC4;RCOR1;UBE2U
prerank,acetylcholine receptor signaling pathway (GO:0095500),0.4515626665747316,1.127541114793151,0.3112244897959184,0.620955947199348,1.0,3/20,8.00%,GNAQ;RGS8;GNB1
prerank,establishment or maintenance of apical/basal cell polarity (GO:0035088),-0.407221160520817,-1.127240470541174,0.28440366972477066,0.8315751629051712,1.0,4/19,4.70%,DLG2;PARD3;DLG3;MTCL1
prerank,regulation of sprouting angiogenesis (GO:1903670),0.409031312044257,1.1269638175288832,0.31456953642384106,0.6217064082887479,1.0,9/33,11.81%,ALOX5;KLF2;S100A1;EPN2;KLF4;SYNJ2BP;ADAMTS9;CEMIP2;JAK1
prerank,megakaryocyte differentiation (GO:0030219),0.5132018675624943,1.1266188118104468,0.330188679245283,0.6219256409624627,1.0,2/11,9.36%,THPO;SH2B3
prerank,cellular response to interferon-gamma (GO:0071346),0.3456127246668776,1.1265690489419116,0.27163781624500666,0.621525674316099,1.0,14/88,8.27%,IRF4;OAS2;GBP3;DAPK1;CD44;CCL8;TLR4;CCL19;B2M;TLR2;GBP7;IRF2;CCL24;TRIM68
prerank,smoothened signaling pathway (GO:0007224),-0.35524176789134765,-1.1263747242843112,0.27851458885941643,0.8324423029208671,1.0,14/32,28.95%,PTCHD1;DYRK2;SMO;GPC2;HIPK1;ULK3;GLI3;DISP2;TMEM231;TMEM17;STIL;TTBK2;TCTN2;B9D1
prerank,negative regulation of macroautophagy (GO:0016242),0.41765073411253306,1.1254460471223486,0.31006493506493504,0.6235202417842891,1.0,6/26,13.46%,NUPR1;MTM1;FEZ2;SMCR8;UBQLN4;RUBCN
prerank,regulation of DNA replication (GO:0006275),0.3735160331575525,1.1253296406742554,0.29012345679012347,0.6232711685651,1.0,11/49,14.26%,EGFR;ORC5;ANKRD17;S100A11;ESCO2;GMNN;ESCO1;PPP2CA;RBBP6;KAT7;TERF1
prerank,mRNA catabolic process (GO:0006402),0.38276820779789145,1.1251212820693355,0.29742033383915023,0.6232273824320517,1.0,10/44,13.34%,DHX34;ZFP36L2;ERN1;TUT7;RC3H1;TUT4;DCP2;DIS3L2;ZC3H12D;LSM2
prerank,regulation of peptidyl-serine phosphorylation (GO:0033135),0.33512166360149465,1.1251163005903184,0.27097661623108665,0.6227208614582249,1.0,22/93,18.10%,EGFR;APP;GAS6;RASSF2;CD44;AXIN1;RACK1;PDE4D;TNF;FNIP1;CNKSR3;RIPK2;DOCK7;ATP2B4;TERF2IP;CNOT9;PRKD2;HSP90AB1;PTEN;SPRY2;IL6;RAF1
prerank,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),0.4125615631783902,1.1244425365119701,0.3168,0.6236967150731783,1.0,9/28,15.86%,SPI1;BCL2;BAG3;TNF;ZDHHC3;CASP8;DIABLO;TNFRSF1A;GABARAP
prerank,receptor recycling (GO:0001881),-0.4828266908496165,-1.1241523095485515,0.3276595744680851,0.8382858790511585,1.0,5/10,32.40%,SORL1;EHD3;PHETA1;NSG1;REP15
prerank,phosphatidylinositol-mediated signaling (GO:0048015),-0.3035453301504446,-1.124131665781002,0.25597269624573377,0.8364493179602982,1.0,18/69,14.02%,PLCL1;PLCB2;PIK3CB;PLCB4;NYAP2;PLEKHA1;PI4KA;NF1;MYO16;INPP5F;PIK3C2B;SIRT2;CSF1R;PLCB1;PLCH1;PIK3R5;C1QBP;TYRO3
prerank,regulation of TORC1 signaling (GO:1903432),-0.34058439749933295,-1.124030433573671,0.2736318407960199,0.8348904985583565,1.0,8/33,8.53%,GPR137B;GPR137C;STK11;RRAGD;ATM;FLCN;SESN3;CASTOR2
prerank,mitochondrion distribution (GO:0048311),0.4937485115859789,1.123022934520071,0.30241187384044527,0.6264036041069672,1.0,4/12,13.59%,MEF2A;MTM1;ARMC1;TRAK2
prerank,axon development (GO:0061564),-0.29008068601152953,-1.1222953032034275,0.2222222222222222,0.8388231051415276,1.0,20/78,16.80%,RTN4RL1;PLP1;GRM7;CTNNA2;PARD3;MAP1B;NEFH;FGFR2;CNTN4;MAPT;NTNG1;LLGL1;S100B;AFG3L2;DSCAML1;APBB1;SLITRK5;ADGRB1;EPHB2;BRSK2
prerank,vasodilation (GO:0042311),0.49724023100182957,1.1216430143168863,0.3263525305410122,0.6289657384805597,1.0,2/13,2.53%,KLF2;ADRB2
prerank,heparan sulfate proteoglycan metabolic process (GO:0030201),-0.3843700859928517,-1.1215628467675796,0.29594272076372313,0.8394039231241031,1.0,6/21,5.89%,EXTL3;XYLT1;HS3ST5;HS3ST4;HS6ST1;SULF1
prerank,negative regulation of potassium ion transmembrane transport (GO:1901380),-0.4729253414416199,-1.121237513192894,0.3340857787810384,0.8386835977253255,1.0,2/11,8.73%,BIN1;ACTN2
prerank,protein deacetylation (GO:0006476),0.3793810150817917,1.121182008981758,0.2981366459627329,0.6295099859235749,1.0,8/41,10.56%,HDAC9;BRMS1L;MIER1;TBL1XR1;MIDEAS;TBL1X;RCOR2;MIER3
prerank,positive regulation of multicellular organismal process (GO:0051240),0.30166644783650043,1.1208832709218302,0.22160356347438753,0.6296562549397596,1.0,41/308,11.19%,DAB2;APOE;IRF4;CLEC6A;CMKLR1;IL15;ZBTB16;RREB1;GAS6;SMURF2;NCOA3;C1QTNF3;CEBPB;ADRB2;BMP2;CD36;ALX1;RGCC;LBP;GHRL;SMAD4;ROCK1;ADIPOR2;SYK;SDCBP;TNF;CXCR4;CCR2;ESRRB;ADRA1D;ADRA1A;PDGFC;STAT6;RTN4;TSHR;TRIM16;PTGER4;HADH;B4GALT5;ACHE;KMT5B
prerank,ureteric bud morphogenesis (GO:0060675),-0.42486963755384044,-1.1208091369261814,0.31381733021077285,0.8381781484153811,1.0,3/16,4.14%,SALL1;NPNT;FGF2
prerank,somite development (GO:0061053),-0.46698179863599554,-1.1207972538885225,0.3224400871459695,0.8363368198216984,1.0,6/11,36.77%,LOXL3;SMO;SOX11;MEOX2;SHH;SFRP2
prerank,positive regulation of double-strand break repair via homologous recombination (GO:1905168),-0.43338731334259534,-1.120783879391643,0.324435318275154,0.8345135394165883,1.0,5/14,20.74%,FUS;PARP1;ERCC6;RAD51AP1;WRAP53
prerank,phosphate-containing compound metabolic process (GO:0006796),-0.2467109200219008,-1.120589578523364,0.14838709677419354,0.8332387044166123,1.0,31/198,11.24%,HK2;INPP4B;CERK;INPP5D;PLCB2;PIK3CB;PLD4;PTPRD;PFKL;EPHA7;PAK1;GFPT1;DUSP10;PLCB4;PLPP3;PI4KA;PLCG1;ALDOA;LPL;GK;MAPK3;PGK1;PLPPR1;DUSP15;ALK;GPX4;PFKP;XYLB;MINPP1;PLCB1;PLCH1
prerank,regulation of membrane repolarization (GO:0060306),-0.44441078793705935,-1.1205109513104552,0.3288888888888889,0.8316636811908428,1.0,3/13,5.92%,KCNJ2;CACNA2D1;AKAP6
prerank,immune response-regulating cell surface receptor signaling pathway (GO:0002768),0.5124441670291294,1.12045157586714,0.34953271028037386,0.6300892183442028,1.0,3/10,6.13%,LYN;LILRB1;CD40
prerank,positive regulation of signaling (GO:0023056),-0.3382351418718485,-1.1201643149010385,0.28450704225352114,0.8309172250511893,1.0,7/37,8.46%,RIMS1;GRIK2;PTPN23;RIMS2;DLG4;KCTD13;INPP5F
prerank,skeletal system morphogenesis (GO:0048705),0.38802455451155965,1.1199120378699894,0.3099236641221374,0.6307701169108506,1.0,7/42,9.99%,LRP6;FGFR1;ALX1;ANKRD11;PDGFRA;RFLNB;CYP26B1
prerank,calcium ion import across plasma membrane (GO:0098703),-0.438808931948529,-1.1188315882552764,0.3458333333333333,0.8335254207136025,1.0,3/14,4.93%,SLC24A2;SLC8A1;CACNA2D1
prerank,pore complex assembly (GO:0046931),0.44053509667507396,1.118682722336323,0.30244755244755245,0.633009523904195,1.0,2/19,1.78%,P2RX7;ANO6
prerank,response to hydrogen peroxide (GO:0042542),0.37524604416315,1.1185519402590884,0.2750759878419453,0.6327990618003299,1.0,15/45,18.05%,MAP3K5;RPS3;OSER1;RIPK1;ADAM9;HMOX1;STK24;FYN;TRPM2;NET1;MAPK7;PRDX3;RELA;IL6;APTX
prerank,I-kappaB phosphorylation (GO:0007252),0.5083138813636563,1.1185514080252636,0.3376865671641791,0.6322800049057029,1.0,2/10,4.23%,TLR4;TLR2
prerank,positive regulation of protein localization to cell periphery (GO:1904377),-0.3159769357781228,-1.1181764877781306,0.25770308123249297,0.8338824232655677,1.0,16/52,17.14%,EPB41L2;DPP10;PRKCE;TREM2;GNAI1;STX3;WNK3;PDPK1;STAC2;NUMA1;EPHA3;EPHB2;CLIP3;ARF6;SQSTM1;STAC
prerank,regulation of mRNA polyadenylation (GO:1900363),-0.4237439441352001,-1.1179449171077813,0.33183856502242154,0.8328231431413639,1.0,5/17,14.43%,CPSF6;CDK9;CTR9;HSF1;NCBP1
prerank,positive regulation of cysteine-type endopeptidase activity (GO:2001056),0.36587993727702645,1.1173528077557464,0.2911764705882353,0.6344244490286536,1.0,11/57,11.05%,NLRC4;MAP3K5;DAPK1;BCL10;SYK;TNF;UACA;FYN;CYCS;RIPK2;CASP8
prerank,peptidyl-lysine trimethylation (GO:0018023),0.41895599476060635,1.1169376635638977,0.30971993410214166,0.6347729296275233,1.0,7/26,13.84%,KMT2A;VCPKMT;TET3;WDR82;BEND3;KMT5B;TET2
prerank,positive regulation of canonical Wnt signaling pathway (GO:0090263),0.3218398244959447,1.1168417323614077,0.2784163473818646,0.6344595711547258,1.0,28/129,17.21%,ZEB2;EGFR;SMURF2;PSMA7;AXIN1;NRARP;GPRC5B;FRAT1;WNK1;PPM1B;PSMB2;TBL1XR1;TBL1X;SFRP1;WLS;JUP;PSMA6;LRRK1;PLEKHA4;PSMA3;PSMD1;PSMD5;GPC3;USP47;PPM1A;AMER1;LGR4;RNF146
prerank,positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),-0.38979915806388377,-1.1167811853346614,0.28935185185185186,0.8349097312460153,1.0,4/23,2.43%,JAK2;OCIAD1;PTK2B;IL10RA
prerank,positive regulation of reactive oxygen species biosynthetic process (GO:1903428),0.4960619196615727,1.1166803394868654,0.3427495291902072,0.6342883734453723,1.0,5/12,17.95%,CD36;TLR4;ZNF205;CYBA;SLC5A3
prerank,regulation of mast cell activation (GO:0033003),0.5178808361728425,1.1166620085886856,0.3474088291746641,0.633816813883354,1.0,3/10,2.86%,LYN;TSLP;HAVCR1
prerank,response to purine-containing compound (GO:0014074),0.4677922080857486,1.1162517647666048,0.34954954954954953,0.6342305268891179,1.0,2/17,3.28%,P2RX7;P2RY6
prerank,maturation of SSU-rRNA (GO:0030490),0.39881929364069235,1.1161237756097953,0.3153724247226624,0.6340046460294342,1.0,8/34,9.97%,RPS16;SNU13;RPS28;RPS8;RIOK3;RPS14;MRPS11;HEATR1
prerank,negative regulation of peptidase activity (GO:0010466),0.376719153229496,1.1154486434305093,0.3005952380952381,0.6349927853357561,1.0,2/47,1.51%,SERPINB8;SERPINB2
prerank,regulation of T cell activation (GO:0050863),-0.32273907810404556,-1.1154342023261798,0.2915451895043732,0.8372948181938016,1.0,3/42,1.26%,SIRPA;PAG1;CCDC88B
prerank,regulation of ERAD pathway (GO:1904292),-0.45897604328954633,-1.1153103690346733,0.3459915611814346,0.8358469836378843,1.0,4/11,11.57%,TMEM259;USP19;BAG6;UBXN1
prerank,ribosomal large subunit biogenesis (GO:0042273),0.3638255164379594,1.115307238351634,0.3033033033033033,0.6347903081717075,1.0,14/54,11.89%,RPL23A;RPL26;SNU13;RSL24D1;RPL24;NOP53;RPL35A;RPLP0;RPL5;MALSU1;RPL14;RPL6;MRPL1;RPL10
prerank,positive regulation of lamellipodium assembly (GO:0010592),0.4313937648004408,1.1147231962846709,0.3126050420168067,0.6355336838743568,1.0,4/24,7.30%,ACTR3;WASF2;CDC42;ARPC2
prerank,negative regulation of endothelial cell migration (GO:0010596),0.40252628676666263,1.1142449283235332,0.33444259567387685,0.6360763994449904,1.0,9/36,12.32%,APOE;MEF2C;RGCC;TNF;SYNJ2BP;ADAMTS9;SP100;JUP;ATP2B4
prerank,intestinal absorption (GO:0050892),-0.4395187267571321,-1.1141396444636418,0.32450331125827814,0.8379788420163178,1.0,3/13,7.13%,F11R;TJP2;SLC2A5
prerank,positive regulation of response to endoplasmic reticulum stress (GO:1905898),0.44865582761976674,1.1140750379211912,0.32525951557093424,0.6359556955118473,1.0,2/18,3.17%,FCGR2B;ERN1
prerank,protein phosphorylation (GO:0006468),0.2882288037674899,1.1136873841668016,0.2167019027484144,0.6362945675296452,1.0,83/478,12.36%,EGFR;FGFR1;APP;MAP3K5;STK17B;SGK3;PEAK1;CDC42BPG;PRKAG2;GAS6;GMFG;LYN;GRK5;FER;DAPK1;IRAK3;ABI1;OXSR1;BMP2;RIPK1;PRKAG3;ERN1;TLR4;MAP3K1;CAMK1D;CDK12;RPS6KA3;TLR2;IP6K3;FRK;CDK6;GSK3B;INSR;CAMKK2;INCENP;PKN2;PAK2;MAPKAPK2;PDGFRA;ROCK1;STK24;STK3;RNASEL;WNK1;VRK2;ACVR2A;SYK;CHEK1;FAM20A;USP15;ZAP70;NRK;HTATIP2;PPP4R1;PRKCB;BIRC6;FYN;ULK2;CDK14;CDK20;VRK1;DDR2;MAPK14;DYRK1A;MAP3K20;MAST1;RPS6KA6;ILF3;EPHB4;MARK2;MAML1;STK10;CDK13;JAK1;STK36;MAP3K3;CDK17;ROCK2;STK38;PRKACB;MKNK1;TRIB2;MAP3K11
prerank,defense response to symbiont (GO:0140546),0.3420114838414415,1.1134993496064973,0.29972375690607733,0.6362000615315785,1.0,16/92,10.67%,TLR8;IFITM3;OAS2;LILRB1;SERINC3;TLR2;TRIM56;RNASEL;CD40;BCL2;BST2;IFNAR2;RNASE6;IRF2;IFITM2;ATG7
prerank,"negative regulation of DNA-templated transcription, elongation (GO:0032785)",-0.435291441280927,-1.1133891342899596,0.3023255813953488,0.8385041123368484,1.0,6/13,11.50%,HNRNPU;NELFB;RNF168;RECQL5;TCERG1;NELFCD
prerank,protein maturation (GO:0051604),-0.280047832157354,-1.1129847594522995,0.23673469387755103,0.838075778090703,1.0,27/95,20.19%,SORL1;NFU1;CLN3;CTSS;APH1A;ADAMTS3;NAA40;F3;NAA60;MMP16;LMF1;DNAJB11;AFG3L2;AEBP1;ISCA1;EEF1AKMT4-ECE2;TSPAN33;NAA35;TYSND1;ADAM10;CPM;CPE;FURIN;STUB1;CIAO1;BOLA2;NNAT
prerank,cellular protein modification process (GO:0006464),0.2810967956426703,1.1125739454090495,0.16177957532861476,0.637768469656234,1.0,190/982,16.43%,F13A1;APOE;MAN2A1;PADI4;IGFBP4;FGFR1;APP;ST8SIA4;MAP3K5;CP;PTPRJ;STK17B;SGK3;PPP3CA;FBXW7;PEAK1;PTPN18;ZBTB16;CDC42BPG;PRKAG2;GAS6;GMFG;PSMA7;UST;LYN;GRK5;DNAJC3;PGAP1;FER;PTPN12;DAPK1;IRAK3;PTPN22;SHISA5;OXSR1;MTM1;BMP2;FUT4;PARP14;ASB14;FGF23;TGM7;PRKAG3;ERN1;MAP3K1;PARP8;ST3GAL1;CDK12;MTMR3;BTBD1;LOX;DUSP12;DUSP1;IP6K3;FRK;KRT10;CDK6;CTDSP1;SERP1;GSK3B;SSH2;MANBA;RHBDD1;INSR;CAMKK2;PKN2;PAK2;PTPRK;MAPKAPK2;NOTUM;ROCK1;KLHL13;STK24;STK3;RNASEL;FBXL5;KLHL5;WNK1;VRK2;ACVR2A;PTPRA;SYK;CHEK1;MSRA;FAM20A;ZAP70;WIPI1;PPM1B;NRK;PSMB2;PIGU;DUSP2;PPP4R1;CTDSP2;UBXN7;PRKCB;BIRC6;FYN;FCGR3A;CDK14;CDK20;VRK1;UBE2D3;ALG5;DYRK1A;MAP3K20;COP1;MAST1;LHPP;RAB1A;PPP2CA;PPP2CB;CUL3;ILF3;FBXO11;PARP16;GNMT;NUS1;PPEF1;PPP4R2;MARK2;MAML1;ATG7;B4GALT5;PPP1CA;CHM;STK10;NGLY1;PSMA6;CDK13;PTP4A2;WFS1;JAK1;STK36;DCAF6;CDK17;ROCK2;ENGASE;STK38;PRKACB;MKNK1;TRIB2;NUCB1;MAP3K11;LOXL2;ERO1A;FBXO10;ATG10;CREB1;LATS2;CDKL4;RARA;RAB11A;ASB12;HIF3A;SERPIND1;SUMF2;TGM4;PSMA3;PSMD1;RPN2;PSMD5;PRKD2;GPC3;ELOC;BMPR1A;MELTF;ST3GAL4;ASB4;FN1;NLK;PTPN13;PPP2R2A;PRKCG;WIPI2;PTPN14;ICMT;USP25;GMFB;FBXW2;RUNX3;GRK4;DUSP7;ATG5;PTEN;COG7;MKNK2;PRRT1;HSP90B1;PPM1A
prerank,positive regulation of viral genome replication (GO:0045070),-0.3546862082906551,-1.1121254695571012,0.3059125964010283,0.8391440102158836,1.0,9/29,18.99%,ADAR;CNOT7;SRPK1;PPIE;SRPK2;ADARB1;TOP2A;TARBP2;TMEM39A
prerank,ether lipid metabolic process (GO:0046485),0.47717919919941354,1.1119094778762664,0.32037037037037036,0.6387436448620408,1.0,8/14,17.11%,AGMO;PLA2G7;PEX7;AGPS;PAFAH1B1;PLAAT3;FAR1;PEDS1
prerank,negative regulation of response to wounding (GO:1903035),0.4435312190578591,1.1117423531192525,0.3188908145580589,0.6386064671693252,1.0,3/19,3.52%,ALOX5;CASK;CRK
prerank,protein export from nucleus (GO:0006611),-0.3624818009193433,-1.1114862041222981,0.30238095238095236,0.8393043349474778,1.0,12/27,36.04%,RANBP17;RANBP3L;EGR2;SMURF1;TGFB1;CSE1L;RANBP3;NUP214;CHP1;STRADB;PKD1;RAN
prerank,secondary palate development (GO:0062009),-0.43527971120597597,-1.1114132469203926,0.3347547974413646,0.8377355943181553,1.0,7/14,27.93%,CHD7;TGFBR3;TGFBR2;TGFB2;WNT5A;LEF1;WNT7A
prerank,negative regulation of cell-matrix adhesion (GO:0001953),0.4054735422963131,1.111085688716429,0.31968503937007875,0.6395567660566446,1.0,7/32,9.55%,CASK;JAG1;RASA1;ITGB1BP1;DUSP22;RCC2;CORO1C
prerank,negative regulation of supramolecular fiber organization (GO:1902904),-0.2962872524443557,-1.1110471062150125,0.22535211267605634,0.8371699851532486,1.0,19/72,13.19%,NAV3;PRKCD;MAP2;TREM2;CLASP2;TBCD;CAMSAP1;FGF13;SHANK1;TWF2;PLEKHH2;IAPP;ARHGEF2;PFDN2;ARFGEF1;VBP1;MAPRE1;EML2;CORO1A
prerank,cellular iron ion homeostasis (GO:0006879),0.36781046622488256,1.1106895850394949,0.29790419161676646,0.6399284434197916,1.0,17/55,16.26%,CP;HMOX1;FTL;NDFIP1;SMAD4;FBXL5;GLRX3;HFE;HMOX2;ATP6V1A;ACO1;NUBP1;FTH1;TFR2;ABCB7;MYC;ATP6V0D1
prerank,positive regulation of supramolecular fiber organization (GO:1902905),0.3375844581095624,1.110498391926814,0.29918032786885246,0.6398410064918907,1.0,12/86,10.39%,APOE;APP;SNX9;ALOX15;FER;RPS3;FCHSD2;RB1;PSEN1;CCL24;CLASP1;SYNPO
prerank,calcium ion import into cytosol (GO:1902656),-0.4231244082408428,-1.1095549686055985,0.348643006263048,0.8403124571126523,1.0,3/15,4.93%,SLC24A2;SLC8A1;CACNA2D1
prerank,response to acidic pH (GO:0010447),0.48031216556716716,1.1095366273661138,0.34065934065934067,0.6415420244301717,1.0,2/13,2.55%,RAB11FIP5;GPR65
prerank,negative regulation of small GTPase mediated signal transduction (GO:0051058),-0.38401085338852614,-1.109490053411998,0.32867132867132864,0.8387005147927965,1.0,4/21,6.23%,RASAL3;ARHGAP25;LZTR1;STAMBP
prerank,homologous chromosome segregation (GO:0045143),-0.3927084173113313,-1.1093756931203491,0.3385012919896641,0.8373316245491913,1.0,5/20,16.00%,CENPC;SIRT7;ZCWPW1;FANCD2;IHO1
prerank,mRNA export from nucleus (GO:0006406),-0.2754081469283925,-1.1092799578502344,0.2518248175182482,0.8358705372776037,1.0,37/102,26.63%,THOC1;SRRM1;SRSF5;PABPN1;HNRNPA2B1;NXF1;DDX39B;SRSF3;NUP210;RANBP2;SRSF2;UPF1;RNPS1;NUP85;U2AF1;MCM3AP;UPF3B;CASC3;NCBP1;SEH1L;NXT1;SRSF11;THOC3;SRSF9;AAAS;SEC13;POLDIP3;GLE1;ALYREF;U2AF2;ALKBH5;SLBP;SRSF6;NDC1;EIF4E;NUP93;NUP50
prerank,regulation of supramolecular fiber organization (GO:1902903),-0.38389796286249434,-1.1092769039556118,0.2853717026378897,0.834107139468866,1.0,9/22,16.22%,MAP2;CAMSAP1;MAP1B;MAPT;AKAP13;MAPRE3;GBA2;AEBP1;PARK7
prerank,nucleotide-excision repair (GO:0006289),-0.2799209403082629,-1.1090496138519736,0.21673003802281368,0.8329763616794632,1.0,30/101,19.24%,GTF2H2;CUL4A;TP53;CCNH;COPS7A;PARP1;COPS8;DDB2;RBX1;ERCC6;SLC30A9;COPS4;PPIE;ERCC2;HUS1;LIG1;XAB2;XRCC1;BRCA2;HMGN1;UVSSA;PRPF19;RFC2;POLR2C;COPS6;GPS1;POLE;POLL;UBB;RFC1
prerank,cortical cytoskeleton organization (GO:0030865),-0.33231662338696166,-1.1087795369850149,0.29916897506925205,0.8320901572593682,1.0,14/41,16.91%,EPB41L3;NCKAP1;FMNL2;NLGN1;RHOBTB2;RHOQ;NCKAP1L;FHOD1;RHOH;LLGL1;STRIP1;LLGL2;ARF6;PLEK
prerank,steroid biosynthetic process (GO:0006694),0.3644055823158938,1.1086133620452991,0.31007751937984496,0.6431284503455641,1.0,8/56,11.94%,PRKAG2;OSBPL9;HMGCR;HSD3B7;CYP27A1;PMVK;OSBPL1A;LBR
prerank,regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),0.4496847591556038,1.1074857341890252,0.3382899628252788,0.6451731798252085,1.0,3/17,2.42%,GMFG;WASF2;FCHSD2
prerank,regulation of hippo signaling (GO:0035330),0.44911984415759537,1.1074200426947152,0.3315696649029982,0.6447874911543415,1.0,8/17,20.00%,MOB3B;LIMD1;MAPK14;WWC1;VGLL4;MARK3;DLG5;WWC2
prerank,positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),0.48585785367057643,1.1072855835342466,0.34124087591240876,0.6440646451360519,1.0,3/12,9.90%,CHP2;TNF;IGF1
prerank,positive regulation of calcineurin-mediated signaling (GO:0106058),0.48585785367057643,1.1072855835342466,0.34124087591240876,0.6440646451360519,1.0,3/12,9.90%,CHP2;TNF;IGF1
prerank,regulation of cell projection organization (GO:0031344),-0.4350809109692327,-1.1071877792906697,0.32421052631578945,0.8356043781185298,1.0,4/13,8.31%,SEMA4D;TREM2;MACF1;NTNG1
prerank,positive regulation of phosphatase activity (GO:0010922),0.4308610011204048,1.1069655953154642,0.34552102376599636,0.6442316938331285,1.0,3/21,2.60%,CHP2;MEF2C;BMP2
prerank,actomyosin structure organization (GO:0031032),0.3483335236124237,1.1068637152912486,0.3121468926553672,0.643942912367605,1.0,12/75,5.51%,FLII;EPB41L1;CDC42BPG;ITGB1;TMOD1;MYH6;MYOM2;TNNT1;RHOA;TMOD3;ROCK1;PDLIM1
prerank,tail-anchored membrane protein insertion into ER membrane (GO:0071816),-0.41670912289925577,-1.106776191995576,0.35362997658079626,0.835081985487651,1.0,8/17,25.31%,EMC9;BAG6;EMC10;EMC1;GET4;EMC6;MMGT1;SGTA
prerank,mesenchyme development (GO:0060485),-0.4214194123377339,-1.1065213244980139,0.3186046511627907,0.8340982876084925,1.0,3/15,9.67%,TGFBR1;FGFR2;CRELD1
prerank,base conversion or substitution editing (GO:0016553),-0.4765539356866343,-1.1055326440787707,0.37606837606837606,0.8354796745613444,1.0,5/11,27.51%,ADAR;ADARB2;ADARB1;METTL3;NUDT16
prerank,regulation of establishment of endothelial barrier (GO:1903140),0.45097022657113517,1.105224165724588,0.35181975736568455,0.6472427056134887,1.0,7/17,14.24%,S1PR2;ROCK1;TNF;VCL;ROCK2;TNFRSF1A;ADD1
prerank,antigen processing and presentation of exogenous peptide antigen (GO:0002478),0.34247002459960824,1.1052105437778863,0.30758620689655175,0.6467512588014859,1.0,19/79,14.77%,AP2A2;FCGR2B;CLTC;RILP;FCER1G;CD74;MFSD6;PIKFYVE;AP2S1;CANX;RAB7A;KIF4A;OSBPL1A;DYNC1I2;SEC24D;AP2B1;CAPZA1;CLTA;CAPZA2
prerank,regulation of nervous system development (GO:0051960),-0.3393584712392634,-1.105199079040206,0.30346820809248554,0.834775462835735,1.0,6/37,9.77%,CX3CR1;CTNNB1;BHLHE41;TENM4;NSUN5;SIRT2
prerank,heterotypic cell-cell adhesion (GO:0034113),0.4219482193547415,1.1050624882652298,0.3316412859560068,0.6465704630029258,1.0,7/25,14.55%,ITGA4;ITGB1;CD200R1;NINJ1;JUP;ITGB2;PARVA
prerank,negative regulation of Ras protein signal transduction (GO:0046580),-0.34538945993539144,-1.103438149954618,0.2931937172774869,0.8386505587901584,1.0,8/35,9.76%,ARHGAP24;RASAL3;LZTR1;SCAI;FLCN;STAMBP;KCTD13;STMN3
prerank,histone H3-K9 demethylation (GO:0033169),0.5035031098510663,1.102918646149461,0.3597122302158273,0.6509455785795198,1.0,6/11,18.87%,PHF8;KDM7A;KDM4D;JMJD1C;KDM1A;KDM4C
prerank,porphyrin-containing compound biosynthetic process (GO:0006779),-0.3738333395434208,-1.1024348627702827,0.30456852791878175,0.8402482222498953,1.0,12/24,25.61%,FECH;CPOX;FXN;ABCG2;COX15;FLVCR1;HMBS;ALAS2;UROD;PGRMC1;PPOX;ALAS1
prerank,cellular component assembly (GO:0022607),0.2990804087293012,1.102169465684889,0.27453271028037385,0.6521048739991278,1.0,31/253,9.90%,EPS8;NEDD9;SNX9;GAS6;KMT2A;OPHN1;REPS2;RP1;VCPIP1;MITF;SPTBN1;CD74;SKAP2;CDC42;RHOA;LCP1;GRHL2;WIPF1;ST13;ACTB;REC8;CD40;DARS1;HFE;STX7;TUBGCP2;RANBP9;MDM2;PLS1;CFAP206;RTN4
prerank,oligodendrocyte development (GO:0014003),-0.43139124386334693,-1.101812666402069,0.3558951965065502,0.8405755654766632,1.0,5/15,11.32%,PLP1;EIF2B3;NSUN5;TPPP;SOX10
prerank,apoptotic process (GO:0006915),0.3041300466170788,1.1017639908385952,0.2724014336917563,0.6525461899036723,1.0,23/203,9.90%,PAEP;TNFRSF25;HIP1;APP;NOTCH2;AHR;ZBTB16;IFT57;BNIPL;DAPK1;LIG4;RIPK1;PRUNE2;TLR2;STK3;BCL2;CHEK1;CXCR4;TNFSF12;ADRA1A;MDM2;PPP2CA;RTN4
prerank,lipid phosphorylation (GO:0046834),-0.4746661507368134,-1.1015330042453726,0.35394456289978676,0.8396864675933479,1.0,3/10,8.78%,DGKI;DGKB;DGKZ
prerank,positive regulation of neuron migration (GO:2001224),0.5022127565629801,1.1015262541025792,0.35877862595419846,0.6525612446328,1.0,2/11,3.92%,KIF20B;RAPGEF2
prerank,regulation of monooxygenase activity (GO:0032768),0.42897836271657785,1.1014680571599953,0.3498402555910543,0.6521930675125087,1.0,8/23,20.34%,EGFR;CYGB;NOSTRIN;CALM1;WASL;LYPLA1;GDNF;SNCA
prerank,cellular response to amino acid starvation (GO:0034198),-0.29121216446077064,-1.1014039224025673,0.26158940397350994,0.8383809741405289,1.0,25/71,20.34%,TCIRG1;RPTOR;ATP6V1C1;GCN1;IMPACT;ATP6V1D;RRAGD;FLCN;SESN3;ATP6V1H;MAPK3;DAP;ATP6V1G1;CASTOR2;ATP6V0B;ATP6V0D2;ATP6V0C;SEH1L;MLST8;RRAGB;MTOR;SEC13;SESN2;ATF4;MAPK8
prerank,protein localization to cell-cell junction (GO:0150105),-0.4353734810072864,-1.1011460159514401,0.32235294117647056,0.8374598275561428,1.0,3/15,5.49%,F11R;TJP1;TJP2
prerank,cellular response to estrogen stimulus (GO:0071391),0.47216541673349943,1.1009614778842562,0.33218588640275387,0.6528482629535923,1.0,6/14,13.72%,ARID5A;TRIM24;SFRP1;BCAS3;SFR1;RARA
prerank,negative regulation of chondrocyte differentiation (GO:0032331),-0.43371770930630027,-1.1007403737502743,0.3297180043383948,0.8369169918228377,1.0,8/14,35.99%,TGFBR1;PTPN11;GREM1;EFEMP1;PTHLH;RFLNA;WNT9A;SNAI2
prerank,negative regulation of type I interferon-mediated signaling pathway (GO:0060339),-0.4295942193120078,-1.1006429604053376,0.3185840707964602,0.8355067833656175,1.0,6/15,26.40%,CNOT7;NLRC5;STAT2;MUL1;METTL3;TTLL12
prerank,regulation of endothelial cell migration (GO:0010594),0.33748926578369653,1.100477003254731,0.30536451169188444,0.6534151087800435,1.0,15/85,12.68%,NRP1;APOE;FOXP1;SASH1;RIN2;GRN;ITGB1BP1;PRCP;SYNJ2BP;FOXC2;ADAMTS9;SP100;ROCK2;ZC3H12A;BCAS3
prerank,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),0.45602221802544984,1.10024914463291,0.3493761140819964,0.653405475929114,1.0,3/17,3.41%,JAG1;TLR4;CD46
prerank,cellular response to inorganic substance (GO:0071241),0.43511326874951345,1.1001982146992728,0.3511586452762923,0.6529950718020285,1.0,6/21,12.87%,AOC1;MTR;DDX11;ATRX;SPIDR;FOXO1
prerank,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),-0.33888073924440065,-1.0998833340269345,0.30563002680965146,0.836161863327324,1.0,16/34,28.56%,FGR;PTK2B;FGF2;FLT1;PIK3R4;P2RY12;FLT3;ATG14;TGFB1;TNFAIP8L3;TEK;PIK3R2;PDGFRB;PIK3R3;IRS1;PRKD1
prerank,atrial septum development (GO:0003283),0.4846050152205171,1.0997955787484468,0.35795454545454547,0.6533819868674099,1.0,4/13,14.72%,NOTCH2;HEY2;DAND5;NPHP3
prerank,positive regulation of peptidyl-lysine acetylation (GO:2000758),-0.37899869365034666,-1.0997298641859994,0.3234567901234568,0.8349096914302845,1.0,4/20,8.88%,DIP2B;DIP2A;MAPK3;BRCA1
prerank,vasculature development (GO:0001944),0.451766127248961,1.099527066694516,0.3533697632058288,0.6534389526471692,1.0,2/16,5.33%,FBXW7;PDGFRA
prerank,activation of protein kinase B activity (GO:0032148),0.40657335562133506,1.0993691000021901,0.33053691275167785,0.6532861084782308,1.0,7/29,14.92%,GAS6;ANG;ITGB1BP1;INSR;IGF1;OSBPL8;PPIA
prerank,protein import into peroxisome membrane (GO:0045046),0.41862113711262156,1.0990084774361815,0.33277870216306155,0.6535994639629269,1.0,4/22,6.62%,RAB8B;SLC25A17;PXMP2;PEX26
prerank,mitochondrion localization (GO:0051646),0.4441935514464998,1.098775140712088,0.35547576301615796,0.6536186702659711,1.0,5/19,13.59%,MEF2A;MTM1;MARK2;BRAT1;TRAK2
prerank,negative regulation of leukocyte migration (GO:0002686),0.5186540562671436,1.0987477677805018,0.3726235741444867,0.6531632728975236,1.0,3/10,11.22%,HMOX1;CD200R1;EMILIN1
prerank,regulation of membrane depolarization (GO:0003254),-0.39513946213575035,-1.0987374692660508,0.31336405529953915,0.8364058329162147,1.0,11/18,41.24%,SMAD7;SCN1B;CAMK2D;SCN2B;GPD1L;HCN4;FHL1;PTPN3;SCN10A;RANGRF;GJA5
prerank,regulation of ion transmembrane transport (GO:0034765),0.39838287642466375,1.0983424828887989,0.33386837881219905,0.6535159221521056,1.0,7/33,14.32%,P2RX7;ANO6;KCNJ14;WNK1;YWHAE;KCNQ1;NEDD4L
prerank,regulation of immunoglobulin production (GO:0002637),0.4364473601479119,1.0979751376093356,0.3679727427597956,0.6538289524046574,1.0,5/23,17.66%,FCGR2B;RBP4;GPI;XBP1;IL6
prerank,chromatin remodeling at centromere (GO:0031055),-0.341290695698762,-1.0977667560261075,0.28969359331476324,0.8377819404053294,1.0,12/31,28.15%,CENPC;NASP;KNL1;MIS18BP1;RUVBL1;CENPX;CENPV;CENPP;CENPN;CENPH;CENPI;MIS18A
prerank,response to interleukin-4 (GO:0070670),0.49912263203339524,1.097501206148262,0.3542074363992172,0.6543561505332354,1.0,2/10,6.00%,DCSTAMP;TCF7
prerank,skeletal muscle contraction (GO:0003009),0.4443243833631071,1.0974649137216446,0.359106529209622,0.6539016101681132,1.0,2/19,3.13%,RCSD1;TNNT1
prerank,positive regulation of growth (GO:0045927),0.35051954105241373,1.097292574606609,0.3342857142857143,0.6537722389186178,1.0,17/64,14.11%,EGFR;CDC42;DNPH1;RPS6KA3;RFTN1;INSR;TRIM32;BCL2;SDCBP;MTPN;CXCL16;H3-3A;SFRP1;WFS1;BRAT1;MFSD2A;DERL2
prerank,regulation of mast cell degranulation (GO:0043304),0.48350242165050433,1.097212376044344,0.3798165137614679,0.6534356886841268,1.0,6/14,19.43%,LYN;FER;SYK;UNC13D;FES;STXBP2
prerank,limb development (GO:0060173),-0.35520552366209046,-1.0971340512916954,0.3489583333333333,0.8381383125704955,1.0,5/28,11.12%,SALL1;CHD7;BMPR1B;IQCE;RSPO2
prerank,renal water homeostasis (GO:0003091),-0.38028798196923075,-1.0970059392968041,0.336734693877551,0.8368220848656899,1.0,7/23,16.43%,ADCY3;ADCY8;PRKAR1A;PRKAR1B;ADCY7;MYO5B;ADCY1
prerank,positive regulation of mitotic cell cycle (GO:0045931),0.4277499708422709,1.096606138893129,0.3885135135135135,0.6543209965305735,1.0,7/26,15.38%,APP;PKN2;MDM2;CUL3;TTL;EIF4EBP1;USP22
prerank,negative regulation of interferon-gamma production (GO:0032689),0.4177702694433014,1.096406101106104,0.3304042179261863,0.6542583657484626,1.0,4/23,3.18%,GAS6;NR1H4;LILRB1;TLR4
prerank,regulation of chemotaxis (GO:0050920),0.4029420419040821,1.0960837030482957,0.32216905901116427,0.6544702839200457,1.0,5/30,7.44%,ZSWIM6;CCL19;PDGFRA;MYCBP2;CXCR4
prerank,heart development (GO:0007507),0.3152805720114204,1.09569766944764,0.2948557089084065,0.654808438343236,1.0,28/150,15.37%,HDAC9;PDLIM5;MEF2A;CRIP1;MEF2C;OSR1;BMP2;MYH6;ALPK3;INSR;PDLIM1;KDM6A;CACYBP;NCOA6;FOXC2;EPHB4;DAND5;CASP8;WDR11;RAMP2;POPDC3;BCOR;RBP4;SMYD4;PKD2;GPC3;MYBPC3;FN1
prerank,negative regulation of cellular process (GO:0048523),0.2847115458202806,1.0953504478191045,0.2442827442827443,0.6550980023957832,1.0,104/521,16.59%,TGFBI;FCGR2B;ALOX5;APP;PTPRJ;TXNIP;CASK;RIPOR2;NUPR1;LYN;RARG;BNIPL;CBFA2T3;ABI1;RASA1;TNFRSF1B;BMP2;LILRB1;PRKRA;DCSTAMP;PLXNC1;S100A11;RGCC;RAPGEF2;ITGB1BP1;PRKN;TLR2;DUSP1;PDE8A;FRK;GSDME;CDK6;RB1;RACK1;SNX3;SMAD4;PTPRK;NR4A1;BCL2;PLXNA4;FOXM1;BST2;KLF4;VPS4B;PDS5B;MALSU1;GMNN;ARHGDIA;KLF10;CDC73;SPOCD1;CGREF1;ADRA1A;CD33;ESR2;THAP12;SH2B3;PPP2CA;RTN4;SFRP1;PARP16;NUP62;SP100;FTH1;SERTAD2;SLIT3;EMILIN1;ST7L;KANK2;CRYAB;VPS13C;PIP4P2;WFS1;STRN;NIBAN2;CDKN2C;PPP1R13B;DIS3L2;PLXND1;DSCAM;GJA1;CTBP2;ZBTB7C;PIWIL2;SPEF1;NR1H2;MDK;CRLF3;CCN5;PKD2;ARHGDIB;NOX4;TMEM109;MYC;RNF41;PINX1;PTPN14;VGLL4;RUNX3;ATG5;PTEN;ANP32B;CD164;MIA3
prerank,regulation of hemopoiesis (GO:1903706),0.5022726078991975,1.095338864864762,0.352165725047081,0.6546137218180273,1.0,4/10,18.21%,CBFB;PRKCB;CREBBP;MAFB
prerank,negative regulation of signaling (GO:0023057),-0.36628057129844416,-1.0951398417343277,0.3333333333333333,0.8410913464162089,1.0,6/25,20.18%,OPTN;ACVR1;UBASH3B;GLRA1;AP1AR;IGFBP3
prerank,heart contraction (GO:0060047),-0.32747458345507446,-1.0947183642596559,0.2928759894459103,0.8407304043794074,1.0,6/41,7.31%,ATP1B1;SCN1B;SLC8A1;SGCD;GRK2;GAA
prerank,positive regulation of establishment of protein localization (GO:1904951),-0.39114940127759834,-1.0947151926240504,0.3471264367816092,0.8390392601911457,1.0,7/18,23.12%,CEP135;TREM2;PTP4A3;CCT7;CCT2;WRAP53;CCT8
prerank,response to light stimulus (GO:0009416),-0.3034544500352825,-1.094573317848516,0.2818181818181818,0.837713986030249,1.0,12/55,12.18%,GTF2H2;MAPK10;UBE2B;MAP2K7;DDB2;PRIMPOL;ERCC6;FECH;ERCC2;CCAR2;UVSSA;CIRBP
prerank,regulation of establishment of planar polarity (GO:0090175),0.33203057712138184,1.093979605533097,0.3074829931972789,0.6572120721387659,1.0,17/88,14.72%,AP2A2;CLTC;SMURF2;PSMA7;PRICKLE1;CDC42;RHOA;CELSR1;AP2S1;PSMB2;PSMA6;SPEF1;AP2B1;PSMA3;PSMD1;PSMD5;NPHP3
prerank,response to amino acid starvation (GO:1990928),-0.2871096232068055,-1.0931887218931136,0.2724252491694352,0.840492375002543,1.0,25/72,20.34%,TCIRG1;RPTOR;ATP6V1C1;GCN1;IMPACT;ATP6V1D;RRAGD;FLCN;SESN3;ATP6V1H;MAPK3;DAP;ATP6V1G1;CASTOR2;ATP6V0B;ATP6V0D2;ATP6V0C;SEH1L;MLST8;RRAGB;MTOR;SEC13;SESN2;ATF4;MAPK8
prerank,glycerophospholipid catabolic process (GO:0046475),-0.3576491464932512,-1.0929335904214479,0.3293269230769231,0.839624951109211,1.0,5/27,8.46%,ABHD12;ENPP2;SMPD4;PLA2G6;INPP5F
prerank,nucleobase-containing small molecule interconversion (GO:0015949),-0.3558501717094211,-1.092767930206641,0.32663316582914576,0.8384858093119638,1.0,8/27,19.33%,AK2;DCTD;TYMS;GLRX;DUT;DTYMK;NUDT13;GUK1
prerank,regulation of ruffle assembly (GO:1900027),-0.36119805582366865,-1.0925553506614227,0.3075,0.8375532338790052,1.0,6/23,6.60%,ABI3;ARHGAP24;EVL;NLGN1;RDX;P2RY12
prerank,amyloid precursor protein metabolic process (GO:0042982),0.44982466069061694,1.0922061953347082,0.3450087565674256,0.6608005869951814,1.0,4/18,10.91%,APOE;ADAM19;PSEN1;ACHE
prerank,negative regulation of lipid storage (GO:0010888),-0.38276107987152314,-1.091558961496049,0.3558139534883721,0.8391655677539284,1.0,3/19,4.04%,ABCG1;TREM2;ITGB3
prerank,cellular response to nerve growth factor stimulus (GO:1990090),-0.377508928710388,-1.0914242613452159,0.35096153846153844,0.8379106237530912,1.0,9/22,17.54%,MAGI2;NTRK3;BDNF;MAPT;TMEM108;WASF1;RAPGEF1;RAB35;SH3GL2
prerank,positive regulation of dephosphorylation (GO:0035306),-0.36361527254078424,-1.0913070829423122,0.3333333333333333,0.8366148845225655,1.0,15/27,22.47%,PRKCD;CALM2;SRC;PPP1R16B;NSMF;CAMTA1;PPP1R7;ANKLE2;PPP2R5A;CDCA2;PTPA;SPPL3;CALM3;TGFB1;PIN1
prerank,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",-0.3794871178483731,-1.0906263803701348,0.34976525821596244,0.8371717921420191,1.0,6/22,9.14%,GTF2H2;CUL4A;PARP1;DDB2;RBX1;ERCC2
prerank,positive regulation of insulin secretion (GO:0032024),0.3819375560351013,1.0906177137883588,0.34548335974643424,0.6639043969489099,1.0,9/36,14.36%,TCF7L2;MCU;IRS2;GHRL;ANO1;DOC2B;GLUD1;TRH;RBP4
prerank,negative regulation of BMP signaling pathway (GO:0030514),0.36765333805113204,1.0905587258286258,0.34194528875379937,0.663519716335553,1.0,10/51,10.70%,SMURF2;CRIM1;BMP2;GDF3;SMAD4;TRIM33;ACVR2A;HTRA3;UBE2D3;DAND5
prerank,kinetochore organization (GO:0051383),-0.4337758497955251,-1.0904171251215233,0.34615384615384615,0.8361966905613372,1.0,8/13,31.65%,CENPC;CENPE;DLGAP5;NDC80;CENPH;CDT1;CENPF;NUF2
prerank,neural crest cell migration (GO:0001755),0.391675189408464,1.0896312428502495,0.3380503144654088,0.6651085413967667,1.0,2/36,0.82%,NRP1;SEMA4A
prerank,positive regulation of cellular component organization (GO:0051130),0.3225755265047526,1.0893040230230149,0.3268733850129199,0.6653507339989135,1.0,10/107,6.94%,DAB2;APOE;RPS3;CCL19;GSK3B;RB1;INSR;RACK1;SYK;TNF
prerank,positive regulation of neuron apoptotic process (GO:0043525),0.4180945664030281,1.0892281320517956,0.3321678321678322,0.6649800687377694,1.0,5/24,6.94%,FBXW7;NUPR1;GRN;MCL1;TNF
prerank,plasma membrane organization (GO:0007009),0.35146718623976114,1.0892279837288392,0.3386396526772793,0.6644617958249486,1.0,11/61,11.79%,P2RX7;SNX9;ANO6;SPTBN1;PLSCR5;MYOF;SERP1;CXCR4;PACSIN2;SNX33;PLSCR4
prerank,regulation of cell adhesion (GO:0030155),0.3204291464113113,1.089163774341512,0.3121098626716604,0.6640848732018451,1.0,30/129,17.26%,TGFBI;PTPRJ;PPP3CA;MYADM;RIPOR2;LYN;RASA1;PLXNC1;ITGB1BP1;DUSP1;ROCK1;PLXNA4;TNF;CXCR4;ARHGDIA;PPP2CA;CYTH1;ROCK2;RSU1;PLXND1;DSCAM;MDK;PRKD2;ARHGDIB;ZDHHC2;CD164;MIA3;CCL5;PODXL;FES
prerank,regulation of protein modification process (GO:0031399),0.3590683772948852,1.0889290488130288,0.32882882882882886,0.6640654700106401,1.0,12/50,11.15%,SPRED1;LYN;FER;NOP53;HSPB1;FNIP1;KDM4D;CORO1C;PPP2CA;ATG7;SPRED2;PHIP
prerank,regulation of protein sumoylation (GO:0033233),-0.4037313838504382,-1.0882211248907006,0.350109409190372,0.8415146223725376,1.0,9/17,23.93%,CTNNB1;CAPN3;PARK7;MUL1;GNL3L;SAE1;UBA2;PIAS4;PIAS3
prerank,leukocyte cell-cell adhesion (GO:0007159),0.4137634566203242,1.0882124563003295,0.351493848857645,0.6651302580266499,1.0,5/24,8.63%,ITGA4;ITGB1;ROCK1;SYK;MSN
prerank,cellular protein-containing complex assembly (GO:0034622),0.3101053978373166,1.0878418833596624,0.3001230012300123,0.6654297252177105,1.0,25/159,11.70%,HIP1;IMMP2L;TCF4;SNX9;FCHO2;EPS15;CLTC;ADRB2;UVRAG;AXIN1;SMAD4;STXBP6;TBCA;AP2S1;HIGD1A;RPL38;PIK3C2A;MAPK8IP2;COX7A2L;RTN4;CENPT;PXN;EIF4B;RAB5IF;TBCE
prerank,fatty acid transmembrane transport (GO:1902001),0.4336917350400556,1.0877703207940295,0.3547297297297297,0.6650824107754763,1.0,2/19,2.76%,PRKAG2;CD36
prerank,carboxylic acid metabolic process (GO:0019752),0.38881052470105476,1.0873647270086497,0.35467980295566504,0.6654614473407682,1.0,7/33,14.45%,ST6GAL1;ST3GAL1;DAO;GNMT;GLUD1;SLC23A1;SLC23A2
prerank,cellular response to radiation (GO:0071478),0.3771051889530008,1.0870207814463881,0.32786885245901637,0.6656933469976466,1.0,10/40,13.18%,LIG4;CLOCK;RRH;GPR52;MAPK14;KDM4D;EEF1D;SPIDR;RHNO1;NET1
prerank,apoptotic DNA fragmentation (GO:0006309),0.44379073077617365,1.0863921708881856,0.3673469387755102,0.666559714333152,1.0,2/16,11.20%,ENDOG;DFFA
prerank,mammary gland epithelium development (GO:0061180),-0.4282778079011724,-1.0860478403710816,0.3561946902654867,0.8469128852081783,1.0,11/14,34.35%,JAK2;CSF1R;ERBB4;ID2;WNT4;WNT7B;AKT1;EPHA2;LATS1;SCRIB;WNT3
prerank,regulation of cell migration (GO:0030334),0.2856064783267251,1.0857452499859148,0.25841476655808904,0.6675286597245554,1.0,48/382,10.04%,DAB2;MCTP1;NEDD9;EGFR;PTPRJ;SEMA4A;SGK3;CCR1;PPP3CA;SASH1;MYADM;RAP2B;ITGB1;FER;JAG1;MITF;CASS4;BMP2;SYNE2;CD74;FGF23;DRD1;GRN;ADAM9;PLXNC1;RHOA;INSR;RACK1;CLIC4;PTPRK;PDGFRA;ROCK1;STK24;TRIM32;PLXNA4;SDCBP;BST2;DUSP22;CXCL16;CCL24;AMOT;VCL;RCC2;PDGFC;CORO1C;NKD1;IGF1;SFRP1
prerank,anion transport (GO:0006820),-0.33857342595571754,-1.0855618199995016,0.328804347826087,0.8467335451809258,1.0,5/33,12.35%,SLCO2B1;VDAC1;SLC4A2;ABCG2;SLC17A5
prerank,protein localization to plasma membrane (GO:0072659),0.3174455961368605,1.085234814575248,0.33162612035851474,0.6682543627392541,1.0,34/129,17.33%,LRP6;MYO5A;EHD4;FCHO2;MYADM;GAS6;SPTBN1;RAB8B;RAB10;RAPGEF2;S100A10;ITGB1BP1;EHD1;RAP1A;ROCK1;TNF;ZDHHC3;DENND4C;PIP5K1A;JUP;KCNB1;ROCK2;RAMP2;TNFRSF1A;SCN3B;FYB1;RAB11A;TMED2;TSPAN14;ZDHHC2;RAB3B;SEC16A;SLMAP;FLOT2
prerank,negative regulation of DNA metabolic process (GO:0051053),0.4112858191735956,1.0851582786602614,0.37082601054481545,0.6679097952929866,1.0,6/24,12.59%,KMT2A;RPS3;ZRANB3;DFFA;NIBAN2;TERF2IP
prerank,regulation of histone H3-K9 acetylation (GO:2000615),0.5020131399592234,1.08515320393871,0.3579136690647482,0.6673998725892131,1.0,3/10,6.61%,KMT2A;SMAD4;CHEK1
prerank,cell-substrate junction assembly (GO:0007044),-0.32864879207942943,-1.084079667206911,0.288,0.8498880512591684,1.0,9/33,17.75%,DST;ITGA6;SRC;FERMT2;ACTN2;LAMA3;TRIP6;THY1;ITGB4
prerank,cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),0.5070698233632862,1.0836292564666539,0.36590038314176243,0.6702747290954415,1.0,4/10,16.59%,CD36;TLR4;CD68;MIA3
prerank,regulation of neurotransmitter transport (GO:0051588),0.44491151764550013,1.0835057410835909,0.36610169491525424,0.6700478266501151,1.0,3/16,7.81%,MCTP1;MEF2C;MCTP2
prerank,negative regulation of protein-containing complex assembly (GO:0031333),-0.3141093050421825,-1.08332554606584,0.34615384615384615,0.8507128395812106,1.0,19/49,24.32%,LDLRAD4;SORL1;TREM2;IMPACT;SRC;ANKRD27;IAPP;HSF1;PYDC1;ULK1;PARK7;LCMT1;HDAC6;HMGB1;TFIP11;TMC8;DACT1;KIF14;PRKCZ
prerank,skin development (GO:0043588),0.34343900108840647,1.0830730572871048,0.3451202263083451,0.670532115033277,1.0,7/65,6.03%,TXNIP;JAG1;ADAM9;KRT10;CLIC4;ATP7A;SFN
prerank,negative regulation of NIK/NF-kappaB signaling (GO:1901223),0.41411316732350056,1.08280999940839,0.3378151260504202,0.6705989075386117,1.0,7/23,16.92%,C1QTNF3;SPI1;UACA;PPM1B;ZC3H12A;PPM1A;RELA
prerank,regulation of neurogenesis (GO:0050767),-0.2991945818865738,-1.0828052158435346,0.294478527607362,0.850671002152207,1.0,7/55,8.35%,CX3CR1;NUMB;SORL1;CTNNB1;TGM2;BHLHE41;NUMBL
prerank,fibroblast growth factor receptor signaling pathway (GO:0008543),0.3352123795001409,1.082765097733315,0.3244005641748942,0.6701805906778688,1.0,11/72,12.18%,FGFR1;SPRED1;FGF23;CBL;FRS2;KIF16B;HNRNPF;RAB14;POLR2B;SPRED2;TRIM71
prerank,positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),0.4815021513207596,1.0824821959335256,0.39147286821705424,0.6703135997594034,1.0,2/11,2.67%,EGFR;RIPK1
prerank,positive regulation of protein acetylation (GO:1901985),-0.44432534939478596,-1.0824061631085091,0.36637931034482757,0.8502624996445907,1.0,3/12,11.61%,DIP2B;DIP2A;RAPGEF3
prerank,protein localization to cell periphery (GO:1990778),0.3151591174307077,1.0818034145340443,0.33163265306122447,0.6713571765387503,1.0,35/133,17.33%,LRP6;MYO5A;EHD4;FCHO2;MYADM;GAS6;SPTBN1;RAB8B;RAB10;RAPGEF2;S100A10;ITGB1BP1;EHD1;RAP1A;ROCK1;TNF;RABEP1;ZDHHC3;DENND4C;PIP5K1A;JUP;KCNB1;ROCK2;RAMP2;TNFRSF1A;SCN3B;FYB1;RAB11A;TMED2;TSPAN14;ZDHHC2;RAB3B;SEC16A;SLMAP;FLOT2
prerank,regulation of filopodium assembly (GO:0051489),0.3829894231085967,1.081614260204342,0.3555926544240401,0.6712673290957238,1.0,5/38,5.36%,NRP1;RIPOR2;ARAP1;CDC42;DOCK11
prerank,regulation of receptor internalization (GO:0002090),-0.33268988009896566,-1.0810652875428477,0.33589743589743587,0.8530314449073424,1.0,9/35,10.48%,RIN3;MAGI2;DLG4;FLOT1;AHI1;FMR1;ARRB2;ANKRD13B;ANKRD13D
prerank,purine ribonucleotide biosynthetic process (GO:0009152),0.3661138043405389,1.0797692913608812,0.36227544910179643,0.6750128026784878,1.0,12/48,14.67%,SLC25A16;GUCY2D;ADCY9;ADSS2;PAPSS2;IMPDH2;SLC35B3;AMPD3;PANK1;NPPC;ADSS1;ACAT1
prerank,branching involved in ureteric bud morphogenesis (GO:0001658),-0.4146528432836367,-1.0795066138645943,0.33573141486810554,0.8563273516304064,1.0,3/16,4.14%,SALL1;NPNT;FGF2
prerank,negative regulation of voltage-gated calcium channel activity (GO:1901386),-0.48017928662230985,-1.0793140279203934,0.40301724137931033,0.8552152577140616,1.0,5/10,24.51%,FMR1;CBARP;GPR35;CALM3;CRHR1
prerank,glycerol metabolic process (GO:0006071),-0.46358971141342287,-1.0792805986359426,0.3593429158110883,0.8536542249068286,1.0,5/10,31.70%,GK;TPI1;ANGPTL3;GOT1;COQ2
prerank,positive regulation of cardiac muscle hypertrophy (GO:0010613),0.4423618035405275,1.0791139876775495,0.35587188612099646,0.675976293501934,1.0,5/16,11.99%,MEF2A;ROCK1;MTPN;IGF1;ROCK2
prerank,regulation of interleukin-2 production (GO:0032663),0.36848616922650607,1.0788899317676062,0.35782747603833864,0.6759612427074646,1.0,8/43,8.66%,VSIG4;IRF4;RPS3;SPTBN1;PDE4D;CD80;CCR2;TRIM27
prerank,regulation of cardiac muscle cell action potential (GO:0098901),-0.35710939194502683,-1.0786695543139586,0.32620320855614976,0.8540441308747653,1.0,8/25,21.06%,NOS1AP;FGF13;ANK2;CTNNA3;CACNA1C;CXADR;CAMK2D;CALM3
prerank,negative regulation of stress fiber assembly (GO:0051497),-0.36511564433440874,-1.0782102738488928,0.3458646616541353,0.8538390740032936,1.0,4/24,2.12%,F11R;TJP1;TMEFF2;CLASP2
prerank,positive regulation of epithelial cell migration (GO:0010634),0.32691804746658426,1.078137748710994,0.3243606998654105,0.6771657871193696,1.0,10/92,3.95%,NRP1;FOXP1;SASH1;RREB1;MAPRE2;RIN2;DOCK1;GRN;ADAM9;ITGB1BP1
prerank,histone mRNA catabolic process (GO:0071044),0.450627750964808,1.0780703328912562,0.36231884057971014,0.6768090568693585,1.0,5/15,16.36%,TUT7;TENT2;TUT4;DCP2;TUT1
prerank,histone H3-K36 demethylation (GO:0070544),0.5001315219969189,1.0780039170046345,0.3713235294117647,0.6764586163916502,1.0,4/10,18.87%,PHF8;KDM7A;KDM2A;KDM4C
prerank,positive regulation of protein serine/threonine kinase activity (GO:0071902),0.3268940427059626,1.0778654806787515,0.3416557161629435,0.67626039866057,1.0,21/101,13.75%,EGFR;FGFR1;ADRB2;RHOA;RGCC;RAPGEF2;INCENP;CD40;PIK3R6;TNF;CCND3;CCNYL1;PDGFC;CCND2;PPP2CA;PARP16;CALM1;ATP2B4;NOD2;CCNY;RALB
prerank,polyol biosynthetic process (GO:0046173),0.4468409597685945,1.0778631150607383,0.337037037037037,0.6757503294020929,1.0,3/16,6.24%,IP6K3;ACER3;CYP27A1
prerank,mononuclear cell differentiation (GO:1903131),-0.35333813558093186,-1.0778040820499948,0.32663316582914576,0.8535067882158291,1.0,7/24,10.35%,IRF8;PDE1B;TREM2;IKZF1;AXL;FLT3;CSF1R
prerank,regulation of epithelial cell migration (GO:0010632),-0.30529019110340627,-1.0777400294910668,0.29411764705882354,0.8520803340472718,1.0,9/51,5.80%,EVL;PRKCE;PTPN23;CLASP2;ENPP2;SRC;DUSP10;PLCG1;MACF1
prerank,GTP metabolic process (GO:0046039),0.4421421796589944,1.0775217466540252,0.3740875912408759,0.6760236944844772,1.0,7/15,19.35%,GNAI3;IMPDH2;RAB23;GTPBP1;EFL1;AK3;AK4
prerank,negative regulation of cell adhesion (GO:0007162),0.34579110350972886,1.0772334859618946,0.340365682137834,0.6761780248565418,1.0,10/72,7.94%,TGFBI;RIPOR2;JAG1;RASA1;PLXNC1;RHOA;ITGB1BP1;DUSP1;PLXNA4;ARHGDIA
prerank,positive regulation of TOR signaling (GO:0032008),-0.3199217812069278,-1.0767305982484054,0.3314121037463977,0.8537404488643848,1.0,7/40,5.53%,RPTOR;GPR137B;TREM2;GPR137C;RRAGD;NCKAP1L;FLCN
prerank,regulation of cell-substrate junction assembly (GO:0090109),0.42675734454472,1.076172565474051,0.365,0.6781092115531565,1.0,8/21,11.99%,PEAK1;RHOA;ROCK1;PTPRA;VCL;CLASP1;CORO1C;ROCK2
prerank,defense response to virus (GO:0051607),0.3275073769396139,1.076157670157187,0.363265306122449,0.677620525095069,1.0,16/100,10.67%,TLR8;IFITM3;OAS2;LILRB1;SERINC3;TLR2;TRIM56;RNASEL;CD40;BCL2;BST2;IFNAR2;RNASE6;IRF2;IFITM2;ATG7
prerank,protein-containing complex disassembly (GO:0032984),0.3531825177873363,1.0761094763708006,0.3386627906976744,0.6772133847914149,1.0,17/54,18.82%,LRP6;RPL23;UVRAG;AXIN1;GSK3B;FRAT1;EPG5;LAMP2;PPP1CA;MYC;VPS16;WIPI2;GABARAP;AMER1;PYM1;VAMP8;DVL3
prerank,fatty acid biosynthetic process (GO:0006633),0.3451943576987056,1.075061514804734,0.35260115606936415,0.6790537441127296,1.0,5/63,7.30%,ALOX5;LTC4S;ALOX15;HACD4;ELOVL5
prerank,positive regulation of response to wounding (GO:1903036),0.4131860753337845,1.074933793983494,0.36470588235294116,0.6788262363015802,1.0,3/24,3.55%,ITGB1;GRN;SCARF1
prerank,artery development (GO:0060840),-0.3673652996528495,-1.074920297477917,0.3641025641025641,0.8578261538731587,1.0,5/23,5.52%,TGFBR1;SMAD7;ROBO2;ROBO1;NF1
prerank,protein polyglutamylation (GO:0018095),-0.45412060606512905,-1.074890132284592,0.3757828810020877,0.8562658079824473,1.0,3/11,12.44%,TTLL11;TTLL7;TTLL1
prerank,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.3286813920769902,1.0744308319065434,0.3296551724137931,0.679517633774321,1.0,10/85,7.46%,AP2A2;CLTC;SMURF2;PSMA7;PRICKLE1;CDC42;RHOA;CELSR1;AP2S1;PSMB2
prerank,regulation of secretion by cell (GO:1903530),0.353822830451568,1.0741592353682543,0.3438914027149321,0.6796001420563322,1.0,9/54,8.73%,MCTP1;MEF2C;RAB8B;RAB10;RIC1;RHBDF1;STXBP5;MCTP2;DNAJC1
prerank,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),0.31954187555216934,1.0739194182763225,0.3298429319371728,0.6796467492141657,1.0,19/104,11.64%,SPRED1;SMURF2;CRIM1;RPS27A;BMP2;SNX6;GDF3;IL17RD;SMAD4;TRIM33;SNX25;ACVR2A;HTRA3;VASN;UBE2D3;DAND5;SPRED2;EMILIN1;PMEPA1
prerank,regulation of dendritic spine morphogenesis (GO:0061001),-0.346077904724191,-1.0739065918569541,0.3548387096774194,0.8577883630920493,1.0,5/31,4.25%,ABI3;TANC2;NLGN1;PPFIA2;KIF1A
prerank,cellular response to sterol (GO:0036315),0.4680385713769579,1.0737524340675257,0.3787878787878788,0.6794844795994425,1.0,1/13,0.46%,LRP6
prerank,phosphatidic acid metabolic process (GO:0046473),-0.3143869998373077,-1.073621088041431,0.3333333333333333,0.8570456826759821,1.0,16/48,27.01%,LPCAT1;DGKB;PLA2G6;LIPH;GNPAT;DGKZ;DDHD1;PLA2G3;ACP6;AGPAT3;GPD1L;SLC27A1;ABHD8;DGKG;AGPAT2;DGKA
prerank,negative regulation of protein autophosphorylation (GO:0031953),-0.4572413463157,-1.0728559619821718,0.37656903765690375,0.8577929648071941,1.0,5/10,32.46%,IMPACT;ERRFI1;ENG;CHP1;MVP
prerank,negative regulation of translational initiation (GO:0045947),0.47747263848351035,1.0726816829908004,0.38779527559055116,0.681282286348989,1.0,6/13,19.13%,EIF3E;RBM4;EIF4EBP2;EIF4EBP1;EIF2AK4;EIF2AK1
prerank,embryo development ending in birth or egg hatching (GO:0009792),0.45163856017614734,1.0722463840640604,0.3644366197183099,0.6817769456866425,1.0,1/15,0.59%,FGFR1
prerank,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",0.3545371505808115,1.072213435907281,0.3413897280966767,0.681333765531072,1.0,23/52,23.07%,SAMD4A;TUT7;RC3H1;DCP1A;TUT4;DDX6;DCP2;EXOSC8;LSM4;LSM2;POLR2D;EXOSC1;CNOT9;HBS1L;CNOT11;CNOT6L;CNOT4;CNOT1;CNOT8;PATL1;PAN3;EXOSC3;CNOT2
prerank,response to growth factor (GO:0070848),-0.31906469724035647,-1.0721860970962396,0.3157894736842105,0.8582600437308728,1.0,10/41,16.57%,TGFBR1;CTNNB1;BMPR1B;ACVR1;TWF2;HTRA2;TGFBR2;ACVR1C;ACVR1B;TBC1D7
prerank,negative regulation of insulin secretion (GO:0046676),0.4417132210501632,1.0717302617929558,0.3859964093357271,0.6819045907346584,1.0,4/17,11.90%,PRKN;SFRP1;CHGA;KCNB1
prerank,response to nutrient levels (GO:0031667),-0.3986825383795199,-1.0713854364770392,0.3719806763285024,0.859196809351005,1.0,5/17,19.69%,RPTOR;EIF4G1;ULK1;MTOR;ATF4
prerank,negative regulation of vascular permeability (GO:0043116),0.4758534235092032,1.0708790364342886,0.3892857142857143,0.6832799166376861,1.0,2/12,4.20%,PTPRJ;PDE2A
prerank,CENP-A containing chromatin organization (GO:0061641),-0.34110840526224745,-1.0701050328640813,0.32432432432432434,0.8598796734900334,1.0,11/29,28.15%,CENPC;NASP;KNL1;MIS18BP1;RUVBL1;CENPX;CENPP;CENPN;CENPH;CENPI;MIS18A
prerank,CENP-A containing nucleosome assembly (GO:0034080),-0.34110840526224745,-1.0701050328640813,0.32432432432432434,0.8598796734900334,1.0,11/29,28.15%,CENPC;NASP;KNL1;MIS18BP1;RUVBL1;CENPX;CENPP;CENPN;CENPH;CENPI;MIS18A
prerank,fibrinolysis (GO:0042730),0.46773850544074935,1.0698844561958154,0.4,0.6849758789256875,1.0,1/13,1.51%,SERPINB2
prerank,regulation of receptor binding (GO:1900120),0.49086169698274484,1.0698301732632802,0.3774597495527728,0.6845930464045297,1.0,3/10,14.25%,B2M;HFE;ATP2A2
prerank,intracellular lipid transport (GO:0032365),0.41632407040088243,1.069632212747292,0.398972602739726,0.684560472961239,1.0,2/21,1.59%,PRKAG2;SGPP1
prerank,positive regulation of natural killer cell mediated immunity (GO:0002717),-0.405982796908981,-1.0695308516687054,0.3793859649122807,0.8599906166274525,1.0,5/16,20.46%,CADM1;NECTIN2;SLAMF6;RASGRP1;KLRD1
prerank,regulation of acrosome reaction (GO:0060046),-0.4535637163342473,-1.0695010055662,0.41358024691358025,0.8584692925996897,1.0,2/10,12.64%,PLCB1;GLRA1
prerank,regulation of actin filament polymerization (GO:0030833),0.3372663671557956,1.0694584504355737,0.3622159090909091,0.6844537070008501,1.0,10/69,8.22%,SNX9;MYADM;ALOX15;FER;RASA1;FCHSD2;ARHGAP18;SSH2;MTPN;CCL24
prerank,phosphate ion transmembrane transport (GO:0035435),-0.4382722479731711,-1.068789136786691,0.39651416122004357,0.8591242890394211,1.0,7/12,20.92%,SLC25A3;SLC37A2;SLC25A14;SLC37A4;SLC25A10;SLC20A2;SLC37A3
prerank,intermediate filament organization (GO:0045109),0.44635783674551743,1.068546020407298,0.3741258741258741,0.6860106356325624,1.0,2/17,4.18%,MTM1;VIM
prerank,establishment of protein localization to extracellular region (GO:0035592),0.37725343373038484,1.0681740722497908,0.36348949919224555,0.6863630298996563,1.0,10/39,16.72%,STEAP3;RCN3;RAB8B;RAB10;AFM;CANX;PDIA4;RAB3B;MIA3;GOLPH3
prerank,negative regulation of cell projection organization (GO:0031345),-0.3036556039553153,-1.0677218169214686,0.33534743202416917,0.8608733633302166,1.0,9/48,10.91%,RTN4RL1;MYLIP;PTPRS;YWHAH;PRAG1;PRNP;MAG;EFNB2;SPOCK1
prerank,monocyte differentiation (GO:0030224),-0.45156307528560763,-1.0676097816965373,0.4031890660592255,0.8595824656533709,1.0,4/10,29.16%,PDE1B;CSF1R;MT1G;BMP4
prerank,axonogenesis (GO:0007409),-0.2363559022136411,-1.0675363082495908,0.2781954887218045,0.8581906207951913,1.0,53/237,13.77%,NCAM1;NRXN3;SEMA4D;UNC5C;PIK3CB;EVL;EFNA5;CTNNA2;ROBO2;EPHA7;SCN1B;SRC;PARD3;NRXN1;SEMA4C;MAP1B;GRB10;PLCG1;NEFH;FGFR2;ROBO1;LYPLA2;KIF5A;SEMA4G;SPG11;PALLD;MAPK3;KIF5C;CNTN4;EPHB1;BDNF;BSG;EPHA10;CNTN6;CNTN2;SHC3;UNC5D;LAMA2;NTNG1;LLGL1;S100B;EFNB2;ENAH;LAMA3;AFG3L2;LGI1;AUTS2;GFRA1;EPHA3;SPTB;DSCAML1;APBB1;SLITRK5
prerank,positive regulation of intracellular protein transport (GO:0090316),0.3027567868288035,1.0674182598244213,0.36788874841972186,0.6875965405556818,1.0,26/144,12.68%,CHP2;TCF7L2;FBXW7;KIF20B;GAS6;YWHAQ;ITGB1BP1;GSK3B;SFN;BCL2;DMAP1;BAG3;PSEN1;FYN;UBE2D3;PCNT;MYO1C;TFDP1;CASP8;JUP;SREBF2;YWHAE;KCNB1;ZC3H12A;PPP1R13B;BCAS3
prerank,inner ear receptor cell stereocilium organization (GO:0060122),-0.45355234606896333,-1.0672639185586907,0.38461538461538464,0.8574093796379108,1.0,3/10,15.96%,WHRN;IFT88;ADGRV1
prerank,cGMP metabolic process (GO:0046068),0.4681888795929603,1.0669685273339555,0.38,0.688065485472765,1.0,3/12,13.93%,PDE2A;GUCY2D;NPPC
prerank,cellular lipid catabolic process (GO:0044242),0.3968984297604476,1.0663215173630225,0.3660245183887916,0.6890369991390829,1.0,1/27,0.11%,AOAH
prerank,positive regulation of secretion by cell (GO:1903532),-0.27844504632882705,-1.066040532318494,0.33793103448275863,0.859751255251439,1.0,9/70,4.88%,FRMD4A;SLC12A2;CADPS;ABCG1;TREM2;CLASP2;RAB27A;IL1A;GRK2
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),0.331057211757874,1.0659435641075947,0.35310344827586204,0.6889029756142626,1.0,18/78,14.77%,AP2A2;FCGR2B;CLTC;RILP;FCER1G;CD74;PIKFYVE;AP2S1;CANX;RAB7A;KIF4A;OSBPL1A;DYNC1I2;SEC24D;AP2B1;CAPZA1;CLTA;CAPZA2
prerank,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),0.331057211757874,1.0659435641075947,0.35310344827586204,0.6889029756142626,1.0,18/78,14.77%,AP2A2;FCGR2B;CLTC;RILP;FCER1G;CD74;PIKFYVE;AP2S1;CANX;RAB7A;KIF4A;OSBPL1A;DYNC1I2;SEC24D;AP2B1;CAPZA1;CLTA;CAPZA2
prerank,Golgi to plasma membrane transport (GO:0006893),0.3516193163336742,1.0657125104149734,0.35179640718562877,0.6889452058889682,1.0,8/47,8.59%,RAB31;EXOC6B;SPTBN1;RAB10;STXBP6;EXOC4;RABEP1;GOLPH3L
prerank,T cell proliferation (GO:0042098),-0.4254647685090776,-1.065644750171705,0.38362068965517243,0.85943019383178,1.0,1/13,0.11%,CADM1
prerank,regulation of intracellular transport (GO:0032386),-0.3258609808966313,-1.0655505444405067,0.34560906515580736,0.8581457463931547,1.0,14/38,20.06%,MAP2;DYNC1H1;NEFH;INPP5F;ATP9A;DYNLT2B;GRIPAP1;NUMA1;ATP13A2;GAS1;DNAJC30;AAAS;PLA2G3;HAP1
prerank,regulation of apoptotic signaling pathway (GO:2001233),0.37107898277129536,1.065263955334653,0.3736434108527132,0.6894129935152515,1.0,8/36,8.50%,DEPTOR;SGMS1;RPS3;RB1;BCL2;TNF;NR4A2;MAPK8IP2
prerank,detection of mechanical stimulus (GO:0050982),-0.38339535902340405,-1.0651613488444596,0.3412322274881517,0.8577911870588311,1.0,4/19,11.79%,CTNNB1;CDH2;PIEZO1;PIEZO2
prerank,positive regulation of sodium ion transmembrane transport (GO:1902307),-0.4342536039727227,-1.0650939960853998,0.3933333333333333,0.8564360677137821,1.0,5/12,19.21%,ATP1B1;ATP1B2;WNK3;GLRX;FXYD1
prerank,positive regulation of chromosome organization (GO:2001252),0.45537232467332434,1.0645909283257775,0.3858407079646018,0.6904415459526839,1.0,3/15,8.37%,LIG4;DDX11;ATRX
prerank,regulation of T cell mediated immunity (GO:0002709),0.5006146710386103,1.0641850413781069,0.4056603773584906,0.6908490932531796,1.0,2/10,7.58%,TNFRSF1B;CCR2
prerank,cholesterol efflux (GO:0033344),0.4145077547680538,1.0641707557291176,0.3734513274336283,0.6903651090144787,1.0,1/20,0.49%,APOE
prerank,regulation of cellular macromolecule biosynthetic process (GO:2000112),0.2821165893597244,1.0641175876128377,0.3477789815817985,0.6899665566046798,1.0,87/366,18.59%,APP;AHR;RREB1;FOXN2;NFXL1;ESR1;HINT1;MEF2C;NCOA2;CEBPB;MITF;ORC5;RYBP;BMP2;ANKRD17;NR3C1;CLOCK;SPI1;RB1;INSR;TGFBRAP1;TCF7;ATXN1;ESCO2;LYL1;MTPN;GMNN;ESCO1;IRF2;ATRX;ZNF628;LIMD1;ESRRB;BACH1;LIN54;HMG20A;ESR2;ATF7;NFATC2;PPP2CA;ZNF205;RPL6;GCFC2;TESMIN;RNF14;JMJD1C;SP1;ATXN1L;CREBBP;MYBL2;FOXK2;HINFP;NFIA;NANOS3;FOXO3;RPL10;TERF2IP;SP3;RBBP6;PSPC1;KAT7;STAT3;EP300;MLF2;HMGN5;WWC1;NAB1;MYT1;NSD3;NLK;NR2C2;SFPQ;RUNX3;HCFC1;PPARGC1B;GPBP1;NR5A2;PRKCQ;RELA;ZNF22;GZF1;METAP1;MAFB;ATF2;RFX3;PERM1;PLAG1
prerank,epiboly involved in wound healing (GO:0090505),0.44059152023274983,1.064098942459713,0.3679417122040073,0.6894927344260553,1.0,3/16,4.01%,CD44;RHOA;LCP1
prerank,cellular response to organic substance (GO:0071310),0.31255782956638684,1.0640733083409386,0.35517693315858456,0.689037172610132,1.0,13/116,7.44%,PID1;PTPN18;PTPN20;NCOA3;PTPN12;NR1H4;NCOA2;RHOA;RACK1;ACVR2A;TNF;KLF4;CXCR4
prerank,dendrite self-avoidance (GO:0070593),-0.3882191830963819,-1.0640155827679538,0.3579418344519016,0.8583127744235264,1.0,6/16,13.61%,PALLD;CNTN4;BSG;CNTN6;CNTN2;DSCAML1
prerank,regulation of brown fat cell differentiation (GO:0090335),0.45144858712741714,1.0638636310121874,0.3626760563380282,0.6889961250779422,1.0,3/16,8.05%,RREB1;METRNL;VSTM2A
prerank,L-alpha-amino acid transmembrane transport (GO:1902475),-0.35472978456263093,-1.0634148408047723,0.3842239185750636,0.8585835257306026,1.0,10/27,30.55%,SLC1A3;SLC36A4;SLC1A1;SLC25A22;SLC7A8;SLC1A2;SLC25A13;SLC1A4;SLC25A29;SLC7A3
prerank,peroxisomal membrane transport (GO:0015919),0.38994249093392347,1.0632090801070557,0.38385502471169686,0.6899893604571533,1.0,5/27,6.62%,RAB8B;SLC25A17;PXMP2;PEX7;PEX26
prerank,Fc-epsilon receptor signaling pathway (GO:0038095),0.313215652300623,1.0628715780730766,0.37617135207496655,0.6902629580647227,1.0,22/109,16.92%,VAV3;PPP3CA;PSMA7;LYN;FER;FCER1G;MAP3K1;BCL10;PAK2;SYK;PSMB2;NFATC2;CALM1;SHC1;PSMA6;PSMA3;PSMD1;PSMD5;NFATC3;TAB3;PRKCQ;RELA
prerank,camera-type eye morphogenesis (GO:0048593),0.49096347112028066,1.0625283401976502,0.39377289377289376,0.6905106905740201,1.0,1/10,0.46%,LRP6
prerank,bicellular tight junction assembly (GO:0070830),-0.30297903877493804,-1.0622464493954553,0.3256484149855908,0.8607923362320683,1.0,4/46,2.61%,F11R;TBCD;PARD3;CLDN11
prerank,regulation of bicellular tight junction assembly (GO:2000810),-0.38036562634144827,-1.0619481153204486,0.39906103286384975,0.860168481271933,1.0,2/19,0.53%,F11R;TJP1
prerank,extracellular matrix disassembly (GO:0022617),-0.2980984072793817,-1.0618795527047862,0.3566666666666667,0.8588327532708158,1.0,24/53,36.07%,KLK2;TLL1;FLOT1;CTSS;BSG;ADAMTS4;MMP16;SCUBE1;ADAM8;ADAM10;FURIN;CTSK;A2M;HPN;MMP15;CAPNS1;MMP14;HTRA1;TLL2;KIF9;MMP8;ADAMTS15;TIMP1;CAPN1
prerank,regulation of cellular senescence (GO:2000772),-0.3414327389703503,-1.0616789603285361,0.36548223350253806,0.8578397462904338,1.0,8/28,13.84%,ABI3;NUAK1;ZKSCAN3;NEK6;CGAS;AKT3;TERF2;YPEL3
prerank,metal ion homeostasis (GO:0055065),-0.3078655867884978,-1.061557676401212,0.323943661971831,0.8566664248607369,1.0,8/40,12.81%,SLC12A2;SLC8A1;SLC12A9;KCNA1;TMTC2;SLC7A8;SLC12A6;COX11
prerank,cellular response to DNA damage stimulus (GO:0006974),0.28291104989628413,1.0611864703277143,0.34933035714285715,0.692970566410824,1.0,81/336,18.35%,VAV3;RNF169;FOXP1;CRIP1;SUSD6;RBBP8;LYN;USP3;RPS3;BABAM2;VCPIP1;TNFRSF1B;UVRAG;WAC;MCL1;FAM111A;BCL2L2;MAPKAPK2;SFN;MCM9;POLE2;NOP53;BCL2;WDR76;CHEK1;TOPBP1;YY1;CHRNA4;PDS5B;DDX11;PSEN1;RPA1;RAD54L;NCOA6;SHPRH;BACH1;ASH2L;MAPK14;NFATC2;RAD52;MTREX;USP16;UBQLN4;SPIDR;ZRANB3;POLE3;KMT5B;XPA;HINFP;POLH;CBX1;ZC3H12A;FOXO1;BRAT1;RBBP6;MUTYH;XPC;USP45;KIN;MMS19;USP28;RAD51B;PWWP3A;MYC;SAMHD1;FBH1;USP47;GTF2H3;MCM8;FANCL;ATR;UBE2U;RFC3;GTF2H1;ASF1A;BATF;ZBTB40;APTX;UBE2A;ZBTB1;ATF2
prerank,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",0.3911869919542473,1.0609560279607846,0.3733974358974359,0.6929966662684959,1.0,6/27,10.98%,SPRED1;CD44;CD74;MDM2;DYRK1A;SPRED2
prerank,G2/M transition of mitotic cell cycle (GO:0000086),-0.2556591711315102,-1.0606738857426927,0.30180180180180183,0.8580275631688306,1.0,50/128,32.09%,CSNK1E;SDCCAG8;CEP135;ODF2;OPTN;DYNC1H1;SKP1;CEP192;CCNH;CEP250;FBXL7;CCDC57;HAUS8;WEE1;CEP63;PLK3;CCP110;PLCB1;HAUS7;CKAP5;MAPRE1;HAUS3;CHEK2;BRSK2;FBXL6;FBXL3;TAF2;DCTN2;LCMT1;BRSK1;CNTRL;MASTL;HAUS2;DCTN1;PLK4;CDK1;HAUS6;CCNA2;YWHAG;FBXL12;TUBA4A;CEP152;BTRC;CCNB2;TUBA1A;LATS1;FBXL22;TUBG1;AURKA;CDK7
prerank,negative regulation of osteoblast differentiation (GO:0045668),0.3816712796071075,1.0602595202277578,0.3562300319488818,0.6941436186718296,1.0,6/31,8.53%,CRIM1;TNN;FGF23;CDK6;GDF10;LIMD1
prerank,signal transduction by p53 class mediator (GO:0072331),-0.3379490539654624,-1.0602471675313598,0.35279187817258884,0.8577166407112049,1.0,16/30,30.90%,DDX5;TP53;STK11;MYO6;MDM4;ACER2;FHIT;PYCARD;SESN2;USP10;GREM1;PDK2;PMAIP1;RRP8;E2F7;MYBBP1A
prerank,negative regulation of hemostasis (GO:1900047),0.4716215283373765,1.0597580715341735,0.4130841121495327,0.6947796110272729,1.0,1/12,0.49%,APOE
prerank,regulation of protein kinase C signaling (GO:0090036),0.44632933750008164,1.059539208823196,0.3677536231884058,0.6947797435279375,1.0,3/14,8.64%,MYADM;CD40;ADRA1A
prerank,Fc receptor signaling pathway (GO:0038093),0.3123532747575587,1.0593990556737958,0.3655913978494624,0.6945866099177634,1.0,22/110,16.92%,VAV3;PPP3CA;PSMA7;LYN;FER;FCER1G;MAP3K1;BCL10;PAK2;SYK;PSMB2;NFATC2;CALM1;SHC1;PSMA6;PSMA3;PSMD1;PSMD5;NFATC3;TAB3;PRKCQ;RELA
prerank,positive regulation of ERAD pathway (GO:1904294),-0.41710175957227513,-1.0593071059460737,0.3659090909090909,0.859098212481679,1.0,7/13,27.02%,TMEM259;BAG6;BCAP31;RNFT1;UBQLN1;SGTA;UBQLN2
prerank,positive regulation of T cell proliferation (GO:0042102),0.3487931607615059,1.058922274010219,0.37771345875542695,0.6951440928211821,1.0,8/55,9.90%,IL15;RPS3;CD46;CCL19;SYK;CD80;CCR2;IGF1
prerank,cellular component disassembly (GO:0022411),-0.2978557656641303,-1.0588595989786787,0.3546325878594249,0.8589194267178951,1.0,24/53,36.07%,KLK2;TLL1;FLOT1;CTSS;BSG;ADAMTS4;MMP16;SCUBE1;ADAM8;ADAM10;FURIN;CTSK;A2M;DYRK3;MMP15;CAPNS1;MMP14;HTRA1;TLL2;KIF9;MMP8;ADAMTS15;TIMP1;CAPN1
prerank,positive regulation of mitotic cell cycle phase transition (GO:1901992),0.35022860594651445,1.0588106433605642,0.3870014771048744,0.6948687212367058,1.0,15/56,14.89%,EGFR;ANKRD17;RGCC;RB1;CDC27;NSMCE2;CCND3;VPS4B;RCC2;CCND2;CUL3;TFDP1;KMT2E;RAB11A;RAD51B
prerank,central nervous system neuron development (GO:0021954),0.44127892016487513,1.0587030130657589,0.38698010849909587,0.6945945458280464,1.0,7/15,17.80%,RAPGEF2;B4GALT6;ATP7A;B4GALT5;HSP90AB1;PTEN;ARHGAP35
prerank,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.3476758020321262,1.0586431096269535,0.3699248120300752,0.6942228464072011,1.0,14/54,17.75%,GAS6;RIPK1;PRKN;BIRC3;RACK1;SYK;TNF;UBE2K;CARD16;CASP8;TNFRSF1A;SPPL2B;SPPL2A;MADD
prerank,positive regulation of potassium ion transmembrane transporter activity (GO:1901018),-0.41259235409778355,-1.0585299665796302,0.3839080459770115,0.8584678743596256,1.0,4/14,8.73%,ATP1B1;ATP1B2;ANK2;ACTN2
prerank,regulation of myotube differentiation (GO:0010830),0.40761740883901243,1.058500431741706,0.37583892617449666,0.6940245198800717,1.0,1/24,0.10%,HDAC9
prerank,response to endoplasmic reticulum stress (GO:0034976),0.31776038777290416,1.0584321548903233,0.37777777777777777,0.6936837522140284,1.0,23/107,16.39%,MAP3K5;ALOX15;CEBPB;RCN3;THBS4;ERN1;NIBAN1;PRKN;GSK3B;RHBDD1;BCL2;ATF6;WFS1;RNF185;UFM1;PDIA4;ERO1A;ATG10;ATP2A2;PPP1R15B;CREB3L1;HSP90B1;SEC16A
prerank,positive regulation of nucleocytoplasmic transport (GO:0046824),0.36032763932629136,1.0582991754779376,0.36450079239302696,0.6934695652398369,1.0,10/46,12.28%,CHP2;TCF7L2;GAS6;GSK3B;DMAP1;BAG3;PSEN1;JUP;YWHAE;ZC3H12A
prerank,ERK1 and ERK2 cascade (GO:0070371),0.41389282720884196,1.058246434224724,0.40418118466898956,0.693076948214923,1.0,5/21,15.18%,ZFP36L2;ZFP36L1;IGF1;PTGER4;MYC
prerank,regulation of endocytic recycling (GO:2001135),-0.4441415167417985,-1.0577659971062072,0.3952991452991453,0.85915272342199,1.0,4/11,8.73%,SORL1;INPP5F;ATP9A;ACTN2
prerank,negative regulation of transferase activity (GO:0051348),-0.3370250917816786,-1.0575714929406812,0.3589108910891089,0.8582085027396474,1.0,9/28,16.22%,SMAD7;SRC;TP53;HNRNPU;EIF4A2;MAPT;CERS1;LIMK1;PARK7
prerank,glycerophospholipid biosynthetic process (GO:0046474),-0.24297909338704796,-1.0575483132988528,0.2914285714285714,0.856719031800325,1.0,38/172,15.13%,LPCAT2;INPP4B;INPP5D;LPIN2;SLC44A2;LPCAT1;PIK3CB;DGKB;PITPNM1;PIP5K1C;PCYT2;SELENOI;PLEKHA1;FGF2;PCYT1B;PI4KA;CLN3;LIPH;PIK3R4;PITPNM3;PTDSS1;SYNJ2;GNPAT;INPP5F;PTDSS2;DGKZ;PIK3C2B;DDHD1;LPCAT3;PIK3R5;MTMR4;ETNK1;CHPT1;MBOAT7;CDS1;PIP4K2B;STARD7;PIP4K2C
prerank,phosphatidylinositol phosphate biosynthetic process (GO:0046854),-0.32022186667232233,-1.057500846116491,0.3611859838274933,0.8553333294201646,1.0,9/39,15.13%,PIK3CB;EFR3B;PI4KA;SOCS2;TTC7B;SOCS7;PIK3C2B;PIP4K2B;PIP4K2C
prerank,branching morphogenesis of an epithelial tube (GO:0048754),0.36883981010588623,1.0574366604888554,0.39285714285714285,0.6944065204316844,1.0,4/39,4.22%,NRP1;LRP6;BMP2;NRARP
prerank,cellular modified amino acid biosynthetic process (GO:0042398),-0.36855803226175265,-1.0573471940597943,0.3811764705882353,0.8542901093530613,1.0,4/20,8.68%,PTDSS1;GSS;GATM;PTDSS2
prerank,chromatin remodeling (GO:0006338),0.3167362747631581,1.056808600228231,0.36139896373056996,0.6952954064596052,1.0,27/100,18.87%,PADI4;ESR1;HNRNPC;BAZ2B;JARID2;ARID1B;RB1;ACTB;KDM6A;SATB2;ATRX;KDM4D;POLE3;KDM5C;TADA2B;SMARCAD1;GATAD2B;MYC;SMARCD1;HDAC4;ARID1A;HCFC1;ZBTB7A;NPM3;ZBTB1;SRCAP;KDM4C
prerank,nucleosome disassembly (GO:0006337),-0.41710765583286086,-1.0566988502362682,0.37901498929336186,0.8532190404875867,1.0,3/14,4.52%,SMARCB1;SMARCC2;SMARCE1
prerank,chromatin disassembly (GO:0031498),-0.41710765583286086,-1.0566988502362682,0.37901498929336186,0.8532190404875867,1.0,3/14,4.52%,SMARCB1;SMARCC2;SMARCE1
prerank,RNA stabilization (GO:0043489),-0.3266105755638068,-1.0566645904490444,0.3417085427135678,0.8518132067263513,1.0,6/33,13.88%,TENT5C;FUS;HNRNPU;TRDMT1;CIRBP;TAF15
prerank,fluid transport (GO:0042044),-0.42241808992438395,-1.0566362689933295,0.3724279835390947,0.850379336583797,1.0,4/12,49.89%,PDPN;AQP4;AQP1;SLC4A11
prerank,positive regulation of peptidyl-serine phosphorylation (GO:0033138),0.3253798653205947,1.0561033966748195,0.3510791366906475,0.6963636988854887,1.0,17/73,18.10%,EGFR;APP;GAS6;CD44;AXIN1;TNF;FNIP1;RIPK2;DOCK7;ATP2B4;TERF2IP;CNOT9;PRKD2;HSP90AB1;SPRY2;IL6;RAF1
prerank,"regulation of synaptic transmission, GABAergic (GO:0032228)",-0.40602099482236464,-1.0560931867355396,0.40130151843817785,0.850462959138372,1.0,8/15,26.38%,NLGN1;CLN3;USP46;SYN3;CNTNAP4;HAP1;BAIAP3;STXBP1
prerank,positive regulation of vascular endothelial growth factor production (GO:0010575),-0.3572540632226332,-1.0559625735111926,0.3829268292682927,0.8493171901541906,1.0,8/24,22.86%,IL1A;SULF1;BRCA1;HPSE;ATF4;CCBE1;TGFB1;HIF1A
prerank,detection of light stimulus involved in visual perception (GO:0050908),-0.4439145128109842,-1.0558741771119122,0.3870967741935484,0.8466113220342337,1.0,1/10,7.70%,CEP250
prerank,detection of light stimulus involved in sensory perception (GO:0050962),-0.4439145128109842,-1.0558741771119122,0.3870967741935484,0.8466113220342337,1.0,1/10,7.70%,CEP250
prerank,cellular response to ionizing radiation (GO:0071479),0.3552797353835575,1.0558155069047082,0.37763371150729336,0.696550313012534,1.0,16/47,16.18%,LIG4;RPL26;CLOCK;TSPYL5;MDM2;MAPK14;MAP3K20;KDM4D;EEF1D;SPIDR;RHNO1;CRYAB;NET1;TMEM109;KDM1A;ATR
prerank,phospholipid catabolic process (GO:0009395),-0.35647390428746395,-1.0553702974762615,0.3824884792626728,0.8467337481834379,1.0,3/24,3.40%,ABHD12;ENPP2;SMPD4
prerank,regulation of axon extension (GO:0030516),-0.3204723320506524,-1.0553511576806034,0.3693181818181818,0.8452912769239378,1.0,9/37,9.72%,MAP2;PTPRS;DIP2B;ZFYVE27;MACF1;TWF2;OLFM1;MAPT;MAG
prerank,regulation of protein import into nucleus (GO:0042306),0.37185135417127707,1.0552129009625981,0.38461538461538464,0.6973674249982431,1.0,9/36,12.28%,CHP2;MDFIC;DMAP1;BAG3;PSEN1;RAB23;JUP;UFM1;ZC3H12A
prerank,cilium assembly (GO:0060271),-0.22808466229611624,-1.0550807869855783,0.25225225225225223,0.844637065197454,1.0,99/296,27.79%,CSNK1E;ASAP1;CFAP74;SDCCAG8;BBS9;CEP135;TRAPPC14;PTPN23;TMEM67;RILPL1;SCLT1;ODF2;DYNC1H1;LRGUK;CCDC66;IFT81;ATP6V1D;CEP97;IFT140;RAB3IP;DZIP1;DYNLRB1;CEP162;IFT88;CEP192;TTC8;AHI1;CEP250;CCDC57;HAUS8;IFT20;BBS7;MKS1;CEP63;DYNLT2B;WDR19;CCDC39;CCP110;SPAG16;DYNC2H1;VANGL2;KIF3A;SSX2IP;TOGARAM1;HAUS7;CKAP5;MAPRE1;HAUS3;TCTN1;IFT52;KIF3B;WDR90;CDC14A;RPGRIP1;CFAP298;CFAP410;NUDCD3;CPLANE2;NOTCH1;IFT43;DYNC2I1;EHD3;B9D2;RAB8A;TMEM138;DNAH5;PLA2G3;BBS4;DCTN2;ARL3;CEP89;IQCB1;HDAC6;TMEM231;MKKS;CCDC40;CNTRL;FLNA;GALNT11;TMEM17;PTPDC1;HAUS2;DCTN1;PLK4;CDK1;HAUS6;KIFAP3;YWHAG;CEP126;EXOC3;TTC39C;UNC119B;CFAP70;CFAP46;IFT172;TTBK2;TUBA4A;CFAP43;CEP152
prerank,positive regulation of DNA metabolic process (GO:0051054),0.33176851150133596,1.0549791529325692,0.3559322033898305,0.6974017268699412,1.0,8/61,8.37%,EGFR;RPS3;BABAM2;RGCC;USP9X;BRCC3;CEBPG;ATRX
prerank,positive regulation of protein processing (GO:0010954),0.4300031430212638,1.0547988745358297,0.4057724957555178,0.6973341373116947,1.0,2/19,4.92%,NLRC4;RHBDD1
prerank,negative regulation of neuron projection development (GO:0010977),-0.29049453391739816,-1.0547979902015439,0.32621951219512196,0.8440952856325402,1.0,11/56,10.91%,RTN4RL1;MYLIP;PTPRS;NLGN1;PRAG1;BCL11A;GDI1;LINGO1;MAG;EFNB2;SPOCK1
prerank,regulation of DNA repair (GO:0006282),0.36042738418388687,1.0544989146366452,0.38235294117647056,0.6974975791887158,1.0,10/44,13.82%,EGFR;RPS3;BABAM2;BRCC3;CEBPG;RAD52;POLH;DEK;UBE2N;KAT7
prerank,protein polyubiquitination (GO:0000209),0.2808984066747898,1.0544925847820972,0.3526140155728587,0.6970044732580783,1.0,56/297,14.43%,WWP1;SASH1;FBXW7;SMURF2;PSMA7;ARIH1;RPS27A;FBXL17;UBE2E3;SIAH2;PELI1;RMND5A;PRKN;TRIM56;LNPEP;RC3H1;SPOP;UBE2Q2;CBFB;TRIM32;FBXL5;ANKIB1;BCL2;CDC27;PSMB2;TRIM68;SHPRH;TRIM27;MDM2;RNF19B;TPP2;UBE2K;UBE2D3;CUL3;MKRN1;FBXO11;RNF14;ZNRF2;AMFR;PSMA6;UBE3B;TRIM71;FBXO10;MKRN3;UBE2R2;RNF115;UBE2N;RBBP6;RNF187;RNF19A;BFAR;ANKRD39;NEDD4L;PSMA3;PSMD1;PSMD5
prerank,regulation of cell differentiation (GO:0045595),-0.2463758633639315,-1.0543481016832787,0.3181818181818182,0.8439704028440805,1.0,26/148,10.04%,TGFBR1;DDX5;BIN1;CDK9;DDX17;OCIAD1;CSF1;YWHAH;NLGN1;SMAD7;CLASP2;ZFHX3;BMPR1B;BIRC2;GPS2;FGFR2;NF1;RPS6KA1;TRIP4;BDNF;SIK1;ALK;TIAM1;AR;ZFHX2;PHLDB1
prerank,excitatory postsynaptic potential (GO:0060079),0.42015390996343566,1.053521919730011,0.3951890034364261,0.6986609293781715,1.0,5/19,10.24%,MEF2C;GSK3B;MPP2;MAPK8IP2;GRIN2D
prerank,actin filament depolymerization (GO:0030042),-0.44803850393161415,-1.0530998053173188,0.389010989010989,0.8464490788931275,1.0,5/11,21.99%,TWF2;MICAL3;MICAL2;TWF1;WDR1
prerank,positive regulation of release of cytochrome c from mitochondria (GO:0090200),-0.3527758447224089,-1.052748582081143,0.375,0.8460936885576362,1.0,5/25,10.63%,TP53;BCL2L11;MLLT11;BMF;TNFSF10
prerank,ketone body metabolic process (GO:1902224),-0.44452083442708823,-1.0526391627918514,0.4127310061601643,0.8449955180178369,1.0,5/10,33.84%,ACSS3;HMGCLL1;OXCT1;AACS;BDH1
prerank,regulation of viral transcription (GO:0046782),0.3638212491271827,1.0526217033134797,0.390282131661442,0.7001899946034952,1.0,9/39,14.37%,MDFIC;IFITM3;LARP7;TRIM32;NELFA;TRIM27;POLR2B;MID2;POLR2D
prerank,phosphatidylethanolamine metabolic process (GO:0046337),0.3916349158038162,1.05238796063313,0.3888888888888889,0.7001799430390914,1.0,7/27,10.19%,ALOX15;CEPT1;PNPLA8;PLA2G2D;CHKB;ETNPPL;PLAAT1
prerank,positive regulation of triglyceride biosynthetic process (GO:0010867),0.4803381877328513,1.0523148141545657,0.41487279843444225,0.699825936546287,1.0,3/11,13.88%,LDLR;NR1H2;MFSD2A
prerank,negative regulation of developmental process (GO:0051093),0.3311514477674433,1.0519784347335093,0.36962750716332377,0.7000640163764426,1.0,17/69,16.90%,GAS6;BMP2;PRKN;HEY2;CDK6;SPI1;RC3H1;ROCK1;FOXM1;RPS6KA6;SFRP1;ROCK2;LOXL2;ANP32B;TBX2;BNIP3;ARPIN
prerank,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),-0.39590700253065564,-1.0517492307252152,0.3811659192825112,0.8460785957047,1.0,5/17,20.46%,CADM1;NECTIN2;SLAMF6;RASGRP1;KLRD1
prerank,regulation of microtubule-based movement (GO:0060632),-0.44043293844219145,-1.0517252853997145,0.4133611691022965,0.8446787870582273,1.0,6/11,21.31%,MAP2;NEFH;DYNLT2B;CFAP298;HAP1;HDAC6
prerank,response to organic cyclic compound (GO:0014070),-0.2954313604399779,-1.0514903818842445,0.3314447592067989,0.8439918001126436,1.0,10/52,11.08%,CTNNB1;SPP1;PAQR8;SOCS2;GGT5;IL18;KYNU;CCL3;GGT7;SLC1A1
prerank,sterol biosynthetic process (GO:0016126),0.3811244747744353,1.05137723049823,0.3996815286624204,0.7008710849648754,1.0,13/33,24.87%,PRKAG2;HMGCR;PMVK;HSD17B7;LBR;FDPS;DHCR7;NSDHL;ACLY;IDI1;CYP51A1;EBP;ACAA2
prerank,embryonic cranial skeleton morphogenesis (GO:0048701),-0.405431627621207,-1.0512263416261938,0.3764172335600907,0.8433224877913765,1.0,2/15,4.91%,TGFBR1;FGFR2
prerank,regulation of tau-protein kinase activity (GO:1902947),0.48141199088987197,1.050882254760675,0.41359223300970877,0.7014684036228346,1.0,2/10,4.87%,C5AR1;RB1
prerank,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),0.4054715299071529,1.0506668484040558,0.40032414910858993,0.7014302414632924,1.0,9/24,16.59%,CNMD;TNMD;EPN2;PRKCB;EMILIN1;MMRN2;NIBAN2;PRKD2;ARNT
prerank,small GTPase mediated signal transduction (GO:0007264),0.3124092142268087,1.0504307911489241,0.3601036269430052,0.7014434265310392,1.0,22/103,14.78%,RGL1;RREB1;RIN2;NRAS;KRAS;SIAH2;ARHGAP18;ARHGAP31;RAPGEF2;GRAP;RB1;NUCB2;GNB1;MAPK14;IGF1;SHC1;RASSF1;NUCB1;NTN1;RALB;RALGDS;USP28
prerank,negative regulation of cell cycle (GO:0045786),0.32468164895573426,1.050251040792445,0.36099585062240663,0.7013432107207161,1.0,17/73,17.22%,NUPR1;BMP2;LILRB1;HECA;DUSP1;CDK6;RB1;PTPRK;NR4A1;GMNN;PPP1R13B;LATS2;NPPC;RUNX3;HEXIM2;PTEN;NR2F2
prerank,protein dephosphorylation (GO:0006470),0.306482916769233,1.050167572352328,0.3587385019710907,0.7010072281504022,1.0,24/135,11.02%,PTPRJ;PPP3CA;PTPN18;PTPN12;PTPN22;MTM1;MTMR3;DUSP12;DUSP1;CTDSP1;SSH2;PTPRK;PTPRA;PPM1B;DUSP22;DUSP2;PPP4R1;CTDSP2;LHPP;PPP2CA;PPP2CB;PPEF1;PPP4R2;PPP1CA
prerank,eye photoreceptor cell development (GO:0042462),0.4477747421188081,1.050154756472507,0.404553415061296,0.7005243931986241,1.0,2/15,7.04%,RP1;MYO7A
prerank,base-excision repair (GO:0006284),-0.30363990676468644,-1.0500911291145236,0.3884057971014493,0.8452989124670842,1.0,16/48,23.22%,DNA2;PARP1;ERCC6;LIG1;XRCC1;POLG;RFC2;NEIL3;POLE;HUWE1;POLL;RFC1;ADPRS;PARG;APEX2;POLD4
prerank,morphogenesis of an epithelium (GO:0002009),0.4086668547730516,1.0496478805319274,0.39195979899497485,0.7011441697590935,1.0,4/25,8.74%,LRP6;ACTB;ARHGAP12;VCL
prerank,acylglycerol biosynthetic process (GO:0046463),0.4068618204374918,1.0487135001784902,0.3901192504258944,0.7027294335252295,1.0,3/23,4.40%,ANG;AGMO;MOGAT2
prerank,muscle tissue morphogenesis (GO:0060415),0.42350037349279823,1.048576298655697,0.40037243947858475,0.702556689289606,1.0,2/16,4.49%,BMP2;HEY2
prerank,positive regulation of locomotion (GO:0040017),-0.3452262915363501,-1.0481842786509423,0.3788300835654596,0.849671095562306,1.0,7/27,13.83%,TREM2;CCDC25;P2RY12;STX3;CSF1R;AIF1;SPOCK2
prerank,proteoglycan biosynthetic process (GO:0030166),-0.32667884885712417,-1.0481523242333697,0.37721518987341773,0.8483197620078693,1.0,14/31,24.48%,CHST11;EXTL3;XYLT1;BMPR1B;CANT1;GAL3ST4;HS3ST3B1;B4GALT7;PXYLP1;CHST10;UGDH;B3GALT6;B3GAT1;GLCE
prerank,snRNA processing (GO:0016180),-0.3971666442647794,-1.0478211060658542,0.4004329004329004,0.8479149991112582,1.0,6/16,25.27%,INTS6L;INTS3;TOE1;INTS9;INTS11;INTS7
prerank,peptidyl-threonine modification (GO:0018210),-0.2784185233465714,-1.0476558642737075,0.3887240356083086,0.8469580544369807,1.0,24/66,22.36%,TGFBR1;PRKCD;GALNT3;ACVR1;CDC42BPA;CIT;GALNT13;MAP3K12;DYRK2;WNK3;PDPK1;CDC42BPB;DYRK1B;TGFBR2;GALNTL6;CDK10;ACVR1B;ULK1;HIPK1;CAMK2D;MAPK8;TAF1;DYRK4;GALNT11
prerank,regulation of NMDA receptor activity (GO:2000310),-0.3292597228650592,-1.0476332962825303,0.38292011019283745,0.8455456346475493,1.0,7/32,3.80%,DLG2;PTK2B;GRIA2;NLGN1;DLG4;DLG3;GRIA4
prerank,response to nitric oxide (GO:0071731),0.45759997131564517,1.047545737720714,0.4080145719489982,0.7043845353128907,1.0,3/13,12.87%,CCL19;MTR;FOXO1
prerank,modulation by host of symbiont process (GO:0051851),-0.33201885704492395,-1.0473712751383146,0.3856041131105398,0.8448907437401149,1.0,17/31,37.60%,CX3CR1;TARDBP;SMARCB1;SAP30BP;CCL3;JUN;HDAC1;NAPEPLD;LEF1;CCNT1;HPN;CARD9;TFAP4;SMARCA4;HMGA2;CCL4;LRRC19
prerank,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",-0.3415615138951702,-1.047077530390229,0.355,0.8443587972926188,1.0,7/29,9.14%,GTF2H2;CUL4A;CCNH;PARP1;DDB2;RBX1;ERCC2
prerank,retinal metabolic process (GO:0042574),-0.44080381487961934,-1.0468276887049326,0.416289592760181,0.843681046237033,1.0,2/12,5.36%,BCO2;RDH10
prerank,organic substance transport (GO:0071702),0.30498548205674114,1.0466376951307383,0.3748378728923476,0.7059339039882431,1.0,27/121,18.80%,PLTP;TXNIP;RCN3;CALCRL;RILP;SLC22A18;ABCA9;TCN2;ABCA6;ARRDC3;RAB7A;CMTM6;DISP1;RAMP2;GM2A;SLC6A2;MFSD2A;SLC23A1;SNX4;CLN8;HSP90B1;MIA3;SLC35F3;SLCO2A1;CHKA;ABCA4;TOM1
prerank,N-acetylglucosamine metabolic process (GO:0006044),-0.39529624368333083,-1.0464962287692872,0.37037037037037035,0.8432867988119427,1.0,3/15,9.37%,LARGE1;CHST1;CHST2
prerank,negative regulation of activated T cell proliferation (GO:0046007),-0.4607650815107402,-1.0464324312892692,0.4146868250539957,0.8420682402694498,1.0,3/10,7.77%,CD274;PRKAR1A;PRNP
prerank,nucleobase-containing small molecule catabolic process (GO:0034656),-0.4018098970011982,-1.0463928384944836,0.40384615384615385,0.8407743846669192,1.0,9/14,37.50%,ENTPD6;ADPRM;NUDT1;ENTPD3;NUDT16;NUDT5;ENTPD2;ENTPD5;NUDT15
prerank,regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),-0.44806979952019954,-1.0455739287142767,0.4126315789473684,0.8418173295950764,1.0,3/10,12.27%,DLGAP2;DLGAP1;NPTX1
prerank,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),0.3655254244674456,1.0451740297840224,0.39143730886850153,0.7088067628096695,1.0,6/37,8.96%,NUPR1;RPS3;GSDME;RACK1;BCL2;RPS7
prerank,regulation of nitric oxide biosynthetic process (GO:0045428),0.3698567198341017,1.0450732410476191,0.4015503875968992,0.708525982996158,1.0,12/38,16.01%,KLF2;CD36;TLR4;INSR;TNF;KLF4;ASS1;ROCK2;ZC3H12A;ATP2B4;PKD2;HSP90AB1
prerank,semaphorin-plexin signaling pathway (GO:0071526),0.3665302941579099,1.0448209057455062,0.3780487804878049,0.7085709708378842,1.0,4/35,7.94%,NRP1;SEMA4A;PLXNA4;ARHGDIA
prerank,presynaptic endocytosis (GO:0140238),0.400370928436869,1.0448103700894948,0.38562091503267976,0.7080827421377022,1.0,4/24,7.72%,FCHO2;OPHN1;SYNJ1;CANX
prerank,negative regulation of NF-kappaB transcription factor activity (GO:0032088),-0.2702191607028117,-1.0447916035122435,0.37543859649122807,0.8428223988552053,1.0,18/76,15.63%,IRAK2;HAVCR2;CYLD;OTULIN;COMMD7;CCDC22;DAP;ARRB2;DDIT3;PRMT2;PARP10;NLRC5;MTURN;CD200;ADORA3;PYDC1;ITCH;CDK5RAP3
prerank,catecholamine metabolic process (GO:0006584),0.43645351939334537,1.0442568433183672,0.397459165154265,0.7088054935039831,1.0,3/14,5.58%,DRD1;PRKN;ATP7A
prerank,positive regulation of apoptotic signaling pathway (GO:2001235),0.34243170676342927,1.0441613936445995,0.38656716417910447,0.7085055173029461,1.0,10/55,8.46%,NUPR1;RPS3;RIPK1;BCL10;GSDME;RACK1;PAK2;BCL2;TNF;TNFSF12
prerank,neuronal action potential (GO:0019228),-0.36307752745883715,-1.043714947862916,0.38271604938271603,0.8447455506202798,1.0,9/22,40.30%,KCNA1;KCNA2;SCN8A;SCN1A;CACNA1H;MYH14;CACNA1G;ANK3;SCN10A
prerank,histone H2A monoubiquitination (GO:0035518),-0.390197074234527,-1.0430505209145429,0.394919168591224,0.8453121165578588,1.0,10/17,26.89%,SKP1;DDB2;RNF168;PCGF5;PCGF6;PCGF2;RING1;BMI1;PCGF1;KDM2B
prerank,regulation of B cell differentiation (GO:0045577),0.42989208348486047,1.0425141991456024,0.4335154826958106,0.711704751965422,1.0,5/17,10.04%,ZFP36L2;ZFP36L1;PPP2R3C;SYK;SFRP1
prerank,positive regulation of cell growth (GO:0030307),-0.26074247624826485,-1.042140361013905,0.35365853658536583,0.8466004812679657,1.0,24/96,16.15%,TGFBR1;RPTOR;SEMA4D;RIMS1;EIF4G1;RIMS2;HDGFL2;ZFYVE27;MACF1;RPS6KA1;AKAP6;TWF2;BDNF;MAPT;EXOSC9;HYAL1;DDX49;FXN;LGI1;LIMK1;NCBP1;PABIR1;ADAM10;CDKL5
prerank,gliogenesis (GO:0042063),-0.4028113333573177,-1.04169108083565,0.4004424778761062,0.8465270742086209,1.0,2/15,2.58%,CD9;CDH2
prerank,regulation of cellular component organization (GO:0051128),0.3027077354274005,1.0416058288527799,0.39748427672955977,0.7132246331663191,1.0,13/135,6.94%,HIP1;APOE;RAP1B;SGK3;OPHN1;IRAK3;CD36;IL17RB;RAPGEF2;RAP1A;ROCK1;AP2S1;TNF
prerank,glycosaminoglycan catabolic process (GO:0006027),0.34431620342399744,1.0415010531537343,0.39798850574712646,0.7129528455733782,1.0,3/55,2.35%,LYVE1;HGSNAT;CD44
prerank,glomerular visceral epithelial cell differentiation (GO:0072112),0.4579495423716974,1.0414868291174357,0.400679117147708,0.7124720164719246,1.0,2/12,1.94%,IQGAP1;JAG1
prerank,regulation of protein modification by small protein conjugation or removal (GO:1903320),-0.37337803916978396,-1.041456857560817,0.3977272727272727,0.8458200171835725,1.0,12/20,36.74%,TGFBR1;DNAJB2;ITCH;EPAS1;HIF1A;UBQLN1;DCUN1D2;DCUN1D5;HSPA1A;DCUN1D3;HSPA1B;EGR1
prerank,maintenance of protein location in nucleus (GO:0051457),-0.3710197805808679,-1.0401736098161765,0.4009216589861751,0.8483401263190925,1.0,7/20,22.07%,SKP1;HNRNPU;SUPT7L;ARL2BP;PARK7;BBS4;TAF8
prerank,positive regulation of innate immune response (GO:0045089),0.3717171488663557,1.0399065929799618,0.3837753510140406,0.7154354227407077,1.0,6/30,12.63%,TLR8;LBP;SPI1;RIOK3;UBE2K;POLR3D
prerank,intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),0.4687782386301566,1.0395827000936135,0.4262948207171315,0.7156988721214607,1.0,3/11,12.19%,MAP3K5;STK24;DIABLO
prerank,mitochondrial genome maintenance (GO:0000002),0.46204385912531265,1.0390625808299123,0.43042671614100186,0.7163699576428469,1.0,5/11,19.55%,MEF2A;MGME1;LONP1;SLC25A4;SLC25A36
prerank,COPII-coated vesicle budding (GO:0090114),-0.2792512780844414,-1.0390307556004779,0.3829113924050633,0.8503277984571495,1.0,24/68,20.89%,TGFA;PREB;KLHL12;TRAPPC3;SEC31A;ANKRD28;CNIH1;NAPA;SEC24A;TBC1D20;F8;PPP6R1;SCAP;TRAPPC9;SEC23B;SEC31B;TRAPPC6A;GOLGA2;SEC24B;TRAPPC2;SEC13;BET1;GOSR2;TRAPPC2L
prerank,inositol lipid-mediated signaling (GO:0048017),-0.29940148029714525,-1.0388757723652464,0.3893805309734513,0.8493733146454846,1.0,11/50,11.24%,PLCL1;ADAP2;PLCB2;PIK3CB;PLCB4;PI4KA;INPP5F;PIK3C2B;CSF1R;PLCB1;PLCH1
prerank,negative regulation of neuron apoptotic process (GO:0043524),0.33042033413271077,1.038810492389216,0.4065155807365439,0.7163975233361286,1.0,8/69,6.34%,APOE;LIG4;MEF2C;RASA1;GRN;SNX6;PRKN;BCL2
prerank,ncRNA metabolic process (GO:0034660),0.3590898227867322,1.038808604019796,0.4003139717425432,0.7158968423333126,1.0,7/37,13.53%,PRKRA;MOV10L1;TUT7;DROSHA;TUT4;TRIM71;PIWIL2
prerank,cell migration involved in sprouting angiogenesis (GO:0002042),0.4231634624208155,1.0386848503423642,0.4117647058823529,0.7156863796438881,1.0,3/17,9.85%,NRP1;NR4A1;EPHB4
prerank,positive regulation of cold-induced thermogenesis (GO:0120162),0.31863806104704584,1.0384556814443509,0.40456989247311825,0.7156487273181624,1.0,15/90,10.91%,IRF4;CMKLR1;CEBPB;ADRB2;CD36;GHRL;ADIPOR2;SYK;CXCR4;CCR2;PDGFC;STAT6;TSHR;HADH;ACHE
prerank,regulation of calcium ion transmembrane transporter activity (GO:1901019),0.39018250432826473,1.0382385855555372,0.40930979133226325,0.7156500302860197,1.0,5/27,11.84%,AHNAK;PDE4D;PLN;CALM1;YWHAE
prerank,regulation of DNA metabolic process (GO:0051052),-0.30404805923284883,-1.038116186764464,0.3712737127371274,0.8503257500642994,1.0,8/44,8.76%,CDK9;XRCC5;THOC1;HDAC8;IL7R;SIRT7;TOM1L1;UPF1
prerank,carbohydrate biosynthetic process (GO:0016051),-0.3627225648937705,-1.0377226957925183,0.41706161137440756,0.850107353907621,1.0,7/21,18.40%,ST3GAL6;B3GALT1;B3GALT5;B3GALT2;ST3GAL3;FUT9;ST3GAL2
prerank,protein K48-linked ubiquitination (GO:0070936),0.34524105453459936,1.0376623413630888,0.40998487140695916,0.7164036592893548,1.0,20/54,19.89%,UBE2E3;PELI1;PRKN;UBE2Q2;TRIM32;UBE2K;UBE2D3;CUL3;AMFR;UBE2R2;RNF115;RNF187;BFAR;NEDD4L;RNF146;FBXO38;UBE2A;SKP2;RNF6;KBTBD7
prerank,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),-0.35007331704055794,-1.0374752296282026,0.3975609756097561,0.8494277887376073,1.0,10/24,23.56%,CTC1;SRC;HNRNPU;PARP1;STN1;TERF2;HNRNPA1;GNL3L;ACD;SLX4
prerank,receptor signaling pathway via STAT (GO:0097696),0.4021977728591467,1.0373938696355036,0.4161073825503356,0.7165118233136755,1.0,9/25,14.70%,IFNAR1;PIAS1;THPO;CCR2;STAT4;IFNAR2;STAT6;STAT3;PKD2
prerank,positive regulation of developmental process (GO:0051094),0.2954006372527908,1.037375672667221,0.37906137184115524,0.7160459229246646,1.0,43/164,20.42%,APOE;FGFR1;ZBTB16;RREB1;SMURF2;NCOA3;CEBPB;BMP2;RPS6KA3;PRKN;MCU;KRT10;INSR;TNF;PSEN1;ESRRB;CLASP1;CORO1C;RTN4;VLDLR;B4GALT5;KMT5B;NIBAN2;GJA1;MDK;BMPR1A;NR2C2;HSP90AB1;SLC6A6;BNIP3;LHX1;SHLD3;XBP1;PA2G4;LMNA;MFF;GDNF;DVL3;CCN2;DLG5;HMCES;SHLD2;DNM1L
prerank,negative regulation of neuron death (GO:1901215),0.314302393271895,1.0372002757492729,0.40217391304347827,0.7159389331405362,1.0,12/93,6.34%,APOE;LIG4;MEF2C;RASA1;TNFRSF1B;GRN;SNX6;PRKN;KIR3DL2;GSK3B;CD200R1;BCL2
prerank,positive regulation of telomerase activity (GO:0051973),-0.32382797573654887,-1.0369498399487247,0.37771739130434784,0.8496127111723921,1.0,12/33,27.96%,CTNNB1;XRCC5;MAPK3;MAP2K7;PTGES3;MAP3K4;CCT2;WRAP53;ACD;NVL;AURKB;GREM1
prerank,positive regulation of potassium ion transport (GO:0043268),-0.3104150931930159,-1.0368686899064252,0.3958333333333333,0.8484290762454144,1.0,6/38,8.73%,KCNMA1;KCNJ2;NOS1AP;ANK2;AKAP6;ACTN2
prerank,protein-containing complex assembly (GO:0065003),0.27915818543862997,1.0367359951613027,0.38173302107728335,0.716500961998575,1.0,35/259,9.68%,HGSNAT;P2RX7;TCF7L2;CTSC;SNX9;TLE4;KMT2A;REPS2;ANO6;MITF;RIPK1;CD74;SKAP2;AXIN1;ITGB1BP1;MCU;GSK3B;WIPF1;ST13;TMED10;TCF7;CD40;DARS1;TNF;HFE;CDC73;ASH2L;TUBGCP2;RANBP9;TRAPPC4;MDM2;TFG;TRAPPC10;RAB1A;CUL3
prerank,central nervous system projection neuron axonogenesis (GO:0021952),0.46608384055638785,1.036571579993227,0.4274661508704062,0.71634215292006,1.0,6/12,19.49%,MYCBP2;PAFAH1B1;SZT2;EPHB6;CHRNB2;SPTBN4
prerank,renal system development (GO:0072001),-0.29936739921224254,-1.036414533964414,0.3888888888888889,0.8483232225883672,1.0,8/52,12.71%,TGFBR1;SALL1;STAT1;IFT88;SULF1;BAG6;PAX8;PROX1
prerank,regulation of autophagy (GO:0010506),0.2840217003445306,1.036283250683642,0.3900709219858156,0.7164841327404802,1.0,55/216,18.23%,FBXW7;PRKAG2;NUPR1;DAPK1;PTPN22;EEF1A1;ATP6V1B1;PRKAG3;LAMP3;ERN1;SNX6;TRIM65;PRKN;MTMR3;MCL1;GSK3B;ROCK1;TBC1D14;ATP6V0A1;BCL2;HSPB1;DRAM1;EXOC4;DRAM2;ATF6;TRIM68;PIK3C2A;ATP6V1A;TRIM27;SMCR8;TPCN1;SREBF2;FOXK2;FOXO3;LAMTOR5;SNX5;ZC3H12A;FOXK1;FOXO1;RUBCN;MID2;STAT3;EP300;VPS26A;RB1CC1;NPRL2;EXOC8;ATP6V0D1;BNIP3;TAB3;HGF;PIP4K2A;WDR41;RHEB;RRAGC
prerank,negative regulation of cell differentiation (GO:0045596),0.2869813706274599,1.0356301974220232,0.3780630105017503,0.7174549123657953,1.0,24/181,10.04%,EGFR;SPRED1;ZBTB16;ZFP36L2;JAG1;CRIM1;TNN;OSR1;XDH;FGF23;IL17RD;CDK6;TRIO;RB1;GDF10;TNF;CDC73;VASN;LIMD1;ESRRB;ASXL1;USF3;PPP2CA;SFRP1
prerank,neurotrophin TRK receptor signaling pathway (GO:0048011),-0.40510053949996383,-1.0348162392262694,0.4148681055155875,0.8518302478939176,1.0,3/15,6.81%,SORT1;ZFYVE27;BDNF
prerank,extracellular matrix organization (GO:0030198),-0.2272652715076283,-1.0348059035687918,0.371900826446281,0.8504568424237482,1.0,80/276,22.31%,DST;TGFBR1;ITGB5;F11R;COL27A1;KLK2;NPNT;GPM6B;ADAMTSL1;JAM2;COL11A1;ITGA6;GFOD2;SPARC;SPP1;ADAMTS16;TLL1;ITGB3;FGF2;FLOT1;ITGAX;CTSS;NF1;P3H2;ADAMTS3;BSG;LOXL3;ADAMTS4;APLP1;ITGA5;LAMA2;PLOD3;MMP16;COL23A1;ADAMTS20;PECAM1;LAMA3;SCUBE1;ADAM8;NDNF;ADAMTS1;MATN4;SPOCK2;COL25A1;COL1A2;COL19A1;COL11A2;ADAM10;TNR;COL8A1;VCAN;VIT;BCAN;COL26A1;ITGB4;FURIN;COL6A2;COL16A1;BGN;COLGALT2;FLRT2;SERPINE1;COL6A3;COL4A2;ITGAV;PDGFA;P3H4;NCAN;COL4A6;TGFB2;ADAMTS2;COL9A3;CTSK;COL9A1;ITGAD;COL3A1;TGFB1;COL6A1;COL20A1;ITGA10
prerank,mitotic sister chromatid cohesion (GO:0007064),0.4440954748106225,1.0346509586426544,0.42805755395683454,0.7192807779408197,1.0,3/16,7.55%,RB1;REC8;PDS5B
prerank,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),-0.3836507872523265,-1.0344785110386105,0.38256658595641646,0.8500113440160219,1.0,6/17,9.77%,EIF4G1;CALM2;SMAD7;PARD3;CADM4;SIRT2
prerank,regulation of cytokine production involved in inflammatory response (GO:1900015),-0.3111190571149838,-1.0344651071999116,0.4177545691906005,0.8486570193359985,1.0,9/37,10.39%,SIRPA;PLD4;TREM2;CUEDC2;PDCD4;APOD;APPL1;ADCY7;ABCD2
prerank,positive regulation of mitotic nuclear division (GO:0045840),0.3710487270580912,1.0338536882896907,0.4152139461172742,0.7205807065706544,1.0,9/34,11.15%,RGCC;RB1;INSR;CDC27;NSMCE2;CUL3;IGF1;NUP62;PHIP
prerank,negative regulation of defense response to virus (GO:0050687),-0.4412735014026384,-1.0336956146520302,0.4455852156057495,0.8495501779435761,1.0,8/10,31.85%,C1QBP;ITCH;PCBP2;MUL1;TARBP2;ILRUN;TRAF3IP1;TSPAN6
prerank,focal adhesion assembly (GO:0048041),0.40499943007395334,1.033622427977227,0.41385135135135137,0.72059441285806,1.0,5/21,10.22%,PEAK1;PTPRK;RCC2;PIP5K1A;THSD1
prerank,ganglioside biosynthetic process (GO:0001574),0.4377090301751079,1.0331224855048833,0.4225092250922509,0.7212093773836494,1.0,3/15,4.20%,ST8SIA4;ST3GAL1;B4GALT6
prerank,inositol phosphate metabolic process (GO:0043647),-0.2951193678960083,-1.0330134541855132,0.3959537572254335,0.8502352611679859,1.0,10/46,11.24%,INPP4B;INPP5D;PLCB2;PLD4;PLCB4;FGF2;PLCG1;MINPP1;PLCB1;PLCH1
prerank,mitochondrial respiratory chain complex I assembly (GO:0032981),-0.2822422462138584,-1.032617334642825,0.36163522012578614,0.8486106116814603,1.0,22/56,31.25%,NUBPL;TMEM126A;NDUFAF6;NDUFS7;NDUFV3;NDUFAF1;NDUFB8;NDUFB7;NDUFV1;NDUFB10;NDUFA8;NDUFA10;TIMM21;ECSIT;NDUFAB1;NDUFS1;NDUFAF8;ACAD9;NDUFA6;DMAC2;NDUFAF3;NDUFV2
prerank,NADH dehydrogenase complex assembly (GO:0010257),-0.2822422462138584,-1.032617334642825,0.36163522012578614,0.8486106116814603,1.0,22/56,31.25%,NUBPL;TMEM126A;NDUFAF6;NDUFS7;NDUFV3;NDUFAF1;NDUFB8;NDUFB7;NDUFV1;NDUFB10;NDUFA8;NDUFA10;TIMM21;ECSIT;NDUFAB1;NDUFS1;NDUFAF8;ACAD9;NDUFA6;DMAC2;NDUFAF3;NDUFV2
prerank,cell proliferation in forebrain (GO:0021846),-0.44519350733014285,-1.0325124252590925,0.4319148936170213,0.8475269267106791,1.0,5/10,27.93%,NUMB;NUMBL;AKNA;KIF14;WNT7A
prerank,establishment of endothelial intestinal barrier (GO:0090557),-0.4357294905470862,-1.0324748027975568,0.44047619047619047,0.8462615957972203,1.0,4/11,10.37%,F11R;TJP1;TJP2;AFDN
prerank,positive regulation of cytokinesis (GO:0032467),0.37829698760354863,1.0324408340778204,0.39901477832512317,0.7222557875976766,1.0,6/32,12.60%,KIF20B;CDC42;RHOA;PKN2;CUL3;SVIL
prerank,positive regulation of vascular permeability (GO:0043117),-0.42087905114800495,-1.0316377814691797,0.4340425531914894,0.8472760602569427,1.0,7/12,30.18%,TJP1;TJP2;PDE3A;TGFB1;ANGPT1;OCLN;TJP3
prerank,negative regulation of epithelial to mesenchymal transition (GO:0010719),0.389947200719039,1.0315856552807146,0.40770465489566615,0.7236723112957721,1.0,10/29,17.88%,SPRED1;IL17RD;VASN;USF3;PPP2CA;SFRP1;SPRED2;PTEN;SPRY2;EFNA1
prerank,RNA 3'-end processing (GO:0031123),-0.28094802756282755,-1.0315217537443238,0.371875,0.8462284101150679,1.0,22/69,21.56%,THOC1;SRRM1;SRSF5;PABPN1;DDX39B;SRSF3;RPRD1A;SRSF2;CSTF2;RNPS1;U2AF1;LIN28B;UPF3B;CASC3;NCBP1;CLP1;SRSF11;THOC3;SRSF9;POLDIP3;ALYREF;U2AF2
prerank,protein transport (GO:0015031),0.2760325984501809,1.0314515202028836,0.39464882943143814,0.7234671966276808,1.0,50/332,11.15%,APOE;SNX9;TXNIP;TBC1D5;TBC1D4;RAB31;SNX8;CLTC;EVI5;STEAP3;RCN3;CALCRL;USP6NL;SPTBN1;RILP;CD36;CD74;ATP6V1B1;SNX6;RAB8B;RAB10;SNX27;EHD1;AP3B1;AFM;RIC1;TBC1D14;ATP6V0A1;TMED10;TBC1D2B;RABGAP1L;HFE;PRKCB;CANX;SGSM1;ARRDC3;RAB7A;ATP6V1A;STX7;GOLPH3L;RAB14;RAB1A;CMTM6;RAB23;LAMP2;ARL4A;VLDLR;WLS;SLC10A7;WDR11
prerank,regulation of sequestering of calcium ion (GO:0051282),-0.4256980189116502,-1.031431450711048,0.43458980044345896,0.8451184373383803,1.0,3/12,4.87%,PTK2B;ANK2;UBASH3B
prerank,phosphatidylcholine metabolic process (GO:0046470),-0.2710859996431014,-1.031196172598763,0.37857142857142856,0.8444113593948143,1.0,7/70,4.22%,LPCAT2;LPIN2;SLC44A2;LPCAT1;ENPP2;PCYT1B;PLA2G6
prerank,tight junction assembly (GO:0120192),-0.29040761266869053,-1.0310637680843486,0.4,0.8434232173168048,1.0,4/49,2.61%,F11R;TBCD;PARD3;CLDN11
prerank,cell cycle checkpoint signaling (GO:0000075),-0.4228411432084832,-1.0310470245822636,0.41252699784017277,0.8421155636884441,1.0,5/12,22.73%,WEE1;BUB1B;BUB1;ZW10;ZWINT
prerank,negative regulation of endopeptidase activity (GO:0010951),0.34508519664055404,1.0308930771778966,0.3825701624815362,0.7242254793697993,1.0,2/47,1.51%,SERPINB8;SERPINB2
prerank,histone mRNA metabolic process (GO:0008334),0.3816352524824091,1.0307090202865632,0.4030612244897959,0.7241785342155888,1.0,8/27,16.42%,TUT7;TENT2;CPSF3;TUT4;SNRPG;DCP2;TUT1;CPSF2
prerank,muscle cell development (GO:0055001),0.37157884344855396,1.0302394222206188,0.41812400635930047,0.7247740810520057,1.0,8/30,13.19%,NRAP;MYH6;ALPK3;MYOF;HEY2;IGF1;RAMP2;NEB
prerank,morphogenesis of a polarized epithelium (GO:0001738),0.4553444317714786,1.0299488515368191,0.41681574239713776,0.7249382998500948,1.0,3/12,5.71%,RAB10;CELSR1;ACTB
prerank,protein targeting to peroxisome (GO:0006625),0.3724949930637574,1.0299316845564768,0.4240924092409241,0.7244660278557284,1.0,5/29,6.62%,RAB8B;SLC25A17;PXMP2;PEX7;PEX26
prerank,ceramide metabolic process (GO:0006672),-0.29692218965706346,-1.0298251183355542,0.38904899135446686,0.844333279764956,1.0,20/49,21.05%,CERK;ST6GALNAC3;SMPD4;PLPP3;NSMAF;ASAH1;ASAH2;CERS4;SAMD8;DEGS1;CERS5;ACER2;CERS1;SGMS2;SPTLC1;SMPD2;TLCD3B;CERS2;ABCA2;PLPP2
prerank,protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),-0.44971799901868026,-1.0290489937678484,0.4435146443514644,0.8453125316329849,1.0,5/10,23.40%,EMC9;EMC10;EMC1;EMC6;MMGT1
prerank,organelle assembly (GO:0070925),-0.2177921940036527,-1.0290401372703337,0.3974358974358974,0.8439869111376216,1.0,116/384,23.08%,ASAP1;CAPN3;BBS9;BIN2;TRAPPC14;PTPN23;TMEM67;RILPL1;SCLT1;SNF8;DYNC1H1;IRGM;CCDC66;IFT81;TMOD2;ATP6V1D;CENPC;HPS4;IFT140;RAB3IP;ATG2A;DZIP1;CEP162;ATXN2L;IFT88;AUP1;TTC8;CHMP4B;CHMP4A;MAPT;AHI1;ATG16L1;CEP250;CCDC57;HAUS8;IFT20;BBS7;TUBGCP5;OGFOD1;MKS1;CEP63;CENPE;DYNLT2B;WDR19;VPS37A;MAPRE3;SPAG16;DYNC2H1;RAB38;CD34;NEK6;WDR45;KIF3A;NSFL1C;SSX2IP;CIRBP;HAUS7;TUBGCP3;FARP2;MAPRE1;HAUS3;CORO1A;TCTN1;IFT52;MAP1LC3A;CDS1;KIF3B;GABARAPL1;WDR90;ATG9A;SQLE;DLGAP5;CDC14A;ULK1;CDS2;ATXN2;CFAP298;CFAP410;NUDCD3;TRAPPC6A;CPLANE2;NOTCH1;GOLGA2;IFT43;HDAC3;DYNC2I1;EMC6;EHD3;ATG14;B9D2;RCC1;RAB8A;TMEM138;DNAH5;PLA2G3;BBS4;TUBGCP6;CHMP6;ARL3;CEP89;CHMP3;RBM14;WDR45B;IQCB1;HDAC6;TMEM231;MKKS;PRRC2C;G3BP1;FLNA;GALNT11;TMEM17;BSCL2;PTPDC1;EDC3;HAUS2
prerank,negative regulation of innate immune response (GO:0045824),0.3699021875630026,1.0285484567451024,0.4403225806451613,0.7270562483558224,1.0,4/34,7.06%,VSIG4;IRAK3;GRN;USP15
prerank,melanosome organization (GO:0032438),-0.3453413586916046,-1.0284667826467486,0.39947780678851175,0.8443011470144312,1.0,6/26,10.65%,LYST;HPS4;AP3D1;AP1M1;SHROOM2;RAB38
prerank,regulation of gluconeogenesis (GO:0006111),0.38358509720499445,1.02834009759395,0.4240400667779633,0.7270300160722086,1.0,5/27,13.99%,C1QTNF3;C1QTNF12;GNMT;ARPP19;EP300
prerank,regulation of T cell differentiation in thymus (GO:0033081),-0.40847660949283027,-1.0282917774622842,0.4434782608695652,0.8434833995090436,1.0,10/13,53.13%,CAMK4;ADAM8;TESPA1;BMP4;SHH;SOD1;TOX;VNN1;ZC3H8;CLPTM1
prerank,positive regulation of cell junction assembly (GO:1901890),-0.2807144676779945,-1.0278726431543976,0.3881118881118881,0.8433060600228658,1.0,16/56,16.57%,GRID2;MAP4K4;PTPRD;NLGN1;CNTNAP2;NRXN1;FERMT2;FLOT1;EPHB1;BDNF;SYNDIG1;TSC1;IL1RAPL1;EPHB2;THY1;IL1RAP
prerank,actin filament-based transport (GO:0099515),0.40365536999624113,1.0275018378508325,0.41403508771929826,0.7283967522878203,1.0,6/21,14.11%,MYO5A;SYNE2;MYO7A;MYO1E;MYO1C;WASL
prerank,fatty-acyl-CoA biosynthetic process (GO:0046949),-0.3394035222042724,-1.0268188063298833,0.4090909090909091,0.8451408652213767,1.0,17/29,37.65%,ACACA;PPT1;TECR;ACSL4;ACSL6;SCD;SLC25A1;ACSBG1;ELOVL1;GCDH;ACSF3;ELOVL7;CBR4;HACD2;ELOVL6;ELOVL2;HSD17B8
prerank,regulation of peptidyl-threonine phosphorylation (GO:0010799),0.3708381660121732,1.0267800266679927,0.43354430379746833,0.7294773356206158,1.0,9/37,10.98%,APP;SPRED1;PRKAG2;AXIN1;S1PR2;UBE2K;RIPK2;CALM1;SPRED2
prerank,phosphatidylcholine catabolic process (GO:0034638),0.4765011462586014,1.0265170338854381,0.4354166666666667,0.7295956098047605,1.0,2/10,4.93%,PLA2G7;PNPLA8
prerank,regulation of peptide hormone secretion (GO:0090276),0.32349692559650045,1.0265056757005928,0.40995607613469986,0.7291160728541771,1.0,18/67,18.37%,ALOX5;CLOCK;RAP1A;TNF;EIPR1;KCNG2;HFE;HADH;SLC8B1;SLC2A2;KCNB1;TFR2;FFAR1;ITPR3;CCL5;IL6;CACNA1A;RFX3
prerank,Wnt signaling pathway (GO:0016055),0.31248699718256306,1.0263583651676902,0.417890520694259,0.7289418068816094,1.0,14/92,10.54%,LRP6;TCF7L2;RARG;RPS27A;WNT2;AXIN1;GSK3B;SNX3;FRAT1;TCF7;WNT6;NR4A2;SFRP1;WLS
prerank,regulation of axonogenesis (GO:0050770),-0.28827598254135356,-1.0261418950810965,0.3870967741935484,0.8456828493923274,1.0,21/51,22.66%,ROBO2;PAK1;CDH2;LRRC4C;PLXNA2;ROBO1;GDI1;MAP6;LINGO1;TIAM1;MAG;TIAM2;OMG;THY1;BRSK2;PAK3;PLXNB2;PLXNB3;BRSK1;PLXNB1;CHODL
prerank,positive regulation of cartilage development (GO:0061036),0.42212996911632883,1.0260866251677383,0.43014705882352944,0.7290317874426337,1.0,4/17,14.31%,ZBTB16;BMP2;LOXL2;MDK
prerank,membrane repolarization during action potential (GO:0086011),-0.4053541551925768,-1.026024938146895,0.4200426439232409,0.8447181610418254,1.0,2/13,2.09%,KCNJ2;ATP1B1
prerank,positive regulation of autophagy (GO:0010508),0.3137857525151333,1.0259173499426353,0.41631504922644164,0.7289407804946911,1.0,21/81,16.79%,DAPK1;SESN1;GNAI3;WAC;TRIM65;PRKN;GSK3B;CAMKK2;ROCK1;ATF6;TRIM68;PIK3C2A;TRIM27;TPCN1;FOXO3;ZC3H12A;FOXO1;MID2;NPRL2;PAFAH1B2;BNIP3
prerank,cAMP biosynthetic process (GO:0006171),-0.4439297229304922,-1.0258079452547169,0.45495495495495497,0.8440293391098234,1.0,4/10,16.43%,ADCY3;ADCY8;ADCY7;ADCY1
prerank,retinoid metabolic process (GO:0001523),0.3252240958134124,1.0257840020662707,0.40083798882681565,0.7287311521644587,1.0,14/71,18.29%,APOE;DHRS3;UGT1A7;UGT1A8;UGT1A1;SDC3;SDC4;CYP26B1;RBP4;GPC3;SCPEP1;RDH5;RBP1;ABCA4
prerank,potassium ion import across plasma membrane (GO:1990573),-0.3100291433042427,-1.025408715466255,0.39755351681957185,0.8438818714588016,1.0,16/41,25.15%,SLC12A2;KCNJ2;ATP1B1;ATP1B2;SLC12A9;SLC12A6;KCNK9;ABCC9;KCNJ3;KCNJ10;KCNJ13;SLC12A4;SLC12A5;KCNJ9;KCNH2;SLC12A1
prerank,peptidyl-lysine acetylation (GO:0018394),0.46197431186795956,1.0253178417721516,0.4275092936802974,0.7292375401925528,1.0,4/10,13.99%,ESCO1;CREBBP;KAT7;EP300
prerank,organelle organization (GO:0006996),0.27010261780006267,1.0250460563618593,0.40540540540540543,0.7293225899746896,1.0,81/388,16.88%,TMCC1;FGD4;NEDD9;APOE;FGD6;DIAPH1;EPS15;RAB31;ATL1;LIG4;ATXN7;USP6NL;ARHGAP21;ARHGAP10;CDC42;ATP8B4;PRKN;TTC29;ATP7A;TMED10;PI4K2B;DPYSL2;PIKFYVE;PEX7;CNN2;CYP26C1;VPS4B;NIPSNAP2;GEM;RAB7A;CCL24;STX7;LIMD1;GOLPH3L;RANBP9;RAB14;RAB30;CLASP1;MAST1;CYCS;KIF4A;RAB1A;CENPT;POLG2;MTX1;PACSIN2;CHMP5;PHIP;VPS13C;FAM161B;CHGA;VAPA;BCAS3;PYROXD2;DIAPH3;LARP4;WASL;MDK;PDZD8;SPTBN5;CEP78;PLAAT3;TMED2;PKD2;SIPA1L3;PPIA;SYNE3;MYC;REEP6;PEX14;FGD3;VPS51;HCFC1;COG7;FAM161A;SEC16A;RAB32;MIA3;GOLPH3;PRDX3;CUL7
prerank,prostaglandin metabolic process (GO:0006693),-0.3413005537196978,-1.0248580167688204,0.41025641025641024,0.8441142085697877,1.0,6/26,11.84%,HPGDS;DAGLB;PTGS1;PTGES3;PTGR2;MIF
prerank,phospholipid dephosphorylation (GO:0046839),0.36302582847579806,1.0245904896618396,0.4276827371695179,0.7298606558015049,1.0,5/37,5.45%,SGPP1;MTM1;SYNJ1;MTMR3;OCRL
prerank,regulation of cell-substrate adhesion (GO:0010810),-0.2976044226504548,-1.0244611149563152,0.40226628895184136,0.8440366934552387,1.0,14/42,18.02%,JAK2;NPNT;PIK3CB;GCNT2;TBCD;NF1;MINK1;SPOCK1;TSC1;NDNF;THY1;PDPN;VIT;NOTCH1
prerank,steroid catabolic process (GO:0006706),-0.4397517524887926,-1.0240836165155534,0.4252136752136752,0.843846812244186,1.0,2/10,3.24%,YWHAH;SPP1
prerank,positive regulation of sprouting angiogenesis (GO:1903672),-0.38939607182649333,-1.0238699261186035,0.4264705882352941,0.8431314514690832,1.0,5/15,11.81%,TJP1;FGF2;PKM;ITGA5;PDPK1
prerank,myelin maintenance (GO:0043217),-0.4540988258425656,-1.0237227629709669,0.43415637860082307,0.8422395537831957,1.0,3/10,10.39%,EPB41L3;DEGS1;ABCD2
prerank,negative regulation of cellular amide metabolic process (GO:0034249),0.31260977392693473,1.0236883535974002,0.40463215258855584,0.731404157284558,1.0,33/84,23.11%,APOE;RPS3;DAPK1;SAMD4A;MRPL13;RACK1;ROCK1;MALSU1;RBM4;ILF3;IGF1;RTN4;ORMDL1;DDX6;NANOS3;TRIM71;SHMT1;CNOT9;SYNCRIP;RNF139;EIF2AK2;EIF2AK3;CNOT1;CNOT8;GIGYF2;ENC1;DAPK3;IGF2BP3;PUS7;RTN3;EPRS1;CPEB3;PCIF1
prerank,regulation of spindle assembly (GO:0090169),-0.34913040380991034,-1.0236192849662,0.427536231884058,0.8412522036508762,1.0,5/25,6.32%,EML3;DYNC1H1;CEP97;HNRNPU;CHMP4B
prerank,positive regulation of protein deacetylation (GO:0090312),-0.4012413233149591,-1.0234501436289904,0.4434589800443459,0.8404378703865525,1.0,5/14,23.54%,AKAP8L;SAP30BP;AKAP8;FNTA;CTBP1
prerank,regulation of potassium ion transmembrane transporter activity (GO:1901016),-0.3319456300537772,-1.0232525588349592,0.4201474201474201,0.8396991861846875,1.0,6/26,13.19%,ATP1B1;ATP1B2;ANK2;CACNA1D;ACTN2;VAMP2
prerank,oligosaccharide biosynthetic process (GO:0009312),-0.36497875445603944,-1.023152869563561,0.4230769230769231,0.8386763347273083,1.0,7/20,18.40%,ST3GAL6;B3GALT1;B3GALT5;B3GALT2;ST3GAL3;FUT9;ST3GAL2
prerank,negative regulation of protein serine/threonine kinase activity (GO:0071901),0.3194283171759466,1.0229963513923535,0.4243281471004243,0.732434959496873,1.0,7/75,4.87%,LRP6;APOE;PTPRJ;LYN;IRAK3;DUSP1;RB1
prerank,neutrophil activation (GO:0042119),0.45331740811886456,1.022996249630987,0.4340344168260038,0.7319270295665701,1.0,3/12,6.57%,IL15;FCER1G;SYK
prerank,phosphatidylcholine acyl-chain remodeling (GO:0036151),-0.3254723013545029,-1.0226075180410392,0.42783505154639173,0.8389107653234266,1.0,5/29,13.89%,LPCAT2;LPCAT1;PLA2G6;LPCAT3;MBOAT7
prerank,regulation of response to cytokine stimulus (GO:0060759),0.4128767026098045,1.022468688773474,0.4377224199288256,0.7325643634462378,1.0,5/19,10.75%,LIFR;CBFB;KLF4;SH2B3;ELF1
prerank,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),0.3941916931222679,1.022285260294707,0.4154676258992806,0.7319823892650573,1.0,7/23,12.56%,YWHAQ;SFN;BCL2;TFDP1;CASP8;YWHAE;PPP1R13B
prerank,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),0.3941916931222679,1.022285260294707,0.4154676258992806,0.7319823892650573,1.0,7/23,12.56%,YWHAQ;SFN;BCL2;TFDP1;CASP8;YWHAE;PPP1R13B
prerank,phosphatidylserine acyl-chain remodeling (GO:0036150),0.40272028270586263,1.0221607595115778,0.43717728055077454,0.7317817490059986,1.0,5/21,15.58%,PLA2G2D;PLAAT3;OSBPL8;OSBPL10;OSBPL5
prerank,mucosal immune response (GO:0002385),0.4398918975563783,1.021673196321621,0.4111310592459605,0.7324285389715371,1.0,1/15,2.50%,RPL39
prerank,regulation of translation (GO:0006417),0.28820634907451176,1.0212555872464175,0.41346153846153844,0.7328026154557523,1.0,54/173,21.16%,APP;RPS3;DAPK1;EIF3E;SAMD4A;NIBAN1;RPL26;RPS6KA3;VIM;MRPL13;RACK1;RPS4X;HSPB1;MTPN;RPL5;MALSU1;LARP4B;RBM4;EIF1;ILF3;DDX6;EIF4B;NANOS3;FOXO3;RPL10;TRIM71;ETF1;LARP4;PIWIL2;SHMT1;CNOT9;EIF3H;EIF5;CSDE1;TRAP1;SYNCRIP;IL6;PYM1;METAP1;NSUN3;EIF2AK4;RNF139;EIF2AK2;GSPT1;BCL3;EIF2AK3;CNOT1;CNOT8;GIGYF2;ENC1;DAPK3;IGF2BP3;MTRF1;PUS7
prerank,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),0.39092157417916784,1.0211322616692515,0.43427620632279534,0.732564817380182,1.0,8/24,18.42%,FCER1G;B2M;MFSD6;HFE;CANX;SEC24D;ERAP1;TAPBP
prerank,phagosome maturation (GO:0090382),-0.31183350957828115,-1.0209169889923129,0.4419889502762431,0.8425027647104048,1.0,12/35,15.53%,TCIRG1;ATP6V1C1;ATP6V0A2;ATP6V1D;ATP6V1H;ATP6V1G1;ATP6V0B;RAB38;ATP6V0D2;ATP6V0C;CORO1A;RAB20
prerank,regulation of T cell mediated cytotoxicity (GO:0001914),0.4221017029065266,1.020719052150452,0.41906474820143885,0.7330115075489713,1.0,2/16,8.48%,LILRB1;STX7
prerank,cell junction maintenance (GO:0034331),0.42954240350074824,1.020674441813357,0.42935779816513764,0.7326016776309063,1.0,1/14,1.21%,MYADM
prerank,piRNA metabolic process (GO:0034587),0.41329690901218236,1.020457523855338,0.4341880341880342,0.7325912637345527,1.0,4/19,23.01%,MOV10L1;PIWIL2;TEX15;TDRKH
prerank,wound healing (GO:0042060),-0.28228572729754686,-1.0203427968332115,0.4041095890410959,0.8428511704192435,1.0,9/62,7.38%,DST;TGFBR1;PAK1;AHNAK2;ITGB3;FGF2;NF1;MACF1;DCBLD2
prerank,spindle assembly (GO:0051225),-0.2756001078063489,-1.0201932105691904,0.4266666666666667,0.8420104447821664,1.0,30/67,23.08%,CLASP2;CEP192;HAUS8;TUBGCP5;CEP63;MAPRE3;NEK6;WRAP73;KIF11;TOGARAM1;HAUS7;NUMA1;TUBGCP3;MAPRE1;HAUS3;CHEK2;KIF3B;KIFC2;KIF2A;GOLGA2;HDAC3;BCCIP;AAAS;RCC1;TUBGCP6;KIFC1;TOGARAM2;FLNA;MAP9;HAUS2
prerank,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",0.3586196303687101,1.0198207177311527,0.415625,0.7335817353450811,1.0,9/36,15.41%,TCF7L2;PPP3CA;GNG2;PDE6A;GNB1;CALM1;PLCB3;TNRC6C;NLK
prerank,regulation of erythrocyte differentiation (GO:0045646),0.36522567179438087,1.0197493019771575,0.41930379746835444,0.7332431682425079,1.0,12/35,18.21%,LYN;ZFP36L1;CDK6;SPI1;ACVR2A;MAPK14;FOXO3;STAT3;PRMT1;ARNT;ABCB10;MAFB
prerank,regulation of cell motility (GO:2000145),0.2981213735871624,1.0196592478082043,0.43198992443324935,0.7329625596227634,1.0,16/121,8.80%,EGFR;SGK3;DIAPH1;FGF23;ARHGAP18;CCL19;CRK;PLXNC1;RHOA;CDK6;PKN2;ROCK1;TRIM32;PLXNA4;AMOT;RCC2
prerank,negative regulation of cellular catabolic process (GO:0031330),0.32747084406724897,1.0194631094603033,0.42775393419170243,0.7328819509250643,1.0,13/63,13.90%,NELL1;NUPR1;PTPN22;RIC1;MCL1;ROCK1;TBC1D14;BCL2;FOXK2;FOXK1;RUBCN;MFSD2A;STAT3
prerank,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),-0.3541518433016041,-1.0193612108072838,0.44761904761904764,0.8431566339716648,1.0,10/21,31.40%,ATM;BUB1B;BUB1;ZW10;IK;ZWINT;MAD2L1;TTK;CENPF;FBXO5
prerank,cardiac muscle cell membrane repolarization (GO:0099622),-0.4136131082598923,-1.0191875926015193,0.42887029288702927,0.8423453217692314,1.0,2/11,2.09%,KCNJ2;ATP1B1
prerank,regulation of postsynaptic membrane potential (GO:0060078),0.3678145051559683,1.0191157453516,0.43729903536977494,0.733156243058565,1.0,8/34,10.28%,MEF2C;GSK3B;MPP2;CHRNA4;MAPK8IP2;INSYN2A;GRIN2D;GABRA3
prerank,purine ribonucleoside triphosphate metabolic process (GO:0009205),0.4339440025253295,1.0189556751445805,0.4320754716981132,0.7330255930369916,1.0,6/13,19.35%,GNAI3;RAB23;GTPBP1;EFL1;AK3;AK4
prerank,regulation of collagen biosynthetic process (GO:0032965),0.4119649125046798,1.018581636352899,0.43119266055045874,0.7333692423863756,1.0,7/19,21.48%,RGCC;VIM;EMILIN1;CREB3L1;IL6;F2R;CIITA
prerank,negative regulation of lipid biosynthetic process (GO:0051055),0.3982710733402607,1.0185742829494133,0.43455497382198954,0.7328779531869422,1.0,3/20,6.29%,FBXW7;BMP2;ERLIN1
prerank,axoneme assembly (GO:0035082),-0.3280535310975821,-1.0184337933550038,0.4106666666666667,0.8431972721585889,1.0,7/30,12.66%,CFAP74;LRGUK;TTC12;CCDC39;SPAG16;TOGARAM1;DNAI4
prerank,leukocyte adhesion to vascular endothelial cell (GO:0061756),0.42197458190062753,1.0183720091338366,0.4473229706390328,0.7328152958019507,1.0,4/18,6.94%,ITGA4;ITGB1;ROCK1;TNF
prerank,regulation of amyloid precursor protein biosynthetic process (GO:0042984),0.4575937560135743,1.0181925310140045,0.4533333333333333,0.7327094439828484,1.0,3/11,15.84%,ITM2B;NECAB2;ITM2C
prerank,positive regulation of cell development (GO:0010720),-0.3205677972672779,-1.0178813641880895,0.430939226519337,0.8434263037332993,1.0,5/31,11.23%,CX3CR1;NUMB;TGM2;NUMBL;PDE3A
prerank,negative regulation of DNA biosynthetic process (GO:2000279),-0.31973945115275426,-1.0176779256279844,0.4097938144329897,0.8427487043924581,1.0,10/30,21.76%,CTC1;SRC;TP53;HNRNPU;STN1;TERF2;CERS1;HNRNPA1;GNL3L;ACD
prerank,cellular transition metal ion homeostasis (GO:0046916),0.30812908071581013,1.017079604641103,0.4144385026737968,0.7347486716973753,1.0,16/91,10.93%,APP;CP;HMOX1;FTL;NDFIP1;SMAD4;ATP7A;FBXL5;GLRX3;HFE;HMOX2;ATP6V1A;ACO1;NUBP1;SLC39A12;FTH1
prerank,regulation of cellular pH (GO:0030641),0.37663557989406804,1.0168694057337344,0.41765704584040747,0.7347148998435508,1.0,7/29,14.19%,SLC9A9;SLC9A4;SLC4A4;SLC4A5;ATP1A4;SLC9A7;SLC9A6
prerank,cytoplasmic translational initiation (GO:0002183),-0.37368988751029014,-1.0167748393914917,0.4054726368159204,0.844089746917529,1.0,5/17,6.69%,EIF4G1;EIF4A1;EIF2B3;EIF4A2;EIF2D
prerank,bone development (GO:0060348),0.35937724612413097,1.0165421704031017,0.4523809523809524,0.7349176293675465,1.0,9/39,13.10%,LRP6;RPL13;NOTUM;VKORC1;SULF2;CYP26B1;PTGER4;SLC10A7;GJA1
prerank,dicarboxylic acid transport (GO:0006835),0.38007426322637733,1.0149612222970634,0.4320388349514563,0.737940978871252,1.0,1/28,0.22%,FOLR2
prerank,regulation of rhodopsin mediated signaling pathway (GO:0022400),0.3898334376705797,1.0149440230280722,0.4452423698384201,0.7374708493925672,1.0,9/23,23.91%,PDE6A;GUCY2D;PPEF1;CALM1;GRK4;METAP1;NMT1;NMT2;METAP2
prerank,positive regulation of glucose import (GO:0046326),0.3937045469330755,1.0144533957329993,0.42248722316865417,0.7380782112132998,1.0,6/21,14.84%,C1QTNF12;IRS2;INSR;IGF1;ARPP19;OSBPL8
prerank,macromolecule catabolic process (GO:0009057),0.3758905218127538,1.013954072319655,0.4518900343642612,0.7386993474551646,1.0,7/26,10.29%,UVRAG;CLN5;CLN6;KIF16B;SNX25;TRIM24;CLPX
prerank,Golgi inheritance (GO:0048313),0.4655224599055417,1.0138098745285085,0.4580896686159844,0.7385214893952197,1.0,2/11,8.51%,VCPIP1;VRK1
prerank,negative regulation of interferon-beta production (GO:0032688),-0.43288174233757637,-1.0135651012863796,0.466,0.8521333012184662,1.0,2/10,1.22%,SIRPA;PTPRS
prerank,snRNA transcription by RNA polymerase II (GO:0042795),-0.2757201525513274,-1.0133248371004846,0.42295081967213116,0.8514752402725136,1.0,26/69,30.13%,CDK9;RPAP2;INTS3;RPRD1A;CCNT2;POU2F2;ICE2;SRRT;POLR2C;NCBP1;INTS13;ELL2;ELL;TAF8;POLR2L;TAF9;INTS9;TBP;CCNK;INTS11;CCNT1;INTS7;POLR2I;TAF13;ICE1;SNAPC1
prerank,regulation of integrin-mediated signaling pathway (GO:2001044),0.4401864814865709,1.0131821801187377,0.4379432624113475,0.7394469616642091,1.0,2/14,3.95%,BST1;ITGB1BP1
prerank,photoreceptor cell development (GO:0042461),0.43216060961655406,1.0131592958423932,0.44582593250444047,0.738994163309932,1.0,3/14,13.88%,RP1;MYO7A;MFSD2A
prerank,lung development (GO:0030324),-0.3141883734414005,-1.013123194078225,0.43434343434343436,0.8507854407379856,1.0,14/33,29.16%,FGF2;FGFR2;LOXL3;BAG6;CCDC39;PROX1;PDPN;ERRFI1;SOX11;CCDC40;FGF1;WNT7B;FGF7;BMP4
prerank,positive regulation of transcription regulatory region DNA binding (GO:2000679),0.40005660586763453,1.0131046273848276,0.44220183486238535,0.7386177004667132,1.0,7/20,18.57%,RB1;IGF1;NIBAN2;LAMTOR5;EP300;GTF2B;TRAF6
prerank,negative regulation of leukocyte activation (GO:0002695),0.42719231043412087,1.0130196099208393,0.4409722222222222,0.7382985004348901,1.0,2/15,3.26%,FCGR2B;GRN
prerank,regulation of toll-like receptor signaling pathway (GO:0034121),0.38118803301366316,1.0128722022872965,0.44516129032258067,0.7381266067201789,1.0,5/26,4.77%,IRAK3;CD36;TLR2;NFKBIL1;BIRC3
prerank,regulation of programmed necrotic cell death (GO:0062098),0.4081284653781149,1.012847685406488,0.45315161839863716,0.7376839226544639,1.0,6/20,11.05%,NUPR1;RIPK1;PELI1;BIRC3;SDCBP;CASP8
prerank,microtubule nucleation (GO:0007020),-0.3614458148619372,-1.0126776200700789,0.4131455399061033,0.8508013269610352,1.0,7/19,19.78%,CLASP2;CCDC57;TUBGCP5;TPPP;TUBGCP3;GOLGA2;TUBGCP6
prerank,negative regulation of cellular biosynthetic process (GO:0031327),0.3372537103098492,1.0123328479143487,0.4192546583850932,0.7382997831999043,1.0,10/47,13.99%,FBXW7;C1QTNF3;C1QTNF12;RAPGEF2;ERLIN1;FYN;ROCK2;ZC3H12A;ATP2B4;EP300
prerank,positive regulation of intracellular transport (GO:0032388),-0.30690416111059465,-1.0121660732909081,0.38903394255874674,0.8510580644671942,1.0,11/38,13.19%,SORL1;PRR5L;DYNC1H1;STX18;STK11;ACTN2;PLK3;ZFAND1;NUMA1;TBC1D20;VAMP2
prerank,negative regulation of peptidyl-serine phosphorylation (GO:0033137),0.3970169779388538,1.0118712163435257,0.4397283531409168,0.738855309476699,1.0,4/21,9.08%,RASSF2;RACK1;PDE4D;CNKSR3
prerank,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),-0.35898503824399713,-1.0117481893664404,0.44144144144144143,0.8510708005565538,1.0,8/19,20.21%,TP53;BAG6;DYRK2;MSH2;HIPK1;PYCARD;PHLDA3;AEN
prerank,response to ATP (GO:0033198),0.40592630651110045,1.0115815760575577,0.4635879218472469,0.739034467144211,1.0,1/18,0.51%,P2RX7
prerank,glycerolipid metabolic process (GO:0046486),-0.4186746809728104,-1.0112531991733231,0.43186582809224316,0.8511975445048089,1.0,5/11,30.67%,DGKB;DGKZ;DGKG;DGKA;DGKQ
prerank,regulation of neuron death (GO:1901214),0.3140194269431622,1.011214716699248,0.43983402489626555,0.7393365715313754,1.0,9/82,5.09%,FCGR2B;MAP3K5;C1QA;MEF2C;TNFRSF1B;PRKN;KIR3DL2;GSK3B;CD200R1
prerank,regulation of oxidative stress-induced cell death (GO:1903201),0.467997413411583,1.0111361068187679,0.43737574552683894,0.7390183948143114,1.0,2/11,8.07%,PRKN;FYN
prerank,potassium ion transport (GO:0006813),-0.24511168549375048,-1.0110721767297173,0.41125541125541126,0.8504249718858569,1.0,16/120,9.84%,KCNMA1;SLC1A3;KCND2;KCNH7;KCNJ2;SLC24A3;SLC24A2;SLC9A8;KCNQ3;NALCN;SLC24A4;KCNQ5;KCNK2;KCNA1;KCNA2;KCNK12
prerank,neuron projection regeneration (GO:0031102),-0.43568301790785613,-1.0109414661506393,0.454337899543379,0.8495343470952941,1.0,1/10,0.26%,RTN4RL1
prerank,cell differentiation in spinal cord (GO:0021515),-0.44078588074607994,-1.010662397166592,0.44246031746031744,0.8490617980952903,1.0,2/10,11.70%,MDGA2;SOX13
prerank,positive regulation of neural precursor cell proliferation (GO:2000179),-0.3547008551245747,-1.0104486582594436,0.41265822784810124,0.8484039665500516,1.0,2/21,0.88%,CX3CR1;CTNNB1
prerank,protein homooligomerization (GO:0051260),0.2995463277876148,1.0103647622606282,0.4394736842105263,0.7403194798780066,1.0,22/114,15.92%,NLRC4;EHD4;ATL1;ALOX5AP;B2M;EHD1;BCL10;MPP2;CLYBL;NINJ1;BEND3;USP16;GNMT;TRPM2;DISP1;TRMT61B;SHMT1;PKD2L1;PKD2;PRMT1;SAMHD1;MLKL
prerank,regulation of Golgi organization (GO:1903358),0.42419191989639116,1.0103453352432403,0.4620811287477954,0.7398600504969581,1.0,2/17,2.47%,MYO5A;USP6NL
prerank,positive regulation of amyloid precursor protein catabolic process (GO:1902993),0.39881898608168465,1.0096999952501742,0.44350758853288363,0.7407721774121173,1.0,9/22,17.88%,LYN;TNF;RANBP9;SP1;ROCK2;RELA;IFNGR1;PICALM;EFNA1
prerank,negative regulation of transforming growth factor beta production (GO:0071635),0.4578979210821967,1.0093105939745706,0.4495967741935484,0.7411421478645864,1.0,3/10,16.01%,LILRB1;FN1;HSP90AB1
prerank,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",0.36633276507069273,1.0091913498816825,0.43760399334442596,0.7408938329553508,1.0,6/29,9.97%,RPS16;RPS21;RPS8;RPS14;MRPS11;HEATR1
prerank,positive regulation of cell cycle G1/S phase transition (GO:1902808),0.35297810807690855,1.0090563672641601,0.4305555555555556,0.7406898469917017,1.0,8/33,13.02%,EGFR;ANKRD17;RGCC;CCND3;CDC73;CCND2;TFDP1;KMT2E
prerank,regulation of calcineurin-NFAT signaling cascade (GO:0070884),0.38050771415111445,1.0090164753800808,0.4217687074829932,0.7402857683067954,1.0,5/26,12.32%,CHP2;GSK3B;TNF;IGF1;ATP2B4
prerank,carboxylic acid transmembrane transport (GO:1905039),0.34886838822949573,1.008782657727687,0.4270833333333333,0.7403129479637858,1.0,11/40,17.60%,SLC16A7;SLC38A6;ABCC1;SLC38A1;SLC38A2;SLC23A1;SLC23A2;SLC25A30;SLC7A7;SLC5A6;SLC36A2
prerank,necroptotic process (GO:0070266),0.41784220929373117,1.0087734273975375,0.43862815884476536,0.7398362473863596,1.0,3/16,5.47%,RIPK1;TLR4;LY96
prerank,regulation of long-term neuronal synaptic plasticity (GO:0048169),0.46337512632489875,1.00842810369292,0.4648148148148148,0.7401485325146073,1.0,1/10,0.63%,APP
prerank,regulation of plasma membrane bounded cell projection organization (GO:0120035),0.37404210531806764,1.0079356311015564,0.45454545454545453,0.7407134208329055,1.0,5/27,8.32%,FCGR2B;GSK3B;DISC1;PSEN1;HOMER1
prerank,cholesterol metabolic process (GO:0008203),0.3180061299393511,1.0070897518191813,0.45335276967930027,0.7420662793080672,1.0,17/68,20.78%,APOE;HMGCR;SCARF1;CLN6;CYP27A1;PMVK;OSBPL1A;HSD17B7;LBR;CLN8;OSBPL5;CEL;FDPS;DHCR7;PIP4P1;NSDHL;ACLY
prerank,cellular response to thyroid hormone stimulus (GO:0097067),0.44606730512061465,1.0068810440509728,0.44216417910447764,0.7420541301951508,1.0,4/12,11.20%,KLF9;CTSB;THRB;GAS2L1
prerank,regulation of neurotransmitter secretion (GO:0046928),0.36697024936653977,1.006663553695394,0.4228395061728395,0.7420290846840868,1.0,4/32,7.81%,MCTP1;MEF2C;GSK3B;MCTP2
prerank,blood vessel endothelial cell migration (GO:0043534),0.3914881307699968,1.00636792719659,0.4595070422535211,0.7421904640518491,1.0,3/22,9.85%,NRP1;NR4A1;EPHB4
prerank,regulation of microtubule-based process (GO:0032886),-0.3052777104577721,-1.006203913408651,0.42480211081794195,0.8593598456665358,1.0,10/36,13.34%,EFNA5;CYLD;CLASP2;MACF1;MAPT;BICD2;MAP6;PHLDB1;TPPP;EPHA3
prerank,regulation of intracellular pH (GO:0051453),0.35872414997483476,1.0061743883656444,0.4364820846905538,0.7421037495758827,1.0,7/34,14.19%,SLC9A9;SLC9A4;SLC4A4;SLC4A5;TMEM165;SLC9A7;SLC9A6
prerank,regulation of cell cycle (GO:0051726),0.2714412713438044,1.0058080334113149,0.4508670520231214,0.7424080502114824,1.0,53/271,16.44%,LRP6;TCF7L2;NOTCH2;IQGAP1;KIF20B;NUPR1;RPL23;GRK5;FBXL17;BMP2;LILRB1;ERN1;ANKRD17;RGCC;DUSP1;CDK6;BIRC3;SND1;RB1;RACK1;PTPRK;NR4A1;TRIM32;NOP53;CHEK1;FOXM1;RPS15A;SDCBP;GMNN;MDM2;LIN54;MAP3K20;UHRF2;SFRP1;GAS2L1;MYBL2;RASSF1;NANOS3;CDKN2C;PPP1R13B;UHMK1;RARA;STAT3;EP300;JUND;CRLF3;PKD2;MYC;PRCC;RUNX3;HSP90AB1;HCFC1;LIN37
prerank,leukocyte tethering or rolling (GO:0050901),0.4220888267363839,1.0057940177950113,0.4454225352112676,0.7419449768181728,1.0,4/17,6.94%,ITGA4;ITGB1;ROCK1;TNF
prerank,regulation of sodium ion transmembrane transport (GO:1902305),-0.3218647049497013,-1.0056748231950519,0.4282115869017632,0.859547439932681,1.0,4/27,2.23%,FGF12;YWHAH;SCN1B;SNTA1
prerank,positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),-0.43389344312709116,-1.0056093005561517,0.45265588914549654,0.8584586266238442,1.0,3/10,7.81%,GRB10;ITGB3;ITGA5
prerank,telomere maintenance via telomere lengthening (GO:0010833),-0.3173350932404673,-1.0054767838374894,0.43874643874643876,0.8575586664665944,1.0,12/33,21.76%,CTC1;STN1;ANKRD28;PTGES3;TNKS1BP1;TERF2;GAR1;DCLRE1B;RFC1;WRAP53;RAD51;ACD
prerank,modulation by host of viral genome replication (GO:0044827),0.4364233734232862,1.0052312796121492,0.43169398907103823,0.7427573271224458,1.0,4/13,12.58%,CCL8;PRKN;ZC3H12A;VAPA
prerank,regulation of synapse assembly (GO:0051963),0.34193340843850273,1.0050597240981862,0.4260089686098655,0.7426254524517667,1.0,5/46,4.90%,PDLIM5;APP;MEF2C;TLR2;GHRL
prerank,response to interferon-beta (GO:0035456),0.38244119793407755,1.004893923969344,0.45501730103806226,0.7425066058521912,1.0,5/22,9.46%,IFITM3;BST2;IFNAR2;UBE2K;IFITM2
prerank,tRNA aminoacylation for protein translation (GO:0006418),-0.2940979599976255,-1.0043823837150314,0.4190751445086705,0.8595535685157366,1.0,21/42,29.06%,FARSA;AARS1;CARS1;TARS2;TARS1;NARS1;YARS1;IARS2;SARS1;DARS2;AARS2;SARS2;PARS2;HARS2;FARSB;WARS1;VARS2;VARS1;PPA2;NARS2;KARS1
prerank,tumor necrosis factor-mediated signaling pathway (GO:0033209),0.29485298949262484,1.0042583708696535,0.4622395833333333,0.7434396918286545,1.0,19/114,14.43%,TNFRSF25;PSMA7;TNFRSF1B;RIPK1;PLVAP;TNFRSF11A;BIRC3;CD40;EDARADD;TNF;EDA;PSMB2;TNFSF12;PSMA6;FOXO3;TNFRSF1A;PSMA3;PSMD1;PSMD5
prerank,positive regulation of endothelial cell chemotaxis (GO:2001028),0.4306652920840679,1.004213635214281,0.46083788706739526,0.743037370422144,1.0,2/15,6.92%,FGFR1;HSPB1
prerank,negative regulation of receptor-mediated endocytosis (GO:0048261),-0.335202353643402,-1.004054960193063,0.47848101265822784,0.8592322310567433,1.0,11/25,20.27%,RIN3;DLG4;ITGB3;APOC1;ANKRD13B;ANKRD13D;ARF6;ATXN2;ITGAV;ANKRD13A;ABCA2
prerank,cellular response to unfolded protein (GO:0034620),0.37888153827270254,1.003617446631896,0.434640522875817,0.743870524544994,1.0,5/26,11.84%,ERN1;PRKN;RHBDD1;BAG3;HSPA13
prerank,desensitization of G protein-coupled receptor signaling pathway (GO:0002029),-0.4210476884614509,-1.0033076391303588,0.45621181262729127,0.8601299316384396,1.0,5/11,13.79%,GTF2H2;GRK2;GRK3;ARRB2;SAG
prerank,cytoskeleton organization (GO:0007010),0.2973138085828406,1.003060645176213,0.4599483204134367,0.7446491624896812,1.0,25/114,15.07%,FGD4;NEDD9;APOE;FGD6;DIAPH1;ARHGAP10;RHOA;DPYSL2;PPP2R3C;CNN2;RHOBTB1;CCL24;LIMD1;RANBP9;MAST1;PACSIN2;PHIP;DIAPH3;LARP4;RND3;RHOC;MDK;PDZD8;SIPA1L3;SYNE3
prerank,microtubule anchoring at centrosome (GO:0034454),0.45340735014432243,1.002689572631596,0.4387947269303202,0.7449684598300824,1.0,3/10,13.96%,NIN;CEP19;PCM1
prerank,regulation of postsynapse organization (GO:0099175),0.37209036845993726,1.0026637137138317,0.46551724137931033,0.7445228095146568,1.0,2/28,0.40%,PDLIM5;FCGR2B
prerank,glycosphingolipid biosynthetic process (GO:0006688),-0.3790786871905609,-1.0026119981164727,0.49557522123893805,0.8608958191068616,1.0,6/16,15.51%,LARGE1;ST3GAL5;ST6GALNAC3;ST6GALNAC4;ST8SIA1;ST8SIA3
prerank,cardiac muscle contraction (GO:0060048),-0.32040025229052127,-1.002172350155693,0.4076923076923077,0.8608370723339676,1.0,5/34,7.31%,ATP1B1;SCN1B;SLC8A1;GRK2;GAA
prerank,heparan sulfate proteoglycan biosynthetic process (GO:0015012),-0.3613456128930918,-1.0021566934205082,0.4459770114942529,0.8596170897827082,1.0,4/19,4.10%,EXTL3;XYLT1;HS3ST5;HS6ST1
prerank,intrinsic apoptotic signaling pathway (GO:0097193),0.3040389024575757,1.0020377174808666,0.43902439024390244,0.7453819100314102,1.0,11/94,6.34%,MAP3K5;CRIP1;HINT1;CEBPB;TNFRSF1B;ERN1;MCL1;BCL2L2;STK24;SFN;BCL2
prerank,carnitine shuttle (GO:0006853),0.4493501519524366,1.002006881354181,0.4854014598540146,0.744947229823033,1.0,1/11,1.30%,PRKAG2
prerank,negative regulation of telomere maintenance via telomerase (GO:0032211),-0.35618963775732504,-1.0018049486149136,0.4251207729468599,0.8593557638748545,1.0,8/19,21.76%,CTC1;SRC;HNRNPU;STN1;TERF2;HNRNPA1;GNL3L;ACD
prerank,positive regulation of epithelial cell differentiation (GO:0030858),-0.37589239024882565,-1.0018017024273582,0.43908045977011495,0.8580905037437483,1.0,4/17,10.64%,FGF2;BTG1;AHI1;TMEM100
prerank,regulation of gastrulation (GO:0010470),0.4311907365192536,1.0010688564058532,0.44765342960288806,0.7465721772315465,1.0,4/14,9.70%,OSR1;RACK1;CLASP1;POGLUT1
prerank,positive regulation of histone deacetylation (GO:0031065),-0.4087543454911292,-1.000814864933604,0.47257383966244726,0.8596149888486148,1.0,3/12,11.96%,AKAP8L;SAP30BP;AKAP8
prerank,positive regulation of DNA recombination (GO:0045911),-0.32827114861688905,-1.0008065294924149,0.43147208121827413,0.8583700623097407,1.0,5/27,9.14%,FUS;PARP1;ERCC6;ZCWPW1;ERCC2
prerank,positive regulation of macroautophagy (GO:0016239),0.33260442591364575,1.0006200379944916,0.45839874411302983,0.7470735658591553,1.0,9/48,10.32%,SESN1;GNAI3;ADRB2;UVRAG;WAC;SPTLC2;BAG3;SMCR8;SLC25A5
prerank,negative regulation by host of viral transcription (GO:0043922),-0.40855773529276246,-1.0005757434031948,0.46406570841889117,0.8578304266931699,1.0,10/12,43.95%,TARDBP;CCL3;JUN;HDAC1;TFAP4;HMGA2;CCL4;PSMC3;POU2F3;REST
prerank,regulation of protein processing (GO:0070613),0.3960063831577176,1.0005006940756118,0.4504347826086956,0.7468477357975049,1.0,2/21,4.92%,NLRC4;RHBDD1
prerank,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",-0.2772293378205814,-0.9995978520524468,0.4785276073619632,0.8569766852459283,1.0,21/61,20.89%,TGFA;PREB;KLHL12;TRAPPC3;SEC31A;ANKRD28;CNIH1;NAPA;SEC24A;TBC1D20;F8;PPP6R1;TRAPPC9;TRAPPC6A;GOLGA2;SEC24B;TRAPPC2;SEC13;BET1;GOSR2;TRAPPC2L
prerank,COPII vesicle coating (GO:0048208),-0.2772293378205814,-0.9995978520524468,0.4785276073619632,0.8569766852459283,1.0,21/61,20.89%,TGFA;PREB;KLHL12;TRAPPC3;SEC31A;ANKRD28;CNIH1;NAPA;SEC24A;TBC1D20;F8;PPP6R1;TRAPPC9;TRAPPC6A;GOLGA2;SEC24B;TRAPPC2;SEC13;BET1;GOSR2;TRAPPC2L
prerank,vesicle coating (GO:0006901),-0.2772293378205814,-0.9995978520524468,0.4785276073619632,0.8569766852459283,1.0,21/61,20.89%,TGFA;PREB;KLHL12;TRAPPC3;SEC31A;ANKRD28;CNIH1;NAPA;SEC24A;TBC1D20;F8;PPP6R1;TRAPPC9;TRAPPC6A;GOLGA2;SEC24B;TRAPPC2;SEC13;BET1;GOSR2;TRAPPC2L
prerank,homotypic cell-cell adhesion (GO:0034109),-0.30514939684822195,-0.9995928046318237,0.4451219512195122,0.855733085940529,1.0,9/39,10.98%,PIK3CB;GNAS;PLPP3;ITGB3;UBASH3B;TJP2;P2RY12;FERMT3;TLN1
prerank,glucose transmembrane transport (GO:1904659),-0.35766617145897905,-0.9995014783988818,0.46559633027522934,0.8547507489806455,1.0,3/18,7.13%,SORT1;SLC2A9;SLC2A5
prerank,positive regulation of sphingolipid biosynthetic process (GO:0090154),-0.4334920658102954,-0.9994544143642093,0.48155737704918034,0.8524035680027193,1.0,3/10,6.30%,PRKCD;PLA2G6;NSMAF
prerank,positive regulation of ceramide biosynthetic process (GO:2000304),-0.4334920658102954,-0.9994544143642093,0.48155737704918034,0.8524035680027193,1.0,3/10,6.30%,PRKCD;PLA2G6;NSMAF
prerank,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),0.37519942927285665,0.999067881826189,0.45563139931740615,0.7496150540088268,1.0,7/26,13.02%,EGFR;ANKRD17;RGCC;CCND3;CCND2;TFDP1;KMT2E
prerank,cellular defense response (GO:0006968),0.34673256586069073,0.9988711914285756,0.46747352496217853,0.7495641114442846,1.0,8/40,10.81%,C5AR1;ITGB1;LBP;KIR3DL2;LY96;ZNF148;RAB23;NCF2
prerank,regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),0.44760006338058855,0.9986119301408802,0.4601449275362319,0.7496632117405257,1.0,2/12,3.50%,PTPRJ;CBL
prerank,proteasomal protein catabolic process (GO:0010498),0.27609190766338165,0.9983174722537452,0.46467065868263474,0.7498243943913223,1.0,39/201,15.31%,WWP1;FBXW7;SMURF2;PSMA7;RCN3;FBXL17;SIAH2;NR1D1;PELI1;RMND5A;PRKN;CLOCK;RHBDD1;SPOP;PSMB2;APPBP2;TBL1XR1;SPOPL;MDM2;TBL1X;UBE2K;UBE2D3;COP1;CUL3;ARMC8;ZFAND2B;ARRB1;PSMA6;RNF185;TRIM71;AGAP3;RNF187;BFAR;NEDD4L;PSMA3;PSMD1;PSMD5;RNF122;RNF41
prerank,contractile actin filament bundle assembly (GO:0030038),0.42481112570143253,0.9981334266978449,0.48727272727272725,0.7492423980167272,1.0,6/15,10.21%,ITGB1;RHOA;PDLIM1;FHDC1;CUL3;ARRB1
prerank,stress fiber assembly (GO:0043149),0.42481112570143253,0.9981334266978449,0.48727272727272725,0.7492423980167272,1.0,6/15,10.21%,ITGB1;RHOA;PDLIM1;FHDC1;CUL3;ARRB1
prerank,SNARE complex assembly (GO:0035493),0.469762505179917,0.9981324969310357,0.46987951807228917,0.7487515920984548,1.0,2/10,5.49%,UVRAG;STXBP6
prerank,fatty acid catabolic process (GO:0009062),-0.26765140187303893,-0.9978339461410247,0.46078431372549017,0.8557778918114263,1.0,26/67,30.12%,LPIN2;ACAD10;PHYH;ECHS1;ACADL;PCCB;AIG1;MMUT;ABCD2;ACADM;MTLN;FAAH;SLC27A2;ECI2;ILVBL;HACL1;SLC27A4;HSD17B10;CPT2;ACADVL;PECR;ACOT8;ABHD2;PCCA;MCEE;ECI1
prerank,cellular biogenic amine catabolic process (GO:0042402),-0.42970522069011985,-0.997733435859142,0.4773218142548596,0.8548333851854258,1.0,6/10,34.65%,COMT;CHDH;SMOX;SARDH;ALDH7A1;LRTOMT
prerank,regulation of osteoblast differentiation (GO:0045667),0.3124989449880716,0.9976363107241593,0.45545977011494254,0.7493642185586868,1.0,13/82,9.90%,NELL1;MEF2C;CRIM1;TNN;BMP2;FGF23;CDK6;GDF10;ACVR2A;IL6R;LIMD1;DDR2;IGF1
prerank,nervous system development (GO:0007399),0.2609260664702882,0.9976353996048888,0.4780278670953912,0.7488718636187666,1.0,37/429,6.20%,WWP1;GDA;ZEB2;NELL1;EDNRB;NAV1;ST8SIA4;ADGRG6;NOTCH2;ITM2B;MBNL1;ZBTB16;OPHN1;JAG1;LIG4;MEF2C;CRIM1;FBXL17;DRD1;WNT2;NES;HMGCR;CLN5;RPS6KA3;PRKN;JARID2;BTBD1;INTU;GRHL2;PMP22;FEZ2;PCDHB13;MTR;CELSR1;GFRA3;DPYSL2;ATXN1
prerank,steroid hormone mediated signaling pathway (GO:0043401),0.4412559174347625,0.9976338796972106,0.4659498207885305,0.748383676142373,1.0,3/13,9.07%,ESR1;NR3C1;ESR2
prerank,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),0.3514158786380477,0.9970086950540689,0.4630541871921182,0.7492423433499625,1.0,7/32,11.97%,RB1;CDK14;ESRRB;BACH1;TFDP1;HINFP;CDK17
prerank,DNA recombination (GO:0006310),0.3467515482816346,0.9968849929997208,0.4665551839464883,0.7490302300516691,1.0,11/37,19.75%,ENDOG;LIG4;RPA1;RAD54L;RAD52;RHNO1;RAD51B;FBH1;DMC1;MRE11;RTEL1
prerank,regulation of synapse organization (GO:0050807),0.3757282543672797,0.9964979004988236,0.45438898450946646,0.7493848487078141,1.0,3/26,6.94%,PDLIM5;MEF2C;TNF
prerank,regulation of organelle assembly (GO:1902115),-0.2668950883780279,-0.996388894854817,0.47474747474747475,0.8572883244421899,1.0,16/72,9.52%,TBC1D16;TBC1D8;SDCCAG8;CYLD;SGSM3;STX18;IFT140;ATXN2L;TBC1D10A;IFT88;RDX;TBC1D22A;IFT20;DYNLT2B;TBC1D22B;TBC1D9B
prerank,pyrimidine nucleoside biosynthetic process (GO:0046134),-0.4049850266539586,-0.9961977186240768,0.47404063205417607,0.8565573956092485,1.0,8/12,40.00%,UPP2;UMPS;UCKL1;CAD;DHODH;TK2;CDA;TK1
prerank,mitochondrial fusion (GO:0008053),-0.3580849322844653,-0.9960093012878783,0.45647058823529413,0.855859340050479,1.0,7/18,25.82%,MFN1;GDAP1;AFG3L2;MIGA2;FIS1;THG1L;USP30
prerank,sulfate transport (GO:0008272),0.43022849078279235,0.9955933529684877,0.47048300536672627,0.7508016376065457,1.0,8/14,26.83%,SLC26A11;SLC26A7;SLC25A30;RACGAP1;SLC13A4;SLC26A8;SLC25A11;SLC26A2
prerank,positive regulation of neuroinflammatory response (GO:0150078),-0.3993220936962546,-0.9954475514810766,0.4696969696969697,0.8562189657154691,1.0,4/12,8.70%,IL33;TREM2;IL18;CCL3
prerank,ether lipid biosynthetic process (GO:0008611),-0.42276878846645366,-0.9954219806795598,0.47334754797441364,0.855080041030938,1.0,4/10,13.64%,LPCAT2;DHRS7B;GNPAT;CHPT1
prerank,regulation of viral genome replication (GO:0045069),0.3257938036850155,0.994579641335589,0.45495495495495497,0.7525239940115855,1.0,9/56,9.78%,IFITM3;OAS2;FAM111A;PKN2;RNASEL;TNF;BST2;IFITM2;ILF3
prerank,maturation of 5.8S rRNA (GO:0000460),-0.36603011494298376,-0.9943669667573075,0.4699074074074074,0.856905757796378,1.0,5/17,11.73%,NSA2;WDR12;MAK16;URB1;FTSJ3
prerank,mitotic spindle checkpoint signaling (GO:0071174),-0.3509829233033998,-0.9943295810785425,0.4731934731934732,0.8533176413969658,1.0,9/20,30.17%,ATM;BUB1B;BUB1;ZW10;IK;ZWINT;MAD2L1;TTK;CENPF
prerank,mitotic spindle assembly checkpoint signaling (GO:0007094),-0.3509829233033998,-0.9943295810785425,0.4731934731934732,0.8533176413969658,1.0,9/20,30.17%,ATM;BUB1B;BUB1;ZW10;IK;ZWINT;MAD2L1;TTK;CENPF
prerank,spindle assembly checkpoint signaling (GO:0071173),-0.3509829233033998,-0.9943295810785425,0.4731934731934732,0.8533176413969658,1.0,9/20,30.17%,ATM;BUB1B;BUB1;ZW10;IK;ZWINT;MAD2L1;TTK;CENPF
prerank,regulation of interferon-gamma production (GO:0032649),0.3112222379566775,0.9943169210930868,0.4544159544159544,0.7526111974714609,1.0,10/71,8.66%,TLR8;GAS6;NR1H4;PTPN22;LILRB1;TLR4;PDE4D;CCR2;CEBPG;TRIM27
prerank,ERAD pathway (GO:0036503),-0.2594012868988945,-0.9940869748524329,0.45185185185185184,0.852826604935992,1.0,38/83,27.85%,TMEM67;MAN1B1;UBE4A;AUP1;USP19;RNF103;BAG6;DNAJB2;EDEM1;UFD1;FBXO44;UBXN4;UBE2J1;NPLOC4;ECPAS;TRIM13;DNAJB14;ERLEC1;RNF5;BRSK2;GET4;STUB1;SYVN1;FAM8A1;SELENOS;RNF103-CHMP3;TMEM129;TOR1A;FOXRED2;FAF2;UBQLN1;YOD1;SEC61B;SGTA;DNAJC18;UBQLN2;UBE2G2;FBXO2
prerank,nucleotide-sugar biosynthetic process (GO:0009226),0.39692829887229725,0.9937690796545415,0.4562289562289562,0.7533270472474485,1.0,10/19,24.76%,GNPDA1;GFPT2;PMM1;UAP1L1;GMPPB;NANS;RENBP;UGP2;UAP1;MPI
prerank,regulation of delayed rectifier potassium channel activity (GO:1902259),-0.3721307042197976,-0.993734089523163,0.47072072072072074,0.852656198043508,1.0,9/17,39.73%,NOS1AP;AKAP6;VAMP2;KCNAB1;RNF207;KCNG1;ANK3;KCNS1;KCNE4
prerank,positive regulation of integrin activation (GO:0033625),-0.4159336494559669,-0.9934780570266163,0.47401247401247404,0.8521447438288017,1.0,4/11,6.60%,SRC;FERMT2;PIEZO1;P2RY12
prerank,regulation of superoxide anion generation (GO:0032928),-0.3873973470345794,-0.9934400802955488,0.4871244635193133,0.8510372871133086,1.0,2/14,7.11%,PRKCD;MAPT
prerank,heart morphogenesis (GO:0003007),-0.27666857068990225,-0.9932883421149883,0.4362017804154303,0.8502420171425233,1.0,10/50,19.41%,TGFBR1;CHD7;ACVR1;OLFM1;TGFBR3;MDM4;NOTCH1;FLRT2;ENG;TGFB2
prerank,interferon-gamma-mediated signaling pathway (GO:0060333),-0.28931892425570427,-0.9932029197715876,0.4789156626506024,0.8492777156874589,1.0,6/45,4.08%,IRF8;PRKCD;NCAM1;JAK2;STAT1;IRF3
prerank,release of sequestered calcium ion into cytosol (GO:0051209),0.3719328798185017,0.9931659090727505,0.47394957983193275,0.7541204180233335,1.0,10/26,22.14%,CCL19;TRPM2;SLC8B1;ERO1A;IBTK;PKD2;ITPR3;F2R;PTPRC;PLCG2
prerank,dorsal/ventral pattern formation (GO:0009953),-0.3597639406026405,-0.9928640363841843,0.4827586206896552,0.8490167225071953,1.0,5/20,13.95%,BMPR1B;ACVR1;MDFI;DSCAML1;LMX1B
prerank,double-strand break repair (GO:0006302),-0.22810906039485412,-0.9928062214210008,0.4861111111111111,0.8479664718944706,1.0,39/158,18.39%,HERC2;DNA2;XRCC5;SETX;HELQ;ACTR8;ATM;AP5Z1;HPF1;PARP1;RMI1;BLM;RNF168;POLM;RECQL5;BRCA1;TNKS1BP1;HUS1;RAD51C;XRCC1;BRCA2;UBXN1;KDM4A;PRPF19;PPP5C;PARP3;PALB2;MORF4L1;XRCC6;APBB1;CHEK2;DDX1;PAXX;REV3L;TDP1;RAD51AP1;DCLRE1B;POLL;PARP9
prerank,regulation of mitotic cell cycle phase transition (GO:1901990),-0.22884674667790023,-0.9927793521625742,0.4942528735632184,0.8468401874657951,1.0,57/184,25.64%,CSNK1E;ANAPC15;SDCCAG8;CEP135;ODF2;HECW2;DYNC1H1;SKP1;PSMD13;CEP192;PSMD12;APPL1;CEP250;HAUS8;CEP63;CENPE;ERCC2;PSMD9;SIRT2;CCP110;NEK6;ANAPC11;UBE2S;PSME3;HAUS7;CKAP5;MAPRE1;HAUS3;BUB1B;PSMA4;PSMD8;PSMF1;PSMD4;CDC14A;UBE2E1;RIOK2;NEK11;ID2;UBE2D1;PSMB8;PSME1;UBB;ANAPC5;DCTN2;HMMR;ZW10;CNTRL;HAUS2;DCTN1;KIF14;PLK4;PSMC2;CDK1;HAUS6;MAD2L1;YWHAG;PSMB10
prerank,negative regulation of peptide hormone secretion (GO:0090278),0.4022406934138185,0.9926486775613836,0.46309963099630996,0.7547622436062593,1.0,4/18,11.90%,PRKN;SFRP1;CHGA;KCNB1
prerank,regulation of vascular endothelial growth factor production (GO:0010574),-0.32918284562874445,-0.9926235129140911,0.46329113924050636,0.8460489802062328,1.0,9/26,22.86%,IL1A;SULF1;BRCA1;SARS1;HPSE;ATF4;CCBE1;TGFB1;HIF1A
prerank,regulation of ceramide biosynthetic process (GO:2000303),-0.38227417583848045,-0.9920064338509393,0.4774193548387097,0.8466019378848846,1.0,4/15,8.07%,PRKCD;PLA2G6;NSMAF;SAMD8
prerank,in utero embryonic development (GO:0001701),0.37499613802245324,0.9918983408816133,0.46219931271477666,0.7559034368017193,1.0,5/25,6.93%,MBNL1;LIG4;BMP2;MYH6;ZNF568
prerank,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),0.3865886382008659,0.9918313580269269,0.47183098591549294,0.7555435054926604,1.0,11/21,23.07%,SAMD4A;TUT7;TUT4;CNOT9;CNOT11;CNOT6L;CNOT4;CNOT1;CNOT8;PAN3;CNOT2
prerank,negative regulation of cell-substrate adhesion (GO:0010812),0.353123558607395,0.991658636055999,0.45054945054945056,0.7554041260390432,1.0,7/39,9.55%,CASK;JAG1;RASA1;RHOA;ITGB1BP1;RCC2;CORO1C
prerank,regulation of protein localization (GO:0032880),-0.27212386434425434,-0.9911902076068935,0.46540880503144655,0.8477840099876983,1.0,9/58,10.37%,CSNK1E;PLEKHM2;CTSD;MAP2;ITGB3;DVL1;PARP1;ADCYAP1;AFDN
prerank,regulation of lamellipodium assembly (GO:0010591),0.3569671670103301,0.9910454663787216,0.4559505409582689,0.7562340587793519,1.0,5/34,7.30%,FER;ACTR3;WASF2;CDC42;ARPC2
prerank,negative regulation of leukocyte apoptotic process (GO:2000107),0.45016483280436903,0.9909308032193221,0.45098039215686275,0.7559729999994778,1.0,3/11,3.51%,GAS6;LILRB1;CCL19
prerank,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),0.3878011971901326,0.9892780448288301,0.46206896551724136,0.7590635670391023,1.0,8/22,25.22%,PSMA7;PSMB2;PSMA6;PSMA3;ENC1;PSMB9;PSMB4;PSME4
prerank,pyrimidine nucleoside catabolic process (GO:0046135),0.4592577426702854,0.9891590671724821,0.47833935018050544,0.7588226116374877,1.0,1/10,1.73%,DPYD
prerank,defense response to fungus (GO:0050832),0.4078732562316662,0.9890110935878923,0.47128378378378377,0.758653699128386,1.0,4/17,12.01%,CLEC6A;BCL10;CLEC4D;FAM3A
prerank,regulation of neuron differentiation (GO:0045664),0.3079713068544927,0.9890109578969225,0.4632768361581921,0.7581613865397238,1.0,8/76,5.88%,FGFR1;TCF4;MEF2C;BMP2;RHOA;GPRC5B;ROCK1;TRIM32
prerank,regulation of actin polymerization or depolymerization (GO:0008064),0.36595472767193093,0.988203198773819,0.4658703071672355,0.7594835873372554,1.0,3/28,3.26%,RASA1;FCHSD2;ARHGAP18
prerank,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),-0.2751066227144232,-0.9881798445843045,0.47214076246334313,0.8551196942148322,1.0,18/57,28.78%,ADCY3;ADCY8;GRM7;GNAI1;P2RY12;CHRM3;ADCY7;PSAP;ADCY1;OPRL1;GNAL;FLNA;HTR1F;ADCY5;AKAP5;HTR1B;HTR4;GPR37L1
prerank,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),-0.41879223779401725,-0.9879948772180087,0.4924078091106291,0.8544296283148091,1.0,7/10,31.97%,IMPACT;SIRT2;JUN;DNAJB1;VHL;HIF1AN;HSPA1A
prerank,regulation of exosomal secretion (GO:1903541),0.3963308227794231,0.9879801750676365,0.46126126126126127,0.7595064096098498,1.0,5/19,9.08%,PRKN;SDCBP;VPS4B;RAB7A;SDC4
prerank,positive regulation of phospholipase activity (GO:0010518),0.3841857147069011,0.98700085399542,0.46153846153846156,0.7611733282068982,1.0,3/22,5.33%,FGFR1;ESR1;PDGFRA
prerank,positive regulation of actin filament polymerization (GO:0030838),0.33489559731887664,0.9866342593848635,0.4599092284417549,0.761487265946146,1.0,4/44,2.42%,SNX9;ALOX15;FER;FCHSD2
prerank,tRNA metabolic process (GO:0006399),-0.3597450955309093,-0.9865686897828643,0.49209932279909707,0.857196209857682,1.0,12/17,34.28%,AARS1;SARS1;DARS2;POP1;RPP21;POP7;THG1L;KARS1;TRPT1;ADAT1;SSB;DTD2
prerank,prostaglandin biosynthetic process (GO:0001516),-0.3597973982701183,-0.9864406213347565,0.46190476190476193,0.8563822229217276,1.0,5/18,11.84%,HPGDS;DAGLB;PTGS1;PTGES3;MIF
prerank,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),0.4238145761930726,0.9859754240890968,0.4844961240310077,0.7624736910827631,1.0,2/13,5.11%,PDE8A;RACK1
prerank,positive regulation of cellular component biogenesis (GO:0044089),0.2996404624768786,0.9859224508627037,0.4825268817204301,0.7620958991627119,1.0,15/88,11.65%,RPS3;RGCC;GSK3B;RACK1;SYK;SDCBP;TNF;VPS4B;RAB7A;FNIP1;SDC4;SPIDR;SYNPO;EMILIN1;CHGA
prerank,negative regulation of stress-activated MAPK cascade (GO:0032873),-0.3074166558561919,-0.9845869948865311,0.4745762711864407,0.8602928446074086,1.0,5/36,3.66%,SIRPA;CYLD;TREM2;DUSP10;GPS2
prerank,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),0.35936280583832364,0.9843832337472033,0.45315161839863716,0.764965788350138,1.0,9/30,16.01%,RYBP;WAC;NOP53;SDCBP;HFE;USP14;EIF3H;RPL11;HSP90AB1
prerank,regulation of insulin receptor signaling pathway (GO:0046626),0.34198390826284836,0.9839992830044391,0.48966613672496023,0.7653214705508612,1.0,2/43,3.09%,PID1;C1QTNF12
prerank,mRNA metabolic process (GO:0016071),-0.24882808807684564,-0.9835412945926888,0.49642857142857144,0.8620166967786878,1.0,26/90,23.79%,DDX5;SON;CPSF6;AKAP8L;SRRM4;SRSF5;HNRNPA2B1;TP53;GEMIN2;SRSF2;RIDA;TCERG1;U2AF1;HSF1;RNH1;NCBP1;PCBP2;SRSF11;SRSF9;PRMT9;U2AF2;METTL3;ALKBH5;NUDT12;SLBP;HNRNPA0
prerank,positive regulation of superoxide anion generation (GO:0032930),-0.38996484418303035,-0.983523622293044,0.48739495798319327,0.860869200988968,1.0,2/13,7.11%,PRKCD;MAPT
prerank,telomere maintenance via telomere trimming (GO:0090737),-0.42300183795159824,-0.9834576405915902,0.4829059829059829,0.8574619009403235,1.0,4/10,25.86%,DNA2;BLM;SLX4;EXO1
prerank,t-circle formation (GO:0090656),-0.42300183795159824,-0.9834576405915902,0.4829059829059829,0.8574619009403235,1.0,4/10,25.86%,DNA2;BLM;SLX4;EXO1
prerank,formation of extrachromosomal circular DNA (GO:0001325),-0.42300183795159824,-0.9834576405915902,0.4829059829059829,0.8574619009403235,1.0,4/10,25.86%,DNA2;BLM;SLX4;EXO1
prerank,genitalia development (GO:0048806),-0.4095725776657943,-0.9833701616300904,0.48026315789473684,0.8565324934589348,1.0,3/12,20.22%,CHD7;PTPN11;WNT5A
prerank,regulation of nucleic acid-templated transcription (GO:1903506),0.26243837902609873,0.9833020992575296,0.5150837988826815,0.7663672244386865,1.0,76/327,18.59%,AHR;RREB1;FOXN2;NFXL1;ESR1;HINT1;MEF2C;NCOA2;CEBPB;MITF;RYBP;BMP2;NR3C1;CLOCK;SPI1;RB1;INSR;TGFBRAP1;TCF7;ATXN1;LYL1;IRF2;ATRX;ZNF628;LIMD1;ESRRB;BACH1;LIN54;HMG20A;ESR2;ATF7;NFATC2;PPP2CA;ZNF205;RPL6;GCFC2;TESMIN;RNF14;JMJD1C;SP1;ATXN1L;CREBBP;MYBL2;FOXK2;HINFP;NFIA;TERF2IP;SP3;PSPC1;KAT7;STAT3;EP300;MLF2;HMGN5;WWC1;NAB1;RALY;MYT1;NSD3;NLK;NR2C2;SFPQ;RUNX3;HCFC1;PPARGC1B;GPBP1;NR5A2;PRKCQ;RELA;ZNF22;GZF1;MAFB;ATF2;RFX3;PERM1;PLAG1
prerank,positive regulation of protein localization to membrane (GO:1905477),0.29491656850170556,0.9828126010629606,0.4815340909090909,0.7669580265976169,1.0,18/98,12.56%,EGFR;ITGB1;SPTBN1;YWHAQ;ITGB1BP1;PRKN;SFN;BCL2;TNF;FYN;PLS1;MYO1C;TFDP1;CASP8;YWHAE;KCNB1;ATP2B4;PPP1R13B
prerank,positive regulation of isotype switching (GO:0045830),0.4191396989565677,0.9821147059048483,0.46286701208981,0.7679841028120026,1.0,6/15,22.88%,CD40;KMT5B;SHLD3;HMCES;SHLD2;TFRC
prerank,negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),0.4196058184634064,0.9817904384377718,0.49452554744525545,0.7682050249873656,1.0,2/14,9.32%,GAS6;CARD16
prerank,regulation of vesicle-mediated transport (GO:0060627),0.2982436428813354,0.9813723982411983,0.4828532235939643,0.7686292522096075,1.0,8/91,6.79%,HIP1;NRP1;OPHN1;RAB8B;RAB10;AP2S1;SYK;STXBP5
prerank,regulation of receptor recycling (GO:0001919),-0.3702633134408472,-0.9813133846255448,0.4713656387665198,0.8610189114305116,1.0,4/16,14.52%,TBC1D16;OPTN;INPP5F;AP1AR
prerank,regulation of mitotic spindle assembly (GO:1901673),-0.35400603994737867,-0.9811964561617499,0.4756380510440835,0.8601447869055747,1.0,4/19,6.32%,EML3;CEP97;HNRNPU;CHMP4B
prerank,cellular response to interferon-beta (GO:0035458),-0.3900655104975469,-0.9811946374545832,0.5011037527593819,0.8589595738759017,1.0,3/14,6.24%,STAT1;IRGM;HTRA2
prerank,regulation of T-helper 17 cell differentiation (GO:2000319),0.46530325880964324,0.9804061769616524,0.483695652173913,0.7701950598714211,1.0,3/10,12.28%,NFKBIZ;RC3H1;ZC3H12A
prerank,peptidyl-glutamic acid modification (GO:0018200),-0.33153124605368856,-0.9802423620360772,0.48205128205128206,0.8604400107666214,1.0,5/24,12.44%,TTLL11;PARP1;TTLL7;GGCX;TTLL1
prerank,positive regulation of T cell mediated immunity (GO:0002711),0.38295176441150836,0.9801948900912268,0.4845360824742268,0.7701791021548556,1.0,5/22,18.57%,B2M;STX7;FBXO38;ZBTB1;TRAF6
prerank,phosphatidylglycerol acyl-chain remodeling (GO:0036148),-0.3592151203153778,-0.9801042026359658,0.4804597701149425,0.8596435837941989,1.0,3/17,19.53%,LPCAT1;LPGAT1;PLA2G3
prerank,termination of RNA polymerase I transcription (GO:0006363),-0.3132825016742383,-0.979740488422767,0.47381546134663344,0.859438411265761,1.0,10/30,23.27%,GTF2H2;CCNH;UBTF;ERCC2;TAF1C;TAF1D;GTF2H4;POLR1C;POLR2L;TBP
prerank,positive regulation of exosomal secretion (GO:1903543),0.4089252297761481,0.9796361605350352,0.4714285714285714,0.7709043177543812,1.0,7/15,22.63%,SDCBP;VPS4B;RAB7A;SDC4;STAM;PDCD6IP;TSG101
prerank,snRNA transcription (GO:0009301),-0.26478188265873376,-0.9794209260557554,0.48355263157894735,0.8592264965467977,1.0,26/70,30.13%,CDK9;RPAP2;INTS3;RPRD1A;CCNT2;POU2F2;ICE2;SRRT;POLR2C;NCBP1;INTS13;ELL2;ELL;TAF8;POLR2L;TAF9;INTS9;TBP;CCNK;INTS11;CCNT1;INTS7;POLR2I;TAF13;ICE1;SNAPC1
prerank,inorganic anion transport (GO:0015698),0.3275754455589425,0.979175206695026,0.48936170212765956,0.7714076383146449,1.0,16/53,21.84%,ANO6;CLCNKB;CLIC4;ANO1;SLC26A11;TTYH3;BEST1;SLC26A7;CLCN1;XPR1;SLC25A30;CLIC5;ENPP1;RACGAP1;SLC13A4;SLC26A8
prerank,development of primary male sexual characteristics (GO:0046546),-0.3086506367245577,-0.978445628060492,0.5069637883008357,0.8606911234710634,1.0,8/34,20.22%,LHFPL2;AR;NCOA4;WNT4;MSH2;TGFB2;COL9A3;WNT5A
prerank,unsaturated fatty acid metabolic process (GO:0033559),0.3401225149970715,0.9783053440042142,0.4842105263157895,0.772810800570943,1.0,4/41,7.30%,ALOX5;ALOX15;PNPLA8;ELOVL5
prerank,regulation of sodium ion transport (GO:0002028),-0.2978762945663339,-0.978149642154293,0.49736842105263157,0.8603578292514032,1.0,5/34,2.23%,FGF12;NKAIN2;YWHAH;SCN1B;SNTA1
prerank,acetyl-CoA metabolic process (GO:0006084),-0.3786920558189009,-0.9780106115399666,0.47477064220183485,0.8595766805828878,1.0,3/15,7.65%,ACACA;DIP2A;ACSS1
prerank,rRNA transcription (GO:0009303),0.4102673125216205,0.9775850353700624,0.4956063268892794,0.7738780490529896,1.0,4/17,12.46%,ANG;GTF3C3;GTF3C6;POLR1G
prerank,regulation of phospholipase activity (GO:0010517),0.4473889627866036,0.977179018075197,0.4990512333965844,0.7742884952223217,1.0,1/10,0.59%,FGFR1
prerank,regulation of mRNA catabolic process (GO:0061013),0.2882790658122492,0.9769208545746604,0.507343124165554,0.7743674752034325,1.0,25/121,14.92%,ZFP36L2;PSMA7;RPS27A;SAMD4A;ZFP36L1;VIM;MAPKAPK2;RC3H1;PUM2;HSPB1;PSMB2;DCP1A;SERBP1;PCID2;DCP2;PSMA6;ZC3H14;ZC3H12A;EXOSC8;GTPBP1;EXOSC1;PSMA3;PSMD1;PSMD5;XPO1
prerank,production of miRNAs involved in gene silencing by miRNA (GO:0035196),0.3509954916185629,0.9768017586694814,0.49087893864013266,0.7741245452822785,1.0,7/29,13.29%,PRKRA;TUT7;PUM2;DROSHA;TUT4;TRIM71;MRPL44
prerank,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),0.35443915457915875,0.9767132541306978,0.46855345911949686,0.7738154110904474,1.0,7/30,12.68%,SH3BP5;PARP14;PIBF1;SH2B3;PPP2CA;SFRP1;SH3BP5L
prerank,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),-0.3067247093496366,-0.9764771643049066,0.5066666666666667,0.8626832890826911,1.0,11/32,20.21%,DDX5;TP53;STK11;BAG6;DYRK2;FHIT;MSH2;HIPK1;PYCARD;PHLDA3;AEN
prerank,regulation of cholesterol biosynthetic process (GO:0045540),0.4069521408332606,0.9764421574605391,0.4722222222222222,0.773910303464348,1.0,3/17,11.27%,APOE;ERLIN1;SREBF2
prerank,positive regulation of protein depolymerization (GO:1901881),0.43553443646969525,0.9763170452095694,0.4923954372623574,0.7736921004403848,1.0,1/11,3.43%,NES
prerank,peptidyl-threonine dephosphorylation (GO:0035970),0.3821546851328017,0.9760115476142072,0.46366782006920415,0.7738916648246752,1.0,8/22,16.43%,DUSP1;PPM1B;DUSP2;PPP2CA;PPP2CB;PPP1CA;DUSP7;PPM1A
prerank,negative regulation of cation channel activity (GO:2001258),-0.3214632543265469,-0.9756666810591454,0.5012594458438288,0.8637130327401116,1.0,11/26,34.96%,CALM2;FMR1;CBARP;EPHB2;GPR35;CALM3;UBQLN1;CRHR1;KCNAB1;GSTO1;EPO
prerank,regulation of pseudopodium assembly (GO:0031272),0.4560884068677795,0.9754877749591759,0.47058823529411764,0.7740726661082123,1.0,1/10,3.32%,CDC42
prerank,positive regulation of pseudopodium assembly (GO:0031274),0.4560884068677795,0.9754877749591759,0.47058823529411764,0.7740726661082123,1.0,1/10,3.32%,CDC42
prerank,DNA unwinding involved in DNA replication (GO:0006268),-0.3557613120836657,-0.9754686745463385,0.4769585253456221,0.8631261845876177,1.0,8/16,26.88%,BLM;RECQL5;SSBP1;MCM6;RAD51;MCM2;MCM7;MCMDC2
prerank,histone H4-K16 acetylation (GO:0043984),0.3914099322588369,0.9750378430908093,0.4844290657439446,0.774576269478445,1.0,6/19,16.20%,KMT2A;PHF20;KANSL2;KANSL1;KAT7;HCFC1
prerank,central nervous system neuron differentiation (GO:0021953),0.3504994015647632,0.9746661222471742,0.4753289473684211,0.7748921813921267,1.0,5/33,7.86%,LRP6;OPHN1;WNT2;ATP7A;NR4A2
prerank,regulation of ubiquitin protein ligase activity (GO:1904666),0.38525226525993517,0.9746350292872067,0.47952218430034127,0.7744558726223999,1.0,6/21,16.22%,RPL23;RPL5;RPS7;RAB1A;RPL11;PTEN
prerank,global genome nucleotide-excision repair (GO:0070911),-0.32409334839483384,-0.9743897663314556,0.5084745762711864,0.8649136707113216,1.0,6/26,9.14%,GTF2H2;CUL4A;PARP1;DDB2;RBX1;ERCC2
prerank,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),0.363916362428847,0.9739679706847192,0.488135593220339,0.7754103036334561,1.0,7/29,13.47%,RIPK1;BCL10;PAK2;TNF;TNFSF12;SFRP1;WWOX
prerank,"positive regulation of gene expression, epigenetic (GO:0045815)",0.32499198111296934,0.9738645767209775,0.4759036144578313,0.775159551173749,1.0,16/48,18.91%,ARID1B;ACTB;CHEK1;POLR1A;POLR1B;MYO1C;ELOF1;SERTAD2;DEK;POLR1G;EP300;SMARCD1;ARID1A;ASF1A;POLR2F;DDX21
prerank,protein localization to membrane (GO:0072657),0.27293032126437305,0.9737634802397198,0.501779359430605,0.7748791561354343,1.0,42/187,16.51%,ITGA4;LRP6;MYO5A;EHD4;FCHO2;MYADM;GAS6;SPTBN1;RAB8B;RAB10;RAPGEF2;S100A10;ITGB1BP1;EHD1;RFTN1;RAP1A;SAV1;ROCK1;TNF;SYNJ2BP;TM9SF2;RABEP1;ZDHHC3;DENND4C;TM9SF3;PIP5K1A;JUP;KCNB1;ROCK2;RAMP2;TNFRSF1A;SCN3B;FYB1;RAB11A;ITGB2;TMED2;SYNE3;TSPAN14;ZDHHC2;RAB3B;SEC16A;RAB32
prerank,angiogenesis involved in wound healing (GO:0060055),-0.40596317967363027,-0.9735884472588965,0.5010989010989011,0.865913279035456,1.0,6/11,18.13%,ITGB3;CD34;MCAM;HPSE;NDNF;SRF
prerank,neurotransmitter transport (GO:0006836),-0.2572025819379208,-0.9735364200082334,0.48188405797101447,0.8648638854053547,1.0,22/73,22.33%,SLC1A3;RIMS1;SNAP25;NRXN1;PPFIA2;PPFIA4;DVL1;APBA1;SYN3;CPLX1;SLC1A1;GABRA2;PTPRN2;LIN7A;VAMP2;LIN7C;SYT1;SLC17A6;SLC1A2;CHAT;BRSK1;GAD1
prerank,regulation of cell division (GO:0051302),0.3072014733043268,0.9733784729962596,0.5064935064935064,0.7752415085775243,1.0,11/72,10.99%,TXNIP;NCOA3;UVRAG;RACK1;KLHL13;SFN;EFHC1;BIRC6;ESRRB;CALM1;CETN2
prerank,protein ubiquitination (GO:0016567),0.25335908111121225,0.9730705775385109,0.5521276595744681,0.775404821584077,1.0,94/471,16.08%,WWP1;SASH1;FBXW7;SMURF2;PSMA7;ARIH1;RPS27A;VCPIP1;SH3RF1;FBXL17;UBE2E3;SIAH2;WAC;CBL;PELI1;RMND5A;PRKN;BCL10;ZNRF3;RNF141;USP9X;RACK1;LNPEP;RC3H1;SPOP;TRIM33;KLHL13;UBE2Q2;CBFB;TRIM32;FBXL5;ANKIB1;MYCBP2;BCL2;CDC27;TRIM24;EIPR1;TRIM47;DTX2;PSMB2;BIRC6;CDC73;TRIM68;SHPRH;TRIM27;MDM2;RNF19B;TPP2;UBE2K;UBE2D3;UHRF2;CUL3;MKRN1;RNF38;ANAPC16;FBXO11;RNF14;ARRB1;ZNRF2;RNF111;AMFR;PSMA6;RNF185;UBE3B;TRIM71;MIB1;FBXO10;MKRN3;UBE2R2;RNF115;UBE2N;RBBP6;RNF187;RNF19A;ASB12;HIF3A;BFAR;NEDD4L;PSMA3;PSMD1;PSMD5;KLHL24;ELOC;MKRN2;RNF122;ASB4;RNF41;USP22;PEX14;FBXW2;FBH1;TRIM25;UBE2W;FANCL
prerank,response to gamma radiation (GO:0010332),0.37073860904172967,0.9728896014943371,0.48214285714285715,0.7753117043997676,1.0,10/24,16.18%,LIG4;RPL26;TSPYL5;MDM2;MAP3K20;CRYAB;TMEM109;MYC;KDM1A;ATR
prerank,protein oxidation (GO:0018158),0.4467094448941598,0.9725733079146174,0.4898336414048059,0.7755392907328038,1.0,4/11,19.44%,LOX;LOXL2;PRDX3;TMX3
prerank,mitotic cytokinesis (GO:0000281),0.3255206237479399,0.9723100296551379,0.506006006006006,0.7756186156297832,1.0,17/47,21.82%,SNX9;RASA1;SPTBN1;INCENP;ROCK1;EFHC1;KIF4A;SNX33;ROCK2;RHOC;STMN1;CUL7;KIF23;PDCD6IP;EFHC2;RACGAP1;CEP55
prerank,negative regulation of protein polymerization (GO:0032272),-0.3136845327284338,-0.9720267362622422,0.49019607843137253,0.8678490844592991,1.0,8/27,16.02%,PRKCD;MAP2;TBCD;TWF2;ARFGEF1;MAPRE1;EML2;CLIP3
prerank,regulation of G2/M transition of mitotic cell cycle (GO:0010389),-0.23172729308218143,-0.97195841074894,0.4954545454545455,0.8668634972937074,1.0,54/145,31.87%,CSNK1E;SDCCAG8;CEP135;ODF2;DYNC1H1;SKP1;PSMD13;CEP192;PSMD12;RBX1;CEP250;FBXL7;HAUS8;CEP63;PSMD9;CDC7;CCP110;RAD51C;PSME3;HAUS7;CKAP5;MAPRE1;HAUS3;PSMA4;PSMD8;PSMF1;PSMD4;PSMB8;PSME1;DCTN2;HMMR;DTL;CNTRL;HAUS2;DCTN1;KIF14;PLK4;PSMC2;CDK1;HAUS6;YWHAG;PSMB10;STOX1;PSMD3;TUBA4A;CEP152;PSMC5;TUBA1A;FHL1;CENPF;PSME2;FBXO5;TUBG1;AURKA
prerank,negative regulation of actin filament bundle assembly (GO:0032232),-0.3253119276260604,-0.9719457008519008,0.4919786096256685,0.8657188379442703,1.0,5/27,5.61%,F11R;TJP1;TMEFF2;CLASP2;SHANK1
prerank,positive regulation of lymphocyte differentiation (GO:0045621),0.3783537581768359,0.9718742255257807,0.5072202166064982,0.7760817848700041,1.0,4/19,7.08%,GAS6;PPP2R3C;SYK;ZAP70
prerank,regulation of interferon-alpha production (GO:0032647),-0.32621792661429505,-0.9715205729131677,0.5127551020408163,0.8657318759678913,1.0,5/23,5.98%,PTPRS;HAVCR2;STAT1;IRF3;MAVS
prerank,potassium ion transmembrane transport (GO:0071805),-0.23120455474821247,-0.9714903631464158,0.5225225225225225,0.8646491927577112,1.0,19/135,9.84%,SLC1A3;KCND2;KCNH7;SLC12A2;KCNJ2;SLC24A3;SLC24A2;ATP1B1;SLC9A8;ATP1B2;SLC12A9;KCNQ3;NALCN;SLC24A4;KCNQ5;KCNK2;KCNA1;KCNA2;KCNK12
prerank,regulation of cardiac muscle cell contraction (GO:0086004),-0.31904189162756486,-0.9713495488995821,0.49604221635883905,0.8638665502285231,1.0,5/27,11.72%,PDE4B;FGF13;ANK2;CTNNA3;CACNA1C
prerank,sensory perception of taste (GO:0050909),0.4590801151866247,0.9710591555009984,0.4961832061068702,0.7773036375270812,1.0,2/10,14.58%,CD36;PKD2L1
prerank,negative regulation of heart contraction (GO:0045822),0.44198146961822293,0.9709429017625444,0.4888888888888889,0.7770822467458681,1.0,4/11,19.49%,PDE4D;PLN;ZC3H12A;SPTBN4
prerank,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),-0.30276733588108895,-0.9707452572718412,0.4838709677419355,0.8644468686140327,1.0,5/32,5.92%,CAPN3;CALM2;PLCG1;TRPC1;AKAP6
prerank,regulation of fatty acid biosynthetic process (GO:0042304),0.37574862877695697,0.970515390500999,0.48580441640378547,0.7775815302767206,1.0,4/26,7.30%,PRKAG2;ADIPOR2;ERLIN1;ELOVL5
prerank,negative regulation of cellular component movement (GO:0051271),-0.36587904333603893,-0.9702459919578418,0.4964705882352941,0.8646376735419576,1.0,8/15,28.51%,CD9;SPOCK3;TGFBR3;PIN1;FRMD5;ACTN1;FBLN1;SPINT2
prerank,UDP-N-acetylglucosamine biosynthetic process (GO:0006048),0.42974960705616305,0.9702256812541237,0.4929328621908127,0.7777445725428894,1.0,4/11,18.50%,GNPDA1;GFPT2;UAP1L1;RENBP
prerank,cellular response to light stimulus (GO:0071482),0.306304756401464,0.969788883395907,0.5185735512630015,0.7781995314789312,1.0,20/66,20.20%,RPL26;RHBDD1;PDE6A;PTPRK;RRH;GPR52;YY1;GNB1;RHNO1;CREBBP;EP300;USP28;MYC;USP47;KDM1A;ATR;ZBTB1;EIF2AK4;GPR88;PCNA
prerank,nucleic acid-templated transcription (GO:0097659),0.3345973960050199,0.9697259776886109,0.48346456692913387,0.7778639268830784,1.0,13/42,19.88%,MEF2A;THRB;EPC1;NR4A2;MED20;POLR2B;NFKBIB;MMS19;POLR2D;RRAGC;POLR2F;BCL3;DTX1
prerank,endomembrane system organization (GO:0010256),0.2700058068553671,0.9697133134469069,0.5109489051094891,0.7773990763587986,1.0,41/178,20.05%,TMCC1;REEP3;ATL1;USP6NL;SPTBN1;ARHGAP21;CDC42;ATP8B4;SRGN;MYOF;SERP1;TMED10;PI4K2B;WASHC4;GOLPH3L;RAB30;CLASP1;RAB1A;SNX10;SNX33;VAPA;BCAS3;SPTBN5;TMED2;REEP6;VPS51;COG7;EXOC8;SEC16A;MIA3;GOLPH3;CUL7;DNAJC13;TOR1B;RAB22A;TMED5;UBXN2B;EIF2AK3;TRIP11;LMAN2;ATP8B2
prerank,cilium organization (GO:0044782),-0.21806298482451011,-0.9694162895777788,0.49624060150375937,0.8657311764152865,1.0,74/209,27.77%,ASAP1;BBS9;TRAPPC14;PTPN23;TMEM67;RILPL1;SCLT1;ODF2;CCDC66;IFT81;ATP6V1D;IFT140;RAB3IP;DZIP1;CEP162;IFT88;TTC8;AHI1;CEP250;CCDC57;IFT20;BBS7;MKS1;DYNLT2B;WDR19;CCP110;SPAG16;DYNC2H1;KIF3A;SSX2IP;TCTN1;IFT52;KIF3B;WDR90;CDC14A;IQCG;ARMC2;CFAP298;CFAP410;NUDCD3;CPLANE2;NOTCH1;IFT43;DYNC2I1;EHD3;B9D2;RAB8A;TMEM138;DNAH5;PLA2G3;BBS4;ARL3;CEP89;IQCB1;HDAC6;TMEM231;MKKS;FLNA;GALNT11;TMEM17;PTPDC1;CFAP126;PLK4;CATIP;KIFAP3;CEP126;EXOC3;TTC39C;UNC119B;CFAP70;MNS1;IFT172;TTBK2;CFAP43
prerank,protein targeting (GO:0006605),-0.23771691806831421,-0.9693428787838629,0.5663716814159292,0.8647756313274371,1.0,39/118,26.44%,SORL1;NLGN1;PARD3;FBXO7;HPS4;RAB3IP;MICALL1;PEX6;AKAP6;TIMM44;VPS37A;ZDHHC18;AP4B1;RTP4;EDEM1;GDAP1;TOMM40;SPCS1;AP1S3;SEC61A1;TIMM8B;AIP;ZDHHC1;TOMM20;ZFAND2A;ZDHHC15;HAP1;HACL1;KATNB1;BCAP31;PEX19;TOMM34;SRP14;ZDHHC22;PRKCI;FIS1;GOLGA7;TOMM5;GIPC1
prerank,cellular protein localization (GO:0034613),0.26418931970433296,0.9689789678932439,0.530933633295838,0.7784939045179291,1.0,37/285,10.54%,ITSN1;EGFR;SNX9;TBC1D5;TBC1D4;RAB31;SNX8;CLTC;EVI5;USP6NL;CD74;SNX6;SNX27;EHD1;AP3B1;RIC1;HEY2;PTPRK;TBC1D14;CELSR1;TMED10;TBC1D2B;MYO7A;WIPI1;PIGU;RABGAP1L;SGSM1;TM9SF2;AMOT;STX7;VCL;RAB14;RAB1A;TM9SF3;RAB23;ARL4A;WLS
prerank,eosinophil migration (GO:0072677),0.4100479318675976,0.9684310926648967,0.4895470383275261,0.7787286333278555,1.0,2/14,8.22%,CCL8;CCL24
prerank,eosinophil chemotaxis (GO:0048245),0.4100479318675976,0.9684310926648967,0.4895470383275261,0.7787286333278555,1.0,2/14,8.22%,CCL8;CCL24
prerank,regulation of autophagy of mitochondrion (GO:1903146),0.38414911565867327,0.9682358381007347,0.5131348511383538,0.7786544570048926,1.0,3/19,5.02%,FBXW7;PRKN;CAMKK2
prerank,calcium ion transport (GO:0006816),0.28428673059710075,0.9680100490472613,0.5216251638269986,0.778617401874917,1.0,19/113,12.83%,P2RX7;CCR1;TPT1;GAS6;ANO6;CALCRL;STIM2;CCL8;STIM1;CHRNA4;PSEN1;FYN;TRPV3;TMEM165;TRPM2;TRPC7;ATP2B4;MCOLN2;RAMP2
prerank,phagolysosome assembly (GO:0001845),0.4354776555520532,0.9670407887253776,0.5076045627376425,0.7802045691089511,1.0,4/12,8.92%,PIKFYVE;RAB7A;RAB7B;RAB14
prerank,regulation of smoothened signaling pathway (GO:0008589),0.3195601546711738,0.966677518253112,0.487256371814093,0.7805088368078177,1.0,12/50,16.62%,HERC4;FBXL17;INTU;RACK1;TTC23;SFRP1;WDR11;CREBBP;STK36;GPC3;TXNDC15;GLIS2
prerank,sphingolipid catabolic process (GO:0030149),-0.37513541194809846,-0.9666499007737526,0.4978448275862069,0.871103633801973,1.0,6/15,13.09%,ENPP2;SMPD4;ASAH1;PPT1;ASAH2;ACER2
prerank,ear morphogenesis (GO:0042471),-0.33832223518757204,-0.9663081443580162,0.5193236714975845,0.8709436108810991,1.0,6/20,15.61%,CHD7;FGFR2;MYO6;PAX8;ZIC1;EPHB2
prerank,macrophage differentiation (GO:0030225),0.42918692634624345,0.9662918092024572,0.4972170686456401,0.78082414674393,1.0,2/13,3.32%,IL15;CDC42
prerank,negative regulation of cell population proliferation (GO:0008285),0.2566052635648116,0.9660368394143651,0.5508196721311476,0.780867755080027,1.0,55/351,15.75%,MTSS1;NELL1;APP;PTPRJ;NUPR1;LYN;ANG;RARG;BNIPL;CBFA2T3;ABI1;TNN;BMP2;PRKRA;S100A11;HMOX1;RGCC;RAPGEF2;ITGB1BP1;B2M;MCC;FRK;GSDME;CDK6;PTPRK;TRIM32;KLF4;PDS5B;KLF10;CDC73;CGREF1;ADRA1A;CD33;THAP12;SH2B3;SFRP1;NUP62;TFDP1;FTH1;KANK2;STRN;NIBAN2;CDKN2C;DIS3L2;CTBP2;ZBTB7C;RBP4;PKD2;NOX4;MYC;RNF41;PINX1;PTPN14;VGLL4;RUNX3
prerank,regulation of cellular biosynthetic process (GO:0031326),0.3647885154293462,0.9659007345978007,0.4959871589085072,0.7806589635635424,1.0,5/28,5.81%,PRKAG2;NR1H4;MITF;TNFRSF1B;ADIPOR2
prerank,establishment of vesicle localization (GO:0051650),-0.35271312364098806,-0.9653878500170172,0.5224215246636771,0.8723715493701968,1.0,10/18,32.25%,RAB27A;KIF5A;SPG11;KIF5C;LIMK2;TOR1A;CCDC186;KIF5B;F8A1;SNAPIN
prerank,activation of protein kinase activity (GO:0032147),-0.23600928579832595,-0.9652412506523919,0.5185185185185185,0.8716200100035174,1.0,29/106,20.49%,MAP4K4;PRKCD;JAK2;PTK2B;ADCY3;ADCY8;PAK1;PRKAR1A;ITGB3;PRKAR1B;STK11;NTRK3;IL18;COPS8;TOM1L1;ADCY7;MINK1;PDPK1;TGFBR2;PARK7;MLST8;ADCY1;MTOR;PAK3;TXN;TGFB2;WNT5A;TLR3;PAK4
prerank,negative regulation of cell motility (GO:2000146),0.2854813933573479,0.9650209350591094,0.5152722443559097,0.7820655060786516,1.0,12/108,7.38%,MCTP1;PTPRJ;RAP2B;JAG1;MITF;CD74;CRK;CLIC4;PTPRK;STK24;BST2;DUSP22
prerank,calcium-mediated signaling using intracellular calcium source (GO:0035584),0.39667939285788695,0.9650089511002259,0.4991212653778559,0.78160553769911,1.0,1/19,0.78%,PTPRJ
prerank,plasma membrane bounded cell projection morphogenesis (GO:0120039),0.32734643368385247,0.9649878880346568,0.5190839694656488,0.7811669099982697,1.0,6/51,7.23%,SNX2;KIF20B;GAS7;TRIO;ATP7A;NRK
prerank,negative regulation of oxidative stress-induced neuron death (GO:1903204),0.4284641717917357,0.9649216058184705,0.497164461247637,0.7808279092841389,1.0,2/11,5.11%,PRKN;RACK1
prerank,regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),0.4300499241518301,0.9647035662168782,0.5046382189239332,0.7807984269398188,1.0,3/12,9.47%,PPHLN1;SETDB2;APOBEC1
prerank,regulation of extracellular matrix organization (GO:1903053),0.397857438413869,0.964662321620204,0.49480968858131485,0.7803952224509408,1.0,3/15,8.61%,RIC1;RB1;DDR2
prerank,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),0.27994432512349465,0.9645088802312448,0.5236907730673317,0.7802731660760556,1.0,18/128,7.63%,NRROS;SMURF2;ITGB1;RPS27A;BMP2;GDF3;ADAM9;CBL;RHOA;USP9X;SMAD4;PTPRK;TGFBRAP1;GDF10;ACVR2A;USP15;DUSP22;HFE
prerank,phosphatidylcholine biosynthetic process (GO:0006656),-0.30530058705574564,-0.9641485124618181,0.5040650406504065,0.873346223251635,1.0,7/32,14.99%,LPIN2;SLC44A2;LPCAT1;PCYT1B;LPCAT3;CHPT1;STARD7
prerank,respiratory tube development (GO:0030323),-0.31680095549965215,-0.963747029323165,0.5074257425742574,0.8732570627113319,1.0,12/28,29.16%,FGF2;FGFR2;LOXL3;BAG6;CCDC39;PROX1;PDPN;CCDC40;FGF1;WNT7B;FGF7;BMP4
prerank,calcium ion import (GO:0070509),-0.31034360085148294,-0.9633446756442593,0.5368956743002544,0.8732045888650019,1.0,7/28,12.39%,CACNB2;SLC8A1;TRPC4;CACNA1D;CACNA1E;CACNA1C;AFG3L2
prerank,regulation of lamellipodium morphogenesis (GO:2000392),0.4441235435094996,0.9632616299282953,0.5196078431372549,0.7824130594177172,1.0,3/11,9.55%,RREB1;CD44;CORO1C
prerank,phosphatidylserine metabolic process (GO:0006658),-0.2946510973590041,-0.9631932682467275,0.493573264781491,0.8724547612142263,1.0,7/32,19.53%,ABHD12;PTDSS1;PTDSS2;LPCAT3;ABHD16A;SERINC1;PLA2G3
prerank,positive regulation of cyclase activity (GO:0031281),-0.3789024959784514,-0.9628474673296447,0.5396825396825397,0.8722381436381913,1.0,4/14,11.72%,CACNA1D;NF1;MAPK3;CACNA1C
prerank,secretory granule organization (GO:0033363),-0.41549314743706006,-0.9628037413862747,0.5285996055226825,0.8711906044048501,1.0,1/10,0.34%,LYST
prerank,programmed necrotic cell death (GO:0097300),0.39249604425984197,0.9627293805690595,0.48736462093862815,0.7830180025603908,1.0,3/18,5.47%,RIPK1;TLR4;LY96
prerank,bone morphogenesis (GO:0060349),0.41765946284586175,0.9627221468368456,0.4927536231884058,0.7825470580425931,1.0,1/14,0.46%,LRP6
prerank,action potential (GO:0001508),-0.28159719075022654,-0.9626747903844917,0.5247813411078717,0.8703972942669915,1.0,8/44,11.36%,KCND2;KCNJ2;YWHAH;CLN3;AKAP6;KCNA1;KCNA2;SCN8A
prerank,positive regulation of epidermal cell differentiation (GO:0045606),0.40209739130748356,0.9625744755992096,0.47920433996383366,0.7823759766435204,1.0,3/15,10.61%,NCOA3;SFN;TRIM16
prerank,regulation of stem cell differentiation (GO:2000736),0.2909639424550859,0.9624349211853701,0.5054945054945055,0.7821797948724334,1.0,15/89,15.12%,KMT2A;ZFP36L2;PSMA7;JAG1;TCF12;PDGFRA;CBFB;PSMB2;ESRRB;NSUN2;PSMA6;PSMA3;PSMD1;PSMD5;BMPR1A
prerank,sodium ion import across plasma membrane (GO:0098719),0.3899197936750016,0.9623665432512736,0.5054545454545455,0.7818427250018578,1.0,4/17,14.19%,SLC9A9;SLC9A4;SLC9A7;SLC9A6
prerank,cytoskeleton-dependent cytokinesis (GO:0061640),0.31317294261308015,0.9618092195480846,0.5102339181286549,0.7825432797209464,1.0,12/56,15.27%,SNX9;RASA1;SPTBN1;RHOA;INCENP;ROCK1;EFHC1;KIF4A;SNX33;ROCK2;RHOC;STMN1
prerank,regulation of integrin activation (GO:0033623),-0.3686227971056491,-0.9616613337999237,0.5426695842450766,0.8720519270977745,1.0,4/15,5.04%,FBLIM1;SRC;FERMT2;PIEZO1
prerank,cellular divalent inorganic cation homeostasis (GO:0072503),0.2848522557769576,0.9615405015972102,0.5187096774193548,0.7826299373133356,1.0,14/107,12.32%,ATP2B1;CCR1;TPT1;STIM2;CCL8;CCL19;CD40;STIM1;CCR2;TMEM165;SLC39A12;SLC10A7;SLC8B1;ATP2B4
prerank,"RNA splicing, via transesterification reactions (GO:0000375)",-0.3236169224578758,-0.9613855930141971,0.5219512195121951,0.8716445139828486,1.0,7/25,15.33%,SRRM1;GEMIN2;SRSF10;PRPF4;SF3B1;PRPF6;DDX23
prerank,regulation of phosphoprotein phosphatase activity (GO:0043666),-0.2972644415763689,-0.9612439273457152,0.511166253101737,0.8708968445156104,1.0,11/35,24.30%,CALM2;MAGI2;NUAK1;PPP1R11;TSC1;PPP6R1;MTOR;PTPA;CALM3;MASTL;PDGFRB
prerank,regulation of RNA export from nucleus (GO:0046831),-0.39998287620523787,-0.9609948208971428,0.504950495049505,0.8704478135911453,1.0,5/11,22.38%,CPSF6;AKAP8L;DHX9;SETD2;NRDE2
prerank,phosphatidylethanolamine biosynthetic process (GO:0006646),0.41105948788515245,0.9609804516484133,0.4875,0.7833171755917763,1.0,4/14,8.79%,ALOX15;CEPT1;CHKB;ETNPPL
prerank,vesicle cytoskeletal trafficking (GO:0099518),-0.284814538241301,-0.9609348437661466,0.5328083989501312,0.8694829231239296,1.0,9/39,12.32%,TANC2;MYO1F;PPFIA2;KIF1A;CLN3;MYO1B;MYO6;MYO1D;MYO5B
prerank,cellular metal ion homeostasis (GO:0006875),0.2881245487448512,0.9608026847247602,0.5276705276705277,0.7832066829887041,1.0,19/102,14.32%,ATP2B1;CCR1;TPT1;STIM2;CCL8;CCL19;CD40;STIM1;CCR2;TMEM165;TESMIN;SLC10A7;SLC8B1;ATP2B4;ATP1A4;ATP1A3;ATP1A1;ATP2A2;NEDD4L
prerank,positive regulation of stem cell differentiation (GO:2000738),-0.3695387944211857,-0.9606825489526639,0.5308056872037915,0.8689893514533877,1.0,9/16,49.71%,SOX5;TGFB2;FOXC1;PTN;SOX6;DHX36;SP7;TCF15;RBM24
prerank,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),0.34646762652727436,0.9594117419530422,0.49514563106796117,0.7856142363972818,1.0,8/31,11.55%,OPHN1;CDC42;RHOA;SYNJ2BP;PARD3B;MSN;MARK2;MYO9A
prerank,regulation of stem cell population maintenance (GO:2000036),0.393483566955939,0.9589377941461498,0.49740932642487046,0.7861252470881928,1.0,4/18,15.18%,NCOA3;ESRRB;LOXL2;MYC
prerank,regulation of double-strand break repair (GO:2000779),0.3367540518636852,0.9587225448739319,0.5048076923076923,0.7861219288128387,1.0,13/39,20.83%,RNF169;CHEK1;FOXM1;DDX11;SPIDR;PPP4R2;DEK;TERF2IP;KDM1A;ACTR2;RTEL1;SHLD2;TRIP12
prerank,positive regulation of angiogenesis (GO:0045766),0.27869102390820694,0.9581961996049811,0.5227882037533512,0.7867843525929884,1.0,22/108,12.83%,SASH1;ITGB1;S100A1;GRN;HMOX1;CD40;PIK3R6;HSPB1;STIM1;KLF4;GAB1;PRKCB;ADAM12;TNFSF12;FOXC2;NINJ1;MYDGF;SP1;JUP;JAK1;ZC3H12A;RAMP2
prerank,positive regulation of osteoblast differentiation (GO:0045669),0.32718607088299284,0.9581249154971556,0.5185758513931888,0.7864681595716624,1.0,7/43,9.90%,NELL1;MEF2C;BMP2;ACVR2A;IL6R;DDR2;IGF1
prerank,negative regulation of transposition (GO:0010529),0.40785256062445663,0.9579263511247842,0.5050847457627119,0.7864381715528002,1.0,4/16,13.53%,TUT7;SPOCD1;TUT4;PIWIL2
prerank,mitochondrial cytochrome c oxidase assembly (GO:0033617),-0.343837827767214,-0.957332669989959,0.5238095238095238,0.8769044670324679,1.0,11/18,42.30%,COX19;COX16;FASTKD3;TIMM21;COX17;COX14;COA3;OXA1L;SURF1;COX20;COX18
prerank,insulin receptor signaling pathway (GO:0008286),0.30657442209817576,0.957113609513539,0.5229226361031518,0.7877114469430017,1.0,16/69,12.87%,FER;ATP6V1B1;GSK3B;IRS2;INSR;ATP6V0A1;GAB1;AP3S1;PIK3C2A;ATP6V1A;FOXC2;ZNF106;PHIP;SHC1;NAMPT;FOXO1
prerank,negative regulation of lymphocyte migration (GO:2000402),0.4479104960814912,0.9564232698615107,0.4963768115942029,0.7886686157158537,1.0,4/10,16.59%,RIPOR2;CD200R1;WASL;MIA3
prerank,interleukin-6-mediated signaling pathway (GO:0070102),0.3917926369029352,0.9563817444409219,0.517304189435337,0.7882688325558385,1.0,7/18,13.90%,FER;CBL;SPI1;SMAD4;IL6R;JAK1;STAT3
prerank,positive regulation of myoblast differentiation (GO:0045663),0.398855836755067,0.9559424767272454,0.5079928952042628,0.7887327952076039,1.0,3/16,9.18%,RIPOR2;MEF2C;MAPK14
prerank,activation of cysteine-type endopeptidase activity (GO:0097202),-0.37784638555129546,-0.9557860313816019,0.5157894736842106,0.8798293111323009,1.0,5/13,10.88%,ASPH;LGMN;TBC1D10A;CYFIP2;GRIN2A
prerank,metal ion transport (GO:0030001),-0.2407235832180823,-0.9551169689316744,0.5410447761194029,0.8805400641806848,1.0,18/86,12.58%,CDH23;SLC8A1;NIPA1;TRPC4;RAMP1;CACNA2D1;GRIN3A;CACNA1D;TRPC1;SLC30A9;CACNA1E;TRPC3;CCL3;CACNG7;CACNA1C;TRPC5;ATP2C1;CACNG8
prerank,response to thyroid hormone (GO:0097066),0.4205335211163507,0.9547880586978962,0.5110294117647058,0.7907006756001898,1.0,4/13,11.20%,KLF9;CTSB;THRB;GAS2L1
prerank,homologous chromosome pairing at meiosis (GO:0007129),-0.3064218415611164,-0.9542923007925148,0.5182291666666666,0.8816506588293791,1.0,8/29,19.16%,SIRT7;BAG6;ZCWPW1;FANCD2;SYCE2;IHO1;STAG3;P3H4
prerank,nuclear migration (GO:0007097),0.4167355486636837,0.9538554121996226,0.5065176908752328,0.7921968088755519,1.0,5/13,15.07%,SYNE2;DOCK7;PAFAH1B1;PCM1;SYNE3
prerank,mitochondrial transport (GO:0006839),0.3150071928905551,0.9538247502874064,0.512781954887218,0.7917839830411042,1.0,4/53,6.74%,SLC25A16;SLC25A24;BCL2;PITRM1
prerank,connective tissue development (GO:0061448),0.3392819311566636,0.9536870110902532,0.513911620294599,0.7915862892070926,1.0,6/35,8.81%,ZBTB16;CD44;GHRL;ATP7A;SPTLC2;SULF2
prerank,regulation of DNA binding (GO:0051101),-0.2823577707574496,-0.9530325171558363,0.5345345345345346,0.8839976151459926,1.0,16/44,23.99%,JAK2;DOT1L;SIRT2;HABP4;JUN;MDFI;EDF1;SMO;EGF;TXN;MAPK8;FOXC1;HMGB1;TGFB1;ILRUN;LEF1
prerank,TOR signaling (GO:0031929),-0.3160200267510764,-0.9528359942089869,0.5445544554455446,0.8833934425361317,1.0,13/26,28.77%,RPTOR;PRR5L;CARD11;FLCN;MLST8;MTOR;RHEBL1;SYAP1;RPS6KB2;PRR5;RPS6KB1;LARP1;AKT1
prerank,aorta development (GO:0035904),0.4028466990397705,0.952005691408139,0.4847942754919499,0.7947101971489969,1.0,5/14,16.56%,JAG1;PDE2A;ADAMTS9;PKD2;TBX2
prerank,positive regulation of transferase activity (GO:0051347),-0.2266151181462584,-0.9518615457910641,0.6134020618556701,0.8848915251250701,1.0,27/142,14.02%,MERTK;SORL1;CTNNB1;XRCC5;TREM2;EPHA7;PABPN1;HNRNPA2B1;ARRDC4;FGFR2;FLT1;NTRK3;MAPK3;AXL;MAP2K7;EPHB1;EPHA10;PTGES3;ALK;FLT3;CSF1R;ERBB4;CD200;RFC2;MAP3K4;EPHA3;TYRO3
prerank,organonitrogen compound biosynthetic process (GO:1901566),0.27479738549782023,0.9518182849193246,0.5588972431077694,0.79461813259891,1.0,28/151,15.27%,APOE;SGMS1;SGPP1;CEPT1;MOCS1;HACD4;MGST3;GCH1;ACER3;SGPL1;SLC25A2;TYW1;SPTLC2;LCMT2;PAM;ELOVL5;CHKB;CERS6;MGST1;B4GALT5;ACHE;ASS1;VAPA;MFSD2A;GSTT1;ARG2;PRKD2;ST3GAL4
prerank,positive regulation of morphogenesis of an epithelium (GO:1905332),-0.32323394124567756,-0.95165879310437,0.5150115473441108,0.8842670913582042,1.0,8/23,24.83%,FGF2;ITGAX;PAX8;WNT5B;SMO;EGF;AGT;SOX8
prerank,negative regulation of cell migration (GO:0030336),0.2765144739919127,0.9508574816629739,0.5375647668393783,0.7961427677841947,1.0,19/137,10.04%,MCTP1;PTPRJ;RAP2B;JAG1;MITF;TNN;CD74;HMOX1;ITGB1BP1;MCC;CLIC4;PTPRK;STK24;BST2;DUSP22;VCL;CLASP1;CORO1C;SFRP1
prerank,regulation of smooth muscle cell proliferation (GO:0048660),0.3245856358488943,0.9506802661724953,0.522273425499232,0.7959954287473247,1.0,7/46,9.90%,TCF7L2;FOXP1;ANG;HMOX1;TNF;IL6R;IGF1
prerank,mRNA methylation (GO:0080009),0.40506305987503066,0.950341257632616,0.5157116451016636,0.7962355134879787,1.0,7/15,23.11%,WTAP;NSUN2;VIRMA;TRMT61B;TRMT61A;METTL16;PCIF1
prerank,regulation of protein-containing complex disassembly (GO:0043244),0.39211261584234064,0.9503040554845253,0.4793233082706767,0.7958278884382141,1.0,8/16,20.98%,IRAK3;INSR;TNF;ETF1;BNIP3;IGF1R;GSPT1;MTRF1
prerank,monovalent inorganic cation homeostasis (GO:0055067),-0.32557020962401334,-0.9502714441786119,0.5314861460957179,0.886924173974133,1.0,16/23,42.65%,SLC12A2;SLC12A9;SLC12A6;SLC9A1;SLC12A4;SLC12A5;KCNH2;SLC12A1;PDK2;CLCN3;TFAP2B;ATP6V0A4;SCNN1A;PDK4;SLC26A4;SLC12A3
prerank,hematopoietic progenitor cell differentiation (GO:0002244),-0.30733248039165184,-0.9498912726080586,0.532967032967033,0.8868507747159874,1.0,9/30,25.17%,PLD4;TP53;FLT1;FLT3;CSF1R;PLEK;TGFB1;PRRC2C;TNFRSF13B
prerank,mitotic spindle organization (GO:0007052),-0.22290879028080826,-0.9498745907289999,0.6183574879227053,0.8857423812952376,1.0,68/153,31.87%,CLASP2;DYNC1H1;CENPC;RANBP2;CEP192;CENPE;WDR62;KNL1;NEK6;NUP85;WRAP73;KIF11;TOGARAM1;CKAP5;EML1;MAPRE1;BUB1B;CHEK2;KIF3B;BUB1;SEH1L;DLGAP5;MAP4;KIFC2;SPDL1;NDC80;KIF2A;INTS13;GOLGA2;SKA2;BCCIP;NSL1;PTPA;CDCA8;AAAS;B9D2;RCC1;SEC13;KIFC1;DCTN2;ZW10;TOGARAM2;CENPP;CENPN;CENPH;FLNA;MAP9;ZWINT;STIL;BIRC5;MAD2L1;CEP126;CENPI;SPC25;AURKB;PMF1;DYNLL2;KIF2C;TTK;CENPF;SGO1;NUDC;PPP1CC;CLIP1;MZT1;NUF2;TUBG1;AURKA
prerank,carboxylic acid transport (GO:0046942),-0.26378481598292247,-0.9496299429612056,0.560126582278481,0.885301712420386,1.0,14/55,17.34%,SLC16A6;SLC36A1;SLC16A3;CLN3;SLC36A4;SLC16A1;SLC1A1;SLC7A8;SLC17A5;SLC16A4;LLGL2;PSAP;SLC16A9;SLC25A10
prerank,artery morphogenesis (GO:0048844),0.3466267411868259,0.9492926818456221,0.5555555555555556,0.797512597599289,1.0,3/30,4.49%,NRP1;JAG1;HEY2
prerank,cell morphogenesis involved in neuron differentiation (GO:0048667),0.29868928095012365,0.9492609704701567,0.5251396648044693,0.7970896221619012,1.0,11/75,10.08%,APP;MEF2A;OPHN1;ATL1;MEF2C;RAB10;RB1;ACTB;MAPK8IP2;CCK;DOCK7
prerank,sensory perception of chemical stimulus (GO:0007606),0.3995793904478601,0.9489587635595139,0.5304659498207885,0.7972302413076146,1.0,2/15,2.76%,C5AR1;CD36
prerank,cellular copper ion homeostasis (GO:0006878),0.41071620627083244,0.9487342770721162,0.5252707581227437,0.7972051402006777,1.0,2/14,5.58%,APP;ATP7A
prerank,Golgi ribbon formation (GO:0090161),-0.37776683269248884,-0.948395598630875,0.5517241379310345,0.8874691325273945,1.0,4/13,18.07%,OPTN;GCC2;STX16;GOLGA2
prerank,regulation of fibroblast migration (GO:0010762),-0.3339797864255203,-0.9476925462777832,0.5261904761904762,0.8881918693131119,1.0,5/20,7.27%,PRKCE;PRR5L;FGF2;CLN3;APPL1
prerank,calcium ion transmembrane import into cytosol (GO:0097553),-0.2799034481019392,-0.947642495767155,0.5652173913043478,0.8871602854373467,1.0,7/41,10.88%,SLC24A2;SLC8A1;HTR2C;FGF2;CACNA2D1;ITPR2;GRIN2A
prerank,regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),-0.3914133142883593,-0.9475888754602084,0.5168539325842697,0.8861586294141065,1.0,5/11,19.07%,NCL;SMARCB1;SIRT7;MTOR;NOL11
prerank,negative regulation of cellular component organization (GO:0051129),0.29918608232595933,0.9473274209397968,0.5290780141843971,0.7997507217812923,1.0,9/74,6.94%,MCTP1;IRAK3;NR1H4;LILRB1;CDC42;GSK3B;RIOK3;NOP53;TNF
prerank,regulation of protein localization to cell surface (GO:2000008),0.3395987517119892,0.9468572968251688,0.5330188679245284,0.8002717860703772,1.0,5/33,7.63%,RAB11FIP5;KCNAB2;LEPROTL1;TNF;HFE
prerank,spinal cord development (GO:0021510),-0.3836293939930814,-0.9458766051061418,0.5254629629629629,0.889617980827277,1.0,4/12,20.57%,NF1;LOXL3;VIT;SOX11
prerank,rRNA modification (GO:0000154),-0.3388012061682756,-0.9457956805739279,0.5555555555555556,0.8886928260061001,1.0,7/21,20.86%,TFB2M;FTSJ3;TSR3;GAR1;MRM2;MTERF4;THUMPD1
prerank,interleukin-35-mediated signaling pathway (GO:0070757),-0.39155919029888187,-0.945758241700478,0.5183585313174947,0.8876636198345828,1.0,3/11,6.18%,JAK2;STAT1;IL12RB2
prerank,regulation of ion transport (GO:0043269),0.29722734700738546,0.9457113454619094,0.5283540802213001,0.8022056258502256,1.0,9/76,7.63%,P2RX7;DRD1;KCNJ14;SNX6;B2M;PRKN;WNK1;CHRNA4;HFE
prerank,cardiolipin metabolic process (GO:0032048),0.40769207999590684,0.9455859059549688,0.5178571428571429,0.8019804272757202,1.0,6/13,21.69%,PNPLA8;HADHA;HADHB;PTPMT1;TAMM41;LCLAT1
prerank,hepaticobiliary system development (GO:0061008),-0.3331968666274471,-0.9451433182208294,0.5492610837438424,0.8880978912979055,1.0,7/20,21.11%,NF1;TGFBR3;PROX1;CDK5RAP3;WNT4;PHF2;ARID5B
prerank,regulation of RNA splicing (GO:0043484),0.2993222820824905,0.9448132804609655,0.5372492836676218,0.8031528415956476,1.0,11/69,9.25%,AHNAK;MBNL1;ERN1;RPS13;LARP7;PTBP3;MBNL2;HNRNPF;PTBP2;GRSF1;DYRK1A
prerank,signal transduction in response to DNA damage (GO:0042770),-0.26899528138845374,-0.9446176691021759,0.5561959654178674,0.8883932860788748,1.0,13/49,13.94%,TP53;ATRIP;ATM;MYO6;DOT1L;ERCC6;CEP63;HUS1;MDM4;PRPF19;ACER2;GADD45A;CHEK2
prerank,organelle fusion (GO:0048284),-0.3226597607657029,-0.9444294408060963,0.5364077669902912,0.8877834309893772,1.0,9/22,25.82%,MFN1;VPS18;GDAP1;AFG3L2;MIGA2;VPS11;FIS1;THG1L;USP30
prerank,positive regulation of cell cycle process (GO:0090068),0.28610707259926127,0.9437779741600372,0.5483870967741935,0.8048440912760141,1.0,16/91,11.15%,KIF20B;CDC42;RHOA;RGCC;INSR;PKN2;DDX11;ATRX;RCC2;MAP3K20;CUL3;IGF1;NUP62;PCID2;RHNO1;PHIP
prerank,regulation of cell communication by electrical coupling (GO:0010649),-0.3795556992282974,-0.9435718046806525,0.5184331797235023,0.8889547851055283,1.0,2/13,2.22%,CALM2;SLC8A1
prerank,RNA catabolic process (GO:0006401),0.3183433871555965,0.9435029005087044,0.5305810397553516,0.8049473894462854,1.0,9/46,13.34%,ZFP36L2;ERN1;SND1;RNASE6;MTREX;DCP2;DIS3L2;ZC3H12D;LSM2
prerank,positive regulation of positive chemotaxis (GO:0050927),0.3922919054666038,0.9434562787269742,0.5081374321880651,0.8045530727405285,1.0,1/15,0.66%,IL16
prerank,"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",-0.3563461093574699,-0.9434512380984704,0.5376106194690266,0.8881680283105944,1.0,8/16,29.31%,NCL;CELF4;CIRBP;NCBP1;RBMXL1;TRA2A;TRA2B;PRDX6
prerank,phosphatidic acid biosynthetic process (GO:0006654),-0.2780846955097229,-0.9431960000153511,0.5684523809523809,0.8877023454015016,1.0,14/46,27.01%,LPCAT1;DGKB;LIPH;GNPAT;DGKZ;DDHD1;ACP6;AGPAT3;GPD1L;SLC27A1;ABHD8;DGKG;AGPAT2;DGKA
prerank,sodium ion transmembrane transport (GO:0035725),0.2917111869393843,0.9427170008839284,0.5658263305322129,0.8056638126458943,1.0,18/84,16.52%,SLC9A9;FXYD2;ANO6;SLC9A4;SLC4A4;HCN3;SCN3B;SLC6A2;SLC6A5;ATP1A4;ATP1A3;ATP1A1;SLC9A7;SLC9A6;PKD2L1;PKD2;SLC6A11;SLC6A6
prerank,ER-associated misfolded protein catabolic process (GO:0071712),-0.39436512230635407,-0.9421674766545669,0.5314401622718052,0.8892744123879913,1.0,5/11,21.40%,AUP1;BAG6;UFD1;RNF5;TOR1A
prerank,positive regulation of smooth muscle cell proliferation (GO:0048661),0.32638630132660756,0.9416083290625784,0.5246153846153846,0.807584222281851,1.0,12/43,17.66%,FOXP1;ERN1;P2RY6;HMOX1;TNF;IL6R;IGF1;RBPMS2;GJA1;BMPR1A;CCL5;IL6
prerank,negative regulation of lipid metabolic process (GO:0045833),0.3696572442648228,0.941189400001341,0.5311418685121108,0.8079820003413378,1.0,4/22,8.14%,UGT1A8;UGT1A1;TNF;NCOR1
prerank,nucleoside catabolic process (GO:0009164),0.4278548091481561,0.941063364714208,0.5357766143106457,0.8077914206988231,1.0,1/11,1.73%,DPYD
prerank,protein modification by small protein conjugation (GO:0032446),0.24949335563924502,0.9408628122124226,0.6174863387978142,0.807711434651772,1.0,70/361,16.01%,WWP1;FBXW7;SMURF2;ARIH1;RPS27A;VCPIP1;PIAS1;FBXL17;UBE2E3;WAC;CBL;PRKN;URM1;BCL10;ZNRF3;USP9X;RACK1;TRIM33;KLHL13;UBE2Q2;TRIM32;FBXL5;MYCBP2;PIAS2;CDC27;TRIM24;NSMCE2;EIPR1;TRIM47;DTX2;BIRC6;NUP133;CDC73;TRIM68;SHPRH;TRIM27;MDM2;UBE2K;UBE2D3;UHRF2;CUL3;MKRN1;RNF38;ANAPC16;FBXO11;RNF14;ARRB1;RNF111;NUP62;ATG7;AMFR;UFM1;MIB1;FBXO10;NUP98;MKRN3;UBE2R2;UBE2N;ATG10;RNF187;ASB12;HIF3A;NEDD4L;KLHL24;ELOC;MKRN2;RNF41;PEX14;FBH1;UBE2W
prerank,long-chain fatty acid metabolic process (GO:0001676),0.30600765737455177,0.9407349240422329,0.5372262773722628,0.8075193028753987,1.0,5/64,7.30%,ALOX5;LTC4S;ALOX15;PNPLA8;ELOVL5
prerank,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),-0.3011119385365441,-0.9401463416882341,0.5411471321695761,0.8933348286007678,1.0,5/28,9.15%,IRAK2;CYLD;IRGM;OTULIN;AAMP
prerank,positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),-0.38241872155873224,-0.9398972956397685,0.5413043478260869,0.8928375122067694,1.0,5/12,23.71%,ADCY8;PLA2G6;CFTR;C2CD2L;BAIAP3
prerank,regulation of dendrite extension (GO:1903859),-0.3430195938417091,-0.9398719461705229,0.5436241610738255,0.8917758361531349,1.0,2/18,2.26%,RIMS1;RIMS2
prerank,glucose 6-phosphate metabolic process (GO:0051156),-0.33007790682716265,-0.939671499832144,0.5517241379310345,0.8911768015911785,1.0,3/21,6.97%,HK2;TALDO1;RPIA
prerank,metanephric mesenchyme development (GO:0072075),-0.3930585210731138,-0.9395176124277537,0.5200892857142857,0.8904956527504035,1.0,2/10,2.98%,BASP1;STAT1
prerank,Golgi to plasma membrane protein transport (GO:0043001),0.33827947209116155,0.9394590126458229,0.538961038961039,0.8097459665758463,1.0,4/30,8.59%,RAB31;SPTBN1;RAB10;GOLPH3L
prerank,ubiquitin-dependent protein catabolic process (GO:0006511),0.249462398308472,0.9390453111289984,0.6267995570321152,0.8101768776100715,1.0,66/341,15.04%,WWP1;RNF150;FBXW7;SMURF2;PSMA7;ARIH1;FBXL17;SIAH2;CBL;PELI1;RMND5A;PRKN;CLOCK;ZNRF3;NDFIP1;USP9X;RC3H1;SPOP;TRIM32;ANKIB1;CDC27;VPS4B;PSMB2;APPBP2;TBL1XR1;BIRC6;SPOPL;MDM2;RNF19B;TBL1X;UBE2K;UBE2D3;COP1;CUL3;ANAPC16;ARMC8;ZFAND2B;UBQLN4;FBXO11;RNF14;VPS37C;ARRB1;RNF111;AMFR;PSMA6;RNF185;UBE3B;TRIM71;MIB1;FBXO10;UBE2R2;AGAP3;RNF115;RBBP6;RNF187;RNF19A;NDFIP2;BFAR;NEDD4L;PSMA3;PSMD1;PSMD5;ANAPC1;ELOC;WDR91;RNF122
prerank,regulation of cellular catabolic process (GO:0031329),0.30134841847324856,0.9389920823844766,0.5477239353891337,0.8098100415374149,1.0,10/62,8.89%,NUPR1;DAPK1;LAMP3;PRKN;MTMR3;ROCK1;HSPB1;DRAM1;DRAM2;SMCR8
prerank,positive regulation of type I interferon production (GO:0032481),0.29277126433137474,0.9386736586573253,0.5430555555555555,0.8100345732507239,1.0,13/73,12.63%,TLR8;OAS2;PTPN22;TLR4;TLR2;TRIM56;RIOK3;LRRFIP1;STAT6;RIPK2;CREBBP;DHX33;POLR3D
prerank,release of cytochrome c from mitochondria (GO:0001836),0.3808235558868735,0.9386158237793385,0.5257548845470693,0.8096896113645419,1.0,2/17,6.34%,SFN;BCL2
prerank,polyol metabolic process (GO:0019751),-0.2681906230103578,-0.9384828228955563,0.5964912280701754,0.8921692497870823,1.0,9/46,11.24%,INPP4B;INPP5D;PLCB2;PLD4;PLCB4;PLCG1;MINPP1;PLCB1;PLCH1
prerank,sphingolipid biosynthetic process (GO:0030148),-0.2532750446395442,-0.9383691237559016,0.6219931271477663,0.8913495416537792,1.0,23/71,21.13%,LARGE1;ST3GAL5;SPNS2;SMPD4;PPM1L;PLPP3;ASAH1;ASAH2;CERS4;SAMD8;DEGS1;ST8SIA1;CERS5;ACER2;CERS1;ST8SIA3;SGMS2;SPTLC1;SMPD2;TLCD3B;CERS2;PLPP2;KDSR
prerank,regulation of actin filament-based movement (GO:1903115),-0.40485084760138834,-0.938121689481108,0.5357873210633947,0.8909006783117568,1.0,2/10,4.57%,PDE4B;ANK2
prerank,pre-mRNA cleavage required for polyadenylation (GO:0098789),-0.37844182976836016,-0.9376548233878655,0.5344129554655871,0.8910198473784241,1.0,3/13,14.43%,CPSF6;CSTF2;NCBP1
prerank,positive regulation of secretion (GO:0051047),0.4202341983931376,0.9375442829921576,0.5105633802816901,0.8114757781830626,1.0,3/11,17.28%,ACSL3;TRH;XBP1
prerank,sphingosine metabolic process (GO:0006670),0.38944400924572364,0.9374127383666502,0.5232974910394266,0.8112724979534904,1.0,3/17,6.07%,SGPP1;ACER3;SPTLC2
prerank,cellular response to catecholamine stimulus (GO:0071870),0.3561700586909319,0.9373624038083812,0.5327586206896552,0.8108919016622348,1.0,6/23,12.32%,GNG2;DRD1;PRKN;GNB1;KCNQ1;ATP2B4
prerank,negative regulation of amyloid-beta formation (GO:1902430),-0.33811956221547745,-0.9372638538645361,0.5478468899521531,0.8908583900040975,1.0,3/17,1.37%,BIN1;SORL1;RTN1
prerank,heterochromatin organization (GO:0070828),0.3969346648439035,0.937234767903562,0.5245901639344263,0.8107014778212609,1.0,4/14,17.46%,SETDB2;POLE3;LOXL2;MECOM
prerank,"negative regulation of gene expression, epigenetic (GO:0045814)",0.36006647985607654,0.9370068595709415,0.5472370766488414,0.8106821812878369,1.0,6/24,9.74%,PPHLN1;JARID2;SPI1;EPC1;TRIM27;H3-3A
prerank,negative regulation of viral release from host cell (GO:1902187),-0.3747678239180482,-0.936742491252815,0.569937369519833,0.8911742935134773,1.0,6/13,22.56%,TRIM28;TRIM13;TRIM11;TRIM21;CHMP3;TRIM8
prerank,visual perception (GO:0007601),0.2853866307210509,0.9367302176165164,0.5427769985974754,0.8107963218624742,1.0,11/84,11.68%,ATXN7;RAX;DHRS3;PITPNA;CRYBG3;MYO7A;DRAM2;ATF6;BEST1;MYO9A;WFS1
prerank,negative regulation of hippo signaling (GO:0035331),0.4134840364344186,0.9365434876443564,0.5358490566037736,0.810698408346761,1.0,7/12,20.00%,LIMD1;MAPK14;WWC1;VGLL4;MARK3;DLG5;WWC2
prerank,membrane repolarization during cardiac muscle cell action potential (GO:0086013),-0.3510161709370821,-0.9357511756011858,0.5422222222222223,0.8927737018035524,1.0,2/15,2.09%,KCNJ2;ATP1B1
prerank,positive regulation of cellular component movement (GO:0051272),-0.31218704750679016,-0.9348656319731206,0.5425,0.8939496478499339,1.0,4/24,4.92%,TGFBR1;ETS1;CCDC25;STK11
prerank,protein deubiquitination (GO:0016579),0.2526915674361077,0.9343842968312881,0.5970149253731343,0.8148312581404147,1.0,53/242,16.95%,ESR1;SMURF2;PSMA7;USP3;RPS27A;BABAM2;VCPIP1;ATXN7;ADRB2;RIPK1;SIAH2;RHOA;PRKN;BIRC3;USP9X;SNX3;SMAD4;ACTB;BRCC3;USP15;YY1;PSMB2;MDM2;ASXL1;USP21;USP16;MINDY2;USP24;PSMA6;FOXK2;USP14;ZC3H12A;FOXK1;TADA2B;WDR20;USP45;USP9Y;EP300;PSMA3;PSMD1;PSMD5;USP28;ENY2;MYC;USP22;USP25;ABRAXAS2;USP47;HCFC1;PTEN;STAM;UCHL3;USP32
prerank,cellular response to ketone (GO:1901655),0.33100480866747467,0.9342225113280487,0.5072463768115942,0.8146660630901575,1.0,9/35,11.99%,AHR;GNG2;NR3C1;KLF9;GNB1;MSN;SFRP1;PTGER4;ROCK2
prerank,positive regulation of blood coagulation (GO:0030194),0.3858713903233236,0.9339697189937244,0.5372340425531915,0.8146843114470698,1.0,5/17,18.04%,ANO6;ENPP4;USF1;ST3GAL4;F2R
prerank,protein-containing complex subunit organization (GO:0043933),0.27449937886505105,0.9339483614788321,0.5802139037433155,0.8142450203817823,1.0,15/109,8.74%,SNX9;KMT2A;REPS2;MITF;CD74;SKAP2;WIPF1;ST13;CD40;DARS1;HFE;NUP133;TUBGCP2;RANBP9;MDM2
prerank,tRNA aminoacylation (GO:0043039),-0.28153621319648187,-0.9338516572642696,0.5779569892473119,0.8954545104458327,1.0,20/37,34.29%,FARSA;AARS1;CARS1;TARS1;NARS1;YARS1;IARS2;SARS1;DARS2;SARS2;HARS2;FARSB;WARS1;VARS1;PPA2;KARS1;QRSL1;HARS1;AIMP2;AIMP1
prerank,translational elongation (GO:0006414),0.28315085152199004,0.9334381104654011,0.5482573726541555,0.8148344112999234,1.0,19/101,14.23%,MRPL23;MRPS12;EEF1A1;EEFSEC;ERAL1;MRPL13;RACK1;MRPL33;MRPS25;MRPS11;EEF1D;MRPL1;MRPL49;MRPL16;MRPS17;GTPBP1;MRPL44;MRPS34;MRPS14
prerank,regulation of lipid storage (GO:0010883),0.35913240985977224,0.9330434379833366,0.5295138888888888,0.8152112989095458,1.0,4/22,12.28%,FBXW7;TNF;VSTM2A;ZC3H12A
prerank,iron ion transport (GO:0006826),0.314539631488848,0.9327506915403994,0.5469208211143695,0.8153728573570934,1.0,12/47,16.26%,CP;CLTC;STEAP3;ATP6V1B1;ATP6V0A1;HFE;ATP6V1A;FTH1;TFR2;ABCB7;MELTF;ATP6V0D1
prerank,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),-0.3094546171714143,-0.9326660812717468,0.5505050505050505,0.8974511269996044,1.0,4/26,4.22%,LRP5;ADCY8;EFNA5;PLA2G6
prerank,sensory organ development (GO:0007423),-0.2667433552063891,-0.9324546423305531,0.5606936416184971,0.896880368339899,1.0,16/51,22.78%,CHD7;PBX2;BMPR1B;AHI1;RAB18;MEIS3;SHROOM2;PAX8;MEIS1;SMG9;HIPK1;PBX1;TGFB2;FOXC1;PBX4;SALL2
prerank,negative regulation of coagulation (GO:0050819),0.40217930424497417,0.9324391675369956,0.5397111913357401,0.8155611465365614,1.0,1/14,0.49%,APOE
prerank,positive regulation of chondrocyte differentiation (GO:0032332),0.43021196363407455,0.9323859777823641,0.5463320463320464,0.8151822252978935,1.0,1/10,1.22%,ZBTB16
prerank,mitotic recombination (GO:0006312),0.39198804653563213,0.9321581843956689,0.5553505535055351,0.8151424641216787,1.0,7/15,24.60%,NSMCE2;RAD52;DMC1;SMC6;XRCC3;RAD51D;ERCC1
prerank,transforming growth factor beta receptor signaling pathway (GO:0007179),0.2857269352561212,0.932014619782,0.5878284923928078,0.8149766906792035,1.0,13/87,7.38%,NRROS;ITGB1;RPS27A;ADAM9;CBL;RHOA;USP9X;SMAD4;PTPRK;TGFBRAP1;GDF10;USP15;DUSP22
prerank,arachidonic acid metabolic process (GO:0019369),0.33806052858608177,0.9316880891838312,0.5522151898734177,0.8151602903762986,1.0,3/35,4.93%,ALOX5;ALOX15;PNPLA8
prerank,anterior/posterior axis specification (GO:0009948),0.397911912490331,0.9316315942438549,0.5508021390374331,0.8147959331166615,1.0,3/15,17.03%,HOXD8;WLS;LHX1
prerank,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",0.29731085686500686,0.9315500207820553,0.5613275613275613,0.8144735288626497,1.0,12/67,14.48%,CYBB;PSMA7;CD36;B2M;PSMB2;NCF2;SNAP23;PSMA6;PSMA3;PSMD1;PSMD5;CYBA
prerank,regulation of anoikis (GO:2000209),0.37160680279042624,0.9313219697441977,0.5193929173693086,0.8144726102740365,1.0,3/19,6.34%,ITGB1;MCL1;BCL2
prerank,positive regulation of neuron projection development (GO:0010976),-0.24155936093775401,-0.9312975215924648,0.6209386281588448,0.8988790401435707,1.0,27/85,21.08%,PTK2B;SETX;ITGA6;SCN1B;MAGI2;TENM3;ATP1B2;NDRG4;SCARB2;NTRK3;TWF2;BDNF;SERPINI1;ALK;CAPRIN1;RAPGEF1;NDNF;EPHA3;GPC2;FUT9;ZDHHC15;DBN1;PLXNB2;PLA2G3;PLXNB3;WNT5A;TWF1
prerank,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.2765044425648245,0.9309341219880191,0.5780189959294437,0.8147728258060051,1.0,14/100,9.99%,EGFR;FGFR1;LYN;CBL;IRS2;INSR;PDGFRA;NOP53;TNF;GAB1;PDGFC;MYDGF;IGF1;PIP5K1A
prerank,negative regulation of mitotic cell cycle phase transition (GO:1901991),0.2836719251496214,0.9306341487886165,0.5531034482758621,0.8149457990986766,1.0,19/87,16.22%,ZFP36L2;PSMA7;ZFP36L1;RGCC;CDK6;RB1;KLF4;PSMB2;CDC73;KANK2;PSMA6;CDKN2C;PSMA3;PSMD1;PSMD5;PKD2;PINX1;USP47;PTEN
prerank,positive regulation of glycogen biosynthetic process (GO:0045725),0.4110904197021624,0.9305998614308585,0.5283363802559415,0.8145367707895745,1.0,3/12,9.90%,IRS2;INSR;IGF1
prerank,UDP-N-acetylglucosamine metabolic process (GO:0006047),0.39692617535176233,0.9303493700657418,0.5288966725043783,0.8145874022561759,1.0,6/13,24.52%,GNPDA1;GFPT2;UAP1L1;RENBP;SLC35A3;UAP1
prerank,negative regulation of sodium ion transmembrane transporter activity (GO:2000650),-0.40663967239188353,-0.9302530424878019,0.576017130620985,0.9005228039639327,1.0,3/10,8.95%,PRKCE;HECW2;HECW1
prerank,membrane lipid biosynthetic process (GO:0046467),0.305557389934503,0.9301734072963439,0.5656565656565656,0.8144699431231972,1.0,8/58,8.84%,SGMS1;SGPP1;HACD4;ACER3;SGPL1;SPTLC2;ELOVL5;CERS6
prerank,inositol phosphate catabolic process (GO:0071545),0.4232329019203388,0.9301631949267799,0.5408921933085502,0.8140027674068465,1.0,4/12,19.24%,SYNJ1;OCRL;PTEN;INPP5K
prerank,dosage compensation by inactivation of X chromosome (GO:0009048),-0.3797619382338443,-0.9298870778557111,0.5491452991452992,0.9003206931505542,1.0,3/12,8.88%,HNRNPU;PCGF5;BRCA1
prerank,negative regulation of cell growth (GO:0030308),-0.22701162664101254,-0.9298064298532734,0.6541666666666667,0.8994001262947446,1.0,24/121,16.16%,APBB2;MAP2;PTPRS;DIP2B;TP53;FGF13;BTG1;OSGIN2;STK11;FLCN;DCBLD2;PPT1;ENO1;CCAR2;MAG;DNAJB2;HYAL1;GNG4;APBB1;BCL6;MINAR1;SMARCA2;ACVR1B;ULK1
prerank,microtubule anchoring (GO:0034453),-0.38910991607247064,-0.929544779001145,0.5608108108108109,0.8989802200847367,1.0,3/12,7.28%,CLASP2;GCC2;BICD2
prerank,protein-DNA complex assembly (GO:0065004),0.2725020919618572,0.9285607045523709,0.5809768637532133,0.8168711568395928,1.0,25/116,17.65%,PADI4;TCF4;PSMA7;RPS27A;ORC5;ORC2;PSMB2;RPA1;GMNN;ATRX;H3-3A;CETN2;PSMA6;XPA;RPA3;XPC;PSMA3;PSMD1;PSMD5;GTF2H3;MCM8;ANP32B;GTF2H1;DMC1;ASF1A
prerank,negative regulation of RNA splicing (GO:0033119),0.37525209992900277,0.9285371231117794,0.5660714285714286,0.8164539399685354,1.0,4/19,7.92%,RPS13;PTBP3;SRSF4;PTBP2
prerank,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.289666932050336,0.9282777941267023,0.5582990397805213,0.8165166208662717,1.0,13/76,12.28%,FBXW7;PIAS1;PRICKLE1;AXIN1;BCL10;BIRC3;NDFIP1;MYCBP2;TSPYL5;CUL3;RIPK2;WFS1;ZC3H12A
prerank,protein auto-ADP-ribosylation (GO:0070213),0.413735330282997,0.9281314585053569,0.5428015564202334,0.816339984854562,1.0,3/12,10.31%,PARP8;PARP11;PARP16
prerank,regulation of mitotic spindle organization (GO:0060236),-0.2918145435364235,-0.927941960775026,0.5739795918367347,0.9021341570614193,1.0,9/35,12.74%,EML3;DYNC1H1;GNAI1;CEP97;HNRNPU;CHMP4B;TACC3;NUMA1;PARP3
prerank,protein heterotetramerization (GO:0051290),-0.3716210470800434,-0.9275718965037238,0.5476718403547672,0.9019855689175529,1.0,2/13,2.84%,CPSF6;FARSA
prerank,mitotic G2 DNA damage checkpoint signaling (GO:0007095),0.33959797460377555,0.9271667551743102,0.5424,0.8178930779443613,1.0,5/32,7.23%,BABAM2;NOP53;CHEK1;BRCC3;TOPBP1
prerank,cellular response to hydrogen peroxide (GO:0070301),0.32534927035614086,0.9271278795244826,0.5475409836065573,0.8174889203491102,1.0,4/33,2.67%,MAP3K5;RPS3;OSER1;RIPK1
prerank,Golgi to lysosome transport (GO:0090160),0.4217995030178471,0.9269704592465686,0.5418994413407822,0.8173335610654788,1.0,2/11,4.55%,ANKFY1;LAMP1
prerank,postsynaptic membrane organization (GO:0001941),-0.341375207258377,-0.9267548321213059,0.5584415584415584,0.9029611031152324,1.0,6/17,13.30%,NLGN1;NRXN1;DLG4;DNAJA3;LRRC4;SHISA7
prerank,mitochondrial gene expression (GO:0140053),0.31926609599362993,0.9265250279047234,0.5344563552833078,0.8177937561178611,1.0,10/42,14.23%,MRPL23;MRPS12;NDUFA7;MRPS11;RARS2;FOXO3;MRPL16;MRPS17;MRPS34;MRPS14
prerank,positive regulation of cardiocyte differentiation (GO:1905209),0.41815193066371326,0.9264704334391188,0.5452865064695009,0.817418845028954,1.0,1/11,2.01%,MEF2C
prerank,regulation of leukocyte migration (GO:0002685),0.3870345376698241,0.9262672221829612,0.545774647887324,0.817342845757086,1.0,2/16,3.80%,BST1;HMOX1
prerank,protein O-linked mannosylation (GO:0035269),-0.3418222533194755,-0.9258498041864011,0.5450346420323325,0.9042539835922916,1.0,3/18,10.09%,LARGE1;TMTC4;TMTC2
prerank,muscle cell differentiation (GO:0042692),0.3347522316003615,0.9257097973774322,0.5634266886326195,0.8180354218383457,1.0,8/32,17.51%,MEF2C;NRAP;HEY2;NINJ1;NEB;POPDC3;KDM1A;GLMN
prerank,stress-activated MAPK cascade (GO:0051403),0.2968677534535041,0.9255276801218648,0.5603448275862069,0.8179515696882468,1.0,12/61,13.05%,MAP3K5;RPS27A;ZFP36L1;CCM2;MAP3K8;MAPK14;MAP3K20;RIPK2;PTGER4;MAP3K11;NOD2;UBE2N
prerank,positive regulation of mRNA catabolic process (GO:0061014),0.3158832398758007,0.9254204438905552,0.5867269984917044,0.8177049577449909,1.0,9/44,13.73%,ZFP36L2;ZFP36L1;RC3H1;ROCK1;NANOS3;ROCK2;ZC3H12A;GTPBP1;TNRC6C
prerank,DNA replication (GO:0006260),0.27272033109802596,0.9250469033008523,0.5971128608923885,0.817991715324628,1.0,20/105,13.86%,RBMS1;RBBP8;ORC5;FAM111A;MCMBP;ORC2;MCM9;POLE2;CHEK1;TOPBP1;TIPIN;RPA1;BRIP1;TOP1MT;POLG2;RHNO1;POLE3;RPA3;KAT7;KIN
prerank,embryonic digestive tract development (GO:0048566),-0.3486145781859361,-0.9249461350296604,0.5771812080536913,0.9055382562801172,1.0,6/18,20.66%,SALL1;FGFR2;ID2;TGFB2;SOX11;GLI3
prerank,positive regulation of dendrite extension (GO:1903861),-0.3430210055709709,-0.9249066711082431,0.5619469026548672,0.9045237227567999,1.0,2/17,2.26%,RIMS1;RIMS2
prerank,calcium ion transport into cytosol (GO:0060402),-0.3227659594878649,-0.9248804245194735,0.5542452830188679,0.9034867536469999,1.0,5/21,11.72%,SLC8A1;CACNA2D1;JPH1;GRIN2A;CACNA1C
prerank,secondary alcohol metabolic process (GO:1902652),0.3144355237985443,0.924592019017978,0.5541795665634675,0.8184395417713346,1.0,11/42,20.23%,APOE;UGT1A4;CLN6;CYP27A1;OSBPL1A;CLN8;OSBPL5;IDH1;PIP4P1;IDH2;NSDHL
prerank,negative regulation of sodium ion transmembrane transport (GO:1902306),-0.40463399186474536,-0.9242387559496816,0.5635593220338984,0.9040562132478867,1.0,3/10,8.95%,PRKCE;HECW2;HECW1
prerank,regulation of synaptic vesicle exocytosis (GO:2000300),0.3778427484057596,0.9238479560300913,0.5418894830659536,0.8195566615249992,1.0,3/18,4.84%,RAP1B;GSK3B;RAP1A
prerank,transcription by RNA polymerase III (GO:0006383),-0.3048282272867818,-0.9237498527922307,0.5654320987654321,0.9042881131385399,1.0,11/27,30.66%,IVNS1ABP;GTF3C2;ICE2;POLR3G;ELL;POLR2L;BRF1;TBP;ICE1;SNAPC1;POLR3GL
prerank,monocarboxylic acid metabolic process (GO:0032787),0.27603115007242707,0.923134983880827,0.5889175257731959,0.8205729685417541,1.0,13/117,9.99%,AOAH;CD36;UGT1A7;UGT1A8;UGT1A1;PNPLA8;GLO1;SGPL1;PDHB;ACOT12;IGF1;ACSL3;CYP26B1
prerank,stress granule assembly (GO:0034063),-0.3303717856781041,-0.9229052312787196,0.5930232558139535,0.9054025630211885,1.0,8/20,22.21%,DYNC1H1;ATXN2L;MAPT;OGFOD1;CIRBP;ATXN2;PRRC2C;G3BP1
prerank,positive regulation of glial cell differentiation (GO:0045687),-0.3338123494226334,-0.9225323719382054,0.5452538631346578,0.9052138797931297,1.0,8/17,21.94%,BIN1;SERPINE2;TENM4;ID2;EGR2;NOTCH1;CLCF1;TGFB1
prerank,sister chromatid segregation (GO:0000819),-0.2955550503667285,-0.9218605325626886,0.5702917771883289,0.9058603112863114,1.0,15/31,32.52%,WRAP73;TOP2A;NDC80;NUSAP1;NSL1;CDCA8;KIFC1;ZW10;ESPL1;ZWINT;SPAG5;SGO1;LATS1;TUBG1;KIF18B
prerank,regulation of cellular response to heat (GO:1900034),-0.23718984445245053,-0.921525202881851,0.6515679442508711,0.9056424873392612,1.0,22/77,20.36%,RPTOR;DNAJC7;NUP210;RANBP2;ATM;MAPK3;MAPT;PTGES3;CCAR2;CD34;NUP85;HSF1;IER5;SEH1L;MLST8;DNAJB1;MTOR;AAAS;SEC13;FKBP4;CAMK2D;BAG5
prerank,peptidyl-tyrosine autophosphorylation (GO:0038083),0.3956585888892169,0.9214940024792447,0.5620300751879699,0.8234756001836658,1.0,1/15,0.45%,EGFR
prerank,defense response to Gram-negative bacterium (GO:0050829),0.31934061854145296,0.9213724961392419,0.5718654434250765,0.823272534142113,1.0,8/42,11.65%,TLR4;LBP;DROSHA;RPL30;RNASE6;IL6R;ROMO1;CHGA
prerank,synaptic vesicle recycling (GO:0036465),0.33899891224673995,0.9213298823244513,0.5585874799357945,0.8228892852073577,1.0,4/31,7.72%,FCHO2;OPHN1;SYNJ1;CANX
prerank,negative regulation of extracellular matrix organization (GO:1903054),0.42753478420026925,0.9211361489968792,0.5502958579881657,0.8228061730356143,1.0,4/10,17.49%,TNFRSF1B;EMILIN1;TNFRSF1A;FAP
prerank,hippo signaling (GO:0035329),-0.3026889912576351,-0.9210812731944965,0.5773955773955773,0.9057163435086252,1.0,7/26,12.02%,TJP1;FAT4;TJP2;WWTR1;YWHAB;TEAD1;DVL2
prerank,positive regulation of cellular amide metabolic process (GO:0034250),0.2882027769918437,0.9208949687860294,0.565880721220527,0.8228261351497481,1.0,21/80,17.88%,EIF3E;SAMD4A;NIBAN1;RPL26;VIM;RACK1;RPS4X;TNF;RPL5;LARP4B;SP1;ROCK2;TNFRSF1A;LARP4;PIWIL2;RELA;IL6;PYM1;IFNGR1;PICALM;EFNA1
prerank,negative regulation of cell division (GO:0051782),0.4171131385737249,0.9206153726965915,0.5400372439478585,0.8229552660209617,1.0,3/11,15.88%,TXNIP;MYC;E2F8
prerank,ceramide biosynthetic process (GO:0046513),-0.2781388759629531,-0.9202506322556903,0.5786516853932584,0.9067643527866781,1.0,17/40,20.08%,ST3GAL5;ST6GALNAC3;SMPD4;ASAH1;ST6GALNAC4;ASAH2;CERS4;SAMD8;DEGS1;CERS5;CERS1;ST8SIA3;SGMS2;SPTLC1;SMPD2;TLCD3B;CERS2
prerank,intracellular sterol transport (GO:0032366),-0.3797930652067444,-0.9200380503295285,0.5753715498938429,0.9062150535649182,1.0,5/13,23.91%,ABCG1;OSBPL2;ARV1;STAR;ABCA1
prerank,positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),0.4276561735912413,0.9198991823333407,0.5676190476190476,0.8240155991427025,1.0,1/10,1.10%,FBXW7
prerank,regulation of G1/S transition of mitotic cell cycle (GO:2000045),0.2919261680652357,0.9197303830613033,0.5681159420289855,0.8238931609365167,1.0,13/66,13.02%,EGFR;ANKRD17;RGCC;CDK6;RB1;KLF4;CCND3;CDC73;CCND2;TFDP1;KANK2;CDKN2C;KMT2E
prerank,DNA repair (GO:0006281),-0.19815836070019877,-0.9191549824088638,0.7969924812030075,0.9074162079667686,1.0,66/284,18.77%,HERC2;GTF2H2;CSNK1E;DNA2;XRCC5;SETX;TP53;UBE2B;ACTR8;INTS3;ASCC1;ATRIP;ATM;HPF1;PARP1;ENDOV;DDB2;PRIMPOL;FANCE;DOT1L;ERCC6;SLC30A9;BLM;RNF168;UPF1;RECQL5;BRCA1;ERCC2;ALKBH2;MLH3;TNKS1BP1;HUS1;LIG1;RAD51C;TRIM28;XRCC1;BRCA2;UBXN1;KDM4A;FANCD2;PPP5C;PARP3;RFC2;GADD45A;NEIL3;APBB1;CHEK2;RPAIN;POLI;FANCA;DDX1;PARP4;FAAP100;ASCC2;PARK7;TDP1;RAD51AP1;CENPX;MSH2;POLE;DCLRE1B;HUWE1;POLL;PARP9;NUDT1;UBB
prerank,negative regulation of smooth muscle cell proliferation (GO:0048662),0.3389502569416077,0.9189873533591538,0.5702875399361023,0.8249316613956319,1.0,3/33,3.80%,ANG;MEF2C;HMOX1
prerank,regulation of cholesterol transport (GO:0032374),-0.3277259692149419,-0.9188634178857105,0.5707434052757794,0.9070855577245996,1.0,9/20,32.69%,OSBPL6;APOC1;ABCB4;ABCA2;ARV1;ABCA5;ABCA13;LRP1;YJEFN3
prerank,response to organophosphorus (GO:0046683),0.3925787828390474,0.9187403895206752,0.5394265232974911,0.8249860107506772,1.0,1/16,0.51%,P2RX7
prerank,diol metabolic process (GO:0034311),0.3648607322087206,0.9185085986322074,0.5393835616438356,0.8250115140148441,1.0,3/19,10.64%,SGPP1;GCH1;CALM1
prerank,phosphorylated carbohydrate dephosphorylation (GO:0046838),0.4236894628316601,0.9184536231440109,0.555765595463138,0.8241762082978549,1.0,4/11,19.24%,SYNJ1;OCRL;PTEN;INPP5K
prerank,inositol phosphate dephosphorylation (GO:0046855),0.4236894628316601,0.9184536231440109,0.555765595463138,0.8241762082978549,1.0,4/11,19.24%,SYNJ1;OCRL;PTEN;INPP5K
prerank,lysosome localization (GO:0032418),-0.2901558336045698,-0.9184426123257013,0.584070796460177,0.9071027637225304,1.0,17/37,36.54%,PLEKHM2;FLCN;MAP6;FAM98A;S100A13;DEF8;HDAC6;KLC2;KXD1;MILR1;KIF5B;TMEM106B;RAB3A;SNAPIN;HPS6;SPAG9;BLOC1S2
prerank,positive regulation of collagen biosynthetic process (GO:0032967),0.3808385201472066,0.9183946738038368,0.566003616636528,0.8238292422820919,1.0,2/16,4.18%,RGCC;VIM
prerank,pancreas development (GO:0031016),0.4098201180856304,0.9181081790794811,0.5509433962264151,0.823938385197892,1.0,1/12,0.84%,TCF7L2
prerank,cellular response to starvation (GO:0009267),0.2590401965364394,0.9179092467640649,0.633373934226553,0.8238795746405906,1.0,41/147,19.12%,MAP3K5;PRKAG2;CEBPB;SESN1;ATP6V1B1;PRKAG3;MTMR3;AOC1;NPRL3;STK24;MIOS;WIPI1;KLF10;ATP6V1A;FNIP1;SFRP1;LAMP2;ATG7;GAS2L1;SREBF2;FOXO3;LAMTOR5;ZC3H12A;FOXO1;RALB;MFSD2A;SZT2;NPRL2;WIPI2;XPR1;GABARAP;ATG5;ATP6V0D1;XBP1;LARS1;TBL2;RHEB;RRAGC;ATF2;EIF2AK4;EIF2AK2
prerank,regulation of voltage-gated calcium channel activity (GO:1901385),0.3619653948340898,0.9178829862309299,0.5618374558303887,0.8234604335342686,1.0,1/22,0.13%,AHNAK
prerank,diol biosynthetic process (GO:0034312),0.381022472231379,0.917541835425327,0.5402504472271914,0.8236805239106931,1.0,3/15,6.07%,GCH1;ACER3;SPTLC2
prerank,glutathione metabolic process (GO:0006749),-0.2688381876732947,-0.9173216453119655,0.6144927536231884,0.9089384493239648,1.0,6/38,16.22%,HPGDS;GGT5;GSS;GGT7;CTNS;PARK7
prerank,establishment of protein localization to plasma membrane (GO:0061951),0.3175008413014318,0.9172851995876273,0.5630914826498423,0.8237459034279517,1.0,5/36,8.59%,RAB31;SPTBN1;RAB10;RAB7A;GOLPH3L
prerank,positive regulation of vasculature development (GO:1904018),0.2721831842388786,0.9171844305470599,0.6021947873799726,0.8234732210967102,1.0,18/94,12.83%,SASH1;ITGB1;GRN;HMOX1;CD40;PIK3R6;HSPB1;STIM1;GAB1;PRKCB;ADAM12;TNFSF12;NINJ1;MYDGF;SP1;JUP;ZC3H12A;RAMP2
prerank,regulation of cellular localization (GO:0060341),0.3126033833625838,0.9168884602803646,0.5694227769110765,0.8236213817681876,1.0,16/46,19.43%,LYN;FER;NR1H4;NR1D1;PRKN;MAD1L1;TTL;TRIM67;UNC13D;WWC1;REEP6;KDM1A;HSP90AB1;FES;DVL3;STXBP2
prerank,"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",-0.3285848511644084,-0.91668424924469,0.5844748858447488,0.9095201190728238,1.0,7/18,19.51%,PTK2B;NLGN1;NRXN1;CACNG7;CACNG8;CACNG4;CACNG2
prerank,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",-0.3118888341387537,-0.9166717454090682,0.5831435079726651,0.9084564867767008,1.0,6/22,11.73%,KRI1;WDR12;EXOSC9;NOP14;URB1;FTSJ3
prerank,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),0.3241278353886423,0.9163768990792512,0.5653495440729484,0.8242033313867927,1.0,6/38,11.05%,RIPK1;HMOX1;GSK3B;SFRP1;SP100;CASP8
prerank,oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),-0.36603417222425705,-0.9163190708174309,0.5495689655172413,0.9082742935080839,1.0,10/13,39.62%,ALG1;ALG12;ALG3;ALG8;SRD5A3;ALG6;DPAGT1;MPDU1;ALG14;ALG13
prerank,amino sugar biosynthetic process (GO:0046349),0.39740934852805004,0.9162138858047498,0.5716783216783217,0.8240793630364536,1.0,4/12,18.50%,GNPDA1;GFPT2;UAP1L1;RENBP
prerank,"retrograde protein transport, ER to cytosol (GO:0030970)",-0.33940670302342923,-0.916193977662572,0.5608108108108109,0.9075193494621571,1.0,8/17,24.75%,AUP1;UFD1;NPLOC4;SYVN1;SELENOS;TMEM129;FAF2;SEC61B
prerank,negative regulation of peptidyl-lysine acetylation (GO:2000757),-0.40129116635849776,-0.9160819660873764,0.5765199161425576,0.9067238083565625,1.0,6/10,35.79%,BRCA1;CTBP1;THAP7;TAF7;SIRT1;NOC2L
prerank,secondary alcohol biosynthetic process (GO:1902653),0.3379127693634325,0.9156300958862659,0.5846645367412141,0.8248044455789717,1.0,12/30,24.87%,HMGCR;PMVK;HSD17B7;LBR;FDPS;DHCR7;NSDHL;ACLY;IDI1;CYP51A1;EBP;ACAA2
prerank,negative regulation of chemokine production (GO:0032682),-0.3538876399053917,-0.9154159963301175,0.5777777777777777,0.9072474657866425,1.0,2/14,5.46%,SIRPA;APOD
prerank,regulation of lymphocyte activation (GO:0051249),-0.3743529302602906,-0.9153299373495356,0.5610766045548654,0.9063780022663932,1.0,1/12,0.26%,PAG1
prerank,regulation of cell communication (GO:0010646),-0.28272149932700186,-0.9153005931008296,0.5891891891891892,0.9053690604629033,1.0,10/35,16.25%,MGLL;SLC8A1;ANK2;GRK2;SOCS2;GRK3;SCG5;NCLN;CXADR;MTCH1
prerank,regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),0.4107033541069654,0.9150680629107366,0.5612052730696798,0.8255442049272023,1.0,1/10,1.56%,ESR1
prerank,glutamine family amino acid catabolic process (GO:0009065),0.4005495583595513,0.9145025092322551,0.5630397236614854,0.826221080377156,1.0,3/13,12.93%,DAO;GLS2;GLUD1
prerank,cholesterol biosynthetic process (GO:0006695),0.335127342931558,0.9142180969129877,0.5879556259904913,0.8263485411378032,1.0,12/31,24.87%,HMGCR;PMVK;HSD17B7;LBR;FDPS;DHCR7;NSDHL;ACLY;IDI1;CYP51A1;EBP;ACAA2
prerank,myelination in peripheral nervous system (GO:0022011),0.39798717798972916,0.9138752916216574,0.5393053016453382,0.8265743655017677,1.0,1/13,0.88%,ADGRG6
prerank,RNA interference (GO:0016246),0.3689846576732363,0.913732008633777,0.5633270321361059,0.8263924905543601,1.0,3/17,13.29%,PRKRA;DROSHA;MRPL44
prerank,regulation of calcium ion import (GO:0090279),-0.31732267059641217,-0.9137248358581012,0.5755208333333334,0.9081746982025759,1.0,5/21,12.29%,CTNNB1;PRNP;CCL3;WNK3;PLPP4
prerank,apoptotic cell clearance (GO:0043277),-0.2947820627910646,-0.9134496783100554,0.6015037593984962,0.9078088799800788,1.0,13/30,21.43%,XKR6;TREM2;TGM2;ITGB3;RHOBTB2;XKR4;RHOH;TYRO3;ADGRB1;SCARB1;ITGAV;RHOG;HMGB1
prerank,cellular response to retinoic acid (GO:0071300),-0.2677382029268145,-0.9134411604730424,0.5994550408719346,0.9067449969495571,1.0,6/42,6.24%,PTK2B;SETX;BRINP3;ATM;TWF2;HTRA2
prerank,organelle disassembly (GO:1903008),-0.29027602579884654,-0.9132935624333838,0.592391304347826,0.9060652885640308,1.0,14/33,28.47%,RETREG1;GFM2;MTIF2;ATG2A;EIF2D;PLK3;ZFAND1;ULK1;GOLGA2;DENR;UBA5;CDK1;KIF5B;DYRK3
prerank,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),-0.24361600446219694,-0.9131938104624784,0.6567164179104478,0.90525803067912,1.0,17/65,18.14%,INTS3;SKP1;PSMD13;PSMD12;RBX1;FBXL7;PSMD9;PSME3;PSMA4;PSMD8;PSMF1;PSMD4;PABIR1;CDK5RAP3;PSMB8;ZFYVE19;PSME1
prerank,regulation of peptidase activity (GO:0052547),-0.33869231487226403,-0.9128973268799672,0.5586734693877551,0.9049246786887924,1.0,7/19,19.51%,NRDC;CST7;ATP13A2;CST3;PSMB8;FURIN;HDAC1
prerank,positive regulation of lymphocyte chemotaxis (GO:0140131),0.3869484324556437,0.9125701050008153,0.5517857142857143,0.8283254366712034,1.0,3/14,7.58%,OXSR1;WNK1;CCR2
prerank,neurotrophin signaling pathway (GO:0038179),-0.31752234552636044,-0.9125206880720472,0.571072319201995,0.9047932607222593,1.0,4/21,6.81%,SORT1;MAGI2;ZFYVE27;BDNF
prerank,histone H2A ubiquitination (GO:0033522),-0.3261795822083639,-0.912515733865955,0.5753424657534246,0.9037340097094044,1.0,4/17,8.21%,UBE2B;SKP1;DDB2;RNF168
prerank,axonal fasciculation (GO:0007413),-0.37489088440955504,-0.9124517530464573,0.5704989154013015,0.9027964098008183,1.0,6/12,29.72%,CNTN4;EPHA3;EPHB2;NRCAM;EPHB3;AMIGO1
prerank,regulation of smooth muscle cell migration (GO:0014910),0.37086031009197395,0.912449071907164,0.5568760611205433,0.8280932821883783,1.0,2/20,3.77%,NRP1;S100A11
prerank,negative regulation of amyloid precursor protein catabolic process (GO:1902992),-0.32085604266577006,-0.9124003009677761,0.571072319201995,0.901846409015335,1.0,3/19,1.37%,BIN1;SORL1;RTN1
prerank,negative regulation of secretion (GO:0051048),0.4320922305661602,0.9122841798402874,0.5722543352601156,0.8279479344761348,1.0,4/10,21.95%,CD74;VAMP8;TIFAB;ERBB3
prerank,protein localization to chromosome (GO:0034502),0.3257105062356711,0.9122796060116976,0.5716510903426791,0.8274808904347475,1.0,13/34,20.98%,ESR1;RB1;MCM9;RPA1;ATRX;TERF2IP;XRCC4;PINX1;MCM8;ATR;CTCF;TINF2;TNKS2
prerank,cellular response to chemical stress (GO:0062197),0.2770191600257092,0.912016977347551,0.6125166444740346,0.8275571008235262,1.0,21/96,17.04%,CYBB;LRRC8D;SLC25A24;VRK2;MSRA;RAD52;CYCS;TXNRD2;ATG7;NCF2;FOXO3;RBM11;ZC3H12A;ERO1A;FOXO1;CYBA;PKD2;PPIA;NOX4;PRDX3;PRDX2
prerank,peptidyl-lysine modification (GO:0018205),0.27745012288510734,0.9119908636382931,0.6248313090418354,0.8271272262293055,1.0,20/99,17.16%,HDAC9;PIAS1;LOX;ATP7A;PIAS2;NSMCE2;VCPKMT;ESCO1;NUP133;NUP62;PLOD1;LOXL2;NUP98;EEF1AKMT3;EP300;USPL1;HDAC4;SENP1;NUP153;SENP6
prerank,mRNA stabilization (GO:0048255),-0.2677973176514925,-0.9119314619083362,0.6203208556149733,0.901927777747873,1.0,5/40,5.23%,TENT5C;FUS;TARDBP;HNRNPU;ELAVL4
prerank,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),0.30485173287498757,0.9118567345365626,0.5949764521193093,0.8269426818896225,1.0,10/52,12.56%,FBXW7;YWHAQ;SFN;BCL2;UBE2D3;TFDP1;CASP8;SREBF2;YWHAE;PPP1R13B
prerank,peptidyl-lysine dimethylation (GO:0018027),-0.325866112474274,-0.9117721051669627,0.5740740740740741,0.9012830601703631,1.0,4/18,8.76%,EHMT2;ASH1L;SETD4;SETD3
prerank,negative regulation of sequestering of calcium ion (GO:0051283),0.350764211767852,0.9116427966955668,0.5794066317626527,0.8268976471616043,1.0,9/24,22.14%,CCL19;TRPM2;ERO1A;IBTK;PKD2;ITPR3;F2R;PTPRC;PLCG2
prerank,positive regulation of organelle assembly (GO:1902117),-0.2661688084679254,-0.9115403878464392,0.6426592797783933,0.9008198194460602,1.0,16/44,24.02%,ASAP1;DYNC1H1;STX18;CROCC;CCP110;ENTR1;NUMA1;PIP4K2B;PIP4K2C;LRSAM1;KCTD17;RAB3GAP2;BBS4;G3BP1;TAPT1;PLK4
prerank,arachidonic acid secretion (GO:0050482),0.4145252993498265,0.9114283305916455,0.550561797752809,0.8263890888230689,1.0,1/10,4.93%,PNPLA8
prerank,arachidonate transport (GO:1903963),0.4145252993498265,0.9114283305916455,0.550561797752809,0.8263890888230689,1.0,1/10,4.93%,PNPLA8
prerank,positive regulation of cellular senescence (GO:2000774),-0.39311626595060284,-0.911397299431614,0.5879828326180258,0.9001311636524757,1.0,3/10,13.84%,ABI3;CGAS;YPEL3
prerank,bile acid biosynthetic process (GO:0006699),0.3442194136583892,0.9113849859416151,0.5655172413793104,0.8260029578714987,1.0,4/24,9.75%,OSBPL9;HSD3B7;CYP27A1;OSBPL1A
prerank,regulation of telomere capping (GO:1904353),-0.30708781963566223,-0.9113624561232253,0.5880952380952381,0.8991545813993859,1.0,5/23,13.29%,ATM;MAPK3;MAP2K7;TERF2;MAP3K4
prerank,positive regulation of nuclear division (GO:0051785),-0.30099361930447854,-0.9112992997569013,0.5736434108527132,0.8982476660838926,1.0,3/25,3.77%,TGFA;LRP5;IL1A
prerank,regulation of lymphocyte differentiation (GO:0045619),0.37356263318864547,0.9111736100030016,0.5586080586080586,0.8259794734617228,1.0,3/18,7.58%,ZFP36L2;ZFP36L1;CCR2
prerank,insulin secretion (GO:0030073),0.3627045928841685,0.9111695877649034,0.5505226480836237,0.8255165808958664,1.0,1/19,0.52%,RAB11FIP5
prerank,transcription elongation from RNA polymerase II promoter (GO:0006368),-0.2503163589436445,-0.9111186074361225,0.654434250764526,0.8976420932094769,1.0,15/62,15.63%,GTF2H2;CDK9;CCNT2;MLLT1;CCNH;SSRP1;NELFB;CTR9;ERCC2;PAF1;NELFCD;EAF1;POLR2C;NCBP1;ELOB
prerank,transition metal ion transport (GO:0000041),-0.28003379597640227,-0.9110464891146993,0.5978552278820375,0.8967804342152416,1.0,9/35,12.46%,ATOX1;TTYH1;TRPC4;TRPC1;SLC30A9;TRPC3;SLC11A2;TRPC5;ATP2C1
prerank,positive regulation of heterochromatin assembly (GO:0031453),0.4116533478648976,0.9106917339991597,0.5576208178438662,0.8260327068729728,1.0,2/11,6.31%,PPHLN1;SETDB2
prerank,positive regulation of glucose transmembrane transport (GO:0010828),0.3364460224960039,0.9105841826596252,0.5621970920840065,0.8257753533271941,1.0,6/26,14.84%,C1QTNF12;IRS2;INSR;IGF1;ARPP19;OSBPL8
prerank,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),0.2815513933747856,0.910357867994392,0.597457627118644,0.825769845517645,1.0,20/86,16.59%,KLF2;PSMA7;RPS27A;HMOX1;HIGD1A;CHEK1;BAG3;PSMB2;LIMD1;BACH1;CREBBP;PSMA6;HIF3A;EP300;PSMA3;PSMD1;PSMD5;ELOC;MAPK7;ARNT
prerank,chordate embryonic development (GO:0043009),0.29646303961380444,0.9102497460577597,0.5878084179970973,0.8255153893064023,1.0,12/55,14.70%,FGFR1;MBNL1;LIG4;BMP2;MYH6;GRHL2;ZNF568;SULF2;HINFP;TRIM71;RBP4;PKD2
prerank,positive regulation of RNA metabolic process (GO:0051254),0.3092991465766361,0.9102062479828866,0.5654853620955316,0.82513252781255,1.0,9/45,12.33%,EGFR;RIPK1;ERN1;NMD3;GRSF1;DYRK1A;HEATR1;ZC3H18;SLC38A2
prerank,response to ionizing radiation (GO:0010212),0.28773924225019076,0.9101597661067102,0.5853293413173652,0.8247648033494966,1.0,17/70,15.18%,LIG4;BABAM2;CLOCK;BRCC3;TOPBP1;MAPK14;COP1;NHEJ1;KDM4D;EEF1D;SPIDR;RHNO1;BRAT1;NET1;XRCC4;USP28;MYC
prerank,regulation of calcium-mediated signaling (GO:0050848),0.35108671322771934,0.9097652446253258,0.5658119658119658,0.8251479809976205,1.0,2/25,1.79%,CMKLR1;BST1
prerank,Golgi organization (GO:0007030),-0.22020633731037462,-0.9095899522757781,0.7105263157894737,0.8994017933153228,1.0,31/112,20.46%,PLEKHM2;CLASP2;OPTN;CSNK1A1;COG3;GCC2;ATP8B1;LYSMD3;PLK3;VTI1B;COG4;SURF4;STX16;ARFGEF1;DYNC2H1;NSFL1C;RAB2A;COG2;ARL1;TBC1D20;NPLOC4;TMED1;HUWE1;TMED7;TANGO2;GOLGA2;DNAJC28;BET1;GOSR2;BAG5;ZW10
prerank,positive regulation of glycogen metabolic process (GO:0070875),0.3940039108669289,0.9095727277792309,0.5886654478976234,0.8250571962190949,1.0,3/13,9.90%,IRS2;INSR;IGF1
prerank,regulation of multicellular organismal development (GO:2000026),0.34314524427745186,0.9094893442778115,0.574750830564784,0.8247433390137503,1.0,8/25,21.32%,OAS2;INSR;RAB14;CCSAP;EHMT1;TRIP12;RACGAP1;NIPBL
prerank,regulation of heart contraction (GO:0008016),0.2781514603469786,0.9092859387508722,0.5911602209944752,0.8246883316264306,1.0,18/90,14.90%,ATP2B1;FXYD2;S100A1;MYH6;PDE4D;TMEM65;STIM1;KCNG2;PLN;CALM1;KCNQ1;ATP2B4;ATP1A4;ATP1A3;ATP1A1;NPPC;ATP2A2;ITPR3
prerank,phosphatidylinositol biosynthetic process (GO:0006661),-0.21934460528681907,-0.9087711325465098,0.695852534562212,0.9004064983752357,1.0,24/119,15.13%,INPP4B;INPP5D;PIK3CB;PGAP2;PITPNM1;PIP5K1C;EFR3B;PLEKHA1;FGF2;PI4KA;SOCS2;PIK3R4;PITPNM3;SYNJ2;TTC7B;INPP5F;SOCS7;PIK3C2B;PIK3R5;MTMR4;MBOAT7;CDS1;PIP4K2B;PIP4K2C
prerank,phagosome-lysosome fusion (GO:0090385),0.4285114050378525,0.908648092345367,0.5823529411764706,0.8255366780662369,1.0,3/10,8.16%,PIKFYVE;RAB7A;RAB7B
prerank,regulation of calcium ion-dependent exocytosis (GO:0017158),-0.28625548155292496,-0.9081576830830935,0.5958549222797928,0.9008266112538368,1.0,14/31,33.95%,SCAMP5;SYT6;CBARP;SYT8;SYT1;SYT13;SYT7;SYT5;STXBP1;SYT17;CACNA1H;ADRA2A;STX1A;CACNA1G
prerank,positive regulation of axon extension (GO:0045773),0.3603355218220927,0.9079866691508983,0.5711892797319933,0.8264298386000605,1.0,1/22,0.34%,NRP1
prerank,male meiosis I (GO:0007141),0.37463941545246654,0.9073853774723287,0.5780141843971631,0.8271621499964561,1.0,2/16,9.21%,MOV10L1;FOXJ3
prerank,response to hydroxyurea (GO:0072710),0.40734850500469955,0.9072847325298442,0.6011904761904762,0.8269022518201716,1.0,4/11,13.82%,DDX11;ATRX;SPIDR;KAT7
prerank,negative regulation of DNA binding (GO:0043392),-0.2980143525660852,-0.9072203429948679,0.6070460704607046,0.9021072965881997,1.0,9/28,24.65%,JAK2;HABP4;JUN;MDFI;SMO;SOX11;ILRUN;LEF1;SIN3A
prerank,embryonic skeletal system development (GO:0048706),-0.2732599519460457,-0.9069731246542625,0.6153846153846154,0.9016299775437697,1.0,10/35,20.57%,KIAA1217;XYLT1;HOXC4;SULF1;HOXA3;DSCAML1;HOXB9;DYNC2I1;WNT5A;SOX11
prerank,positive regulation of vacuole organization (GO:0044090),0.41765096019034914,0.9067659630677558,0.5830039525691699,0.827489654497378,1.0,4/10,17.95%,GRN;ANXA2;RALB;PIP4K2A
prerank,mRNA 3'-end processing (GO:0031124),-0.23646112691965246,-0.9056848003400191,0.6688311688311688,0.903806354943471,1.0,24/78,21.56%,CPSF6;THOC1;SRRM1;SRSF5;PABPN1;DDX39B;SRSF3;RPRD1A;SRSF2;CSTF2;RNPS1;PAF1;U2AF1;UPF3B;CASC3;NCBP1;CLP1;SRSF11;THOC3;SRSF9;AHCYL1;POLDIP3;ALYREF;U2AF2
prerank,protein insertion into ER membrane (GO:0045048),0.3228147574602774,0.9055587877756239,0.5817307692307693,0.8294801591532697,1.0,6/37,12.58%,APP;HMOX1;SERP1;TRAM2;EMC7;VAPA
prerank,maintenance of protein localization in endoplasmic reticulum (GO:0035437),-0.37147137628490867,-0.9055200935706629,0.6008492569002123,0.9031917476455803,1.0,3/12,23.42%,GPAA1;ANKRD13C;TAPT1
prerank,regulation of phospholipid metabolic process (GO:1903725),0.42305885289443224,0.9055162496498282,0.5655737704918032,0.8290866989957526,1.0,3/10,16.40%,MTMR3;MFSD2A;MTMR1
prerank,nucleosome assembly (GO:0006334),0.3280202002570724,0.9053961831646585,0.5687789799072643,0.8288786143426279,1.0,11/31,22.30%,PADI4;ATRX;H3-3A;HAT1;ANP32B;ASF1A;IPO4;NAP1L2;CHAF1B;GRWD1;NPM1
prerank,embryonic skeletal system morphogenesis (GO:0048704),-0.2820861700763634,-0.9053902694682242,0.6053333333333333,0.9024720103840445,1.0,9/31,20.57%,TGFBR1;HOXC4;FGFR2;TGFBR2;HOXA3;DSCAML1;HOXB9;DYNC2I1;SOX11
prerank,negative regulation of dephosphorylation (GO:0035305),0.3610617606796464,0.9052611138869154,0.5817223198594025,0.8286768453603922,1.0,3/18,11.42%,MFHAS1;PPP1R26;ARPP19
prerank,negative regulation of neuron differentiation (GO:0045665),0.3434008739057885,0.9050903863329501,0.5658783783783784,0.8285542969457576,1.0,2/22,4.76%,B2M;GSK3B
prerank,chaperone cofactor-dependent protein refolding (GO:0051085),-0.29572352675972824,-0.9049877666088249,0.6203473945409429,0.9024017354800565,1.0,12/25,34.20%,DNAJC7;PTGES3;SDF2;DNAJB14;DNAJB1;DNAJB5;HSPA9;DNAJC18;DNAJB13;SDF2L1;HSPA1A;HSPA1B
prerank,regulation of cellular response to stress (GO:0080135),0.2653346801463784,0.9048326035333375,0.6243386243386243,0.8286128586026247,1.0,21/115,12.62%,ALOX5;NUPR1;CEBPB;PRKN;MCL1;GSK3B;MAPKAPK2;MANF;BAG3;RPA1;NUP133;NUP62;HSBP1;AMFR;CREBBP;CRYAB;YWHAE;ROCK2;SLC38A2;RPA3;NUP98
prerank,aminoglycan biosynthetic process (GO:0006023),-0.2546351792267401,-0.9048187289283721,0.6417910447761194,0.9017315964820135,1.0,21/49,26.33%,XYLT1;GCNT2;HS3ST5;HS6ST1;B3GALT1;SDC2;B3GALT5;B3GALT2;HS3ST3B1;B3GNT2;B4GALT7;GPC6;PXYLP1;GPC2;GPC5;UGDH;B3GALT6;GPC1;HSPG2;HS3ST1;HAS1
prerank,"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",-0.3960564136248722,-0.904582479880997,0.599609375,0.9012651654117722,1.0,3/10,23.94%,NCKAP1L;TGFBR2;CD81
prerank,kidney development (GO:0001822),-0.24321224664558716,-0.9043813174893248,0.5868055555555556,0.9007161839362695,1.0,10/65,12.71%,TGFBR1;SALL1;ROBO2;NF1;IFT88;SULF1;BAG6;VANGL2;PAX8;PROX1
prerank,regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),0.34815893154568944,0.9043452051720967,0.5735294117647058,0.829142948305643,1.0,3/23,5.38%,SMURF2;SMAD4;TRIM33
prerank,L-serine metabolic process (GO:0006563),0.42599017871191613,0.9043228615002241,0.5613382899628253,0.8287140115980831,1.0,5/10,23.92%,SERINC3;SHMT1;SERINC5;SRR;PSPH
prerank,supramolecular fiber organization (GO:0097435),0.2420363903621736,0.9042418782902952,0.7109111361079865,0.8284171174582479,1.0,62/333,16.01%,HIP1;TGFBI;APP;MYO5A;ITM2B;FLII;RPS27A;TMOD1;MTM1;RIPK1;FIGNL2;SIAH2;CD36;MYH6;DPT;CDC42;RHOA;B2M;PRKN;VIM;LOX;TMOD3;USP9X;ATP7A;KATNAL2;MYO7A;ARHGAP12;VPS4B;COL22A1;COL9A2;RHOBTB1;MFAP4;DDR2;TUBGCP2;MDM2;COL14A1;CORO1C;H3-3A;MYO1E;MYO1C;PXDN;EMILIN1;ARHGAP17;PLOD1;LOXL2;CORO7;RND3;COL24A1;KATNAL1;P4HA2;TPM3;PCM1;TNXB;RHOC;CGNL1;KLHL24;ELMO3;STMN1;TSPAN14;NCSTN;MARCKSL1;HSP90AB1
prerank,regulation of coagulation (GO:0050818),-0.38472783551818723,-0.9041356132019337,0.5991820040899796,0.9002764452349209,1.0,3/11,26.62%,HS3ST5;EPHB2;PROCR
prerank,zinc ion transport (GO:0006829),-0.3156252204081653,-0.903971154713238,0.5855421686746988,0.8996372737209358,1.0,8/21,31.65%,SLC30A9;SLC39A11;SLC39A13;SLC39A14;SLC39A6;SLC39A1;SLC30A3;SLC39A7
prerank,histone H2A acetylation (GO:0043968),-0.34058440911646926,-0.9033196744127141,0.5897435897435898,0.90022728265044,1.0,5/16,14.67%,MORF4L2;NAA40;BRD8;MORF4L1;RUVBL1
prerank,fatty acid elongation (GO:0030497),0.394675142553193,0.9033138809621991,0.5547309833024119,0.829870437827226,1.0,2/13,7.30%,HACD4;ELOVL5
prerank,V(D)J recombination (GO:0033151),0.4144036497507757,0.9031542250842897,0.5521235521235521,0.8297228021929622,1.0,2/11,13.41%,LIG4;XRCC4
prerank,regulation of hematopoietic progenitor cell differentiation (GO:1901532),0.28270437643286095,0.9027663303970859,0.6200873362445415,0.8300698060331351,1.0,11/73,14.43%,KMT2A;PSMA7;TCF12;KITLG;SPI1;CBFB;PSMB2;PSMA6;PSMA3;PSMD1;PSMD5
prerank,regulation of sister chromatid cohesion (GO:0007063),-0.37031939827070226,-0.9024963429344256,0.5883668903803132,0.9012108302548314,1.0,2/12,2.27%,CTNNB1;HDAC8
prerank,phospholipid biosynthetic process (GO:0008654),0.32010108260966363,0.9022034724268109,0.6029654036243822,0.8307315653809996,1.0,7/36,10.36%,SGMS1;CPNE7;AGPAT5;DOLPP1;PIP5K1A;HDHD5;NUS1
prerank,xenobiotic transport (GO:0042908),0.37271986252615985,0.901689052956407,0.5797872340425532,0.8313031056217599,1.0,3/17,13.10%,SLC22A18;ABCC1;GJA1
prerank,chemical homeostasis (GO:0048878),0.2910507457905814,0.9016888375273167,0.5889830508474576,0.8308353700509388,1.0,7/61,7.77%,FBXW7;ZBTB20;IRS2;PNPLA8;WNK1;SLC4A4;SLC4A5
prerank,endosome transport via multivesicular body sorting pathway (GO:0032509),-0.31105975434061495,-0.9011488305420683,0.6264775413711584,0.9034129613041919,1.0,4/25,6.32%,LYST;SORT1;CHMP4B;CHMP4A
prerank,metanephros development (GO:0001656),-0.29348116813227587,-0.9005286687136452,0.6151761517615176,0.9039520534710253,1.0,3/26,5.52%,BASP1;ROBO2;NF1
prerank,cellular response to UV (GO:0034644),0.2774778773045086,0.9005090472297811,0.5943262411347517,0.8327576620866957,1.0,18/76,16.18%,CRIP1;RPL26;RHBDD1;PTPRK;CHEK1;YY1;MFAP4;CARD16;RHNO1;CREBBP;XPA;XPC;EP300;USP28;MYC;USP47;KDM1A;ATR
prerank,mitochondrion organization (GO:0007005),0.25538228777799293,0.9002951746526825,0.645398773006135,0.8327084821152881,1.0,36/165,21.09%,PID1;IMMP2L;MEF2A;MTM1;PRKN;ATP7A;HIGD1A;PITRM1;NIPSNAP2;FMC1;CYCS;COX7A2L;CHCHD3;POLG2;MTX1;VPS13C;RAB5IF;MGME1;PYROXD2;TRAK2;HCFC1;RAB32;PRDX3;BNIP3;TMEM11;MFF;LONP1;SLC25A4;GABPB1;SLC25A36;DNM1L;TRAK1;ADCK1;PISD;AIFM1;MTX2
prerank,spliceosomal snRNP assembly (GO:0000387),-0.27748472667002433,-0.900094909039182,0.5994318181818182,0.9039608108116203,1.0,20/38,36.29%,GEMIN2;SRSF10;DDX20;CD2BP2;PRPF19;SRSF12;TGS1;STRAP;PRPF6;SART1;SART3;PRPF31;AAR2;SNUPN;SNRPC;SNRPF;SNRPD3;GEMIN6;GEMIN5;PRMT7
prerank,positive regulation of regulated secretory pathway (GO:1903307),-0.3341234521502751,-0.8994811619719036,0.6060606060606061,0.9044434771358882,1.0,3/17,7.54%,NLGN1;RAB27A;SCAMP5
prerank,regulation of primary metabolic process (GO:0080090),0.26301808176219404,0.8991015789162383,0.6280254777070063,0.8346504794747824,1.0,21/126,14.43%,APOE;LDLR;PSMA7;NCOA2;NR1D1;HMGCR;IRS2;PSMB2;TBL1XR1;NCOR1;NCOA6;TBL1X;PMVK;SP1;SREBF2;CREBBP;PSMA6;ROCK2;PSMA3;PSMD1;PSMD5
prerank,gonad development (GO:0008406),-0.2697579508774689,-0.8990882861839601,0.6005747126436781,0.9043608114524895,1.0,10/41,21.47%,SALL1;BASP1;AR;NCOA4;WNT4;MSH2;TGFB2;COL9A3;WNT5A;MKKS
prerank,"regulation of synaptic transmission, glutamatergic (GO:0051966)",0.306354655934587,0.8989826907927932,0.6112852664576802,0.8343796482773735,1.0,8/46,8.50%,OPHN1;MEF2C;TSHZ3;DRD1;TNF;CCR2;HOMER1;MAPK8IP2
prerank,tRNA processing (GO:0008033),-0.24873580865201675,-0.8986675508599494,0.6780185758513931,0.9044094009548306,1.0,34/61,34.37%,AARS1;QTRT1;TRDMT1;PTCD1;CSTF2;TRNT1;SARS1;ANKRD16;POP1;DDX1;QTRT2;TRMT9B;FAM98B;CLP1;RPP21;METTL1;THUMPD1;CTU2;RTCB;AARS2;TSEN54;TRMT10B;TSEN15;POP7;THG1L;KARS1;ADAT2;PUS3;TRPT1;TRMT6;DTWD1;ADAT1;SSB;NSUN6
prerank,regulation of blood circulation (GO:1903522),0.32030583158650067,0.8979507509056598,0.5802469135802469,0.8359925669672138,1.0,5/34,11.86%,S100A1;MYH6;KCNG2;PLN;KCNQ1
prerank,3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),0.3614778346500387,0.897840363968013,0.5565068493150684,0.8357525992624736,1.0,4/19,13.72%,SULT1A1;PAPSS2;SLC35B3;SULT6B1
prerank,protein import (GO:0017038),0.2741547974409101,0.8973411010103157,0.6027972027972028,0.8362669983396918,1.0,12/84,11.69%,APOE;PRICKLE1;RAB8B;SLC25A17;PXMP2;SYK;PEX26;IPO11;NUP133;LAMP2;NUP62;SNX33
prerank,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.28543318997917805,0.8971373624863594,0.6133720930232558,0.8362075947001836,1.0,23/60,24.20%,TCF7L2;CEBPB;HEY2;CBFB;MED16;MED20;MED6;MED26;MED15;TNRC6C;MED27;PTEN;MED17;RELA;IL6;MECP2;MED14;NFKB1;MED7;MED24;AGO3;CCND1;SUB1
prerank,regulation of trophoblast cell migration (GO:1901163),0.3894215850274646,0.8971153350580351,0.5775401069518716,0.8357845565436711,1.0,3/14,14.86%,SMURF2;GJA1;ARHGDIB
prerank,positive regulation of triglyceride metabolic process (GO:0090208),0.37068854022749814,0.8969010173602868,0.5797872340425532,0.8357483209774491,1.0,5/16,20.76%,LDLR;NR1H2;MFSD2A;CNEP1R1;ABHD5
prerank,protein import into mitochondrial matrix (GO:0030150),-0.3235670308618459,-0.8967017871412836,0.6014851485148515,0.9082192370333845,1.0,6/18,20.49%,TIMM44;TOMM40;GRPEL1;TOMM20;TOMM40L;TIMM21
prerank,cardiac ventricle development (GO:0003231),0.3559654196827614,0.8966752267599539,0.5608465608465608,0.8357403488152592,1.0,4/20,10.70%,PDE2A;HEY2;TMEM65;DAND5
prerank,neuromuscular process (GO:0050905),-0.33895392770100524,-0.8966717532655661,0.5924276169265034,0.9072413206935285,1.0,7/16,23.96%,NRXN1;CLN3;SHANK1;KCNA1;TPP1;UBA5;DCTN1
prerank,lamellipodium assembly (GO:0030032),0.33553396697550025,0.8966107861215135,0.5918367346938775,0.8354101052165157,1.0,11/26,24.02%,ITGB1;VCL;S1PR1;PARVB;SPEF1;GOLPH3;ARFIP2;ARHGEF6;KIT;PTPRO;CCDC88A
prerank,positive regulation of hormone secretion (GO:0046887),0.36247070854517455,0.8965501192408124,0.5813528336380256,0.8350682347379694,1.0,6/17,20.37%,C1QTNF3;HFE;TFR2;SNX4;VAMP8;NMB
prerank,negative regulation of DNA-dependent DNA replication (GO:2000104),0.4010225283633284,0.8963641191286797,0.5981308411214953,0.8350073024879422,1.0,4/11,15.81%,TIPIN;GMNN;ZRANB3;FBH1
prerank,acidic amino acid transport (GO:0015800),-0.33186417795919976,-0.8962975260070096,0.6008771929824561,0.9071397751065322,1.0,7/17,26.44%,SLC1A3;SLC1A1;SLC25A22;SLC6A1;SLC1A2;SLC25A13;GIPC1
prerank,striated muscle contraction (GO:0006941),-0.25374744590418447,-0.8962921165915949,0.6510903426791277,0.9061191371814025,1.0,7/53,7.31%,ATP1B1;SCN1B;SLC8A1;ALDOA;GRK2;DTNA;GAA
prerank,chromosome organization (GO:0051276),-0.2245150473618863,-0.8962826642472088,0.7301587301587301,0.9051118410144476,1.0,34/99,22.31%,LDB1;HDAC8;CUL4A;SAFB;BRWD1;COPS7A;FAM50A;PARP1;COPS8;GATAD1;DDB2;RBX1;DOT1L;COPS4;HDAC11;LRWD1;HMGN1;HDAC5;TOP2A;PADI2;COPS6;NDC80;GPS1;MSH2;PHF1;HDAC3;CDCA8;UBB;CENPV;HDAC1;MTF2;CENPH;BAHD1;HMGN2
prerank,cation transport (GO:0006812),-0.2062439827822965,-0.8962281542856636,0.7337278106508875,0.9042249861930249,1.0,27/167,16.85%,KCNMA1;SLC12A2;KCNJ2;ATP1B1;SLC8A1;SLC36A1;SGK1;TRPM3;FGF13;CLN3;PIEZO1;SLC38A7;KCNA1;SLC36A4;KCNA2;SLC11A2;SLC1A1;SLC7A8;SCN8A;PIEZO2;TMEM63C;KCNS3;SCN1A;KCNK9;KCNN2;ABCC9;KCNK6
prerank,positive regulation of protein transport (GO:0051222),0.2801365021316293,0.8957522614451979,0.6216216216216216,0.8357942268053158,1.0,16/67,14.92%,KIF20B;ANG;EXPH5;ADAM9;RACK1;TMED10;TNF;GOLPH3L;CD33;IGF1;ACSL3;PCNT;ACHE;BCAS3;PCM1;PPIA
prerank,membrane assembly (GO:0071709),-0.2774512757958043,-0.8956824241571564,0.6392572944297082,0.904521399542698,1.0,9/34,15.04%,PTPRD;NLGN1;NRXN1;FLOT1;CHMP4B;TLCD2;NSFL1C;IL1RAPL1;STX2
prerank,cellular response to acid chemical (GO:0071229),-0.2915321270046808,-0.8956790871797743,0.6119402985074627,0.9035043369211603,1.0,12/27,27.37%,RPTOR;IPO5;NSMF;RRAGD;GLRA1;RRAGB;MTOR;SESN2;GLRA2;CPEB1;RRAGA;SH3BP4
prerank,negative regulation of interleukin-1 beta production (GO:0032691),0.35701002881119476,0.8956451437976533,0.559931506849315,0.8355293620882823,1.0,6/19,13.56%,GHRL;CD33;CARD16;IGF1;ZC3H12A;FFAR1
prerank,protein processing (GO:0016485),-0.2175416745212739,-0.8953589857155394,0.7232142857142857,0.9032430327951055,1.0,21/102,17.76%,KLK2;LGMN;CLN3;VSIR;CTSS;APH1A;ADAMTS3;HTRA2;F3;MMP16;FXN;SEC11C;AFG3L2;AEBP1;SPCS1;EEF1AKMT4-ECE2;TYSND1;ADAM10;CPM;CPE;FURIN
prerank,positive regulation of leukocyte degranulation (GO:0043302),0.3971698393237901,0.8951529348919277,0.5844402277039848,0.8360625603135554,1.0,3/13,14.16%,LAMP1;SYK;ITGB2
prerank,cellular response to cadmium ion (GO:0071276),0.33860742063621835,0.8951226008939265,0.5940099833610649,0.835663857724317,1.0,1/24,0.45%,EGFR
prerank,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),0.35930927541658986,0.8948092082383918,0.5885416666666666,0.8358550382318551,1.0,3/18,10.32%,GSK3B;ZNF205;SLC25A5
prerank,error-prone translesion synthesis (GO:0042276),0.3545523265509427,0.8942214660802063,0.5844594594594594,0.8365717836215741,1.0,5/21,12.34%,RPS27A;POLE2;RPA1;POLH;RPA3
prerank,selective autophagy (GO:0061912),0.28879507328623594,0.8941916176268799,0.6208869814020028,0.8361692834892177,1.0,14/56,16.21%,WDFY3;RPS27A;PRKN;VIM;ULK2;RAB7A;PCNT;DYNC1I2;UFM1;UBE2N;AMBRA1;RB1CC1;TEX264;ATG5
prerank,regulation of myoblast differentiation (GO:0045661),0.3230194351303558,0.8940920533029927,0.6044142614601019,0.8358979326968627,1.0,3/32,3.70%,RIPOR2;MEF2C;ZFP36L1
prerank,dicarboxylic acid metabolic process (GO:0043648),0.29400422606962434,0.8937485972523262,0.615727002967359,0.8361476090203114,1.0,12/52,20.78%,FOLR2;MTHFD2L;SDHA;ASS1;GCLM;SHMT1;IDH1;OGDH;IDH2;MTHFD1L;ME1;ACLY
prerank,respiratory chain complex IV assembly (GO:0008535),-0.31482722588578643,-0.8931926770448048,0.6019184652278178,0.9074052910145061,1.0,13/21,42.30%,COX19;COX15;COX16;FASTKD3;TIMM21;COX17;COA6;COX14;COA3;OXA1L;SURF1;COX20;COX18
prerank,sulfur compound transport (GO:0072348),0.33818855240466383,0.8930449057080961,0.5844155844155844,0.8370879414751969,1.0,11/27,21.84%,LRRC8D;SLC26A11;MGST1;SLC26A7;SLC25A30;SLC6A6;SLC5A6;SLC35F3;RACGAP1;SLC13A4;SLC26A8
prerank,positive regulation of peptidase activity (GO:0010952),0.35167172353986903,0.8925766534465388,0.5996503496503497,0.8375964547048581,1.0,2/20,3.26%,RCN3;GRN
prerank,glycosaminoglycan metabolic process (GO:0030203),0.29080916919823957,0.8919038710504907,0.6253731343283582,0.8384396609538181,1.0,10/54,15.07%,HGSNAT;EXT1;CLN6;SDC3;HS3ST2;SDC4;HS3ST3A1;XYLT2;GPC3;HEXA
prerank,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),0.3133630448877934,0.8915467215718257,0.5930232558139535,0.8386576148553673,1.0,10/33,15.93%,ESR1;NCOA2;AXIN1;CBFB;TRIM68;H3-3A;RNF14;UFM1;EP300;KDM1A
prerank,outflow tract septum morphogenesis (GO:0003148),0.34217701891176117,0.8913492396288046,0.5860215053763441,0.8385957597760539,1.0,2/24,5.19%,NRP1;SMAD4
prerank,positive regulation of RNA splicing (GO:0033120),-0.27816831098685035,-0.8909541456441518,0.6308068459657702,0.911640819214717,1.0,8/29,14.75%,SETX;NCL;HNRNPLL;CELF4;HABP4;CIRBP;NCBP1;RBMXL1
prerank,"nucleotide-excision repair, DNA gap filling (GO:0006297)",0.33928314562316014,0.890853392740735,0.5844594594594594,0.8390725849558641,1.0,7/24,20.20%,LIG4;RPS27A;RPA1;RPA3;RFC3;POLD2;PCNA
prerank,central nervous system myelination (GO:0022010),-0.37986386949264245,-0.8908490323564994,0.5873983739837398,0.9108809086242944,1.0,3/11,11.32%,PLP1;TENM4;SOX10
prerank,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.2775423015715051,0.8902920376060727,0.620933521923621,0.839711682945171,1.0,11/72,9.90%,FGFR1;LYN;CBL;IRS2;INSR;PDGFRA;TNF;GAB1;PDGFC;MYDGF;IGF1
prerank,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.2868333110968181,0.8901536557068594,0.6028169014084507,0.8395234537824299,1.0,8/62,8.74%,TPT1;PRKN;MCL1;BCL2L2;TRIM32;BCL2;HSPB1;MDM2
prerank,regulation of blood coagulation (GO:0030193),0.33645118611122665,0.8898581529795507,0.5980392156862745,0.8396416826407584,1.0,6/27,18.04%,APOE;ENPP4;ST3GAL4;TFPI;FAP;F2R
prerank,positive regulation of macrophage chemotaxis (GO:0010759),-0.3421094635111717,-0.8897548227226074,0.5938189845474614,0.9125060607041618,1.0,4/14,10.35%,CSF1;MAPK3;AKIRIN1;CSF1R
prerank,positive regulation of telomere capping (GO:1904355),-0.31994036240283574,-0.88964264375781,0.6415929203539823,0.9117449000440411,1.0,3/17,13.29%,MAPK3;MAP2K7;MAP3K4
prerank,cellular response to interleukin-1 (GO:0071347),0.25329825875489875,0.8893600170077898,0.6691635455680399,0.8401601764586523,1.0,48/143,25.22%,GBP3;PSMA7;IRAK3;RPS27A;CCL8;NR1D1;CCL19;PELI1;RC3H1;CD40;MAP3K8;PSMB2;CCL24;SFRP1;RIPK2;PSMA6;MAP3K3;ZC3H12A;NOD2;UBE2N;PSMA3;PSMD1;PSMD5;TAB3;CCL5;RELA;ACOD1;CCL25;TRAF6;IRAK4;TOLLIP;HAS2;PSMD2;CCL14;PSMD11;PSMB9;NFKB1;CD47;IL1R1;TANK;MAPK11;PSMB4;UBC;PSMD10;DAB2IP;MYD88;PSME4;FBXW11
prerank,negative regulation of catalytic activity (GO:0043086),-0.2991462975018322,-0.8891963028723029,0.6143958868894601,0.9117665518140267,1.0,14/24,35.99%,TP53;CLN3;NOSIP;CCAR2;NOTCH1;PARP9;HDAC6;TMBIM1;PHPT1;CAND1;SIRT1;TIMP1;OXA1L;HP
prerank,steroid metabolic process (GO:0008202),0.2775468497364111,0.8891928723757705,0.6384839650145773,0.8400413750910692,1.0,8/72,9.99%,UGT1A7;UGT1A8;UGT1A1;CYP27A1;SULT1A1;CYP26C1;HSD17B7;CYP26B1
prerank,androgen metabolic process (GO:0008209),-0.3221811969124471,-0.8889211551699993,0.6184834123222749,0.9113802170074816,1.0,13/18,51.30%,SPP1;SRD5A3;HSD17B10;HSD17B11;DHRS9;SHH;SRD5A2;MED1;HSD3B2;HSD17B3;AKR1D1;CYP19A1;HSD17B4
prerank,peptidyl-threonine phosphorylation (GO:0018107),-0.24327686434061258,-0.8888038834783776,0.6802325581395349,0.9106475957467858,1.0,20/59,22.19%,TGFBR1;PRKCD;ACVR1;CDC42BPA;CIT;MAP3K12;DYRK2;WNK3;PDPK1;CDC42BPB;DYRK1B;TGFBR2;CDK10;ACVR1B;ULK1;HIPK1;CAMK2D;MAPK8;TAF1;DYRK4
prerank,posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),-0.36515174447809895,-0.8881406670573576,0.6038543897216274,0.9111258359605829,1.0,5/12,25.31%,CHMP4B;CHMP4A;SEC61A1;SEC61B;SGTA
prerank,macrophage activation involved in immune response (GO:0002281),0.38481663710267633,0.8879881504199566,0.5763016157989228,0.8419858715903994,1.0,3/13,6.57%,GRN;LBP;SYK
prerank,chondrocyte differentiation (GO:0002062),0.32341033022525456,0.8879470499538278,0.6054421768707483,0.841607403545611,1.0,3/32,2.60%,MEF2C;OSR1;BMP2
prerank,response to hexose (GO:0009746),-0.2973527371338246,-0.8877701373345555,0.5990338164251208,0.9110119000333647,1.0,5/25,7.13%,PFKL;SELENOT;EIF2B3;LPL;SLC2A5
prerank,"regulation of DNA-templated transcription, initiation (GO:2000142)",0.27940926116297937,0.8876665213190228,0.631578947368421,0.8417010731747948,1.0,23/59,23.58%,TCF7L2;CEBPB;MITF;CBFB;MED16;MED20;MED6;MED26;MED15;TNRC6C;MED27;PTEN;MED17;RELA;IL6;THRA;MECP2;MED14;NFKB1;MED7;MED24;AGO3;CCND1
prerank,"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",0.38624608758906864,0.8876066111417487,0.6051188299817185,0.8413545314992619,1.0,2/13,3.58%,SPRED1;RPL26
prerank,regulation of endopeptidase activity (GO:0052548),0.28944682980008635,0.8875876078252255,0.6242690058479532,0.840926783969366,1.0,3/59,4.77%,SERPINB8;SERPINB2;BIRC3
prerank,positive regulation of rRNA processing (GO:2000234),-0.37820486879385984,-0.8870980987115921,0.6242038216560509,0.9116532839818087,1.0,3/10,15.66%,SIRT7;WDR75;RIOK2
prerank,chromatin assembly (GO:0031497),0.31422792266482574,0.8869051272494108,0.6054313099041534,0.8418242857164853,1.0,12/38,22.30%,PADI4;ATRX;LIN54;H3-3A;POLE3;ANP32B;ASF1A;CTCF;NAP1L2;CHAF1B;GRWD1;NPM1
prerank,protein import into peroxisome matrix (GO:0016558),-0.36225098849131376,-0.8866154450419451,0.5957894736842105,0.9118255411834048,1.0,3/12,11.85%,PEX5L;PEX6;PEX10
prerank,DNA replication-independent nucleosome assembly (GO:0006336),-0.2694967015521055,-0.8864179193659115,0.6620498614958449,0.9112282925948338,1.0,12/38,21.91%,CENPC;UBN1;NASP;KNL1;MIS18BP1;RUVBL1;CENPX;ASF1B;CABIN1;CENPP;CENPN;CENPH
prerank,positive regulation of keratinocyte differentiation (GO:0045618),0.4067786482066411,0.8862137429431381,0.6143410852713178,0.8427828084300147,1.0,2/10,10.61%,NCOA3;TRIM16
prerank,iron ion transmembrane transport (GO:0034755),-0.37906162256709003,-0.8862116156854868,0.6206896551724138,0.9106598795421247,1.0,3/10,15.86%,SLC40A1;SLC11A2;SLC39A14
prerank,vesicle transport along actin filament (GO:0030050),0.35393336219368865,0.8862062869840073,0.5866425992779783,0.8423337324129129,1.0,5/19,14.11%,MYO5A;MYO7A;MYO1E;MYO1C;WASL
prerank,cell junction organization (GO:0034330),0.2804455632035873,0.8861842109733545,0.6306179775280899,0.8419152361483744,1.0,8/71,5.71%,APP;C1QA;OPHN1;CDC42;RAB8B;RHOA;GRHL2;ACTB
prerank,alpha-amino acid catabolic process (GO:1901606),-0.2829219569298224,-0.8858454664111995,0.6506666666666666,0.9104823239777194,1.0,10/29,23.50%,KYNU;ACADSB;FAH;IL4I1;ALDH4A1;SARDH;PRODH;HSD17B10;HOGA1;MTRR
prerank,mitochondrial RNA metabolic process (GO:0000959),-0.3398087539554201,-0.8855667397072052,0.6188340807174888,0.9101326360778028,1.0,9/14,33.11%,FASTKD1;TFB2M;MTERF2;TFAM;SLC25A33;MRPL12;TFB1M;PNPT1;FASTKD5
prerank,negative regulation of protein dephosphorylation (GO:0035308),0.34137451627397314,0.8855627849178465,0.6003616636528029,0.8426864066056874,1.0,4/21,11.84%,MFHAS1;GSK3B;ARPP19;YWHAE
prerank,N-terminal protein amino acid acetylation (GO:0006474),-0.3327948488957261,-0.8853304527861453,0.5904139433551199,0.9096515339251628,1.0,6/16,23.50%,NAA40;NAA60;NAA35;NAA25;NAA80;NAA30
prerank,T cell mediated immunity (GO:0002456),0.37834961668217476,0.8852786471674639,0.5674676524953789,0.842801463818194,1.0,2/13,3.41%,JAG1;CD46
prerank,response to cadmium ion (GO:0046686),0.3313025385309608,0.8852409082796491,0.5926544240400667,0.8424116694719817,1.0,1/26,0.45%,EGFR
prerank,"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",0.3715873777647655,0.8849295389848745,0.6139705882352942,0.8426020946601915,1.0,5/15,13.46%,NYNRIN;LACTB2;ZC3H12A;ZC3H12D;RPP30
prerank,glycine transport (GO:0015816),-0.3895427107892814,-0.8847533138615999,0.5906313645621182,0.9099588608664145,1.0,2/10,11.34%,SLC36A1;SLC7A8
prerank,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",-0.26758199061571275,-0.884690648334858,0.6537396121883656,0.9091028643042899,1.0,11/38,22.10%,NDUFS7;NDUFV3;NDUFAF1;NDUFB8;NDUFB7;NDUFV1;NDUFB10;NDUFA8;NDUFA10;NDUFAB1;NDUFS1
prerank,plasma membrane bounded cell projection organization (GO:0120036),0.2605490073346988,0.884581701130033,0.6927016645326505,0.8428240790310632,1.0,14/124,6.22%,APOE;APP;OPHN1;LYN;RAPGEF2;EHD1;LRP12;TTC29;GSK3B;RB1;ROCK1;FRY;MANF;BLOC1S5
prerank,peptidyl-serine modification (GO:0018209),-0.20520807668034985,-0.8845405774835488,0.8118279569892473,0.9084322328874642,1.0,31/166,13.66%,TGFBR1;PRKCD;CSNK1E;MAST4;PRKCE;GALNT3;SGK1;CSNK1A1;GRK2;ATM;STK38L;RPS6KA1;HPF1;PARP1;PDK3;GALNT13;CAMK4;MAP3K12;DYRK2;DCLK3;CDC7;NEK6;SRPK2;RPS6KA2;PDPK1;IKBKE;AKT3;NDNF;DYRK1B;TGFBR2;MAP4K1
prerank,mitotic nuclear division (GO:0140014),0.28153882299196653,0.8843316633973742,0.6282051282051282,0.8428782469645446,1.0,16/71,20.13%,EPS8;PIBF1;RHOA;STAG2;CLASP1;NUP62;STAG1;SPICE1;RAB11A;ABRAXAS2;CENPK;CCDC61;SMC4;KPNB1;NDEL1;CTDP1
prerank,defense response to tumor cell (GO:0002357),0.4110416323487303,0.884126201039386,0.583180987202925,0.8428224643542837,1.0,3/10,7.22%,DAPK1;SPI1;KLF4
prerank,positive regulation of alpha-beta T cell differentiation (GO:0046638),0.3891577975000623,0.8840195114752928,0.5893536121673004,0.8425764474192735,1.0,2/13,5.69%,NKAP;CBFB
prerank,negative regulation of TORC1 signaling (GO:1904262),-0.3522550825534762,-0.8837360062040847,0.627906976744186,0.9092516879056786,1.0,4/13,8.53%,STK11;ATM;SESN3;CASTOR2
prerank,vacuolar acidification (GO:0007035),0.3410625377300288,0.8836998682732506,0.6040609137055838,0.8427351497411215,1.0,5/21,6.12%,GRN;CLN5;CLN6;ATP6V0A1;DMXL1
prerank,nerve growth factor signaling pathway (GO:0038180),0.40555338820159453,0.8836509126686082,0.5761467889908257,0.8423615515436271,1.0,2/10,4.84%,RAPGEF2;RAP1A
prerank,positive regulation of glycoprotein biosynthetic process (GO:0010560),-0.36306432601092753,-0.8833456735183414,0.5788288288288288,0.9091792993563674,1.0,5/13,20.27%,IL33;RAMP1;PLCB1;GOLGA2;ABCA2
prerank,anterograde axonal transport (GO:0008089),-0.26736010081499756,-0.8830664076829625,0.6789772727272727,0.908889182420162,1.0,9/37,14.09%,DLG2;KIF1A;KIF5A;KIF5C;AP3B2;AP3D1;KIF1C;KIF3A;KIF3B
prerank,peripheral nervous system development (GO:0007422),0.34258070774503535,0.8828414555277515,0.5969387755102041,0.8435592422467011,1.0,3/23,5.95%,ADGRG6;PMP22;GFRA3
prerank,copper ion homeostasis (GO:0055070),0.3677110593781955,0.8825241279187197,0.6252220248667851,0.8437306264531035,1.0,2/17,5.58%,APP;ATP7A
prerank,very long-chain fatty acid biosynthetic process (GO:0042761),0.3890121054669858,0.8823915040113568,0.5925233644859813,0.8435240290917307,1.0,3/13,13.47%,HACD4;ELOVL5;TECRL
prerank,transferrin transport (GO:0033572),0.3188507052994428,0.8823757568623496,0.63125,0.8430946168340139,1.0,6/33,8.32%,CLTC;STEAP3;ATP6V1B1;ATP6V0A1;HFE;ATP6V1A
prerank,negative regulation of transcription regulatory region DNA binding (GO:2000678),0.3893287846358084,0.882318039233203,0.6006655574043261,0.8427434898957783,1.0,2/13,7.76%,HEY2;PSEN1
prerank,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",-0.29929784460669207,-0.8816451235141575,0.6264775413711584,0.911255205724215,1.0,6/22,11.18%,THOC1;DDX39B;CCNT2;ERCC6;TCERG1;HMGN1
prerank,recombinational repair (GO:0000725),0.27566472154245497,0.8812863084504056,0.6304985337243402,0.8443488001192132,1.0,20/77,15.90%,RBBP8;MCM9;NSMCE2;YY1;RPA1;RAD52;KDM4D;SPIDR;RHNO1;RPA3;AP5S1;UBE2N;SFR1;MMS22L;SEM1;RAD51B;SAMHD1;SFPQ;FBH1;MCM8
prerank,regulation of neuron migration (GO:2001222),0.3348410971658437,0.8809427959197277,0.6003316749585407,0.8445561074690447,1.0,3/26,3.92%,KIF20B;TNN;RAPGEF2
prerank,RNA metabolic process (GO:0016070),0.2540343556119798,0.8809385382278806,0.6745098039215687,0.844102535047524,1.0,18/127,9.72%,DHX8;RBMS1;RNASE4;HNRNPC;SND1;DROSHA;RNASEL;TENT2;ATXN1;NOL9;HNRNPF;RNASE6;RNGTT;RBM4;WTAP;APOBEC1;MTREX;POLR2B
prerank,histone H4 acetylation (GO:0043967),0.2973772435509785,0.8808168533022581,0.6280864197530864,0.8438870689855228,1.0,13/47,16.46%,KMT2A;PHF20;EPC1;DMAP1;BEND3;TRIM16;KANSL2;HAT1;KANSL1;KAT7;EP300;HCFC1;PER1
prerank,ESCRT III complex disassembly (GO:1904903),0.4039246318529111,0.8807356295972302,0.6050583657587548,0.8431226778990484,1.0,2/10,10.87%,VPS4B;CHMP5
prerank,ESCRT complex disassembly (GO:1904896),0.4039246318529111,0.8807356295972302,0.6050583657587548,0.8431226778990484,1.0,2/10,10.87%,VPS4B;CHMP5
prerank,response to UV-B (GO:0010224),0.393394655346753,0.8805756542868185,0.5973534971644613,0.8429891135902613,1.0,2/12,8.43%,CRIP1;MFAP4
prerank,regulation of defense response to virus by host (GO:0050691),-0.2850329109695544,-0.8801721587562535,0.6827956989247311,0.9137237687625033,1.0,11/30,21.23%,STAT1;MAVS;RNF216;CGAS;PQBP1;ZDHHC1;MUL1;TARBP2;PARP9;DHX9;TRAF3IP2
prerank,regulation of G0 to G1 transition (GO:0070316),0.30544301131092444,0.8799839588889907,0.6188976377952756,0.8437417470357783,1.0,7/38,11.22%,RBBP8;RYBP;EPC1;CHEK1;TFDP1;RHNO1;PHC3
prerank,positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),0.38845208605909254,0.8797577374459481,0.5812720848056537,0.8437145397282325,1.0,2/12,8.20%,ERN1;ATF6
prerank,positive regulation of T cell receptor signaling pathway (GO:0050862),0.3742276573661336,0.8795698961987989,0.5985401459854015,0.8436338258620893,1.0,2/14,4.15%,RPS3;BCL10
prerank,regulation of transcription by RNA polymerase I (GO:0006356),0.3554653163027951,0.87936434988832,0.6044142614601019,0.8435834426539032,1.0,4/18,12.04%,PHF8;RASL11A;HEATR1;DHX33
prerank,cellular response to gamma radiation (GO:0071480),0.3541828024642294,0.8793567242888549,0.5981818181818181,0.8431471420491653,1.0,8/17,16.18%,RPL26;TSPYL5;MDM2;MAP3K20;CRYAB;TMEM109;KDM1A;ATR
prerank,RNA modification (GO:0009451),-0.24941628121655374,-0.8789218374491111,0.7051282051282052,0.915664350754501,1.0,20/54,22.29%,ADAR;AARS1;QTRT1;TRDMT1;NSUN5;FTSJ3;ADARB1;TSR3;MEPCE;ANKRD16;BCDIN3D;QTRT2;TRMT9B;MRM2;PUS7L;METTL1;THUMPD1;CTU2;METTL3;AARS2
prerank,protein acetylation (GO:0006473),0.3166522388970905,0.8786719797002505,0.625,0.8440318550055179,1.0,9/30,16.47%,CLOCK;ESCO2;ESCO1;CREBBP;HAT1;FOXO1;EP300;KAT6A;GTF2B
prerank,cellular response to pH (GO:0071467),0.3638375507581411,0.8785395008848624,0.600358422939068,0.8438443038551124,1.0,1/17,0.52%,RAB11FIP5
prerank,visual system development (GO:0150063),0.3038840561989707,0.8785299444643261,0.6162420382165605,0.8434050883348592,1.0,5/37,8.20%,C1QA;GDF3;PBX3;ADAMTS18;ATF6
prerank,positive regulation of chemotaxis (GO:0050921),0.3002243047470702,0.8784822667016993,0.6155038759689923,0.8430359509761793,1.0,8/43,14.69%,NRP1;CCL19;HSPB1;CCR2;IL6R;DSCAM;MDK;PRKD2
prerank,rRNA 3'-end processing (GO:0031125),0.40267616035348675,0.8783834980099695,0.583969465648855,0.8427669231688326,1.0,2/10,12.43%,RPS21;EXOSC8
prerank,replication fork processing (GO:0031297),-0.26537887640543445,-0.8783210702067601,0.6631016042780749,0.9160792449949418,1.0,7/38,11.07%,DNA2;CDK9;THOC1;ETAA1;PRIMPOL;BLM;BRCA2
prerank,response to metal ion (GO:0010038),0.28218992595125986,0.8779906365543909,0.6354609929078014,0.8430648381960292,1.0,17/67,15.24%,PPP3CA;CRIP1;ADAM9;PAM;BCL2;HFE;HOMER1;PPP2CA;PPP2CB;TESMIN;CALM1;PPP1CA;LOXL2;TFR2;NEDD4L;ITPR3;MTF1
prerank,P-body assembly (GO:0033962),0.3918931487570406,0.8778335695876447,0.5944333996023857,0.8429246424266715,1.0,4/12,12.88%,RC3H1;LIMD1;DDX6;LSM4
prerank,oxoacid metabolic process (GO:0043436),0.32722461731706604,0.8776698764182338,0.6131147540983607,0.8427967522197735,1.0,5/27,13.72%,DAO;THAP4;SULT1A1;GNMT;SULT6B1
prerank,regulation of histone acetylation (GO:0035065),0.31429922873434424,0.8776177109763336,0.6347687400318979,0.8424567046446922,1.0,6/33,12.41%,KMT2A;SPI1;CHEK1;IWS1;ARRB1;TADA2B
prerank,regulation of lipid metabolic process (GO:0019216),0.269667316921826,0.8773183742927768,0.6755674232309746,0.8425783870381891,1.0,14/88,11.67%,PRKAG2;NCOA2;NR1D1;HMGCR;IRS2;TBL1XR1;NCOR1;NCOA6;TBL1X;PMVK;SP1;SREBF2;CREBBP;NPC2
prerank,negative regulation of ubiquitin-protein transferase activity (GO:0051444),0.36680861771250484,0.8772551309329426,0.5961538461538461,0.8422353565190596,1.0,4/15,14.84%,RPL23;RPL5;RPS7;RPL11
prerank,IRE1-mediated unfolded protein response (GO:0036498),0.2935006268748099,0.8772514345437111,0.6383601756954612,0.8417864305001015,1.0,20/52,19.76%,DNAJC3;ERN1;SERP1;WIPI1;DDX11;CTDSP2;MYDGF;PARP16;SRPRB;SHC1;WFS1;EXTL2;ADD1;ATP6V0D1;CUL7;EXTL1;XBP1;LMNA;PPP2R5B;ERN2
prerank,atrioventricular valve morphogenesis (GO:0003181),0.34877946432823176,0.8772134441939456,0.6152482269503546,0.8414037903461924,1.0,6/19,17.88%,BMP2;HEY2;SMAD4;SLIT3;BMPR1A;EFNA1
prerank,protein targeting to mitochondrion (GO:0006626),-0.24793817581863659,-0.8771137215263228,0.660436137071651,0.9178137208656405,1.0,23/52,32.19%,FBXO7;HSPA4;SAMM50;TIMM44;GDAP1;TOMM40;TIMM8B;GRPEL1;AIP;TOMM20;TOMM40L;TIMM29;TIMM21;AGK;BCAP31;TOMM34;FIS1;TOMM5;IMMP1L;TIMM17B;TIMM13;DNLZ;CHCHD4
prerank,inorganic cation transmembrane transport (GO:0098662),-0.19358036866793565,-0.8770626988822673,0.90625,0.9169237068754863,1.0,47/268,16.18%,SLC1A3;KCND2;KCNH7;SLC12A2;KCNJ2;SLC24A3;SLC24A2;ATP1B1;SCN1B;SLC8A1;SLC36A1;SLC9A8;MCOLN3;TRPM3;SLC40A1;KCNQ3;TRPC4;CACNA1D;TRPC1;ATP6V1H;NALCN;SLC24A4;KCNQ5;TRPC3;SLC39A11;KCNK2;KCNA1;KCNA2;SLC11A2;KCNK12;SLC25A14;SCN8A;CACNA1C;TRPC5;ATP6V0C;ATP2C1;KCNS3;HVCN1;SCN1A;KCNK9;COX15;SLC39A13;SLC9A1;SLC39A14;KCNN2;SLC6A1;ABCC9
prerank,regulation of cell adhesion mediated by integrin (GO:0033628),0.31925673016676986,0.8769507207689715,0.6347107438016529,0.841436933849389,1.0,5/33,8.49%,LYN;ADAM9;ITGB1BP1;SYK;FOXC2
prerank,regulation of protein autophosphorylation (GO:0031952),-0.2652977828488502,-0.8762627519719296,0.6666666666666666,0.9177229444735686,1.0,11/36,21.06%,CALM2;EPHA7;IMPACT;TOM1L1;TNKS1BP1;PPP2R5C;PPP2R5A;ERRFI1;PDGFA;ENG;CALM3
prerank,regulation of mRNA stability (GO:0043488),0.25132760787630787,0.8761665062006205,0.6918158567774936,0.8424819666133285,1.0,26/145,14.92%,ZFP36L2;PSMA7;RPS27A;SAMD4A;ZFP36L1;VIM;MAPKAPK2;TENT5A;RC3H1;PUM2;ROCK1;HSPB1;PSMB2;DCP1A;SERBP1;PCID2;DCP2;PSMA6;ROCK2;ZC3H14;EXOSC8;EXOSC1;PSMA3;PSMD1;PSMD5;XPO1
prerank,regulation of attachment of spindle microtubules to kinetochore (GO:0051988),0.39705652788285783,0.8756679596025486,0.5922330097087378,0.8429518958790899,1.0,2/10,8.80%,CDC42;RCC2
prerank,protein localization to microtubule organizing center (GO:1905508),0.37469384138411144,0.8753594570988616,0.6046511627906976,0.8431028056289517,1.0,4/15,13.96%,PIBF1;CCDC14;SNX10;PCM1
prerank,smooth muscle contraction (GO:0006939),0.37722130503697004,0.8751555115767845,0.6397058823529411,0.8430543726279676,1.0,5/14,17.25%,ROCK1;PIK3C2A;ADRA1A;ROCK2;CHRNB2
prerank,positive regulation of sodium ion transmembrane transporter activity (GO:2000651),0.3671969546100753,0.8747070556113685,0.6014362657091562,0.8434818127050825,1.0,2/14,5.93%,FXYD2;WNK1
prerank,'de novo' posttranslational protein folding (GO:0051084),-0.2717402574348065,-0.8746424017143555,0.6597402597402597,0.9204074305929028,1.0,14/30,34.20%,DNAJC7;PTGES3;SDF2;DNAJB14;DNAJB1;DNAJB5;CCT2;HSPA9;DNAJC18;DNAJB13;SDF2L1;HSPA1A;CHCHD4;HSPA1B
prerank,triglyceride metabolic process (GO:0006641),0.29789846154291916,0.8742559115972933,0.6398809523809523,0.8439110945996251,1.0,3/48,4.40%,APOE;AGMO;MOGAT2
prerank,negative regulation of cell cycle G1/S phase transition (GO:1902807),0.32238053798743854,0.8741766262333872,0.618421052631579,0.8436088453501699,1.0,10/31,20.40%,CDK6;RB1;KLF4;CDC73;KANK2;CDKN2C;PKD2;PTEN;GPNMB;BRD7
prerank,cyclic purine nucleotide metabolic process (GO:0052652),-0.3013422843166433,-0.8736621323407211,0.6567901234567901,0.9216557512674232,1.0,4/21,10.16%,ADCY3;ADCY8;GUCY1B1;ADCY7
prerank,regulation of cellular response to growth factor stimulus (GO:0090287),-0.32579575753178447,-0.8734845928236464,0.664367816091954,0.921057917449253,1.0,6/17,17.63%,TWSG1;SULF1;FSTL1;XIAP;TMEM204;DOK5
prerank,modification-dependent protein catabolic process (GO:0019941),0.24399604042479428,0.8734598315886241,0.7164887307236062,0.8445385053854635,1.0,62/193,22.86%,RNF150;SMURF2;ARIH1;RPS27A;SIAH2;CBL;PRKN;ZNRF3;NDFIP1;RC3H1;TRIM32;ANKIB1;CDC27;BIRC6;MDM2;RNF19B;UBE2K;CUL3;ANAPC16;UBQLN4;FBXO11;RNF14;ARRB1;RNF111;AMFR;RNF185;UBE3B;MIB1;FBXO10;UBE2R2;RBBP6;RNF19A;NDFIP2;BFAR;NEDD4L;ANAPC1;ELOC;WDR91;TRIM25;RNF146;XBP1;UBE4B;UBE2A;CNOT4;LONP1;ANAPC10;ATXN3;TOLLIP;RNF6;TRPC4AP;SIAH1;TRIP12;RNF130;UBR3;CHFR;RNF149;PSMD11;NEDD4;ANAPC2;NUB1;FBXO8;RNF40
prerank,regulation of dephosphorylation (GO:0035303),0.3599563111608912,0.8731961252157576,0.6231617647058824,0.8445916278796519,1.0,4/15,9.45%,MTMR3;SMG6;PPP1R17;IGBP1
prerank,positive regulation of calcium ion transport into cytosol (GO:0010524),0.31333744585748624,0.8731037719256911,0.626984126984127,0.8443136000565565,1.0,2/32,2.97%,P2RX7;DRD1
prerank,regulation of kinase activity (GO:0043549),0.26830609915916737,0.8731023002328612,0.6539473684210526,0.843864963017527,1.0,9/89,5.33%,EGFR;FGFR1;EEF1A1;CD74;IRS2;RB1;INSR;CAMKK2;PDGFRA
prerank,negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),0.40012126711110263,0.8730964599226873,0.6082089552238806,0.8434248304241827,1.0,1/10,3.88%,RGCC
prerank,regulation of viral life cycle (GO:1903900),0.34394108607178364,0.8721498296604935,0.6267605633802817,0.8448333410698979,1.0,6/21,15.82%,LAMP3;TRIM68;TRIM27;KPNA2;PPIA;TRIM25
prerank,striated muscle cell differentiation (GO:0051146),0.36801891420049115,0.8718897750939418,0.6081081081081081,0.8448838739656817,1.0,2/16,2.60%,MEF2C;BMP2
prerank,positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),0.40521159327279893,0.8714759819436845,0.6142322097378277,0.8452405269259402,1.0,4/10,12.73%,TLR4;TLR2;NAMPT;NOD2
prerank,regulation of axon regeneration (GO:0048679),-0.35789508024143823,-0.8708719525439026,0.6385809312638581,0.9260539223143204,1.0,3/12,8.46%,RTN4RL1;PTPRS;INPP5F
prerank,regulation of protein localization to membrane (GO:1905475),0.32475242512543717,0.8708678828357692,0.6262135922330098,0.8459800278123956,1.0,10/28,18.68%,SPTBN1;PRKN;ACTB;FYN;STX7;GPC3;NECAB2;ZDHHC2;SLC5A3;VAMP8
prerank,peptidyl-serine phosphorylation (GO:0018105),0.24878473827347938,0.8705259049363478,0.70875,0.8462162355970982,1.0,43/153,19.60%,SGK3;GAS6;RIPK1;ERN1;CAMK1D;RPS6KA3;GSK3B;PKN2;PAK2;MAPKAPK2;ROCK1;WNK1;PIKFYVE;VRK2;PRKCB;ULK2;VRK1;MAPK14;DYRK1A;MAST1;RPS6KA6;MARK2;ROCK2;STK38;MKNK1;LATS2;UHMK1;PRKD2;NLK;PRKCG;ATR;MKNK2;PRKCQ;CAB39;MARK3;HIPK3;CAMK2A;CSNK1G3;PLK2;MORC3;CSNK2A2;CSNK2A1;EIF2AK3
prerank,microtubule bundle formation (GO:0001578),-0.2621816162706103,-0.86934329028374,0.6988304093567251,0.9284143315329281,1.0,10/42,12.41%,CFAP74;LRGUK;CCDC66;NCKAP5L;MTCL1;NCKAP5;SPAG16;TPPP;TOGARAM1;NUMA1
prerank,positive regulation of telomere maintenance (GO:0032206),-0.27483950498925813,-0.8693309906728279,0.6775,0.9274399804797213,1.0,4/31,6.67%,HNRNPA2B1;ATM;MAPK3;MAP2K7
prerank,purine ribonucleotide metabolic process (GO:0009150),0.2735838600182252,0.8692758877887432,0.6694214876033058,0.8481897374633826,1.0,18/68,20.88%,HINT1;GNAI3;SULT1A1;ADSS2;ACOT12;RAB23;AMPD3;GTPBP1;SULT6B1;NT5C2;ADSS1;ACAT1;EFL1;ENPP1;AK3;AK4;ACLY;HPRT1
prerank,N-terminal protein amino acid modification (GO:0031365),-0.34256255694143434,-0.8690680210740526,0.652267818574514,0.9270358102159516,1.0,3/14,14.40%,NAA40;NAA60;NAA35
prerank,negative regulation of transmembrane transport (GO:0034763),0.41019507385262444,0.8688073976442564,0.6111111111111112,0.8486323861498756,1.0,2/10,7.67%,IRS2;PRKCB
prerank,negative regulation of oxidoreductase activity (GO:0051354),0.40734430965514384,0.8687329279378168,0.6295585412667947,0.8483302861373052,1.0,1/10,4.00%,PRKN
prerank,T cell receptor signaling pathway (GO:0050852),0.25124612109279704,0.8684686505073594,0.7215025906735751,0.8483616569598097,1.0,25/138,14.69%,PTPRJ;PSMA7;PTPN22;DENND1B;NFKBIZ;RFTN1;BCL10;THEMIS2;PAK2;RC3H1;PDE4D;WNK1;ZAP70;PSMB2;FYN;RIPK2;EIF2B1;PSMA6;ZC3H12A;UBE2N;FYB1;PSMA3;PSMD1;PSMD5;PRKD2
prerank,alanine transport (GO:0032328),-0.3846884314793909,-0.8684593365589568,0.6323529411764706,0.9274468553724559,1.0,2/10,9.30%,SLC36A1;SLC36A4
prerank,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.295356541855455,0.8684250877420729,0.6430769230769231,0.848000155485634,1.0,6/48,6.34%,CRIP1;TNFRSF1B;MCL1;BCL2L2;SFN;BCL2
prerank,negative regulation of axon extension involved in axon guidance (GO:0048843),-0.3143917863198165,-0.8683507888923316,0.6388888888888888,0.9267166380482302,1.0,3/20,5.59%,SEMA4D;SEMA4C;SEMA4G
prerank,stem cell development (GO:0048864),-0.3291800237987656,-0.867246029890315,0.6493212669683258,0.928205171594421,1.0,9/16,36.58%,CDH2;KLHL12;SOX11;TAPT1;SOX8;WNT7A;KBTBD8;SNAI2;SHH
prerank,negative regulation of striated muscle cell differentiation (GO:0051154),-0.3143589487656637,-0.8665021578209928,0.6334106728538283,0.9288358663161945,1.0,7/18,19.51%,TMEM119;BHLHE41;BDNF;HDAC5;NOTCH1;HDAC3;HDAC1
prerank,positive regulation of cell division (GO:0051781),0.30671151689648246,0.8664807767352214,0.6524486571879937,0.8513225819437562,1.0,6/38,12.60%,KIF20B;CDC42;RHOA;PKN2;CUL3;SVIL
prerank,regulation of DNA-dependent DNA replication (GO:0090329),0.3821249632186785,0.8664659616523216,0.6284658040665434,0.8508989498613176,1.0,3/12,13.82%,TIPIN;GMNN;KAT7
prerank,positive regulation of gene silencing by miRNA (GO:2000637),0.31920949899295065,0.866367196636195,0.6312178387650086,0.8506306035542706,1.0,5/27,10.79%,EGFR;RIPK1;PUM2;LIMD1;DDX6
prerank,apoptotic mitochondrial changes (GO:0008637),-0.27213853773100966,-0.8657540275516524,0.6639784946236559,0.9295166528364168,1.0,9/32,24.56%,HK2;CCAR2;ERBB4;AIFM2;THEM4;NDUFS1;NAIF1;BBC3;FIS1
prerank,cellular polysaccharide biosynthetic process (GO:0033692),0.32705655393178756,0.8651841961464994,0.62478184991274,0.8524215656104821,1.0,1/25,0.47%,EXT1
prerank,positive regulation of DNA replication (GO:0045740),0.3603503103205406,0.8647038116371525,0.6121673003802282,0.8529368601523744,1.0,1/16,0.45%,EGFR
prerank,DNA catabolic process (GO:0006308),0.397036712944611,0.8645704307960688,0.6280834914611005,0.8527599324196448,1.0,2/11,15.81%,DNASE1L1;FBH1
prerank,regulation of pH (GO:0006885),0.395575917139663,0.8644066646320576,0.6333973128598849,0.8526240912914121,1.0,3/11,14.18%,ATP6V1B1;ATP1A4;SLC9A7
prerank,glycoprotein metabolic process (GO:0009100),0.2841561326685399,0.8643761781456674,0.6359649122807017,0.8522453997814762,1.0,8/53,11.99%,MAN2A1;ST8SIA4;CNMD;MANBA;ADAMTS9;B4GALT5;NGLY1;ENGASE
prerank,NAD biosynthetic process (GO:0009435),-0.30807520612987593,-0.8642566371090584,0.6253041362530414,0.9317873359827746,1.0,8/20,24.57%,KYNU;PARP10;NAXD;PARP9;NMNAT1;NUDT12;PTGIS;NADSYN1
prerank,positive regulation of cell aging (GO:0090343),-0.36534333631468074,-0.8639563098008338,0.6379690949227373,0.9315079828056283,1.0,3/11,13.84%,ABI3;CGAS;YPEL3
prerank,"protein alpha-1,2-demannosylation (GO:0036508)",-0.3095352819744343,-0.8638750214469634,0.6875,0.9306631924127154,1.0,9/22,19.29%,MAN1B1;MAN1C1;RNF103;EDEM1;TRIM13;MAN1A2;RNF5;UBB;SYVN1
prerank,regulation of fatty acid oxidation (GO:0046320),0.3583439679915876,0.8636370654520852,0.6156583629893239,0.8532442933495172,1.0,1/16,1.30%,PRKAG2
prerank,regulation of stress-activated protein kinase signaling cascade (GO:0070302),0.3955670750185407,0.8636264018473397,0.6098484848484849,0.8528146315136584,1.0,1/10,1.72%,LYN
prerank,mitochondrial transcription (GO:0006390),-0.370732632745362,-0.8636081691108959,0.6414686825053996,0.930256620574645,1.0,6/10,31.15%,TFB2M;MTERF2;TFAM;SLC25A33;MRPL12;TFB1M
prerank,regulation of sequestering of triglyceride (GO:0010889),-0.32714819663194106,-0.8635979861764077,0.6446469248291572,0.9292823055488552,1.0,2/15,5.91%,TREM2;LPL
prerank,hexose metabolic process (GO:0019318),0.2983255041939087,0.8634160295407564,0.6415094339622641,0.8527504709137625,1.0,8/39,14.02%,SORD;IRS2;GHRL;FUOM;GALK2;PMM1;BRAT1;ADPGK
prerank,regulation of mitotic cell cycle (GO:0007346),-0.19866065252989923,-0.8634137233832091,0.8839779005524862,0.9287143077369828,1.0,37/171,16.77%,TTC28;ANAPC15;CDK9;CYLD;LGMN;BRINP3;SKP1;BTG1;PSMD13;HNRNPU;SIK1;PSMD12;ASAH2;CCDC57;CUL9;ERCC2;PSMD9;NEK6;ANAPC11;UBE2S;PSME3;HSF1;BUB1B;GAS1;PSMA4;PSMD8;PSMF1;CDK11B;PSMD4;DLGAP5;UBE2E1;CDK5RAP3;CDK10;NEK11;UBE2D1;ANGEL2;PSMB8
prerank,positive regulation of response to DNA damage stimulus (GO:2001022),0.28599300668374505,0.8633117599230056,0.6676691729323309,0.8525016848221383,1.0,4/53,2.20%,EGFR;SPRED1;RPS3;BABAM2
prerank,negative regulation of DNA recombination at telomere (GO:0048239),0.34642465531751776,0.8632150191541188,0.6366782006920415,0.8518051214617516,1.0,7/19,20.86%,ATRX;POLR2B;TERF2IP;TERF1;POLR2D;POLR2F;TINF2
prerank,regulation of DNA recombination at telomere (GO:0072695),0.34642465531751776,0.8632150191541188,0.6366782006920415,0.8518051214617516,1.0,7/19,20.86%,ATRX;POLR2B;TERF2IP;TERF1;POLR2D;POLR2F;TINF2
prerank,detection of calcium ion (GO:0005513),0.38679616908334435,0.8632122007254763,0.6348920863309353,0.8513609479835166,1.0,3/13,10.64%,KCNMB1;STIM1;CALM1
prerank,negative regulation of organelle assembly (GO:1902116),0.30924107397812167,0.8631629833342194,0.664576802507837,0.851002045174281,1.0,5/35,8.89%,NUPR1;MTM1;FEZ2;SMAD4;SMCR8
prerank,positive regulation of alpha-beta T cell proliferation (GO:0046641),0.3715138929497854,0.8626141793678218,0.6605839416058394,0.851601847602225,1.0,3/14,7.58%,PTPN22;SYK;CCR2
prerank,neural crest cell development (GO:0014032),-0.2583798416109476,-0.8625602233517159,0.7017543859649122,0.9296066845387078,1.0,7/44,11.32%,SEMA4D;CDH2;SEMA4C;KLHL12;SEMA4G;ERBB4;SOX10
prerank,cellular response to dsRNA (GO:0071359),0.36457660357258115,0.8621083699136173,0.6289198606271778,0.8520908913410524,1.0,2/15,5.78%,COLEC12;RIOK3
prerank,regulation of vasculature development (GO:1901342),-0.28204498253214083,-0.8620338621341037,0.6666666666666666,0.9297234831430763,1.0,4/26,5.52%,CTNNB1;ETS1;FGF2;NF1
prerank,protein trimerization (GO:0070206),0.3805519445899318,0.8620015386840357,0.6074766355140186,0.8514003436416916,1.0,5/14,18.51%,ALOX5AP;CLYBL;DISP1;MLKL;SCARA5
prerank,protein homotrimerization (GO:0070207),0.3805519445899318,0.8620015386840357,0.6074766355140186,0.8514003436416916,1.0,5/14,18.51%,ALOX5AP;CLYBL;DISP1;MLKL;SCARA5
prerank,sulfur amino acid catabolic process (GO:0000098),-0.36309127177822254,-0.8618571605110502,0.652267818574514,0.9291247491042722,1.0,5/10,34.62%,TST;MTRR;CBS;GADL1;CTH
prerank,snRNA metabolic process (GO:0016073),-0.31894711875186155,-0.8610146464934675,0.6659340659340659,0.9299148570990775,1.0,6/17,25.27%,ZCCHC8;INTS3;MEPCE;INTS9;INTS11;INTS7
prerank,positive regulation of viral process (GO:0048524),-0.23900829473860577,-0.8605226385713813,0.7585139318885449,0.9300516703374678,1.0,16/60,18.99%,CDK9;ADAR;CNOT7;SRPK1;AXL;NELFB;PPIE;SRPK2;NELFCD;ADARB1;TBC1D20;TYRO3;POLR2C;TARBP2;DHX9;TMEM39A
prerank,protein kinase A signaling (GO:0010737),0.3866883520449691,0.8604836875929883,0.6346863468634686,0.8538729558365907,1.0,5/12,25.64%,LCP1;PRKACB;EZR;RAB13;MYOM1
prerank,multivesicular body organization (GO:0036257),-0.27573982716645795,-0.8600949887672255,0.6941747572815534,0.9299897187241458,1.0,5/31,9.42%,SNF8;RAB27A;CHMP4B;CHMP4A;VPS37A
prerank,regulation of protein polymerization (GO:0032271),-0.26845344446923,-0.8598866408165882,0.6740331491712708,0.9294580816220298,1.0,11/35,20.20%,MAP2;CAMSAP1;MAPT;PLEKHG2;MAPRE3;GBA2;TPPP;HAX1;PAK3;DBN1;PRUNE1
prerank,histone H2B ubiquitination (GO:0033523),0.3939145076747008,0.8595068871807736,0.6401515151515151,0.8553014981387406,1.0,2/10,8.11%,WAC;CDC73
prerank,positive regulation of transcription by RNA polymerase I (GO:0045943),0.3345980774978264,0.8591634540456407,0.6556836902800659,0.8555265201958333,1.0,5/22,12.04%,PHF8;RASL11A;DDX11;HEATR1;DHX33
prerank,mitochondrial respiratory chain complex assembly (GO:0033108),-0.2193562175836822,-0.8582472961674764,0.7777777777777778,0.9321433430497938,1.0,34/87,31.25%,SAMM50;COX19;NUBPL;UQCC1;SDHAF4;TMEM126A;NDUFAF6;NDUFS7;NDUFV3;NDUFAF1;NDUFB8;NDUFB7;NDUFV1;COX16;NDUFB10;FASTKD3;SDHAF2;NDUFA8;NDUFA10;TTC19;TIMM21;ECSIT;NDUFAB1;COX17;NDUFS1;NDUFAF8;SLC25A33;ACAD9;NDUFA6;COX14;COA3;DMAC2;NDUFAF3;NDUFV2
prerank,membrane lipid catabolic process (GO:0046466),-0.3699216668179628,-0.858124685082866,0.654,0.93142208375755,1.0,3/10,18.59%,ENPP2;PPT1;SMPD2
prerank,sno(s)RNA 3'-end processing (GO:0031126),0.3939785715168544,0.8580612211609986,0.6272189349112426,0.8571902701619437,1.0,1/11,4.19%,LARP7
prerank,RNA destabilization (GO:0050779),0.34762513364995407,0.8580561563996753,0.6348122866894198,0.8567512285096397,1.0,10/18,27.72%,ROCK1;ZC3H18;ROCK2;DXO;GIGYF2;METTL16;FTO;YTHDF3;CELF1;YTHDF1
prerank,regulation of mRNA 3'-end processing (GO:0031440),0.3802732193947836,0.8579887551675567,0.6227897838899804,0.8564374966891477,1.0,3/11,14.91%,ZFP36L1;CDC73;PAPOLA
prerank,DNA methylation (GO:0006306),-0.29160025990295557,-0.8578989434510786,0.652073732718894,0.9309355779576566,1.0,2/23,1.41%,DNMT3A;EHMT2
prerank,cellular response to oxygen levels (GO:0071453),-0.37400289908985007,-0.8578851541288529,0.6800847457627118,0.9299785306549405,1.0,3/10,14.69%,ATP6V0A2;ATP6V1G1;TMEM199
prerank,heterochromatin assembly (GO:0031507),-0.30594293611796475,-0.857774003637558,0.655328798185941,0.9292328723325531,1.0,13/20,34.71%,SIRT2;CENPV;HDAC1;BAHD1;NRDE2;MBD2;SMCHD1;RRP8;HELLS;CDKN2A;SIRT1;HMGA1;HMGA2
prerank,protein modification by small protein removal (GO:0070646),0.2323780739274798,0.8576597241384323,0.7775229357798165,0.8566103014393881,1.0,54/252,17.16%,ESR1;SMURF2;PSMA7;USP3;RPS27A;BABAM2;VCPIP1;ATXN7;ADRB2;RIPK1;SIAH2;RHOA;PRKN;BIRC3;USP9X;SNX3;SMAD4;ACTB;BRCC3;USP15;YY1;PSMB2;MDM2;ASXL1;USP21;USP16;USP24;PSMA6;FOXK2;USP14;ZC3H12A;FOXK1;TADA2B;WDR20;USP45;USP9Y;EP300;PSMA3;PSMD1;PSMD5;USP28;USPL1;MYC;USP22;SENP1;USP25;ABRAXAS2;USP47;HCFC1;PTEN;STAM;UCHL3;USP32;SENP6
prerank,protein K63-linked ubiquitination (GO:0070534),0.28828146356599543,0.8575484384531203,0.6789137380191693,0.8563801178472975,1.0,8/41,13.97%,UBE2E3;PELI1;PRKN;TRIM56;TRIM27;RNF115;UBE2N;BFAR
prerank,embryonic axis specification (GO:0000578),0.35947403944009737,0.8558566276940704,0.6277372262773723,0.8591946351385494,1.0,1/15,2.81%,HOXD8
prerank,mitochondrial fission (GO:0000266),-0.31498620747245354,-0.8556289779522713,0.6541019955654102,0.9329937995609585,1.0,8/16,31.71%,DNM3;GDAP1;MUL1;FIS1;SLC25A46;MTFR1;MTFP1;MTFR2
prerank,nucleic acid metabolic process (GO:0090304),-0.2312645048247625,-0.8554339862512443,0.7634069400630915,0.9324377363930999,1.0,24/69,28.38%,DNA2;HNRNPA3;HNRNPA2B1;HNRNPU;RECQL5;POLG;DDX1;POLR2C;NCBP1;PCBP1;PCBP2;HNRNPA1;HNRNPH1;ATXN2;DDX24;METTL3;POLR2L;DNASE1L2;HNRNPA0;RAD50;DDX54;DUSP11;POLR2I;HNRNPK
prerank,regulation of NLRP3 inflammasome complex assembly (GO:1900225),0.3620934708123133,0.855406054786614,0.6365248226950354,0.8596452071413228,1.0,2/15,3.18%,CD36;TLR4
prerank,substantia nigra development (GO:0021762),0.30115456867709556,0.8553089835796404,0.65086887835703,0.8593767771034867,1.0,11/37,14.12%,S100A1;CDC42;RHOA;YWHAQ;ACTB;ZNF148;CALM1;CCDC14;YWHAE;GLUD1;GNB4
prerank,positive regulation of leukocyte proliferation (GO:0070665),0.3778864097907725,0.8550546555055074,0.6291512915129152,0.8594276208862348,1.0,2/12,7.18%,LYN;BST2
prerank,actin filament network formation (GO:0051639),0.39187170368713237,0.8547677400064863,0.6429872495446266,0.8595523748106307,1.0,2/11,9.06%,LCP1;PLS1
prerank,mitochondrion disassembly (GO:0061726),0.3066275219479149,0.8544953338510558,0.658307210031348,0.8596478766131523,1.0,15/34,21.05%,PRKN;WIPI1;ULK2;MARK2;ATG7;AMBRA1;RB1CC1;WIPI2;GABARAP;ATG5;BNIP3;ATG3;FUNDC1;FUNDC2;MAP1LC3B
prerank,positive regulation of striated muscle cell differentiation (GO:0051155),0.33016751619855345,0.85444494047817,0.6454849498327759,0.8593027610573177,1.0,5/23,12.09%,MEF2C;MAPK14;IGF1;MAML1;NIBAN2
prerank,positive regulation of T cell cytokine production (GO:0002726),0.3355916394936065,0.8543431839037734,0.6057347670250897,0.8590368881392084,1.0,2/20,3.98%,DENND1B;B2M
prerank,cellular response to topologically incorrect protein (GO:0035967),0.3125752219369378,0.8542844218678364,0.6320907617504052,0.8587148173780323,1.0,9/31,20.82%,ERN1;PRKN;RHBDD1;BAG3;HSPA13;UBE2W;ATXN3;TMBIM6;HSPA2
prerank,organophosphate biosynthetic process (GO:0090407),0.3023423213504869,0.8540976657783008,0.6639871382636656,0.8586127173491743,1.0,6/37,9.99%,MOCS1;TPK1;IP6K3;AGPAT5;TKT;PIP5K1A
prerank,regulation of rRNA processing (GO:2000232),-0.32076692037980736,-0.8539373868981451,0.654292343387471,0.9346723946583808,1.0,6/16,29.78%,SIRT7;WDR75;RIOK2;RIOK1;NUDT16;METTL18
prerank,negative regulation of nervous system development (GO:0051961),0.3447946779593258,0.8537307826448324,0.627906976744186,0.8588441940111275,1.0,6/17,17.66%,B2M;TLR2;TNF;SLIT1;PCM1;IL6
prerank,tricarboxylic acid metabolic process (GO:0072350),0.3776448228919085,0.8534216665613216,0.6284658040665434,0.8589939199204506,1.0,7/12,20.78%,ACO1;ASS1;GLUD1;IDH1;IDH2;IREB2;ACLY
prerank,cellular response to hydroxyurea (GO:0072711),0.3929296337527115,0.8531243241199624,0.6405622489959839,0.8590932704296176,1.0,3/10,10.34%,DDX11;ATRX;SPIDR
prerank,attachment of mitotic spindle microtubules to kinetochore (GO:0051315),-0.3502803331099529,-0.8527655944438991,0.6637931034482759,0.9362778268573558,1.0,8/12,31.91%,CENPC;CENPE;SEH1L;NDC80;CDT1;KIF2C;NUF2;BOD1
prerank,regulation of T cell differentiation (GO:0045580),0.3019568337956171,0.8527240053950148,0.6649916247906198,0.8593932915410244,1.0,11/33,23.39%,CBFB;TCF7;ZAP70;CCR2;NFATC2;MDK;XBP1;ZBTB1;ZMIZ1;IL7;TBX21
prerank,negative regulation of mRNA catabolic process (GO:1902373),-0.2772241794314752,-0.8525750645537232,0.7146464646464646,0.9357507464726594,1.0,6/29,13.88%,TENT5C;FUS;HNRNPU;FMR1;CIRBP;TAF15
prerank,regulation of vascular endothelial growth factor signaling pathway (GO:1900746),-0.3116863836180559,-0.8525474433336178,0.6751740139211136,0.9348207553167981,1.0,7/19,23.03%,PIK3CB;ROBO1;ADAMTS3;CADM4;TSPAN12;CCBE1;DCN
prerank,lytic vacuole organization (GO:0080171),-0.27473077175594096,-0.8524723562786136,0.6938271604938272,0.9340114746090442,1.0,7/32,9.45%,GNPTAB;HPS4;CLVS1;CLN3;GAA;VPS18;ZKSCAN3
prerank,"DNA-templated transcription, elongation (GO:0006354)",-0.23247538521771813,-0.8522199628369586,0.7975077881619937,0.9335495981264048,1.0,15/64,15.63%,GTF2H2;CDK9;CCNT2;MLLT1;CCNH;SSRP1;NELFB;CTR9;ERCC2;PAF1;NELFCD;EAF1;POLR2C;NCBP1;ELOB
prerank,protein O-linked glycosylation (GO:0006493),0.2572348574045984,0.8521833349999977,0.7329624478442281,0.8599449525843507,1.0,14/96,15.27%,POMK;ST6GAL1;LARGE2;ST3GAL1;C1GALT1;POGLUT3;TET3;POGLUT1;B4GALT5;PLOD1;TET2;FKRP;POMT2;ST3GAL4
prerank,late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),-0.32471553990937185,-0.852112341882967,0.6609808102345416,0.9328007465958033,1.0,4/16,12.06%,SNF8;CHMP4B;CHMP4A;TMEM50B
prerank,positive regulation of response to stimulus (GO:0048584),0.29848948314598606,0.8520366295420515,0.6682242990654206,0.859779576528042,1.0,5/40,8.32%,FCGR2B;IL15;B2M;CD80;HOMER1
prerank,negative regulation of bone remodeling (GO:0046851),0.39317465667665324,0.8516958354995703,0.6202290076335878,0.8600080557230206,1.0,1/11,0.51%,P2RX7
prerank,negative regulation of cell-substrate junction organization (GO:0150118),0.35888690839792314,0.8516807414633842,0.6436170212765957,0.8591443003945353,1.0,8/16,22.14%,ITGB1BP1;DUSP22;RCC2;CORO1C;BCAS3;PTEN;ACVRL1;DLC1
prerank,negative regulation of focal adhesion assembly (GO:0051895),0.35888690839792314,0.8516807414633842,0.6436170212765957,0.8591443003945353,1.0,8/16,22.14%,ITGB1BP1;DUSP22;RCC2;CORO1C;BCAS3;PTEN;ACVRL1;DLC1
prerank,regulation of protein targeting to mitochondrion (GO:1903214),0.29910804779340844,0.8516654160003484,0.6730769230769231,0.8587278276133771,1.0,5/38,11.27%,FBXW7;PRKN;PARL;UBE2D3;SREBF2
prerank,positive regulation of protein localization to plasma membrane (GO:1903078),0.2775735209640026,0.8514568885534332,0.6521060842433697,0.8586718687337673,1.0,7/52,9.97%,EGFR;ITGB1;SPTBN1;RACK1;TNF;PLS1;ACSL3
prerank,proton transmembrane transport (GO:1902600),0.29699422335185954,0.8513311589604775,0.653968253968254,0.8584526817329631,1.0,10/36,18.90%,ATP6V1B1;ATP5PO;ATP6V1A;ATP1A4;ATP1A3;ATP1A1;ATP6V0D1;SLC36A2;ATP5MF;SLC25A27
prerank,regulation of transcription regulatory region DNA binding (GO:2000677),0.32765223184466086,0.8509804631649962,0.6352941176470588,0.8586883545594169,1.0,6/25,18.57%,HEY2;RB1;IGF1;NIBAN2;ZBTB7A;TRAF6
prerank,positive regulation of DNA biosynthetic process (GO:2000573),-0.23311719987222532,-0.8508824374264882,0.7573770491803279,0.9344461549887947,1.0,21/60,27.96%,CTNNB1;XRCC5;FGF2;ATM;MAPK3;MAP2K7;PTGES3;RFC2;MAP3K4;CCT7;HNRNPA1;CCT2;WRAP53;ACD;CHTF18;NVL;CCT8;PDGFRB;FBXO4;AURKB;GREM1
prerank,interleukin-27-mediated signaling pathway (GO:0070106),0.3732416253866172,0.850695766691668,0.6524953789279113,0.8587423573444282,1.0,4/13,13.90%,OAS2;CANX;JAK1;STAT3
prerank,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",-0.25901992462529383,-0.8505887232275063,0.7037037037037037,0.9341534264708432,1.0,6/37,9.14%,GTF2H2;CUL4A;PARP1;DDB2;RBX1;ERCC2
prerank,positive regulation of mRNA processing (GO:0050685),-0.2998279838128087,-0.850520852049998,0.6880952380952381,0.9333582957540584,1.0,6/21,14.75%,NCL;CELF4;PAF1;CIRBP;NCBP1;RBMXL1
prerank,macroautophagy (GO:0016236),-0.20795800118368105,-0.8500224499368237,0.8382978723404255,0.9334167492600824,1.0,35/118,23.41%,TCIRG1;TECPR1;MTERF3;SRC;SNF8;RUBCNL;PRKAG1;CLN3;MFN1;PGAM5;PIK3R4;CHMP4B;CHMP4A;ATG16L1;VTI1B;VPS37A;VDAC1;TOMM40;ATP13A2;MAP1LC3A;PIP4K2B;GABARAPL1;ULK1;TOMM20;VIPAS39;SQSTM1;ULK3;ATG14;VAMP7;CHMP6;CHMP3;SNX14;ILRUN;UBQLN1;YOD1
prerank,nuclear transport (GO:0051169),0.3560178759670975,0.850014946042925,0.6465028355387523,0.859577641712217,1.0,7/16,22.30%,RSRC1;NUP98;BANF1;XPO1;RGS14;RBM15B;NPM1
prerank,metallo-sulfur cluster assembly (GO:0031163),-0.2910392642052003,-0.8491625761024988,0.6971153846153846,0.9342948042668899,1.0,11/22,27.13%,NFU1;NUBPL;ISCU;FXN;NFS1;ISCA1;CIAO1;GLRX5;HSPA9;CIAO2B;CIAPIN1
prerank,"base-excision repair, gap-filling (GO:0006287)",-0.26029278892091134,-0.8490698269254504,0.7165775401069518,0.9335112094224444,1.0,11/35,23.22%,PARP1;LIG1;XRCC1;POLG;RFC2;POLE;POLL;RFC1;ADPRS;PARG;POLD4
prerank,regulation of protein serine/threonine kinase activity (GO:0071900),0.2572482889930283,0.8490531569947839,0.7029177718832891,0.8608876064276442,1.0,16/104,12.43%,LRP6;ADRB2;UVRAG;RHOA;CDK12;RB1;INCENP;ACTB;CCND3;CCND2;PPP2CA;CCNJ;PARP16;CALM1;TRIB2;CDKN2C
prerank,"nucleotide-excision repair, DNA incision (GO:0033683)",-0.2568892748996173,-0.8489221479691214,0.7081081081081081,0.9328349427669494,1.0,6/39,9.14%,GTF2H2;CUL4A;PARP1;DDB2;RBX1;ERCC2
prerank,positive regulation of protein ubiquitination (GO:0031398),0.2616535805982521,0.8484981693751027,0.7067039106145251,0.8614539108824775,1.0,14/80,13.83%,FBXW7;PRICKLE1;AXIN1;BCL10;BIRC3;NDFIP1;MYCBP2;ARRDC3;TSPYL5;CUL3;RIPK2;WFS1;UBE2N;NDFIP2
prerank,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),-0.19604895223711635,-0.8484631058423744,0.9090909090909091,0.9327770895856682,1.0,43/173,21.80%,TGFA;PREB;KLHL12;DYNC1H1;BCAP29;NRBP1;TRAPPC3;ANK2;SEC31A;COG3;HYOU1;ANK1;VTI1B;COG4;CNIH1;NAPA;ERGIC3;SEC24A;RAB2A;COG2;TBC1D20;SPTB;F8;USE1;TEX261;TMED1;TMED7;TRAPPC6A;SPTBN2;GOLGA2;SEC24B;TRAPPC2;COPA;SEC13;BET1;VAMP7;GOSR2;DCTN2;ZW10;TRAPPC2L;GOPC;CAPZB;TRAPPC12
prerank,carnitine metabolic process (GO:0009437),-0.3491295331157359,-0.8483748784973864,0.6644444444444444,0.9319865011192912,1.0,6/12,35.94%,ACADL;ACADM;CPT1C;CPT2;CPT1B;BBOX1
prerank,positive regulation of keratinocyte migration (GO:0051549),-0.3696239976296023,-0.8480478606859717,0.6703056768558951,0.9316987482303689,1.0,2/10,1.10%,MAP4K4;IQSEC1
prerank,negative regulation of myoblast differentiation (GO:0045662),0.3665199187520474,0.848047317557078,0.658252427184466,0.861863494418506,1.0,1/13,2.61%,PRICKLE1
prerank,embryonic digit morphogenesis (GO:0042733),0.33603938018067364,0.8480016123491769,0.6551724137931034,0.8615084253920292,1.0,4/18,11.28%,OSR1;INTU;MAP3K20;CREBBP
prerank,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),-0.31848397142527446,-0.8475289312025541,0.6794582392776524,0.9318381286680341,1.0,2/16,4.14%,PPP1R16B;FGF2
prerank,long-chain fatty acid import into cell (GO:0044539),0.4017776258539608,0.8472716227527963,0.6469500924214417,0.8623910148202734,1.0,2/10,9.97%,CD36;ACSL3
prerank,mesoderm formation (GO:0001707),0.34054602782406257,0.8471842749432111,0.6509090909090909,0.8620957442981209,1.0,1/17,1.84%,ITGB1
prerank,tetrahydrobiopterin metabolic process (GO:0046146),0.3791440845134017,0.8468709343112766,0.6452830188679245,0.862283692251542,1.0,2/11,10.64%,GCH1;CALM1
prerank,retinoic acid receptor signaling pathway (GO:0048384),0.39056738515433664,0.8464943541003198,0.6476190476190476,0.8624852528668835,1.0,3/10,14.89%,RARG;RARA;SNW1
prerank,negative regulation of epithelial cell migration (GO:0010633),0.3047295299578757,0.8461168500679581,0.6623586429725363,0.8627368347964116,1.0,6/33,10.54%,APOE;MCC;SYNJ2BP;ADAMTS9;CORO1C;SP100
prerank,"protein localization to chromosome, centromeric region (GO:0071459)",-0.30936358650991713,-0.8460301660390995,0.6977272727272728,0.9340372966896007,1.0,9/17,31.91%,KNL1;HASPIN;SPDL1;ZW10;IK;CDK1;AURKB;TTK;BOD1
prerank,chromatin organization (GO:0006325),0.24910225457587365,0.8458774700826722,0.7389033942558747,0.8627266612124583,1.0,28/132,18.20%,PADI4;ESR1;BAZ2B;JARID2;SPI1;RB1;SETDB2;KDM6A;DDX11;SATB2;ATRX;HMG20A;KDM4D;KDM5C;LOXL2;TADA2B;SMARCAD1;EHMT1;PWWP3A;MYC;SMARCD1;HDAC4;ARID1A;HCFC1;ZBTB7A;MECOM;NPM3;ZBTB1
prerank,cation transmembrane transport (GO:0098655),-0.2508638339208227,-0.8458661069942855,0.7313432835820896,0.933389340779837,1.0,17/44,37.42%,ATP1B1;TRPM3;SLC36A4;SLC7A8;ATP13A2;ABCC9;ABCC8;MFSD12;TRPM7;SLC25A29;CACNA1H;SLC7A3;TRPM6;P2RX3;SLC3A2;TRPM1;SLC25A19
prerank,regulation of natural killer cell mediated cytotoxicity (GO:0042269),-0.2885145238884469,-0.8451188208803666,0.6903073286052009,0.9339471996224158,1.0,4/23,11.87%,CADM1;ARRB2;NECTIN2;SLAMF6
prerank,protein localization to lysosome (GO:0061462),-0.2737429166092967,-0.8447677490207884,0.7124352331606217,0.9336990165122373,1.0,8/28,16.92%,SORL1;SCARB2;GCC2;GLMP;ATP13A2;NCOA4;RNF128;GGA3
prerank,plasma membrane tubulation (GO:0097320),0.36882957644857894,0.8443923820366186,0.6413043478260869,0.8650373286021282,1.0,3/13,11.69%,SNX9;PACSIN2;SNX33
prerank,positive regulation of exocytosis (GO:0045921),0.2983078584790712,0.843940975619098,0.6703125,0.8654613631942337,1.0,8/35,12.63%,EXPH5;STXBP5;SDCBP;VPS4B;RAB7A;SDC4;CLASP1;UNC13D
prerank,negative regulation of cytokine-mediated signaling pathway (GO:0001960),0.28017066894395126,0.8439164006424611,0.6697247706422018,0.865069181910802,1.0,8/48,15.22%,GAS6;IRAK3;PARP14;CARD16;SH2B3;SLIT3;NR1H2;SAMHD1
prerank,protein acylation (GO:0043543),0.2939904439391032,0.8438615741959464,0.6793893129770993,0.8647269525934115,1.0,10/38,16.47%,CLOCK;ZDHHC14;ZDHHC3;CREBBP;FOXO1;EP300;KAT6A;ZDHHC20;ZDHHC2;GTF2B
prerank,fatty-acyl-CoA metabolic process (GO:0035337),-0.2963145528106323,-0.8437217144439138,0.6650124069478908,0.9349265220924091,1.0,7/20,27.36%,ACACA;PPT1;ACSL4;SCD;SLC25A1;DGAT2;GCDH
prerank,muscle organ development (GO:0007517),0.27842428914875317,0.8428267998646647,0.6948640483383686,0.8662361675244212,1.0,5/54,3.79%,MEF2A;TCF12;MEF2C;MYH6;UTRN
prerank,regulation of cAMP-dependent protein kinase activity (GO:2000479),0.36733920050297963,0.842679341939578,0.6454720616570327,0.866069685409891,1.0,2/14,3.92%,ADRB2;RAPGEF2
prerank,positive regulation of translation (GO:0045727),0.2564599287163851,0.8424911697656937,0.7243243243243244,0.8659693381256722,1.0,15/94,14.37%,EIF3E;SAMD4A;NIBAN1;RPL26;VIM;RPUSD3;RPS4X;RPL5;LARP4B;RPS9;USP16;LARP4;PIWIL2;UHMK1;POLR2D
prerank,regulation of keratinocyte migration (GO:0051547),-0.3508851712708336,-0.8424495191437411,0.6703786191536748,0.9366827472120006,1.0,2/12,1.10%,MAP4K4;IQSEC1
prerank,phosphatidylinositol metabolic process (GO:0046488),0.2495547568058097,0.8422553311133094,0.7435567010309279,0.8659690880565967,1.0,36/109,22.14%,INPP4A;PGAP1;MTM1;SYNJ1;MTMR3;FIG4;IP6K3;OCRL;PI4K2B;PIKFYVE;PIK3R6;PLCD1;PLA2G2D;PIK3C2A;RAB14;PIP5K1A;PLCB3;PIP4P2;PLEKHA4;PLAAT3;PLBD1;PTPN13;PTEN;MTMR1;PIP4K2A;PIP4P1;INPP5K;PIK3C3;PIK3CD;MTMR6;PLA2G4C;LCLAT1;PI4K2A;MTMR12;RAB5A;PLCG2
prerank,epithelium development (GO:0060429),-0.20826767246624026,-0.8416807114944905,0.8699186991869918,0.9373348883842789,1.0,30/107,24.94%,SALL1;JAK2;STAT1;NDRG4;FGFR2;DVL1;LOXL3;AHI1;PGK1;VDAC1;CASP6;CD34;SOX10;PAX8;PROX1;UPK1B;SMO;ALDH1A2;WNT4;TPP1;ERRFI1;TST;FN3K;SOX11;TGFB1;DACT1;STIL;ACADVL;SOX8;CDK1
prerank,histone exchange (GO:0043486),-0.24757912382108943,-0.8411302561423561,0.7228260869565217,0.9374528126433023,1.0,12/37,28.15%,CENPC;NASP;KNL1;MIS18BP1;RUVBL1;CENPX;CENPP;CENPN;CENPH;CENPI;ACTR6;MIS18A
prerank,non-motile cilium assembly (GO:1905515),0.30773333583077656,0.8409571316690446,0.6731707317073171,0.8679325573799709,1.0,3/30,5.55%,IFT57;PIBF1;DISC1
prerank,C-terminal protein amino acid modification (GO:0018410),0.39306642543138454,0.8400495347313571,0.6684587813620072,0.8691398869050798,1.0,4/11,16.21%,ATG7;TTL;ICMT;ATG5
prerank,response to peptide hormone (GO:0043434),-0.2509433574502242,-0.8399461266707269,0.7465181058495822,0.9389090315633669,1.0,8/43,11.26%,SORT1;SRC;STAT1;GNAI1;EIF2B3;TGFBR3;STAT2;TSC1
prerank,protein glycosylation (GO:0006486),0.24541352039011263,0.839738393975635,0.7654639175257731,0.8692822911231514,1.0,21/125,14.52%,POMK;ST8SIA4;FUT4;LARGE2;ST3GAL1;MGAT2;SERP1;GFPT2;ALG9;TET3;TMEM165;ALG5;DOLPP1;POGLUT1;NUS1;B4GALT5;PLOD1;PMM1;TET2;RPN2;POMT2
prerank,positive regulation of protein-containing complex assembly (GO:0031334),0.24696700329825758,0.8397009937874578,0.7477124183006536,0.8689064098019124,1.0,19/113,14.26%,RAP1B;ESR1;RPS3;CD36;TLR4;LCP1;GSK3B;RACK1;SYK;TNF;RPA1;FNIP1;SPIDR;XPA;DHX33;RPA3;RHOC;IL5;TERF1
prerank,positive regulation of protein import into nucleus (GO:0042307),0.31184143221460237,0.8395892588731279,0.6746794871794872,0.8686712047303861,1.0,6/28,12.28%,CHP2;DMAP1;BAG3;PSEN1;JUP;ZC3H12A
prerank,regulation of secretion (GO:0051046),0.36775474500678806,0.8393510153952153,0.6590106007067138,0.8686860076011659,1.0,3/13,11.86%,OAS2;ACSL3;KCNQ1
prerank,T cell migration (GO:0072678),0.367577788990169,0.839230816017939,0.6511226252158895,0.8684604619264674,1.0,6/13,20.25%,ZAP70;CXCL16;MSN;S1PR1;GPR183;PIK3CD
prerank,positive regulation of leukocyte cell-cell adhesion (GO:1903039),0.3143178312336531,0.8390929170523586,0.6743801652892562,0.8682679770355465,1.0,11/27,19.85%,CD44;RHOA;TNF;CCR2;ITGB2;MDK;PRKCQ;RELA;IL6;TRAF6;HAS2
prerank,NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),-0.33527551116369303,-0.8388291925222653,0.6802721088435374,0.94024721224913,1.0,5/13,24.00%,PARP10;NAXD;PARP9;NUDT12;PTGIS
prerank,apical junction assembly (GO:0043297),0.2794175834314019,0.8385017119959808,0.6826783114992722,0.8689146303308688,1.0,9/53,14.23%,CTNNA1;RHOA;GRHL2;PKN2;PAK2;VCL;STRN;RAMP2;RHOC
prerank,DNA integrity checkpoint signaling (GO:0031570),-0.25677505755409014,-0.8381606179123872,0.7317708333333334,0.9406694973148287,1.0,9/36,13.94%,DNA2;ATRIP;ATM;DOT1L;ERCC6;CEP63;HUS1;PRPF19;CHEK2
prerank,positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.30627051405864825,0.8375513546537875,0.6587436332767402,0.870220394157483,1.0,5/31,13.05%,FBXW7;AXIN1;ARRDC3;RAB1A;UBE2N
prerank,respiratory electron transport chain (GO:0022904),0.3603458138754156,0.8374975185163488,0.6546112115732369,0.8698814338324509,1.0,5/14,17.74%,ETFDH;ETFA;SDHA;UQCRFS1;ETFB
prerank,negative regulation of fatty acid metabolic process (GO:0045922),0.35025231668819223,0.8373166602278157,0.6532399299474606,0.8697519607478992,1.0,3/16,8.14%,UGT1A8;ERLIN1;NCOR1
prerank,ATP-dependent chromatin remodeling (GO:0043044),-0.24877691012355116,-0.8370692019958739,0.7347560975609756,0.9419145409607486,1.0,9/42,11.43%,ACTR8;SMARCB1;SMARCC2;SMARCE1;ERCC6;CHD3;NASP;CECR2;SMARCA1
prerank,positive regulation of posttranscriptional gene silencing (GO:0060148),0.37493118535406517,0.8368620445822849,0.666023166023166,0.8701438440637376,1.0,3/11,13.90%,PUM2;LIMD1;STAT3
prerank,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),0.3057163920230404,0.8367603737670979,0.6887417218543046,0.8698812654282517,1.0,7/29,16.77%,ESR1;AXIN1;CBFB;KANK2;UFM1;CNOT9;STRN3
prerank,inorganic cation import across plasma membrane (GO:0098659),0.2601509244141189,0.8367118215140473,0.7317415730337079,0.8695235385262582,1.0,13/75,14.19%,SLC9A9;FXYD2;KCNJ14;SLC9A4;TRPV3;SLC39A12;TRPM2;ATP2B4;ATP1A4;ATP1A3;ATP1A1;SLC9A7;SLC9A6
prerank,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",0.3435602505848802,0.8365570570411921,0.6821305841924399,0.8693661729021251,1.0,7/17,21.39%,CYCS;COX7A2L;COX7C;COX10;NDUFA4;COX6C;COX5A
prerank,isotype switching (GO:0045190),0.3892197048511161,0.836473950380017,0.6589147286821705,0.8690706193694251,1.0,1/10,2.01%,LIG4
prerank,regulation of amyloid-beta formation (GO:1902003),0.2947026150743145,0.8358044292064905,0.6798780487804879,0.8698151693231518,1.0,12/34,17.88%,APOE;ROCK1;TMED10;TNF;IGF1;RTN4;SP1;ROCK2;RELA;IFNGR1;PICALM;EFNA1
prerank,regulation of protein acetylation (GO:1901983),0.3621401344337139,0.8357351587208044,0.6544401544401545,0.8694952023338327,1.0,3/12,16.34%,GSK3B;TERF2IP;FAM161A
prerank,negative regulation of cAMP-mediated signaling (GO:0043951),-0.3637239127296746,-0.8356991012460425,0.6779661016949152,0.9437793199338419,1.0,3/10,11.23%,PDE3B;UBE2B;PDE3A
prerank,bile acid metabolic process (GO:0008206),0.31295381388512483,0.8355639224172396,0.656140350877193,0.8693550295537819,1.0,4/27,9.75%,OSBPL9;HSD3B7;CYP27A1;OSBPL1A
prerank,RNA methylation (GO:0001510),-0.22888955987908757,-0.8348601839039634,0.8080808080808081,0.9445404618093702,1.0,27/60,35.50%,TRDMT1;METTL2A;METTL2B;NSUN5;TFB2M;FTSJ3;TRMT12;MEPCE;ALKBH8;TGS1;BCDIN3D;MRM2;MTERF4;METTL1;METTL3;ZC3H13;CBLL1;WDR6;GTPBP3;TRMT44;TFB1M;NOP2;TRMT6;FBL;THUMPD3;NSUN6;FTSJ1
prerank,regulation of telomere maintenance via telomere lengthening (GO:1904356),-0.3139983141367616,-0.8348242688495012,0.6614349775784754,0.9436470292122353,1.0,4/16,12.36%,HNRNPA2B1;ATM;PARP1;TERF2
prerank,DNA metabolic process (GO:0006259),0.22712469743490585,0.8347846703231059,0.826879271070615,0.8703641099208472,1.0,69/270,20.20%,TCF7L2;ENDOG;RBBP8;USP3;LIG4;RPS27A;ORC5;UVRAG;DNASE1L1;ORC2;POLE2;NOP53;CHEK1;PRIM2;TOPBP1;CHRNA4;PDS5B;RPA1;GMNN;RAD54L;BACH1;TOP1MT;RAD52;UHRF2;PURA;ZRANB3;SP100;POLE3;KMT5B;XPA;HINFP;POLH;RPA3;TERF2IP;UBE2N;MUTYH;XPC;USP45;TERF1;KPNA2;MMS19;SMARCAD1;RAD51B;PWWP3A;SAMHD1;POLE4;GTF2H3;MCM8;FANCL;ATR;TOP2B;UBE2U;PRIM1;RFC3;GTF2H1;DMC1;ASF1A;MPG;UBE2A;ZBTB1;LONP1;SUMO1;DDX21;APEX1;POLD2;MRE11;RTEL1;USP7;PCNA
prerank,tRNA methylation (GO:0030488),-0.25636443416050636,-0.8345730554157273,0.7352185089974294,0.9431777053122378,1.0,16/34,35.50%,DALRD3;TRDMT1;METTL2A;METTL2B;TRMT12;ALKBH8;BCDIN3D;METTL1;HSD17B10;PRORP;WDR6;GTPBP3;TRMT44;THUMPD3;NSUN6;FTSJ1
prerank,cellular biogenic amine biosynthetic process (GO:0042401),0.35689584899338345,0.8340523247985074,0.6841155234657039,0.8712597055282967,1.0,3/15,12.34%,HDC;MOXD1;SAT2
prerank,regulation of protein ubiquitination (GO:0031396),0.24728539315025366,0.8339666960587214,0.7496706192358367,0.8709700643652811,1.0,24/108,17.43%,SASH1;FBXW7;RPS3;PRICKLE1;AXIN1;PRKN;BCL10;BIRC3;NDFIP1;MYCBP2;SPOPL;TSPYL5;CUL3;RIPK2;ARRB1;WFS1;UBE2N;NDFIP2;PINX1;PRKCG;HSP90AB1;AMER1;FANCI;SPRY2
prerank,lipid biosynthetic process (GO:0008610),0.25999107940768446,0.8338388563684014,0.7090395480225988,0.8707534444147319,1.0,8/77,9.99%,ALOX5;HMGCR;PDSS1;PAM;AGPS;AGPAT5;DOLPP1;PIP5K1A
prerank,positive regulation of transforming growth factor beta production (GO:0071636),0.3871182264538144,0.8338368646128397,0.6372180451127819,0.8703173423888844,1.0,3/11,18.00%,CD46;BMPR1A;ATP6AP2
prerank,negative regulation of leukocyte chemotaxis (GO:0002689),-0.3527178959219672,-0.8335791461752967,0.6908315565031983,0.9441943896245464,1.0,5/11,27.96%,RIN3;MIF;PADI2;SLAMF8;GREM1
prerank,aminoglycan catabolic process (GO:0006026),0.3097520314718991,0.8329863946964172,0.6774716369529984,0.8714508019913771,1.0,3/28,9.08%,HGSNAT;SDC3;SDC4
prerank,regulation of necroptotic process (GO:0060544),0.3235376842273835,0.8328353942498727,0.6715927750410509,0.8712846664227126,1.0,9/23,20.62%,RIPK1;PELI1;BIRC3;SDCBP;CASP8;MLKL;FLOT2;SLC25A4;PDCD6IP
prerank,positive regulation of myeloid cell differentiation (GO:0045639),0.30732606237051313,0.8327392931146486,0.6848673946957878,0.8710336595849079,1.0,14/33,23.28%,THPO;ACVR2A;RAB7B;MAPK14;FOXO3;STAT3;PRMT1;ARNT;ABCB10;FES;PITHD1;FAM210B;STAT5B;MAPK11
prerank,positive regulation of T cell activation (GO:0050870),0.2677094543989778,0.8326354552091998,0.7197724039829303,0.8708029371024804,1.0,20/62,23.00%,IL15;CD46;CCL19;CD80;ZAP70;CCR2;NOD2;MDK;CCL5;PRKCQ;XBP1;FLOT2;IL6;ZBTB1;PTPRC;ZMIZ1;IL7;CD47;TFRC;NCK1
prerank,regulation of mitotic nuclear division (GO:0007088),0.276520930429618,0.8325243826449659,0.7136563876651982,0.870567036401497,1.0,9/55,11.62%,KIF20B;RGCC;DUSP1;INSR;CHEK1;IGF1;NUP62;PHIP;CDK13
prerank,ventricular cardiac muscle cell action potential (GO:0086005),-0.30668135689581144,-0.8325204036748741,0.6791569086651054,0.9453473877573991,1.0,2/17,4.57%,SNTA1;ANK2
prerank,positive regulation of cellular protein localization (GO:1903829),-0.2210022529330474,-0.8324280818552802,0.8277945619335347,0.9445797436295458,1.0,23/69,24.94%,GPR137B;FERMT2;WWTR1;CROCC;MAPT;CEP250;STX3;ENTR1;NUMA1;TMEM35A;CDK5RAP3;PARK7;LIMK2;NDC80;PARP9;ABCA7;GNL3L;SESN2;TRAPPC12;TGFB1;GPD1L;TM9SF4;CDK1
prerank,divalent inorganic cation homeostasis (GO:0072507),0.3179439126127366,0.8322737721543099,0.6639344262295082,0.8706039523309614,1.0,5/25,14.66%,ATP6V1B1;PRKN;FAM20A;WFS1;CNNM4
prerank,regulation of cell growth (GO:0001558),0.2320665382510223,0.8319501372131256,0.8040865384615384,0.8707516454721499,1.0,34/204,14.33%,EGFR;PTPRJ;SGK3;CDC42;DCSTAMP;DNPH1;RPS6KA3;IL17RB;RB1;RACK1;SMAD4;TRIM32;BCL2;SDCBP;BST2;MTPN;CXCL16;ESR2;NUBP1;PPP2CA;H3-3A;RTN4;SFRP1;SERTAD2;SLIT3;ST7L;EBAG9;CDKN2C;BRAT1;GJA1;NET1;MFSD2A;DERL2;CRLF3
prerank,melanosome transport (GO:0032402),0.3338570401248207,0.8318842974646056,0.658703071672355,0.870007598993277,1.0,2/18,6.22%,MYO5A;BLOC1S5
prerank,pigment granule transport (GO:0051904),0.3338570401248207,0.8318842974646056,0.658703071672355,0.870007598993277,1.0,2/18,6.22%,MYO5A;BLOC1S5
prerank,positive regulation of interferon-alpha production (GO:0032727),0.33531267194285064,0.8317290680967753,0.6742160278745645,0.8698412394111775,1.0,2/19,3.18%,TLR8;TLR4
prerank,regulation of neuron apoptotic process (GO:0043523),0.25732348793329995,0.8314274503785514,0.7475728155339806,0.8699264404599633,1.0,10/96,6.94%,APOE;NUPR1;LIG4;MEF2C;RASA1;GRN;SNX6;PRKN;BCL2;TNF
prerank,oogenesis (GO:0048477),0.35592891309778263,0.8312157096370388,0.6501831501831502,0.8698708248183444,1.0,7/15,26.18%,NANOS3;HORMAD1;PIWIL2;MDK;MARF1;FMN2;NANOS1
prerank,protein modification by small protein conjugation or removal (GO:0070647),-0.334288262676364,-0.8311746925215646,0.6673913043478261,0.946013385325259,1.0,5/13,22.46%,UBA3;UBA7;SAE1;UBA2;UBA5
prerank,protein targeting to membrane (GO:0006612),0.2564201264451856,0.8306914068119879,0.7421124828532236,0.8703665887727305,1.0,21/83,18.14%,RAB8B;SLC25A17;PXMP2;PIKFYVE;ZDHHC14;PEX26;SDCBP;ZDHHC3;VPS37C;SEC63;MYO1C;CHM;ZDHHC24;RABGEF1;ZDHHC20;PEX14;ICMT;ZDHHC2;GET3;PXMP4;ATG3
prerank,cell-cell junction maintenance (GO:0045217),-0.3508600647549007,-0.8306466537906848,0.6652078774617067,0.9460851299002268,1.0,3/11,10.35%,TJP1;FERMT2;CSF1R
prerank,cognition (GO:0050890),0.28797948124840833,0.8302344145896474,0.6982892690513219,0.8707347315128178,1.0,10/42,17.97%,APP;C5AR1;TNF;CHRNA4;MFSD2A;CBR3;GPR155;ST3GAL4;CHRNB2;JAKMIP1
prerank,negative regulation of reactive oxygen species metabolic process (GO:2000378),-0.2861216200672016,-0.8301098238501605,0.7397260273972602,0.9462524873008638,1.0,6/21,21.31%,BRCA1;SIRT2;ABCD2;SIRT5;PARK7;HDAC6
prerank,regulation of ATP metabolic process (GO:1903578),0.2712283083278836,0.828739286072916,0.7264296754250387,0.8730143177782461,1.0,15/54,21.55%,PRKAG2;PGAM1;ATP7A;NUP133;BEND3;COX7A2L;NUP62;NUP98;EP300;NUP153;ZBTB7A;AK4;SLC2A6;NUP35;RAE1
prerank,regulation of protein-containing complex assembly (GO:0043254),0.24447056149016216,0.8283605706875291,0.7660130718954249,0.873280672784498,1.0,12/110,8.33%,APOE;RPS3;CD36;CDC42;GSK3B;RB1;RACK1;RIOK3;NOP53;SYK;TNF;FNIP1
prerank,nitrogen compound transport (GO:0071705),0.23880527741228857,0.8282959701960918,0.7793190416141236,0.8729465231045397,1.0,25/141,17.79%,TXNIP;SLC16A10;RCN3;CALCRL;RILP;TCN2;LRRC8D;SLC43A2;ABCC1;ARRDC3;RAB7A;CMTM6;SLC38A1;SLC38A2;RAMP2;SLC6A2;SLC23A1;SNX4;SLC7A7;HSP90B1;SLC6A6;MIA3;SLC35F3;SLC36A2;CERT1
prerank,urogenital system development (GO:0001655),0.36934068731816344,0.8281093051818634,0.6715063520871143,0.8728363407146482,1.0,1/11,2.38%,OSR1
prerank,negative regulation of DNA-binding transcription factor activity (GO:0043433),0.23913000895408967,0.8278906931997981,0.7774968394437421,0.8727982680433378,1.0,27/136,19.30%,TCF7L2;CMKLR1;GAS6;ESR1;NUPR1;IRAK3;NFKBIL1;SPI1;RB1;KLF4;CEBPG;ARRB1;SP100;WFS1;ZC3H12A;PKD2;HDAC4;PEX14;KDM1A;GLIS2;ACOD1;PIM1;SUMO1;ID3;EIF2AK4;BRMS1;TRIB1
prerank,regulation of histone H3-K4 methylation (GO:0051569),-0.310404792819027,-0.8275464304104903,0.7056179775280899,0.9504122452660709,1.0,6/16,14.85%,CTNNB1;WDR5;CTR9;BRCA1;AUTS2;DNMT1
prerank,regulation of synapse maturation (GO:0090128),-0.3612524348438001,-0.8275166511684473,0.7305263157894737,0.9495022480185259,1.0,1/10,2.75%,NRXN1
prerank,positive regulation of histone H3-K4 methylation (GO:0051571),-0.32116851310192196,-0.8264604490839669,0.7133182844243793,0.9506096256694482,1.0,6/14,14.85%,CTNNB1;WDR5;CTR9;BRCA1;AUTS2;DNMT1
prerank,regulation of G protein-coupled receptor signaling pathway (GO:0008277),0.2575452295149073,0.8261833527529809,0.7578347578347578,0.8754744299523493,1.0,10/75,11.99%,RASGRP4;GRK5;PDE6A;GUCY2D;ROCK1;ZDHHC3;PPEF1;CALM1;PDE6H;ROCK2
prerank,motile cilium assembly (GO:0044458),0.36791546449487256,0.8261011612589129,0.6831501831501832,0.8751913812300083,1.0,1/12,3.60%,SPATA6
prerank,3'-UTR-mediated mRNA stabilization (GO:0070935),0.35568114462140277,0.8254314413295512,0.6709090909090909,0.8759531850104019,1.0,3/14,9.18%,HNRNPC;MAPKAPK2;MAPK14
prerank,positive regulation of ATPase activity (GO:0032781),-0.24383070249342648,-0.8253730963932734,0.7593123209169055,0.9518208385586421,1.0,14/41,29.07%,ATP1B1;ATP1B2;HNRNPU;SSBP1;DNAJB2;DNAJB11;MSH2;DNAJB1;DHX9;DNAJC9;TPM1;UHRF1;MSH6;DYNLL2
prerank,positive regulation of DNA binding (GO:0043388),0.30207002273902384,0.8248452700406848,0.6883333333333334,0.8765807047939423,1.0,8/31,18.57%,PRKN;RB1;CEBPG;IGF1;NIBAN2;PINX1;PLAUR;TRAF6
prerank,signal peptide processing (GO:0006465),0.37527291806192425,0.8247844453229546,0.6711538461538461,0.8762653696280587,1.0,2/11,5.82%,CLN5;PARL
prerank,telomere capping (GO:0016233),-0.30717154597047147,-0.8238786100373151,0.7095343680709535,0.9537980520850805,1.0,7/16,24.66%,CTC1;STN1;TERF2;DCLRE1B;TFIP11;ACD;RAD50
prerank,negative regulation of synaptic transmission (GO:0050805),0.32472838178086527,0.8237287515054617,0.6625,0.8777969005197227,1.0,7/23,21.08%,TMEM25;ACHE;PTEN;PRRT1;PLK2;SLC30A1;PICK1
prerank,negative regulation of response to biotic stimulus (GO:0002832),0.3114427007602192,0.8235937442602075,0.6828859060402684,0.8775824694057097,1.0,4/26,9.32%,IRAK3;NFKBIL1;PPM1B;CARD16
prerank,negative regulation of cation transmembrane transport (GO:1904063),-0.2931143712263082,-0.8234528982346726,0.7108433734939759,0.9536835531408759,1.0,1/18,0.35%,BIN1
prerank,regulation of cell-cell adhesion mediated by cadherin (GO:2000047),0.3306678437751821,0.8233797768109165,0.689119170984456,0.8775293364722924,1.0,2/19,3.88%,ADAM19;RGCC
prerank,hematopoietic stem cell proliferation (GO:0071425),-0.3442935732289128,-0.8226224337771025,0.7160493827160493,0.9543264048515362,1.0,5/11,36.77%,CD34;ARIH2;WNT5A;YJEFN3;SFRP2
prerank,copper ion transport (GO:0006825),0.3721161917384114,0.8224385442827943,0.6902173913043478,0.8787958461208165,1.0,2/11,5.58%,STEAP3;ATP7A
prerank,neurogenesis (GO:0022008),0.2830561586925024,0.8224347607488232,0.7145085803432137,0.8783652472662196,1.0,8/43,13.59%,WNT2;CLN5;BTBD1;CDK6;CXCR4;DCHS1;VXN;TRAK2
prerank,regulation of actin filament bundle assembly (GO:0032231),0.31135847603140704,0.8224216735435063,0.7050610820244329,0.8779452304139046,1.0,6/26,11.99%,CDC42;PRKN;ROCK1;SYNPO;PTGER4;ROCK2
prerank,sprouting angiogenesis (GO:0002040),0.27395297514307027,0.8223573644004484,0.730593607305936,0.8776100192812877,1.0,10/51,16.59%,NRP1;ITGB1BP1;NRARP;NR4A1;EPHB4;LOXL2;RAMP2;PARVA;E2F8;MIA3
prerank,positive regulation of mRNA metabolic process (GO:1903313),-0.3301665406818463,-0.8210526960593111,0.6979166666666666,0.9564487274976522,1.0,3/13,8.76%,PRR5L;CNOT7;UPF1
prerank,"positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",-0.3278369705284364,-0.820163712330341,0.7036247334754797,0.9571939389172246,1.0,5/12,23.12%,CCT7;GNL3L;CCT2;WRAP53;CCT8
prerank,mitotic DNA damage checkpoint signaling (GO:0044773),0.2681374988084727,0.8200590552711218,0.7387518142235123,0.8813365316478198,1.0,7/57,7.70%,BABAM2;WAC;NOP53;CHEK1;BRCC3;TOPBP1;TIPIN
prerank,protein K11-linked ubiquitination (GO:0070979),0.3038507760575741,0.8200494354716682,0.7090301003344481,0.8809119284742488,1.0,8/27,18.64%,UBE2E3;PRKN;CDC27;UBE2D3;ANAPC1;UBE2W;UBE2A;ANAPC10
prerank,positive regulation of production of molecular mediator of immune response (GO:0002702),0.2961443746908513,0.8194581270907852,0.7055016181229773,0.8815090181423554,1.0,7/34,17.66%,PTPN22;NOD2;RBP4;GPI;SCIMP;XBP1;IL6
prerank,integrated stress response signaling (GO:0140467),-0.3256134626788586,-0.8193221677605764,0.6991150442477876,0.9578100775593268,1.0,2/14,9.18%,IMPACT;DDIT3
prerank,regulation of store-operated calcium entry (GO:2001256),0.38008022071040926,0.8187483894502767,0.6551059730250481,0.8823288561540156,1.0,3/10,11.86%,STIM1;HOMER1;SLC8B1
prerank,neuron projection fasciculation (GO:0106030),-0.34971007124231446,-0.8187386602765262,0.7139874739039666,0.9579983736595553,1.0,5/10,29.72%,CNTN4;EPHB2;NRCAM;EPHB3;AMIGO1
prerank,cellular nitrogen compound biosynthetic process (GO:0044271),0.3115891445833974,0.8184880242138785,0.7149837133550488,0.8823274127479158,1.0,3/26,6.07%,GCH1;ACER3;SPTLC2
prerank,positive regulation of transporter activity (GO:0032411),0.36023877231409096,0.818487778942567,0.6805807622504537,0.8818893157207321,1.0,1/13,1.43%,KMT2A
prerank,protein heterooligomerization (GO:0051291),-0.2997760356542309,-0.8178037260434253,0.717948717948718,0.9588573978529237,1.0,8/17,32.48%,CPSF6;FARSA;TMEM120B;FARSB;KCNC2;CPSF7;CBR4;PKD1
prerank,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),-0.2074313084586737,-0.8176112162089665,0.8776223776223776,0.958253706700665,1.0,36/88,31.26%,FBXL18;CUL4A;SKP1;PSMD13;FBXW5;PSMD12;RBX1;FBXL7;PSMD9;CUL2;PSME3;FBXO44;PSMA4;PSMD8;PSMF1;FBXL2;PSMD4;PSMB8;FBXL6;PSME1;FBXL3;FBXO31;FBXL16;KIF14;PSMC2;PSMB10;FBXL12;FBXO4;PSMD3;FBXO2;FBXL14;PSMC5;BTRC;DMAC2;FBXL22;PSME2
prerank,regulation of lymphocyte migration (GO:2000401),0.37952927656286106,0.8173457571838887,0.6765799256505576,0.8835300581211687,1.0,5/10,16.59%,MSN;STK10;SLC8B1;WASL;MIA3
prerank,cellular response to UV-A (GO:0071492),-0.3484071081281104,-0.8173002277254676,0.7267080745341615,0.957893006624163,1.0,6/11,51.19%,CERS1;OPN3;TIMP1;PPID;OPN5;MME
prerank,presynapse organization (GO:0099172),0.3685101044436387,0.8172661200498375,0.647887323943662,0.883237029126112,1.0,1/10,1.45%,C5AR1
prerank,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),-0.2753667247183288,-0.817255344939551,0.7360406091370558,0.9570102659032035,1.0,6/24,22.61%,CALM2;AKAP6;JPH1;CAMK2D;CALM3;JPH3
prerank,positive regulation of protein import (GO:1904591),0.30035822028991077,0.8171353854734021,0.7096774193548387,0.8830325552370315,1.0,6/30,12.28%,CHP2;DMAP1;BAG3;PSEN1;JUP;ZC3H12A
prerank,positive regulation of behavior (GO:0048520),0.38516211485778507,0.816754084585868,0.6783625730994152,0.8832927718671889,1.0,1/10,2.01%,MEF2C
prerank,lipoprotein catabolic process (GO:0042159),0.3672660949471123,0.8164260594629693,0.6853281853281853,0.8834024046877923,1.0,2/11,5.36%,APOE;NOTUM
prerank,apical protein localization (GO:0045176),-0.3595604074665689,-0.8162990255142087,0.7097457627118644,0.9578439543572067,1.0,5/10,14.95%,ATP8B1;MAL;SHROOM2;VANGL2;INSC
prerank,regulation of macroautophagy (GO:0016241),0.2424625606737582,0.8162639797380844,0.7884097035040432,0.8832507141255015,1.0,12/105,8.89%,PRKAG2;SESN1;GNAI3;ATP6V1B1;PRKAG3;ERN1;SNX6;WAC;ATP6V0A1;EXOC4;ATP6V1A;SMCR8
prerank,long-term synaptic potentiation (GO:0060291),-0.2866608455255223,-0.8162313322804586,0.7276995305164319,0.9570246049262516,1.0,5/21,13.19%,PTK2B;SLC24A2;SHANK2;GRIN2A;VAMP2
prerank,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),0.3003242782982062,0.8161597299734851,0.6897106109324759,0.8830285956636712,1.0,3/30,4.76%,RIPK1;HMOX1;GSK3B
prerank,skeletal muscle tissue development (GO:0007519),0.3012269410621115,0.8159049235444886,0.7264,0.8830390118034036,1.0,2/32,3.07%,MEF2C;MYORG
prerank,magnesium ion transport (GO:0015693),-0.32822244124625133,-0.8156267789803338,0.7068965517241379,0.9572044613016932,1.0,7/12,42.10%,NIPA1;TUSC3;MMGT1;NIPAL4;NIPAL3;NIPA2;NIPAL1
prerank,pre-replicative complex assembly (GO:0036388),0.2591883163628215,0.8153932145597509,0.7454289732770746,0.8835180588684487,1.0,11/64,15.90%,PSMA7;RPS27A;ORC5;ORC2;PSMB2;GMNN;PSMA6;PSMA3;PSMD1;PSMD5;MCM8
prerank,regulation of cysteine-type endopeptidase activity (GO:2000116),-0.28505327599960817,-0.8143129609351596,0.7463054187192119,0.9587747909513051,1.0,3/21,5.09%,EPHA7;BIRC2;USP50
prerank,protein localization to cell surface (GO:0034394),-0.2755132231377908,-0.8142942473344935,0.7723970944309927,0.9578709931213967,1.0,14/26,33.65%,CTNNB1;ANK2;ARF6;GGA3;PIGK;SMURF1;FLNA;ANGPT1;EMP2;GGA1;FGF7;MESD;JAM3;FBLN5
prerank,regulation of mitochondrial depolarization (GO:0051900),0.36777161724036844,0.81366988027239,0.6895238095238095,0.8861659416547198,1.0,2/10,6.34%,RACK1;BCL2
prerank,sensory perception of light stimulus (GO:0050953),0.24709342315372115,0.8123971528265793,0.7773109243697479,0.8879590610656417,1.0,11/87,11.68%,ATXN7;RAX;DHRS3;PITPNA;CRYBG3;MYO7A;DRAM2;ATF6;BEST1;MYO9A;WFS1
prerank,regulation of stem cell proliferation (GO:0072091),0.34132351461973176,0.8121877887421262,0.7026086956521739,0.8878701516047985,1.0,8/17,26.04%,ZFP36L1;GJA1;KDM1A;EIF2AK2;PTPRC;AGO3;KDF1;TERT
prerank,ribonucleoprotein complex assembly (GO:0022618),0.23464915292450195,0.8116343134148066,0.8041237113402062,0.8883998372234649,1.0,29/132,15.19%,RPL23A;RPS15;ERAL1;RPSA;RPS28;RSL24D1;RPL24;NOP53;RPL38;PRPF18;RPLP0;RPL5;CELF3;CDC73;RPS14;SNRPG;RPS5;MRPS11;RPL6;GCFC2;GEMIN7;EIF4B;RPL10;LSM4;RAMAC;POLR2D;TXNL4A;RPL11;EIF5
prerank,histone H4-K8 acetylation (GO:0043982),0.34168124922280924,0.8116146513367772,0.703125,0.8875553206650584,1.0,6/15,19.67%,PHF20;KANSL2;KANSL1;KAT7;HCFC1;JADE3
prerank,histone H4-K5 acetylation (GO:0043981),0.34168124922280924,0.8116146513367772,0.703125,0.8875553206650584,1.0,6/15,19.67%,PHF20;KANSL2;KANSL1;KAT7;HCFC1;JADE3
prerank,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.2536315775117912,0.8113901131373735,0.7750342935528121,0.8875016536808574,1.0,15/78,17.42%,EGFR;RGCC;ACTB;CCND3;CCNYL1;CCND2;CCNJ;CDKN2C;LATS2;CCNY;PKD2;HEXIM2;PTEN;NR2F2;GTF2H1
prerank,"regulation of gene expression, epigenetic (GO:0040029)",0.25295607816351956,0.8113146363289487,0.7439544807965861,0.8872030248324327,1.0,20/73,19.66%,PPHLN1;JARID2;SPI1;ACTB;EPC1;POLR1A;TRIM27;POLR1B;H3-3A;MYO1C;DEK;POLR1G;EP300;HDAC4;GLMN;POLR2F;DDX21;CTCF;MECP2;CREBZF
prerank,autophagosome maturation (GO:0097352),-0.25870627685770664,-0.8112054892533892,0.7702020202020202,0.9628393815208262,1.0,12/32,23.38%,TECPR1;RUBCNL;CLN3;VTI1B;MAP1LC3A;GABARAPL1;VIPAS39;ATG14;VAMP7;CHMP3;SNX14;UBQLN1
prerank,response to cholesterol (GO:0070723),-0.29895414420067523,-0.8109492494488761,0.764172335600907,0.9623850768469714,1.0,8/17,21.94%,TGFBR1;GRAMD1A;CCL3;TGFBR2;GRAMD1C;SMO;ABCA2;TGFB1
prerank,protein kinase B signaling (GO:0043491),0.3136387240530227,0.8104018890383977,0.7252173913043478,0.8883999163788083,1.0,4/23,9.90%,GAS6;ZFP36L1;TNF;IGF1
prerank,positive regulation of protein localization to Cajal body (GO:1904871),0.3655600765441024,0.8098583614119735,0.6900584795321637,0.8884627985297077,1.0,3/11,16.82%,LARP7;CCT6A;CCT3
prerank,regulation of protein localization to Cajal body (GO:1904869),0.3655600765441024,0.8098583614119735,0.6900584795321637,0.8884627985297077,1.0,3/11,16.82%,LARP7;CCT6A;CCT3
prerank,cell differentiation in hindbrain (GO:0021533),0.3714870424283634,0.8093433140243731,0.6854368932038835,0.8888852354273385,1.0,2/11,5.58%,OPHN1;ATP7A
prerank,regulation of ubiquitin-protein transferase activity (GO:0051438),0.2958299459713666,0.8091994664053404,0.714527027027027,0.8887004388598426,1.0,3/29,7.74%,FBXW7;AXIN1;ARRDC3
prerank,prostanoid biosynthetic process (GO:0046457),-0.3092606040739909,-0.8089259531783276,0.7066666666666667,0.9651676004875522,1.0,7/15,25.30%,DAGLB;PTGS1;PTGES3;MIF;PTGIS;PTGDS;PRXL2B
prerank,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",0.25617085549751467,0.8082284045847633,0.7702127659574468,0.889953151194657,1.0,23/72,20.20%,RPL26;RGCC;SFN;FOXM1;ATRX;ARID3A;MDM2;RPS6KA6;SP100;TFDP1;EP300;CNOT9;PRMT1;E2F8;CNOT11;CNOT6L;BATF;CNOT4;PLK2;BCL3;CNOT1;CNOT8;PCNA
prerank,keratan sulfate biosynthetic process (GO:0018146),-0.2731607936179603,-0.808095304651283,0.7764127764127764,0.9657297667718444,1.0,10/26,26.16%,ST3GAL6;CHST1;B4GALT4;CHST2;ST3GAL3;B3GNT2;ST3GAL2;FMOD;PRELP;B4GALT2
prerank,epidermis development (GO:0008544),0.26255460727864743,0.8080799788913743,0.7701492537313432,0.8897748530343019,1.0,2/56,4.62%,EMP1;GRHL2
prerank,epithelial cell development (GO:0002064),0.318379139774172,0.8073590471072123,0.7142857142857143,0.8905566380653669,1.0,2/20,4.62%,EXPH5;GRHL2
prerank,negative regulation of T cell differentiation (GO:0045581),-0.3532570219393145,-0.8073557929944178,0.7264770240700219,0.9661886998355613,1.0,1/10,2.39%,LAG3
prerank,regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),-0.32617780544936165,-0.80724497117591,0.7361419068736141,0.9654372802618181,1.0,4/12,21.06%,CALM2;GJD3;CAMK2D;CALM3
prerank,serine family amino acid biosynthetic process (GO:0009070),0.36574815021277984,0.8071542613898804,0.6826568265682657,0.8904612825329038,1.0,5/12,24.38%,SERINC3;SERINC5;SRR;PSPH;SEPHS2
prerank,cellular response to BMP stimulus (GO:0071773),0.26235145772356,0.806422430171998,0.7691176470588236,0.8913097497280432,1.0,13/66,15.12%,BMP2;GDF3;USP9X;SMAD4;ACVR2A;USP15;HFE;VSTM2A;HIVEP1;SFRP1;USP9Y;SLC33A1;BMPR1A
prerank,sulfur compound biosynthetic process (GO:0044272),0.24296136591815615,0.8063931966931109,0.7997347480106101,0.89092052951137,1.0,13/104,11.83%,DSE;UST;TPK1;ST3GAL1;MGST3;B4GALT6;CHST12;PAPSS2;MGST1;SLC35B3;B4GALT5;SLC10A7;GCLM
prerank,regulation of cytokinesis (GO:0032465),0.249307651438544,0.8063008873306572,0.7605042016806722,0.8906387795800312,1.0,12/78,13.78%,KIF20B;UVRAG;CDC42;RHOA;PKN2;KLHL13;BIRC6;CUL3;CALM1;CETN2;SVIL;RAB11A
prerank,ncRNA transcription (GO:0098781),0.35665286600750773,0.8061398074714451,0.6778398510242085,0.8904533236979429,1.0,7/13,24.65%,ANG;POLR1G;USPL1;SNAPC2;NIFK;CAVIN1;SNAPC3
prerank,negative regulation of mitotic cell cycle (GO:0045930),0.2756959934822055,0.8059147428853011,0.7326589595375722,0.8904017798463657,1.0,5/45,6.61%,ZFP36L2;HECA;ZFP36L1;RGCC;CHEK1
prerank,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),-0.2552562403494341,-0.8058781525449433,0.7875647668393783,0.9670960128975271,1.0,6/35,11.19%,JAK2;OCIAD1;IL10RA;DOT1L;JAK3;ERBB4
prerank,phosphatidylinositol acyl-chain remodeling (GO:0036149),0.3297920938487314,0.8055446333318617,0.696588868940754,0.8905783036452756,1.0,5/17,21.69%,PLA2G2D;PLAAT3;PLBD1;PLA2G4C;LCLAT1
prerank,negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),0.34031702019272353,0.8055046114171021,0.70817843866171,0.8902213028348585,1.0,7/13,25.70%,RACK1;WFS1;BFAR;PPP1R15B;NCK1;UFL1;HSPA5
prerank,pyrimidine-containing compound metabolic process (GO:0072527),0.37587585362404347,0.8049970716175069,0.6795774647887324,0.8906820928619642,1.0,1/11,2.63%,TPK1
prerank,negative regulation of G0 to G1 transition (GO:0070317),0.28339340830373466,0.8049846813327272,0.7282958199356914,0.8902725254354251,1.0,6/36,11.22%,RBBP8;RYBP;EPC1;CHEK1;TFDP1;PHC3
prerank,regulation of nitric-oxide synthase biosynthetic process (GO:0051769),0.3532025010759318,0.8048683876492077,0.6950998185117967,0.8900276282054344,1.0,4/13,12.73%,TLR4;TLR2;NAMPT;NOD2
prerank,response to retinoic acid (GO:0032526),0.2570985015561403,0.8046728451429142,0.7544642857142857,0.8899367023134475,1.0,11/59,14.89%,LYN;RARG;WNT2;OVCA2;WNT6;ASXL1;TRIM16;CREB1;RARA;RBP4;SNW1
prerank,positive regulation of cell adhesion (GO:0045785),0.2539015275262631,0.8046052215167824,0.787661406025825,0.8896206050746026,1.0,7/74,8.49%,PTPRJ;PPP3CA;ALOX15;ADAM9;SYK;TNF;FOXC2
prerank,positive regulation of CREB transcription factor activity (GO:0032793),-0.293354551330875,-0.8043760155088572,0.7470449172576832,0.9687775884580584,1.0,5/18,16.43%,ADCY8;CRTC2;CRTC1;CD200;ADCY1
prerank,tryptophan catabolic process (GO:0006569),-0.3415028429748445,-0.8040625203432428,0.7384615384615385,0.9684379429501709,1.0,5/11,35.78%,KYNU;IL4I1;AFMID;IDO2;HAAO
prerank,regulation of cell cycle process (GO:0010564),0.2392594195896886,0.8039456060505679,0.8172043010752689,0.8903281784928305,1.0,16/104,12.38%,KIF20B;UVRAG;CDC42;SND1;MAD1L1;KLHL13;CEP85;CHEK1;TIPIN;BIRC6;SFRP1;CALM1;CETN2;TTL;CDK13;HORMAD1
prerank,regulation of presynapse organization (GO:0099174),0.32578999893011307,0.8036625758567073,0.7041522491349481,0.8899381572724964,1.0,1/18,0.63%,APP
prerank,regulation of presynapse assembly (GO:1905606),0.32578999893011307,0.8036625758567073,0.7041522491349481,0.8899381572724964,1.0,1/18,0.63%,APP
prerank,pteridine-containing compound metabolic process (GO:0042558),0.3512912213936227,0.8035334653251094,0.7296786389413988,0.8897301296938313,1.0,2/13,10.64%,GCH1;CALM1
prerank,regulation of cardiac conduction (GO:1903779),0.26503870566890814,0.8035105215363664,0.7536656891495601,0.8893492080333139,1.0,11/54,14.90%,ATP2B1;FXYD2;TMEM65;STIM1;ATP2B4;ATP1A4;ATP1A3;ATP1A1;NPPC;ATP2A2;ITPR3
prerank,early endosome to late endosome transport (GO:0045022),0.32330470617933216,0.8034480172596914,0.7341549295774648,0.8890265010114269,1.0,12/20,27.15%,RILP;KIF16B;RAB7A;SNX16;WDR91;EEA1;PIK3C3;RAB5A;STX8;BECN1;LMTK2;HOOK3
prerank,cellular response to exogenous dsRNA (GO:0071360),0.3557672148826691,0.8031429770415591,0.6850828729281768,0.8891291358176421,1.0,1/12,0.80%,COLEC12
prerank,neuron differentiation (GO:0030182),0.22618036544912803,0.8031254444513644,0.8349633251833741,0.8887266741862729,1.0,16/165,8.83%,LRP6;OPHN1;MEF2C;PHOX2A;WNT2;PBX3;MANF;IRX2;WNK1;MYO7A;MTPN;WNT6;NR4A2;LHX5;IRX5;OLIG2
prerank,DNA double-strand break processing (GO:0000729),-0.2940145706183982,-0.8028336885406393,0.7327188940092166,0.9696536903160629,1.0,4/18,8.88%,DNA2;ATM;BLM;BRCA1
prerank,sphingoid metabolic process (GO:0046519),0.352627006526483,0.8025375336115478,0.6978021978021978,0.8893023645173572,1.0,1/12,1.59%,SGPP1
prerank,mitotic intra-S DNA damage checkpoint signaling (GO:0031573),-0.3076138518583801,-0.8023331087344996,0.7523364485981309,0.9695793707487497,1.0,8/15,33.35%,HUS1;FANCD2;CHEK2;NEK11;RAD9A;EME1;MDC1;RAD17
prerank,regulation of endothelial cell chemotaxis (GO:2001026),-0.3082280240608875,-0.8020169733020773,0.7333333333333333,0.9691844591789658,1.0,7/15,32.29%,LGMN;FGF2;NOTCH1;FGF1;PRKD1;SMOC2;MET
prerank,positive regulation of collagen metabolic process (GO:0010714),0.330128481693186,0.8020033049342264,0.7192028985507246,0.889765152645659,1.0,2/17,4.18%,RGCC;VIM
prerank,regulation of histone H3-K9 methylation (GO:0051570),0.37024052118033296,0.8016724575659165,0.6774193548387096,0.8899020609011689,1.0,3/10,15.93%,JARID2;ATRX;KDM1A
prerank,cellular response to purine-containing compound (GO:0071415),0.36717523451838474,0.8016458349444108,0.6827852998065764,0.8895207890072084,1.0,2/10,10.88%,P2RY6;TRPM2
prerank,melanocyte differentiation (GO:0030318),0.3714588076160783,0.8016045682108742,0.696588868940754,0.8891627379897684,1.0,2/11,2.31%,MEF2C;MITF
prerank,regulation of response to interferon-gamma (GO:0060330),-0.31168991319123407,-0.8015525843253215,0.7231121281464531,0.9690561861628778,1.0,2/14,2.98%,JAK2;STAT1
prerank,histone lysine methylation (GO:0034968),0.2887512446033941,0.8015311697065762,0.7432216905901117,0.8888662877743201,1.0,5/33,8.91%,KMT2A;SETDB2;KDM6A;ASH2L;WDR82
prerank,protein insertion into mitochondrial inner membrane (GO:0045039),-0.33393339953357115,-0.8013678931939104,0.76,0.9684255048593579,1.0,5/11,34.54%,TIMM8B;TIMM29;AGK;TIMM13;TIMM10
prerank,DNA duplex unwinding (GO:0032508),-0.23016023072028335,-0.8011847350900096,0.8398791540785498,0.9677856847599933,1.0,9/50,9.42%,GTF2H2;CUL4A;PARP1;DDB2;RBX1;BLM;RECQL5;ERCC2;SSBP1
prerank,translational termination (GO:0006415),0.24574277563907526,0.8009016758686617,0.7852161785216178,0.8894386829153621,1.0,30/95,22.80%,MRPL23;MRPS12;ERAL1;MRPL13;MRPL33;MRPS25;MRRF;MRPS11;MRPL1;MRPL49;MRPL16;MRPS17;ETF1;MRPL44;MRPS34;MRPS14;MRPS30;MRPS15;MRPL4;MRPS31;GSPT1;MTRF1;MRPL28;MRPL30;MRPL48;MRPS27;TRMT112;MRPL40;MRPL22;CHCHD1
prerank,cellular response to drug (GO:0035690),0.30434228803703145,0.800331203650649,0.7166947723440135,0.8899975594511634,1.0,2/25,2.01%,GAS6;MEF2C
prerank,glutathione derivative metabolic process (GO:1901685),0.3147116976648718,0.8002178303344177,0.7145214521452146,0.8893246925997806,1.0,5/20,20.72%,MGST3;MGST1;GSTT1;ESD;GSTA3
prerank,glutathione derivative biosynthetic process (GO:1901687),0.3147116976648718,0.8002178303344177,0.7145214521452146,0.8893246925997806,1.0,5/20,20.72%,MGST3;MGST1;GSTT1;ESD;GSTA3
prerank,regulation of spindle organization (GO:0090224),-0.29411871837979375,-0.7998818584061769,0.7510917030567685,0.9691771382861658,1.0,8/18,23.96%,DYNC1H1;GNAI1;TACC3;NUMA1;PARP3;FSD1;MAP9;DCTN1
prerank,negative regulation of JUN kinase activity (GO:0043508),-0.34172939388390744,-0.7997730184116653,0.734020618556701,0.9684118893145112,1.0,2/10,3.54%,DUSP10;PDCD4
prerank,determination of left/right symmetry (GO:0007368),-0.24344264137977123,-0.7996672111399046,0.8189415041782729,0.9676438231093881,1.0,11/36,23.61%,BBS7;CCDC39;KIF3B;SMO;NOTCH1;DNAH5;MKKS;ODAD2;CCDC40;GALNT11;STIL
prerank,DNA dealkylation involved in DNA repair (GO:0006307),-0.33845469740234746,-0.7996618915548303,0.7351694915254238,0.965770708818183,1.0,5/10,27.59%,ASCC1;ALKBH2;ASCC2;ALKBH5;ALKBH1
prerank,DNA dealkylation (GO:0035510),-0.33845469740234746,-0.7996618915548303,0.7351694915254238,0.965770708818183,1.0,5/10,27.59%,ASCC1;ALKBH2;ASCC2;ALKBH5;ALKBH1
prerank,"transcription, DNA-templated (GO:0006351)",0.22103626300883247,0.7995862829917458,0.8695121951219512,0.8899874203081479,1.0,55/207,20.31%,MAF;MEF2A;RREB1;TCEA2;NFIC;THRB;CBFB;EPC1;TRIM24;NELFA;MED16;NR4A2;RNGTT;IWS1;CDC73;GTF2A2;RO60;NCOA6;GTF3C3;GTF3C6;MED20;POLR2B;TFDP1;GTF2E2;EAF2;FOXO3;DEK;NFIX;GTF2A1;KLF13;NFKBIB;MBD1;MMS19;POLR2D;ELOC;GTF2H3;GTF2B;CRCP;LHX1;TAF12;XBP1;GTF2H1;RRAGC;HIPK3;TEFM;POLR2F;THRA;DDX21;BCL3;TRIP11;AFF4;DTX1;NELFE;CTDP1;SNAPC2
prerank,glycosaminoglycan biosynthetic process (GO:0006024),0.24052268576772112,0.7993665587286837,0.8,0.8899502305782659,1.0,17/95,15.27%,DSE;EXT1;UST;ST3GAL1;B4GALT6;SDC3;CHST12;HS3ST2;SDC4;B4GALT5;SLC10A7;HS3ST3A1;XYLT2;GPC3;CHST3;HEXA;ST3GAL4
prerank,negative regulation of oxidative stress-induced cell death (GO:1903202),0.3032990738155833,0.7991896083658768,0.7448979591836735,0.8898349568155376,1.0,4/26,8.07%,PRKN;PDE8A;HSPB1;FYN
prerank,cAMP metabolic process (GO:0046058),-0.3177450425580784,-0.7988632597015698,0.7408256880733946,0.9662164511701986,1.0,2/13,1.42%,ADCY3;ADCY8
prerank,external encapsulating structure organization (GO:0045229),0.22338651265578596,0.7986384465571724,0.8657074340527577,0.8903728927402291,1.0,30/205,14.16%,TGFBI;ITGA4;APP;ADAM19;ADAMTSL5;ITGB1;ITGA9;CD44;ST7;LOX;ATP7A;ADAMTS19;ADAMTS18;COL22A1;COL9A2;ADAMTS10;ADAM12;DDR2;ADAMTS9;COL14A1;MIA;PXDN;COLQ;MMP28;MMP24;MMP25;NID2;ADAMTS17;COL24A1;ITGB2
prerank,regulation of chromosome organization (GO:0033044),-0.2755169789106201,-0.7983857117644956,0.7821100917431193,0.9660999065310241,1.0,7/22,15.30%,XRCC5;HDAC8;MAPT;UPF1;TERF2;BUB1;SHCBP1L
prerank,nuclear envelope organization (GO:0006998),0.31227750878608257,0.798327431964867,0.7024647887323944,0.8904663345055567,1.0,1/20,1.25%,REEP3
prerank,transport across blood-brain barrier (GO:0150104),0.2471439582400124,0.7978287787160647,0.8,0.890882046397548,1.0,14/83,13.91%,SLC16A7;SLC28A2;CD36;SLC2A4;INSR;ABCC4;SLC29A1;ABCC1;SLC4A4;SLC38A1;ATP2B4;SLC38A2;MFSD2A;ATP1A4
prerank,negative regulation of cell cycle G2/M phase transition (GO:1902750),-0.2191574056175736,-0.7974618860795648,0.8367346938775511,0.9667820228703103,1.0,13/55,18.14%,SKP1;PSMD13;PSMD12;RBX1;FBXL7;PSMD9;PSME3;PSMA4;PSMD8;PSMF1;PSMD4;PSMB8;PSME1
prerank,regulation of gene silencing by miRNA (GO:0060964),-0.2175323407807835,-0.7968235123363688,0.8651026392961877,0.9669761668241185,1.0,23/62,29.33%,EIF4G1;NUP210;RANBP2;FMR1;NUP85;IPO8;POLR2C;SEH1L;TNRC6A;AAAS;DHX9;SEC13;FXR1;AGO1;TGFB1;POLR2L;NDC1;NUP93;NUP50;POLR2I;WTIP;NUP54;NUP214
prerank,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",-0.3137049573963874,-0.7966775975935432,0.7547169811320755,0.9662968663421099,1.0,7/14,26.34%,WDR12;URB1;FTSJ3;BOP1;ZNHIT6;ZNHIT3;DDX18
prerank,regulation of regulatory T cell differentiation (GO:0045589),-0.2800365224229632,-0.7966629886870442,0.7758620689655172,0.9653845764262137,1.0,6/22,15.85%,LAG3;DUSP10;VSIR;FANCA;BCL6;IL4I1
prerank,protein autoprocessing (GO:0016540),-0.2916489861028555,-0.7964106345973514,0.7524038461538461,0.9648977799831951,1.0,6/17,28.76%,HTRA2;FXN;AFG3L2;PIDD1;SPRTN;MYRFL
prerank,determination of bilateral symmetry (GO:0009855),-0.26441852717259706,-0.7962576493607918,0.7909738717339667,0.9642608589448384,1.0,8/24,23.61%,BBS7;KIF3B;NOTCH1;DNAH5;MKKS;ODAD2;GALNT11;STIL
prerank,regulation of stress-activated MAPK cascade (GO:0032872),0.2666364407396177,0.7961826396915247,0.7496206373292867,0.8932089007756858,1.0,13/47,19.12%,EGFR;FOXM1;MAPK8IP2;IGBP1;NOD2;FOXO1;PPIA;MYC;PER1;SCIMP;IGF1R;MID1;EIF2AK2
prerank,regulation of cell aging (GO:0090342),-0.3361040296993172,-0.7960728497688878,0.7235772357723578,0.9636660933983833,1.0,3/11,11.84%,NUAK1;NEK6;MIF
prerank,regulation of nervous system process (GO:0031644),0.3249532917518232,0.796043973405418,0.7219343696027634,0.8930025338313111,1.0,5/18,16.42%,APP;NPTX2;ROCK2;BEGAIN;DLGAP4
prerank,positive regulation of histone acetylation (GO:0035066),-0.2723743034386401,-0.7958301442132695,0.7433862433862434,0.9631491382197181,1.0,4/23,9.20%,SMARCB1;MAPK3;BRCA1;WBP2
prerank,peptidyl-lysine methylation (GO:0018022),-0.26546692032160357,-0.7957186505601321,0.7975308641975308,0.9624178734631675,1.0,13/26,37.27%,EHMT2;SETD4;SETD3;SMYD1;EEF2KMT;SETD2;SETD6;SMYD2;METTL18;EEF1AKMT2;METTL21A;SETD7;SUV39H2
prerank,"DNA-templated transcription, termination (GO:0006353)",-0.21036016442866756,-0.794615586233775,0.88,0.9634360022570375,1.0,18/68,23.75%,GTF2H2;SETX;PABPN1;CCNH;UBTF;ERCC2;CSTF2;NCBP1;TAF1C;TAF1D;MAZ;CLP1;MTERF2;GTF2H4;POLR1C;POLR2L;TBP;SLBP
prerank,DNA geometric change (GO:0032392),-0.2682578078143351,-0.7945593955311008,0.7622549019607843,0.9626166828380064,1.0,9/24,24.66%,DNA2;HNRNPA2B1;BLM;RECQL5;DDX1;DHX9;HMGB1;HMGB3;RAD50
prerank,regulation of gene silencing by RNA (GO:0060966),-0.22655184437270598,-0.7942339846769301,0.8166666666666667,0.9613303318561504,1.0,19/50,29.33%,EIF4G1;NUP210;RANBP2;FMR1;NUP85;IPO8;POLR2C;SEH1L;TNRC6A;AAAS;SEC13;AGO1;POLR2L;NDC1;NUP93;NUP50;POLR2I;NUP54;NUP214
prerank,regulation of posttranscriptional gene silencing (GO:0060147),-0.22655184437270598,-0.7942339846769301,0.8166666666666667,0.9613303318561504,1.0,19/50,29.33%,EIF4G1;NUP210;RANBP2;FMR1;NUP85;IPO8;POLR2C;SEH1L;TNRC6A;AAAS;SEC13;AGO1;POLR2L;NDC1;NUP93;NUP50;POLR2I;NUP54;NUP214
prerank,muscle tissue development (GO:0060537),-0.3149773644187311,-0.7939404188727786,0.7266811279826464,0.9609219105778399,1.0,5/13,29.16%,NF1;SMO;ENG;CSRP2;BMP4
prerank,autophagy of mitochondrion (GO:0000422),0.28067892112655385,0.7938022776443338,0.7383900928792569,0.8963568127873508,1.0,15/38,21.05%,PRKN;WIPI1;ULK2;MARK2;ATG7;AMBRA1;RB1CC1;WIPI2;GABARAP;ATG5;BNIP3;ATG3;FUNDC1;FUNDC2;MAP1LC3B
prerank,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),-0.3141727577322354,-0.7937880385992151,0.7370786516853932,0.960261280945026,1.0,3/13,14.90%,CNOT7;TNRC6B;TNRC6A
prerank,regulation of mitotic metaphase/anaphase transition (GO:0030071),0.30158810039081135,0.7937447583458059,0.7361563517915309,0.896028478269392,1.0,5/26,9.68%,DUSP1;RB1;CDC27;NSMCE2;CUL3
prerank,sensory perception (GO:0007600),0.277483591178483,0.7935509742390368,0.746969696969697,0.8959215494168559,1.0,5/45,7.58%,P2RX7;C5AR1;MYO7A;CHRNA4;CCR2
prerank,post-translational protein modification (GO:0043687),0.21076949887478766,0.7928695170644167,0.9078801331853497,0.8966177860573565,1.0,54/332,16.88%,APOE;IGFBP4;APP;CP;FBXW7;ZBTB16;GAS6;PSMA7;DNAJC3;SHISA5;ASB14;FGF23;BTBD1;RHBDD1;NOTUM;KLHL13;FBXL5;KLHL5;ESCO2;PSMB2;UBXN7;ESCO1;COP1;RAB1A;CUL3;FBXO11;CHM;PSMA6;PTP4A2;WFS1;DCAF6;NUCB1;FBXO10;RAB11A;ASB12;HIF3A;SERPIND1;SUMF2;PSMA3;PSMD1;PSMD5;GPC3;ELOC;MELTF;ASB4;FN1;ICMT;FBXW2;ATG5;HSP90B1;MIA3;UCHL3;DCAF8;CUL7
prerank,autophagy of nucleus (GO:0044804),0.33671612895694647,0.792832495991177,0.7221238938053097,0.8962450057233851,1.0,7/16,18.14%,WIPI1;ULK2;ATG7;RB1CC1;WIPI2;ATG5;ATG3
prerank,DNA methylation or demethylation (GO:0044728),0.31994024261240817,0.7928283465268178,0.7190812720848057,0.8953878701481449,1.0,7/19,14.71%,DMAP1;GATAD2A;SPOCD1;ATRX;BEND3;KMT2E;EHMT1
prerank,DNA alkylation (GO:0006305),0.31994024261240817,0.7928283465268178,0.7190812720848057,0.8953878701481449,1.0,7/19,14.71%,DMAP1;GATAD2A;SPOCD1;ATRX;BEND3;KMT2E;EHMT1
prerank,positive regulation of phosphoprotein phosphatase activity (GO:0032516),-0.2974771169201201,-0.7926431753070942,0.7456521739130435,0.9612299845394232,1.0,6/17,24.30%,CALM2;MAGI2;MTOR;PTPA;CALM3;PDGFRB
prerank,mitochondrial translation (GO:0032543),0.23920054761398069,0.7923139539651525,0.7818428184281843,0.8958203090341061,1.0,31/104,22.80%,MRPL23;MRPS12;ERAL1;MRPL13;MRPL33;MRPS25;MRRF;NDUFA7;EARS2;MRPS11;RARS2;MRPL1;MRPL49;MRPL16;MRPS17;MRPL44;MRPS34;MRPS14;MTIF3;MRPS30;MRPS15;MRPL4;MRPS31;MTRF1;MRPL28;MRPL30;MRPL48;MRPS27;MRPL40;MRPL22;CHCHD1
prerank,iron-sulfur cluster assembly (GO:0016226),-0.2630068737541672,-0.7920132305123662,0.7699757869249395,0.9613590895317363,1.0,12/24,27.13%,NFU1;NUBPL;ISCU;FXN;NFS1;ISCA1;CIAO1;BOLA2;GLRX5;HSPA9;CIAO2B;CIAPIN1
prerank,negative regulation of calcium ion transmembrane transport (GO:1903170),0.3516350986971204,0.7919231488009709,0.6972972972972973,0.8960570591346422,1.0,3/10,11.84%,SESTD1;PLN;YWHAE
prerank,cellular amide metabolic process (GO:0043603),0.23686839599955975,0.7918293133038428,0.8306666666666667,0.8957619714603039,1.0,9/102,10.19%,FOLR2;ST6GAL1;ST3GAL1;SGPL1;MTHFD2L;ACOT12;PPP2CA;ORMDL1;PLAAT1
prerank,negative regulation of ion transmembrane transporter activity (GO:0032413),-0.2860763356565557,-0.7914654862179658,0.7729468599033816,0.9613487379087016,1.0,4/20,8.95%,PRKCE;HECW2;ACTN2;HECW1
prerank,positive regulation of long-term synaptic potentiation (GO:1900273),0.34769438856561513,0.7912161879492839,0.7195571955719557,0.8963507069526734,1.0,1/13,0.63%,APP
prerank,nitric oxide metabolic process (GO:0046209),0.3460937162213924,0.7910779258748144,0.724561403508772,0.8961394033530008,1.0,2/14,14.55%,GCH1;ARG2
prerank,low-density lipoprotein particle remodeling (GO:0034374),0.35794333011995,0.7910386744367125,0.710727969348659,0.8957734069977565,1.0,1/11,2.21%,PLA2G7
prerank,"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",0.34496102510945725,0.7907767266569862,0.7238095238095238,0.8957855848667016,1.0,2/13,6.39%,RPS21;NOL9
prerank,endodermal cell differentiation (GO:0035987),-0.2533234202448482,-0.7896810605303577,0.808,0.9634414267667668,1.0,11/31,22.24%,ITGB5;COL11A1;ITGA5;CTR9;PAF1;LAMA3;COL8A1;COL4A2;ITGAV;SETD2;COL6A1
prerank,regulation of cellular protein localization (GO:1903827),0.269837379995886,0.7891476194475171,0.7772795216741405,0.8980256958275576,1.0,11/45,16.01%,RAB11FIP5;VCPIP1;KCNAB2;LCP1;HFE;SPIDR;TRIM67;RALB;GPC3;KDM1A;HSP90AB1
prerank,mitochondrial ATP synthesis coupled electron transport (GO:0042775),-0.21044116637034085,-0.7889148985108888,0.8859060402684564,0.9638173157858605,1.0,19/69,22.10%,COX5B;NDUFS7;NDUFV3;UQCRC1;NDUFAF1;UQCRB;AFG1L;NDUFB8;NDUFB7;COX15;NDUFV1;NDUFB10;SDHAF2;NDUFA8;NDUFA10;UQCR10;NDUFAB1;COA6;NDUFS1
prerank,negative regulation of cell death (GO:0060548),0.2420388783415304,0.788825112996314,0.8052486187845304,0.8981064405177867,1.0,25/88,20.39%,TNFRSF1B;PRKN;PDE8A;KIR3DL2;GSK3B;CD200R1;VPS4B;FYN;PARP16;NUP62;KANK2;CHGA;WFS1;SPEF1;CCN5;TMEM109;ATG5;BNIP3;MECOM;TXNDC12;CCN2;BTBD10;SNCA;GPNMB;DUS2
prerank,negative regulation of autophagy (GO:0010507),0.25754258186889983,0.788693105329091,0.7898550724637681,0.8979060653513106,1.0,11/54,13.90%,NUPR1;PTPN22;MCL1;TBC1D14;BCL2;SMCR8;ATG7;FOXK2;FOXK1;RUBCN;STAT3
prerank,positive regulation of cation channel activity (GO:2001259),-0.23806231602356276,-0.788638967950517,0.8338461538461538,0.9633596123069157,1.0,11/40,23.17%,CALM2;ANK2;CTSS;AKAP6;ACTN2;STAC2;EPHB2;STAC;HAP1;CALM3;STAC3
prerank,organic anion transport (GO:0015711),0.2462063127993403,0.7885941455383295,0.7917771883289124,0.8976455039231229,1.0,14/76,18.52%,LRRC8D;SLC25A17;SLC25A24;ABCC4;SLC4A4;SLC4A5;MGST1;SLCO5A1;SLC2A2;SLC23A1;SLC26A7;SLCO2A1;LRRC8C;SLC25A4
prerank,negative regulation of cell morphogenesis involved in differentiation (GO:0010771),0.35004391332855744,0.7885301762446997,0.6923076923076923,0.8969042940532198,1.0,4/12,15.23%,ITGB1BP1;RCC2;CORO1C;MELTF
prerank,negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),0.35004391332855744,0.7885301762446997,0.6923076923076923,0.8969042940532198,1.0,4/12,15.23%,ITGB1BP1;RCC2;CORO1C;MELTF
prerank,regulation of branching involved in ureteric bud morphogenesis (GO:0090189),-0.30301451032809185,-0.7884289516636135,0.7583732057416268,0.9627901532736409,1.0,7/15,39.74%,PAX8;SMO;AGT;SOX8;BMP4;VEGFA;NOG
prerank,protein localization to vacuole (GO:0072665),0.34457675828516554,0.7881726037811587,0.7104761904761905,0.8971156708868285,1.0,5/13,16.93%,LMBRD1;RTN4;LAMTOR5;SZT2;MFSD1
prerank,branched-chain amino acid metabolic process (GO:0009081),-0.278525767020838,-0.7880694876373806,0.7658536585365854,0.961559681713648,1.0,9/20,28.08%,BCKDHA;ECHS1;ACADSB;IVD;SLC25A44;HSD17B10;BCKDHB;BCAT1;MCCC2
prerank,branched-chain amino acid catabolic process (GO:0009083),-0.278525767020838,-0.7880694876373806,0.7658536585365854,0.961559681713648,1.0,9/20,28.08%,BCKDHA;ECHS1;ACADSB;IVD;SLC25A44;HSD17B10;BCKDHB;BCAT1;MCCC2
prerank,tryptophan metabolic process (GO:0006568),0.3641483830235556,0.7875733951476672,0.747148288973384,0.8976782071620222,1.0,2/11,10.61%,ATP7A;KYAT1
prerank,endochondral bone morphogenesis (GO:0060350),-0.34287243487006575,-0.7875270670249996,0.7360824742268042,0.9615844088553778,1.0,8/11,32.70%,BMPR1B;TMEM119;FOXC1;INPPL1;COL13A1;SCX;BMP4;BMPR2
prerank,double-strand break repair via homologous recombination (GO:0000724),0.24226306328489577,0.7868602329736235,0.8288543140028288,0.8984449006768919,1.0,23/95,17.39%,RBBP8;MCM9;REC8;NSMCE2;YY1;RPA1;RAD54L;RAD52;KDM4D;SPIDR;RPA3;AP5S1;UBE2N;SFR1;MMS22L;SEM1;RAD51B;SAMHD1;SFPQ;FBH1;MCM8;GINS2;NSMCE1
prerank,nitric oxide biosynthetic process (GO:0006809),0.3461028484394826,0.786836892217292,0.7157894736842105,0.898052171316041,1.0,2/13,14.55%,GCH1;ARG2
prerank,negative regulation of blood pressure (GO:0045776),0.35410553621283225,0.7866663833344644,0.728515625,0.8978954217003635,1.0,2/13,15.66%,PRCP;SCPEP1
prerank,regulation of intracellular protein transport (GO:0033157),0.28110304398657887,0.7860487533106176,0.7516025641025641,0.8984993350510714,1.0,10/32,20.04%,KIF20B;LCP1;PCNT;BCAS3;UHMK1;PCM1;PTPN14;OAZ2;NDEL1;OAZ1
prerank,positive regulation of T cell differentiation (GO:0045582),-0.2400166789599139,-0.7860233723804656,0.8315217391304348,0.9631639677445171,1.0,10/36,20.66%,DUSP10;VSIR;NCKAP1L;RHOH;ADAM8;BCL6;IL4I1;SART1;TESPA1;GLI3
prerank,vesicle organization (GO:0016050),0.2681745983489465,0.785926800044971,0.7849624060150376,0.8982788362233829,1.0,16/46,23.68%,EPS15;SRGN;PI4K2B;WASHC4;SNX10;SNX33;WASL;EXOC8;DNAJC13;RAB22A;SAR1B;PI4K2A;LAPTM4B;ARFGEF2;SAR1A;CAV1
prerank,peptide catabolic process (GO:0043171),0.3035056992478412,0.7858449448535195,0.7346600331674958,0.8979959098105583,1.0,3/23,10.23%,CPQ;LNPEP;ENPEP
prerank,glycine metabolic process (GO:0006544),-0.32476413735218973,-0.7856749660231994,0.725,0.9628424863246419,1.0,9/12,47.58%,RIDA;GCSH;SHMT2;GLDC;SDS;GCAT;DLD;AMT;BAAT
prerank,maturation of LSU-rRNA (GO:0000470),-0.2588665549021732,-0.7854115224769681,0.7848970251716247,0.9624012683771329,1.0,7/26,15.80%,NSA2;WDR12;MAK16;URB1;FTSJ3;BOP1;ZNHIT6
prerank,positive regulation of cellular protein metabolic process (GO:0032270),0.23485943249185404,0.785238732862786,0.8326745718050066,0.8985179842685154,1.0,18/101,13.67%,EIF3E;SAMD4A;NIBAN1;RPL26;CLN6;VIM;TRIM32;RPS4X;KLF4;RPL5;LARP4B;MSN;ATG7;CASP8;ATG10;LARP4;PIWIL2;NR1H2
prerank,G1/S transition of mitotic cell cycle (GO:0000082),0.2426337586793563,0.7851543401945953,0.8117816091954023,0.8982458968122752,1.0,22/83,20.20%,PHF8;CDK6;RB1;CDK14;BACH1;CACUL1;CUL3;TFDP1;HINFP;CDK17;EIF4EBP1;TRIM71;CDKN2C;LATS2;CRLF3;MYC;BRD4;CUL5;CAMK2A;PLK2;GSPT1;PCNA
prerank,"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",-0.30644768042066534,-0.7850126687005923,0.7643020594965675,0.9621462392161091,1.0,7/15,23.30%,CSTF2;DDX1;FAM98B;CLP1;RTCB;TSEN54;TSEN15
prerank,monocarboxylic acid biosynthetic process (GO:0072330),0.2536251062874375,0.7849068374135885,0.8044444444444444,0.898228835600438,1.0,4/59,6.24%,ALOX5;OSBPL9;HSD3B7;CYP27A1
prerank,cellular response to interleukin-7 (GO:0098761),0.326749702214599,0.7848368900407027,0.7379310344827587,0.8974951938673674,1.0,5/17,13.90%,TSLP;IRS2;JAK1;CRLF2;STAT3
prerank,interleukin-7-mediated signaling pathway (GO:0038111),0.326749702214599,0.7848368900407027,0.7379310344827587,0.8974951938673674,1.0,5/17,13.90%,TSLP;IRS2;JAK1;CRLF2;STAT3
prerank,DNA damage checkpoint signaling (GO:0000077),-0.2533003663512156,-0.7846566043962687,0.7745098039215687,0.9618132814174098,1.0,8/28,13.94%,ATRIP;ATM;DOT1L;ERCC6;CEP63;HUS1;PRPF19;CHEK2
prerank,cellular response to misfolded protein (GO:0071218),-0.2785873828400254,-0.7842986359671241,0.7801724137931034,0.9615409532324104,1.0,9/20,28.28%,AUP1;BAG6;UFD1;DNAJB14;RNF5;STUB1;TOR1A;DNAJC18;RNF126
prerank,positive regulation of dendritic spine development (GO:0060999),0.3153507470802403,0.7839792944100469,0.7350427350427351,0.8984550061044699,1.0,2/20,7.76%,APOE;PSEN1
prerank,protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),0.2962810733967626,0.7839661405425321,0.7441860465116279,0.8980501048694793,1.0,9/25,18.78%,FBXL17;CUL3;NGLY1;RNF185;UGGT1;POMT2;UBE2W;LONP1;ATXN3
prerank,regulation of systemic arterial blood pressure (GO:0003073),-0.2938335431695749,-0.7839544177090964,0.7670940170940171,0.9611850477129826,1.0,2/16,7.13%,KLK2;SLC2A5
prerank,protein monoubiquitination (GO:0006513),0.27279412491385635,0.7838406518104619,0.782608695652174,0.8978297426476575,1.0,9/36,16.08%,WAC;PRKN;CDC73;UBE2D3;CUL3;UBE2R2;TRIM25;UBE2W;FANCL
prerank,melanosome localization (GO:0032400),0.30350000291486723,0.7834435976814659,0.7048903878583473,0.8980492243845062,1.0,2/21,6.22%,MYO5A;BLOC1S5
prerank,microtubule anchoring at microtubule organizing center (GO:0072393),0.3428897815313863,0.7834173224512498,0.7389635316698656,0.8976749923663706,1.0,3/12,13.96%,NIN;CEP19;PCM1
prerank,C21-steroid hormone metabolic process (GO:0008207),-0.2773606687183907,-0.7833375857479553,0.7795823665893271,0.9612889615217127,1.0,11/20,43.60%,STARD3;AKR1B1;FDX1;HSD17B10;STAR;CYP46A1;TSPOAP1;DHRS9;FDXR;HSD3B2;FDX2
prerank,protein N-linked glycosylation via asparagine (GO:0018279),0.2930827284082731,0.7828986879305049,0.7595993322203672,0.8980746886456267,1.0,7/30,15.21%,ST6GAL1;MGAT2;ALG5;ASGR2;UGGT1;RPN2;MCFD2
prerank,positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),0.3177716290884498,0.7828888864415684,0.726643598615917,0.8976638338128243,1.0,5/17,19.12%,LYN;NOD2;SCIMP;MID1;EIF2AK2
prerank,sphingosine biosynthetic process (GO:0046512),-0.32734896632230437,-0.7825803748437592,0.7553648068669528,0.9607149564430877,1.0,5/11,20.27%,ASAH1;ASAH2;ACER2;SPTLC1;ABCA2
prerank,sphingoid biosynthetic process (GO:0046520),-0.32734896632230437,-0.7825803748437592,0.7553648068669528,0.9607149564430877,1.0,5/11,20.27%,ASAH1;ASAH2;ACER2;SPTLC1;ABCA2
prerank,response to unfolded protein (GO:0006986),0.2639062992859874,0.7823406132493339,0.7873303167420814,0.8980874518485118,1.0,5/48,6.92%,ERN1;PRKN;RHBDD1;BAG3;HSPB1
prerank,negative regulation of actin filament polymerization (GO:0030837),0.30320587764147494,0.7820679309142483,0.7466442953020134,0.8981165890578962,1.0,2/22,4.79%,MYADM;SSH2
prerank,striated muscle tissue development (GO:0014706),-0.24613396848851588,-0.7820036692336314,0.8157248157248157,0.9607717400301959,1.0,5/29,12.36%,SGCD;IGSF8;CFLAR;SGCZ;ZBTB18
prerank,positive regulation of heterotypic cell-cell adhesion (GO:0034116),0.3427642638366866,0.7813784752942313,0.7137745974955277,0.8987757291544668,1.0,2/12,6.94%,CD44;TNF
prerank,response to X-ray (GO:0010165),-0.3000368770131668,-0.7808635290116578,0.7792792792792793,0.9617316725956193,1.0,5/14,17.16%,XRCC5;ATM;BLM;XRCC6;MSH2
prerank,camera-type eye development (GO:0043010),-0.2603122392400344,-0.780582616046456,0.7901554404145078,0.9612583705449903,1.0,4/25,11.72%,TENM3;NF1;SHROOM2;CACNA1C
prerank,establishment of melanosome localization (GO:0032401),0.3101490422810502,0.780510216768349,0.7338983050847457,0.8997283931694604,1.0,2/19,6.22%,MYO5A;BLOC1S5
prerank,protein localization to centrosome (GO:0071539),0.3222285228765156,0.7803169849511908,0.7205623901581723,0.8996263834425176,1.0,4/17,13.96%,PIBF1;CCDC14;SNX10;PCM1
prerank,nuclear pore complex assembly (GO:0051292),0.3564879028393724,0.7803164937245828,0.7391304347826086,0.8992038403876145,1.0,3/10,16.84%,RTN4;NUP98;NUP153
prerank,phosphatidylethanolamine acyl-chain remodeling (GO:0036152),0.30431502001847033,0.7801756351482777,0.7326388888888888,0.8990072916951934,1.0,7/23,24.80%,PNPLA8;PLA2G2D;PLAAT3;PLBD1;PLA2G4C;MBOAT1;MBOAT2
prerank,C21-steroid hormone biosynthetic process (GO:0006700),-0.3143888138951023,-0.7795684854047013,0.7744034707158352,0.9618876835907673,1.0,6/12,30.43%,STARD3;AKR1B1;FDX1;STAR;CACNA1H;TSPOAP1
prerank,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),0.3147453685066626,0.7794611659278803,0.7431506849315068,0.8997330682758733,1.0,5/18,17.09%,PRKN;HSPB1;PPIA;MAPK7;TRAP1
prerank,mitotic G1 DNA damage checkpoint signaling (GO:0031571),0.2519909568178205,0.7793100980540779,0.7893217893217893,0.8995349429343004,1.0,18/63,20.20%,WAC;RPL26;RGCC;SFN;ARID3A;MDM2;TFDP1;EP300;CNOT9;PRMT1;E2F8;CNOT11;CNOT6L;CNOT4;PLK2;CNOT1;CNOT8;PCNA
prerank,peroxisome organization (GO:0007031),-0.25614337759463657,-0.7792866199242859,0.784841075794621,0.9614283420330803,1.0,10/25,29.43%,PEX6;ABCD2;PEX10;PEX3;PEX11B;PEX19;FIS1;ACOT8;PEX11G;TMEM135
prerank,glucan catabolic process (GO:0009251),-0.2995855390974828,-0.7790736557708103,0.7680851063829788,0.9608930793407092,1.0,9/15,33.17%,PHKB;GAA;PYGL;PHKA2;PGM2;PYGB;AGL;PHKG1;PYGM
prerank,organelle transport along microtubule (GO:0072384),0.2854798691371489,0.7790546161939244,0.75,0.8995234760485316,1.0,10/31,20.59%,ARHGAP21;CDC42;RAB1A;BORCS5;PAFAH1B1;TRAK2;PEX14;UXT;NDEL1;TRAK1
prerank,entry into host (GO:0044409),0.3361893262632764,0.7789962923372298,0.7359855334538878,0.8991936547841688,1.0,3/13,7.44%,CBL;CTNND1;CXCR4
prerank,muscle contraction (GO:0006936),0.22728688066268435,0.7785415390483558,0.8658064516129033,0.8994915114731719,1.0,19/126,15.49%,TMOD1;MYH6;MYOM2;TNNT1;UTRN;MYOF;VIM;TMOD3;ROCK1;ADRA1A;VCL;CALM1;PXN;CRYAB;ROCK2;NEB;TPM3;MYBPC3;CLCN1
prerank,cellular response to heat (GO:0034605),0.2777629443623782,0.7785166142582933,0.7770800627943485,0.8991031322170859,1.0,9/35,18.84%,HMOX1;ANO1;BAG3;HSBP1;YWHAE;POLR2D;HSP90AB1;ATXN3;SUMO1
prerank,regulation of AMPA receptor activity (GO:2000311),-0.26164563271553204,-0.7778149314072837,0.8328840970350404,0.9620166825784467,1.0,9/25,19.51%,NLGN1;SHANK1;GSG1L;CACNG7;MINK1;CACNG8;SHISA7;CACNG4;CACNG2
prerank,inner dynein arm assembly (GO:0036159),-0.341384951658907,-0.7777267591347865,0.7710843373493976,0.9612684426704944,1.0,6/10,41.68%,CCDC39;CCDC40;DNAI3;DNAAF1;DNAH1;CFAP100
prerank,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",0.2833335004455753,0.7776153332007105,0.7920792079207921,0.900130653553016,1.0,12/31,22.11%,DCP1A;DDX6;DCP2;EXOSC8;DIS3L2;LSM4;LSM2;EXOSC1;HBS1L;CNOT8;PATL1;EXOSC3
prerank,UV protection (GO:0009650),0.35916470988979443,0.7775279493806405,0.7346938775510204,0.8998418927519003,1.0,2/10,11.59%,MFAP4;XPA
prerank,brain morphogenesis (GO:0048854),-0.32279089047394927,-0.7772137963459049,0.759825327510917,0.9611983270703883,1.0,4/12,21.47%,CTNNA2;SPEF2;BBS4;MKKS
prerank,extracellular structure organization (GO:0043062),0.21682178907826546,0.7771652757645072,0.8916666666666667,0.8999820880079296,1.0,30/204,14.16%,TGFBI;ITGA4;APP;ADAM19;ADAMTSL5;ITGB1;ITGA9;CD44;ST7;LOX;ATP7A;ADAMTS19;ADAMTS18;COL22A1;COL9A2;ADAMTS10;ADAM12;DDR2;ADAMTS9;COL14A1;MIA;PXDN;COLQ;MMP28;MMP24;MMP25;NID2;ADAMTS17;COL24A1;ITGB2
prerank,positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),0.31027730809139,0.7771330991102937,0.7564322469982847,0.8996137973558928,1.0,5/21,15.12%,ERN1;P2RY6;IGF1;GJA1;BMPR1A
prerank,endodermal cell fate commitment (GO:0001711),-0.33311613050158423,-0.7770371984603269,0.7505070993914807,0.9605706816223434,1.0,2/10,10.85%,CTR9;PAF1
prerank,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),-0.22935982251709378,-0.7767034440139133,0.8698060941828255,0.9601972997681424,1.0,4/43,4.14%,DDX5;TP53;ETS1;FGF2
prerank,endothelial cell differentiation (GO:0045446),0.3409826321118948,0.77648945227086,0.722735674676525,0.9002254320346064,1.0,1/12,1.94%,JAG1
prerank,regulation of nuclear division (GO:0051783),0.3093261509729238,0.7762634441632422,0.745674740484429,0.900160493537683,1.0,5/20,21.80%,KIF20B;CDK13;CUL7;DAPK3;BORA
prerank,ventricular cardiac muscle tissue development (GO:0003229),-0.26767365398327503,-0.7760609309372779,0.8035714285714286,0.9603171995309577,1.0,6/23,16.41%,SMAD7;FGFR2;TGFBR3;PROX1;HOPX;ID2
prerank,aromatic amino acid family catabolic process (GO:0009074),-0.2995350586134112,-0.7760192889266829,0.7821100917431193,0.9594936251932684,1.0,3/15,15.85%,KYNU;FAH;IL4I1
prerank,replicative senescence (GO:0090399),-0.3135145600032261,-0.7756404214091571,0.7986725663716814,0.9591894752811372,1.0,4/12,18.67%,TP53;ATM;CHEK2;SERPINE1
prerank,negative regulation of cytoskeleton organization (GO:0051494),0.2831603839117287,0.7754181009577655,0.7661538461538462,0.9011349761629744,1.0,5/29,9.33%,MYADM;PRKN;SSH2;SMAD4;CLASP1
prerank,mitochondrial translational termination (GO:0070126),0.24005762990902949,0.7749713751105335,0.8135593220338984,0.90145473860434,1.0,27/88,22.80%,MRPL23;MRPS12;ERAL1;MRPL13;MRPL33;MRPS25;MRRF;MRPS11;MRPL1;MRPL49;MRPL16;MRPS17;MRPL44;MRPS34;MRPS14;MRPS30;MRPS15;MRPL4;MRPS31;MTRF1;MRPL28;MRPL30;MRPL48;MRPS27;MRPL40;MRPL22;CHCHD1
prerank,gas transport (GO:0015669),-0.33779417934003914,-0.7749350068484655,0.7586206896551724,0.9593869329508572,1.0,1/10,0.98%,IPCEF1
prerank,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),0.2812762086097702,0.7748106420335594,0.767479674796748,0.9012675365220246,1.0,8/33,16.22%,CDK6;RB1;KLF4;CDC73;KANK2;CDKN2C;PKD2;PTEN
prerank,positive regulation of cell adhesion mediated by integrin (GO:0033630),0.3181603429695293,0.7747616555059549,0.7611111111111111,0.9009262262849119,1.0,5/17,17.02%,ADAM9;SYK;FOXC2;CCL5;PODXL
prerank,autophagy of peroxisome (GO:0030242),-0.31883370177515924,-0.7744232245455481,0.7741935483870968,0.9592658456446058,1.0,2/12,5.66%,ATM;PIK3R4
prerank,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),0.29215419074689597,0.774265903631972,0.7646076794657763,0.9012701719036127,1.0,6/26,13.05%,RPS27A;ALPK1;RIPK2;CASP8;NOD2;UBE2N
prerank,mesenchymal cell development (GO:0014031),-0.2847813400181462,-0.7729572672937794,0.7845804988662132,0.9606502398685898,1.0,7/18,24.83%,CDH2;KLHL12;NOTCH1;SOX11;FOXC1;TAPT1;SOX8
prerank,positive regulation of protein targeting to membrane (GO:0090314),0.2988071473026549,0.7727090273197261,0.7677966101694915,0.9032943124293479,1.0,5/24,14.16%,ITGB1BP1;FYN;MYO1C;KCNB1;ITGB2
prerank,glycerophospholipid metabolic process (GO:0006650),0.23884061692723402,0.7726141831672033,0.8337950138504155,0.9030260664947992,1.0,15/75,16.55%,PLA2G7;SYNJ1;IP6K3;CPNE7;PLCD1;PLA2G2D;PIP5K1A;DGKH;HDHD5;PLAAT1;PLCB3;PAFAH1B1;FAR1;PIGQ;PIGX
prerank,positive regulation of histone methylation (GO:0031062),0.29468519325092474,0.7725810025298908,0.7748776508972267,0.9026610736201603,1.0,3/24,5.19%,KMT2A;JARID2;SMAD4
prerank,regulation of vascular associated smooth muscle cell migration (GO:1904752),0.3433506677541059,0.7724389886928367,0.7352415026833632,0.9024613390085447,1.0,2/12,10.08%,MEF2C;DOCK7
prerank,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),-0.2524592928836442,-0.772363316785631,0.8049382716049382,0.9606784331834148,1.0,1/29,0.11%,CADM1
prerank,endocardial cushion development (GO:0003197),-0.26541678198284135,-0.7723228800206897,0.7939914163090128,0.959868056601476,1.0,6/21,19.41%,ACVR1;CRELD1;MDM4;NOTCH1;ENG;TGFB2
prerank,positive regulation of receptor internalization (GO:0002092),0.2964323650401157,0.7721482664659708,0.7614213197969543,0.9025005605651777,1.0,3/22,10.21%,TBC1D5;INSR;ARRB1
prerank,negative regulation of TOR signaling (GO:0032007),0.2699248293244859,0.7721003223127227,0.7795275590551181,0.9021582907123172,1.0,4/36,8.33%,DEPTOR;SESN1;NPRL3;FNIP1
prerank,positive regulation of immune system process (GO:0002684),0.32277694345582464,0.7720940251873896,0.7712765957446809,0.9017474699225285,1.0,1/16,1.12%,IL15
prerank,neuromuscular synaptic transmission (GO:0007274),0.3146665345750458,0.7715586353473224,0.7387687188019967,0.9021670711880293,1.0,4/18,17.25%,FCHSD2;ERC2;RIMBP2;CHRNB2
prerank,cGMP biosynthetic process (GO:0006182),0.353763623800488,0.771506411052936,0.7392120075046904,0.9018224421973029,1.0,2/10,13.93%,GUCY2D;NPPC
prerank,positive regulation of receptor signaling pathway via STAT (GO:1904894),0.30009809089733835,0.7713596954700633,0.7713248638838476,0.9016386049191072,1.0,8/22,18.04%,TSLP;IL10RB;TNF;CRLF2;CRLF3;CCL5;IL6;F2R
prerank,histone methylation (GO:0016571),-0.25931547816697376,-0.7713564515739458,0.8248730964467005,0.9604355856620466,1.0,12/26,37.27%,EHMT2;SIRT7;PRMT2;CARM1;SMYD1;SETD6;EZH2;SMYD2;PRMT8;FBL;PRMT7;SUV39H2
prerank,hexose transmembrane transport (GO:0008645),-0.26844527421136477,-0.7712607952161592,0.8357487922705314,0.9596969442990514,1.0,6/21,22.65%,SLC2A9;SLC2A5;SLC50A1;SLC45A3;SLC2A3;SLC45A1
prerank,alpha-amino acid metabolic process (GO:1901605),0.2632762180481543,0.7705881290675684,0.8066561014263075,0.9024477055095291,1.0,9/45,17.62%,ATP7A;THAP4;GNMT;KYAT1;ASS1;GLS2;GLUD1;NOX4;RIMKLA
prerank,positive regulation of mitochondrial fission (GO:0090141),0.32346904138217475,0.770384424115292,0.7569060773480663,0.9023439098585093,1.0,2/18,4.25%,PRKN;MCU
prerank,intracellular protein transport (GO:0006886),0.20652795099779053,0.7702219988099905,0.9363128491620112,0.9022083599971835,1.0,35/304,10.54%,SNX9;TBC1D5;TBC1D4;RAB31;SNX8;CLTC;EVI5;USP6NL;PRICKLE1;CD74;SNX6;SNX27;EHD1;AP3B1;RIC1;TBC1D14;TMED10;SYK;IPO11;AP4S1;BAG3;TBC1D2B;RABGAP1L;SGSM1;NUP133;RAB7A;STX7;RAB14;RAB1A;RAB23;LAMP2;ARL4A;NUP62;MYO1C;WLS
prerank,diterpenoid metabolic process (GO:0016101),0.2514375846987979,0.7701024113307275,0.8287769784172662,0.9019630029935463,1.0,9/55,18.29%,APOE;DHRS3;SDC3;SDC4;RBP4;GPC3;RDH5;RBP1;ABCA4
prerank,establishment of spindle orientation (GO:0051294),-0.2459631963847972,-0.7700477077576742,0.8225,0.9607223597807172,1.0,11/28,25.00%,LLGL1;NSFL1C;NUMA1;INSC;MAP4;LLGL2;SPDL1;NDC80;ZW10;DCTN1;MAD2L1
prerank,nuclear pore organization (GO:0006999),0.3257419396555582,0.7696884999148088,0.7388059701492538,0.902203641065346,1.0,5/14,21.42%,NUP133;RTN4;NUP98;NUP153;NUP35
prerank,tRNA wobble uridine modification (GO:0002098),0.3257818473397814,0.7687525091130051,0.7341772151898734,0.9032441824090549,1.0,4/14,13.88%,URM1;DPH3;ELP4;CTU1
prerank,pyrimidine nucleoside metabolic process (GO:0006213),0.33579845155697513,0.7686260544512861,0.7427536231884058,0.9030240204432708,1.0,1/14,1.73%,DPYD
prerank,purine-containing compound salvage (GO:0043101),0.34346477017034305,0.7684979314340932,0.7276051188299817,0.9028169716611448,1.0,2/12,10.48%,ADK;AMPD3
prerank,protein localization to organelle (GO:0033365),0.22365315080896,0.7679418119136319,0.8813775510204082,0.9032637191224785,1.0,22/133,13.78%,APP;LAMP3;HMOX1;EHD1;LAMP1;SERP1;UBAC2;PIKFYVE;LMBRD1;RPA1;DCP1A;TRAM2;MDM2;LAMP2;PACSIN2;CD68;SNX10;XPA;YWHAE;VAPA;CNTLN;RAB11A
prerank,bicarbonate transport (GO:0015701),-0.2583114485629225,-0.7677121967891771,0.8112244897959183,0.9634931524188346,1.0,6/25,19.19%,SLC4A10;SLC4A2;CYB5R1;CA2;CFTR;SLC4A3
prerank,nucleosome organization (GO:0034728),0.2511257629116622,0.7676808445741957,0.8260211800302572,0.9032650934267842,1.0,18/55,22.30%,PADI4;DMAP1;ATRX;LIN54;H3-3A;POLE3;SMARCD1;ARID1A;ANP32B;ASF1A;SRCAP;CTCF;SET;NAP1L2;ANP32E;CHAF1B;GRWD1;NPM1
prerank,endocardial cushion morphogenesis (GO:0003203),-0.27546158036468915,-0.7671780432092744,0.7945492662473794,0.9634495654548437,1.0,6/18,19.41%,ACVR1;MDM4;TGFBR2;NOTCH1;ENG;TGFB2
prerank,peptidyl-asparagine modification (GO:0018196),0.2826235466003352,0.7669101547949914,0.7944078947368421,0.9040989550357119,1.0,7/31,15.21%,ST6GAL1;MGAT2;ALG5;ASGR2;UGGT1;RPN2;MCFD2
prerank,negative regulation of cell communication (GO:0010648),-0.26967352593505967,-0.7662201450350252,0.8135964912280702,0.9640509536390527,1.0,3/21,12.64%,ACVR1;UBASH3B;GLRA1
prerank,positive regulation of defense response to virus by host (GO:0002230),0.2925837937011286,0.7655211879193666,0.7743506493506493,0.9057066608429928,1.0,2/24,2.74%,PTPN22;LILRB1
prerank,cellular response to virus (GO:0098586),0.27884502071322764,0.7640895387277137,0.7814992025518341,0.9074555468829233,1.0,8/30,18.60%,CCL19;GSDME;RIOK3;MAPK14;ZC3H12A;CCL5;IL6;RRP1B
prerank,spermatid development (GO:0007286),-0.23843817783264892,-0.7638027418779606,0.8564476885644768,0.9668078344940736,1.0,7/32,24.16%,JAM2;NECTIN2;IQCG;NME5;BBS4;MKKS;SYCP3
prerank,activation of NF-kappaB-inducing kinase activity (GO:0007250),-0.297097969910025,-0.7636494986694099,0.7876984126984127,0.966153244746793,1.0,7/14,38.68%,COPS8;TLR3;TRAF2;MALT1;IRAK1;CARD10;MAP3K7
prerank,mitochondrial ATP synthesis coupled proton transport (GO:0042776),0.321975039282519,0.7636490027428939,0.7522123893805309,0.907744638690623,1.0,5/16,18.62%,ATP5PO;ATP5MC2;ATP5F1E;ATP5MC1;ATP5MF
prerank,lipid translocation (GO:0034204),0.3028179439806973,0.7635426533771255,0.7508710801393729,0.9074761963534002,1.0,4/21,10.78%,ATP11C;ATP8B4;ABCC1;ATP10B
prerank,cell cycle G1/S phase transition (GO:0044843),0.24961176579236377,0.7635385071308177,0.8173652694610778,0.9070655336607223,1.0,17/61,19.33%,PHF8;CDK6;RB1;CACUL1;CUL3;HINFP;EIF4EBP1;TRIM71;MAP3K11;CDKN2C;LATS2;CRLF3;MYC;CUL5;CAMK2A;PLK2;GSPT1
prerank,cellular response to glucose starvation (GO:0042149),0.26200365129685993,0.7632509049245771,0.8221528861154446,0.9070938289771799,1.0,4/41,4.05%,PRKAG2;SESN1;PRKAG3;MTMR3
prerank,negative regulation of phosphoprotein phosphatase activity (GO:0032515),0.2998890375891217,0.7632367628440503,0.7625649913344887,0.9066975592708432,1.0,4/22,11.99%,GSK3B;ROCK1;TNF;ROCK2
prerank,positive regulation of endopeptidase activity (GO:0010950),-0.25199191186882125,-0.7627582223593284,0.84251968503937,0.9666137940011481,1.0,4/26,5.87%,MBP;VSIR;USP50;APH1A
prerank,negative regulation of smoothened signaling pathway (GO:0045879),0.2905914447024205,0.7619973186019975,0.7813021702838063,0.9081215394463426,1.0,6/23,19.31%,HERC4;RACK1;GPC3;GPR161;GLIS2;ENPP1
prerank,response to UV (GO:0009411),0.2235642385778603,0.761134094283432,0.8573333333333333,0.9089773609883722,1.0,25/95,19.40%,EGFR;RPL26;RHBDD1;PTPRK;TRIM32;YY1;MFAP4;ZRANB3;RHNO1;CREBBP;XPA;POLH;EP300;USF1;USP28;MYC;USP47;KDM1A;ATR;RELA;UBE4B;UBE2A;ZBTB1;EIF2AK4;BCL3
prerank,regulation of actomyosin structure organization (GO:0110020),0.3282806030864964,0.760677417975772,0.7208413001912046,0.9092149734285628,1.0,4/13,11.99%,CDC42;ROCK1;PTGER4;ROCK2
prerank,C4-dicarboxylate transport (GO:0015740),-0.2978512271875423,-0.7600296727160427,0.7986870897155361,0.9697131574227937,1.0,6/14,24.81%,SLC1A1;SLC25A14;SLC25A22;SLC25A10;SLC1A2;SLC25A13
prerank,eye development (GO:0001654),-0.21074656731055783,-0.7597561720350723,0.8871951219512195,0.9692523116548163,1.0,15/54,22.78%,PBX2;BMPR1B;RAB18;MEIS3;SHROOM2;CACNA1C;MEIS1;SMG9;HIPK1;PBX1;TGFB2;FOXC1;CRYBA4;PBX4;SALL2
prerank,cellular amino acid catabolic process (GO:0009063),0.23214161957274793,0.7593835046916828,0.8457446808510638,0.9107433733564174,1.0,14/87,17.52%,HAL;HDC;DAO;HIBADH;KYAT1;HIBCH;ACAD8;GLS2;GLUD1;SHMT1;ACAT1;HNMT;HYKK;PHYKPL
prerank,positive regulation of sodium ion transport (GO:0010765),-0.30915280947457324,-0.7593720627132479,0.7917570498915402,0.968967371179765,1.0,4/12,23.06%,SCN1B;WNK3;AHCYL1;GPD1L
prerank,establishment of mitotic spindle localization (GO:0040001),-0.24640515787605732,-0.7584087649418607,0.8542199488491049,0.9695139492553982,1.0,11/28,25.00%,CLASP2;NSFL1C;NUMA1;INSC;SPDL1;NDC80;NUSAP1;ZW10;ESPL1;DCTN1;MAD2L1
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",0.251049247345094,0.7581461313694373,0.8264094955489614,0.9121811188466477,1.0,17/54,20.20%,RPL26;RGCC;SFN;ARID3A;MDM2;TFDP1;EP300;CNOT9;PRMT1;E2F8;CNOT11;CNOT6L;CNOT4;PLK2;CNOT1;CNOT8;PCNA
prerank,amide biosynthetic process (GO:0043604),-0.22330921000893278,-0.7580801128265791,0.8645533141210374,0.9691109135586565,1.0,17/47,22.64%,SMPD4;ASAH1;ASAH2;CERS4;SAMD8;DEGS1;CERS5;CERS1;FURIN;NMRAL1;SGMS2;SPTLC1;SMPD2;TLCD3B;CERS2;ASMT;AGK
prerank,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),0.2875987416086753,0.7577221888008518,0.7724252491694352,0.9124075670055657,1.0,8/25,16.91%,CDK12;LARP7;NELFA;CDC73;EAF2;CDK13;BRD4;EAPP
prerank,positive regulation of mitochondrion organization (GO:0010822),-0.2105493963074016,-0.7576641413441496,0.89171974522293,0.9688341204744954,1.0,9/57,11.22%,TREM2;FBXO7;TP53;BCL2L11;HTRA2;MLLT11;BMF;TNFSF10;DDHD1
prerank,regulation of cyclin-dependent protein kinase activity (GO:1904029),-0.21488120894301657,-0.7568117241267523,0.9105431309904153,0.9692217813872117,1.0,19/50,32.59%,CCNG2;CCNT2;CCNH;BLM;GADD45A;CDK5RAP3;BCCIP;CDK5R2;CCNG1;CCNK;CDKN3;CCNT1;CCNA2;STOX1;CAMK2N1;CCNE1;CCNB2;CDK7;SERTAD1
prerank,growth hormone receptor signaling pathway (GO:0060396),0.3268585510242845,0.7566373128255818,0.7649122807017544,0.9136047916353819,1.0,4/14,13.90%,LYN;STAT6;PXN;STAT3
prerank,regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),-0.2912571832458579,-0.7566259624685746,0.7985948477751756,0.9686201412370311,1.0,3/15,14.90%,CNOT7;TNRC6B;TNRC6A
prerank,positive regulation of small molecule metabolic process (GO:0062013),0.32319629964891217,0.7565512377025916,0.7809187279151943,0.913311378810042,1.0,2/15,4.79%,ADM;IRS2
prerank,regulation of mitochondrial membrane permeability (GO:0046902),0.303049445794583,0.7564703891066568,0.7557522123893805,0.9130182352943168,1.0,5/18,18.59%,BCL2;SLC25A5;BNIP3;SLC25A4;CAMK2A
prerank,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),0.2676896220653934,0.7563468848611624,0.8245341614906833,0.912792758899134,1.0,7/37,16.22%,MEF2C;ERN1;P2RY6;IGF1;GJA1;BMPR1A;PTEN
prerank,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",-0.2527069092313806,-0.7562827705037636,0.837378640776699,0.9682522761233711,1.0,2/24,1.71%,IRAK2;CYLD
prerank,nucleic acid phosphodiester bond hydrolysis (GO:0090305),0.23908758831427107,0.7562000544269246,0.8467048710601719,0.9126019105056874,1.0,19/72,20.20%,RNASE4;RPS27A;DNASE1L1;RPA1;RNASE6;DCP1A;XPA;ZC3H12A;RPA3;HORMAD1;FBH1;GTF2H3;RFC3;GTF2H1;DXO;ENPP1;POLD2;MRE11;PCNA
prerank,protein O-linked glycosylation via serine (GO:0018242),-0.3349214729543352,-0.7548075912760516,0.8023952095808383,0.9694506578962263,1.0,2/10,8.46%,GALNT3;GALNT13
prerank,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),-0.3184221469426751,-0.7543703216430663,0.7761194029850746,0.9692044440414572,1.0,4/11,11.39%,TP53;ATF6B;DDIT3;ATF3
prerank,homocysteine metabolic process (GO:0050667),-0.3188751573670953,-0.7542443974838944,0.7734553775743707,0.9685129770766745,1.0,5/11,34.62%,MMUT;TST;MTRR;CBS;CTH
prerank,regulation of neural precursor cell proliferation (GO:2000177),0.28924570836616625,0.7535303250049533,0.7831932773109244,0.916068537697087,1.0,4/22,15.93%,NES;TRIM71;MDK;KDM1A
prerank,potassium ion export across plasma membrane (GO:0097623),0.32590036571764913,0.7534562092879421,0.7439703153988868,0.9157545257668827,1.0,3/13,17.48%,KCNQ1;KCNK5;KCNE3
prerank,"protein localization to chromosome, telomeric region (GO:0070198)",-0.29880794931067556,-0.7531524338738937,0.7955555555555556,0.969149054348779,1.0,5/14,21.76%,XRCC5;BRCA2;TERF2;TPP1;ACD
prerank,growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),0.3460465182998155,0.752503302871588,0.7482014388489209,0.9167430832535375,1.0,3/10,13.90%,LYN;STAT6;STAT3
prerank,regulation of isotype switching (GO:0045191),0.33060091602443237,0.7523973320429362,0.7592920353982301,0.916483532358246,1.0,5/14,22.88%,KMT5B;SHLD3;HMCES;SHLD2;TFRC
prerank,negative regulation of fatty acid biosynthetic process (GO:0045717),0.3373547303559937,0.7518949986062489,0.7518382352941176,0.9167957763574551,1.0,2/12,6.29%,PIBF1;ERLIN1
prerank,blood circulation (GO:0008015),0.25563311148624435,0.7518132321066465,0.8256333830104322,0.9164874004357635,1.0,7/49,11.99%,C3AR1;MYOF;ITGB1BP1;ROCK1;PLN;GCLM;ROCK2
prerank,establishment of protein localization to organelle (GO:0072594),-0.20432604218164557,-0.7517833138515102,0.9235668789808917,0.9702767998354382,1.0,29/72,30.04%,HK2;IPO5;IL10RA;APPL1;RANBP17;NUP85;IPO13;RPAIN;IPO8;NXT1;LRSAM1;ZDHHC15;LAMP5;SEC13;PPP1R10;PEX19;TNPO2;E2F3;CSE1L;TSC2;PTTG1IP;NUP93;NUP50;PHB2;NXT2;FAM53A;AKT1;NUP214;EIF4ENIF1
prerank,"negative regulation of translation, ncRNA-mediated (GO:0040033)",0.3381380967063615,0.7513902976583599,0.7686567164179104,0.9163158647642597,1.0,3/11,13.73%,RBM4;TRIM71;TNRC6C
prerank,miRNA mediated inhibition of translation (GO:0035278),0.3381380967063615,0.7513902976583599,0.7686567164179104,0.9163158647642597,1.0,3/11,13.73%,RBM4;TRIM71;TNRC6C
prerank,digestive tract development (GO:0048565),0.2715094199546282,0.7511771819961693,0.791958041958042,0.916213319384086,1.0,2/32,6.94%,EDNRB;TNF
prerank,DNA conformation change (GO:0071103),0.311064709884225,0.7511367769832354,0.7601351351351351,0.9158519286495663,1.0,4/17,16.23%,TOP1MT;HAT1;KAT6A;TOP2B
prerank,vascular transport (GO:0010232),0.23225492432096329,0.7511045477401884,0.8765603328710125,0.9154766789855103,1.0,13/81,13.91%,SLC16A7;SLC28A2;SLC2A4;INSR;ABCC4;SLC29A1;ABCC1;SLC4A4;SLC38A1;ATP2B4;SLC38A2;MFSD2A;ATP1A4
prerank,negative regulation of mononuclear cell migration (GO:0071676),0.3322736698946075,0.7500559339704579,0.7851985559566786,0.9165703623557843,1.0,3/12,16.59%,DUSP1;WASL;MIA3
prerank,regulation of transmembrane transport (GO:0034762),0.27868380237348905,0.7496938092911146,0.8098360655737705,0.9166785686344372,1.0,4/31,7.67%,KCNJ14;ACTB;BCL2;PRKCB
prerank,protein ADP-ribosylation (GO:0006471),0.2847972564378285,0.7494423358468022,0.7904599659284497,0.9166347230778349,1.0,3/28,3.97%,PARP14;PARP8;PARP11
prerank,regulation of translational initiation (GO:0006446),0.24050152154286406,0.7492685943532275,0.8539493293591655,0.9164595450789206,1.0,16/63,16.92%,DNAJC3;CEBPB;EIF3E;HSPB1;RBM4;EIF1;EIF4B;EIF4EBP2;EIF4EBP1;UHMK1;POLR2D;EIF3H;EIF5;PPP1R15B;CCL5;CSDE1
prerank,glucose import (GO:0046323),-0.2977153204862071,-0.7492543175964287,0.7982062780269058,0.9729362863165366,1.0,4/13,23.77%,SORT1;SLC27A4;SLC2A3;SLC27A1
prerank,negative regulation of cell adhesion mediated by integrin (GO:0033629),-0.3286105214532883,-0.7488634054844322,0.7931034482758621,0.9725859862274293,1.0,3/10,18.67%,PDE3B;ACER2;SERPINE1
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",0.34417265469584435,0.748684171499614,0.7630597014925373,0.9168795824345599,1.0,3/10,10.54%,FOXM1;RPS6KA6;SP100
prerank,aerobic electron transport chain (GO:0019646),-0.19991190947647489,-0.748445758368338,0.9435215946843853,0.9722761459536342,1.0,18/68,22.10%,COX5B;NDUFS7;NDUFV3;UQCRC1;NDUFAF1;UQCRB;AFG1L;NDUFB8;NDUFB7;COX15;NDUFV1;NDUFB10;SDHAF2;NDUFA8;NDUFA10;UQCR10;NDUFAB1;NDUFS1
prerank,peptidyl-methionine modification (GO:0018206),-0.30317494972320097,-0.7483736987270628,0.7690677966101694,0.9714861664891492,1.0,4/12,26.57%,NAA60;NAA25;NAA30;METAP1D
prerank,regulation of carbohydrate biosynthetic process (GO:0043255),-0.32324293690375205,-0.7481136249189443,0.779835390946502,0.9709615943956372,1.0,5/10,30.67%,SIRT7;ZNF692;SELENOS;PDK2;DGKQ
prerank,protein secretion (GO:0009306),0.24581263745547302,0.7479859338846049,0.8148148148148148,0.9174919694507602,1.0,10/56,16.72%,STEAP3;RCN3;RAB8B;RAB10;CANX;WLS;PDIA4;RAB3B;MIA3;GOLPH3
prerank,cellular response to hypoxia (GO:0071456),0.2189715644172681,0.7477138251552108,0.900131406044678,0.9174819732349523,1.0,23/126,15.18%,PSMA7;RPS27A;ZFP36L1;HMOX1;RGCC;NOP53;HIGD1A;PSMB2;LIMD1;BACH1;MDM2;CARD16;SFRP1;CREBBP;PSMA6;FAM162A;HIF3A;EP300;PSMA3;PSMD1;PSMD5;ELOC;MYC
prerank,regulation of cellular carbohydrate metabolic process (GO:0010675),-0.2805105056384195,-0.7475114298658206,0.7923250564334086,0.9708899931998952,1.0,3/16,7.49%,SCARB2;PDK1;PDK3
prerank,ubiquinone metabolic process (GO:0006743),-0.2840225876869247,-0.7474436786701396,0.7897091722595079,0.9701152911407898,1.0,4/15,15.43%,COQ8B;PDSS2;AIFM2;COQ7
prerank,double-strand break repair via nonhomologous end joining (GO:0006303),0.2449838039208815,0.7473711767921487,0.8396946564885496,0.9175611958960702,1.0,12/58,17.18%,LIG4;BABAM2;UVRAG;DCLRE1C;BRCC3;NSMCE2;NHEJ1;UBE2N;XRCC4;KDM2A;CYREN;ZBTB7A
prerank,regulation of TOR signaling (GO:0032006),0.24037950210695833,0.7472406906337291,0.8565340909090909,0.9173323959078831,1.0,14/67,18.23%,DEPTOR;GAS6;NPRL3;MIOS;FNIP1;SMCR8;LAMTOR5;HTR6;NPRL2;GOLPH3;GPAT3;LARS1;RHEB;RRAGC
prerank,positive regulation of fatty acid biosynthetic process (GO:0045723),-0.3238644123066943,-0.7464536452838809,0.8,0.9706060219632291,1.0,3/10,16.53%,LPGAT1;ABCD2;SLC45A3
prerank,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),0.31996209747638954,0.7457690492437637,0.7767527675276753,0.919067071735668,1.0,5/14,19.75%,PRKN;CREB3L1;XBP1;TXNDC12;TMBIM6
prerank,phospholipid homeostasis (GO:0055091),-0.31417902732637515,-0.7457591215822027,0.796812749003984,0.9707044819662699,1.0,2/11,6.50%,ABCG1;TLCD2
prerank,regulation of protein localization to nucleus (GO:1900180),0.25385300555065027,0.7453911897932513,0.8419405320813772,0.9191956095929651,1.0,3/43,4.76%,CTNNA1;MFHAS1;GSK3B
prerank,mitotic cell cycle phase transition (GO:0044772),0.21018446853622016,0.7452307304527663,0.9358353510895884,0.9190174725198244,1.0,34/203,15.54%,EPS8;FBXL17;PHF8;NES;CDK6;RB1;CDC27;FOXM1;CCND3;CDK14;CLASP1;CCND2;CCNJ;CACUL1;CUL3;PCNT;DYNC1I2;CETN2;ARPP19;HINFP;YWHAE;EIF4EBP1;TRIM71;CDKN2C;LATS2;PAFAH1B1;CCNY;PCM1;CRLF3;CEP78;HAUS5;ANAPC1;MYC;PPP2R2A
prerank,regulation of centriole replication (GO:0046599),0.2979448616061425,0.7445418316821573,0.7992957746478874,0.9195885218829982,1.0,8/17,25.74%,CEP295NL;NUP62;SPICE1;CEP76;PLK2;NPM1;KAT2B;MDM1
prerank,regulation of signal transduction by p53 class mediator (GO:1901796),0.21362970283362362,0.7444652486899334,0.9257362355953905,0.9192737574383504,1.0,35/148,20.40%,PRKAG2;RPL23;RBBP8;PRKAG3;RPS15;RPL37;RPS20;PHF20;NOP53;CHEK1;TOPBP1;RPL5;RPA1;BRIP1;MDM2;MAPK14;RHNO1;RPA3;PPP1R13B;EP300;KAT6A;EHMT1;RPL11;ATR;TAF12;RFC3;RRS1;PIP4K2A;PIP4P1;CSNK2A2;CSNK2A1;MRE11;USP7;JMY;BRD7
prerank,endoplasmic reticulum mannose trimming (GO:1904380),0.30667982787869025,0.7440916783750102,0.7871621621621622,0.9193859326940156,1.0,5/18,14.11%,RPS27A;AMFR;RNF185;UGGT1;DERL2
prerank,regulation of exit from mitosis (GO:0007096),-0.21968608705884224,-0.7438310693391715,0.9030303030303031,0.9724215486730332,1.0,11/38,20.46%,ANAPC15;SIRT2;ANAPC11;UBE2S;BUB1B;CDC14A;UBE2E1;UBE2D1;UBB;ANAPC5;ZW10
prerank,negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),-0.2911724254648478,-0.7434154828980668,0.7933194154488518,0.9721148634579511,1.0,9/14,36.85%,FGF2;SULF1;GPC1;SPRY1;SPRY4;GATA3;SPRY3;APLN;FUZ
prerank,positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),0.30609136531605924,0.7421836203053566,0.7757352941176471,0.9217366849250941,1.0,4/16,15.06%,PDE6H;CHGA;ACP3;NECAB2
prerank,triglyceride biosynthetic process (GO:0019432),0.30736442088228455,0.7420358077644771,0.7905759162303665,0.9215442067575373,1.0,2/18,4.40%,AGMO;MOGAT2
prerank,amyloid precursor protein catabolic process (GO:0042987),0.31999157095392083,0.7404617136135484,0.7713787085514834,0.9233939583797769,1.0,3/14,9.25%,ADAM19;PSEN1;DYRK1A
prerank,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),-0.2495694168227969,-0.7394259985790903,0.8523316062176166,0.9765465624832874,1.0,10/26,33.29%,CALM2;FMR1;CBARP;GPR35;CALM3;UBQLN1;CRHR1;TLR9;GSTO1;ADRA2A
prerank,positive regulation of macrophage activation (GO:0043032),0.30470765176725456,0.7385952786239393,0.7709790209790209,0.9255568406436248,1.0,2/17,4.14%,TLR4;LBP
prerank,erythrocyte differentiation (GO:0030218),0.2528686573152904,0.73842637322741,0.8433179723502304,0.9253687145953063,1.0,7/44,13.02%,LYN;MFHAS1;CEBPG;RPS14;SH2B3;SLC25A5;KMT2E
prerank,"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",-0.29732953222407127,-0.7384057498114649,0.7961783439490446,0.9769796243174003,1.0,7/13,27.81%,EDEM1;UBE2J1;ERLEC1;BRSK2;BCAP31;YOD1;UBE2G2
prerank,negative regulation of cell cycle process (GO:0010948),-0.201344237165963,-0.7381511203723861,0.9413680781758957,0.9764338556116742,1.0,25/61,31.73%,EHMT2;MGA;TOM1L1;PCGF6;BRCA1;CDC7;CCP110;PCGF2;CBX5;TERF2;RING1;ZFYVE19;RAD51;PPP1R10;BMI1;ESPL1;EZH2;AURKB;CHMP4C;YAF2;BMP4;PHC1;E2F7;FBXO5;CBX3
prerank,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.19734586276275148,0.7381484389469573,0.9544950055493896,0.9253329297219394,1.0,49/314,15.04%,WWP1;FBXW7;SMURF2;PSMA7;RPS27A;FBXL17;SIAH2;SEL1L2;PELI1;RMND5A;PRKN;CLOCK;RB1;SPOP;FBXL5;ERLIN1;CDC27;PSMB2;APPBP2;TBL1XR1;SPOPL;RNF121;MDM2;TBL1X;UBE2K;UBE2D3;COP1;RHBDD2;CUL3;ANAPC16;ARMC8;ZFAND2B;ARRB1;AMFR;PSMA6;FBXO48;WFS1;RNF185;TRIM71;AGAP3;RNF187;BFAR;DERL2;NEDD4L;PSMA3;PSMD1;PSMD5;ANAPC1;RNF122
prerank,regulation of cell cycle phase transition (GO:1901987),-0.186587587410022,-0.7376019911502045,0.9739776951672863,0.9762886028211599,1.0,19/91,16.77%,ANAPC15;TP53;SKP1;PSMD13;PSMD12;ERCC2;PSMD9;ANAPC11;UBE2S;PSME3;BUB1B;PSMA4;PSMD8;PSMF1;PSMD4;UBE2E1;NEK11;UBE2D1;PSMB8
prerank,mitotic G2/M transition checkpoint (GO:0044818),0.25617687256390703,0.7368728629944604,0.8269525267993875,0.9267256805190038,1.0,5/43,7.23%,BABAM2;NOP53;CHEK1;BRCC3;TOPBP1
prerank,serine family amino acid catabolic process (GO:0009071),0.3433884506664356,0.7367969034737923,0.7587476979742173,0.926417203960319,1.0,2/10,13.56%,DAO;SHMT1
prerank,cellular response to superoxide (GO:0071451),0.3357224390649096,0.7361121606033311,0.7814814814814814,0.9269665925691195,1.0,2/10,17.04%,ATP7A;PRDX2
prerank,positive regulation of myeloid leukocyte mediated immunity (GO:0002888),-0.3032275190819036,-0.7357093964890697,0.8134615384615385,0.9778356274009639,1.0,2/11,8.56%,MAVS;CAMK4
prerank,snRNA 3'-end processing (GO:0034472),-0.2689731797780486,-0.7356297191190323,0.8215962441314554,0.9770671448771471,1.0,2/19,8.16%,INTS6L;EXOSC9
prerank,chromosome condensation (GO:0030261),0.2606376252458597,0.7354074071119289,0.8442622950819673,0.9275256442534642,1.0,16/36,27.24%,PHF8;RB1;INCENP;BANF1;SMC4;CSNK2A2;CSNK2A1;SET;ERN2;AIFM1;CSNK2B;MCPH1;PLK1;ACIN1;NCAPD3;CHMP1A
prerank,"wound healing, spreading of cells (GO:0044319)",0.2801165924347063,0.7351711049253793,0.8054607508532423,0.9274406146791435,1.0,3/24,4.01%,CD44;RHOA;LCP1
prerank,cardiocyte differentiation (GO:0035051),-0.3245038100653642,-0.7350716627017831,0.805327868852459,0.9768800610524986,1.0,4/10,19.41%,SIK1;AKAP13;EEF1AKMT4-ECE2;TGFB2
prerank,positive regulation of establishment of protein localization to telomere (GO:1904851),-0.31309026728329903,-0.734348639044817,0.7894736842105263,0.9768825557169025,1.0,4/10,23.12%,CCT7;CCT2;WRAP53;CCT8
prerank,neural tube development (GO:0021915),-0.2858531642582406,-0.733873194887418,0.8488664987405542,0.9766355567838152,1.0,7/15,23.61%,DVL1;PROX1;ALDH1A2;SOX11;TGFB1;DACT1;STIL
prerank,regulation of cell death (GO:0010941),0.22453272265608196,0.7330014199947309,0.9063772048846676,0.9299974404204493,1.0,18/94,16.81%,TNFRSF1B;CD36;PRKN;PDE8A;ACER3;SLC25A24;VPS4B;RIPK2;PARP16;CRYAB;ZC3H12A;SPEF1;CCN5;TMEM109;ATG5;SNCG;BNIP3;CCL5
prerank,negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),-0.3078485678046218,-0.7323662479575546,0.8200455580865603,0.9768140459652778,1.0,1/11,1.86%,CALM2
prerank,negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),-0.3078485678046218,-0.7323662479575546,0.8200455580865603,0.9768140459652778,1.0,1/11,1.86%,CALM2
prerank,positive regulation of double-strand break repair (GO:2000781),-0.22094232038165126,-0.731844885081122,0.895774647887324,0.9766287964007455,1.0,5/39,8.00%,FUS;SLF2;PARP1;ERCC6;ZCWPW1
prerank,regulation of ion transmembrane transporter activity (GO:0032412),0.25145488425686785,0.7305715964615125,0.8541033434650456,0.932843268053333,1.0,8/39,15.47%,FXYD2;RIPK1;UTRN;HOMER1;YWHAE;SCN3B;NEDD4L;FXYD5
prerank,platelet aggregation (GO:0070527),0.26311504237538813,0.7301996098712004,0.8395061728395061,0.9329042019914364,1.0,5/33,8.74%,RAP2B;PDGFRA;ACTB;HSPB1;VCL
prerank,histone acetylation (GO:0016573),0.2295235699405316,0.7294710937809827,0.8733431516936672,0.9334588408336307,1.0,18/69,19.67%,PHF20;SPI1;EPC1;DMAP1;BEND3;TRIM16;POLE3;CREBBP;HAT1;KAT7;EP300;KAT6A;PER1;TAF12;SGF29;ATF2;PHF20L1;JADE3
prerank,positive regulation of cellular carbohydrate metabolic process (GO:0010676),-0.3100148449093297,-0.7293309102497051,0.7940552016985138,0.9788697452142385,1.0,7/10,37.23%,PRKCE;SLC45A3;IRS1;PMAIP1;AKT1;GPLD1;PTH1R
prerank,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),0.26836174205863045,0.7291014236652713,0.830820770519263,0.9335131713002807,1.0,11/29,22.11%,DCP1A;DDX6;DCP2;EXOSC8;LSM4;LSM2;EXOSC1;HBS1L;CNOT8;PATL1;EXOSC3
prerank,telomere maintenance via recombination (GO:0000722),0.32450904634166144,0.7285436298688619,0.7764705882352941,0.9338066362887509,1.0,5/11,24.60%,NSMCE2;SMC6;XRCC3;RAD51D;ERCC1
prerank,protein-DNA complex disassembly (GO:0032986),-0.27607811688281325,-0.7280223720249643,0.84375,0.9796531229493213,1.0,3/16,4.52%,SMARCB1;SMARCC2;SMARCE1
prerank,positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),-0.2950342303823814,-0.7275308179472184,0.8067415730337079,0.9794003042907159,1.0,4/12,24.83%,PAX8;SMO;AGT;SOX8
prerank,diacylglycerol metabolic process (GO:0046339),-0.25002437994622806,-0.7269150464831557,0.8781094527363185,0.9793101120728166,1.0,4/23,9.45%,DGKI;DGKB;DGKZ;DAGLA
prerank,positive regulation of viral transcription (GO:0050434),0.2744964661969202,0.7268383571093608,0.8180272108843537,0.9356909453241533,1.0,7/25,20.13%,MDFIC;NELFA;POLR2B;POLR2D;POLR2F;NELFE;CTDP1
prerank,lysosome organization (GO:0007040),0.2591751076271416,0.7261285116093059,0.8474025974025974,0.9362698341255036,1.0,6/36,10.78%,GRN;CLN5;CLN6;MYO7A;TMEM165;ATP10B
prerank,protein tetramerization (GO:0051262),-0.1911211226633771,-0.7246838021855384,0.9570552147239264,0.9811801112731444,1.0,5/67,4.43%,CPSF6;KCNJ2;FARSA;ACACA;ALDOA
prerank,retinol metabolic process (GO:0042572),0.3089498429185188,0.7239274494567467,0.8257575757575758,0.9387484977984218,1.0,2/14,14.36%,DHRS3;RBP4
prerank,regulation of protein localization to cell periphery (GO:1904375),0.2921926797742072,0.7237176182124664,0.8059440559440559,0.9386039377739105,1.0,3/18,8.48%,SPTBN1;ACTB;STX7
prerank,DNA-dependent DNA replication (GO:0006261),0.2092695321215795,0.7224391320788723,0.9341935483870968,0.9399029360099481,1.0,25/128,17.34%,PSMA7;RPS27A;ORC5;MCMBP;ORC2;POLE2;PRIM2;TOPBP1;PSMB2;RPA1;GMNN;PURA;POLG2;POLE3;PSMA6;RPA3;MGME1;PSMA3;PSMD1;PSMD5;POLE4;MCM8;GINS2;PRIM1;RFC3
prerank,protein localization to kinetochore (GO:0034501),-0.27941923360552806,-0.7223916082535028,0.8232662192393736,0.9830779518796815,1.0,7/14,29.81%,KNL1;SPDL1;ZW10;IK;CDK1;AURKB;TTK
prerank,fatty acid oxidation (GO:0019395),0.23752231843547064,0.7214730082154956,0.8558823529411764,0.9407208039877427,1.0,8/57,14.67%,ALOX15;SLC25A17;EHHADH;ADIPOR2;HADH;HADHA;HADHB;ACAT1
prerank,cellular response to nutrient levels (GO:0031669),0.2299386121901441,0.7207450496425128,0.8826025459688827,0.9411942300394344,1.0,17/62,18.23%,STK24;WIPI1;KLF10;FNIP1;SFRP1;LAMP2;CD68;ATG7;GAS2L1;SREBF2;KCNB1;FOXO1;RALB;MFSD2A;WIPI2;XBP1;RRAGC
prerank,embryonic organ morphogenesis (GO:0048562),0.24604823524567718,0.7203548303998769,0.8366412213740458,0.9412741860208077,1.0,3/42,5.33%,RARG;ALX1;PDGFRA
prerank,renal filtration (GO:0097205),0.3380032199312837,0.7197107043559902,0.7857142857142857,0.9417056360618585,1.0,3/10,10.51%,XPNPEP3;SULF2;MYO1E
prerank,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),0.2716649987026573,0.719646468280347,0.8144329896907216,0.9413676341343811,1.0,2/22,7.60%,ESR1;MED16
prerank,negative regulation of fat cell differentiation (GO:0045599),0.2567019701252714,0.7196463840973502,0.8370607028753994,0.9409464405620614,1.0,6/34,12.87%,ZFP36L2;TRIO;TNF;ASXL1;TRIB2;FOXO1
prerank,7-methylguanosine RNA capping (GO:0009452),-0.23061541834908333,-0.7194390069898255,0.892018779342723,0.984973250263676,1.0,15/31,38.32%,GTF2H2;CCNH;ERCC2;POLR2C;NCBP1;GTF2H4;POLR2L;POLR2I;CDK7;RNMT;POLR2H;ERCC3;GTF2F1;NCBP2;POLR2G
prerank,7-methylguanosine mRNA capping (GO:0006370),-0.23061541834908333,-0.7194390069898255,0.892018779342723,0.984973250263676,1.0,15/31,38.32%,GTF2H2;CCNH;ERCC2;POLR2C;NCBP1;GTF2H4;POLR2L;POLR2I;CDK7;RNMT;POLR2H;ERCC3;GTF2F1;NCBP2;POLR2G
prerank,nucleotide metabolic process (GO:0009117),0.2803094099753035,0.7191629222824037,0.824212271973466,0.9411477123848275,1.0,8/23,21.87%,REXO2;CMPK1;NMNAT3;NMNAT2;AK8;AK4;ME1;RNASEH2B
prerank,JNK cascade (GO:0007254),0.24499222392311162,0.718899680280016,0.8500772797527048,0.9410673834405827,1.0,7/40,13.05%,MAP3K5;RPS27A;RIPK2;PTGER4;MAP3K11;NOD2;UBE2N
prerank,regulation of release of cytochrome c from mitochondria (GO:0090199),-0.21565995949406536,-0.7181256000730472,0.907859078590786,0.9856315637829054,1.0,6/40,11.25%,TP53;BCL2L11;MLLT11;BMF;TNFSF10;FXN
prerank,positive regulation of mRNA 3'-end processing (GO:0031442),-0.3116596936485291,-0.7180106158068146,0.8306122448979592,0.9849081357911119,1.0,3/10,14.43%,PAF1;HSF1;NCBP1
prerank,extracellular transport (GO:0006858),-0.28809671813926296,-0.7177454067050687,0.806841046277666,0.9843401870625612,1.0,6/12,36.07%,SPEF2;CCDC40;CABYR;ARRDC1;DNAAF2;SPA17
prerank,positive regulation of cytokine production involved in immune response (GO:0002720),0.27455748252512324,0.7176322818496232,0.8523131672597865,0.9423044689644476,1.0,6/25,22.27%,B2M;NOD2;SCIMP;TRAF6;PLCG2;KIT
prerank,steroid hormone biosynthetic process (GO:0120178),-0.23095603020517452,-0.7174557307864299,0.895,0.9838367216623456,1.0,16/29,43.60%,STARD3;AKR1B1;FDX1;SRD5A3;STAR;HSD17B2;HSD17B1;HSD17B11;TSPOAP1;HSD17B8;SRD5A2;FDXR;MED1;HSD3B2;HSD17B14;FDX2
prerank,regulation of lipase activity (GO:0060191),-0.2870513229896883,-0.7171467731366269,0.8456521739130435,0.9833612123313981,1.0,4/13,18.04%,LPL;LMF1;FURIN;ANGPTL3
prerank,endoderm formation (GO:0001706),0.25267340173355546,0.716958022181779,0.85,0.9427505884601184,1.0,3/35,7.52%,ITGA4;DUSP1;DUSP2
prerank,digestive tract morphogenesis (GO:0048546),-0.27620653634083525,-0.7167540370099318,0.8336842105263158,0.9829499119883559,1.0,4/14,20.57%,FGFR2;BBS7;ID2;SOX11
prerank,monosaccharide transmembrane transport (GO:0015749),0.3007989183623014,0.7166454009790066,0.8121739130434783,0.9427113053979254,1.0,6/16,20.08%,SLC2A2;SLC23A1;SLC23A2;SLC2A12;SLC5A3;SLC2A6
prerank,pentose-phosphate shunt (GO:0006098),-0.3069654398679239,-0.7166395041002585,0.8466257668711656,0.9822188573253966,1.0,4/11,20.95%,TALDO1;RPIA;PGM2;PGD
prerank,cellular response to decreased oxygen levels (GO:0036294),-0.19775400570796386,-0.7165521996855369,0.9804560260586319,0.9814566734143386,1.0,22/65,28.73%,KCND2;TP53;HYOU1;CPEB2;PGK1;SIRT2;MDM4;EGLN2;TSC1;ADAM8;NDNF;NPEPPS;MTOR;STUB1;EPAS1;HIF1A;UBQLN1;PTGIS;CPEB1;SLC8A3;PMAIP1;OPRD1
prerank,negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),-0.31708562420900144,-0.7163050297740612,0.8364779874213837,0.980880828982748,1.0,2/10,8.69%,PIK3CB;CADM4
prerank,"DNA damage response, signal transduction resulting in transcription (GO:0042772)",0.3254326111583078,0.7160182565135152,0.8250460405156538,0.9431223884236052,1.0,3/11,10.54%,FOXM1;RPS6KA6;SP100
prerank,peptidyl-amino acid modification (GO:0018193),0.3302980092950816,0.7159528776829511,0.7973977695167286,0.9427907008904315,1.0,4/10,23.91%,ATP7A;METAP1;TTLL4;METAP2
prerank,regulation of hematopoietic stem cell differentiation (GO:1902036),0.22669412215125662,0.7149215462343249,0.8955882352941177,0.9437129914826252,1.0,9/70,14.43%,KMT2A;PSMA7;TCF12;CBFB;PSMB2;PSMA6;PSMA3;PSMD1;PSMD5
prerank,negative regulation of neurogenesis (GO:0050768),0.2582915146751458,0.7148819964730995,0.8562300319488818,0.9433464477332163,1.0,6/34,9.90%,RHOA;RAPGEF2;B2M;TNF;ARHGDIA;RTN4
prerank,NLS-bearing protein import into nucleus (GO:0006607),-0.2818447643560793,-0.7146597103615656,0.8329979879275654,0.9819241894876767,1.0,2/13,4.84%,IPO5;RANBP2
prerank,regulation of protein targeting to membrane (GO:0090313),0.26600618580478197,0.7145686140879036,0.8178861788617886,0.9433131970239956,1.0,7/28,19.24%,ITGB1BP1;FYN;MYO1C;KCNB1;ITGB2;MFF;INPP5K
prerank,positive regulation of ubiquitin protein ligase activity (GO:1904668),-0.2901642240790093,-0.7143688864967432,0.8259911894273128,0.9813674093505184,1.0,5/12,29.43%,SKP1;UBE2S;GOLGA2;GORASP1;BTRC
prerank,mRNA modification (GO:0016556),0.2797760351842572,0.7137283536000968,0.8442906574394463,0.9440057775574556,1.0,8/22,23.11%,WTAP;NSUN2;VIRMA;TRMT61B;PUS7;TRMT61A;METTL16;PCIF1
prerank,very-low-density lipoprotein particle assembly (GO:0034379),-0.29101381269322446,-0.7135598247447402,0.8432671081677704,0.9814382233140654,1.0,4/12,26.09%,APOC1;LPCAT3;APOC4;MTTP
prerank,cellular component maintenance (GO:0043954),0.3160554462969302,0.7129038595762566,0.8090909090909091,0.9445970337538124,1.0,4/12,21.08%,INSR;FYN;IGF1R;PICK1
prerank,post-transcriptional gene silencing by RNA (GO:0035194),0.27697077102452633,0.7126122537514812,0.8448566610455311,0.9445518212777614,1.0,10/20,26.46%,MOV10L1;LIMD1;HELZ;TNRC6C;CNOT1;CNOT8;AGO3;AJUBA;CELF1;AGO2
prerank,carbohydrate transport (GO:0008643),0.32536706929910025,0.7123023080953083,0.7922077922077922,0.9445290616222626,1.0,3/11,14.45%,SLC2A2;SLC23A1;SLC23A2
prerank,nucleocytoplasmic transport (GO:0006913),0.2476125416060056,0.7117396987904558,0.8569131832797428,0.9448104262910277,1.0,13/40,22.30%,ATXN1;HTATIP2;SNRPG;RSRC1;GEMIN7;NUP98;XPO1;RGS14;LSG1;SNRPE;SNRPD2;RBM15B;NPM1
prerank,negative regulation of histone methylation (GO:0031061),-0.3047233966234473,-0.711683549118325,0.8340248962655602,0.9826512246537774,1.0,5/10,20.61%,WDR5;BRCA1;DNMT1;PHF1;MTF2
prerank,activation of adenylate cyclase activity (GO:0007190),0.25316982521880277,0.7114612703776881,0.8480620155038759,0.9447413572508627,1.0,5/35,10.30%,ADRB2;DRD1;ADCY9;ACR;TSHR
prerank,glycogen catabolic process (GO:0005980),-0.2728607756226065,-0.7109494321202132,0.8405172413793104,0.9825933910808428,1.0,9/15,33.17%,PHKB;GAA;PYGL;PHKA2;PGM2;PYGB;AGL;PHKG1;PYGM
prerank,mitochondrial translational elongation (GO:0070125),0.22023592713473655,0.7108794112272127,0.9121338912133892,0.9450161867946941,1.0,14/88,14.23%,MRPL23;MRPS12;ERAL1;MRPL13;MRPL33;MRPS25;MRPS11;MRPL1;MRPL49;MRPL16;MRPS17;MRPL44;MRPS34;MRPS14
prerank,internal peptidyl-lysine acetylation (GO:0018393),-0.2340819515692912,-0.7107133027768225,0.8883495145631068,0.9820157230321155,1.0,6/27,14.67%,MORF4L2;BAG6;MRGBP;BRD8;MORF4L1;RUVBL1
prerank,modulation by symbiont of entry into host (GO:0052372),0.292722648775782,0.7098677216100364,0.8202443280977313,0.945855329118907,1.0,4/16,15.82%,TRIM68;TRIM27;EXOC2;TRIM25
prerank,mitochondrial membrane organization (GO:0007006),0.25351513407917986,0.7088502270098156,0.8446280991735537,0.9466689849346066,1.0,8/32,18.52%,APOOL;BCL2;CHCHD3;SLC25A5;MTX1;BNIP3;TMEM11;SLC25A4
prerank,BMP signaling pathway (GO:0030509),0.23423652680411655,0.7084860848338048,0.9036144578313253,0.9467014672077799,1.0,8/62,8.88%,BMP2;GDF3;USP9X;SMAD4;ACVR2A;USP15;HFE;HIVEP1
prerank,positive regulation of protein localization to nucleus (GO:1900182),0.2271297734259383,0.7077923924246599,0.9046242774566474,0.9471208836612031,1.0,11/66,13.82%,CHP2;LARP7;NMD3;DMAP1;BAG3;PSEN1;CCT6A;JUP;LAMTOR5;ZC3H12A;KAT7
prerank,histone ubiquitination (GO:0016574),0.27142110466992125,0.706631998186378,0.8601769911504424,0.9481139384856909,1.0,8/21,22.86%,WAC;CDC73;UBE2N;USP22;UBE2U;UBE2A;ATXN7L3;RNF40
prerank,ATP synthesis coupled proton transport (GO:0015986),0.2940109736930611,0.7062705488281262,0.8209219858156028,0.9481371883346718,1.0,5/17,18.62%,ATP5PO;ATP5MC2;ATP5F1E;ATP5MC1;ATP5MF
prerank,phosphatidylglycerol metabolic process (GO:0046471),-0.23330511549586982,-0.7056179140669432,0.9117647058823529,0.9868101248010734,1.0,5/24,23.77%,LPCAT1;LPGAT1;CDS2;PLA2G3;SLC27A1
prerank,mitochondrion transport along microtubule (GO:0047497),-0.28657416619830545,-0.705571807993641,0.8721174004192872,0.9859924895441249,1.0,3/13,22.86%,MAPT;UBB;HIF1A
prerank,resolution of meiotic recombination intermediates (GO:0000712),-0.26532343691089155,-0.705081768365805,0.8627002288329519,0.9856849109840585,1.0,7/16,36.80%,RMI1;TOP2A;CENPX;SLX4;EME1;ERCC4;CENPS
prerank,protein N-linked glycosylation (GO:0006487),0.22484921375027117,0.7042868192242867,0.9237170596393898,0.9501301685076794,1.0,13/66,15.21%,ST6GAL1;ST3GAL1;MGAT2;GFPT2;ALG9;TMEM165;ALG5;DOLPP1;ASGR2;PMM1;UGGT1;RPN2;MCFD2
prerank,positive regulation of immunoglobulin production (GO:0002639),0.26286815764394467,0.7041160140893915,0.8351822503961965,0.9499147595494685,1.0,10/31,22.88%,KMT5B;RBP4;GPI;SHLD3;XBP1;IL6;HMCES;SHLD2;PTPRC;TFRC
prerank,reticulophagy (GO:0061709),-0.29171143015380885,-0.7040525313194594,0.8382687927107062,0.9858608475178748,1.0,2/12,4.98%,RETREG1;ATG2A
prerank,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),0.2865954325131086,0.7039324458986571,0.8509532062391681,0.9496947978021262,1.0,6/18,19.61%,VPS4B;RCC2;RAB11A;RAD51B;BRD4;MECP2
prerank,aminoglycan metabolic process (GO:0006022),-0.2969240639953996,-0.7037654116508766,0.8333333333333334,0.9853042316011897,1.0,4/10,22.91%,XYLT1;B4GALT7;B3GALT6;B3GAT1
prerank,membrane fusion (GO:0061025),0.2545320160936653,0.7036886042623044,0.8685897435897436,0.9495788635911291,1.0,12/33,22.33%,DCSTAMP;MYOF;RABEP1;SNAP23;VAPA;RABIF;UBXN2B;USO1;SNAP29;DNM1L;STX11;DYSF
prerank,tRNA wobble base modification (GO:0002097),0.30169067640761255,0.7036722745614581,0.8321033210332104,0.9491748921201076,1.0,4/14,13.88%,URM1;DPH3;ELP4;CTU1
prerank,monocarboxylic acid catabolic process (GO:0072329),-0.24945493558775417,-0.7035965659203712,0.8898678414096917,0.9846478739877947,1.0,6/21,25.18%,LPIN2;FAH;FAAH;HOGA1;AGXT;ACOT8
prerank,import into nucleus (GO:0051170),-0.18764956987872433,-0.703548611593163,0.9672131147540983,0.9838485850733774,1.0,36/73,36.58%,IPO5;GEMIN2;BACH2;APPL1;RANBP17;DDX20;NUP85;IPO13;RPAIN;IPO8;HNRNPA1;NXT1;SEC13;PPP1R10;TNPO2;E2F3;CSE1L;TSC2;PTTG1IP;NUP93;NUP50;PHB2;NXT2;FAM53A;AKT1;NUP214;SNUPN;EIF4ENIF1;NUP88;SNRPF;SNRPD3;GEMIN6;RAN;GEMIN5;SPRN;FAM53C
prerank,GPI anchor metabolic process (GO:0006505),0.2635636825158499,0.7033673898850582,0.8578595317725752,0.9491208715742852,1.0,4/26,15.50%,PGAP1;PIGU;PGAP4;PIGQ
prerank,positive regulation of glucose metabolic process (GO:0010907),0.3004064403998882,0.7033614346490606,0.8409090909090909,0.9487089360950971,1.0,2/14,11.42%,IRS2;ARPP19
prerank,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),0.25110057767014016,0.7033131986627744,0.8684627575277337,0.9483536852996041,1.0,7/33,14.01%,NR3C1;SPI1;TNF;KLF4;FOXO3;STAT3;KLF5
prerank,DNA replication checkpoint signaling (GO:0000076),-0.2662280964645938,-0.703305387167602,0.8708971553610503,0.9832791474481402,1.0,10/16,39.46%,DNA2;HUS1;RAD9A;TICRR;CDT1;ORC1;RAD17;TIMELESS;CDC45;NAE1
prerank,positive regulation of amyloid-beta formation (GO:1902004),0.28981853790941137,0.7032634249235921,0.8469565217391304,0.9479883402026015,1.0,7/18,17.88%,TNF;SP1;ROCK2;RELA;IFNGR1;PICALM;EFNA1
prerank,negative regulation of ion transport (GO:0043271),0.2732834424994009,0.7022059587364443,0.8521594684385382,0.9488324439011904,1.0,4/24,8.81%,LILRB1;WNK1;CD33;PLN
prerank,ion homeostasis (GO:0050801),-0.2246350900450787,-0.7021917766976639,0.9115281501340483,0.9836344539652748,1.0,12/30,29.98%,SLC4A10;AP3D1;WNK3;SLC4A2;SLC4A3;CAMK2D;UNC80;SLC12A5;KLHL3;HCN4;SLC30A3;FHL1
prerank,mismatch repair (GO:0006298),0.26167639294217765,0.7019748612126253,0.8429752066115702,0.9486713993130212,1.0,10/27,24.60%,MCM9;RPA1;RPA3;MUTYH;XPC;POLD2;PCNA;MLH1;RNASEH2A;ERCC1
prerank,glycoprotein catabolic process (GO:0006516),0.289326473782882,0.701872600248809,0.8297872340425532,0.9483782098848477,1.0,3/17,11.33%,MANBA;ADAMTS9;NGLY1
prerank,2-oxoglutarate metabolic process (GO:0006103),-0.27770640849411077,-0.7015828411885693,0.8610526315789474,0.9834371922676249,1.0,5/13,31.57%,PHYH;GPT2;GOT1;ADHFE1;D2HGDH
prerank,regulation of cellular ketone metabolic process (GO:0010565),0.22680531283506988,0.7013679305575978,0.9106881405563689,0.9485594122060143,1.0,3/61,2.03%,PRKAG2;PSMA7;NR1H4
prerank,midbody abscission (GO:0061952),-0.25855413330112964,-0.7012146092501224,0.8512035010940919,0.9829713645700457,1.0,9/17,34.66%,CHMP4B;CHMP4A;MITD1;CHMP6;CHMP3;CHMP4C;CHMP1B;KIF20A;CHMP2A
prerank,negative regulation of release of cytochrome c from mitochondria (GO:0090201),0.29078003341762754,0.7011995734286619,0.8191881918819188,0.9483425280681821,1.0,2/15,9.90%,PRKN;IGF1
prerank,tetrahydrofolate metabolic process (GO:0046653),0.31854628741221364,0.700755182893775,0.8106060606060606,0.9484759319152335,1.0,4/10,23.43%,MTHFD2L;SHMT1;MTHFD1L;MTHFS
prerank,DNA replication-independent nucleosome organization (GO:0034724),0.31868747193044844,0.7005140392819007,0.8071833648393195,0.9483337914449546,1.0,5/11,20.94%,ATRX;H3-3A;HAT1;ASF1A;IPO4
prerank,negative regulation of calcineurin-mediated signaling (GO:0106057),0.3102019613652808,0.7002184033870853,0.8274509803921568,0.9478571615019353,1.0,2/12,12.32%,GSK3B;ATP2B4
prerank,negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),0.3102019613652808,0.7002184033870853,0.8274509803921568,0.9478571615019353,1.0,2/12,12.32%,GSK3B;ATP2B4
prerank,positive regulation of wound healing (GO:0090303),0.24914834625510224,0.6999473887518224,0.8779342723004695,0.9477559860687441,1.0,4/36,10.53%,RREB1;ITGB1;FOXC2;ENPP4
prerank,transcription preinitiation complex assembly (GO:0070897),0.3091290875870444,0.699708372121214,0.8264925373134329,0.9476031121874845,1.0,3/12,17.19%,GTF2A2;GTF2B;TAF12
prerank,peptidyl-proline modification (GO:0018208),-0.23437942919940702,-0.6994832690514204,0.8839506172839506,0.9839574803997141,1.0,13/25,38.63%,P3H2;PPIL3;PPIE;OGFOD1;FKBP7;FKBP4;PIN1;PPIL6;PPIC;FKBP10;PPIL1;PPIG;PPWD1
prerank,fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),-0.2719241249507336,-0.699219529590435,0.888646288209607,0.983382049753842,1.0,1/14,0.92%,ACOX3
prerank,purine-containing compound biosynthetic process (GO:0072522),0.26830659916314814,0.6991928310685308,0.862012987012987,0.9477971949679431,1.0,8/25,21.17%,ADK;AMPD3;SHMT1;GMPS;PRPS1L1;PRPS1;HPRT1;PAICS
prerank,error-free translesion synthesis (GO:0070987),0.2748835468007401,0.698481766608336,0.8472468916518651,0.9481896080480717,1.0,4/22,12.34%,RPS27A;RPA1;POLH;RPA3
prerank,negative regulation of growth (GO:0045926),0.20503132547346606,0.6983472473984044,0.9473684210526315,0.9479234331378042,1.0,16/121,13.10%,PTPRJ;NOTCH2;DCSTAMP;RB1;RACK1;SMAD4;BST2;ESR2;PPP2CA;RTN4;SFRP1;SERTAD2;SLIT3;ST7L;CDKN2C;GJA1
prerank,tyrosine metabolic process (GO:0006570),0.3170216745208718,0.6971028997222364,0.8206106870229007,0.9489334551510586,1.0,1/11,5.75%,THAP4
prerank,proteolysis (GO:0006508),0.19066800501983985,0.6965290226210817,0.9785067873303167,0.9492107026240549,1.0,38/252,17.66%,CTSC;CPQ;ADAM19;ENDOU;SRGN;XPNPEP3;FAM111A;LNPEP;CTSB;PRCP;PARL;CAPN5;HTRA3;ZMPSTE24;PITRM1;PSEN1;RNPEP;MDM2;TBL1X;ADAMTS9;ENPEP;CLPX;CASP8;PSMA6;MMP24;MMP25;ATG4C;SPPL2B;SENP1;USP25;NCSTN;FBXW2;ERAP1;SPPL2A;CUL7;SENP6;FAP;HGF
prerank,amino acid transport (GO:0006865),0.23393765526467325,0.696411668331428,0.9039301310043668,0.948930813123219,1.0,8/49,17.60%,SLC16A10;SLC43A2;SLC38A6;SLC38A1;SLC38A2;SLC7A7;SLC6A6;SLC36A2
prerank,regulation of oxidoreductase activity (GO:0051341),0.3059574167179816,0.6960499518848423,0.8380281690140845,0.9489332486529998,1.0,3/13,14.70%,ATP7A;NOD2;SZT2
prerank,liver development (GO:0001889),-0.2187192896258722,-0.6957005380166182,0.9300518134715026,0.9861913403885637,1.0,10/32,22.15%,NF1;TGFBR3;CCDC39;PCK2;PROX1;CDK5RAP3;WNT4;PHF2;ARID5B;CCDC40
prerank,primary miRNA processing (GO:0031053),0.31040150656185744,0.6948231037383307,0.8317025440313112,0.9499846921736717,1.0,4/10,19.15%,DROSHA;MRPL44;DGCR8;SMAD1
prerank,positive regulation of oxidoreductase activity (GO:0051353),0.2772128240421373,0.6945681886357473,0.8558875219683656,0.9498661469970381,1.0,6/18,22.93%,ATP7A;TNF;NOD2;GDNF;SIRT3;POR
prerank,DNA strand elongation (GO:0022616),-0.2536088798956876,-0.6942488133612962,0.8761682242990654,0.9867595922740318,1.0,6/18,26.88%,MCM3;GINS3;DCLRE1B;RAD50;MCM7;MCMDC2
prerank,regulation of non-canonical Wnt signaling pathway (GO:2000050),0.2959535035006179,0.6937725257300866,0.8483245149911817,0.9503378437630966,1.0,5/15,14.85%,ZNRF3;SFRP1;SPEF1;NPHP3;GPC3
prerank,photoperiodism (GO:0009648),0.256327301535188,0.6934994276206984,0.867862969004894,0.9502290870331483,1.0,4/28,11.02%,FBXL17;CLOCK;RBM4;PPP1CA
prerank,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),0.2699940671099615,0.6929178308072963,0.8636363636363636,0.9504697967680393,1.0,12/20,27.78%,LATS2;HEXIM2;PTEN;NR2F2;CDKN1C;INCA1;CDKN1B;CEBPA;HEXIM1;PLK1;APC;HHEX
prerank,purine ribonucleoside bisphosphate metabolic process (GO:0034035),0.30004653854020386,0.692888224350484,0.8256227758007118,0.9500862897929132,1.0,5/13,26.65%,SULT1A1;SULT6B1;ENPP1;SULT4A1;BPNT1
prerank,positive regulation of stem cell proliferation (GO:2000648),0.28197909321068393,0.6926248175634845,0.8419301164725458,0.949952517610867,1.0,6/17,21.38%,THPO;GJA1;KAT7;KDM1A;N4BP2L2;PTPRC
prerank,negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),0.28349463050062645,0.692515965346309,0.8624787775891342,0.9496490820502755,1.0,1/17,2.01%,MEF2C
prerank,"energy coupled proton transport, down electrochemical gradient (GO:0015985)",0.3245943166964237,0.6923122810512445,0.8152380952380952,0.9494665285576851,1.0,2/10,9.79%,ATP5PO;ATP5MC2
prerank,negative regulation of T-helper cell differentiation (GO:0045623),-0.28946942017145216,-0.6910984469461224,0.854389721627409,0.9890771108835504,1.0,2/11,10.70%,SMAD7;JAK3
prerank,natural killer cell activation (GO:0030101),-0.23826977855640558,-0.6910142461985788,0.9052369077306733,0.9883299898199981,1.0,7/23,20.82%,IL21R;AXL;BAG6;RABL3;PBX1;RASGRP1;ULBP1
prerank,response to progesterone (GO:0032570),-0.25293667672556197,-0.6908833346653189,0.8575063613231552,0.987605286969277,1.0,8/18,34.97%,SRC;WBP2;TGFB2;TGFB1;CATSPERD;ABHD2;UBE3A;TGFB3
prerank,establishment of protein localization to endoplasmic reticulum (GO:0072599),0.292156538108876,0.6908728108141086,0.8531073446327684,0.9506215641049792,1.0,3/15,10.74%,RAB10;ZFAND2B;SRPRB
prerank,indolalkylamine catabolic process (GO:0046218),-0.2968446518401311,-0.6907657054468073,0.859504132231405,0.9868908740131442,1.0,4/10,35.78%,KYNU;IL4I1;IDO2;HAAO
prerank,tRNA 5'-end processing (GO:0099116),-0.26663311139575974,-0.6898040477060213,0.8625,0.986974435386397,1.0,6/15,24.68%,RPP14;POP1;RPP21;HSD17B10;PRORP;POP7
prerank,preassembly of GPI anchor in ER membrane (GO:0016254),-0.26518814638986776,-0.6895458377967331,0.8761682242990654,0.986390565169424,1.0,6/16,32.80%,PIGL;PIGH;PIGB;DPM2;PIGV;PIGC
prerank,protein localization to nucleus (GO:0034504),-0.17233149746881757,-0.688999703010317,0.9922178988326849,0.9861169692110379,1.0,37/102,30.04%,IPO5;SKP1;HNRNPU;DVL1;APPL1;RANBP17;SUPT7L;PAF1;NUP85;IPO13;RPAIN;IPO8;NOL8;ARL2BP;NXT1;INTS13;CTDNEP1;ABCA7;SEC13;BBS4;TOR1A;TAF8;PPP1R10;TNPO2;E2F3;CSE1L;TSC2;PTTG1IP;NUP93;NUP50;PHB2;NXT2;FAM53A;AKT1;BMP4;NUP214;EIF4ENIF1
prerank,positive regulation of translational initiation (GO:0045948),-0.25312572613262035,-0.688683382619712,0.8782816229116945,0.9855724144714693,1.0,7/18,27.95%,HABP4;MTOR;RPS6KB2;EIF2B5;BOLL;RPS6KB1;LARP1
prerank,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),-0.2569866405116768,-0.6886143994497806,0.8857142857142857,0.9848071726631255,1.0,10/18,36.82%,TECR;ACSL4;ACSL6;ACSBG1;ELOVL1;ACSF3;ELOVL7;HACD2;ELOVL6;ELOVL2
prerank,gene silencing by miRNA (GO:0035195),0.24529271988511342,0.6886100692610553,0.8930921052631579,0.9526939171023161,1.0,6/32,13.73%,PRKRA;PUM2;RBM4;LIMD1;TRIM71;TNRC6C
prerank,mitochondrial outer membrane permeabilization (GO:0097345),0.29256083006726524,0.6885019789541288,0.8186915887850468,0.9524010220557396,1.0,1/13,2.82%,RTL10
prerank,adipose tissue development (GO:0060612),-0.29040293218065555,-0.6878515601685341,0.8628318584070797,0.9846947428426092,1.0,5/11,24.83%,LRP5;DYRK1B;ARID5B;DGAT2;SOX8
prerank,endoplasmic reticulum calcium ion homeostasis (GO:0032469),0.27686463036897313,0.6876473410979956,0.8540268456375839,0.9529559018631014,1.0,4/20,14.25%,BCL2;PSEN1;WFS1;ATP2A2
prerank,O-glycan processing (GO:0016266),0.22475445611237027,0.6867819039049724,0.8974739970282318,0.9534580517400545,1.0,3/54,3.83%,ST6GAL1;ST3GAL1;C1GALT1
prerank,mitotic spindle assembly (GO:0090307),0.23880023572068243,0.6863337132197981,0.880184331797235,0.9535270476778045,1.0,12/42,19.23%,PIBF1;RHOA;STAG2;CLASP1;KIF4A;STAG1;SPICE1;RAB11A;ABRAXAS2;CCDC61;KIF23;KPNB1
prerank,peptide metabolic process (GO:0006518),0.21555639780029956,0.6858024950093046,0.9133425034387895,0.9537022516027647,1.0,7/75,11.33%,CPQ;CLN5;LNPEP;PARL;PSEN1;ENPEP;ETHE1
prerank,translesion synthesis (GO:0019985),-0.2043997672813661,-0.6857709691580539,0.9345794392523364,0.9858304273827294,1.0,17/42,27.23%,PRIMPOL;PARP10;UFD1;RFC2;NPLOC4;POLI;RCHY1;REV3L;UBB;RFC1;POLN;PCLAF;DTL;POLD4;USP10;SPRTN;FAAP20
prerank,positive regulation of insulin receptor signaling pathway (GO:0046628),0.30140262548005237,0.6844834248936701,0.8390151515151515,0.9547154305365714,1.0,3/12,12.26%,C1QTNF12;GKAP1;SNX5
prerank,regulation of DNA biosynthetic process (GO:2000278),0.25719587996392645,0.684176858364122,0.8690671031096563,0.9546282525781142,1.0,8/27,20.17%,RGCC;SMG6;NIBAN2;PRKD2;MYC;PINX1;HGF;ACVRL1
prerank,protein import into nucleus (GO:0006606),0.21584602726892466,0.6829552228552074,0.9288888888888889,0.9555163322536614,1.0,10/66,14.28%,RPL23;PRICKLE1;KPNA4;SYK;IPO11;NUP133;NUP62;CBLB;STAT3;KPNA2
prerank,negative regulation of fibroblast proliferation (GO:0048147),0.2794562427954739,0.6816226888270671,0.842832469775475,0.9565418291364439,1.0,5/18,15.18%,TRIM32;CDC73;SFRP1;FTH1;MYC
prerank,positive regulation of activated T cell proliferation (GO:0042104),0.27539108152665226,0.6814408721238893,0.8612521150592216,0.9563060781066718,1.0,2/18,9.90%,RPS3;IGF1
prerank,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),0.2643043147330034,0.6813260520487056,0.8696369636963697,0.956007308409246,1.0,7/23,18.84%,PIAS1;PARP14;JAK1;NR1H2;HSP90AB1;IFNGR1;SUMO1
prerank,cellular biogenic amine metabolic process (GO:0006576),0.3010042736150064,0.6806618558351231,0.821969696969697,0.9563203084936799,1.0,4/12,19.36%,ATP7A;TRH;HNMT;OAZ2
prerank,positive regulation of leukocyte migration (GO:0002687),0.2547090606742722,0.6799330234240774,0.89,0.9566887741864031,1.0,6/27,17.66%,PLVAP;TNF;IL6R;MDK;MIA3;IL6
prerank,negative regulation of protein localization to cell surface (GO:2000009),0.3059453273409614,0.6794715278185413,0.8433098591549296,0.9567700010075312,1.0,4/11,17.84%,LEPROTL1;SNX33;NEDD4L;PICALM
prerank,telomere maintenance in response to DNA damage (GO:0043247),0.31300660399506913,0.6787065898321252,0.8237547892720306,0.9571555879195714,1.0,4/10,19.75%,DCLRE1C;TERF2IP;APEX1;RTEL1
prerank,aspartate family amino acid catabolic process (GO:0009068),0.2737549456760662,0.6778260527733282,0.8644366197183099,0.9576447481564236,1.0,19/19,72.66%,HYKK;PHYKPL;OGDH;DDO;GOT2;AADAT;SDSL;MAT1A;DLST;ASPA;CRYM;DLD;SDS;AASS;PIPOX;SLC25A21;ALDH7A1;GOT1;GCDH
prerank,protein K48-linked deubiquitination (GO:0071108),-0.2329314520977463,-0.677773365146112,0.9073170731707317,0.9921756975924524,1.0,15/23,40.53%,OTUD5;USP50;OTUB1;USP34;USP5;USP33;YOD1;USP8;OTUD3;OTUD7B;OTUD7A;BAP1;OTUB2;OTUD4;TNFAIP3
prerank,regulation of centrosome duplication (GO:0010824),-0.221596728186015,-0.6775551412866033,0.9238845144356955,0.9915242510795745,1.0,4/29,8.09%,TMEM67;FBXW5;CHMP4B;CENATAC
prerank,regulation of protein localization to centrosome (GO:1904779),0.31605400512044446,0.6775409221790526,0.8420074349442379,0.9575288604777374,1.0,2/10,10.44%,GSK3B;NUP62
prerank,protein lipidation (GO:0006497),0.22069556126148682,0.6770514415686357,0.9206349206349206,0.9576234879163467,1.0,12/59,16.21%,ZDHHC14;WIPI1;PIGU;ZDHHC3;ATG7;ATG10;PGAP4;ZDHHC20;PIGQ;WIPI2;ZDHHC2;ATG5
prerank,negative regulation of leukocyte cell-cell adhesion (GO:1903038),0.27515283361025045,0.6765817188234635,0.8523489932885906,0.9576823619010578,1.0,3/18,11.25%,PTPN22;WNK1;ASS1
prerank,regulation of glycogen metabolic process (GO:0070873),0.3010350401157181,0.6764046783878239,0.8451730418943534,0.9574633437456516,1.0,4/12,19.24%,PPP1R3C;PPP1R3D;PPP1R3B;INPP5K
prerank,cellular response to increased oxygen levels (GO:0036295),0.30721124552937207,0.676348047685152,0.8121546961325967,0.957103802475175,1.0,7/11,25.85%,ATP6V1A;ATG7;FOXO1;ATP6V0D1;CAV1;CCDC115;FAS
prerank,protein destabilization (GO:0031648),0.24567178568769277,0.6760300484349099,0.86709886547812,0.9570152329561527,1.0,7/32,13.99%,NR1D1;PRKN;CDC73;MDM2;CUL3;CREBBP;EP300
prerank,regulation of defense response to virus (GO:0050688),-0.26540618444256364,-0.6758855939789061,0.9054621848739496,0.992162798155919,1.0,8/14,31.80%,RNF216;C1QBP;ITCH;PCBP2;DHX9;ILRUN;IFNLR1;TRAF3IP1
prerank,histone monoubiquitination (GO:0010390),0.2548055868102654,0.6740067925767581,0.8983333333333333,0.9586905995548287,1.0,3/24,8.11%,RYBP;WAC;CDC73
prerank,cellular response to steroid hormone stimulus (GO:0071383),0.2844134754252316,0.6738803295476843,0.8513274336283185,0.9583897025643566,1.0,5/17,16.96%,NR3C1;ATP1A3;ATP1A1;TFPI;ACOD1
prerank,protein methylation (GO:0006479),-0.20274014753743336,-0.6729574675746871,0.9680232558139535,0.9938302081663607,1.0,18/40,37.86%,EHMT2;SETD3;PRMT2;METTL22;CARM1;FAM98B;FAM98A;EEF2KMT;LCMT1;PCMT1;EZH2;RAB6A;PRMT8;EEF1AKMT2;SNRPD3;METTL21A;PRMT7;CAMKMT
prerank,positive regulation of protein sumoylation (GO:0033235),0.3138228099807388,0.6728710165139545,0.8416988416988417,0.959027993673718,1.0,1/10,2.33%,PIAS1
prerank,"synaptic transmission, GABAergic (GO:0051932)",-0.28844314860551923,-0.6716391825129838,0.9042553191489362,0.994099056563352,1.0,5/10,29.49%,GABRA2;GABRG2;GABRA4;GABRG3;GABRE
prerank,positive regulation of immunoglobulin mediated immune response (GO:0002891),0.28743634545160035,0.6707148073691332,0.853195164075993,0.960749287354821,1.0,5/14,22.88%,KMT5B;SHLD3;HMCES;SHLD2;TFRC
prerank,negative regulation of cell aging (GO:0090344),0.2748499214139427,0.6694532187422585,0.8685121107266436,0.9616053080615797,1.0,3/16,11.96%,CDK6;FOXM1;MAP3K3
prerank,cellular senescence (GO:0090398),-0.21875924055639934,-0.6684163757927215,0.9207920792079208,0.9960455580186797,1.0,6/27,18.15%,PRKCD;TERF2;HRAS;ID2;SRF;ULK3
prerank,response to zinc ion (GO:0010043),0.24863911849164966,0.667685012378336,0.8926829268292683,0.962908684111631,1.0,2/25,6.21%,CRIP1;PAM
prerank,regulation of cilium movement (GO:0003352),-0.29597698652984655,-0.6675240974179201,0.875,0.9959415578430411,1.0,5/10,27.77%,CCDC39;CFAP298;ODAD2;CCDC40;CFAP43
prerank,multivesicular body assembly (GO:0036258),-0.21664854855840582,-0.6666574673959723,0.9318734793187348,0.9958191104078759,1.0,4/30,9.42%,SNF8;CHMP4B;CHMP4A;VPS37A
prerank,autophagosome assembly (GO:0000045),0.2230314623599339,0.6661479026005982,0.9356223175965666,0.9639433987198077,1.0,22/52,26.16%,WIPI1;ULK2;RAB7A;RAB1A;RAB23;ATG7;ATP2A2;AMBRA1;RB1CC1;WIPI2;GABARAP;ATG5;ATG3;UBXN2B;PIK3C3;MAP1LC3B;RAB19;TP53INP2;ATG16L2;TMEM41B;BECN1;VMP1
prerank,regulation of purine nucleotide metabolic process (GO:1900542),0.23021862804925755,0.6655994520618663,0.9258649093904449,0.9640546065674053,1.0,11/41,21.55%,PRKAG2;PGAM1;NUP133;NUP62;NUP98;EP300;NUP153;ZBTB7A;SLC2A6;NUP35;RAE1
prerank,positive regulation of cell cycle G2/M phase transition (GO:1902751),0.2615377931491096,0.6654731077265665,0.8788927335640139,0.9637606054451657,1.0,8/21,23.58%,VPS4B;RCC2;RAB11A;RAD51B;BRD4;MECP2;NPM1;CCND1
prerank,protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),0.30796627304532703,0.6654106826478567,0.8336557059961315,0.9634042041656703,1.0,4/10,21.08%,DGKH;F2R;DGKD;PICK1
prerank,regulation of catabolic process (GO:0009894),0.2707354481415969,0.6652125627816609,0.872791519434629,0.9631719791579605,1.0,5/18,17.49%,ITGB1;MDM2;NEDD4L;ZDHHC2;FAP
prerank,regulation of nucleobase-containing compound metabolic process (GO:0019219),0.3053858854208965,0.6649074020814427,0.847985347985348,0.96303707392468,1.0,1/11,2.25%,RASA1
prerank,sensory perception of mechanical stimulus (GO:0050954),0.20549640916238365,0.6646726290284828,0.9596774193548387,0.9628650172327607,1.0,9/85,11.86%,RIPOR2;CCDC50;ATP6V1B1;GSDME;GRAP;MYO7A;TBL1X;WFS1;KCNQ1
prerank,regulation of mitochondrial translation (GO:0070129),-0.23126839273390845,-0.6646231151472616,0.9254807692307693,0.9966569808188219,1.0,10/21,34.51%,RMND1;MTG2;C1QBP;FASTKD3;MTG1;ALKBH1;COA3;SHMT2;UQCC2;TRUB2
prerank,RNA biosynthetic process (GO:0032774),0.24397093663689381,0.6640764037233314,0.9098228663446055,0.9630012355326611,1.0,6/31,17.19%,TCEA2;PRIM2;NCOA6;GTF2B;PRIM1;TAF12
prerank,neurotransmitter biosynthetic process (GO:0042136),0.28206651243986913,0.663977740392109,0.854419410745234,0.9626932721099923,1.0,2/14,10.91%,MOXD1;ACHE
prerank,regulation of systemic arterial blood pressure by hormone (GO:0001990),0.2867905575087895,0.663913910462146,0.8623693379790941,0.9623432988007492,1.0,14/14,71.35%,ENPEP;CORIN;NOS3;EDN1;AGTR1;AVPR1A;EDN2;EDN3;OXTR;ACE2;ACE;AVPR2;RASL10B;ECE1
prerank,regulation of cellular amine metabolic process (GO:0033238),-0.18934138488011046,-0.6637902372996565,0.9765395894428153,0.9964902624955231,1.0,11/50,18.14%,AZIN1;PSMD13;PSMD12;PSMD9;PSME3;PSMA4;PSMD8;PSMF1;PSMD4;PSMB8;PSME1
prerank,apoptotic nuclear changes (GO:0030262),0.24984498054222778,0.6632279273052674,0.8614864864864865,0.9625751000923813,1.0,1/24,1.51%,ENDOG
prerank,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),0.2317331694910267,0.6624338326135297,0.9138461538461539,0.9629205607659262,1.0,9/40,16.18%,FAM111A;MCM9;DDX11;TIPIN;ATRX;ZRANB3;MMS22L;FBH1;ATR
prerank,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),0.24554702749178395,0.660935883874933,0.918918918918919,0.9638765320115738,1.0,3/30,5.38%,SMURF2;SMAD4;TRIM33
prerank,interleukin-1-mediated signaling pathway (GO:0070498),0.1985619134077871,0.660681044133403,0.96684350132626,0.9636927049116076,1.0,30/94,25.22%,PSMA7;IRAK3;RPS27A;PELI1;MAP3K8;PSMB2;RIPK2;PSMA6;MAP3K3;NOD2;UBE2N;PSMA3;PSMD1;PSMD5;TAB3;RELA;TRAF6;IRAK4;TOLLIP;PSMD2;PSMD11;PSMB9;NFKB1;IL1R1;PSMB4;UBC;PSMD10;MYD88;PSME4;FBXW11
prerank,mesenchyme morphogenesis (GO:0072132),-0.2394928430419145,-0.6602655963623629,0.913135593220339,0.9984600119358319,1.0,5/17,19.41%,ACVR1;MDM4;NOTCH1;ENG;TGFB2
prerank,mammary gland development (GO:0030879),-0.23476242523537752,-0.6597982365998686,0.941031941031941,0.997983964568485,1.0,4/21,18.95%,JAK2;ERBB4;WNT4;NOTCH4
prerank,PERK-mediated unfolded protein response (GO:0036499),-0.29010487812770824,-0.6595456521043818,0.8755274261603375,0.9973477507457887,1.0,2/10,19.69%,DDIT3;ATF4
prerank,regulation of oligodendrocyte differentiation (GO:0048713),0.2680227899123473,0.6587879561118797,0.8940754039497307,0.9650326815190864,1.0,2/18,7.44%,TNFRSF1B;CXCR4
prerank,mitotic metaphase plate congression (GO:0007080),-0.18980983110111513,-0.657784908972862,0.9758308157099698,0.9979028957137095,1.0,22/51,31.91%,EML3;CENPC;CHMP4B;CHMP4A;CENPE;SEH1L;SPDL1;NDC80;CDCA8;KIFC1;CHMP6;DCTN2;ZW10;CHMP3;KIF14;CHMP4C;CDT1;KIF2C;CHMP1B;NUDC;NUF2;BOD1
prerank,glial cell differentiation (GO:0010001),0.2458523401209156,0.6575106057772442,0.898989898989899,0.9657770725755045,1.0,4/28,13.90%,ADGRG6;METRN;MMP24;STAT3
prerank,negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),-0.27152468665877916,-0.6567263124729994,0.9018789144050104,0.9978698684573817,1.0,2/12,8.69%,PIK3CB;CADM4
prerank,regulation of DNA recombination (GO:0000018),0.23503247236500985,0.655534577229947,0.9039735099337748,0.9671498314139115,1.0,11/32,20.29%,CHEK1;SPIDR;ZRANB3;PPP4R2;TERF2IP;KPNA2;SMARCAD1;KDM1A;MRE11;RTEL1;SHLD2
prerank,positive regulation of cellular response to insulin stimulus (GO:1900078),0.2828187765559972,0.6541219244998102,0.8523364485981308,0.9679654933443076,1.0,3/13,12.26%,C1QTNF12;GKAP1;SNX5
prerank,detection of chemical stimulus involved in sensory perception of taste (GO:0050912),-0.27492408015709263,-0.6538499769923714,0.8901098901098901,0.9992590090398191,1.0,2/11,23.52%,RTP4;PKD1L3
prerank,cristae formation (GO:0042407),0.24715230874060773,0.6535879731875399,0.9055374592833876,0.9680599879533753,1.0,8/27,18.62%,ATP5PO;APOOL;ATP5MC2;CHCHD3;ATP5F1E;UQCC3;ATP5MC1;ATP5MF
prerank,negative regulation of endothelial cell apoptotic process (GO:2000352),0.25456883656203455,0.6527912101911055,0.9184027777777778,0.9683634964784367,1.0,1/24,1.36%,GAS6
prerank,protein alkylation (GO:0008213),-0.22500416173572313,-0.6525358612410224,0.9333333333333333,0.9993601939826732,1.0,13/22,39.86%,PRMT2;METTL22;FAM98B;FAM98A;EEF2KMT;LCMT1;PCMT1;PRMT8;EEF1AKMT2;SNRPD3;METTL21A;CAMKMT;SNRPB
prerank,hematopoietic stem cell differentiation (GO:0060218),-0.2809537787356563,-0.6522195444760198,0.8818380743982495,0.9987587284097978,1.0,1/10,3.73%,TP53
prerank,sensory perception of sound (GO:0007605),0.19993103260477182,0.6515815006231201,0.9723684210526315,0.9689859709898896,1.0,9/88,11.86%,RIPOR2;CCDC50;ATP6V1B1;GSDME;GRAP;MYO7A;TBL1X;WFS1;KCNQ1
prerank,peptidyl-L-cysteine S-palmitoylation (GO:0018230),0.2553370294292767,0.6507607794277056,0.9119086460032626,0.9688749216050958,1.0,5/22,15.73%,ZDHHC14;ZDHHC3;ZDHHC24;ZDHHC20;ZDHHC2
prerank,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),0.2553370294292767,0.6507607794277056,0.9119086460032626,0.9688749216050958,1.0,5/22,15.73%,ZDHHC14;ZDHHC3;ZDHHC24;ZDHHC20;ZDHHC2
prerank,regulation of water loss via skin (GO:0033561),0.2755997518877086,0.6506460224145261,0.8795986622073578,0.9681600279497621,1.0,6/15,28.30%,SFN;STMN1;UGCG;LSR;KDF1;FA2H
prerank,establishment of skin barrier (GO:0061436),0.2755997518877086,0.6506460224145261,0.8795986622073578,0.9681600279497621,1.0,6/15,28.30%,SFN;STMN1;UGCG;LSR;KDF1;FA2H
prerank,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),-0.27834673328430937,-0.6504483378654551,0.896049896049896,0.9991959793322761,1.0,3/10,13.98%,UFD1;C1QBP;NPLOC4
prerank,cardiac muscle tissue morphogenesis (GO:0055008),0.23799252785011987,0.6501587297022259,0.9378151260504202,0.9681701863881538,1.0,2/29,2.89%,BMP2;MYH6
prerank,regulation of protein neddylation (GO:2000434),-0.28319366568030924,-0.6491424724789555,0.8962655601659751,0.9992763152257396,1.0,7/10,33.61%,EPAS1;COPS9;HIF1A;DCUN1D2;DCUN1D5;DCUN1D3;DCUN1D4
prerank,regulation of telomerase RNA localization to Cajal body (GO:1904872),0.26338288132857623,0.6484265614012381,0.8725663716814159,0.9692518912489909,1.0,4/18,16.82%,CCT6A;DCP2;NOP10;CCT3
prerank,protein localization to endoplasmic reticulum (GO:0070972),-0.24434047016862367,-0.6481879023700551,0.9315068493150684,0.9991295736126471,1.0,2/16,4.57%,BCAP29;ANK2
prerank,regulation of histone methylation (GO:0031060),0.2865422516217674,0.6476416024249193,0.8939670932358318,0.9694909352865264,1.0,1/13,4.03%,JARID2
prerank,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),-0.2332403792167303,-0.6469457840322631,0.9287356321839081,0.9991538785700649,1.0,5/17,23.38%,TREM2;HTRA2;NME5;BAG5;UBQLN1
prerank,protein K63-linked deubiquitination (GO:0070536),-0.20682253148623847,-0.6468975211735771,0.9347826086956522,0.9983535311067346,1.0,4/31,6.23%,CYLD;OTUD5;USP50;STAMBP
prerank,regulation of lipid kinase activity (GO:0043550),-0.2776749358098361,-0.6466202845997384,0.888421052631579,0.9977184175418384,1.0,5/11,25.54%,RBL2;PPP2R5A;EEF1A2;PIK3R2;PIK3R3
prerank,mRNA cleavage involved in mRNA processing (GO:0098787),-0.25514352431842524,-0.6461784860507032,0.9098360655737705,0.997182031785369,1.0,3/14,14.43%,CPSF6;CSTF2;NCBP1
prerank,regulation of execution phase of apoptosis (GO:1900117),-0.27008407397161355,-0.6447182636395083,0.8852459016393442,0.9973935167293242,1.0,2/11,9.77%,TP53;SIRT2
prerank,regulation of telomere maintenance (GO:0032204),-0.21521775029287823,-0.6441161401758623,0.9519230769230769,0.9969909926059954,1.0,4/26,12.36%,XRCC5;HDAC8;UPF1;TERF2
prerank,protein transmembrane import into intracellular organelle (GO:0044743),-0.20303960638812196,-0.6423175247660278,0.9598930481283422,0.997375901325203,1.0,8/31,20.49%,PEX6;TIMM44;PEX10;TOMM40;GRPEL1;TOMM20;TOMM40L;TIMM21
prerank,neutral amino acid transport (GO:0015804),0.23722461684248888,0.6416041919183287,0.9137645107794361,0.9741194632078075,1.0,6/28,17.60%,SLC43A2;SLC38A6;SLC38A1;SLC38A2;SLC6A6;SLC36A2
prerank,negative regulation of DNA recombination (GO:0045910),0.21617083463539322,0.6414880764911296,0.9438700147710487,0.9737967673792771,1.0,13/43,20.86%,ATRX;POLR2B;UBQLN4;ZRANB3;TERF2IP;TERF1;POLR2D;FBH1;SHLD3;POLR2F;RTEL1;SHLD2;TINF2
prerank,inner mitochondrial membrane organization (GO:0007007),0.21921753321046436,0.6406829272570115,0.9537313432835821,0.9740672766314243,1.0,11/47,18.62%,ATP5PO;APOOL;ATP5MC2;CHCHD3;MTX1;ROMO1;ATP5F1E;UQCC3;TMEM11;ATP5MC1;ATP5MF
prerank,negative regulation of telomere maintenance (GO:0032205),0.26981998031169563,0.640657965668238,0.8946395563770795,0.9736729542013592,1.0,8/15,25.33%,SMG6;TERF2IP;TERF1;PINX1;RTEL1;TNKS2;ERCC1;NBN
prerank,eye morphogenesis (GO:0048592),0.26150909938467864,0.6397215755867173,0.9124343257443083,0.9739787775192613,1.0,3/19,13.90%,RARG;NKD1;STAT3
prerank,autophagosome organization (GO:1905037),0.21594980396754865,0.6395690151902722,0.9525179856115108,0.9736944388851265,1.0,22/50,26.16%,WIPI1;ULK2;RAB7A;RAB1A;RAB23;ATG7;ATP2A2;AMBRA1;RB1CC1;WIPI2;GABARAP;ATG5;ATG3;UBXN2B;PIK3C3;MAP1LC3B;RAB19;TP53INP2;ATG16L2;TMEM41B;BECN1;VMP1
prerank,negative regulation of reactive oxygen species biosynthetic process (GO:1903427),0.2851946298218606,0.6391014585435512,0.8659003831417624,0.9736662968730707,1.0,4/11,21.75%,FYN;ABCB7;TRAP1;MPV17L
prerank,long-chain fatty-acyl-CoA metabolic process (GO:0035336),-0.2209248130910542,-0.6390685626654226,0.949748743718593,0.9987322027041234,1.0,12/23,36.82%,TECR;ACSL4;ACSL6;ACOT7;ACSBG1;DGAT2;ELOVL1;ACSF3;ELOVL7;HACD2;ELOVL6;ELOVL2
prerank,DNA strand elongation involved in DNA replication (GO:0006271),-0.2324167832737153,-0.6388948824861397,0.9284116331096197,0.9980099724432296,1.0,6/18,26.88%,LIG1;MCM3;GINS3;POLE;MCM7;MCMDC2
prerank,positive regulation of mitochondrial translation (GO:0070131),-0.25044206922743656,-0.6383596495124794,0.9166666666666666,0.9975439643545284,1.0,3/14,16.05%,RMND1;C1QBP;FASTKD3
prerank,positive regulation of catalytic activity (GO:0043085),0.22202718533505067,0.6377861696684917,0.9352850539291218,0.9742980188311413,1.0,9/37,17.95%,ATP7A;PSEN1;MAPK14;NHEJ1;BCAS3;NOD2;XRCC4;NCSTN;SLC5A3
prerank,regulation of cell cycle G1/S phase transition (GO:1902806),0.22575764862590683,0.6370767238038205,0.9241935483870968,0.9744050093872858,1.0,8/33,22.23%,FBXW7;CDC73;ATP2B4;PTEN;PTPN6;APPL2;PLCG2;CDKN1B
prerank,negative regulation of locomotion (GO:0040013),0.2821043570029134,0.6360753664410909,0.885036496350365,0.9748084043635767,1.0,1/12,3.52%,CRK
prerank,regulation of cellular amino acid metabolic process (GO:0006521),-0.17936619742804705,-0.6356287409067114,0.9848484848484849,0.9984886204211173,1.0,11/53,18.14%,AZIN1;PSMD13;PSMD12;PSMD9;PSME3;PSMA4;PSMD8;PSMF1;PSMD4;PSMB8;PSME1
prerank,telomere maintenance via telomerase (GO:0007004),-0.20741804821657242,-0.6353516462761065,0.959349593495935,0.9978522753096852,1.0,9/28,24.66%,ANKRD28;PTGES3;TNKS1BP1;TERF2;GAR1;RFC1;WRAP53;ACD;RAD50
prerank,negative regulation of voltage-gated potassium channel activity (GO:1903817),0.2947526989706251,0.635218524683649,0.8913443830570903,0.9750680386573234,1.0,10/10,70.54%,KCNE3;SUMO1;CAV1;KCNRG;KCNE5;KCNE1;KCNE2;KCNE4;ANK3;KCNAB1
prerank,nucleus organization (GO:0006997),0.21138737587022108,0.6351556783639832,0.9537480063795853,0.9746968569720604,1.0,6/47,12.62%,REEP3;ATXN7;VPS4B;NUP133;CHMP5;NUP98
prerank,regulation of establishment of protein localization to telomere (GO:0070203),0.286011363048546,0.6351106126231258,0.8671586715867159,0.9743200940127955,1.0,3/11,16.82%,CCT6A;TERF1;CCT3
prerank,heart process (GO:0003015),-0.24547854124508042,-0.6346092647006147,0.9220489977728286,0.9974881425343375,1.0,10/14,46.71%,SGCD;SGCZ;GPX1;MYL2;PPCS;RAMP3;ACE;SOD1;TNNI3;SGCG
prerank,protein sumoylation (GO:0016925),-0.18270102542102862,-0.6328286275693729,0.976401179941003,0.9977932190657548,1.0,18/49,29.33%,NUP210;RANBP2;BCL11A;TRIM28;NUP85;SEH1L;EGR2;AAAS;SAE1;UBA2;EYA1;PIAS4;PIAS3;NDC1;NUP93;NUP50;NUP54;NUP214
prerank,synaptonemal complex assembly (GO:0007130),-0.24267532404148878,-0.6323096893919951,0.9426605504587156,0.996493865145656,1.0,4/15,19.16%,BAG6;SYCE2;STAG3;P3H4
prerank,synaptonemal complex organization (GO:0070193),-0.24267532404148878,-0.6323096893919951,0.9426605504587156,0.996493865145656,1.0,4/15,19.16%,BAG6;SYCE2;STAG3;P3H4
prerank,ncRNA catabolic process (GO:0034661),0.24043126412827356,0.6316444144766288,0.9137645107794361,0.9766325238798957,1.0,5/28,12.66%,SND1;TUT4;MTREX;EXOSC8;DIS3L2
prerank,amino acid transmembrane transport (GO:0003333),0.21491749382320774,0.6312733009274323,0.9514866979655712,0.9764881504896757,1.0,7/45,17.60%,LRRC8D;SLC38A6;SLC38A1;SLC38A2;SLC7A7;SLC6A6;SLC36A2
prerank,positive regulation of erythrocyte differentiation (GO:0045648),0.24429255441082123,0.6306910173820773,0.9109243697478991,0.9765345699745295,1.0,10/25,23.28%,ACVR2A;MAPK14;FOXO3;STAT3;PRMT1;ARNT;ABCB10;FAM210B;STAT5B;MAPK11
prerank,nucleobase-containing compound biosynthetic process (GO:0034654),-0.22680518464823257,-0.6306854793676904,0.9487179487179487,0.9966994710197129,1.0,5/19,18.02%,GMPR;TYMS;DGUOK;GMPR2;POLL
prerank,stabilization of membrane potential (GO:0030322),-0.23676398587974737,-0.6304756848397025,0.919908466819222,0.9959965873386802,1.0,8/16,34.85%,KCNK2;KCNK12;KCNK9;KCNK6;KCNK10;KCNK3;CHCHD10;KCNK7
prerank,regulation of type I interferon-mediated signaling pathway (GO:0060338),-0.2049167165174696,-0.6292259580774353,0.9712918660287081,0.9959614491835872,1.0,8/29,21.66%,CNOT7;MAVS;NLRC5;STAT2;MUL1;PTPN11;WNT5A;METTL3
prerank,regulation of mitochondrial fission (GO:0090140),0.24531227068338216,0.6288324983770572,0.9152542372881356,0.9774999493631122,1.0,2/24,4.25%,PRKN;MCU
prerank,positive regulation of smoothened signaling pathway (GO:0045880),0.2483715783049263,0.6287640440676565,0.9169491525423729,0.97713818413148,1.0,5/21,19.40%,TTC23;SFRP1;STK36;TXNDC15;DLG5
prerank,negative regulation of protein exit from endoplasmic reticulum (GO:0070862),0.2860909951088694,0.6282180782841353,0.8849056603773585,0.9771336100935623,1.0,2/10,14.11%,UBAC2;DERL2
prerank,positive regulation of viral life cycle (GO:1903902),-0.21479693448656698,-0.627395537896739,0.9260969976905312,0.9962358371957546,1.0,5/22,20.73%,AXL;FMR1;TYRO3;TRIM11;CHMP3
prerank,regulation of carbohydrate catabolic process (GO:0043470),0.21441173939354027,0.6265566031909225,0.9389067524115756,0.9779306776549366,1.0,11/41,21.55%,PRKAG2;PGAM1;NUP133;NUP62;NUP98;EP300;NUP153;ZBTB7A;SLC2A6;NUP35;RAE1
prerank,insulin-like growth factor receptor signaling pathway (GO:0048009),-0.2598302989261425,-0.625532719072272,0.9262472885032538,0.9965590184470116,1.0,6/11,30.33%,PLCB1;GIGYF1;TSC2;IRS1;AKT1;GHR
prerank,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),0.24164818252925643,0.6247480435183327,0.9294320137693631,0.9787975769826396,1.0,13/22,28.33%,LATS2;HEXIM2;PTEN;NR2F2;CDKN1C;INCA1;CDKN1B;CEBPA;HEXIM1;PLK1;APC;HHEX;CDKN1A
prerank,membrane depolarization (GO:0051899),0.22881029250547133,0.6245928756611635,0.9309791332263242,0.9784869230615025,1.0,1/32,0.51%,P2RX7
prerank,positive regulation of cell cycle phase transition (GO:1901989),0.26241418801539623,0.6239971211971285,0.9221238938053097,0.978501206141915,1.0,5/15,22.30%,CDC73;CUL3;KLHL18;PLCG2;NPM1
prerank,renal absorption (GO:0070293),-0.2638725384195083,-0.6239398730441627,0.9189765458422174,0.996642170889595,1.0,1/10,2.97%,SGK1
prerank,postreplication repair (GO:0006301),0.21420745618599316,0.6238559309819707,0.9707602339181286,0.9781922925747031,1.0,17/45,24.00%,RPS27A;RPA1;POLH;RPA3;UBE2N;WDR33;TRIM25;RFC3;NSMCE1;UBE2A;ZBTB1;POLD2;PCNA;REV1;UBE2V2;UBE2L6;UBC
prerank,NIK/NF-kappaB signaling (GO:0038061),-0.16534041110507605,-0.6237749761704051,1.0,0.9959234103690119,1.0,24/72,31.26%,BIRC2;SKP1;PSMD13;PSMD12;COPS8;PSMD9;PSME3;PSMA4;PSMD8;PSMF1;PSMD4;PSMB8;PSME1;TLR3;MAP3K14;PSMC2;PSMB10;TRAF2;PSMD3;AKT1;PSMC5;BTRC;MALT1;PSME2
prerank,negative regulation of biosynthetic process (GO:0009890),0.2576068242655522,0.622318521804025,0.9030520646319569,0.9788541384669615,1.0,5/16,21.48%,EMILIN1;ABCB7;TRAP1;IL6;CIITA
prerank,"mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",0.2836998329772193,0.6218367122328186,0.9256505576208178,0.9788033057474171,1.0,4/11,18.20%,CYCS;UQCRFS1;UQCC3;UQCRC2
prerank,regulation of chromosome segregation (GO:0051983),0.25866325931629186,0.6217345260336242,0.9105263157894737,0.9784811305655222,1.0,5/16,19.57%,PUM2;HORMAD1;CSNK2A2;CSNK2A1;SMC6
prerank,rRNA pseudouridine synthesis (GO:0031118),0.29193176347745564,0.6209738102693126,0.8986866791744841,0.9785918180172543,1.0,2/10,16.18%,RPUSD3;NOP10
prerank,positive regulation of coagulation (GO:0050820),0.28995319160702826,0.6208494924719565,0.8937381404174574,0.9778548072019068,1.0,3/10,18.04%,ENPP4;ST3GAL4;F2R
prerank,positive regulation of hemostasis (GO:1900048),0.28995319160702826,0.6208494924719565,0.8937381404174574,0.9778548072019068,1.0,3/10,18.04%,ENPP4;ST3GAL4;F2R
prerank,lysine metabolic process (GO:0006553),0.2736346516007533,0.6198056854334043,0.9021526418786693,0.9777596343232776,1.0,12/12,72.66%,HYKK;PHYKPL;OGDH;AADAT;DLST;CRYM;DLD;AASS;PIPOX;SLC25A21;ALDH7A1;GCDH
prerank,lysine catabolic process (GO:0006554),0.2736346516007533,0.6198056854334043,0.9021526418786693,0.9777596343232776,1.0,12/12,72.66%,HYKK;PHYKPL;OGDH;AADAT;DLST;CRYM;DLD;AASS;PIPOX;SLC25A21;ALDH7A1;GCDH
prerank,positive regulation of protein localization to cell surface (GO:2000010),-0.24647224182622463,-0.6197239944301495,0.9453781512605042,0.9973794725389519,1.0,5/13,24.66%,STX3;TMEM35A;ABCA7;GPD1L;TM9SF4
prerank,negative regulation of mitochondrion organization (GO:0010823),-0.1896811652934849,-0.6187974188460104,0.9666666666666667,0.9970864194488586,1.0,7/33,17.44%,FLCN;MAPT;IAPP;FXN;MUL1;TMEM14A;HUWE1
prerank,mitotic nuclear membrane disassembly (GO:0007077),0.2705290947442338,0.6173792330989534,0.905123339658444,0.9789945719194875,1.0,2/12,8.51%,PRKCB;VRK1
prerank,polyamine metabolic process (GO:0006595),-0.2524231034736314,-0.6169110434626203,0.9279475982532751,0.9972921962695058,1.0,6/13,29.54%,SAT1;SMOX;SMS;HDAC6;ODC1;SRM
prerank,negative regulation of phosphatase activity (GO:0010923),0.23043933254419224,0.6167165451480024,0.9418604651162791,0.9790117227740647,1.0,2/25,4.76%,PPP1R26;GSK3B
prerank,organic cation transport (GO:0015695),-0.21649802819846514,-0.6164744314163136,0.9527027027027027,0.9967236960352742,1.0,2/20,10.20%,SLC44A2;SLC25A26
prerank,regulation of feeding behavior (GO:0060259),0.2792885226307775,0.6162358193620533,0.8964879852125693,0.9789075495802323,1.0,3/11,21.73%,STAT3;EIF2AK4;AGRP
prerank,primary alcohol metabolic process (GO:0034308),0.22846696407724368,0.6160780928952273,0.9354275741710296,0.9785977726471481,1.0,3/25,14.36%,DHRS3;IGF1;RBP4
prerank,dolichol-linked oligosaccharide biosynthetic process (GO:0006488),-0.22879813672164045,-0.6157697484715592,0.9324618736383442,0.9962958073681135,1.0,12/17,39.62%,ALG1;ALG12;ALG3;ALG8;DOLK;SRD5A3;MVD;ALG6;DPAGT1;MPDU1;ALG14;ALG13
prerank,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),-0.21566340748788992,-0.6155810292232724,0.9661016949152542,0.9955894709951312,1.0,6/21,20.66%,BCL2L11;DDIT3;CREB3;PARK7;SYVN1;SELENOS
prerank,interleukin-2-mediated signaling pathway (GO:0038110),-0.26691655589316315,-0.6153006649514885,0.9276315789473685,0.9941378627985997,1.0,3/11,14.92%,PTK2B;JAK3;IL2RG
prerank,cellular response to interleukin-2 (GO:0071352),-0.26691655589316315,-0.6153006649514885,0.9276315789473685,0.9941378627985997,1.0,3/11,14.92%,PTK2B;JAK3;IL2RG
prerank,inositol phosphate biosynthetic process (GO:0032958),0.276851537268622,0.6151609910052478,0.9145631067961165,0.9787802702389158,1.0,1/11,4.31%,IP6K3
prerank,cytoplasmic sequestering of transcription factor (GO:0042994),-0.23811816105815342,-0.614142497077913,0.9393258426966292,0.993912980500834,1.0,5/14,32.50%,CCDC22;MDFI;SUFU;PKD1;NFKBIE
prerank,positive regulation of calcium ion-dependent exocytosis (GO:0045956),-0.2446624049867231,-0.614084916579316,0.9323144104803494,0.9931341374055875,1.0,6/13,33.95%,SCAMP5;SYT1;CACNA1H;HYAL3;STX1A;CACNA1G
prerank,peptide hormone secretion (GO:0030072),-0.20443979504300921,-0.6139716186571063,0.9588688946015425,0.9924031309549552,1.0,3/26,9.80%,RIMS2;PTPRN;ADCYAP1
prerank,regulation of dopamine secretion (GO:0014059),0.23176244318152073,0.6126621640620796,0.9297658862876255,0.9799902094137053,1.0,10/25,25.62%,PRKN;CHRNA4;CHRNB2;SYT3;GDNF;SNCA;SYT11;SYT12;SYT10;DRD3
prerank,GPI anchor biosynthetic process (GO:0006506),0.2234411799275542,0.6117129178235435,0.9579288025889967,0.9801571700516378,1.0,5/30,16.55%,PGAP1;PIGU;PGAP4;PIGQ;PIGX
prerank,plasma membrane repair (GO:0001778),0.26716039912880546,0.6098401244191405,0.8936170212765957,0.9809530344775723,1.0,1/13,3.80%,MYOF
prerank,negative regulation of double-strand break repair (GO:2000780),0.22242226635217294,0.609179438660571,0.9425837320574163,0.9809670759064865,1.0,7/30,20.83%,RNF169;UBQLN4;FBH1;CYREN;SHLD3;SHLD2;TRIP12
prerank,nuclear membrane disassembly (GO:0051081),-0.23832160527813273,-0.6088666407300226,0.9487179487179487,0.994253585252013,1.0,7/14,33.20%,AKAP8L;NEK6;CTDNEP1;DCTN1;CDK1;CCNB2;LPIN1
prerank,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),-0.1969167764891961,-0.6088089294294751,0.9505208333333334,0.9934785030889862,1.0,7/28,21.74%,SIRT7;ERCC6;HSF1;PARP3;PARP9;WRAP53;TFIP11
prerank,mitotic cytokinetic process (GO:1902410),0.2383763918949501,0.6084297119390476,0.9430604982206405,0.9810093284315742,1.0,3/20,10.87%,RHOA;VPS4B;CHMP5
prerank,regulation of IRE1-mediated unfolded protein response (GO:1903894),-0.2413666048079422,-0.6082406999934253,0.9470198675496688,0.9929498472451016,1.0,5/14,34.22%,BCL2L11;TMEM33;FICD;DDRGK1;PTPN1
prerank,positive regulation of protein targeting to mitochondrion (GO:1903955),0.22243025203540043,0.6081845336471138,0.9535655058043118,0.9807636139201669,1.0,3/30,11.27%,FBXW7;UBE2D3;SREBF2
prerank,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.23280497950463253,0.6081711060008459,0.9301533219761499,0.9803618895178806,1.0,2/21,7.60%,MITF;MED16
prerank,dicarboxylic acid catabolic process (GO:0043649),-0.24182847042853473,-0.6073375519359642,0.9414316702819957,0.9926341667589778,1.0,5/13,34.72%,GAD1;ACOT8;GOT1;ACSF3;ACOT4
prerank,rRNA catabolic process (GO:0016075),-0.22682668479085957,-0.606826329401464,0.9577464788732394,0.9920984820993235,1.0,2/16,9.98%,EXOSC9;DIS3
prerank,outer dynein arm assembly (GO:0036158),-0.23626656995797327,-0.6051677646099697,0.9393258426966292,0.9921291189841338,1.0,4/14,21.79%,DNAH8;DNAH5;ODAD1;ODAD2
prerank,tRNA 5'-leader removal (GO:0001682),-0.24422038447771482,-0.6028216141864196,0.9509594882729211,0.9924404262230115,1.0,5/13,24.68%,RPP14;POP1;RPP21;PRORP;POP7
prerank,anaphase-promoting complex-dependent catabolic process (GO:0031145),0.18649804370130335,0.6027235229129175,0.9902234636871509,0.9832468053351956,1.0,12/84,14.87%,PSMA7;RPS27A;RB1;CDC27;PSMB2;CUL3;ANAPC16;PSMA6;PSMA3;PSMD1;PSMD5;ANAPC1
prerank,cilium movement (GO:0003341),0.20869703658226818,0.6022795862648248,0.9677914110429447,0.9831024345423359,1.0,11/47,20.46%,TTC29;TEKT5;CFAP206;CFAP91;ODAD3;SPEF1;CFAP53;DNAH11;DNAAF5;SPAG17;ADCY10
prerank,regulation of viral release from host cell (GO:1902186),-0.2120563048129776,-0.6022494308591004,0.9705882352941176,0.9918834102637045,1.0,6/21,22.56%,TRIM28;TRIM13;TRIM11;TRIM21;CHMP3;TRIM8
prerank,negative regulation of Rho protein signal transduction (GO:0035024),0.2458157390729837,0.6005959320766697,0.9443478260869566,0.9836998362304296,1.0,4/18,17.80%,RIPOR2;CUL3;STMN1;ARHGAP35
prerank,T cell homeostasis (GO:0043029),-0.2607280485716195,-0.6004455682683575,0.9285714285714286,0.99195398128478,1.0,7/10,42.17%,NCKAP1L;JAK3;PMAIP1;AKT1;FOXP3;FADD;RIPK3
prerank,anion transmembrane transport (GO:0098656),0.19347388758437403,0.5989468753545628,0.9856938483547926,0.9842198799190959,1.0,11/67,18.52%,SLC16A7;LRRC8D;ABCC1;SLC25A5;SLC6A5;SLC23A1;SLC23A2;SLC25A30;SLC5A6;LRRC8C;SLC25A4
prerank,tRNA modification (GO:0006400),0.19582279946221556,0.5987507026737939,0.9732394366197183,0.9839158211507724,1.0,11/62,14.20%,DTWD2;URM1;TYW1;LCMT2;TRMO;NSUN2;ELP5;TRMT61B;CTU1;CDKAL1;TRIT1
prerank,protein localization to phagophore assembly site (GO:0034497),-0.2559925576134483,-0.5981842622360146,0.949671772428884,0.9922376693692532,1.0,5/11,30.82%,WDR45;ATG9A;WDR45B;PACS2;ATG9B
prerank,pseudouridine synthesis (GO:0001522),-0.23595059479186628,-0.5975233609378815,0.9497816593886463,0.9917155377568223,1.0,7/13,40.05%,GAR1;PUS1;PUS7L;PUS3;TRUB2;NHP2;DKC1
prerank,DNA modification (GO:0006304),-0.208723159701854,-0.5963785421185869,0.9631336405529954,0.9914575160487061,1.0,4/22,13.51%,PARP1;TERF2;PARP3;NEIL3
prerank,positive regulation of fatty acid oxidation (GO:0046321),0.2672484709455855,0.5955031241109952,0.8920454545454546,0.985376541457639,1.0,1/12,4.79%,IRS2
prerank,mitotic G1/S transition checkpoint signaling (GO:0044819),0.2604728349000946,0.5941771133530321,0.9281767955801105,0.9856944015538375,1.0,1/12,3.41%,WAC
prerank,negative regulation of smooth muscle cell migration (GO:0014912),0.2580032080946267,0.5940204447748267,0.9123434704830053,0.985373602502795,1.0,1/14,2.01%,MEF2C
prerank,cellular respiration (GO:0045333),-0.1775374784455128,-0.5925402840287141,0.9760479041916168,0.9923074574789512,1.0,17/41,35.37%,SDHAF4;SDHB;NDUFS7;SLC25A14;UQCRC1;UQCRB;COX15;MTLN;UQCR10;NDUFS1;SLC25A13;MTFR1;PPARGC1A;MTFR2;ATP5F1D;ETFRF1;OXA1L
prerank,negative regulation of nuclear division (GO:0051784),0.26309805843888134,0.5903129140395479,0.9084249084249084,0.987032564137784,1.0,1/11,6.61%,CHEK1
prerank,nucleotide biosynthetic process (GO:0009165),0.24457802605452678,0.5901819896135441,0.9462738301559792,0.9866981031636703,1.0,6/18,20.88%,NMNAT3;NMNAT2;PRPS1L1;PRPS1;ME1;HPRT1
prerank,regulation of fatty acid beta-oxidation (GO:0031998),-0.22297367308805516,-0.5900236145992479,0.9621848739495799,0.9926197096652796,1.0,7/14,36.76%,ABCD2;TYSND1;MTLN;IRS1;AKT1;PPARA;TWIST1
prerank,mitotic chromosome condensation (GO:0007076),0.2211943940271902,0.5874520377950497,0.9503424657534246,0.987696150079262,1.0,2/26,4.87%,PHF8;RB1
prerank,mitotic DNA integrity checkpoint signaling (GO:0044774),-0.23674669130963888,-0.5870775474505004,0.95,0.9930433136908817,1.0,5/12,33.35%,HUS1;CHEK2;TICRR;ORC1;RAD17
prerank,positive regulation of T cell mediated cytotoxicity (GO:0001916),-0.24036666065649737,-0.5863923245353129,0.9563318777292577,0.9925084789551015,1.0,2/13,16.56%,NECTIN2;MR1
prerank,quinone biosynthetic process (GO:1901663),0.25234426501026985,0.5850788434030967,0.9267399267399268,0.9885134358116381,1.0,6/14,23.50%,PDSS1;UBIAD1;COQ9;COQ5;COQ8A;COQ3
prerank,mitotic sister chromatid segregation (GO:0000070),0.17581684617708007,0.5850238893085105,1.0,0.9881253535928337,1.0,24/98,21.82%,PHF8;PIBF1;RB1;REC8;VPS4B;PDS5B;CUL3;NUP62;CHMP5;DIS3L2;RAB11A;PINX1;CENPK;RRS1;KIF23;SMC4;KPNB1;CSNK2A2;CSNK2A1;SET;PDCD6IP;NIPBL;MIS12;CEP55
prerank,poly(A)+ mRNA export from nucleus (GO:0016973),0.2421972930776939,0.5847502122151153,0.9387040280210157,0.987851960290999,1.0,4/18,15.05%,IWS1;NUP133;PCID2;ENY2
prerank,DNA packaging (GO:0006323),0.2439921760487508,0.5843728215535663,0.9425493716337523,0.9876321724957227,1.0,5/16,21.94%,HAT1;BANF1;KAT6A;AIFM1;CHAF1B
prerank,regulation of glucose metabolic process (GO:0010906),0.20759386258129134,0.5833507409822597,0.9611197511664075,0.9877220351547997,1.0,5/34,12.35%,PRKN;IRS2;GNMT;FOXK2;FOXK1
prerank,positive regulation of DNA-dependent DNA replication (GO:2000105),-0.2520064438402039,-0.5821812723529338,0.9531568228105907,0.9933704120568836,1.0,2/10,9.59%,SSBP1;CDC7
prerank,meiosis I (GO:0007127),0.22495900879757835,0.5817245041585083,0.9559322033898305,0.9881416081727854,1.0,2/23,9.21%,MOV10L1;FOXJ3
prerank,regulation of generation of precursor metabolites and energy (GO:0043467),0.19352443070759529,0.5808695621027689,0.9768875192604006,0.9881578808217778,1.0,11/48,21.55%,PRKAG2;PGAM1;NUP133;NUP62;NUP98;EP300;NUP153;ZBTB7A;SLC2A6;NUP35;RAE1
prerank,ubiquinone biosynthetic process (GO:0006744),0.24400014813434212,0.5808491940812135,0.9273049645390071,0.9877535906605913,1.0,6/15,23.50%,PDSS1;UBIAD1;COQ9;COQ5;COQ8A;COQ3
prerank,positive regulation by host of viral transcription (GO:0043923),-0.2216236108553301,-0.5797859285942437,0.9497716894977168,0.9935042609385679,1.0,7/15,32.64%,SMARCB1;JUN;LEF1;CCNT1;HPN;TFAP4;SMARCA4
prerank,fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),-0.25056818702947803,-0.5785053257828809,0.941304347826087,0.9932187322781906,1.0,5/10,27.36%,ACADL;ACADM;IVD;ACADVL;GCDH
prerank,nucleotide-sugar metabolic process (GO:0009225),0.2519477287687026,0.576511402423171,0.9478764478764479,0.9894950139072427,1.0,3/12,14.21%,GMDS;GFPT2;EXTL2
prerank,glutamate metabolic process (GO:0006536),-0.20951466645459949,-0.5753397810662068,0.9792147806004619,0.99363382369948,1.0,6/19,28.45%,ALDH18A1;ALDH5A1;PRODH;GAD1;GCLC;GOT1
prerank,establishment of mitotic spindle orientation (GO:0000132),0.22295511893437797,0.5741127506203677,0.9605488850771869,0.9901882644287466,1.0,5/23,19.46%,ITGB1;GJA1;PAFAH1B1;UBXN2B;NDEL1
prerank,response to peptide (GO:1901652),0.20972692092228704,0.5737176201809988,0.9594813614262561,0.9899747997193441,1.0,7/33,13.90%,STAT4;FYN;STAT6;EIF2B1;NOD2;KAT7;STAT3
prerank,ethanol metabolic process (GO:0006067),0.2559994561868262,0.5732741254269427,0.9398058252427185,0.9897703785311086,1.0,1/12,6.32%,SULT1A1
prerank,regulation of cell-cell adhesion mediated by integrin (GO:0033632),0.2645109048421619,0.5716330083127479,0.9291044776119403,0.9900921671210043,1.0,3/10,17.02%,WNK1;CCL5;PODXL
prerank,UV-damage excision repair (GO:0070914),0.24621016925825315,0.5713747402246943,0.9461400359066428,0.9898019271787883,1.0,2/12,13.59%,XPA;XPC
prerank,axonal transport of mitochondrion (GO:0019896),-0.2375917572943898,-0.5712772531751892,0.9479166666666666,0.9943047056573701,1.0,3/11,22.86%,MAPT;HAP1;HIF1A
prerank,regulation of catecholamine secretion (GO:0050433),0.213730073996917,0.570928510208385,0.9614093959731543,0.9895947309551301,1.0,11/29,25.62%,PRKN;CHRNA4;CHGA;KCNB1;CHRNB2;SYT3;SNCA;SYT11;SYT12;SYT10;DRD3
prerank,mitotic nuclear membrane organization (GO:0101024),0.18505665984197384,0.5708959491594433,0.9845679012345679,0.9887946038232888,1.0,11/51,19.23%,REEP3;NUP133;VRK1;PPP2CA;LBR;NUP98;BANF1;PPP2R2A;LMNA;SUMO1;KPNB1
prerank,mitotic nuclear membrane reassembly (GO:0007084),0.18505665984197384,0.5708959491594433,0.9845679012345679,0.9887946038232888,1.0,11/51,19.23%,REEP3;NUP133;VRK1;PPP2CA;LBR;NUP98;BANF1;PPP2R2A;LMNA;SUMO1;KPNB1
prerank,RNA-dependent DNA biosynthetic process (GO:0006278),0.2087939596077475,0.5701571851927744,0.9638932496075353,0.9887313698075644,1.0,10/29,20.86%,RPA1;TERF2IP;TERF1;PPIA;PINX1;HSP90AB1;NOP10;MRE11;RTEL1;TINF2
prerank,regulation of activated T cell proliferation (GO:0046006),0.2093957932760626,0.5699745624466719,0.982200647249191,0.9884100176954328,1.0,3/30,9.90%,RPS3;RC3H1;IGF1
prerank,regulation of nucleocytoplasmic transport (GO:0046822),0.2514245863307685,0.5693233266904644,0.924953095684803,0.9882860134081773,1.0,3/12,15.59%,RBM4;UHMK1;PTPN14
prerank,"base-excision repair, AP site formation (GO:0006285)",0.23248174870539834,0.5685691139798001,0.946236559139785,0.9881775710517593,1.0,5/17,20.86%,TERF2IP;MUTYH;TERF1;MPG;TINF2
prerank,tRNA transport (GO:0051031),-0.17324325135922927,-0.5675008051018947,0.9975124378109452,0.9947971169705154,1.0,19/35,40.35%,NUP210;RANBP2;NUP85;SEH1L;TOMM20;AAAS;SEC13;NDC1;NUP93;NUP50;NUP54;NUP214;NUP88;SSB;RAN;TOMM20L;NUP205;NUP107;YBX1
prerank,interstrand cross-link repair (GO:0036297),0.18874265370604223,0.5667001405176464,0.9864864864864865,0.9885747656134211,1.0,11/53,18.67%,RPS27A;DCLRE1C;MCM9;RPA1;XPA;RPA3;MCM8;FANCL;ATR;FANCI;ERCC6L2
prerank,ncRNA export from nucleus (GO:0097064),-0.1740101343671127,-0.5665339295056784,0.9950372208436724,0.9943201388071933,1.0,17/36,37.39%,NUP210;RANBP2;TSC1;NUP85;SEH1L;AAAS;SEC13;NDC1;NUP93;NUP50;NUP54;NUP214;NUP88;SSB;RAN;NCBP2;NUP205
prerank,positive regulation of cell killing (GO:0031343),0.25026306126625597,0.5653150380663615,0.9466437177280551,0.9887544917154413,1.0,2/13,14.48%,SYK;CYBA
prerank,protein prenylation (GO:0018342),-0.24124581809042936,-0.5651464290649617,0.9646569646569647,0.9939774620561413,1.0,5/10,35.65%,RABGGTB;FNTA;PTAR1;RABGGTA;FNTB
prerank,alpha-linolenic acid metabolic process (GO:0036109),0.24798017887326,0.5647964452444865,0.9464285714285714,0.9885687869366745,1.0,1/12,7.30%,ELOVL5
prerank,atrioventricular valve development (GO:0003171),0.23825338347320896,0.5636831823224137,0.9553398058252427,0.9886301846091952,1.0,3/14,15.12%,BMP2;SLIT3;BMPR1A
prerank,termination of RNA polymerase II transcription (GO:0006369),0.19973586950635278,0.5607685415207612,0.9787928221859706,0.9894320765112986,1.0,11/33,23.23%,CPSF3;SNRPG;SCAF8;MED18;PAPOLA;WDR33;CPSF2;CSTF2T;SNRPE;LSM11;CSTF3
prerank,negative regulation of cellular senescence (GO:2000773),-0.22513597702932725,-0.5591833367870004,0.9509345794392523,0.9950574874843102,1.0,10/13,41.95%,ZKSCAN3;AKT3;TERF2;FBXO5;RBL1;SIRT1;HMGA2;TWIST1;YBX1;SLC30A10
prerank,positive regulation of protein autophosphorylation (GO:0031954),0.21859204171102306,0.558703173815896,0.9582637729549248,0.989833667785416,1.0,3/22,10.64%,RASSF2;PDGFC;CALM1
prerank,erythrocyte development (GO:0048821),0.2605858298850459,0.5585054345457845,0.9594594594594594,0.9894971949521834,1.0,3/10,17.18%,SH2B3;ABCB10;ZBTB7A
prerank,regulation of extracellular matrix disassembly (GO:0010715),0.23543917095822095,0.557514925830697,0.9592198581560284,0.9894766630391786,1.0,5/15,17.66%,DDR2;CLASP1;MELTF;FAP;IL6
prerank,positive regulation of T-helper 1 type immune response (GO:0002827),0.2500859941093212,0.5570402065359512,0.9566003616636528,0.9892686752153658,1.0,1/12,7.58%,CCR2
prerank,nucleoside salvage (GO:0043174),-0.24048493819599365,-0.5560085950641167,0.9694323144104804,0.9952003754674716,1.0,5/10,40.00%,UPP2;UCKL1;TK2;CDA;TK1
prerank,response to ketone (GO:1901654),0.21486076208978772,0.5552625147326496,0.9667774086378738,0.989567618661795,1.0,3/24,11.10%,CCL19;CATSPER3;SLIT3
prerank,negative regulation of histone acetylation (GO:0035067),-0.23475625692575275,-0.5549291710303318,0.9711340206185567,0.9947119691741114,1.0,7/11,35.79%,BRCA1;CTBP1;SIN3A;THAP7;TAF7;SIRT1;NOC2L
prerank,nuclear membrane reassembly (GO:0031468),0.18104130009780778,0.5545504737182918,0.9922480620155039,0.9894292392313706,1.0,12/54,19.33%,REEP3;NUP133;VRK1;PPP2CA;LBR;NUP98;BANF1;PPP2R2A;LMNA;SUMO1;KPNB1;UBXN2B
prerank,regulation of alcohol biosynthetic process (GO:1902930),-0.23326483602306558,-0.5531386642567304,0.9681818181818181,0.9944674557402003,1.0,6/12,38.47%,LPCAT3;CLCN2;ABCA2;DGKQ;RAN;MBTPS1
prerank,zinc ion transmembrane transport (GO:0071577),-0.19285230086690938,-0.5529549367009333,0.9847328244274809,0.9937353765795294,1.0,7/22,31.65%,SLC39A11;SLC39A13;SLC39A14;SLC39A6;SLC39A1;SLC30A3;SLC39A7
prerank,purine nucleotide biosynthetic process (GO:0006164),-0.2235981380706183,-0.5527452196427731,0.970917225950783,0.9930149486030094,1.0,4/12,28.41%,PRPSAP1;GART;PRPSAP2;AMPD2
prerank,serine family amino acid metabolic process (GO:0009069),0.2351086996839163,0.5519405692743233,0.9649446494464945,0.9899920328683933,1.0,3/16,13.56%,DAO;SEPSECS;SHMT1
prerank,positive regulation of acute inflammatory response (GO:0002675),0.23293640921875558,0.5505855277343235,0.9524680073126143,0.9901057831554729,1.0,2/14,17.66%,TNF;IL6
prerank,aspartate family amino acid metabolic process (GO:0009066),-0.20226038409461772,-0.5493252735618583,0.9779735682819384,0.9932148039938188,1.0,7/18,34.93%,NAALAD2;SMS;SLC25A13;GOT1;FOLH1;GADL1;NIT2
prerank,regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),0.23720520560617248,0.549233117846663,0.9569120287253142,0.9901825495099684,1.0,2/13,10.73%,DUSP1;PCID2
prerank,gastrulation (GO:0007369),0.23337103141082083,0.5474471265899085,0.9618181818181818,0.9904199255823938,1.0,4/15,17.03%,LMBRD1;NPHP3;GPC3;LHX1
prerank,glutamine family amino acid metabolic process (GO:0009064),-0.17149979412140992,-0.5472912958596825,0.9974619289340102,0.9929722457091305,1.0,9/33,28.45%,ALDH18A1;ALDH5A1;SIRT4;ALDH4A1;PRODH;DDAH1;CAD;GCLC;GOT1
prerank,negative regulation of histone modification (GO:0031057),0.23418105656847754,0.5463578539503156,0.9501845018450185,0.9903951339795142,1.0,1/14,4.03%,JARID2
prerank,hydrogen peroxide catabolic process (GO:0042744),0.2489072079954874,0.5458686596260112,0.9353049907578558,0.9901453418857149,1.0,3/11,17.04%,PXDN;PRDX3;PRDX2
prerank,regulation of double-strand break repair via homologous recombination (GO:0010569),0.18734242810135468,0.5454261666906103,0.9805194805194806,0.9898786541889035,1.0,12/42,20.29%,CHEK1;UBQLN4;SPIDR;PPP4R2;TERF2IP;MMS19;FBH1;KDM1A;ACTR2;SHLD3;RTEL1;SHLD2
prerank,protein homotetramerization (GO:0051289),0.18065314387161685,0.5440925653464803,0.9845916795069337,0.9899448378213935,1.0,8/49,15.22%,B2M;USP16;GNMT;TRPM2;SHMT1;PKD2L1;PKD2;SAMHD1
prerank,methylguanosine-cap decapping (GO:0110156),0.24817208796326115,0.5439436186038751,0.9553398058252427,0.9895908300251582,1.0,2/10,11.37%,DCP1A;DCP2
prerank,negative regulation of ATPase activity (GO:0032780),0.2240174207956716,0.543447774277846,0.9677966101694915,0.98937637006613,1.0,2/16,8.81%,VCPKMT;PLN
prerank,epithelial structure maintenance (GO:0010669),0.24690689175777908,0.5404753930418733,0.9461966604823747,0.9899780358948808,1.0,2/11,14.36%,NOD2;RBP4
prerank,positive regulation of lipid localization (GO:1905954),0.23379639670076371,0.5382696746703288,0.9644194756554307,0.9902506008016606,1.0,2/11,12.28%,VSTM2A;ZC3H12A
prerank,regulation of centrosome cycle (GO:0046605),-0.18908190926229498,-0.5356812690162027,0.9861111111111112,0.9951223540774058,1.0,11/21,38.46%,FBXW5;CHMP4B;CHMP3;CHMP4C;CHMP1B;AURKA;SIRT1;CHMP2A;GEN1;CEP131;PKHD1
prerank,fatty acid beta-oxidation (GO:0006635),0.1797446246174598,0.5347364797680987,0.9954954954954955,0.9909065298163007,1.0,12/51,20.36%,SLC25A17;EHHADH;ETFDH;ETFA;HADH;HADHA;HADHB;ACAT1;ETFB;ECHDC1;ACOX1;MCAT
prerank,nucleoside diphosphate metabolic process (GO:0009132),0.22201919352971206,0.5332959403995406,0.9523809523809523,0.9909332211629001,1.0,4/15,19.35%,CMPK1;AK8;ENTPD1;AK4
prerank,basement membrane organization (GO:0071711),0.22596439811078906,0.5259364738304477,0.9699646643109541,0.9926424496578793,1.0,4/14,14.04%,PXDN;NID2;RAMP2;NTN4
prerank,nucleobase-containing compound catabolic process (GO:0034655),0.18489436137828943,0.5250189965873129,0.9921259842519685,0.9924888667031401,1.0,4/37,9.57%,SND1;DNASE1L1;RNASE6;MTREX
prerank,nucleoside phosphate catabolic process (GO:1901292),0.22775951844946826,0.5232329554733488,0.96875,0.9925764519807171,1.0,1/13,3.78%,SMPDL3A
prerank,hydrogen peroxide metabolic process (GO:0042743),0.20935414409959438,0.5207602089827691,0.9726962457337884,0.9928289609506128,1.0,5/19,19.21%,PXDN;CYBA;PRDX3;PRDX2;ACOX1
prerank,regulation of fibrinolysis (GO:0051917),-0.21145712413357942,-0.520356805095178,0.9779735682819384,0.9976986173789807,1.0,9/13,47.51%,SERPINE1;APOH;SERPINF2;F11;KLKB1;PLG;F12;THBS1;HRG
prerank,negative regulation of cholesterol transport (GO:0032375),-0.22377820513497637,-0.5197243704845761,0.9772727272727273,0.9970371299464117,1.0,2/10,20.27%,APOC1;ABCA2
prerank,cilium-dependent cell motility (GO:0060285),0.20647177445230813,0.5194743817463496,0.9757785467128027,0.9927518450565175,1.0,2/22,8.69%,EFHC1;TEKT5
prerank,response to steroid hormone (GO:0048545),0.1913469848128162,0.5187854825915696,0.9872408293460925,0.9925195261662121,1.0,6/31,16.37%,NR3C1;CATSPER3;ATP1A3;ATP1A1;CATSPER2;TFPI
prerank,regulation of muscle contraction (GO:0006937),0.1945272393038161,0.5146461921753168,0.9858044164037855,0.9931562691435317,1.0,1/26,3.13%,TNNT1
prerank,intracellular protein transmembrane transport (GO:0065002),0.17518138490246252,0.5140345157849836,0.9938650306748467,0.9929000065335639,1.0,14/42,25.70%,PEX7;PEX26;ZFAND2B;SEC63;ROMO1;PEX14;DNAJC15;AIFM1;PEX12;GRPEL2;SEC62;DNAJC19;TOMM70;HSPA5
prerank,positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),0.2206248222706138,0.5139965810271374,0.9771528998242531,0.992504121862365,1.0,4/16,20.29%,KDM4D;KMT5B;SHLD3;SHLD2
prerank,motor neuron axon guidance (GO:0008045),0.21783464218321075,0.513858887680961,0.9584086799276673,0.9921364262629704,1.0,3/15,17.03%,SLIT1;NTN1;LHX1
prerank,DNA synthesis involved in DNA repair (GO:0000731),0.17291879713302538,0.504429589787578,0.9940298507462687,0.993878708321048,1.0,12/42,24.00%,RPS27A;RPA1;POLH;RPA3;TRIM25;RFC3;ZBTB1;POLD2;PCNA;REV1;UBE2L6;UBC
prerank,negative regulation of receptor signaling pathway via STAT (GO:1904893),-0.2144587924613986,-0.5044263296195619,0.9831223628691983,0.9989269279809659,1.0,5/11,34.86%,PTPRT;VHL;ADIPOR1;SOCS3;SOCS1
prerank,tRNA export from nucleus (GO:0006409),0.18144780035856123,0.5040638543781008,0.9865546218487395,0.9931596231897444,1.0,4/32,12.62%,NOL6;NUP133;NUP62;NUP98
prerank,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),0.18144780035856123,0.5040638543781008,0.9865546218487395,0.9931596231897444,1.0,4/32,12.62%,NOL6;NUP133;NUP62;NUP98
prerank,epithelial cilium movement involved in extracellular fluid movement (GO:0003351),-0.18409538187878308,-0.5006030376730295,0.9886621315192744,0.9987330049123782,1.0,9/18,38.98%,CCDC39;SPEF2;CCDC40;CABYR;NEK10;DNAAF2;SPA17;AQP4;DNAAF1
prerank,sulfur amino acid metabolic process (GO:0000096),0.19390238868858717,0.49817524199053753,0.9899497487437185,0.9939890569265752,1.0,4/24,16.62%,MTR;MSRA;NOX4;MPST
prerank,positive regulation of fatty acid metabolic process (GO:0045923),0.21095636224976066,0.49648998851863807,0.9656946826758147,0.9938909250791094,1.0,2/15,13.67%,ELOVL5;NR1H2
prerank,regulation of acute inflammatory response (GO:0002673),0.20579914338924762,0.4952990085041786,0.9758812615955473,0.9937103418160866,1.0,1/18,6.84%,PLA2G2D
prerank,very long-chain fatty acid metabolic process (GO:0000038),0.1810313804797956,0.49419869526311677,0.989983305509182,0.9935081949076444,1.0,4/30,13.87%,HACD4;ELOVL5;TECRL;SLC27A6
prerank,entrainment of circadian clock by photoperiod (GO:0043153),0.18335074444464378,0.49320034620261183,0.99185667752443,0.9932997012904218,1.0,3/27,11.02%,FBXL17;RBM4;PPP1CA
prerank,protein palmitoylation (GO:0018345),0.18096875389902461,0.4866569697440937,0.9952153110047847,0.9940618899518743,1.0,5/30,15.73%,ZDHHC14;ZDHHC3;ZDHHC24;ZDHHC20;ZDHHC2
prerank,cochlea morphogenesis (GO:0090103),-0.20296587879140054,-0.48603884294448724,0.9911111111111112,0.9999546562865057,1.0,5/10,50.70%,MYO3B;HPN;POU3F4;TBX1;TBX18
prerank,amyloid-beta metabolic process (GO:0050435),0.20941427262447848,0.48464888657671,0.9880546075085325,0.9939990543788789,1.0,3/16,15.71%,PSEN1;DYRK1A;NCSTN
prerank,regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),0.19315820023239005,0.4809100560100257,0.9857397504456328,0.9941612536721469,1.0,5/20,17.43%,SULF2;PRKD2;DSTYK;CREB3L1;SPRY2
prerank,regulation of transposition (GO:0010528),0.21382331841381635,0.4793843112489752,0.9722222222222222,0.994002664971426,1.0,2/13,13.53%,SPOCD1;PIWIL2
prerank,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),0.20088450974464322,0.4781887767447551,0.9804270462633452,0.9937787994523897,1.0,3/15,16.82%,CCT6A;NOP10;CCT3
prerank,inorganic ion transmembrane transport (GO:0098660),-0.19847034744335573,-0.4723105264165388,0.9957081545064378,1.0,1.0,8/12,48.53%,ABCC9;ABCC8;CACNA1H;P2RX3;TRPM4;RHAG;KCNJ8;ATP1B4
prerank,male gonad development (GO:0008584),-0.14836713733971502,-0.468889318591962,0.9972222222222222,1.0,1.0,7/34,20.22%,AR;NCOA4;WNT4;MSH2;TGFB2;COL9A3;WNT5A
prerank,negative regulation of double-strand break repair via homologous recombination (GO:2000042),-0.17224979405607826,-0.4566277308389441,0.9884526558891455,1.0,1.0,8/16,37.51%,CGAS;PARPBP;RADX;RMI2;SMCHD1;POLQ;RIF1;MAD2L2
prerank,nonribosomal peptide biosynthetic process (GO:0019184),-0.17769386957787286,-0.44287452909139996,0.9928909952606635,1.0,1.0,1/12,7.76%,GSS
prerank,positive regulation of dendrite development (GO:1900006),-0.19435489121972643,-0.4384665921494213,0.9954648526077098,1.0,1.0,2/10,18.29%,ALK;ZDHHC15
prerank,negative regulation of phosphate metabolic process (GO:0045936),0.1686524459521615,0.43363357127925917,0.9965928449744463,0.9983138911723244,1.0,7/22,24.29%,ROCK1;CDKN2C;INPP5K;CDKN1C;DYNLL1;CDKN1B;STAP1
prerank,glutathione biosynthetic process (GO:0006750),-0.17769873598169061,-0.4329444807236906,0.9952718676122931,0.9997100710499596,1.0,1/11,7.76%,GSS
prerank,DNA biosynthetic process (GO:0071897),0.17956230630316355,0.43181220909563145,0.998158379373849,0.9980421574093469,1.0,4/16,19.50%,POLH;PPIA;RFC3;POLD2
prerank,protein peptidyl-prolyl isomerization (GO:0000413),0.16806124441454007,0.4276151615645985,0.9947552447552448,0.9979467196145505,1.0,5/20,21.37%,FKBP5;PPIA;NKTR;FKBP1A;CWC27
prerank,microtubule-based transport (GO:0099111),-0.17178511801946517,-0.4179814828171533,0.9979381443298969,0.999603854724469,1.0,6/12,37.74%,SPEF2;CCDC40;CABYR;DNAAF2;SPA17;DYNC1I1
prerank,negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),0.18130453889133052,0.41484771554058963,0.9962406015037594,0.9983356989082769,1.0,13/13,81.88%,NFATC3;RELA;PPARG;SOX9;NFIB;POU5F1;PDGFB;NFATC4;REST;PPARD;PPARA;BMP4;SRF
prerank,regulation of actin nucleation (GO:0051125),-0.16905210295040804,-0.4069795254560726,0.9957264957264957,0.9991627770106304,1.0,12/12,83.11%,CORO1A;CORO1B;ARFIP1;WASHC5;ARF1;SCIN;WHAMM;VIL1;GSN;PICK1;ARFIP2;ARPIN
prerank,fat-soluble vitamin metabolic process (GO:0006775),0.1520030361582194,0.38809680772981203,0.9983108108108109,0.9990667242453283,1.0,3/22,17.49%,VKORC1;UBIAD1;RBP1
